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Bolzano; 2007–2009, AstraZeneca (UK); 2002–2007, York Structural Biology Laboratory 
(YSBL); 2000–2002, International Centre for Genetic Engineering and Biotechnology (ICGEB)/Elettra 
Synchrotron Trieste, Italy; 1996–2000, European Molecular Biology Laboratory (EMBL), Hamburg, 
Germany; 1992–1996, Institute of Agricultural Chemistry, University of Bologna. 
Education: 2001, Ph.D. in Chemistry, EMBL Hamburg (DE)/University of York (UK); 1991, Master 
in Agricultural Science, University of Bologna (Italy).
ix

 International Journal of 
Molecular Sciences
Editorial
Carbohydrate-Active Enzymes: Structure, Activity,
and Reaction Products
Stefano Benini
Bioorganic Chemistry and Bio-Crystallography laboratory (B2Cl), Libera Università di Bolzano,
39100 Bolzano, Italy; Stefano.Benini@unibz.it
Received: 7 April 2020; Accepted: 11 April 2020; Published: 15 April 2020
Carbohydrate-active enzymes are responsible for both the biosynthesis and breakdown of
carbohydrates and glycoconjugates. They are involved in many metabolic pathways, in the biosynthesis
and degradation of various biomolecules, such as bacterial exopolysaccharides, starch, cellulose,
and lignin, and in the glycosylation of proteins and lipids. Their interesting reactions have attracted
the attention of researchers belonging to different scientific fields ranging from basic research to
biotechnology. Interest in carbohydrate-active enzymes is due not only to their ability to build and
degrade biopolymers, which is highly relevant in biotechnology, but also because they are involved
in bacterial biofilm formation, and in the glycosylation of proteins and lipids, which has important
health implications.
This Special Issue features a collection of research papers and reviews representing an up-to-date
state of the art in this growing field of research to broaden our understanding about carbohydrate-active
enzymes, their mutants, and their reaction products at the molecular level.
Tindara Venuto et al. wrote a paper about alpha2,8-sialyltransferases from ray-finned fish and
showed that, in tetrapods, duplicated st8sia genes like st8sia7, st8sia8, and st8sia9 have disappeared while
orthologues are maintained in teleosts [1]. They reconstructed the evolutionary history of st8sia genes
in fish genomes and by bioinformatics analysis showed changes in the conserved polysialyltransferase
domain of the fish sequences possibly accounting for variable enzymatic activities [1].
PhNah20A, a β-N-acetylhexosaminidase from the marine bacterium Paraglaciecola hydrolytica
S66T, was identified and characterized. By phylogenetic analysis, the authors discovered
that PhNah20A is located outside clusters of other studied β-N-acetylhexosaminidases, in a
unique position between bacterial and eukaryotic enzymes. PhNah20A is the first characterized
member of a distinct subgroup within GH20 β-N-acetylhexosaminidases. The recombinant
PhNah20A showed optimum hydrolytic activity on GlcNAc β-1,4 and β-1,3 linkages in
chitobiose (GlcNAc)2 and GlcNAc-1,3-β-Gal-1,4-β-Glc (LNT2), the core structure of a human milk
oligosaccharide, at pH 6.0 and 50 ◦C. Interestingly PhNah20A catalyzed the formation of LNT2,
the non-reducing trisaccharide β-Gal-1,4-β-Glc-1,1-β-GlcNAc, and in low amounts the β-1,2- or
β-1,3-linked trisaccharide β-Gal-1,4(β-GlcNAc)-1,x-Glc by a transglycosylation of lactose using
2-methyl-(1,2-dideoxy-α-d-glucopyrano)-oxazoline (NAG-oxazoline) as the donor [2].
The production of biofuels from lignocellulosic biomasses is hampered by the saccharification
step of the biomasses requiring the concerted action of lignocellulose cellulases and hemicellulases.
Zhang et al. characterized the secretome of Trichoderma harzianum EM0925 under induction of
lignocellulose cellulases and hemicellulases [3]. Compared with the commercial enzyme preparations,
the T. harzianum EM0925 enzyme cocktail presented significantly higher lignocellulolytic enzyme
activities and hydrolysis efficiency against lignocellulosic biomasses. The enzyme mixture used on
ultrafine grinding and alkali pretreated corn stover yielded 100% glucose and xylose. The authors
suggest that natural cellulases mixed with the hemicellulases enzyme cocktail from T. harzianum
EM0925 used for complete conversion of lignocellulose biomasses have a great potential for industrial
applications [3].
Int. J. Mol. Sci. 2020, 21, 2727; doi:10.3390/ijms21082727 www.mdpi.com/journal/ijms1
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BaAG2 from the early-diverged yeast Blastobotrys (Arxula) adeninivorans is an α-glucosidase of
the GH13 family. The enzyme was overexpressed in Escherichia coli, purified, and characterized.
BaAG2’s preferred substrates were maltose, other maltose-like molecules and malto-oligosaccharides
with degrees of polymerization (DP) up to 4-7, and sucrose, whereas isomaltose and isomaltose-like
substrates were not hydrolyzed, confirming that BaAG2 is a maltase. At high maltose concentrations,
BaAG2 exhibited transglycosylating ability, producing di- and trisaccharides. BaAG2 was inhibited by
acarbose, Tris, and also by isomaltose-like sugars and glucose [4].
Levansucrases (LSCs, EC 2.4.1.10) are enzymes studied for their potential use in biotechnological
application for the production of fructooligosaccharides and the transfructosylation of a wide
range of acceptors. While LSCs from Gram-positive bacteria can produce long-chain levan
(e.g., Bacillus megaterium SacB), LSCs from Gram-negative bacteria such as Erwinia tasmaniensis
(EtLSC) are interesting biocatalysts for the production of fructooligosaccharides (FOSs). The crystal
structure of EtLSC in complex with levanbiose (LBS) was obtained by soaking the preformed crystals
in a solution containing a high concentration of sucrose followed by crystal storage in liquid N2. LBS is
a di-fructose FOS intermediate formed during the synthesis of longer-chain FOSs. The binding pocket
discovered in this crystal structure represents a starting point for planning mutagenesis studies in
order to understand its biological relevance and role in FOS chain elongation [5].
Two major lipoglycans, lipomannan (LM) and lipoarabinomannan (LAM), are produced by
Mycobacteria. Their structural characterization is very difficult due to their heterogeneity in terms of
internal and terminal covalent modifications and branching patterns. To allow identification of the
reducing end of these molecules, enzymes such as endo-α-(1→6)-D-mannanase from Bacillus circulans
proved useful in cleaving the mannan backbone of LM and LAM. Angala et al. report the production
and purification of the glycosyl hydrolase domain of the endo-α-(1→6)-D-mannanase gene from
B. circulans TN-31 and studied its substrate specificity [6].
A GH3 β-glucosidase from the thermophilic fungus Chaetomium thermophilum was structurally
characterized by Mohsin et al [7]. The structure provides useful information for determining a
better use of enzymes in biotechnological applications for cellulose degradation in the production
of biofuels, as thermophilic fungi are a promising source of enzymes with improved stability.
The enzyme displays moderate glycosylation compared to other GH3 family β-glucosidases with
similar structure, and a comparison of several thermostability parameters suggests that glycosylation
and electrostatic interactions between charged residues may contribute to the enzyme’s stability at high
temperatures. The structure provides insights into the GH3 enzyme family for further improvements
of the β-glucosidases used in biotechnological cellulose degradation [7].
Two homologous uridine-5’-diphosphate (UDP)-glucose pyrophosphorylase enzymes produced
by Rhodococcus opacus, 1CP—RoGalU1 and RoGalU2, their genes were cloned and the corresponding
proteins characterized by Kumpf et al [8]. UDP-glucose is a versatile building block in both prokaryotes
and eukaryotes. UDP-glucose is synthesized by the enzyme UDP-glucose pyrophosphorylase (GalU).
The two enzymes are encoded by most Rhodococcus strains, known to synthesize natural products (i.e.,
trehalose-containing biosurfactants). Like other GalUs, RoGalU2 seems to be rather specific for the
substrates UTP and glucose 1-phosphate, while dTTP and galactose 1-phoshate are substrates with
merely 2% of residual activity. In comparison to other bacterial GalU, RoGalU2 activity was greater
even at high temperatures [8].
The peptidoglycan of bacterial cell walls is hydrolyzed by muramidases/lysozymes, a lysozyme
glycoside hydrolase (GH) family 22 C-type, from the upper gastrointestinal tract of the folivorous
bird Opisthocomus hoazin in the native form and various mutants were expressed in Aspergillus oryzae.
All mutants were enzymatically active; four of them with improved thermostability at pH 4.7, compared
to the wild type. The X-ray structure of the enzyme was determined in the apo form and in complex,
with chitin oligomers providing valuable information on substrate binding. Bioinformatic analysis
of avian GH22 amino acid sequences showed that they split into three distinct subgroups, and the
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enzyme from O. hoazin is found in the “other birds” group. Taylor et al. propose that this represents a
new cluster of avian upper-gut enzymes [9].
The use of deep eutectic solvents (DES) for the synthesis of alkyl glycosides catalyzed by the
thermostableα-amylase from Thermotoga maritima Amy A was investigated by Miranda-Molina et al [10].
While DES containing alcohols, sugars, and amides as hydrogen-bond donors (HBD) as cosolvents
performed best, pure DES almost completely deactivated the enzyme. Circular dichroism measurements
of Amy A showed that large conformational changes were observed above 60 ◦C, changes not observed
in aqueous medium. The authors claim that this is the first report on the effect of DES and temperature
on an enzyme, to establish the temperature limit for a thermostable enzyme in DES [10].
The 15-O-glycosylation of ganoderic acid A (GAA) into GAA-15-O-β-glucoside is carried out by
the enzyme BtGT_16345 from Bacillus thuringiensis GA A07. The enzyme was identified by whole
genome sequencing of strain GA A07. A phylogenomic analysis revealed the species of the GA
A07 strain to be B. thuringiensis. The enzyme is also regioselective toward triterpenoid substrates.
BtGT_16345 showed glycosylation activity toward seven flavonoids (apigenin, quercetin, naringenin,
resveratrol, genistein, daidzein, and 8-hydroxydaidzein) and two triterpenoids (GAA and antcin K) [11].
Roth et al. describe novel fungal amylases from Thamnidium elegans and Cordyceps farinosa with
potential industrial applications, as they feature activity and high stability in a broad pH spectrum
extending to pH 8 [12]. These enzymes have the typical GH13 α-amylase fold but feature shortened
loops flanking the substrate-binding cleft, creating a large crevice. The inhibitor acarbose, in form
of a transglycosylation product, was bound in the active site in the amylases from T. elegans and
C. farinosa. Moreover, a potential novel binding site in the C-terminal domain of the Cordyceps enzyme
was identified, which might be part of a starch interaction site [12].
A directed evolution approach was used by Yoav et al. to enhance the thermostability of
Clostridium thermocellum β-Glucosidase [13]. In the process of cellulose utilization, β-glucosidases are
key enzymes that convert cellobiose, produced by cellulose hydrolysis, to glucose. A thermostable
mutant with kcat and Km, similar to those of the wild-type enzyme, was produced. The addition of
the thermostable double mutant (A17S and K268N) to C. thermocellum secretome in order to carry out
the hydrolysis of microcrystalline cellulose at 70 ◦C drastically increased the soluble glucose yield
compared to the activity of the secretome supplemented with the wild-type enzyme [13].
A series of crystal structures of the wild type of the cold-adapted β-d-galactosidase from
Arthrobacter sp. 32cB, as well as its mutant E441Q, in complex with various ligands were obtained in
order to describe the reaction mechanism. Comparative analysis with mesophilic homologs revealed
striking differences in the enzymatic reaction. Access of the substrate to the active site is facilitated by
the fact that in ArthβDG a 10-aa loop is moved outward, while in mesophilic GH2 βDGs the same
loop hampers access to the active site. The authors suggest that the exposure of the active site entrance
improves the turnover rate of the cold-adapted enzyme [14].
Franceus et al. report the characterization of a sucrose 6F-phosphate phosphorylases member
(SPP) of the family GH13 subfamily 18 from Ilumatobacter coccineus and its comparison with the enzyme
from Thermoanaerobacterium thermosaccharolyticum [15]. Crystal structures of both SPPs were determined
to provide insight into their similarities and differences. These enzymes are interesting because of their
reversible phosphorolysis reactions in the synthesis of various glycosidic compounds. I. coccineus has
stricter specificity than the promiscuous SPP from T. thermosaccharolyticum. Considerable differences
between the two enzymes were found in the residues responsible for binding the fructose 6-phosphate
group in subsite +1. Mutants that provided a higher degree of substrate promiscuity in the SPP from
I. coccineus were probed, thus paving the way to rational enzyme engineering in biotechnology [15].
The degradation of pectins carried out by pectate lyases are of great interest in food and textile
industrial production. An alkaline pectate lyase gene (pppel9a) from Paenibacillus polymyxa KF-1
belonging to the polysaccharide lyase family 9 (PL9) was cloned and the corresponding enzyme was
expressed and characterized by Yuan et al [16]. The enzyme substrates are homogalacturonan-type
(HG) pectins vis-à-vis rhamnogalacturonan-I (RG-I)-type pectins. The lyase activity was found to be
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optimal at pH 10.0 and 40 ◦C. The molecular mass of citrus pectin (~230.2 kDa) was reduced by PpPel9a
action to ~24 kDa. PpPel9a was shown to be an endo-pectate lyase, acting primarily on the HG domain
of citrus pectin. The enzyme was proposed to have potential in the preparation of pharmacologically
active pectin products [16].
A xylanase belonging to family GH10 from the halo-thermophilic bacterium Roseithermus
sacchariphilus strain RA (XynRA2) was characterized by Teo et al. [17]. XynRA2 is composed of
a family 4_9 carbohydrate-binding module (CBM4_9), a family 10 glycoside hydrolase catalytic
domain (GH10), and a C-terminal domain (CTD) for a type IX secretion system (T9SS). This study
reports the identification and biochemical characterization of XynRA2 and its CBM-truncated
variant (XynRA2ΔCBM). The mutant XynRA2ΔCBM showed a lower activity compared to the
wild type, underlying the importance of XynRA2 carbohydrate-binding module in determining
enzyme performance [17].
The review by Roman et al. reports an up-to-date analysis of the structural and functional diversity
of β-xylosidases and discusses their inhibition by monosaccharides. β-xylosidases are crucial enzymes
in biotechnology because they hydrolyze the glycosidic bonds of cellulosic biomasses with a high
potential for degradation into reducing sugars, which can be used in the subsequent fermentation into
bioethanol [18].
The review by Mestrom discusses the use of Leloir glycosyltransferases, as they offer excellent
control over the reactivity and selectivity of glycosylation reactions. One-pot multi-enzyme
glycosylation cascades have been achieved by the development of nucleotide-recycling cascades
for the production and reuse of nucleotide sugar donors, and complex stereochemistry glycans and
glycoconjugates can be constructed. Therefore, Leloir glycosyltransferases, on account of their reactivity
and selectivity of glycosylation reactions with unprotected carbohydrates, are good candidates for
biotechnological industrial applications in multi-enzyme glycosylation cascades [19].
In a review about the ketal-pyruvylation of monosaccharides, Hager et al. illustrate different
classes of pyruvylated glycoconjugates and their associated functions, as well as the pyruvyltransferases
responsible of the modification. Ketal-pyruvylation is present in diverse classes of glycoconjugates,
produced in bacteria, algae, and yeast, but is absent in humans. The authors collected up-to-date
information on the prevalent ketal-pyruvylation of monosaccharides, including specificity and sequence
space of pyruvyltransferases, and provided insights into pyruvate analytics [20].
Conflicts of Interest: The authors declare no conflict of interest.
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Abstract: We identified and analyzed α2,8-sialyltransferases sequences among 71 ray-finned fish
species to provide the first comprehensive view of the Teleost ST8Sia repertoire. This repertoire
expanded over the course of Vertebrate evolution and was primarily shaped by the whole genome
events R1 and R2, but not by the Teleost-specific R3. We showed that duplicated st8sia genes like st8sia7,
st8sia8, and st8sia9 have disappeared from Tetrapods, whereas their orthologues were maintained in
Teleosts. Furthermore, several fish species specific genome duplications account for the presence of
multiple poly-α2,8-sialyltransferases in the Salmonidae (ST8Sia II-r1 and ST8Sia II-r2) and in Cyprinus
carpio (ST8Sia IV-r1 and ST8Sia IV-r2). Paralogy and synteny analyses provided more relevant and
solid information that enabled us to reconstruct the evolutionary history of st8sia genes in fish genomes.
Our data also indicated that, while the mammalian ST8Sia family is comprised of six subfamilies
forming di-, oligo-, or polymers of α2,8-linked sialic acids, the fish ST8Sia family, amounting to a total
of 10 genes in fish, appears to be much more diverse and shows a patchy distribution among fish
species. A focus on Salmonidae showed that (i) the two copies of st8sia2 genes have overall contrasted
tissue-specific expressions, with noticeable changes when compared with human co-orthologue,
and that (ii) st8sia4 is weakly expressed. Multiple sequence alignments enabled us to detect changes
in the conserved polysialyltransferase domain (PSTD) of the fish sequences that could account for
variable enzymatic activities. These data provide the bases for further functional studies using
recombinant enzymes.
Keywords: molecular phylogeny; α2,8-sialyltransferases; polySia motifs; evolution; ST8Sia;
functional genomics
1. Introduction
Glycoproteins and glycolipids can be modified with numerous different glycans during their
transit to the cell surface. Here, these glycoconjugates form a dense meshwork, the glycocalyx,
influencing several essential processes, such as adhesion and migration mechanisms in addition to
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cell signaling. Intriguingly, all living cells are surrounded by such a sugar-coat, which demonstrates
the importance of glycans for all living organisms [1]. However, glycoconjugates are not only found
on the cellular membranes, but also on released extracellular vesicles and soluble glycoconjugates;
likewise, various physiological and pathological can be targeted by their released forms. Several
different monosaccharides are utilized for the formation of glycans. Nevertheless, a very special
position among the building blocks of glycans takes the family of sialic acids [2,3]. These α-keto
acids consist of a nine-carbon backbone with a carboxylic acid group at C1 and a ketone group at
C2 [4]. Remarkably, more than 50 derivatives are known in nature. Besides N-acetylneuraminic acid
(Neu5Ac), N-glycolylneuraminic acid (Neu5Gc) is the most common sialic acid and the hydroxyl
groups of both can be additionally substituted, for example, by acetylation. The same applies for
a further common sialic acid, which is mainly used in lower vertebrates, deaminated neuraminic
acid (KDN, 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid) [5]. All three of these sialic acids are
frequently added by α2,3- and α2,6-sialyltransferases (ST3Gal, ST6Gal and ST6GalNAc) to nascent
glycans. However, in contrast to other commonly utilized monosaccharides of glycans, an attached
sialic acid residue can only be used to add another sialic acid residue, which explains their outermost
position on sialylated glycans. The elongation at position C8 of α2,3- or α2,6-linked sialic acid residues
is catalyzed by sialyltransferases belonging to the group of α2,8-sialyltransferases (ST8Sia) and long
polymers of sialic acids can be enzymatically synthesized in this way [6–8].
All those animal sialyltransferases (α2,3-, α2,6- α2,8-sialyltransferases) belong to the CAZy
glycosyltransferase family GT29, which indicates their common modular organization (GT-A-like fold)
and their common ancestral origin [8,9]. These protein sequences are characterized by the presence of
four consensus motifs called sialylmotifs (L (Large), S (Small), III, and VS (Very Small)) involved in 3D
structure maintenance, substrate binding, and catalysis [10,11]. The sialylmotifs are very useful for in
silico identification of sialyltransferases-related sequences [12]. On the basis of their sugar acceptor
specificity and glycosidic linkage formed, GT29 is subdivided into four families ST3Gal, ST6Gal,
ST6GalNAc, and ST8Sia in vertebrates [7,13], each of which is characterized by family motifs likely
involved in linkage specificity [14–16]. The biosynthesis of α2,8-sialylated molecules is an ancient
pathway achieved by the ST8Sia, a group of enzymes that emerge in the first eukaryotes [8] and
expanded very early in animal evolution [14]. Up to now, the ST8Sia enzymes have been studied and
characterized in mammalian tissues and primarily in the adult brain. The human and mouse genomes
show six ST8Sia subfamilies: ST8Sia I, ST8Sia V, and ST8Sia VI are mono-α2,8-sialyltransferases and
constitute a first group of ST8Sia enzymes involved in di-sialylation of glycoconjugates, while ST8Sia
III in addition to ST8Sia II and ST8Sia IV form a second group of oligo- and poly-α2,8-sialyltransferases
implicated in the polysialylation of glycoproteins [15].
Interestingly, our recent studies pointed to the fact that the st8sia gene family appears
to be much larger in teleost fish genomes [14,17]. The emergence of several novel vertebrate
mono-α2,8-sialyltransferases subfamilies like ST8Sia VII and ST8Sia VIII was described in this first group
of ST8Sia and their enzymatic specificities remain to be determined. These mono-α2,8-sialyltransferase
genes have arisen as a consequence of whole genome duplications (WGDs, R1 and R2) at the base
of vertebrates and were maintained in fish, whereas some others such as st8sia6, maintained in
Tetrapods, have disappeared in fish [17,18]. In the second ST8Sia group, the enzymes responsible
for the biosynthesis of sialic acid polymers, the poly-α2,8-sialyltransferases ST8Sia II and ST8Sia
IV and the oligo- α2,8-sialyltransferase ST8Sia III, have been cloned and characterized from
mammalian tissues, essentially the brain, where they act on α2,3-sialylated N-glycans of the neural
cell adhesion molecule (NCAM), leading to an increased neuronal plasticity in embryos [19–26].
From a structural point of view, the poly-α2,8-sialyltransferases share a high degree of similarity
in their sequence and structure [27–29] and are characterized by two additional sequence motifs,
termed the polysialyltransferase domain (PSTD), of 32 amino acids located upstream of the sialylmotif
S, and the polybasic region (PBR), of 35 amino acids located in the stem region of the enzymes
involved in protein-specific polysialylation [30,31]. The oligo-α2,8-sialyltransferases ST8Sia III also
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show additional broadly conserved motifs with respect to ST8Sia II and ST8Sia IV (motifs III-1 and
III-2) [14] with potential implication in the oligosialylation activity [32]. Their fish orthologues have
been identified, cloned, and characterized in zebrafish (Danio rerio) in addition to rainbow trout
(Oncorhynchus mykiss) [18,33,34].
Our previous phylogenetic studies also identified novel α2,8-sialyltransferases-related sequences
like the ST8Sia III-related (ST8Sia III-r) found in a few fish orders like Perciformes, Tetraodontiformes,
and Beloniformes, whereas the ST8Sia IV disappeared from the Neognathi fish [14]. It has long been
appreciated that gene-, segmental-, and genome duplication, as well as gene loss events, have played
important role in evolution, providing new genetic materials, which may facilitate new adaptation for
the organism [35,36].
In this study, we used a BLAST strategy to identify over 700 ST8Sia-related sequences from
ray-finned fish genomes and performed phylogenetic analyses and sequences alignments to reevaluate
their evolutionary relationships and fate, focusing on those responsible for polysialic acid (polySia)
biosynthesis with implications for the evolution of nervous system, immunological system, and cell–cell
interactions. Our findings point to a particular distribution of ST8Sia in fish, revealing novel st8sia
gene members and further suggesting their functional divergence in vertebrates.
2. Results and Discussion
2.1. In Silico Identification and Phylogenetic Reconstruction of ST8Sia Sequences
To investigate st8sia genes’ expansion and distribution in vertebrates, we performed public database
screenings in the National Center for Biotechnology Information (NCBI), ENSEMBL, and Phylofish
databases [37] using a BLAST strategy [38]. The obtained results led to the identification of more than
700 ST8Sia-related sequences (Supplemental Data 1) in chordate genomes, including 71 ray-finned
fish genomes (68 Teleosts genomes). Putative ST8Sia sequences with significant similarity to the
known human ST8Sia based on the presence of the sialylmotifs L, S, III and VS found in all GT29
sialyltransferases, and of family motifs characteristic for the ST8Sia family were selected, and multiple
sequence alignments were performed to select the complete open reading frame. The orthologues
of ST8Sia I and ST8Sia V involved in gangliosides biosynthesis are identified in all the investigated
genomes, suggesting a high conservation of the gangliosides biosynthetic pathways in vertebrates
(Supplemental Table S1). Similarly, the ST8Sia III and the recently described fish ST8Sia VIII [17]
could be found in all the Actinopterygii (ray-finned fishes) genomes (Figure 1; Supplemental Table S1).
Intriguingly, multiple copies of st8sia-related gene sequences were identified in Teleost genomes and
their number varied considerably from one fish order or species to another. For example, there are 6
st8sia-related genes in the medaka (Oryzias latipes), 8 in the clownfish (Amphiprion oscellaris) and the
common carp (C. carpio), and up to 10 in the rainbow trout. Indeed, multiple copies of ST8Sia VIII (>3)
were found in Perciformes, Cichliiformes, and Cyprinodontiformes; that is, two copies of the ST8Sia VII
in Cypriniformes, two copies of the ST8Sia II in Salmoniformes, and two copies of the ST8Sia IV were
found in the Cypriniforme C. carpio (Supplemental Table S1). In addition, some other st8sia genes could
not be found like ST8Sia VI in Teleosts and Chondrostei [17]; ST8Sia IV in Neoteleostei genomes [14];
or ST8Sia II in Esociformes, Siluriformes, or Gymnotiformes (except Electrophorus electricus) genomes
(Table 1). This resulted in a particular distribution of ST8Sia observed in the Actinopterygii compared
with the Sarcopterygii (lobbed-finned fishes and Tetrapods) and Chondrichtyes (sharks) (Figure 1;
Supplemental Table S1), which might have facilitated the acquisition of evolutionary innovations
during vertebrate evolution [35]. These observations prompted us to re-examine the genetic events,
which have shaped α2,8-sialylation in Teleosts.
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Figure 1. A schematic phylogenetic tree of vertebrate evolution. A simplified phylogenetic tree depicting
the evolution of the jawed vertebrates Gnathostomes after the two rounds of whole genome duplication
(WGD, R1 and R2). It is hypothesized here that WGD-R2 occurred after the Gnathostomes-Agnathes
(jawless vertebrates) split. The Gnathostomes branch is divided into two categories: the cartilaginous
fish Chondrychtyes (sharks and rays) and the bony fish Osteichthyes. The Osteichthyes are split into
the lobe-finned fish Sarcopterygii that contain Tetrapods, and the ray-finned fish Actinopterygii that
contain Neopterygii (Chondrostei, Holostei, and Teleosts).
Table 1. Fish orders that have lost st8sia genes.
Missing Sialyltransferase Fish Order
st8sia2 Siluriformes, Gymnotiformes, Esociformes
st8sia4
Perciformes, Tetraodontiformes, Beloniformes, Cichliiformes,
Cyprinodontiformes, Gadiformes, Gobiiformes, Pleuronectiformes,
Anabantiformes, Syngnathiforme, Synbranchiformes
st8sia9 Cypriniformes, Siluriformes, Clupeiformes, Gymnotiformes,Characiformes, Lepisosteiformes, Amiiformes
st8sia7 Osteoglossiformes, Cichliiformes, Clupeiformes, Cyprinodontiformes,Gadiformes, Gobiiformes, Pleuronectiformes, Siluriformes
To determine whether the expansion of st8sia genes observed in Actinopterygii could be associated
to WGD or smaller scale duplication events, we took advantage of the improved genome sequencing
of several critical species for basal Vertebrates as Agnathans (Lampreys and Hagfish) and for
Actinopterygii as Chondrostei (Sturgeons) and Holostei (Gars and Bowfin) (Figure 1). A simplified
dataset was constructed including sequences of Agnathans (Lethenteron camtschaticum, Petromyzon
marinus, Eptatretus burgii), Chondrichthyans (Callorhinchus milii, Squalus acanthias, and Heterodontus
zebra), basal Actinopterygians (Acipenser sinensis, Amia calva, and Lepisosteus oculatus) and basal
Teleosteans such as the Elopomorphs Anguilla anguilla and Mastacembelus armatus, in addition
to two Teleosts, the Beloniforme O. latipes (medaka) and the Characiforme Astyanax mexicanus
(cave fish). The potential orthology of the selected sequences was assessed through the construction of
phylogenetic trees (Figure 2). The topology of these trees indicated two major phylogenetic groups of
mono-α2,8-sialyltransferases on one hand, and oligo- and poly-α2,8-sialyltransferases on the other, as
previously described [7,14].
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Figure 2. Minimum evolution phylogenetic tree of 89 chordates ST8Sia. The evolutionary history of 89
ST8Sia (see names and sequences in Supplemental Data 1) was inferred using the minimum evolution
(ME) method. The optimal tree drawn to scale with the sum of branch length = 16.02931149 is shown.
The evolutionary distances were computed using the JTT (Jones-Taylor-Thornton) matrix-based method
and the rate variation among sites was modeled with a gamma distribution (shape parameter = 5).
The ME tree was searched using the close-neighbor-interchange (CNI) algorithm at a search level of
1. The neighbor-joining algorithm [39] was used to generate the initial tree. The analysis involved 89
amino acid sequences and all positions with less than 95% site coverage were eliminated. A total of
226 positions were in the final dataset (see multiple sequence alignments in Supplemental Data 2).
Evolutionary analyses were conducted in MEGA7.0 [40]. The nine Vertebrate subfamilies of ST8Sia
(ST8Sia I to ST8Sia IX) are indicated by various colors.
In the mono-α2,8-sialyltransferases group, a series of Agnathan sequences are found at the base of
each of ST8Sia I and ST8Sia V. The results corroborate previous findings suggesting the emergence of
these two subfamilies around 596 and 563 million years ago (MYA), well before vertebrates emergence
and prior WGD R1 and R2 [14]. Consistent with our previous data [17], we identified st8sia7 genes in
the jawless vertebrates Lethenteron camtschaticum, Petromyzon marinum, and Eptatretus burgeri genomes.
Thus, these genes might have arisen from the ancestral st8sia6/7/8 gene after the first WGD R1 event
(~552 MYA), although timing of these events with respect to the divergence of agnathans is still a matter
of debate [41,42]. Interestingly, Agnathans possess two copies of this later enzyme, named ST8Sia VII
and ST8Sia VII-r in Figure 2, likely resulting from species specific large-scale gene duplication events.
Similarly, in Teleosts, the eel A. anguilla (Elopomorphes, see the work of [43]) also harbors two copies
of ST8Sia VII, ST8Sia I, and ST8Sia V enzymes (Figure 2). This observation is in favor of a large-scale
genome duplication event different from the Teleost specific third round of WGD R3 (TGD) [44,45],
which may have taken place in a common ancestor of freshwater eels sometime after the split of
Elopomorpha and Osteoglossomorpha [46]. The ST8Sia VI and ST8Sia VIII subfamilies likely have
arisen from the second WGD at the base of Vertebrates; the first one was maintained in Sarcopterygii
and disappeared in Actinopterygii, and vice versa for ST8Sia VIII [17]. The many gene copies of st8sia7
and st8sia8 identified in Teleosts genomes (Supplemental Table S1) are likely the result of single gene
duplication events because they were identified on the same piece of chromosome (data not shown),
and were thus noted with -A, -B, or -C extension. However, it is difficult to infer the origin of these
segmental duplications as they have occurred in many, but not all terminal branches of clades.
The second branch encompasses both oligo- and poly-α2,8-sialyltransferases. Regarding
poly-α2,8-sialyltransferases, the Agnathan sequences were attributable only to ST8Sia IV, indicative
of a divergence between ST8Sia II and ST8Sia IV dating back to WGD-R1 (Figure 2) [14] followed by
st8sia2 gene loss in Agnathans. In contrast, the Agnathan sequences of oligo-α2,8-sialyltransferases are
at the base of the ST8Sia III and ST8Sia III-r subfamilies, while there are orthologues to the ST8Sia III
from sharks to Tetrapod lineages, suggesting a genome duplication event linked to WGD-R2 consistent
with previous dating around 474 MYA [14]. Despite the fact that the ST8Sia III-r sequences appear to
be restricted to Teleosteans, including Elopomorphes, and are lost in Chondrichthyans and Tetrapods
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lineages, they were not issued from the Teleost specific WGD, and thus were renamed ST8Sia IX
according to the previously described nomenclature [12].
2.2. Identification and Phylogenetic Analysis of the Fish St8sia Genes (st8sia2, st8sia4, st8sia3, and st8sia9)
Interestingly, in the oligo- and poly-α2,8-sialyltransferases group, the ST8Sia II and ST8Sia
IV appeared to be duplicated or lost in several Teleost lineages after divergence of Actinopterygii
from Sarcopterygii [47,48], whereas the ST8Sia III was found in all the Actinopterygii. In the basal
Elopomorphes and Osteoglossiformes branches, the four st8sia genes (st8sia2, st8sia3, st8sia4, and st8sia9)
could be identified. The results indicate that these genes already existed in the common ancestor of the 68
Teleost fishes examined. All Otocephalan lineages lack the st8sia9 gene and the Siluriformes lack both the
st8sia9 and st8sia2 genes. Consequently, the st8sia9 gene was lost shortly after Otocephala emergence
around 176.2 MYA and the st8sia2 gene was lost more recently (~82.6 MYA) during siluriformes
evolution [49]. As previously observed, all Neoteleostei fish lack the st8sia4 gene [14], which was
lost at the basis of Neoteleostei lineage. Finally, the Esociformes lack the st8sia2 gene only (Table 1).
Furthermore, two ST8Sia II-related sequences were identified in all the investigated Salmoniformes
(Oncorhynchus, Coregonus, Salmo, Salvelinus, and Thymallus) and two ST8Sia IV-related sequences
were identified only in the Cypriniformes C. carpio and Sinocyclocheilus anhuiensis (Supplemental
Table S1). We took advantage of the improved genome and transcriptome sequencing of several
fish [37,50], selected several representative Salmoniformes and Cypriniformes ST8Sia sequences,
and constructed phylogenetic trees (Supplemental Figure S1). The topology of these trees indicated
that the later duplications of st8sia genes were not associated to the Teleost specific genome duplication
(TGD, WGD R3), but rather to more recent lineage-specific genome duplication events described in
Salmonidae (SGD) lineage [51] and in C. carpio species [52].
2.3. Synteny and Paralogy Analyses of the st8sia2, st8sia4, st8sia3, and st8sia9 Gene Loci
To explain the gain or loss of ST8Sia subfamilies, we further analyzed the evolutionary relationships
between these st8sia genes. The kind of event that created duplication was characterized by analyzing
the conserved synteny between ST8Sia paralogues. It was expected that the st8sia genes created by
a WGD would be far apart on different chromosomes in one genome, but surrounded by similar
genes in each of the duplicated regions (i.e., paralogons). Significant Tetrapod paralogons containing
st8sia2 and st8sia4 genes were found and a well conserved synteny could be established for st8sia2
and st8sia4 gene loci in Tetrapods (i.e., human, mouse, chicken, and xenopus) genomes (Figure 3A) as
previously described [14]. However, in the fish genomes, as the st8sia2 gene was absent in Esociformes
and Siluriformes, we considered the neighboring furin, fes, sv2b, fam147b, mctp2, and chd2 genes around
st8sia2 on the medaka chromosome 6 to retrieve the synteny on Esox lucius LG19 and on Ictularus
punctatus chromosome 4. Similarly, ppip5k2, pam, chd1 erap1a, and syk genes conserved around the
st8sia4 locus were used to retrieve the synteny on O. latipes chromosome 12, Gasterosteus oculatus
chromosome XIV, and Xiphophorus maculatus chromosome 8. Interestingly, paralogues of these genes
could be identified on other chromosomes in the various fish genomes indicative of an ancient Teleost
specific WGD (TGD) followed by intense gene rearrangements. This further suggests that the st8sia
genes have undergone the TGD and the duplicated st8sia genes were rapidly lost during Teleost
evolution. In the Salmoniformes, a highly conserved synteny was found around the two st8sia2-r
gene loci corresponding to one ohnologous region in the spotted gar (L. oculatus), likely resulting from
the fourth round of WGD (SGD) that took place more recently in the Salmoniforme genomes [51].
The two st8sia4-r genes were localized on two distinct chromosomes in C. carpio genome, supporting
the hypothesis of a more recent species-specific genome duplication event in C. carpio [52] in spite of
a weak synteny conservation (Figure 3A).
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Figure 3. Syntenic relationships of the oligo- and poly-α2,8-sialyltransferases gene loci in vertebrates.
Chromosomal locations of the st8sia genes and neighboring gene loci were determined in the human
(Homo sapiens, Hsa), the mouse (Mus musculus (Mmu), the chicken (Gallus gallus, Gga), the spotted
gar (L. oculatus, Locu), the western clawed frog (Xenopus tropicalis, Xtro), the zebrafish (D. rerio, Dre),
the Japanese medaka (O. latipes, Ola), the channel catfish (I. punctatus, Ipu), the northern pike (E. lucius,
Elu), the rainbow trout (O. mykiss, Omy), the Atlantic salmon (Salmo salar, Ssa), the African weakly
electric fish (Paramormyrops kingsleyae, Pki), the three-spined stickleback (G. aculeatus, Gac), the southern
platyfish (X. maculatus, Xma), and the European carp (C. carpio, Cca). Information from the National
Center for Biotechnology Information (NCBI) and ENSEMBL release 97 was used to identify putative
orthologues, which were visualized using the Genomicus 97.01 [53]. Paralogous genes in the fish
genomes are indicated in green and in purple in the human genome. The st8sia genes are indicated in
red or in grey when lost. (A) Syntenic relationships of the st8sia2 and st8sia4 gene loci in vertebrates.
(B) Syntenic relationships of the st8sia3 and st8sia9 gene loci in vertebrates.
The synteny around the st8sia3 gene locus including wdr7, onecut2, and fech genes is highly
conserved in vertebrate lineages from fish to mammals (Figure 3B). Synteny around st8sia9 locus is less
conserved and is limited to a smaller syntenic block with ccng2 and ppef2 genes, which is reminiscent
of ancient WGD followed by intrachromosomal rearrangement in the ancestral fish genome.
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Altogether, our phylogenetic analyses enabled us to refine the evolutionary history of the fish
ST8Sia and to propose a model of their evolution illustrated in Figure 4, which agrees with the fish
phylogenetic tree of life [54]. It is interesting to note that, while Braasch and Postlethwait (2012)
determined duplicated gene retention rates of 12–24% after the TGD 320 MYA [55], we observed
no remaining st8sia gene copy from this event and no modification on the fish ST8Sia repertoire.
However, more recent polyploidization events were recorded in several families (Salmonidae, 80 MYA),
genera (Anguilla) or species (C. carpio, 8 MYA), which impacted the overall poly-α2,8-sialyltransferases
repertoire. In Salmonidae, we described only two remaining st8sia2 duplicates after the Ss4R among the
eight ancestral st8sia genes (12% duplicate retention), while Lien et al. (2016) revealed a global retention
rate around 55% [56]. In the carp C. carpio, two st8sia4 genes were retained as duplicates among the
seven st8sia genes (14% duplicate retention), while Li et al. (2015) calculated a global value of 92% [57].
Furthermore, these studies highlighted the fact that the retained genes after tetraploidization were
specifically involved in signal transduction, protein complex formation, and immune system, which
prompted us to focus on the functional divergence of these poly-α2,8-sialyltransferase duplicated
genes (neofunctionalization) and on their expression divergence (subfunctionalization).
 
Figure 4. Schematic representation of the ST8Sia family evolution in the ray-finned fishes. This model
for the evolution of st8sia genes is based on the evidence from protein sequence phylogeny, conserved
synteny of genomic st8sia loci in vertebrate species and their paralogous relationships in fish genomes.
The model takes into account the evolution of five ancestral groups of ST8Sia (st8sia6/7/8, st8sia2/4,
st8sia1, st8sia5, and st8sia3/9) indicated in green and present in the ancestor of Chordates that predate
the WGD R1 and WGD R2. Open red circles depict gene losses on the phylogenetic tree and yellow
stars correspond to the WGDs R1, R2, R3 (teleost specific duplication, TGD), and R4 (salmonids specific
duplication, SGD).
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2.4. Molecular Evolution of the Poly-α2,8-Sialyltransferases
A remarkable difference between α2,8-linked polySia chains found in mammals and salmonid fish
seems to be the structural diversity of polySia in fish [58–60]. Whereas in mammals, homopolymers
of Neu5Ac residues are typically formed [61], in rainbow trout eggs, polymers can consist of
Neu5Ac, Neu5Gc, and KDN in addition to their O-acetylated forms [62]. One explanation could be
a better accessibility to different sialic acids in fish, because, in transgenic mice—showing a Neu5Gc
overexpression in brain—besides Neu5Ac, Neu5Gc also seems to be utilized to build polySia [63].
Another explanation might be the occurrence of structural changes of the protein backbone
during the evolution of the polysialyltransferases. We thus investigated the potential consequences of
specific-lineages’ st8sia gene loss and duplication on the functional fate of duplicates, an issue that is
still poorly understood [64,65]. Substitution rate analysis of the duplicated st8sia2 genes maintained
in Salmoniformes genome after the SDG event indicated four amino acid substitutions in the ST8Sia
II-r2 coding sequences compared with ST8Sia II-r1 and the rest of Teleost ST8Sia II sequences, while
there were only two substitutions in the ST8Sia II-r1 sequence. Of particular note, among the four
substitutions found in ST8Sia II-r2, the H→ Y is recorded in sialylmotif L, and the R→ Q between
sialylmotifs S and III, whereas the two substitutions in the ST8Sia II-r1 sequence are located nearby
the PSTD motif (Figure 5A). In addition, two convergent substitutions leading to the same amino
acid were identified near the end of sialylmotif L (i.e., acquisition of a G from a Q) and beyond the
sialylmotif III (i.e., acquisition of an H from an S), respectively. These drastic modifications in amino
acid properties in functionally important locations in the catalytic domain of these salmonid ST8Sia
II let us suggest profound changes in both ST8Sia II functions (i.e., neofunctionalization). Likewise,
we examined the impact of st8sia4 loss on the remaining st8sia2 gene in Neoteleostei using parsimony
analysis. We found two substitutions, A→ S and Q→ S, located in the sialylmotif L and between the
sialylmotifs III and VS that of Neosteleostei ST8Sia II, respectively (Figure 5B). Interestingly, we also
found a convergent T→ K substitution located between the sialylmotifs III and VS that of Neosteleostei
ST8Sia II that restores the K amino acid characteristic of all the ST8Sia IV sequences (Figure 5B), further
suggesting changes in ST8Sia II functions in Neoteleotei. No substitution could be detected in ST8Sia
IV sequences after the loss of st8sia2 gene in Esociformes and Osmeriformes. Finally, we recorded the
substitutions on the ancestral sequence of ST8Sia III after ST8Sia IX loss in Otocephala. We observed
three substitutions in ST8Sia III sequence: V→ T near the sialylmotif L, A→ T in the sialylmotif VS,
and Y→ F beyond (Figure 5C).
The most striking domain of both polysialyltransferases—ST8Sia II and ST8Sia IV—is PSTD, which
is essential for the polysialylation of NCAM [31,66]. This motif contains a high number of basic amino
acids and is important for substrate binding and the catalytic activity. Troy and co-workers exchanged
several of these amino acids to determine their distinct impact on the enzymatic activity of human
ST8Sia IV [31]. Doubled substituent mutants with an exchange of the first basic residues (declared as
K2 and K4 in Figure 6) by neutral amino acids retained approximately 80% of the enzyme activity and
comparable values were determined, when only K6 was replaced. Stronger effects were observed in
single substituted mutants where R8, H18, K28, K32, or R33 was replaced by a neutral amino acid.
All these changes reduced activity by more than 50%. Their experiments demonstrated that, in addition
to the neutral amino acid I31 (mutants retained only 6% of their activity), especially the basic amino
acids of PSTD were key elements for polysialylation. Most of these important amino acids of the human
ST8Sia IV are also highly conserved in the fish enzyme. Changes occurred sporadically at K2, K4, K6,
and R8 in individual fish species (Figure 6). On the basis of the work of Troy and co-workers [31], the R8
change may have the highest impact on the general enzyme activity, as a replacement of this amino
acid reduced the activity to less than 25%. However, we observed an exchange of R8 only in three
fish species including I. punctatus. Nevertheless, as mentioned above, other substituted amino acids
may also influence the interaction with the nascent sialic acid chain, depending on the composition
(Neu5Ac, Neu5Gc, KDN, and O-acetylated variations) of the polySia chain.
15
Int. J. Mol. Sci. 2020, 21, 513
Figure 5. Substitution rate analysis of the impact of st8sia gene duplications and losses. The sialylmotifs
are indicated by red boxes and the transmembrane domain by a grey box. (A) Duplication of st8sia2
genes in Salmoniformes. The substitutions observed in ST8Sia II-r1 and ST8Sia II-r2 are indicated by
an arrow above and below, respectively. The position of the substitutions corresponds to the alignment
in Supplemental Data 2. The black rectangles correspond to convergent mutations retrieved in both
sequences. In T > K, for example, T is the ancestral state and K is the derived one. (B) Impact of
st8sia4 gene loss in Neoteleostei on the remaining fish ST8Sia II sequences. The code for substitution
is the same as in A. The corresponding amino acid present in the paralogue ST8Sia IV sequence is
given below. (C) Impact of st8sia9 gene loss in Otocephala on the remaining fish ST8Sia III sequences
(same abbreviations as in B).
More consistent variations were observed when ST8Sia II sequences were compared. In addition
to the mentioned K2 and H4 (K instead of H in ST8Sia IV), an exchange of a basic amino acid occurs
more frequently and is often highly conserved within one family. For instance, in Salmoniformes,
lysine residues at position 2 and 28 are changed with apolar amino acids and the strongly basic R8
residue is exchanged with histidine, which is only partly positively charged at neutral pH. On the
basis of the studies of Nakata et al. using human ST8Sia IV, we can also assume remarkable changes in
the enzymatic activity of ST8Sia II [31]. For instance, ST8Sia IV mutants with a neutral amino acid at
position K28 retained less than 25% of their enzymatic activity. This is in line with studies by Kitajima
and co-workers demonstrating that rainbow trout ST8Sia II isoforms show only low enzymatic activity
in vitro [33]. Intriguingly, in Neoteleostei, the very important lysine at position 28 was also exchanged
with a neutral amino acid. Notably, in contrast to Salmoniformes, in Neoteleostei, ST8Sia II is the
only polysialyltransferase because ST8Sia IV is absent. The presence of only one polysialyltransferase
in Neoteleostei, which additionally includes such a striking mutation, suggests that polysialylation
significantly changed in Neoteleostei in comparison with other vertebrates.
In addition to sequence alignments, we simulated the PSTD 3D structure of fish ST8Sia II and ST8Sia
IV, based on the determined 3D structure of human ST8Sia IV PSTD (PDB 6AHZ) (Figure 7), which were
published by Peng and colleagues [66]. Volkers et al. described that PSTD acts as a basic furrow, leading
the nascent sialic acid chain to the active site of the polysialyltransferase [32]. The 3D simulation of
the human ST8Sia IV PSTD shows that only significant differences between the electrostatic potential
surfaces are detectable at the N-terminal region. Especially the orientation of the basic areas changed
between the species. In contrast, the central and C-terminal area exhibited only minor changes. In the
case of ST8Sia II, the most prominent alterations also occurred at the N-terminal domain (Figure 8).
However, exchanging the N6 with aspartate, an exposed acidic segment is formed in Salmoniformes
and Neoteleostei, which may influence the interaction between PSTD and the negatively charged sialic
acid polymers. However, regarding the 3D simulation of PSTD, it has to be noted that a simulation is
only a simulation and crystal structures of PSTD in addition to the whole enzymes are necessary for
the generation of unambiguous 3D models.
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Figure 6. Sequence-based analysis of the polysialyltransferase domain (PSTD) in fish ST8Sia II and
ST8Sia IV. Multiple sequence alignment of PSTD were performed with CLUSTAL OMEGA of EMBL-EBI
by MUSCLE (3.8) edited and annotated in Jawa Alignment Jalview [67]. The used protein entries
from different species are listed in Supplemental Table S1. The different colors from Clustal X scheme
codes indicate the following characteristics: hydrophobic (blue), positive charge (red), negative charge
(magenta), polar (green), cysteine (pink), glycine (orange), proline (yellow), aromatic (cyan), and gap
(white). It should be noted that one additional amino acid was added to the N-terminus and two
additional amino acids to the C-terminus of PSTD.
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Figure 7. Three-dimensional (3D) structure of PSTD motifs in fish ST8Sia IV. The 3D model of human
ST8Sia IV PSTD (Protein Data Bank entry 6AHZ)—electrostatic potential surfaces—is displayed
in addition to the simulated structure of PSTD from I. punctatus and C. maraena using YASARA.
The exchanged amino acids are colored in an additional version of the 3D structure to highlight the
position of the exchange: N3→ R3 (orange), K6→ P6 (magenta), R8→H8 (green), T9→M9 (green),
I17→ V17 (violet), and P30→ N30 (grey) for I. punctatus and L1→ V1 (yellow), N3→ R3 (orange),
K6→ R6 (magenta), V29→ I29, and P30→N30 (grey) for C. maraena. It should be noted that, for the
determination of the 3D structure of human ST8Sia IV PSTD, a peptide was used with one additional
amino acid on the N-terminus and two additional amino acids on the C-terminus of PSTD [66].
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Figure 8. Three-dimensional (3D) structure of PSTD motifs in fish ST8Sia II. The 3D model of human
ST8Sia II PSTD in addition to PSTD from P. fluviatilis and C. maraena was simulated, based on the 3D
model of human ST8Sia IV PSTD (Protein Data Bank entry 6AHZ) using YASARA. The electrostatic
potential surfaces are displayed. The exchanged amino acids are colored in an additional version of the
3D structure to highlight the position of the exchange: K2→ L2 (yellow), H4→ T4 (orange), N6→ D6
(magenta), Y11→ F11 (green), and K28→N28 (red) for P. fluviatilis and K2→ L2 (yellow), H4→ T4
(orange), N6→ D6 (magenta), R8→ H8 (violet), Y11→ F11 (green), K28→ N28 (red), and H30→ Q30
(light blue) for C. maraena. For the determination of the 3D structure of human ST8Sia IV PSTD,
a peptide with one additional amino acid on the N-terminus and two additional amino acids on the
C-terminus of PSTD were used [66].
Taken together, our sequence alignments and 3D simulations demonstrate that, in fish,
characteristic alterations of the amino acid sequences occurred within PSTD and that several of
these replaced amino acids are important for the enzymatic activity in the case of human ST8Sia IV,
as demonstrated by Troy and co-workers [31]. These variations might also influence the ability of
PSTD to interact with sialic acid chains consisting of other sialic acids than Neu5Ac, such as Neu5Gc
and KDN, as well as their O-acetylated forms. However, to definitively proof this hypothesis of
neofunctionalization of fish polysialyltransferases, their enzymatic activity has to be characterized in
more detail.
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2.5. Expression of Polyα2,8-Sialyltransferase Genes in C. Maraena Tissues
Having characterized the chromosomal localization, evolutionary history, and structure of the
poly-α2,8-sialyltransferases ST8Sia II and ST8Sia IV encoded by the st8sia2 and st8sia4 genes, respectively,
we eventually profiled their expression in ten organs and tissues of C. maraena as a representative
of the Salmoniformes (Figure 9A,B). As st8sia2 is duplicated in salmonid fishes, we investigated
whether the expression of both genes is tissue-specific, and thus possibly function-specific. To this
end, discriminating primer pairs for st8sia2-r1 and st8sia2-r2 as well as for st8sia4 transcripts were
designed. The RT-qPCR analysis revealed that st8sia2-r1 transcripts were on low levels in liver, heart,
spleen, head kidney, gills, hypothalamus, and hind brain (>300 copies/ng RNA), and almost absent
in muscle (>10 copies/ng RNA) (Figure 9A). In stark contrast, the copy numbers of st8sia2-r1 were at
a high level in gonads (~1700 copies/ng RNA) and telencephalon (~ 2140 copies/ng RNA) (Figure 9B).
The transcript levels of the gene copy st8sia2-r2 were generally higher compared with its paralogue,
ranging from a 1.5-fold difference in gonads to a 233-fold difference in spleen (Figure 9A). While the
expression of st8sia2-r2 was not detectable in hind brain and telencephalon, it exceeded the expression
level of st8sia2-r1 by 4622-fold in the hypothalamus.
 
Figure 9. Expression profiling of poly-α2,8-sialyltransferase-encoding genes in maraena whitefish.
(A) Transcript levels of st8sia2-r1 (black bars), st8sia2-r2 (gray), and st8sia4 (blank) were determined in
ten tissues from maraena whitefish (n = 4), as indicated on the abscissa. Bars represent the averaged
copy numbers normalized against three reference genes; error bars represent the standard deviation.
(B) A heat map represents the same copy numbers per target gene as shown in (A) relative to the
expression in gonads (set as 1.0). These relative expression values are colored according to the code
given at the right. Non-detectable transcript numbers are indicated by gray fields.
The expression level of st8sia4 was at a similarly low or even significantly lower level compared
with that of st8sia2-r1 with the highest copy numbers in spleen (~330 copies/ng RNA). No or only
very few st8sia4 transcripts were detectable in liver, muscle, and heart (Figure 9B). The results are
partially different in comparison with the determined mRNA levels in rainbow trout using Northern
blot analysis and semi-quantitative PCR [33]. For instance, spleen samples were negative for st8sia2
transcripts, which might not only be the result of differences in the applied methods, but also in general
differences between these two Salmoniformes.
Taken together, profiling the expression of the poly-α2,8-sialyltransferase genes revealed
a tissue-specific expression pattern of st8sia2 genes in C. maraena tissues indicative of their
subfunctionalization. Probably one of the most striking differences between the expression profiles in
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maraena whitefish and humans is the presence of st8sia2 and st8sia4 transcripts in the reproductive
tract. Whereas in humans, only a weak signal for st8sia2 mRNA and no signal for st8sia4 mRNA could
be detected by Northern blotting [68], in C. maraena, the gonads belongs to the tissues with the highest
expression levels of polysialyltransferases. This was already described by Kitajima and colleagues
using rainbow trout ovaries [33]. Besides the gonads, remarkable differences were also observed
in spleen. Contrary to humans, where no st8sia2 mRNA was detectable [68], st8sia2-r2 expression
was extremely high in the spleen of C. maraena, indicating that ST8Sia II-r2 might play a role during
immunologic reactions in maraena whitefish. Altogether, these results let us suggest that, in addition
to the number of active polysialyltransferases, as well as their enzymatic activity, the physiological
roles of these polysialyltransferases may have changed during the evolution of vertebrates.
3. Materials and Methods
3.1. Materials and Animals
Maraena whitefish were provided by the Institute for Fisheries of the State Research Centre for
Agriculture and Fishery Mecklenburg-Western Pomerania (Born, Germany), and BiMES, Binnenfischerei
GmbH (Friedrichsruhe, Germany). Fish were held in fresh-water recirculation systems with a 12:12
day-and-night cycle at 18 ◦C. Water quality was maintained by automated purification and disinfection
(bio-filter and UV light). In addition, the concentrations of selected chemical and physical water
parameters were constantly determined.
Sampling of ten organs or tissues (gills; gonads; head kidney; heart; liver; muscle; spleen; and the
brain regions hypothalamus, hind brain, and telencephalon) from four maraena whitefish followed
the standards described in the German Animal Welfare and was approved by the Landesamt für
Landwirtschaft, Lebensmittelsicherheit und Fischerei, Mecklenburg-Vorpommern, Germany (LALLF
M-V/TSD/7221.3-1-069/18) in November 2018. The tissues were sampled rapidly and immediately
frozen in liquid nitrogen to be kept at −80 ◦C until RNA extraction.
3.2. In Silico Identification and Phylogenetic Analysis of ST8Sia Sequences
A local alignment BLAST approach was used to retrieve the vertebrate st8sia nucleotide sequences
with significant homology to the mammalian sequences from the genomic and Transcriptome Shotgun
Assembly (TSA) divisions of the GenBank/EBI databases at the National Center for Biotechnology
Information (NCBI) (last accessed on 27 September 2019), ENSEMBL (release 97) and from the PhyloFish
database [7,14,37]. The protein sequence analysis was performed using the Expert Protein Analysis
System (ExPASy; Swiss Institute of Bioinformatics, Switzerland; website (https://www.expasy.org/)).
Sequence alignments were performed using the clustalW (PRABI; https://npsa-prabi.ibcp.fr/cgi-bin/
npsa_automat.pl?page=/NPSA/npsa_clustalw.html). Phylogeny was determined aligning the known
vertebrate ST8Sia sequences with MUSCLE in MEGA7.0 [40]. The multiple sequence alignments
of the selected vertebrate ST8Sia sequences were conducted using MUSCLE and Clustal Omega
algorithms in MEGA7.0 and manually refined (see Supplementary Data 1 and 2). Phylogenetic trees
were produced by the neighbor-joining (NJ), maximum likelihood, and minimum evolution method in
MEGA 7.0 [40,69].
To determine the consequences of duplication or loss of genes of a given order of Actinopterygian,
we considered what happened on its closest paralogue. The amino acid substitutions that occurred
at its base were deduced using the parsimony method implemented in Protpars program (PHYLIP
package vers. 3.69) [70].
3.3. Synteny Analysis, Paralogon Detection, and Ancestral Genome Reconstruction
Synteny between the st8sia gene loci and neighbour genes in vertebrate genomes was assessed by
manual chromosome walking and reciprocal BLAST. Detection of paralogous blocks was visualized with
Genomicus (version 97.01) http://www.genomicus.biologie.ens.fr/genomicus-92.01/cgi-bin/search.pl,
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last accessed August 2019 [53]. When the st8sia gene of interest was not found in a genome, physically
close genes were used as a seed to identify syntenic segments.
3.4. Sequence Alignments, Motifs Analysis, and 3D Simulation of PSTD
Multiple sequence alignments were performed with MUSCLE of EMBL-EBI (version 3.8; https:
//www.ebi.ac.uk/Tools/msa/muscle/) from selected species using published sequences (accession
numbers in Supplemental Data 1). The sequences were conducted, edited, and annotated in Jawa
Alignment Viewer Jalview 2.11.0, and manually refined [67]. The 3D structure of the human PSTD of
ST8Sia II as well as ST8Sia IV was generated in YASARA (Version 19.9.17) using the following Protein
Data Bank (PDB) entries: ST8Sia IV (code: 6AHZ) (PDB, https://www.rcsb.org/pdb/home/sitemap.do
https://www.wwpdb.org/pdb?id=pdb_00006ahz). The ST8Sia II was generated in YASARA changing
the amino acid in the positions N3, K4, L5, and K6, corresponding to H3, H4, V5, and N6, respectively.
The human amino acid sequences of ST8Sia II and ST8Sia IV were modified at the positions with the
following amino acids according to the different fish PSTD sequences: C. maraena ST8Sia II, L2, T4,
D6, H8, F11, N28, and Q30; P. fluviatilis ST8Sia II, L2, T4, D6, F11, and N28; I. punctatus ST8Sia IV, R3,
P6, H8, M9, V17, and N30; and C. maraena ST8Sia IV, V1, R3, R6, I29, and N30. We designed only one
PSTD motif of C. maraena because there is only one difference at position R22 between ST8Sia II-r1 and
ST8Sia II- r2.
3.5. RNA Extraction, cDNA Synthesis, Primer Design, and RT-qPCR
Total RNA was isolated from the individually homogenized organs and tissues using TRIzol
(Invitrogen/Thermo Fisher Scientific, Darmstadt Germany), followed by an additional purification step
(RNeasy Mini Kit, Qiagen). The quantity and integrity of the isolated RNA were determined using the
NanoDrop 2000 photometer (Thermo Fisher Scientific) and agarose gel electrophoresis. Subsequently,
we reverse-transcribed the total RNA using the SuperScript II Reverse Transcriptase (Thermo Fisher
Scientific) and a mixture of oligo-d(T) and random hexanucleotides. This reaction was carried out at
42 ◦C (50 min), followed by an inactivation step (70 ◦C, 15 min). The resulting cDNA was diluted in
100 μL distilled water.
Real-time fluorescence-based quantitative RT-PCR (RT-qPCR) was used to determine the
mRNA abundance of the two st8sia2 gene variants in the above ten organs and tissues of
maraena whitefish (n = 4). To this end, we identified discriminating sequence motifs to derive
the oligonucleotides for st8sia2-r1 (sense, 5′-AGCCTCATCAGGAAGAACATCC-3′; antisense,
5′-TTCCCTACGATGGCACAGCGT-3′) and st8sia2-r2 (sense, 5′-CGTTCAACAGGAGCCTCTCTAA-3′;
antisense, 5′-TTCCCTACGATGGCACAGCGC-3′). Moreover, we designed a st8sia4-specific primer pair
(sense, 5′-ATGATAAGGAAGGACGTGCTGC-3′; antisense, 5′-TGTTGAGCGTTCGGCGTCTGT-3′).
These RT-qPCR primers were designed (Pyrosequencing Assay Design software v.1.0.6; Biotage,
Uppsala, Sweden) to synthesize amplicons between 121 bp and 226 bp. eef1a1a2 (encoding eukaryotic
translation elongation factor, variant a2), rpl9, and rpl32 (ribosomal proteins L9 and L32) were selected
as reference genes [71]. The RT-qPCR analyses were conducted with the LightCycler 96 System (Roche,
Mannheim, Germany) using the SensiFAST SYBR No-ROX Kit (Bioline, Luckenwalde, Germany).
We only considered crossing point (CP) values >35 for The expression analysis of the st8sia2-r1
st8sia2-r2, and st8sia4. The calculation of their copy numbers was based on standard curves having
been generated on 10-fold dilutions of the respective PCR-generated fragments (1 × 103 to 1 × 106
copies). Melting-curve analyses validated the amplification of the distinct products. Amplicons were
visualized on 3% agarose gels in order to assess product size and quality.
3.6. Data Availability
To identify the maraena whitefish ST8Sia II sequences, the orthologous sequences from rainbow
trout and Atlantic salmon were aligned with the software Bowtie2 (v 2.2.4) to our RNA-seq read
collection from maraena whitefish [72]. The alignments were then indexed and sorted with the software
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package Samtools (v.16) and the final consensus sequences were obtained with the Ugene software
(v 1.29).
4. Conclusions
In this study, we highlighted an expansion and particular distribution of the ray-finned fish
ST8Sia repertoire owing to several duplications and loss events of st8sia genes, and we refined
their evolutionary history. Our analyses of the molecular evolution in ST8Sia sequences and in
key functional motifs (i.e., motif L and PSTD) let us suggest that the polysialyltransferases might
evolved new enzymatic activities and/or specificities in the course of Vertebrate evolution. Their
expression profiles in Salmonid tissues differ from those observed in mammals and further point to
a subfunctionalization of these poly-α2,8-sialylatransferases. Altogether, we have laid the foundation
for further studies towards understanding of the remarkable differences between α2,8-linked polySia
chains found in mammals and fish.
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polySia or PSA polysialic acid
PDB Protein Data Bank
PSGP salmonid egg polysialoglycoprotein
ST8Sia α2,8-sialyltransferase
WGD whole genome duplication
KDN 2-keto-3-deoxynononic acid
MSA multiple sequence alignment
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Abstract: β-N-Acetylhexosaminidases are glycoside hydrolases (GHs) acting on N-acetylated
carbohydrates and glycoproteins with the release of N-acetylhexosamines. Members of the
family GH20 have been reported to catalyze the transfer of N-acetylglucosamine (GlcNAc)
to an acceptor, i.e., the reverse of hydrolysis, thus representing an alternative to chemical
oligosaccharide synthesis. Two putative GH20β-N-acetylhexosaminidases, PhNah20A and PhNah20B,
encoded by the marine bacterium Paraglaciecola hydrolytica S66T, are distantly related to previously
characterized enzymes. Remarkably, PhNah20A was located by phylogenetic analysis outside
clusters of other studied β-N-acetylhexosaminidases, in a unique position between bacterial and
eukaryotic enzymes. We successfully produced recombinant PhNah20A showing optimum activity
at pH 6.0 and 50 ◦C, hydrolysis of GlcNAc β-1,4 and β-1,3 linkages in chitobiose (GlcNAc)2 and
GlcNAc-1,3-β-Gal-1,4-β-Glc (LNT2), a human milk oligosaccharide core structure. The kinetic
parameters of PhNah20A for p-nitrophenyl-GlcNAc and p-nitrophenyl-GalNAc were highly similar:
kcat/KM being 341 and 344 mM−1·s−1, respectively. PhNah20A was unstable in dilute solution, but
retained full activity in the presence of 0.5% bovine serum albumin (BSA). PhNah20A catalyzed the
formation of LNT2, the non-reducing trisaccharideβ-Gal-1,4-β-Glc-1,1-β-GlcNAc, and in low amounts
the β-1,2- or β-1,3-linked trisaccharide β-Gal-1,4(β-GlcNAc)-1,x-Glc by a transglycosylation of lactose
using 2-methyl-(1,2-dideoxy-α-d-glucopyrano)-oxazoline (NAG-oxazoline) as the donor. PhNah20A
is the first characterized member of a distinct subgroup within GH20 β-N-acetylhexosaminidases.
Int. J. Mol. Sci. 2020, 21, 417; doi:10.3390/ijms21020417 www.mdpi.com/journal/ijms29
Int. J. Mol. Sci. 2020, 21, 417
Keywords: N-acetylhexosamine specificity; glycoside hydrolase; GH20; phylogenetic
analysis; transglycosylation; NAG-oxazoline; acceptor diversity; lacto-N-triose II; human milk
oligosaccharides; NMR
1. Introduction
A new marine bacterial species Paraglaciecola hydrolytica S66T of the family Alteromonadaceae
isolated from eelgrass (Zostera sp.) was shown by genome-sequencing [1] to encode 270 protein
modules potentially acting on carbohydrates, 188 of which belong to enzyme families involved in
degradation of carbohydrates [2,3]. The algal polysaccharides agar, agarose, alginate, porphyran
or laminarin, but not carrageenans, fucoidan and ulvan, sustained the growth of P. hydrolytica as a
sole carbon source, and the bacterium also grew on the plant polysaccharides: starch, amylopectin,
amylose, xylan and pectin [2]. Overall, the large number of encoded carbohydrate-active enzymes
(CAZymes) [4] and the flexibility with regard to carbon source indicates a very promising potential of
the genome of P. hydrolytica for the discovery of enzymes with rare or not yet described activities.
Enzymes hydrolyzing glycosidic bonds with the release of N-acetylglucosamine (GlcNAc) are in
focus since these carbohydrate residues occur in vital complex glycans, such as milk oligosaccharides
and glycosphingolipids, for which there is a great demand [5]. Human milk oligosaccharides
(HMOs) in particular are considered beneficial and needed for research and clinical trials within
nutrition and as ingredients in functional foods and infant formulas [6–8]. HMOs are also regarded
as emerging prebiotics or novel foods with positive health effects [9,10]. However, the chemical
and enzymatic production of HMOs and their precursors or purification from natural sources are
problematical [6,11,12], which creates bottlenecks for assessing the functional roles and applications of
HMOs [13–15].
Lacto-N-triose II (LNT2, β-GlcNAc-1,3-β-Gal-1,4-Glc) is an HMO core structure in which
N-acetylglucosamine is β-1,3-linked to lactose [6,16,17]. A few β-N-acetylhexosaminidases (β-NAHAs;
EC 3.2.1.52) of the glycoside hydrolase family 20 (GH20) from bacteria, fungi and plants are reported
to produce HMO-type GlcNAc-containing oligosaccharides with 1,3 linkages [15,18,19], as well as
chitooligosaccharides and their analogs in transglycosylation reactions with the formation of 1,6 rather
than 1,4 linkages [18,20–22]. In Nature, β-NAHAs from GH3, 20, 84, 109 and 116 [5,23,24] categorized
in the CAZy database (www.cazy.org) [4] degrade N-acetylhexosamine-containing compounds by
releasing GlcNAc and GalNAc from the non-reducing ends of N-acetylglucosides, N-acetylgalactosides,
glycosphingolipids and glycoproteins [5,25–27]. Interestingly, these families display a variety of
mechanisms, either retaining via a substrate-assisted mechanism (GH20 and GH84) [28,29] or a
glycosyl-enzyme intermediate (GH3 and GH116) [30], or inverting via an oxidized form of nicotinamide
adenine dinucleotide (NAD+)-depending mechanism (GH109) [31]. While being represented in five
distinct GH families, the large majority of β-NAHAs belong to GH20.
N-acetylated oligo- and polysaccharides, e.g., chitooligosaccharides and chitin, are prevalent in
marine organisms, thus crustaceans represent an abundant source of GlcNAc in marine environments.
The National Center for Biotechnology Information (NCBI) database (https://www.ncbi.nlm.nih.gov/)
currently has more than 112,000 predicted β-NAHAs, but out of the more than 200 characterized
EC 3.2.1.52 enzymes (www.brenda-enzymes.org) [32], only a small number are of marine
origin [21,26,33–36]. Accordingly, only six out of the 133 characterized GH20 β-NAHAs are from
a marine organism (from www.cazy.org, 21st of November, 2019) even though a large number of
sequences, also of marine origin, are annotated in genomes and metagenomes. These six characterized
marine GH20 enzymes comprise Hex99 and Hex86 from Pseudoalteromonas piscicida (previously
Alteromonas sp.) [21,35], Nag20A [36] and NagB [34] from the widespread Aeromonas hydrophila,
chitobiase of Vibrio harveyi [37] and ExoI from Vibrio furnissii [33]. However, of these, only Hex99 from
P. piscicida was examined for its ability to catalyze transglycosylation reactions [21].
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Biochemical characteristics such as pH optimum (between pH 6.0-7.0) and temperature optimum
(37-50 ◦C) of the six enzymes are rather similar. Moreover, based on KM and Vmax values, most of
the enzymes have higher specific activity towards p-nitrophenyl-GlcNAc (pNPGlcNAc) compared to
p-nitrophenyl-GalNAc (pNPGalNAc) [25,33,34,36].
It has not been possible to clearly distinguish between GH20 β-NAHAs from water-living and
terrestrial organisms or from bacterial and eukaryotic organisms based solely on different functional
features of the enzymes. The biochemical characteristics of GH20 β-NAHAs vary considerably, as it has
been reviewed recently by Zhang et al. [25]. For example, pH optima of GH20 enzymes range from pH 3.0
for Hex of Streptomyces plicatus to pH 8.0 for Hex1 (from a metagenomic library) [18,25,38]. Affinities as
given by KM values for pNPGlcNAc range from 53μM for Cf Hex20 from Cellulomonas fimi [39] to 120 mM
for BbhI of Bifidobacterium bifidum [40]. Murine cytosolicβ-NAHA shows KM = 0.25 mM on pNPGalNAc,
which it preferred over pNPGlcNAc [41]. Similarly, human plasma and pig brain β-NAHAs have a
lower KM for pNPGalNAc of 0.17 mM and 0.2 mM, respectively [42,43]. Interestingly, salt-tolerant
HJ5Nag from Microbacterium sp. has a high Vmax towards pNPGlcNAc of 3097 μmol·mg−1·min−1 [44].
One of the highest kcat and catalytic efficiency values reported towards pNPGlcNAc are for Cf Hex20
of C. fimi reaching 480 s−1 and 9000 mM−1·s−1, respectively [39]. Crystal structures are available
for several terrestrial GH20 β-NAHAs, e.g., Hex1T from Paenibacillus sp. TS12 [45], StrH from
Streptococcus pneumoniae [46], HexA from Streptomyces coelicolor [47], Hex from S. plicatus [38] and
Am2301 from Akkermansia muciniphila [48], but not for any aquatic GH20 enzymes.
Here, the genome of P. hydrolytica S66T encoding 113 predicted glycoside hydrolases [1,3] was
mined for β-NAHAs potentially acting on GlcNAc-containing compounds, e.g., chitooligosaccharides,
which are abundant in the marine environment. Two putative GH20 encoding genes were identified
in the genome, and one of the corresponding enzymes, PhNah20A, was produced recombinantly,
characterized biochemically and moreover shown to catalyze transglycosylation using the GH20
reaction intermediate NAG-oxazoline [2-methyl-(1,2-dideoxy-α-d-glucopyrano)-oxazoline] as donor
and lactose as well as a series of monosaccharides as acceptors.
2. Results and Discussion
2.1. Identification of Putative β-NAHAs in P. hydrolytica and Organization of Vicinal Genomic Regions
The marine bacterium P. hydrolytica degrades effectively many different polysaccharides [2] and
its genome exhibits potential for the degradation of chitin and chitooligosaccharides. P. hydrolytica was
grown in marine mineral medium supplemented with a mixture of chitooligosaccharides (GlcNAc)1–6 as
the sole carbon source, which were hydrolyzed to GlcNAc (Supplementary Information 1, Figure S1A,B).
P. hydrolytica, however, did not hydrolyze α-chitin from crab shells used to supplement the marine
mineral medium, as neither GlcNAc nor chitooligosaccharides appeared during the incubation
(Figure S1C). β-NAHA activity from P. hydrolytica was detected by a hydrolysis of the chromogenic
5-bromo-4-chloro-3-indolyl N-acetyl-β-d-glucosaminide (X-GlcNAc) on a complex marine agar medium
(Figure S1D). These results indicated that the bacterium produced at least one β-NAHA which was
active towards chitooligosaccharides.
The draft genome sequence of P. hydrolytica [1], deposited on the RAST server (http://rast.nmpdr.
org/), encodes two putative GH20 β-NAHAs (EC 3.2.1.52) based on automatic annotation. Both
genes were found in contig 11 of the P. hydrolytica whole genome shotgun sequence (NCBI accession:
NZ_LSNE01000003.1). The protein sequence identity between full-length PhNah20A (WP_068373836.1)
and PhNah20B (WP_082768773.1) was 23%.
Top hits of protein BLAST, showing up to 54% to PhNah20A and up to 49% sequence identity to
PhNah20B, were GH20 β-NAHAs or chitobiases from phylogenetically closely related marine and soil
bacteria belonging mostly to the same order as P. hydrolytica—Alteromonadales (Table S1). None of these
proteins, encoded by genes from Paraglaciecola or related bacteria (Table S1), had been recombinantly
produced or characterized.
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The closest relatives of PhNah20A are GH20 β-NAHAs from Bowmanella denitrificans and
Lacimicrobium alkaliphilum with 53%-54% sequence identity (Table S1). PhNah20A contains two
domains, the GH20 catalytic (β/α)8-barrel domain (Pfam: PF00728) and the N-terminal GH20b
domain (also referred to as GH20 domain 2; Pfam: PF02838) of a predicted zincin-like fold similar to
zinc-dependent metalloproteases [49] consisting of four antiparallel β-strands and an α-helix [27,50].
These two domains are typical for GH20 enzymes [50], and importantly they constitute an active
and stable minimum functional unit of GH20 enzymes, thus requiring both a catalytic GH20 and a
GH20b domain [50]. PhNah20A has no predicted signal peptide sequence and most probably is not
secreted, whereas a 28 residues N-terminal signal peptide was predicted for the hypothetical PhNah20B
(Figure 1A). Therefore, during the growth of P. hydrolytica on chitooligosaccharides, PhNah20B probably
performs the initial degradation of these substrates. PhNah20B, in addition to the GH20b and
GH20 domains, contains a putative carbohydrate binding domain of the CHB_HEX superfamily
(Pfam: PF03173) having a predicted β-sandwich structure similar to cellulose binding domains
in cellulases [51], and a C-terminal CHB_HEX_C domain (Pfam: PF03174) of unknown function
resembling an immunoglobulin-like fold [50,51]. A similar four-domain architecture was seen in
the crystal structure of a chitobiase from S. marcescens [51], and has only been reported for bacterial
GH20 enzymes [50,51]. Based on its protein sequence identity and domain architecture, PhNah20B
resembles a biochemically uncharacterized GH20 chitobiase from Aliiglaciecola lipolytica and β-NAHAs
from other phylogenetically close marine bacteria (Table S1). It can be concluded that one of the
reasons for low sequence identity, i.e., 23%, between two putative GH20 enzymes of P. hydrolytica,
was the different domain architecture of PhNah20A and PhNah20B (Figure 1A), as PhNah20B has two
additional domains besides the GH20 catalytic domain and an N-terminal GH20b domain. The identity
between the two proteins remained low when only the predicted GH20b and GH20 domain sequences
were compared, as some regions are not aligning between proteins (Supplementary Information 2).
Figure 1. Schematic domain architecture of P. hydrolytica PhNah20A and PhNah20B (A) and of
genomic regions flanking the two putative β-N-acetylhexosaminidases (β-NAHAs) (red arrows) (B).
(A) GH20 catalytic domains are gray and the N-terminal signal peptide is striped. (B) Predicted
protein functions are color coded. The information was retrieved from the National Center for
Biotechnology Information (NCBI) database (NZ_LSNE01000003.1), Uniprot and Pfam databases.
The regions flanking PhNah20A (3): 1, LemA family protein; 2, hypothetical protein; 4, sodium:solute
symporter, putative SLC5sbd family protein; 5, RidA (reactive intermediate/imine deaminase A)
family protein; 6, d-aminoacylase; 7, MurR/RpiR family transcriptional regulator; 8, amino acid
deaminase; 9, sodium/proton-translocating pyrophosphatase. The regions flanking PhNah20B
(5): 1, TonB-dependent receptor; 2, DUF1624 domain-containing protein, putative acyltransferase;
3, glucose/galactose MFS transporter; 4, hypothetical protein, putative BadF-type ATPase; 6, LacI family
DNA-binding transcriptional regulator; 7, dCTP deaminase; 8, iron–sulfur cluster carrier protein ApbC;
9, methionine-tRNA ligase; 10, TetR/AcrR family transcriptional regulator. Predicted operons are in
dashed frames.
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Genomic regions flanking the two annotated P. hydrolytica β-NAHAs, PhNah20A and PhNah20B,
were examined for the presence of operons (Figure 1B), but were found not to be organized similarly to
the operon responsible for chitobiose-utilization in Escherichia coli [52]. Surrounding putative genes,
however, encoded proteins potentially participating in the modification of acetylated compounds,
the transporter function and transcription regulation (Figure 1B; Table S2). Notably, a predicted
operon of six genes that harbors PhNah20A (Figure 1B) included a putative amino acid deaminase,
d-aminoacylase and the RidA (reactive intermediate/imine deaminase A) family protein, possibly
associated with the processing of acylated compounds or amino acids [53]. A two-gene operon was
predicted to harbor PhNah20B and a putative ATPase (Figure 1B, Table S2). Thus, GH20 β-NAHAs
genes of P. hydrolytica were not situated adjacent to genes encoding proteins directly coupled to
β-NAHA activity, but flanking genes may be important for regulation or substrate transport.
2.2. Phylogenetic Analysis of PhNah20A and PhNah20B
Sequences of PhNah20A, PhNah20B and 41 characterized GH20 enzymes were aligned
(Supplementary Information 2). PhNah20A and PhNah20B shared a low sequence identity with
the other GH20 enzymes (up to 34.1% for PhNah20A and 37.9% for PhNah20B) and only a few
highly conserved regions were identified among these GH20 members (Supplementary Information
2). The closest homologs of PhNah20A were Hex2 of an uncultured Bacteroidetes (34.1% identity)
and ExoI of the marine bacterium V. furnissii (33.1% identity). Remarkably, GH20 sequences from
eukaryotes (human and mouse) were 31.3% and 30.9% identical and more similar to PhNah20A than
most other included bacterial sequences. The PhNah20B sequence was most similar to chitobiases from
S. marcescens (37.9% identity) and V. harveyi (36.4% identity). The evolutionary relationship illustrated
by a radial phylogenetic tree (Figure 2; for bootstrap values see Figure S2) showed that bacterial GH20s
segregate into three groups.
PhNah20B clustered with β-NAHAs from water-living bacteria from the phylogenetically close
species such as V. harveyi, P. piscicida and A. hydrophila. However, PhNah20A did not cluster with
characterized bacterial β-NAHAs but seems to represent a new distinct group of GH20 enzymes
situated between predominantly water-living bacteria and the eukaryotes (Figure 2).
NagA of the slime mold Dictyostelium discoideum which clusters not far from PhNah20A
(Figure 2), is a lysosomal enzyme that maintains the size of pseudoplasmodia [54], and shares
28.5% sequence identity with PhNah20A. According to the BLAST analysis, PhNah20A has higher
sequence identity to biochemically uncharacterized β-NAHAs from phylogenetically close marine
bacteria (Table S1). Additionally, protein sequences with 44–47% identity to PhNah20A were found in
compost, hydrothermal vent and marine sediment metagenomes (Table S1) highlighting unexplored
resources harbouring a new group of β-NAHAs.
According to the literature, substrate specificities and biochemical features (e.g., pH and
temperature optima) are reported for 41 β-NAHAs of GH20 [4,32] mostly from terrestrial organisms.
The few enzymes being from marine bacteria comprise ExoI and chitobiase from Vibrio sp. [33,37],
Hex99 and Hex86 from P. piscicida [21,35] and Nag20A and NagB from A. hydrophila [34,36]. The limited
knowledge on GH20 from marine organisms motivated the present characterisation of β-NAHA from
P. hydrolytica S66T.
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Figure 2. Schematic phylogenetic tree of PhNah20A, PhNah20B (both marked with red circles) and
41 biochemically characterized GH20 (EC 3.2.1.52) enzymes. Evolutionary analyzes were conducted,
and the tree was composed and visualized using MEGA v 7.0.26 [55]. Protein sequences were aligned
with Clustal Omega and the BLOSUM62 protein weight matrix was used. Evolutionary relationships
were calculated using the Neighbor-Joining method. Evolutionary distances were computed using
the Poisson correction method. All positions containing gaps and missing data were eliminated, and
there was in total 292 positions in the final dataset. The tree is in scale with branch lengths in the same
units as those of the evolutionary distances used to infer the phylogenetic tree. Bacterial (), fungal (),
plant (Δ), insect () and mammal () sequences. Amoebae and C. elegans sequences are marked with a
filled diamond (). Characterized GH20 enzymes from marine organisms are underlined.
2.3. Cloning and Production of β-NAHA
From the two candidateβ-NAHA genes (Figure 1A), only recombinant PhNah20A was successfully
produced in E. coli (Figure 3). PhNah20B cloned without the N-terminal signal peptide (Figure S3)
was not obtained despite expression attempts in three E. coli strains [BL21(DE3), BL21(DE3)ΔlacZ
and Rosetta], using different induction methods: isopropyl thio-β-d-galactoside (IPTG)-induction in
lysogeny broth (LB) or auto-induction. PhNah20B was not found in the insoluble fraction by analyzing
whole cells from IPTG-induced cultures (Figure S4). The yield of PhNah20A was modest, probably
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due to a low expression level. Using different strains and induction strategies resulted in the highest
β-NAHA activity of 6 μmol p-nitrophenol released per min and per mg protein in the E. coli cell lysate
for IPTG-induced BL21(DE3) transformants in LB medium (Figure 3).
Figure 3. β-NAHA activity in μmol per min per mg of total protein in the lysates of three different
Escherichia coli (E. coli) strains harboring PhNah20A grown in lysogeny broth (LB) induced by isopropyl
thio-β-d-galactoside (IPTG) or in the auto-induction medium ZYM-5052 [56] (30 h). E. coli BL21(DE3)
transformants carrying the full-length PhNah20A gene in an pURI3TEV expression vector were used in
the auto-induction experiment. Values are given as the average of three independent experiments and
the standard deviation (SD) is shown.
Previously, an increased expression of GH20 β-NAHAs from a metagenome [18] was achieved in
E. coli strains BL21(DE3), Turner, C41 or C43 grown in an auto-induction medium ZYM-5052 [56], but
this medium gave a very low yield of PhNah20A (Figure 3) and failed to lead to PhNah20B production.
Up to 2 mg of PhNah20A was purified in two chromatographic steps from one liter of E. coli
BL21(DE3) culture (see Section 3.4). Expression of truncated PhNah20A and PhNah20B, containing
only the catalytic and not the GH20b domain (see Figure S3), did not result in protein production which
is in agreement with previous findings that GH20b is essential for enzyme production and activity [50].
Attempts to produce PhNah20B without the CHB_HEX domains (Figure S3) also gave no detected
protein or β-NAHA activity.
2.4. Characterization of PhNah20A
2.4.1. Enzyme Stability
The activity of PhNah20A decreased immediately after dilution to the low concentration of
5 μg·mL−1, even when kept on ice (Figure 4). By contrast, 1 mg·mL−1 PhNah20A retained activity
at least four months at 4 ◦C in 50 mM sodium phosphate pH 7.0, 0.3 M NaCl and 0.02% NaN3. The
presence of 0.5% BSA or 0.5% Triton X-100 efficiently stabilized PhNah20A at 5 μg·mL−1 and pH 6.0
(see Figure 5A), whereas 0.5 and 2 M NaCl had no effect (Figure 4). This behavior and the absence of a
signal peptide suggest PhNah20A is an intracellular enzyme. Without a stabilizing agent, 5 μg·mL−1
PhNah20A was completely inactivated within 5 min at 50 ◦C, while 50% and 3% activity were retained
after 20 min and 4 h, respectively, in 0.5% BSA (Figure S5), and activity was fully retained after 4 d
at 37 ◦C. β-NAHAs from E. coli [57], Prunus serotina [58], Bos taurus [59], Hordeum vulgare [60] and
Streptomyces plicatus [61] were similarly found to lose activity by dilution. BSA has been identified
as an activating compound to some β-NAHAs, e.g., from Mus musculus [41] and human plasma [42].
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Notably, Hex, the commercial S. plicatus β-NAHA, is produced as a fusion with maltose-binding
protein to secure stability and the Hex reaction mixture contained 0.3% of BSA to maintain activity [38].
Figure 4. Effect of bovine serum albumin (BSA), Triton X-100, and NaCl on the stability of 5 μg·mL−1
PhNah20A on ice. The retained activity was measured at 37 ◦C in McIlvaine buffer, pH 6.0, using 2 mM
pNPGlcNAc as the substrate. PhNah20A, BSA, NaCl and Triton X-100 were further 10 times diluted in
the activity assay done at 0.5 μg·mL−1 PhNah20A, 0.05% or 0.5% BSA, 0.05% or 0.5% Triton X-100, 0.05
or 0.2 M NaCl.
Figure 5. PhNah20A pH and temperature optima. The effect of pH (A) at 37 ◦C and the temperature at
pH 6.0 (B) on initial rates of the hydrolysis of 2 mM pNPGlcNAc are both expressed as relative activity
(%) from optimal activity values.
2.4.2. pH and Temperature Optima
PhNah20A was most active at pH 5.0–7.5 with a maximum around pH 6.0 (Figure 5A) and
a temperature optimum at 50 ◦C (Figure 5B). The pH optimum of PhNah20A is highly similar to
numerous characterized GH20 β-NAHAs [25], e.g., from Microbacterium sp. [44], Paenibacillus sp. [45]
and A. hydrophila [34]. Some fungal β-NAHAs have more acidic pH optima (pH 4–5) [62–64]. Similarly
high temperature optima as for PhNah20A were found for chitinases from Salinivibrio costicola [65],
β-NAHAs from Serratia marcescens [66], A. hydrophila [36] as well as Penicillium oxalicum [27]. PhNah20A,
however, when diluted in buffer lost activity completely within 5 min at 50 ◦C in the absence of
stabilizers (Figure S5), emphasizing the importance of an environment with high protein concentration
for the stability of PhNah20A. The optimal growth temperature of P. hydrolytica was 20–25 ◦C [2], but
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the temperature optimum for PhNah20A activity was much higher, which is a common phenomenon
reported for other bacterial GH20 enzymes [27,66].
2.4.3. Substrate Specificity and Kinetic Parameters of PhNah20A
PhNah20A hydrolyzed N,N′-diacetylchitobiose [chitobiose, (GlcNAc)2, β-GlcNAc-1,4-GlcNAc]
and lacto-N-triose II (β-GlcNAc-1,3-β-Gal-1,4-Glc, LNT2) with the release of GlcNAc. Chitobiose was
a poor substrate and 1 U·mL−1 (11.6 μg·mL−1) PhNah20A converted only 25% of 200 mM chitobiose
in 20 h at pH 6.0 as analyzed by high-performance anion exchange chromatography with pulsed
amperometric detector (HPAEC-PAD). Similarly, only trace amounts of GlcNAc were released from
chitobiose by the GH20 BbhI from B. bifidum [40]. The action on LNT2 motivated assaying for
transglycosylation activity (see Section 2.5), i.e., the ability to catalyze the reverse reaction of hydrolysis
and in particular to produce HMOs, as described for the BbhI from B. bifidum [15,40].
Kinetic parameters for PhNah20A hydrolyzing pNPGlcNAc and pNPGalNAc (Table 1)
were very similar, kcat being slightly higher on pNPGalNAc. This identified PhNah20A
as an N-acetylhexosaminidase rather than either an N-acetylglucosaminidase or an
N-acetylgalactosaminidase. Most β-NAHAs, especially bacterial GH20 enzymes, prefer pNPGlcNAc
(Table 1) and are referred to as N-acetylglucosaminidases. For instance, S. marcescens β-NAHA showed
only 28.1% activity on pNPGalNAc compared to pNPGlcNAc [66]. Similarly, HexA from the ameba
E. histolytica had 38% activity on pNPGalNAc compared to pNPGlcNAc [67]. Nag20A from A. hydrophila
had very similar KM for pNPGlcNAc and pNPGalNAc, but Vmax for pNPGalNAc was only 13% of
Vmax for pNPGlcNAc [36]. Nag20B, also from A. hydrophila, showed about 20 times higher KM for
pNPGlcNAc and pNPGalNAc [34] than PhNah20A. Other differences include V. furnissii ExoI showing
3.6 times lower KM towards pNPGlcNAc than pNPGalNAc [33]. Similarly, Hex1 and Hex2 from a
metagenomic library showed very poor activity for pNPGalNAc [18]. On the other hand, β-NAHAs of
human and mouse prefer pNPGalNAc as a substrate over pNPGlcNAc and have a high affinity towards
it (KM of 0.17 and 0.25 mM, respectively) [41,42]. Another eukaryotic β-NAHA from D. discoideum
showed equal affinity (KM of 1.5 mM) for both substrates [68], thus resembling more PhNah20A
and some other bacterial enzymes (Table 1). Interestingly, BbhI had very high KM of 120 mM for
pNPGlcNAc (Table 1), but much lower KM of 0.36 mM for LNT2 [40].
Table 1. Kinetic parameters of PhNah20A and β-NAHAs from the literature on pNPGlcNAc and
pNPGalNAc. Sm—S. marcescens; Ah—A. hydrophila; Bb—B. bifidum; Cf —C. fimi; Vf —V. furnissii;
Eh—E. histolytica; Tr—Trichoderma reesei.
Enzyme Substrate KM (mM) Vmax (μmoL·mg−1·min−1) kcat (s−1) kcat/KM (mM−1·s−1)
PhNah20A
pNPGlcNAc 0.43 ± 0.07 93.7 ± 5.0 146.8 341
pNPGalNAc 0.56 ± 0.11 123.0 ± 7.0 192.7 344
SmChb 1 pNPGlcNAc 56.7 ± 4.3 NI 111.0 1.95
AhNag20A 2
pNPGlcNAc 0.52 115 NI NI
pNPGalNAc 0.5 7.6 NI NI
AhNagB 2
pNPGlcNAc 8.57 25 NI NI
pNPGalNAc 11.1 11 NI NI
BbhI of Bb 3
pNPGlcNAc 120.0 ± 0.2 NI 213 178
pNPGalNAc NA NA NA NA
Cf Hex20 4
pNPGlcNAc 0.053 NI 482.3 9090
pNPGalNAc 0.066 NI 129.1 1950
Vf ExoI 5
pNPGlcNAc 0.09 270 NI NI
pNPGalNAc 0.33 130 NI NI
Hex2 6 pNPGlcNAc 0.48 NI 60.0 ± 1.7 NI
EhHexA 7 pNPGlcNAc 0.1 3.8 NI NI
TrNag1 pNPGlcNAc 69.4 ± 4.0 NI NI 1023 ± 23
Data from 1 [69], 2 [36] and [34], 3 [40], 4 [39], 5 [33], 6 [18], 7 [67]. NI—not indicated; NA—no detected activity.
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2.5. Transglycosylation by PhNah20A
There are a few reports on LNT2 formation by GH20 catalyzed transglycosylation with (GlcNAc)2
or pNPGlcNAc as donors and lactose as the acceptor [15,18,64] (see Figure 6). Hydrolysis of LNT2
by PhNah20A, an HMO core structure [70], warranted the investigation of the transglycosylation
with (GlcNAc)2 and the GH20 reaction intermediate NAG-oxazoline [2-methyl-(1,2-dideoxy-
α-d-glucopyrano)-oxazoline] [71] as a donor and lactose as an acceptor (Figure 7A). We here also
demonstrated transglycosylation by the commercial GH20 N-acetylglucosaminidase from S. plicatus
(SpHex) [38] (see Figure S6), which has not been previously reported. Notably, the protein sequence
identity between SpHex and a bacterial transglycosylating enzyme Hex1 isolated from a metagenome [18]
was as high as 53.6%.
 
Figure 6. Scheme of transglycosylation reactions catalyzed by GH20 enzymes showing three different
possible donors and lactose as an acceptor.
Figure 7. Time course of transglycosylation by PhNah20A (10 U·mL−1) with 100 mM NAG-oxazoline
as donor and either 200 mM lactose (A) or d-galactose (B) as acceptor (see Section 3.8 for details).
Chitooligosaccharides (M), lacto-N-triose II (LNT2) and lacto-N-biose (LNB) were used as references.
Transglycosylation by β-NAHAs has been rarely investigated, and in one case there is a report on
a bacterial GH20 enzyme for which no transglycosylation was detected [72], indicating that not all
GH20 enzymes have the ability to transglycosylate. A GH20 chitobiase Hex99 from the Alteromonas sp.
strain O-7 (currently classified as P. piscicida) of the order Alteromonadales formed β-GlcNAc-1,6-GlcNAc
from (GlcNAc)2 by transglycosylation. It is to date the only marine GH20 enzyme reported to produce
GlcNAc-containing oligosaccharides [21]. Notably, P. piscicida belongs to the same bacterial order
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as P. hydrolytica. Hex99 has a unique substrate specificity, as it hydrolyzed only chitobiose and
pNP(GlcNAc)2, but neither other chitooligosaccharides nor pNPGlcNAc.
PhNah20A transglycosylated lactose with NAG-oxazoline as the donor (Figure 7A), resulting
in three trisaccharides (Figure 8). 2, purified by gel permeation chromatography (GPC) (Figure S7)
migrated similarly to LNT2 in thin-layer chromatography (TLC), and nuclear magnetic resonance (NMR)
spectroscopy confirmed the product structure (Figure S9). 1 was determined to be a non-reducing
trisaccharide, β-Gal-1,4-β-Glc-1,1-β-GlcNAc (Figure 8 and Figure S8; Tables S3 and S4), once reported
as a transglycosylation product of a β-NAHA from Aspergillus flavofurcatis CCF 3061 [73]. For full NMR
assignment as well as all measurable 3JH,H coupling constants of 1, see Tables S3 and S4. The 1,1-linkage
was supported by heteronuclear multiple-bond correlation spectroscopy (HMBC) and rotating frame
nuclear Overhauser effect spectroscopy (ROESY) correlations between the two anomeric positions as
well as by lack of a reducing end. Lastly, the β-configuration was determined of the anomeric positions
using the 3JH,H coupling constants between the anomeric proton and the neighboring proton (Table S4).
A third trisaccharide (3) was detected, but not fully characterized due to low abundance. Based on
chemical shifts of 3 (Figure S10), however, it seemed unlikely that the galactose moiety in lactose
acted as an acceptor, as none of the corresponding chemical shifts were affected. Consequently, most
probably the glucose moiety was the acceptor. As O6 was determined to be unsubstituted and glucose
was the reducing end residue, therefore either β-Gal-(β-GlcNAc)-1,2-Glc or β-Gal-(β-GlcNAc)-1,3-Glc
was produced (Figure S10).
 
Figure 8. Structures of transglycosylation products determined by nuclear magnetic resonance (NMR).
The three detected regioisomers are β-Gal-1,4-β-Glc-1,1-β-GlcNAc (1), β-GlcNAc-1,3-β-Gal-1,4-Glc,
LNT2 (2) and β-Gal-1,4-(β-GlcNAc)-1,x-Glc (3), (x = 2, 3). Both possible structures of 3 are shown.
Several examples exist in Nature of β-Gal-(β-GlcNAc)-1,2-Glc and β-GlcNAc-1,3-Glc being part
of polysaccharide backbones, such as the O-antigens (O-polysaccharides) of lipopolysaccharides from
Gram-negative bacteria, i.e., Proteus sp., Hafnia alvei and Citrobacter werkmanii [74–76].
The overall transglycosylation yield for trisaccharides was estimated from the high-performance
anion exchange chromatography with pulsed amperometric detector (HPAEC-PAD) chromatogram
to 3.8% obtained with 200 mM acceptor and 100 mM donor. Since other trisaccharides were formed,
no further optimization of transglycosylation conditions were pursued, even though LNT2 was the
major product. Notably, the three trisaccharides were not completely separated by gel permeation
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chromatography (GPC) (Figure S7), but thin-layer chromatography (TLC) and HPAEC-PAD analysis
(Figures S7 and S11) showed products consistent with trisaccharides 1 and 3 (Figure 8).
The acceptor specificity of PhNah20A was explored usingd-galactose, d-glucose, 2-deoxy-d-glucose
or l-fucose as an acceptor and NAG-oxazoline as a donor. These monosaccharides all proved to be
transglycosylated (Figure 7B and Figure S12) with the similar velocity and transglycosylation products
being detected in the most cases already after 0.03 h (2 min) incubation. Therefore, 2 h incubation was
sufficient to assess the transglycosylation ability of PhNah20A (Figure 7 and Figure S12). PhNah20A
thus showed unusual promiscuity towards acceptor molecules, but due to the low yields and formation
of several products as seen by TLC (Figure 7, Figure S12), purification and NMR analysis were not
pursued. Remarkably, however, the ability to transglycosylate a wide range of acceptors has very rarely
been reported for GH20 enzymes [18] and perhaps is associated with the marine origin and the unique
phylogenetic relation of PhNah20A. S. marcescens Chb (see Section 2.2) is able to transglycosylate
several alcohols, albeit sugar alcohols were not effective acceptors [66]. Some bacterial and fungal
β-NAHAs can use lactose as their acceptor [15,18,64], and two Hex enzymes from uncultured bacteria
were reported to transfer GlcNAc to d-glucose, d-galactose, sucrose and maltose [18].
3. Materials and Methods
3.1. Materials
LNT2 was purchased from Elicityl Oligotech (Crolles, France). Lactose, pNPGalNAc and
5-bromo-4-chloro-3-indolyl N-acetyl-β-d-glucosaminide (X-GlcNAc) were from Carbosynth (San Diego,
CA, USA), N,N′-diacetylchitobiose [(GlcNAc)2] from Omicron Biochemicals (South Bend, IN, USA),
and N,N′,N”-triacetylchitotriose [(GlcNAc)3] and pNPGlcNAc from Megazyme (Bray, Co. Wicklow,
Ireland). A mixture of chitooligosaccharides, (GlcNAc)1–6, was from Koyo Chemicals (Osaka, Japan).
All other chemicals were purchased from Sigma-Aldrich (Merck, Darmstadt, Germany) and used
without further purification. S. plicatus β-NAHA in fusion with maltose-binding protein was purchased
from New England Biolabs (Ipswich, MA, USA).
3.2. Bacterial Strains and Media
Paraglaciecola hydrolytica (type strain S66T) [1,2] was grown at 23 ◦C in Difco Marine Broth 2216
(BD, Franklin Lakes, NJ, USA) or on Marine Broth supplemented with 15 g·L−1 agar. X-GlcNAc was
added to the marine agar medium to 20 mg·L−1. Hydrolytic activity was assessed in 5 mL marine
mineral medium [77] supplemented with chitooligosaccharides (5 g·L−1) or α-chitin (2 g·L−1) at 23 ◦C.
E. coli DH5α was used for molecular cloning, E. coli BL21(DE3), BL21(DE3)ΔlacZ [78] and Rosetta
(Novagen, Merck, Darmstadt, Germany) for gene expression and E. coli BL21(DE3) for recombinant
protein production. E. coli was grown in Lysogeny Broth (LB; MoBio Laboratories, Carlsbad, CA, USA)
or on LB agar plates at 37 ◦C. Media were supplemented with 100 mg·L−1 ampicillin for selection.
Auto-induction medium ZYM-5052 was prepared as described [56]. Liquid cultures were aerated on a
shaker (160 rpm).
3.3. Molecular Cloning and Plasmids
P. hydrolytica genomic DNA was purified using the Gentra Puregene Yeast/Bact kit B (Qiagen,
Venlo, The Netherlands) and plasmid DNA was isolated using the GeneJET Plasmid Miniprep kit
(Thermo Fisher Scientific, Waltham, MA, USA). DNA content was determined on NanoDrop Lite
(Thermo Fisher Scientific, Waltham, MA, USA). Two putative P. hydrolytica β-NAHA-encoding genes
were amplified from genomic DNA by Phusion high-fidelity polymerase (Thermo Fisher Scientific,
Waltham, MA, USA) using specific primers (Table S5). Genes were cloned as full-length or truncated
variants (see Figure S3) into the pURI3TEV vector by PCR cloning [79].
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DNA sequencing (Eurofins Genomics, Ebersberg, Germany) verified that cloned sequences
matched the sequences in the P. hydrolytica genome. Plasmids were transformed into E. coli DH5α or
BL21(DE3) by electroporation.
3.4. Recombinant Protein Production and Purification
For initial expression analysis E. coli BL21(DE3) harboring PhNah20A in pURI3TEV grown in
20 mL LB medium at 37 ◦C until OD600nm ≈ 0.5 was induced by 0.5 mM isopropyl thio-β-d-galactoside
(IPTG), and incubated at 22 ◦C. Aliquots (10 μL) were mixed at 0, 4, 20 h with 4 μL SDS-PAGE sample
buffer, heated (10 min, 80 ◦C) to lyse cells and denature proteins, centrifuged (12,000× g, 1 min, RT) and
analyzed on pre-cast SDS-polyacrylamide gels according to the manufacturers’ instructions (NuPAGE,
Thermo Fisher Scientific, Waltham, MA, USA) in an XCell SureLock mini-cell electrophoresis system
(Thermo Fisher Scientific, USA). Gels were stained by Coomassie Brilliant Blue G-250. Cell lysates were
prepared from cell pellets after IPTG-induction by suspension in 0.4 mL 50 mM sodium phosphate pH
7.0, added 0.4 mL BugBuster protein extraction reagent (Merck, Darmstadt, Germany), approx. 100 U
Benzonase nuclease (Merck, Darmstadt, Germany), and centrifuged (12,000× g, 20 min, 4 ◦C).
For enzyme preparation E. coli BL21(DE3) harboring PhNah20A in pURI3TEV was grown in 1 L LB
medium at 37 ◦C to OD600nm ≈ 0.5, induced by 0.5 mM IPTG, and incubated (20 h, 22 ◦C). Cells collected
by centrifugation (10,000× g, 15 min, 4 ◦C) were resuspended in 50 mL lysis buffer (50 mM sodium
phosphate, pH 7.0, 0.3 M NaCl, 20 mM imidazole containing 250 U Benzonase nuclease), disrupted
(Cell Pressure Homogenizer, Stansted, UK) and centrifuged to remove debris (25,000× g, 20 min,
4 ◦C). The supernatant was filtered (0.45 μm sterile polyvinylidene fluoride (PVDF) membrane filter,
Millex-HV, Merck, Darmstadt, Germany) and PhNah20A purified by Ni2+-affinity chromatography
(HisTrapHP, GE Healthcare, Uppsala, Sweden) followed by size-exclusion chromatography (HiLoad
16/60 Superdex 200 pg; ÄKTA Avant chromatography system, GE Healthcare, Uppsala, Sweden) in
50 mM sodium phosphate, pH 7.0, 0.3 M NaCl at a flow rate of 2 mL·min−1. Eluate was analyzed
by SDS-PAGE and fractions containing PhNah20A were pooled, concentrated (Amicon ultra-15 30K
centrifugal filter device, Merck, Darmstadt, Germany), and had added to them 0.02% Na-azide, and
then were stored in the above-mentioned buffer at 4 ◦C. Protein concentration was determined by the
Pierce Coomassie (Bradford) Protein Assay Kit (Thermo Fisher Scientific, Waltham, MA, USA) for cell
lysates and NanoDrop Lite (Themo Fisher Scientific, Waltham, MA, USA) for purified protein using
the calculated ε280 = 136,835 M−1·cm−1 (ExPasy server; https://web.expasy.org/protparam/). After
spectrophotometric determination of the concentration of PhNah20A, bovine serum albumin (BSA)
was added to 0.5% of final concentration for storage.
3.5. Activity Assays
PhNah20A activity was routinely determined on 2 mM pNPGlcNAc at 37 ◦C in two-fold diluted
McIlvaine buffer pH 6.0 (63 mM Na2HPO4; 18 mM citric acid), containing 0.05% BSA. The reaction (total
volume 500 μL) was performed in McIlvaine buffer, pH 6.0 (250 μl), 100 μl milliQ water and 100 μL of
substrate was added. The reaction was initiated by adding 50 μL of PhNah20A (prepared immediately
before use in McIlvaine buffer, pH 6.0, 0.5% BSA, and kept on ice) to the reaction mixture yielding
a final concentration of 0.3–5 μg·mL−1. The reaction was stopped typically after 2–5 min by 250 μL
1 M Na2CO3 and the product was measured spectrophotometrically at 400 nm (Ultrospec 3100 pro
UV/Visible spectrophotometer, GE Healthcare, Uppsala, Sweden) using pNP (ε400 = 18,000 M−1·cm−1)
as the standard. One U of activity was defined as the amount of enzyme releasing 1 μmol pNP per min
from 2 mM pNPGlcNAc. pH activity optimum was determined for PhNah20A in McIlvaine buffers
(pH 4.0–8.0) at 37 ◦C towards 2 mM pNPGlcNAc and the temperature optimum was determined from
the initial rates of pNP release at temperatures in the range 10–65 ◦C at pH 6.0.
To determine the hydrolysis by PhNah20A 200 mM (GlcNAc)2 was incubated with 1 U·mL−1
(11.6 μg·mL−1) or 5 mM LNT2 with 10 U·mL−1 (116 μg·mL-1) in 50 mM sodium phosphate, pH 6.0, 0.5%
BSA, at 37 ◦C for 20 h. The release of GlcNAc was monitored by high-performance anion exchange
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chromatography with pulsed amperometric detector (HPAEC-PAD) for (GlcNAc)2 and by thin-layer
chromatography (TLC) for LNT2 (see Section 3.9).
3.6. Kinetics
PhNah20A (final concentration 0.3–1.2 μg·mL-1) was added to initiate the hydrolysis of 0.05–2 mM
pNPGlcNAc (six concentrations) and 0.1–2 mM pNPGalNAc (five concentrations) in 500 μL two-fold
diluted McIlvaine buffer pH 6.0, 0.05% BSA at 37 ◦C. The reaction was stopped at suitable time points
by the addition of 250 μL 1 M Na2CO3 and quantified spectrophotometrically as above. Initial rates
calculated from pNP formation versus time were plotted against substrate concentration and fitted to
the Michaelis-Menten equation using OriginPro 2015 (OriginLab, Northampton, MA, USA) to obtain
kcat and KM. The kcat/KM values were either calculated or determined from rates of hydrolysis at low
substrate concentration.
3.7. Synthesis of NAG-Oxazoline
NAG-oxazoline [2-methyl-(1,2-dideoxy-α-d-glucopyrano)-oxazoline] was synthesized and
purified as described previously [71]. Briefly, 2 g GlcNAc (9 mmol) was dissolved in 20 mL acetic
anhydride, then we added 10 mL pyridine and stirred overnight at room temperature (RT). After
extraction by dichloromethane (DCM) and successive washings (Na2CO3, H2O, H2SO4, H2O) the
organic layer was dried and evaporated. Trimethylsilyl trifluoromethanesulfonate (0.8 mL) was added
to 1.5 g peracetylated glucosamine dissolved in 1,2-dichloroethane and stirred at 50 ◦C until completion
of the reaction (about 4 h). Trimethylamine was added (2 mL) followed by 50 mL DCM, washed with
cold water, dried and evaporated. The product was purified by flash chromatography (cyclohexane:
1% triethylamine in ethyl acetate 100:0 to 40:60). Peracetylated oxazole (300 mg) in 10 mL anhydrous
methanol at 0 ◦C was added 15 μL 5.3 M sodium methanolate in methanol and stirred at RT until
the reaction was completed (about 3 h). The resulting NAG-oxazoline was dried and used without
further purification.
3.8. Transglycosylation
Reaction mixtures for transglycosylation contained either 100 mM NAG-oxazoline (from 1 M
stock in 50 mM sodium borate, pH 9.3) or 100 mM (GlcNAc)2 donor, and as acceptor 200 mM
lactose, d-galactose, d-glucose, 2-deoxy-d-glucose or l-fucose; 1 or 10 U·mL−1 (11.6 or 116 μg·mL−1)
PhNah20A or 10 U·mL−1 S. plicatus β-NAHA in 50 mM sodium phosphate, pH 8.0, 0.5% BSA, at 37 ◦C.
The reaction volume was typically 20 μL for TLC analysis and 250 μL for product yield and structure
determination. Slightly basic conditions were required as NAG-oxazoline is not stable at neutral or
acidic pH [71]. Reactions were stopped at various time points by heating (5 min, 90 ◦C), cooled to
RT and centrifuged (12,000× g, 1 min, 4 ◦C). Samples were diluted four- and 150-fold in milliQ water
for TLC and HPAEC-PAD (see Section 3.9), respectively. For the reaction mixtures for the analysis
of transglycosylation products after gel permeation chromatography (GPC), containing 10 U·mL−1
PhNah20A, 100 mM NAG-oxazoline and 200 mM lactose in 50 mM sodium phosphate pH 8.0, 0.5%
BSA were incubated 2 h at 37 ◦C followed by heating (5 min, 90 ◦C). To the sample was added three
volumes of sterile milliQ water, and the enzyme was removed (Amicon Ultra 0.5 mL centrifugal device,
Mw cut-off 30 kDa; Merck, Darmstadt, Germany) followed by filtration (0.45 μm filters; Millex-HV,
Merck, Darmstadt, Germany) prior to GPC.
3.9. Chromatographic Methods
Reaction mixtures containing 15–30 μg carbohydrate were spotted onto TLC plates (Silica
Gel 60 F254 plates; Merck, Darmstadt, Germany) developed twice in chloroform:acetic acid:water
(6:7:1; v:v:v) [80,81] or n-butanol: ethanol: water (5:3:2; v:v:v) [82]. Carbohydrates were visualized with
orcinol (0.5% 5-methyl resorcinol and 10% H2SO4 in ethanol) or aniline dye (1.2% aniline hydrochloride
and 1.2% diphenylamine in acidic methanol).
42
Int. J. Mol. Sci. 2020, 21, 417
Oligosaccharides were also separated by HPAEC-PAD at 22 ◦C (Dionex CarboPac PA1 column,
250 × 4 mm with 50 × 4 mm Guard, Thermo Fisher Scientific, Waltham, MA, USA) using an ICS-5000
system (Thermo Fisher Scientific, Waltham, MA, USA) equipped with AS autosampler and pulsed
amperometric detector (carbohydrate four-potential waveform, sampling rate 2 Hz) with a gold
electrode (Au) and an Ag/AgCl reference electrode.
The elution was done with (A) water; (B) 1 M NaOH; (C) 200 mM NaOH + 800 mM NaOAc
isocratically using 7.5% B in A (25 min) followed by 100% C (1 min) and column re-equilibration
(9 min) at 7.5% B in A at 1.0 mL·min−1. Oligosaccharides in water (10 μL) containing 9 μM l-fucose
as standard were injected by autosampler kept at 5 ◦C. LNT2, glucose, galactose, lactose, GlcNAc,
(GlcNAc)2 and chitooligosaccharides were used as standards for calibration. Reaction mixtures
(0.5 mL) containing approximately 10 mg oligosaccharides were separated by GPC (Bio-Gel P-2,
Bio-Rad Laboratories, Hercules, CA, USA; 16 × 900 mm XK16/100 mounted on an ÄKTAprime plus
chromatography system, GE Healthcare, Sweden), eluted by degassed milliQ water at flow rate of
0.1 mL·min−1 at RT and pressure limit set to 0.3 MPa. Reducing sugar in collected fractions (2 mL)
were quantified by the Nelson-Somogyi method [83] using glucose and GlcNAc as standards. Fractions
containing trisaccharides were dried (SpeedVac, Thermo Fisher Scientific, Waltham, MA, USA) at
50 ◦C, dissolved in 50 μL milliQ water and subjected to TLC for the preliminary identification of
transglycosylation products. For NMR analysis, identical trisaccharide-containing fractions from two
GPC runs were pooled, dried (SpeedVac) and dissolved in 0.5 mL D2O (Sigma-Aldrich, USA). Each
fraction contained a major component and trace amounts of one or two other products.
3.10. Nuclear Magnetic Resonance (NMR)
All NMR spectra were recorded on an 800 MHz Bruker Avance III (799.75 MHz for 1H and
201.10 MHz for 13C) equipped with a 5 mm TCI cryoprobe. Acetone was used as internal reference
(2.22 ppm and 30.89 ppm for 1H and 13C, respectively). The following experiments were used for the
structure elucidation: 1H with presaturation, double quantum filtered correlation spectroscopy
(DQF-COSY), rotating frame nuclear Overhauser effect spectroscopy (ROESY), heteronuclear
single-quantum correlation spectroscopy (HSQC), heteronuclear single-quantum correlation
spectroscopy-total correlation spectroscopy (HSQC-TOCSY) and heteronuclear multiple-bond
correlation spectroscopy (HMBC) all performed using standard Bruker pulse sequences. LNT2 and
lactose were used as reference compounds. Structural elucidation was carried out by first identifying
all 1H and corresponding 13C chemical shifts using 1H with presaturation and HSQC. Subsequently,
the different signals belonging to each position in each monosaccharide were determined, primarily
using DQF-COSY and HSQC-TOCSY, and finally the connections between the monosaccharides were
determined using HMBC and ROESY, as well as comparing chemical shifts to reference compounds.
3.11. In Silico Methods
The draft genome sequence of P. hydrolytica S66T [1] annotated on the RAST server (http:
//rast.nmpdr.org/) [84] was mined on 20 March 2016, to identify putative β-NAHAs. Visualization of
the RAST-annotated proteins was done on the SEED Viewer v 2.0 (www.theSEED.org).
Protein sequences of characterized β-NAHAs were retrieved from UniprotKB (https://www.
uniprot.org/) on 10 February 2019. Nucleotide BLAST and protein BLAST tools (https://blast.ncbi.
nlm.nih.gov/Blast.cgi) were used in 10 February 2019 and 3 January 2020 for identity analysis of
nucleotide and protein sequences, respectively. Multiple sequence alignments were carried out with
Clustal Omega v 2.1 (https://www.ebi.ac.uk/Tools/msa/clustalo/) and visualized by BioEdit v 7.0.5.3
(https://www.softpedia.com/get/Science-CAD/BioEdit.shtml).
The phylogenetic tree was constructed and visualized using MEGA v 7.0.26 (https://megasoftware.
net/) [55].
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N-terminal signal peptide prediction was done by SignalP v 4.1 with sensitive default cut-off values
(http://www.cbs.dtu.dk/services/SignalP/) [85]. Promoter locations were predicted by SoftBerry tool
BPROM (http://www.softberry.com/berry.phtml?topic=bprom&group=programs&subgroup=gfindb).
4. Conclusions
The genome of the marine bacterium P. hydrolytica S66T encodes two putative GH20
β-N-acetylhexosaminidase (EC 3.2.1.52) having protein sequences that differed remarkably from
earlier characterized β-NAHAs (≤30% identity). PhNah20A was positioned on a phylogenetic tree
between β-NAHAs of water-associated bacteria, i.e., Vibrio furnissii and Aeromonas hydrophila, and
unicellular eukaryotes (amobae). PhNah20A, produced in E. coli, was unstable if diluted, but was
stabilized by BSA or Triton X-100. PhNah20A is a genuine β-NAHA with essentially the same catalytic
efficiency for pNPGlcNAc and pNPGalNAc, and thus differs from most of the previously studied
bacterial β-NAHAs, which prefer pNPGlcNAc as a substrate while some eukaryotic GH20 prefer
pNPGalNAc. PhNah20A also hydrolyzed LNT2, a core structure of human milk oligosaccharides,
and showed biosynthetic activity (transglycosylation) which is a poorly studied aspect of GH20
β-NAHAs, especially from eukaryotes and water-living prokaryotes. PhNah20A was able to form
LTN2 by transglycosylation using NAG-oxazoline as a donor and lactose as an acceptor, LNT2,
β-Gal-1,4-β-Glc-1,1-β-GlcNAc and β-Gal-1,4-(β-GlcNAc)-1,2/3-Glc being identified by NMR as main
transglycosylation products. Several monosaccharides were also recognized as acceptors by PhNah20A.
To date, based on pH and temperature optima, kinetic parameters or stability characteristics alone,
no clear distinction can be made between eukaryotic versus prokaryotic or terrestrial versus aquatic
GH20 β-NAHAs. However, this may be due to the very limited number of characterized β-NAHAs of
salt or fresh water origin. PhNah20A is the first characterized member of a distinct group of GH20
β-NAHAs located phylogenetically between eukaryotic and prokaryotic enzymes.
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Abstract: Fermentable sugars are important intermediate products in the conversion of lignocellulosic
biomass to biofuels and other value-added bio-products. The main bottlenecks limiting the production
of fermentable sugars from lignocellulosic biomass are the high cost and the low saccharification
efficiency of degradation enzymes. Herein, we report the secretome of Trichoderma harzianum
EM0925 under induction of lignocellulose. Numerously and quantitatively balanced cellulases and
hemicellulases, especially high levels of glycosidases, could be secreted by T. harzianum EM0925.
Compared with the commercial enzyme preparations, the T. harzianum EM0925 enzyme cocktail
presented significantly higher lignocellulolytic enzyme activities and hydrolysis efficiency against
lignocellulosic biomass. Moreover, 100% yields of glucose and xylose were obtained simultaneously
from ultrafine grinding and alkali pretreated corn stover. These findings demonstrate a natural
cellulases and hemicellulases mixture for complete conversion of biomass polysaccharide, suggesting
T. harzianum EM0925 enzymes have great potential for industrial applications.
Keywords: glycoside hydrolyase; Trichoderma harzianum; complete saccharification; lignocellulose
1. Introduction
Recently, bio-based industries have developed rapidly, and potential bio-based products including
ethanol, aldehydes, organic acids, polyhydric alcohols, and other bio-chemicals and biomaterials
have attracted a lot of attention. As the most important intermediate compounds of biological and
chemical transformation from biomass, fermentable sugars (mainly glucose and xylose) are crucial
for the production of downstream products [1,2]. Due to the structural complexity of lignocellulose,
complete enzymatic deconstruction requires the synergistic action of cellulases, hemicellulases, and
ligninases [3]. In order to obtain high yield of glucose from cellulose, endoglucanase, cellobiohydrolase,
and β-glucosidase are required to work together. Endoglucanases randomly cleave the internal
O-glycosidic bonds and produce glucan chains with different lengths, cellobiohydrolases attack the
reducing and non-reducing ends of cellulose to release β-cellobiose, and β-glucosidases hydrolyze
the terminal non-reducing β-d-glucosyl residues into glucose. These enzymes can be produced by
many fungi (like Aspergillus and Trichoderma) and bacteria (like Cellulomonas and Clostridium) [2,3]. In
any case, the rapid and complete conversion of cellulose is the limiting step during the process of
bio-refinery [4].
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Currently, Trichoderma reesei has been commonly used as a cellulase producer. Although two
exoglucanases (CBH I and CBH II), eight endoglucanases (EGI-EGVIII), and seven β-glucosidase
(BG I-BG VII) are produced by this fungus, the fairly low protein abundance (<1%) of β-glucosidase
in the extracellular proteome limited the effective conversion of cellubiose to glucose [5]. The total
cellulase activities of commercial preparations Viscozyme L and Celluclast 1.5L were as high as
33 and 95.2 FPU/mL, but the β-glucosidase activity was only 0.2 and 0.3 U/mL, respectively [6].
When β-glucosidase preparation Novezyme 188 was supplied to Celluclast 1.5L, glucose yield from
sugarcane bagasse increased 1.5-fold than that of Celluclast 1.5L alone [7]. In addition, higher content
of cellobiohydrolase in Trichoderma reesei extracellular proteome was detected, which caused the
accumulation of cellobiose on account of the deficient amount of β-glucosidase, and then gave rise
to severe product feedback inhibition of endoglucanase and cellobiohydrolase [8]. Some researchers
found that hemicellulases, oxidoreductases, non-hydrolytic proteins and other auxiliary enzymes
synergize to achieve an efficient enzymatic hydrolysis of cellulose [2]. Hemicellulase and pectinase
could degrade the non-cellulose polysaccharide that covered cellulose and in turn increase the cellulose
hydrolysis efficiency, and this synergistic effect could give rise to the cost reduction in deconstruction
of lignocellulose [9]. Goldbeck et al. [10] found that when xylanase was added to the commercial
cellulase preparation Accellerase 1500, the glucose yield of dilute acid pretreated sugarcane bagasse
presented a 1.4-fold increase than that of Accellerase 1500 alone. Furthermore, hemicellulose hydrolysis
products (xylose, arabinose, mannose, and galactose etc.) also have great potential in food and
feed industry applications. Therefore, in terms of the whole component utilization of plant cell
wall polysaccharides, not only lack of β-glucosidase restricted the efficient conversion of cellulose,
the lack of hemicellulase in Trichoderma reesei extracellular proteome also made it difficult to utilize
hemicellulose [11]. Hemicellulase activity of commercial cellulase production model strains T. reesei
QM6a and T. reesei QM9414 has been determined by Li et al. [12], in which the xylanase activity was
5.42 and 1.27 U/mL, while xylosidase activity was only 0.4 and 0.005 U/mL, respectively. Recent
studies showed that extracellular enzymes from Penicillium species perform better than cellulases
from Trichoderma sp. On account of the higher hemicellulases activities of enzyme mixture secreted
by Penicillium sp., greater fermentable sugar yield was obtained [13,14]. Yang et al. [15] found that
when 50% of the commercial cellulase was replaced by Penicillium chrysogenum enzyme cocktail,
release of reducing sugars was 78.6% higher than that with the cellulase alone, while the glucan
and xylan conversion was increased by 37% and 106%, respectively. Additionally, the hydrolysis
efficiency of cellulase increased more with the addition of multi-component hemicellulases cocktail
than with xylanase alone. The artificial enzyme cocktail of pectinase, xylanase, arabinofuranosidase,
acetyl xylan esterase, and ferulic acid esterase presented higher efficiency of bagasse degradation than
the single component [16]. The appropriate dosage of auxiliary enzymes for efficient conversion of
different lignocellulosic biomass is still uncertain. Therefore, exploring novel lignocellulosic degrading
strains with complete and balanced enzyme cocktail for efficiently saccharification of lignocellulose is
necessary for industrial enzyme preparation production.
Production of extracellular enzymes with high cellulase activity has been proved in members
of Trichoderma [17]. T. reesei Rut-C30 mainly expresses cellulases including cellobiohydrolase and
endoglucanase with a total abundance of 90–95% of the extracellular proteins [18]. Compared with the
industrial cellulase producer T. reesei, Trichoderma harzianum harbors more comprehensive lignocellulosic
degrading enzyme encoding genes in its genome [19]. To be specific, a total of 42 cellulase genes and
24 hemicellulase genes were annotated in genome of T. harzianum T6776, which were 1.5 and 1.7-fold
of those of T. reesei Rut-C30 [20]. Meanwhile, the expression levels of xylanase, mannase, and various
glycosidases of T. harzianum was significantly higher than that in T. reesei [19,21]. Compared with
T. reesei, some T. harzianum strains produced a cellulolytic complex with higher β-glucosidase and
endoglucanases activities, and the xylanase activity of some T. harzianum strains was higher than that
of T. reesei [22–24]. However, efficiency of simultaneous cellulose and hemicellulose hydrolysis by the
secretome of T. harzianum was still low [23,25]. Lignocellulose degrading enzymes in microbes are
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induced by substrates, and the low-cost carbon source and culture conditions had a great influence
on the enzyme secretion and composition [26]. Nevertheless, the mechanism of lignocellulolytic
enzyme inducing was still unclear [27]. So, searching and exploring highly effective enzyme systems
for efficiently converting the whole component of plant cell wall polysaccharides is expected, and
the comprehensive understanding of secretomes in the related microbes could help the development
of efficiently tailor-made lignocellulolytic enzyme cocktails in vitro [28]. Isolated in our laboratory,
T. harzianum EM0925 could secret high levels of cellulase and hemicellulase simultaneously, and its
extracellular enzyme cocktail showed strong ability of lignocellulose degradation. The enzyme cocktail
of T. harzianum EM0925 contained a great amount of complete lignocellulolytic enzymes as revealed
by proteome analysis under the optimal inducing condition. Aiming at analyzing the degradation
mechanism of T. harzianum EM0925, we performed the present study. The results provide a basis for
tailor-made preparation of low-cost enzymes to effectively degrade the whole component of plant cell
wall polysaccharides.
2. Results
2.1. Substrate Selection for Lignocellulosic Enzyme Production by T. Harzianum EM0925
In order to prepare low-cost lignocellulolytic enzymes cocktails, different kinds of lignocellulosic
substrates were used separately as the carbon source for T. harzianum EM0925, including wheat bran,
sunchoke (Jerusalem artichoke) stalks, corncob, miscanthus, giant juncao grass, switchgrass, corn stover,
sugarcane bagasse, and straw of Triarrhena lutarioriparia. Measurement of the extracellular cellulase
and xylanase revealed that the highest filter paper activity (1.54 U/mL) was induced by corn stover
after seven days of cultivation (Figure 1). Simultaneously, high levels of endoglucanase activity (8.61
U/mL) and xylanase activity (54 U/mL) were induced (Figure 1), in which the xylanase activity was
91% of the maximum value (59.9 U/mL) detected in the culture with corncob after seven days of
cultivation. In addition, when corn stover was used, rapid enzyme production capacity was observed
in T. harzianum EM0925. The filter paper activity reached more than 70% of the maximum value, while
the endoglucanase and xylanase activities reached more than 80% of their maximum values after two
days of fermentation. Therefore, corn stover was selected as the optimal substrate for T. harzianum
EM0925 to prepare the lignocellulolytic enzyme cocktail (EM0925) in further study.
2.2. Enzyme Activities of Enzyme Cocktail EM0925
Enzyme activities of commercial preparations (C 9748 and Celluclast 1.5L) and EM0925 (Enzyme
preparation of T. harzianum EM0925) were measured by using the model substrates. The three
enzyme preparations showed significant differences in their specific activities of cellulases, including
endoglucanase, cellobiohydrolase, and β-glucosidase. The endoglucanase activity of EM0925 was
only 56.9% of C 9748, and the cellobiohydrolase activity showed no significant difference with that of
Celluclast 1.5L. Most notably, EM0925 displayed the highest level of β-glucosidase activity, which was
311 and 2.9 folds of that in C 9748 and Celluclast 1.5L, respectively. In addition, EM0925 displayed
significantly higher hemicellulases activities than the two commercial preparations. The xylanase
specific activitiy of EM0925 was 310.70 U/mg, which was 29.1 folds higher than that of Celluclast
1.5L. Xylosidase and arabinofuranosidase activities were as high as 203.60 and 11.72 U/mg, which was
333.8 and 37.8 folds higher than that of commercial enzyme preparations C 9748 and Celluclast 1.5L,
respectively. Furthermore, amylase activities of EM0925 and C 9748 were 3.92 and 0.3 U/mg, respectively,
and it was not detected in Celluclast 1.5L. EM0925 contained a more complete lignocellulosic enzyme
system than the commercial enzyme preparations. It presented high levels of glycosidases that were
necessary for cellulose and hemicellulose degradation, and showed a broader prospect in fermentable
monosaccharide production from complex polysaccharide compounds (Table 1).
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Figure 1. Activities of cellulase and hemicellulase secreted by T. harzianum EM0925 induced by different
kinds of lignocellulosic biomass. (a) FPA in cultures; (b) CMCase activities in cultures; (c) hemicellulases
activities in cultures.
Table 1. Cellulase and hemicellulase activities of EM0925 and commercial enzyme preparations (specific
activities, U/mg protein).
Cocktail FPA EG CBH βG Xyl βX Ara Man Amy




















































FPA, filter paper activity; EG, CMCase activity; CBH, cellobiohydrolase activity; βG, β-glucosidase activity; Xyl,
xylanase activity; βX, β-xylosidase activity; Ara, arabinofuranosidase activity; Man, mannase activity; Amy, amylase
activity; C 9748, commercial cellulase preparation from Sigma; Celluclast 1.5 L, commercial cellulase preparation
from Novozyme; EM0925, enzyme cocktail of T. harzianum EM0925; ND, not detected. a, b, c statistical significance is
indicated by different letters in table as assessed by ANOVA (p < 0.05).
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2.3. Extracellular Enzymes in the Proteome of T. harzianum EM0925
By using the label free quantitative proteomic approach, a total of 154 proteins were identified in
the T. harzianum EM0925 secretome, which were common in all the three biological replicates. The
predicted proteins in the secretome of T. harzianum EM0925 were grouped according to their biological
function annotated in Pfam and dbCAN database. The 81 detected CAZymes contained 27 cellulases
covering a complete cellulolytic enzyme system with 13 endoglucanases (GH5, GH7, GH16, GH17,
GH30, GH55, GH64, GH81), 2 cellobiohydrolases (GH6, GH7), and 12 glucosidases (GH3, GH15,
GH16, GH55) (Figure 2a, Figure S1). The detection of 39 hemicellulases revealed that this kind of
enzymes was more abundant than the cellulases in T. harzianum EM0925 secretome, which included 8
xylanases (GH11, GH30), 1 xylosidases (GH3), 3 arabinofuranosidases (GH54, GH127), 7 galactosidases
(GH2, GH22, GH27, GH30), 11 mannosidases (GH2, GH47, GH92, GH125), 1 mananase (GH26), and 8
carboxylesterases (CE1, CE5, CE10) (Figure 2b, Figure S1).
Figure 2. Functional classification of enzymes secreted by T. harzianum EM0925. (a) Functional
classification of T. harzianum EM0925 enzyme cocktail; (b) numbers of different lignocellulosic enzyme
in proteome of T. harzianum EM0925. (c) Abundance of lignocellulose degradading enzymes in the
proteome of T. harzianum EM0925. EG, Endoglucanase; CBH, cellobiohydrolase; βG, β-glucosidase;
LPMO, lytic polysaccharide monooxygenase; Xyl, xylanase; βX, β-xylosidase; Ara, arabinofuranosidase;
Man, mannosidase; Gal, galactosidases; ES, carboxylesterase.
The quantitative proteomic data showed high ratios in the protein abundance of a core set
of glycoside hydrolases secreted by T. harzianum EM0925, including total cellulase abundance of
31.5% and total hemicellulase abundance of 32.2% (Figure 2c). Cellulases, including endoglucanases,
cellobiohydrolases and glucosidases accounted for 11.85%, 8.8%, and 9.76% of the total proteins,
respectively (Figure 2c). Among the secreted cellulases and hemicellulases, some proteins in these
sets took up a great proportion. For instance, the two GH5 endogluananses accounted for 4.54%
and 5.30% of the total proteins, respectively, and both contained a CBM domain at each of the C
and N ends of the protein. Cellobiohydrolases I (GH7) and cellobiohydrolases II (GH6) accounted
for 7.30% and 1.50% of total protein abundance, respectively. Two GH3 β-glucosidases accounted
for an outstanding proportion among the multiple glucosidases, with abundances of 6.00% and
1.76% (Figure 3a). Multiple abundant hemicellulases were also detected, including xylanase (21.01%),
xylosidases (0.24%), arabinofuranosidases (6.66%), galactosidases (2.1%), mannosidases (1.18%), and
carboxylesterase (1.01%). It was noteworthy that two highly expressed xylanases were relatively
abundant in the secretome, with an abundance index of 14.69% and 4.51%, and accounted for 91.4% of
the total xylanase abundance. A lytic polysaccharide monooxygenase (LPMO, AA9) secreted by T.
harzianum EM0925 accounted for 3.23% of the total quantified CAZymes (Figure 2c). Moreover, the
main glycosidases (glucosidases, xylosidases, arabinofuranosidases, and mannosidases) accounted for
17.2% of the total extracellular degradation enzymes secreted by T. harzianum EM0925 (Figure 3).
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Figure 3. Cellulase and hemicellulase abundance in the proteome of T. harzianum EM0925. (a) Cellulase
content in the proteome of T. harzianum EM0925; (b) hemicellulase content in the proteome of T.
harzianum EM0925.
2.4. Properties of Enzyme Cocktail EM0925
The optimum temperatures of filter paper degrading enzymes and endoglucanases in the enzyme
cocktail secreted by T. harzianum EM0925 were 60 ◦C, and that of xylanases were 50 ◦C. Filter paper
activities and endoglucananse activities were 98.94% and 85.38% of their highest activities at 50 ◦C,
respectively. When T. harzianum EM0925 enzymes were incubated at 50 ◦C for 1 h, the endoglucanases,
total cellulases and xylanases still maintained 100%, 83.22%, and 85.72% relative activity, respectively.
The optimal pH of total cellulases, endoglucanases and xylanases was 4.5. The activity was above
75% of the highest activity for total cellulase at pH 3.0–6.0, above 70% for endoglucanase at pH 3.5–5.0,
and above 90% for xylanase at pH 2.5–5.0. In addition, favorable pH stability was also observed for the
enzymes: 75% total cellulase activity was maintained after 1 h of incubation at pH-values between 2.0
and 12.0, in which 90% activity was maintained at pH 3.0 to 9.0. In addition, about 98% endoglucanase
activity and 80% xylanase activity were maintained at the pH range of 2.0–12.0 after 1 h incubation,
which 95% xylanase activity was maintained at the pH range of 2.0–9.0 (Figure 4).
2.5. Hydrolysis of Lignocellulosic Biomass by Enzyme Cocktail EM0925
The structural carbohydrate and lignin contents of differently pre-treated fractions of corn stover
were determined (Figure 5a). As expected, chlorite/acetic acid and NaOH pretreatment resulted a
significant decrease in lignin content: only 2% of the initial lignin content remained in ALKCS, whereas
the relative cellulose content was highly increased up to 60.7%, which was 1.4-fold of that in NTCS.
Dilute acid and steam explosion treatment significantly decreased the content of hemicellulose, which
decreased from 26.1% to 5% in DACS, and the highest cellulose content (62.5%) was observed at the
same time (Figure 5a). At the enzyme dosage of 5 mg proteins/g substrate, hydrolysis with EM0925
generated 14.62, 19.00, 13.22, 12.43, and 8.83 mg reducing sugars per 20 mg of ultrafine grinding corn
stover (UGCS), sodium hydroxide treated corn stover (ALKCS), sodium chlorite treated corn stover
(DLCS), dilute acid treated corn stover (DACS), and stream explosion treated corn stover (SECS) after
72 h reaction, respectively. In contrast, only 4.31 mg reducing sugars were released from 20 mg of
NTCS. Reducing sugar yield of UGCS and ALKCS was 96.6% and 100%, respectively. Furthermore,
rapid saccharification was observed with these two substrates, which resulted in a sugar yield of 81.9%
and 74.2% after 24 h of hydrolysis (Figure 5b).
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Figure 4. Characterization of FPA, CMCase, and xylanase of T. harzianum EM0925 enzyme cocktail.
(a) The effect of temperatrure on FPA, CMCase, and xylanase of T. harzianum EM0925 enzyme cocktail;
(b) thermostability of FPA, CMCase, and xylanase of T. harzianum EM0925 enzyme cocktail; (c) the
effect of pH on FPA, CMCase, and xylanase of T. harzianum EM0925 enzyme cocktail; (d) pH stability of
FPA, CMCase, and xylanase of T. harzianum EM0925 enzyme cocktail. pH stability was determined by
measuring the residual activity after incubation of T. harzianum EM0925 enzyme cocktail in different
buffers for 1 h. The relative activity was determined, and the maximum activity was defined as 100%
(a,c). The initial activity of T. harzianum EM0925 enzyme cocktail not pre-incubated in different buffers
was defined as 100% (b,d). Values are the mean of three replicates ± SD.
Figure 5. Reducing sugar yield from differently pre-treated fractions of corn stover by T. harzianum
EM0925 enzyme cocktail. (a) Chemical compositon of pretreated corn stover. NTCS, matural corn
stover without pretreatment; UGCS, ultrafine grinding corn stover; ALKCS, sodium hydroxide treated
corn stover; DLCS, sodium chlorite treated corn stover; DACS, dilute acid treated corn stover; SECS,
stream explosion treated corn stover. (b) Release of reducing sugars from differently pre-treated
fractions of corn stover.
To compare the saccharification efficiency of EM0925 with those of two commercial enzyme
preparations, an enzyme loading of 5, 10, and 30 FPU/g substrate was selected as the low, moderate and
high enzyme dosage, respectively. Glucose and xylose yields from UGCS and ALKCS were measured
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after 72 h of hydrolysis reaction. Cellulose of UGCS was completely converted to glucose by EM0925
at low enzyme dosage, and a xylan conversion of 72.35% was obtained simultaneously. Meanwhile,
only 45.68% of the cellulose and 57.15% of the xylan were converted by Celluclast 1.5L. The xylan
conversion gradually increased with increasing enzyme dosages, xylose yield was 100% when 30
FPU EM0925 enzymes/g substrate was used. Meanwhile, only 85.59% of the cellulose and 66.18% of
the xylan were converted by Celluclast 1.5L even at the highest enzyme dosage (Figure 6a,b). When
ALKCS was used as substrate, 63.08% cellulose conversion and 70.47% xylan conversion were obtained
at low dosage of EM0925, which were 1.55 and 1.40-fold of the same conversions by Celluclast 1.5L.
The yields of glucose and xylose were all gradually improved with increasing enzyme dosages of the
two preparations. 100% glucose and xylose were released when 30 FPU/g EM0925 was used, and
only 73.78% of the cellulose and 81.28% of the xylan were converted by Celluclast 1.5L at the highest
enzyme dosage (Figure 6c,d).
Figure 6. Conversion of glucan and xylan and sugar yield from UGCS and ALKCS by commercial
enzyme preparation and T. harzianum EM0925 enzyme cocktails. (a) Glucan conversion and glucose
yield from UGCS by commercial and T. harzianum EM0925 enzyme cocktails; (b) xylan conversion
and xylose yield from UGCS by commercial and T. harzianum EM0925 enzyme cocktails; (c) glucan
conversion and glucose yield from ALKCS by commercial and T. harzianum EM0925 enzyme cocktails;
(d) xylan conversion and xylose yield from ALKCS by commercial and T. harzianum EM0925 enzyme
cocktails. Celluclast 1.5 L, commercial cellulase preparation; UGCS, ultrafine grinding corn stover;
ALKCS, sodium hydroxide treated corn stover.
When polysaccharides were completely converted to monosaccharides, 11.20 and 13.48 mg glucose
were obtained from 20 mg of UGCS and ALKCS, respectively, while 6.11 and 7.98 mg pentose were
released simultaneously. Monosaccharides yield was 865.5 mg/g of UGCS and 1073 mg/g of ALKCS,
which was 1.29 and 1.31-fold of the highest monosaccharide yield obtained by Celluclast 1.5 L. In
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addition, the highest sugar yield from UGCS was obtained when EM0925 was applied at the dosage
corresponding to 1/6 of the Celluclast 1.5 L dose (Figure 6a,b). These saccharification yields are among
the highest yields reported in literature [29–34] (Table S1).
3. Discussion
Saprophytic fungi secrete a series of enzymes to degrade the plant cell walls in order to obtain
nutrition for their growth. The main drawback of biofuels and other value-added bio-products
generated from biomass are the high cost and the low saccharification efficiency of lignocellulolytic
enzymes. In addition, the global market for industrial enzymes was expected to increase from nearly
$5.0 billion in 2016 to $6.3 billion in 2021. Hence, lignocellulolytic enzymes which can be produced
at low-cost and are capable of producing high yields of fermentable sugars require investigation.
Using the agricultural residue corn stover as the sole carbon source, T. harzianum EM0925 secreted a
quantitatively balanced enzyme system, which provides a low-cost enzyme preparation for biomass
hydrolysis. High levels of endoglucanases and β-glucosidases could be secreted by T. harzianum, which
has a high potential for application in industrial settings. According to Li et al. [12], the filter paper
activity of the enzyme cocktail secreted by T. harzianum K223452 (CGMCC 17199) was 1.62 U/mL using
sugarcane bagasse as the substrate supplied with 20 g/L glucose as carbon source. We observed a
comparable activity for T. harzianum EM0925 when grown on corn stover without supplementation.
These facts illustrate the possibility to develop low-cost degradation enzyme cocktails with high
efficiency [2,26]. The high levels of lignocellulolytic enzymes and rapid enzyme production capacity of
T. harzianum EM0925 made it a suitable candidate for enzyme cocktail production, since most of the
previous studies on developing cost-effective cell wall degrading enzymes have focused on improving
the activity of cellulase by adopting genetic operation and screening natural strains so as to obtain high
yield of glucose [4,35]. Meng et al. [36] overexpressed the endoglucanase gene in T. reesei Rut-C30, which
showed 90.0% and 132.7% increases in the activities of total cellulases and endoglucanases under flask
culture conditions, respectively. Furthermore, hemicellulose is the second most abundant component
of lignocellulose and is mainly composed of xylan, mannan, and xyloglucan. Hemicelluloses can be
hydrolyzed into pentoses (xylose and arabinose) and hexoses (glucose, mannose and galactose) at high
yield which is important for bio-refinery applications [37,38]. Besides the enzymes degrading the main
chains of the structural polysaccharides in plant cell walls, various glycosidases have been found to
be essential for obtaining fermentable sugars from lignocellulose [39]. Glucosidase, xylosidase, and
arabinofuranosidase played key roles in the production of glucose, xylose, and arabinose, respectively.
In addition, mannosidase, galactosidase, and esterase were also necessary to deconstruct the complex
lignocellulose [40]. It was reported that T. harzianum LZ117 could secrete a more complete enzyme
cocktail than T. reesei. This strain produced 29.24 U/mg xylanase after 144 h of fermentation, but its
CMCase, pNPCase, and pNPGase were only 4.30, 0.19, and 1.81 U/mg, respectively, much lower than
the other cellulase producers [12]. In our present study, CMCase, pNPCase, and pNPGase of EM0925
enzyme cocktail was 11.20, 33.76, and 84.97 U/mg, respectively. In addition, high levels of pNPXase
and pNPAFase activities up to 203.60 and 11.72 U/mg were detected. Specific activities of glycosidases
of EM0925 was the highest compared to the two extensively used inartificial enzyme cocktails under
the conditions tested (Table 1). When using natural lignocellulose substrate as the sole carbon source, T.
harzianum that secret cellulase and hemicellulase simultaneously, especially high levels of glycosidases
has not been reported [27]. Therefore, the patterns of enzyme activities observed for T. harzianum
EM0925 highlight its potential as efficient enzyme producer for industrial applications.
Different induction conditions have been shown to greatly influence the secretion of cellulolytic
enzymes by fungi as revealed by Filho et al. [20], at the transcriptional level. In the transcriptome of
T. harzianum, the GH7 endoglucanase gene was the highest expressed one when grown on cellulose,
while expression level of GH10 xylanase was significantly increased when grown on the natural
bagasse [20]. Secretome analysis of T. harzianum EM0925 demonstrated the multiple functions and
the synergistic effects of the lignocellulolytic enzymes. The balanced abundance of three kinds of
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cellulases play a crucial role for their synergistic degradation effects [41]. The abundant endoglucanases
increased the frequency for randomly degrading the main chain of cellulose, which provided more
access points for cellobiohydrolases. The high abundance of glucosidases could quickly remove
the cellobiose and release glucose efficiently. In addition, much higher abundance of glycosidases
responsible for side chain degradation could also effectively release series of fermentable sugars from
complex polysaccharides [42]. A total of 44 glycosidases among the 81 CAZymes were found in the
secretome of EM0925, with GH3, GH5, GH11, GH30, and GH55 as the dominant components, which
may play crucial role in lignocellulose degradation (Figure S1). Vanessa et al. [43] also reported that the
glycoside hydrolases were the most abundant class of proteins secreted by Trichoderma harzianum IOC
3844, which represent 67% of the total proteins; however, pretreated (partially delignified) cellulolignin
from sugarcane bagasse was used in their study as the inducer for lignocellulosic enzyme secretion. In
addition, the most abundant groups in the secretome of T. harzianum IOC 3844 were GH3 (17%), GH5
(11%), GH 7 (10%), GH6 (6%), and GH55 (6%), which was slightly different from those verified for T.
harzianum EM0925 in our present study and demonstrated the possible effects of the secretome.
For lignocellulose degradation, the amount of cellulases is not the most critical factor affecting
sugar yield, since the synergistic effects between the cellulases and hemicellulases and between the
enzymes for main- and side-chain degrading enzymes of the polysaccharides complex might be
more important. Therefore, the high conversion efficiency of the secretome of T. harzianum EM0925
might be achieved from its numerously and quantitatively balanced cellulases and hemicellulases.
Previously, partial replacement of cellulases with auxiliary enzymes has reduced the required amount
of commercial cellulases to achieve high hydrolysis yields [11,44]. Yang et al. [45] reported a degree of
synergy of 1.35 for the hydrolysis of delignified corn stover when studying the synergistic effect between
a commercial enzyme preparation and a bifunctional enzyme consisting of an acetyl xylan esterase
and a α-l-arabinofuranosidase. For glucan conversion of delignified corn stover, Zhu et al. [46] found
a synergy of 1.96 between a hemicellulase preparation EMSD5 (including xylanases, β-xylosidases,
α-l-arabinofuranosidases, α-glucuronidases, and acetyl xylan esterases) and the commercial cellulase
from T. reesei. These findings revealed the significant role of glycosidases for efficient lignocellulose
degradation. Moreover, 9 carbohydrate binding modules (CBMs) were also observed, which could
help hydrolyze substrate more effectively [46]. In T. harzianum EM0925 enzyme enzyme cocktail, a
LPMO with abundance of 3.23% was found. It was discovered that LPMOs promote degradation of
the most recalcitrant crystalline cellulose by carrying out oxidative cleavage of polysaccharides [47].
Several studies showed synergetic effects between LPMOs and the lignocellulolytic enzymes during
the saccharification process of cellulose and hemicellulose components [9,47]. All CAZymes and
non-hydrolyzed protein detected in the secreted proteins of T. harzianum EM0925 are important for
fermentable sugars production. In addition, some glycoside hydrolases such as GH30 xylanase and
GH26 mannase secreted by T. harzianum EM0925 have been rarely studied in Trichoderma. Synergy
between cellulolytic enzymes and these enzymes from Acremonium alcalophilum and Aspergillus nidulans
has been described, which deserves more attention in the future [48,49]. The currently reported
lignocellulosic degrading bacteria and fungi with industrial application prospects presented distinct
optimal conditions for different enzymes even in the same induced enzyme system, and the stabilities
against temperature and pH were also different, so it is necessary to determine the optimal conditions
for enzymatic hydrolysis and saccharification with overall consideration [1,50,51]. In the present
study, similar optimal temperature and pH for various functional enzymes in T. harzianum EM0925
enzyme cocktail were observed, which gave rise to better synergistic effects in efficient deconstruction
of lignocellulose complex. Pretreatments could make the macroscopic and microscopic deconstruction
and change chemical composition of lignocellulose, which improve the accessibility of enzymes and
facilitate release of fermentable sugars. Among many pretreatment methods, dilute alkali treatment is
widely used because of its remarkable effect, and physical crushing pretreatment without any pollution
has been widely used as well [52].
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When EM0925 was used, reducing sugar yields of 96.6% and 100% were obtained from UGCS
and ALKCS, respectively, after 72 h of saccharification. The efficacy after 24 h of saccharification was
81.9% and 74.2%, respectively. (Figure 5b). So, the enzyme cocktail EM0925 was much more effective
than the current commercial products under the conditions tested, since only 46.9% sugar yield was
acquired from UGCS by Celluclast 1.5 L after 72 h hydrolysis [33] (Table S1). In general, saccharification
efficiency of lignocellulose biomass by EM0925 was better than that in any other literature reported
under the conditions tested [29–34]. To be specific, in our study, the maximum 85.59% glucose yield
and 66.18% xylose yield were obtained from UGCS hydrolyzed with 30 FPU/g of Celluclast 1.5 L used;
while 100% glucose yield and 100% xylose yield were obtained from UGCS and ALKCS with the same
enzyme dosage of T. harzianum EM0925. To some extent, the glucose and xylose yields by EM0925 were
lower than the total sugar yields when the same substrates were used, which indicated that not only
monosaccharides but also oligosaccharides were obtained from UGCS and ALKCS. From these results,
it could be estimated that various auxiliary enzyme including hemicellulase and amylase played
important role to completely and effectively deconstruct the complex lignocellulose substrates [11].
Some accessory enzymes that assist biomass degradation could be used to improve the recovery
of fermentable sugars for use in a biorefinery setting in order to improve total utilization of biomass.
Supplementation of a commercial enzyme preparation with 30% crude enzyme complex from Aspergillus
oryzae P21C3 increased the conversion of cellulose derived from pretreated sugarcane bagasse by
36%, which demonstrated the potential to use the supplementary enzymes in the total lignocellulose
degradation, although 51.2% of cellulose conversion and 78.1% of xylan conversion were obtained [53].
With supplementary of β-glucosidase produced by Aspergillus niger and endoglucanase produced by
Talaromyces emersonii to the currently used commercial enzyme cocktails, greater saccharification of
alkaline-pretreated bagasse (87% glucose yield and 94% of xylose yield) was obtained, but its enzyme
dosage was as high as 500 FPU/g substrate [54]. In the present study, only enzyme dosage of 5 mg
EM0925/g substrate (13.85 FPU/g) was required for complete saccharification of lignocellulose, which
provided sufficient sugars for the downstream fermentation of downstream products. Therefore,
EM0925 presented great potential in industrial applications. To the best of our knowledge, it was
the first example that enzyme cocktail from T. harzianum completely and simultaneously converted
cellulose and xylan in natural biomaterials into fermentable sugars at the same time. To date, induction
and saccharification mechanisms of lignocellulosic enzymes secreted by T. harzianum are still unknown.
Differences in the composition of the T. harzianum secretome in response to different substrates
was reported, which revealed the diversity of the fungus enzymatic toolbox [55]. Nevertheless,
enzyme cocktails with excellent efficiency of complete saccharification of lignocellulose should be
tailor-made, and degradation mechanisms remain to be elucidated in more detail. The expression of
total extracellular proteins of T. harzianum EM0925 also could be optimized at the molecular level, in
order to further expand the application scope of T. harzianum EM0925.
4. Materials and Methods
4.1. Strain and Culture Conditions
Thrichoderma harzianum EM0925 was isolated and screened for activities of lignocellulolytic enzyme
in our laboratory previously. For enzyme production, the strain was incubated on potato agar for 3 days
at 30 ◦C, then, 5 slices with diameter 0.5 cm of the agar plate were inoculated into each flask containing
200 mL Mandel’s salt solution (4.0 KH2PO4, 2.8 (NH4)2O4, 0.6 MgSO4·7H2O, 0.01 FeSO4·7H2O, 0.003
MnSO4·H2O, 0.003 ZnSO4·7H2O, 0.004 CoCl2·6H2O, and 2.0 peptone, in g·L−1) supplemented with 2%
(w/v) lignocellulose substrate at 30 ◦C [15].
4.2. Preparation of Enzyme Cocktail EM0925
Different carbon sources were used to induce the enzyme production of T. harzianum EM0925.
Lignocellulosic enzyme activities in the culture solution were measured each day, the optimal incubation
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time was estimated according to the filter paper activity (FPA), and the activities of endoglucanase
(EG) and xylanase (XYL) [15]. Ammonium sulfate precipitation with a final concentration of 85% (w/v)
was used to prepare the enzyme cocktails. After incubation at 4 ◦C for 4 h, the precipitate fraction
containing the secreted enzymes was collected by centrifugation at 10,000× g for 20 min at 4 ◦C and
then dissolved in sodium acetate buffer (50 mM, pH 5.0) and filtered through a 0.45 μm filter membrane
(Millipore, Bedford, MA, USA). Proteins in the supe rnatant were dialyzed against sodium acetate
buffer (50 mM, pH 5.0) and then freeze-dried. Commercial cellulase enzyme C 9748 derived from
Trichoderma longibrachiatum (C 9748, Sigma Aldrich, St. Louis, MO, USA) and Celluclast 1.5 L from
Trichoderma reesei ATCC 26921 (Sigma, USA, Novozyme products) were used as reference. The protein
content of the enzyme cocktail was determined by a Bradford protein assay regent (Bio-rad, Hercules,
CA, USA) [12].
4.3. Enzymatic Assays
FPA was measured according to the method reported by Urbánszki et al. [56]. EG and XYL were
measured with carboxymethyl cellulose (CMC-Na, TCI, Tokyo, Japan) and Beechwood xylan (Sigma,
USA) as substrates, respectively. Briefly, to measure the xylanase activity, an aliquot of 100 μL diluted
crude enzyme was mixed with 100 μL 1% (w/v) of xylan. After 15 min of incubation at 40 ◦C, 150
μL of the 3,5-dinitrosalicylic acid (DNS) reagent was added. For CMCase activity measurement, an
aliquot of 50 μL of diluted crude enzyme was mixed with 150 μL of 0.5% carboxymethyl cellulose.
After incubation at 50 ◦C for 30 min, 50 μL of 1 M NaOH and the DNS reagent were sequentially added.
After boiling the mixture at 100 ◦C for 5 min, it was cooled in cold water and the absorbance was read
at 540 nm. Activities were calculated with glucose or xylose as the standard. One unit of enzyme
activity was defined as the amount of enzyme catalyzing the release of 1 μmol of reducing sugars in 1
min from the substrate under the above conditions [57]. The cellobiohydrolase (CBH), β-d-glucosidase
(βG), β-xylosidase (βX) and α-l-arabinofuranosidase (ABF) activities were determined according
to the protocol of Zhu et al. [46] with minor modification: using p-nitrophenyl-β-d-cellobioside
(pNPC), p-nitrophenyl-β-glucopyranoside (pNPG), p-nitrophenyl-β-d-xylopyranoside (pNPX), and
p-nitrophenyl-α-l-arabinofuranoside (pNPAF) as substrate, respectively. The reaction mixture contained
50 μL of enzyme, 50 μL of 50 mM sodium acetate buffer (pH 5.0), and 50 μL of 10 mM substrate
solution. After incubation at 50 ◦C for 10 min, the reaction was terminated by adding 50 μL of 1
M Na2CO3 and the absorbance of released p-nitrophenol was measured at 405 nm. Activities were
calculated using p-nitrophenol as the standard. One unit of enzyme activity was defined as the amount
of enzyme that produced 1 μmol of pNP in 1 min from the substrate under the above conditions.
In addition, β-mannase activity (Man) was determined by the DNS method using mannose as the
standard according to the methods of Li et al. [38]. The amylolytic activity (Amy) was assayed by the
DNS method using maltose as the standard as reported by He et al. [58].
To determine the optimal temperature for FPA, EG, and XYL of the enzyme cocktail from T.
harzianum EM0925, assays were performed in the temperature range from 30–70 ◦C at an interval
of 10 ◦C. The optimal pH values for cellulases and hemicellulases were investigated at the optimal
temperature in buffers ranging from pH 2–8 at intervals of 0.5 pH units, using 0.05 M different buffers:
glycine-HCl (pH 2.0–3.0), sodium acetate (pH 4.0–5.0), and citric-Na2HPO4 (pH 6.0–8.0). Thermal
stability of EM0925 was assessed by measuring the residual activity in the optimal conditions after
incubation of the cocktail at different temperature (50, 60, and 70 ◦C) for 1 h. A dose of 1.0 mg/mL of
enzyme cocktail was pre-incubated in 0.05 M sodium acetate, enzyme cocktail without pre-incubated
was used as the control. The stabilities of various enzymes at different pH values were determined by
measuring the residual activities in standard conditions after the enzyme incubation in 0.05 M buffers
of different pH (pH 2.0, 3.0, 4.0, 5.0, 6.0, 7.0, 8.0, 9.0, 10.0, 11.0, and 12.0) at room temperature for 1 h.
The buffers used were glycine-HCl (pH 2.0, 3.0), sodium acetate (pH 4.0, 5.0), citric-Na2HPO4 (pH
6.0–8.0) and glycine-NaOH (pH 9.0–12.0). One mg/mL of enzyme cocktail was pre-incubated in 0.05 M
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of the corresponding buffers, buffers, and enzyme cocktails without pre-incubated was used as the
control [45].
4.4. Biomass Pretreatment and Component Analysis
The mature corn stover was collected from Shandong Province of China, and the other biomasses
were available in our laboratory. The dried biomasses were ground and passed through a 50 mesh
sieve before drying at 50 ◦C to a constant weight. Un-treated corn stover (NTCS) was subjected to
different pretreatments as follows. Ultrafine grinding pretreatment corn stover (UGCS) was prepared
by mixing NTCS and ZrO2 balls (6–10 nm diameter) with a ratio of 1:2 and grinding for 0.5 h in a
CJM-SY-B ultrafine vibration ball mill (Taiji Ring Nano Products Co., Hebei, China) [33]. Alkali-treated
corn stover (ALKCS) was prepared by mixing the biomass and 1% (w/v) of NaOH at a solid-liquid ratio
of 1: 10 and autoclaving the mixture at 121 ◦C for 1 h [59]. Sodium chlorite/acetic acid delignificated
corn stover (DLCS) was obtained according to the protocol of Hu et al. [44]. Dilute acid pretreated
corn stover (DACS) was treated with dilute acid according to the procedure of Ji et al. [59]. The steam
explosion pretreated corn stover (SECS) was obtained by steam exploding the substrate according to
the procedure of Liu et al. [57]. All slurries were filtered and washed until the pH reached 5.0 prior
to use.
The structural carbohydrate and lignin contents of different pretreated biomasses were determined
according to the laboratory analytical procedure of the National Renewable Energy Laboratory [60]. In
brief, a sample of 0.5 g dry biomass was hydrolyzed at 30 ◦C with 3.0 mL H2SO4 (72%, w/v) for 1 h.
Then 84 mL deionized water was added and a second hydrolysis was carried out in the autoclave at
121 ◦C for 1 h. All slurries were filtered and washed until reaching neutral pH. The glucose and xylose
concentrations in the filter liquor were determined by HPLC. Acid-insoluble lignin was determined by
subtracting the ash content from the solid residue dried at 60 ◦C. The ash content was determined by
heating the solid residue at 575 ◦C for 12 h. The weight percentages of cellulose, xylan, arabinan, and
lignin were calculated according to the method described previously [46].
4.5. Enzymatic Hydrolysis
Hydrolysis of all biomasses was conducted in 50 mM sodium citrate buffer (pH 4.5) in a 1 mL
volume system containing 2% (w/v) substrate. The reaction was conducted in a 37 ◦C air bath with
shaking at 200 rpm. Varying amounts (5 mg protein/g substrate and 5, 10, 30 FPU/g substrate) of
enzyme loading were used for hydrolysis reactions. Samples were taken after 8 h, 12 h, 24 h, 48 h
and 72 h of hydrolysis, and then heated at 100 ◦C for 10 min to terminate the reaction. Supernatants
were collected by centrifugation at 10,000× g for 10 min. The content of total reducing sugars was
determined by the DNS method. Monosaccharides in samples were determined by HPLC. Treatments
containing substrate or enzyme alone were used as blank controls [15].
4.6. Extracellular Quantitative Proteome Analysis
The freeze-dried enzyme preparation of T. harzianum EM0925 dissolved in deionized water was
separated by 12% (w/v) sodium dodecyl sulphate-poly-acrylamide gel electrophoresis (SDS-PAGE)
at 120 V. The gel bands were excised and subjected to tryptic digestion and separated. The resulting
peptides were reconstituted in 0.1% formic acid and then label-free quantitative proteomics identification
by LC-MS/MS was performed. MaxQuant (version 1.4.1.2, https://www.maxquant.org/maxquant/) was
used as the search engine in order to identify and quantify the extracellular proteins of T. harzianum
EM0925. Raw data were preprocessed with Mascot Distiller 2.5 (Matrix Science, Boston, MA, USA) for
peak picking, and resulting peaks were searched against the UniProt database (https://www.uniprot.org/)
for T. harzianum strain CBS 226.95. The remaining parameter “intensity-based absolute quantification
(iBAQ)” option was enabled. Only proteins identified with at least two peptides were considered
for label-free quantification. Calculation of the protein label free quantification (LFQ) intensity was
based on unique peptides using the built-in label-free quantification algorithm. The identified proteins
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were annotated using the Pfarm (https://pfam.xfam.org/search#tabview=tab1) and dbCAN database
(http://bcb.unl.edu/dbCAN2/). Relative quantifications of extracellular proteins of T. harzianum EM0925
were analyzed. Three technical replicates were included in all the analyses [42,61].
5. Conclusions
Under induction of lignocellulosic biomass, T. harzianum EM0925 could rapidly secrete glycoside
hydrolases, including numerically and quantitatively balanced cellulases and hemicellulases and
especially high levels of glycosidases. T. harzianum EM0925 enzyme cocktail presented significantly
higher enzyme activities than the commercial preparations under the conditions tested, and released
100% of glucose and xylose from UGCS and ALKCS simultaneously. These findings clearly indicate
that T. harzianum EM0925 enzyme cocktail has great potential for industrial applications.
Supplementary Materials: The following are available online at http://www.mdpi.com/1422-0067/21/2/371/s1,
Table S1: A comparison of different previous reported enzyme cocktails for lignocellulose saccharification. Figure
S1: Distribution of glycoside hydrolase family in proteome of T. harzianum EM0925.
Author Contributions: Conceptualization, Y.Z. and H.Y.; methodology, Y.Z. and L.L. (Lijin Luo); software, Y.Z.
and L.L. (Liang Liu); validation, J.Y., E.W., and H.Y.; formal analysis, R.W.; investigation, J.L.; data curation, Y.Z.,
R.W., and H.Y.; writing—original draft preparation, Y.Z.; writing—review and editing, E.W. and H.Y.; visualization,
J.Y.; supervision, H.Y.; project administration, J.Y. All authors have read and agreed to the published version of
the manuscript.
Funding: This research was funded by the project for extramural scientists of state key laboratory of
agrobiotechnology, grant number 2018SKLAB6-28.
Conflicts of Interest: The authors declare no conflict of interest.
Abbreviations





LPMO Lytic polysaccharide monooxygenase
HPLC High-performance liquid chromatography








LC-MS/MS Liquid chromatography-tandem mass spectrometry
NTCS Non-pretreated corn stover
UGCS Ultrafine grinding pretreated corn stover
ALKCS Alkali pretreated corn stover
DACS Dilute acid pretreated corn stover
DLCS Sodium chlorite/acetic acid delignificated corn stover





iBAQ Intensity-based absolute quantification
LFQ Label free quantification
64
Int. J. Mol. Sci. 2020, 21, 371
References
1. Wang, J.; Chen, X.; Chio, C.; Yang, C.; Su, E.; Jin, Y.; Cao, F.; Qin, W. Delignification overmatches hemicellulose
removal for improving hydrolysis of wheat straw using the enzyme cocktail from Aspergillus niger. Bioresour.
Technol. 2019, 274, 459–467. [CrossRef]
2. Paz, A.; Outeirino, D.; Perez Guerra, N.; Dominguez, J.M. Enzymatic hydrolysis of brewer’s spent grain to
obtain fermentable sugars. Bioresour. Technol. 2018, 275, 402–409. [CrossRef] [PubMed]
3. Xin, F.; Dong, W.; Zhang, W.; Ma, J.; Jiang, M. Biobutanol production from crystalline cellulose through
consolidated bioprocessing. Trends Biotechnol. 2019, 37, 167–180. [CrossRef] [PubMed]
4. Kun, R.S.; Gomes, A.C.S.; Hilden, K.S.; Cerezo, S.S.; Makela, M.R.; de Vries, R.P. Developments and
opportunities in fungal strain engineering for the production of novel enzymes and enzyme cocktails for
plant biomass degradation. Biotechnol. Adv. 2019, 37, 1–16. [CrossRef] [PubMed]
5. De Castro, A.M.; Pedro, K.C.; da Cruz, J.C.; Ferreira, M.C.; Leite, S.G.; Pereira, N., Jr. Trichoderma harzianum
IOC-4038: A promising strain for the production of a cellulolytic complex with significant beta-glucosidase
activity from sugarcane bagasse cellulignin. Appl. Biochem. Biotechnol. 2010, 162, 2111–2122. [CrossRef]
6. Gama, R.; Van Dyk, J.S.; Pletschke, B.I. Optimisation of enzymatic hydrolysis of apple pomace for production
of biofuel and biorefinery chemicals using commercial enzymes. 3 Biotech 2015, 5, 1075–1087. [CrossRef]
7. De Paula, R.G.; Antonieto, A.C.C.; Nogueira, K.M.V.; Ribeiro, L.F.C.; Rocha, M.C.; Malavazi, I.; Almeida, F.;
Silva, R.N. Extracellular vesicles carry cellulases in the industrial fungus Trichoderma reesei. Biotechnol. Biofuels
2019, 12, 146. [CrossRef]
8. Jiang, Y.; Wu, R.; Zhou, J.; He, A.; Xu, J.; Xin, F.; Zhang, W.; Ma, J.; Jiang, M.; Dong, W. Recent advances of
biofuels and biochemicals production from sustainable resources using co-cultivation systems. Biotechnol.
Biofuels 2019, 12, 155. [CrossRef]
9. Sanhueza, C.; Carvajal, G.; Soto-Aguilar, J.; Lienqueo, M.E.; Salazar, O. The effect of a lytic polysaccharide
monooxygenase and a xylanase from Gloeophyllum trabeum on the enzymatic hydrolysis of lignocellulosic
residues using a commercial cellulase. Enzym. Microb. Technol. 2018, 113, 75–82. [CrossRef] [PubMed]
10. Goldbeck, R.; Gonçalves, T.A.; Damásio, A.R.L.; Brenelli, L.B.; Wolf, L.D.; Paixão, D.A.A.; Rocha, G.J.M.;
Squina, F.M. Effect of hemicellulolytic enzymes to improve sugarcane bagasse saccharification and
xylooligosaccharides production. J. Mol. Catal. B Enzym. 2016, 131, 36–46. [CrossRef]
11. Sun, F.F.; Hong, J.; Hu, J.; Saddler, J.N.; Fang, X.; Zhang, Z.; Shen, S. Accessory enzymes influence cellulase
hydrolysis of the model substrate and the realistic lignocellulosic biomass. Enzym. Microb. Technol. 2015,
79–80, 42–48. [CrossRef] [PubMed]
12. Li, J.; Zhang, F.; Li, J.; Zhang, Z.; Bai, F.; Chen, J.; Zhao, X. Rapid production of lignocellulolytic enzymes
by Trichoderma harzianum LZ117 isolated from Tibet for biomass degradation. Bioresour. Technol. 2019, 292,
122063. [CrossRef] [PubMed]
13. Liu, G.; Qin, Y.; Li, Z.; Qu, Y. Improving lignocellulolytic enzyme production with Penicillium: From strain
screening to systems biology. Biofuels 2014, 4, 523–534. [CrossRef]
14. Gusakov, A.V.; Sinitsyn, A.P. Cellulases from Penicillium species for producing fuels from biomass. Biofuels
2014, 3, 463–477. [CrossRef]
15. Yang, Y.; Yang, J.; Liu, J.; Wang, R.; Liu, L.; Wang, F.; Yuan, H. The composition of accessory enzymes of
Penicillium chrysogenum P33 revealed by secretome and synergistic effects with commercial cellulase on
lignocellulose hydrolysis. Bioresour. Technol. 2018, 257, 54–61. [CrossRef]
16. Berlin, A.; Maximenko, V.; Gilkes, N.; Saddler, J. Optimization of enzyme complexes for lignocellulose
hydrolysis. Biotechnol. Bioeng. 2007, 97, 287–296. [CrossRef]
17. Berrin, J.G.; Herpoel-Gimbert, I.; Ferreira, N.L.; Margeot, A.; Heiss-Blanquet, S. Use of cellulases from
Trichoderma reesei in the Twenty-First Century-Part II: Optimization of cellulolytic cocktails for saccharification
of lignocellulosic feedstocks. In Biotechnology and Biology of Trichoderma; Eisevier: Amsterdam, The
Netherlands, 2014; pp. 263–280.
18. Chundawat, S.P.; Lipton, M.S.; Purvine, S.O.; Uppugundla, N.; Gao, D.; Balan, V.; Dale, B.E. Proteomics-based
compositional analysis of complex cellulase-hemicellulase mixtures. J. Proteome Res. 2011, 10, 4365–4372.
[CrossRef]
65
Int. J. Mol. Sci. 2020, 21, 371
19. De Castro, A.M.; Ferreira, M.C.; da Cruz, J.C.; Pedro, K.C.; Carvalho, D.F.; Leite, S.G.; Pereira, N. High-Yield
Endoglucanase Production by Trichoderma harzianum IOC-3844 cultivated in pretreated sugarcane mill
byproduct. Enzym. Res. 2010, 2010, 854526. [CrossRef]
20. Ferreira Filho, J.A.; Horta, M.A.C.; Beloti, L.L.; Dos Santos, C.A.; de Souza, A.P. Carbohydrate-active enzymes
in Trichoderma harzianum: A bioinformatic analysis bioprospecting for key enzymes for the biofuels industry.
BMC Genom. 2017, 18, 779. [CrossRef]
21. Benoliel, B.; Torres, F.A.G.; de Moraes, L.M.P. A novel promising Trichoderma harzianum strain for the
production of a cellulolytic complex using sugarcane bagasse in natura. Springer Plus 2013, 2, 656. [CrossRef]
22. Delabona Pda, S.; Farinas, C.S.; da Silva, M.R.; Azzoni, S.F.; Pradella, J.G. Use of a new Trichoderma harzianum
strain isolated from the Amazon rainforest with pretreated sugar cane bagasse for on-site cellulase production.
Bioresour. Technol. 2012, 107, 517–521. [CrossRef]
23. Zhao, X.; Xiong, L.; Zhang, M.; Bai, F. Towards efficient bioethanol production from agricultural and forestry
residues: Exploration of unique natural microorganisms in combination with advanced strain engineering.
Bioresour. Technol. 2016, 215, 84–91. [CrossRef]
24. Li, X.; Xie, X.; Liu, J.; Wu, D.; Cai, G.; Lu, J. Characterization of a putative glycoside hydrolase family 43
arabinofuranosidase from Aspergillus niger and its potential use in beer production. Food Chem. 2020, 305,
125382. [CrossRef] [PubMed]
25. Hu, J.; Arantes, V.; Pribowo, A.; Gourlay, K.; Saddler, J.N. Substrate factors that influence the synergistic
interaction of AA9 and cellulases during the enzymatic hydrolysis of biomass. Energy Environ. Sci. 2014, 7,
2308–2315. [CrossRef]
26. Gusakov, A.V. Alternatives to Trichoderma reesei in biofuel production. Trends Biotechnol. 2011, 29, 419–425.
[CrossRef]
27. De Souza, M.F.; da Silva, A.S.A.; Bon, E.P.S. A novel Trichoderma harzianum strain from the Amazon Forest
with high cellulolytic capacity. Biocatal. Agric. Biotechnol. 2018, 14, 183–188. [CrossRef]
28. Li, C.; Pang, A.P.; Yang, H.; Lv, R.; Zhou, Z.; Wu, F.G.; Lin, F. Tracking localization and secretion of cellulase
spatiotemporally and directly in living Trichoderma reesei. Biotechnol. Biofuels 2019, 12, 200. [CrossRef]
[PubMed]
29. Boussaid, A.; Robinson, J.; Cai, Y.; Gregg, D.J.; Saddler, J.N. Fermentability of the hemicellulose-derived
sugars from steam-exploded softwood (douglas fir). Biotechnol. Bioeng. 1999, 64, 284–289. [CrossRef]
30. Li, C.; Knierim, B.; Manisseri, C.; Arora, R.; Scheller, H.V.; Auer, M.; Vogel, K.P.; Simmons, B.A.; Singh, S.
Comparison of dilute acid and ionic liquid pretreatment of switchgrass: Biomass recalcitrance, delignification
and enzymatic saccharification. Bioresour. Technol. 2010, 101, 4900–4906. [CrossRef]
31. Herbaut, M.; Zoghlami, A.; Habrant, A.; Falourd, X.; Foucat, L.; Chabbert, B.; Paes, G. Multimodal analysis
of pretreated biomass species highlights generic markers of lignocellulose recalcitrance. Biotechnol. Biofuels
2018, 11, 52. [CrossRef]
32. Chylenski, P.; Forsberg, Z.; Stahlberg, J.; Varnai, A.; Lersch, M.; Bengtsson, O.; Saebo, S.; Horn, S.J.;
Eijsink, V.G.H. Development of minimal enzyme cocktails for hydrolysis of sulfite-pulped lignocellulosic
biomass. J. Biotechnol. 2017, 246, 16–23. [CrossRef] [PubMed]
33. Li, J.; Zhang, H.; Lu, M.; Han, L. Comparison and intrinsic correlation analysis based on composition,
microstructure and enzymatic hydrolysis of corn stover after different types of pretreatments. Bioresour.
Technol. 2019, 293, 122016. [CrossRef]
34. Sills, D.L.; Gossett, J.M. Assessment of commercial hemicellulases for saccharification of alkaline pretreated
perennial biomass. Bioresour. Technol. 2011, 102, 1389–1398. [CrossRef]
35. Liu, G.; Qu, Y. Engineering of filamentous fungi for efficient conversion of lignocellulose: Tools, recent
advances and prospects. Biotechnol. Adv. 2018, 37, 519–529. [CrossRef] [PubMed]
36. Meng, Q.; Liu, C.; Zhao, X.; Bai, F. Engineering Trichoderma reesei Rut-C30 with the overexpression of egl1 at
the ace1 locus to relieve repression on cellulase production and to adjust the ratio of cellulolytic enzymes for
more efficient hydrolysis of lignocellulosic biomass. J. Biotechnol. 2018, 285, 56–63. [CrossRef] [PubMed]
37. Ajijolakewu, K.A.; Leh, C.P.; Lee, C.K.; Wan Nadiah, W.A. Characterization of novel Trichoderma hemicellulase
and its use to enhance downstream processing of lignocellulosic biomass to simple fermentable sugars.
Biocatal. Biotransfor. 2017, 11, 166–175. [CrossRef]
66
Int. J. Mol. Sci. 2020, 21, 371
38. Li, Y.; Yi, P.; Liu, J.; Yan, Q.; Jiang, Z. High-level expression of an engineered beta-mannanase (mRmMan5A)
in Pichia pastoris for manno-oligosaccharide production using steam explosion pretreated palm kernel cake.
Bioresour. Technol. 2018, 256, 30–37. [CrossRef]
39. Lyu, Y.; Zeng, W.; Du, G.; Chen, J.; Zhou, J. Efficient bioconversion of epimedin C to icariin by a glycosidase
from Aspergillus nidulans. Bioresour. Technol. 2019, 289, 121612. [CrossRef]
40. Oliveira, D.M.; Mota, T.R.; Oliva, B.; Segato, F.; Marchiosi, R.; Ferrarese-Filho, O.; Faulds, C.B.; Dos
Santos, W.D. Feruloyl esterases: Biocatalysts to overcome biomass recalcitrance and for the production of
bioactive compounds. Bioresour. Technol. 2019, 278, 408–423. [CrossRef]
41. Kim, I.J.; Lee, H.J.; Kim, K.H. Pure enzyme cocktails tailored for the saccharification of sugarcane bagasse
pretreated by using different methods. Process Biochem. 2017, 57, 167–174. [CrossRef]
42. Hwangbo, M.; Tran, J.L.; Chu, K.H. Effective one-step saccharification of lignocellulosic biomass using
magnetite-biocatalysts containing saccharifying enzymes. Sci. Total Environ. 2019, 647, 806–813. [CrossRef]
[PubMed]
43. Vanessa, A.L.R.; Roberto, N.M.; Pereira, N.; Marcelo, F.K.; Elias, L.; Rachael, S.; Clare, S.K.; Leonardo, D.G.;
Simon, J.M.M. Characterization of the cellulolytic secretome of Trichoderma harzianum during growth on
sugarcane bagasse and analysis of the activity boosting effects of swollenin. Biotechnol. Prog. 2016, 32,
327–336.
44. Hu, J.; Chandra, R.; Arantes, V.; Gourlay, K.; Van Dyk, J.S.; Saddler, J.N. The addition of accessory enzymes
enhances the hydrolytic performance of cellulase enzymes at high solid loadings. Bioresour. Technol. 2015,
186, 149–153. [CrossRef] [PubMed]
45. Yang, Y.; Zhu, N.; Yang, J.; Lin, Y.; Liu, J.; Wang, R.; Wang, F.; Yuan, H. A novel bifunctional acetyl
xylan esterase/arabinofuranosidase from Penicillium chrysogenum P33 enhances enzymatic hydrolysis of
lignocellulose. Microb. Cell Factories 2017, 16, 166. [CrossRef] [PubMed]
46. Zhu, N.; Yang, J.; Ji, L.; Liu, J.; Yang, Y.; Yuan, H. Metagenomic and metaproteomic analyses of a corn
stover-adapted microbial consortium EMSD5 reveal its taxonomic and enzymatic basis for degrading
lignocellulose. Biotechnol. Biofuels 2016, 9, 243. [CrossRef]
47. Agger, J.W.; Isaksen, T.; Varnai, A.; Vidal-Melgosa, S.; Willats, W.G.T.; Ludwig, R.; Horn, S.J.; Eijsink, V.G.H.;
Westereng, B. Discovery of LPMO activity on hemicelluloses shows the importance of oxidative processes in
plant cell wall degradation. Proc. Natl. Acad. Sci. USA 2014, 111, 6287–6292. [CrossRef]
48. Šuchová, K.; Puchart, V.; Spodsberg, N.; Mørkeberg Krogh, K.B.R.; Biely, P. A novel GH30 xylobiohydrolase
from Acremonium alcalophilum releasing xylobiose from the non-reducing end. Enzym. Microb. Technol. 2020,
134, 109484. [CrossRef]
49. Von Freiesleben, P.; Spodsberg, N.; Blicher, T.H.; Anderson, L.; Jorgensen, H.; Stalbrand, H.; Meyer, A.S.;
Krogh, K.B. An Aspergillus nidulans GH26 endo-beta-mannanase with a novel degradation pattern on highly
substituted galactomannans. Enzym. Microb. Technol. 2016, 83, 68–77. [CrossRef]
50. Aulitto, M.; Fusco, F.A.; Fiorentino, G.; Bartolucci, S.; Contursi, P.; Limauro, D. A thermophilic enzymatic
cocktail for galactomannans degradation. Enzym. Microb. Technol. 2018, 111, 7–11. [CrossRef]
51. Yang, Z.; Liao, Y.; Fu, X.; Zaporski, J.; Peters, S.; Jamison, M.; Liu, Y.; Wullschleger, S.D.; Graham, D.E.;
Gu, B. Temperature sensitivity of mineral-enzyme interactions on the hydrolysis of cellobiose and indican by
beta-glucosidase. Sci. Total Environ. 2019, 686, 1194–1201. [CrossRef]
52. Gatt, E.; Rigal, L.; Vandenbossche, V. Biomass pretreatment with reactive extrusion using enzymes: A review.
Ind. Crop. Prod. 2018, 122, 329–339. [CrossRef]
53. Braga, C.M.P.; Delabona, P.D.S.; Lima, D.; Paixao, D.A.A.; Pradella, J.; Farinas, C.S. Addition of feruloyl
esterase and xylanase produced on-site improves sugarcane bagasse hydrolysis. Bioresour. Technol. 2014, 170,
316–324. [CrossRef] [PubMed]
54. Valadares, F.; Goncalves, T.A.; Goncalves, D.S.; Segato, F.; Romanel, E.; Milagres, A.M.; Squina, F.M.; Ferraz, A.
Exploring glycoside hydrolases and accessory proteins from wood decay fungi to enhance sugarcane bagasse
saccharification. Biotechnol. Biofuels 2016, 9, 110. [CrossRef] [PubMed]
55. Gomez-Mendoza, D.P.; Junqueira, M.; do Vale, L.H.; Domont, G.B.; Ferreira Filho, E.X.; Sousa, M.V.;
Ricart, C.A. Secretomic survey of Trichoderma harzianum grown on plant biomass substrates. J. Proteome Res.
2014, 13, 1810–1822. [CrossRef]
56. Urbánszki, K.; Szakács, G.; Tengerdy, R.P. Standardization of the filter paper activity assay for solid substrate
fermentation. Biotechnol. Lett. 2000, 22, 65–69. [CrossRef]
67
Int. J. Mol. Sci. 2020, 21, 371
57. Liu, L.; Yang, J.; Yang, Y.; Luo, L.; Wang, R.; Zhang, Y.; Yuan, H. Consolidated bioprocessing performance
of bacterial consortium EMSD5 on hemicellulose for isopropanol production. Bioresour. Technol. 2019, 292,
121965. [CrossRef]
58. He, L.; Mao, Y.; Zhang, L.; Wang, H.; Alias, S.A.; Gao, B.; Wei, D. Functional expression of a novel
alpha-amylase from Antarctic psychrotolerant fungus for baking industry and its magnetic immobilization.
BMC Biotechnol. 2017, 17, 22. [CrossRef]
59. Ji, G.; Han, L.; Gao, C.; Xiao, W.; Zhang, Y.; Cao, Y. Quantitative approaches for illustrating correlations
among the mechanical fragmentation scales, crystallinity and enzymatic hydrolysis glucose yield of rice
straw. Bioresour. Technol. 2017, 241, 262–268. [CrossRef]
60. Hussin, M.H.; Rahim, A.A.; Mohamad Ibrahim, M.N.; Yemloul, M.; Perrin, D.; Brosse, N. Investigation on
the structure and antioxidant properties of modified lignin obtained by different combinative processes of
oil palm fronds (OPF) biomass. Ind. Crop. Prod. 2014, 52, 544–551. [CrossRef]
61. Zhu, N.; Liu, J.; Yang, J.; Lin, Y.; Yang, Y.; Ji, L.; Li, M.; Yuan, H. Comparative analysis of the secretomes of
Schizophyllum commune and other wood-decay basidiomycetes during solid-state fermentation reveals its
unique lignocellulose-degrading enzyme system. Biotechnol. Biofuels 2016, 9, 42. [CrossRef]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
68
 International Journal of 
Molecular Sciences
Article
Characterization of a Maltase from an Early-Diverged
Non-Conventional Yeast Blastobotrys adeninivorans
Triinu Visnapuu, Aivar Meldre, Kristina Põšnograjeva, Katrin Viigand, Karin Ernits and
Tiina Alamäe *
Department of Genetics, Institute of Molecular and Cell Biology, University of Tartu, Riia 23,
51010 Tartu, Estonia; triinu.visnapuu@ut.ee (T.V.); aivarmeldre@gmail.com (A.M.);
kristina.poshnograjeva@gmail.com (K.P.); katrin.viigand@gmail.com (K.V.); karin.ernits@gmail.com (K.E.)
* Correspondence: tiina@alamae.eu
Received: 28 November 2019; Accepted: 30 December 2019; Published: 31 December 2019
Abstract: Genome of an early-diverged yeast Blastobotrys (Arxula) adeninivorans (Ba) encodes
88 glycoside hydrolases (GHs) including two α-glucosidases of GH13 family. One of those,
the rna_ARAD1D20130g-encoded protein (BaAG2; 581 aa) was overexpressed in Escherichia coli,
purified and characterized. We showed that maltose, other maltose-like substrates (maltulose,
turanose, maltotriose, melezitose, malto-oligosaccharides of DP 4-7) and sucrose were hydrolyzed by
BaAG2, whereas isomaltose and isomaltose-like substrates (palatinose, α-methylglucoside) were not,
confirming that BaAG2 is a maltase. BaAG2 was competitively inhibited by a diabetes drug acarbose
(Ki = 0.8 μM) and Tris (Ki = 70.5 μM). BaAG2 was competitively inhibited also by isomaltose-like
sugars and a hydrolysis product—glucose. At high maltose concentrations, BaAG2 exhibited
transglycosylating ability producing potentially prebiotic di- and trisaccharides. Atypically for yeast
maltases, a low but clearly recordable exo-hydrolytic activity on amylose, amylopectin and glycogen
was detected. Saccharomyces cerevisiae maltase MAL62, studied for comparison, had only minimal
ability to hydrolyze these polymers, and its transglycosylating activity was about three times lower
compared to BaAG2. Sequence identity of BaAG2 with other maltases was only moderate being the
highest (51%) with the maltase MalT of Aspergillus oryzae.
Keywords: Arxula adeninivorans; glycoside hydrolase; α-glucosidase; maltose; panose; amylopectin;
glycogen; inhibition by Tris; transglycosylation
1. Introduction
A non-conventional yeast Blastobotrys adeninivorans (syn. Arxula adeninivorans) belongs to a
basal clade of Saccharomycotina subphylum and diverged in the evolution of fungi long before
Saccharomyces [1–5]. A recent study states that the divergence of basal Saccharomycotina from
Saccharomyces cerevisiae took place between 200 and 400 million years ago [4].
B. adeninivorans has several biotechnologically relevant properties: accumulation of lipids [6], salt
tolerance, temperature-induced filamentation that promotes protein secretion and the ability to use a
wide range of carbon and nitrogen sources, including purines, tannin and butanol, that are unusual
nutrients for yeasts [2,7]. B. adeninivorans has been engineered for butanol production, applied in
kits for the detection of hormones and dioxine in water as well as for manufacturing of tannase and
cutinases [7]. Some other enzymes of B. adeninivorans have also been investigated, including alcohol
dehydrogenase [8], extracellular glucoamylase [9] and invertase [10]. A highly active endo-inulinase
of B. adeninivorans was cloned and recently characterized [11]. The genome of B. adeninivorans was
sequenced in 2014 [2].
The genes potentially encoding α-glucosidases in the genomes of non-conventional yeasts were
analysed in Viigand et al. [12]. The genes encoding two putative α-glucosidases designated as AG1
Int. J. Mol. Sci. 2020, 21, 297; doi:10.3390/ijms21010297 www.mdpi.com/journal/ijms69
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and AG2 were revealed in genome of B. adeninivorans. In the genomes of most yeasts addressed in
Viigand et al. [12], the α-glucosidase genes resided in maltose utilization (MAL) clusters, whereas no
MAL clusters were detected in B. adeninivorans.
α-Glucosidases have been popular objects to study protein evolution and phylogenesis [13–16],
but they also have a biotechnological value. Thus, some of them have a high transglycosylating activity
thanks to which they produce prebiotic oligosaccharides and potential functional food ingredients
such as panose, melezitose, isomelezitose and isomalto-oligosaccharides [17–21]. For example, the
α-glucosidase of S. cerevisiae produced isomelezitose from sucrose when the substrate concentration was
high [21]. Transglycosylating ability of maltose by the α-glucosidase of Xanthophyllomyces dendrorhous
(syn. Phaffia rhodozyma) has been studied in detail, and synthesis of tri- and tetrasaccharides with
α-1,6 linkages was detected. This enzyme certainly has a biotechnological potential—it produced
3.6 times more transglycosylation products than the S. cerevisiae α-glucosidase studied at the same
conditions [17,20].
Considering α-glucosidases of yeasts, they have mostly been studied in S. cerevisiae as these
enzymes are crucial in baking and brewing [22]. S. cerevisiae has two types of α-glucosidases—maltases
(EC 3.2.1.20) and isomaltases (EC 3.2.1.10)—that differ for substrate specificity. Maltases degrade
maltose and maltose-like sugars, i.e., maltotriose, turanose and maltulose, but cannot degrade
isomaltose and isomaltose-like sugars (α-1,6 linkages) such as palatinose. Both types of enzymes
hydrolyze sucrose and a synthetic substrate p-nitrophenyl-α-d-glucopyranoside (pNPG) [15,16,23,24].
At the same time, some yeasts such as Ogataea polymorpha and Scheffersomyces stipitis, have promiscuous
maltase-isomaltases that hydrolyze maltose- and isomaltose-like substrates [12,16,25].
In the current work, we expressed heterologously in Escherichia coli and biochemically characterized
the α-glucosidase BaAG2 of B. adeninivorans encoded by rna_ARAD1D20130g. We confirmed that
BaAG2 is a maltase with a considerable transglycosylating activity. Not typical for yeast maltases,
BaAG2 had exo-hydrolytic activity on amylose, amylopectin and glycogen. BaAG2 is the first maltase
characterized from B. adeninivorans.
2. Results
2.1. In Silico Analysis of BaAG2
According to annotations provided at the MycoCosm website [26], the genome of Blastobotrys
(Arxula) adeninivorans [2] encodes 185 carbohydrate-active enzymes, including 88 glycoside hydrolases
(GHs) assigned to different families. When mining the genome of B. adeninivorans [2] for the genes
related to maltose hydrolysis, we found two genes encoding intracellular GH13 family proteins.
Respective proteins were designated as AG1 and AG2 [12]. In MycoCosm, the AG1 was annotated as a
protein similar to maltase Mal1 of Schizosaccharomyces pombe and the AG2 as similar to maltases of
filamentous fungi Aspergillus and Penicillium. Both of these proteins were predicted to lack a signal
peptide and to locate intracellularly. We confirmed this by using the SignalP program (see Materials
and Methods). Aside from these two GH13 proteins, three putative extracellular α-glucosidases of
GH31 family were detected in B. adeninivorans genome (see Table S1 of Supplementary Materials).
Table S1 also includes two B. adeninivorans enzymes that have been experimentally studied: a secreted
invertase AINV belonging to GH31 family [10] and a secreted glucoamylase [9] of GH15 family.
Substrate specificity of α-glucosidases can be in silico predicted based on so-called amino acid
signature—a set of amino acids that locate in the vicinity of the substrate-binding pocket [12,15,27,28].
The upper panel of Figure 1 shows the amino acid signature of O. polymorpha maltase-isomaltase MAL1,
S. cerevisiae maltase MAL62, isomaltase IMA1, and B. adeninivorans AG2. The amino acids of these
proteins corresponding to Val216 of ScIMA1 are shown inside a red frame as this position is considered
of key importance in selective substrate binding [28].
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Figure 1. Amino acid signature of yeast α-glucosidases, including B. adeninivorans AG2 (upper panel)
and their designation on the three-dimensional (3D) structure of S. cerevisiae isomaltase IMA1 in
complex with isomaltose (RCSB Protein Data Bank, PDB: 3AXH [29]) (lower panel). Location of Val216
in the structure is marked with a red circle.
We then visualized the S. cerevisiae IMA1 structure in complex with isomaltose (PDB: 3AXH) [29]
using PyMol [30] in order to display all these amino acids (Figure 1, lower panel). In BaAG2, a Thr is
present at position of Val216 and therefore we predicted that this enzyme is most probably a maltase.
However, as maltase-isomaltases also have a Thr at that position (Figure 1, upper panel; [12,16]),
based on the amino acid signature, BaAG2 may also be a promiscuous enzyme with a wide substrate
spectrum like O. polymorpha MAL1.
Figure 2 presents fragments of sequence comparison of BaAG2 with those of five experimentally
studied maltases from GH13 family: two from bacteria, two from yeasts and one from a filamentous
fungus Aspergillus. The identity matrix of these proteins is presented in Supplementary Materials
(Table S2). Though the proteins aligned sufficiently well over the entire sequence, BaAG2 showed
only moderate sequence identity with the other maltases ranging from 35% with Halomonas sp. H11
α-glucosidase to 51% with Aspergillus oryzae maltase MalT (Table S2). In silico assay of α-glucosidases
of non-conventional yeasts [12] identified a putative α-glucosidase protein AG1 of Lipomyces starkeyi as
the closest homologue (50% identity) of BaAG2. The amino acid signature of the Lipomyces protein was
YTVNKLSHE, and it was, therefore, predicted as a maltase [12].
The GH13 enzymes use an Asp (D) as a nucleophile and a Glu (E) as an acid-base catalyst [31].
Additionally, an Asp of the conserved ‘NHD’ motif serves as a transition state stabilizer [32]. In the
BaAG2 protein, Asp216 was predicted as a nucleophile, Glu274 as an acid-base catalyst and Asp348 as
a stabilizer (Figure 2). Thr217 is located next to the catalytic nucleophile Asp216 in BaAG2 (Figure 2).
In maltases and maltase-isomaltases, either Thr or Ala is present at respective position, whereas
in isomaltases, a Val is present [12,15,27,28], indicating that a Val residue at this position interferes
with hydrolysis of maltose-like substrates. Indeed, if respective Thr was substituted with Val in
O. polymorpha maltase-isomaltase, utilization of maltose-like sugars was severely hampered [16].
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Furthermore, after substitution of Val216 in S. cerevisiae IMA1 with Thr, the isomaltase IMA1 gained
the ability to hydrolyze maltose [28,29].
 
Figure 2. Fragments of sequence alignment of six maltases. BaAG2, Blastobotrys adeninivorans
AG2 (580 aa); SpMal1, Schizosaccharomyces pombe Mal1 (579 aa, NP_595063.1) [33]; ScMAL62,
Saccharomyces cerevisiae MAL62 (584 aa, P07265) [23]; GsAG, Geobacillus stearothermophilus
exo-α-1,4-glucosidase (555 aa, BAA12704.1) [34]; HaAG, Halomonas sp. H11 α-glucosidase (538 aa,
BAL49684.1) [35]; AoMalT, Aspergillus oryzae maltase MalT (574 aa, XP_001825184.1) [36]. Highlights:
catalytic nucleophile (turquoise), acid-base catalyst (green), a transition state stabilizer (yellow) and
a residue crucial for substrate specificity (red). Cc, Clustal consensus. Marking below the sequence
alignment is according to Clustal consensus showing conservation: * positions with fully conserved
residue; : positions with residues of strongly similar properties; . positions with residues of weakly
similar properties.
2.2. Maltose-Like and Isomaltose-Like Sugars Are Growth Substrates for B. adeninivorans
According to the information present in the CBS-KNAW culture collection [37], B. adeninivorans
CBS 8244 used in current work assimilates following α-glucosidic sugars: maltose, sucrose, melezitose,
trehalose and α-MG. Of those, melezitose is a maltose-like sugar, and α-MG (a synthetic analogue
of isomaltose [38]) is an isomaltose-like sugar. Glucose and many other monosaccharides are
also assimilated. We asked if B. adeninivorans can also assimilate some other α-glucosidic sugars.
We cultivated B. adeninivorans on Yeast Nitrogen Base (YNB) mineral medium containing 2 g/L of sugars
indicated in Figure 3, and evaluated growth according to an optical density (OD) of 600 nm achieved
by 24 h of growth (Figure 3). Our assay confirmed that five above-mentioned α-glucosidic sugars were
indeed all assimilated. In addition, maltotriose, maltulose, turanose (maltose-like sugars) as well as
isomaltose and palatinose (an isomaltose-like sugar) were identified as new growth substrates for this
yeast. Thus, B. adeninivorans grows on both maltose-like and isomaltose-like sugars, meaning that it
should possess enzymes for the hydrolysis of both types of sugars.
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Figure 3. Growth of B. adeninivorans on sugars (supplemented at 2 g/L) evaluated by an optical density
(OD) of the culture at 600 nm achieved by 24-h cultivation on a microplate at 37 ◦C. Isomaltose and
isomaltose-like sugars are indicated by dark blue bars. Error bars are representing standard deviations
(SD) of two independent experiments with two replicates.
2.3. Cloning of the BaAG2 Gene and Heterologous Expression of the BaAG2 Enzyme
The BaAG2 protein deduced from the gene is 580 aa long. The protein was predicted as
intracellular—no secretion signal was detected by the SignalP program v. 5.0 [39]. BaAG2 was
overexpressed in E. coli with the His6-tag in its C-terminus that enabled purification of the protein
using Ni2+-affinity chromatography. The calculated molecular weight of the protein was 67.9 kDa
and a prominent band of respective size was detected by electrophoresis of the lysate produced from
induced E. coli cells overexpressing the AG2 gene (Figure S1). The E. coli lysate exhibited catalytic
activity of 1 mM pNPG hydrolysis at 30 ◦C (71 U/mg), which after purification of the protein increased
5.8 times, reaching 411.5 U/mg.
2.4. Properties of BaAG2
2.4.1. Dependence of the BaAG2 Activity on Temperature and pH. Thermal Stability of BaAG2
The pH optimum of BaAG2 was in moderately acidic region—from 5.5 to 6.5 (Figure S2). At pH
7.5, the activity was 81% from the maximum, and at pH 8.5, it was decreased to 52%. At pH 4.5 and 4.4,
the respective values were 93 and 15%. Thus, the activity of BaAG2 was significantly reduced at pH
values below 4.5 and over 8.5 (Figure S2). The pH optimum of the O. polymorpha maltase is 6.0–6.5 [40],
of S. cerevisiae maltase 6.5–6.8 [23,24] and of Schizosaccharomyces pombe maltase 6.0 [33]. In the current
work, we routinely used the buffer with pH of 6.5 to characterize substrate specificity, kinetics and
other properties of the enzyme.
As shown in Figure 4 (left panel), catalytic activity of BaAG2 was the highest at 45 ◦C being 24%
higher than activity measured at 30 ◦C—the temperature we routinely used for enzyme activity assay.
Figure 4 shows that at temperature over 50 ◦C, the activity of the enzyme rapidly declined. Thermal
stability assay of BaAG2 indicated that the enzyme was rather thermolabile: if kept for 30 min at
temperatures above 37 ◦C, its catalytic activity reduced significantly (Figure 4, right panel). Therefore,
we routinely performed enzymatic assays at 30 ◦C since some reactions (e.g., transglycosylation and
polysaccharide degradation assays) were conducted up to several days.
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Figure 4. The effect of temperature on activity (left panel) and stability (right panel) of BaAG2. For the
thermostability assay, the enzyme was incubated for 30 min at the indicated temperature and residual
activity was determined at 30 ◦C with pNPG as a substrate (see Materials and Methods, paragraph 4.4.
for details). SDs of two to three replicates at each temperature are shown by error bars.
2.4.2. The Hydrolysis of Maltose and Maltose-Like Sugars
We predicted in silico that BaAG2 is either maltase or maltase-isomaltase (see Figure 1). To find out
which of the predictions was correct, the purified BaAG2 protein was reacted with a selection of 100 mM
sugars and 1 mM pNPG that serves as a substrate for maltases, isomaltases and maltase-isomaltases
(Figure 5). According to our assay, BaAG2 could hydrolyze universal substrates (pNPG and sucrose),
maltose and maltose-like sugars such as turanose, maltotriose, melezitose and maltulose. Isomaltose
and isomaltose-like substrates palatinose and α-methylglucoside were not hydrolyzed (Figure 5).
Therefore, BaAG2 should be considered as a maltase.
 
Figure 5. Activity of BaAG2 on 100 mM sugars and 1 mM pNPG. Universal substrates are indicated by
green, maltose and maltose-like sugars by yellow, and isomaltose and isomaltose-like sugars by blue
bars. The composition and linkage types of the tested substrates are indicated. SD values of three to
five replicates on each substrate are indicated.
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2.4.3. The Kinetic Parameters of Hydrolysis of Maltose, Maltose-Like and Universal Substrates
We studied the kinetics of the hydrolysis of pNPG, maltose, sucrose, maltotriose, melezitose,
maltulose and turanose to calculate Km, Vmax, kcat and catalytic efficiency (kcat/Km) values for these
substrates. Results are presented in Table 1.
Table 1. Km, Vmax, kcat and kcat/Km values of hydrolysis of pNPG and sugars by BaAG2.
Substrate * Km ± SD (mM) Vmax ± SD(μmol/(mg ×min)) kcat ± SD (1/s) kcat/Km (1/(mM × s))
pNPG 0.76 ± 0.03 751.3 ± 14.5 850.2 ± 16.4 1106.1
Maltose 25.8 ± 1.6 336.4 ± 5.8 380.7 ± 6.5 14.8
Maltotriose 32.5 ± 3.3 117.9 ± 4.4 133.5 ± 5.0 4.1
Sucrose 35.9 ± 2.7 412.4 ± 8.9 466.8 ± 10.1 13.0
Turanose 45.2 ± 6.0 190.1 ± 10.4 215.1 ± 11.9 4.8
Maltulose 7.8 ± 1.0 52.2 ± 1.8 59.1 ± 2.1 7.6
Melezitose 238.3 ± 51.8 231.0 ± 31.8 261.4 ± 36.1 1.1
* For the structure and linkage type of the substrates, see Figure 5. SD, standard deviation.
Table 1 shows that natural sugars, maltose and sucrose (α-d-Glc-(1→2)-β-d-Fru) were hydrolyzed
by BaAG2 with the highest catalytic efficiency (kcat/Km). Additionally, BaAG2 had a high affinity
and activity towards a synthetic substrate pNPG—the Km for pNPG was 0.76 mM and the Vmax over
750 U/mg. Affinity of BaAG2 for maltose was slightly higher than for sucrose. From this aspect,
BaAG2 differs from the maltases of S. cerevisiae [23,24] and Candida albicans [41], and also from the
maltase-isomaltase of O. polymorpha [16,40,42], for which affinity for sucrose is about twice higher
than for maltose. In contrast, the maltase of Schizosaccharomyces pombe prefers maltose to sucrose [33].
Among the substrates tested, the affinity and catalytic efficiency of BaAG2 was the lowest for melezitose.
Thin layer chromatography (TLC) analysis showed that the glycosidic bond of turanose moiety of
melezitose was hydrolyzed first, yielding sucrose and glucose as products (Figure S3). Similar mode of
melezitose hydrolysis was earlier shown for the maltase-isomaltase of O. polymorpha [16]. Interestingly,
isomelezitose was hydrolyzed by BaAG2 with release of palatinose (Figure S3).
We would like to emphasize that the activity of BaAG2 (Table 1) was higher compared to some
of other studied maltases of yeasts and filamentous fungi. For example, its Vmax on maltose was
7.5 times higher compared to S. cerevisiae maltase MAL62 [23], and over two times higher compared to
maltase-isomaltase of O. polymorpha [16]. On the other hand, α-glucosidases of X. dendrorhous and
A. niveus preferred polysaccharides such as starch, amylopectin and glycogen, and their kcat values on
maltose were respectively 25 and 28 times lower compared to the value of BaAG2 [43,44]. Catalytic
constant of α-glucosidase of A. niger on maltose was 144 1/s (2.6 times lower than BaAG2), but the
affinity towards maltose was very high (0.75 mM) [45]. Based on the literature, only one α-glucosidase
of yeast and filamentous fungi has much higher kcat on maltose than that of BaAG2—the extracellular
α-glucosidase of Schizosaccharomyces pombe (kcat = 709 1/s) [46].
2.4.4. The Inhibition Studies of Acarbose, Tris, Isomaltose-Like Sugars and Glucose
Having seen that isomaltose and isomaltose-like sugars are not hydrolyzed by BaAG2 (Figure 5),
we measured inhibition of pNPG hydrolysis reaction by these sugars as in [16]. Because maltases are
usually strongly inhibited by glucose and acarbose, and much less by fructose [16], these substrates
were also assayed as potential inhibitors of BaAG2. When testing the effect of different buffers during
the experiments, we noticed that the activity of BaAG2 was lost in Tris-HCl buffer. More precise assay
of the effect of tris(hydroxymethyl)aminomethane (Tris) on BaAG2 revealed strong inhibition of the
enzyme by this compound (Table 2). All tested compounds inhibited pNPG hydrolysis competitively,
and the most powerful inhibitors of BaAG2 were acarbose, Tris and glucose.
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Table 2. Ki values and inhibition mode for BaAG2 inhibitors of pNPG hydrolysis.
Inhibitor Ki ± SD (mM) Inhibition Mode
Palatinose 1.4 ± 0.1 Competitive
Isomaltose 22.7 ± 3.0 Competitive
α-MG 21.8 ± 1.4 Competitive
Acarbose 0.83 ± 0.01* Competitive
Glucose 0.86 ± 0.05 Competitive
Fructose 36.9 ± 2.4 Competitive
Tris 70.5 ± 4.3* Competitive
* These values are given in μM. SD, standard deviation.
We expected that binding of the substrates or competitive inhibitors of the enzyme should increase
its thermostability. To confirm this, we conducted a differential scanning fluorimetry (DSF) assay of
BaAG2 in the presence and absence of competing inhibitors as in [16,47]. Acarbose, palatinose, Tris
and glucose (strong inhibitors of pNPG hydrolysis by BaAG2) and fructose that inhibited the reaction
only weakly (see Table 2) were used as ligands. The melting temperature (Tm) values calculated from
the DSF data are presented in Figure 6. The Tm of BaAG2 without a ligand was similar to that of
maltase-isomaltase MAL1 of O. polymorpha—51 ◦C [16]. Presence of acarbose (the strongest inhibitor
of BaAG2) increased the Tm of BaAG2 by 11.4 ◦C. Presence of Tris raised the Tm value by 5.8 ◦C, and of
glucose by 4.4 ◦C. Fructose and palatinose had only a minor effect on the Tm (Figure 6).
 
Figure 6. Thermostability of BaAG2 in the presence and absence of indicated ligands. The Tm value of
unliganded BaAG2 (a grey bar) was 51 ◦C and the increase of Tm in the presence of a ligand is indicated
above every bar. SDs of at least two independent experiments with two replicates at each condition are
shown by error bars.
2.4.5. The Hydrolysis of Malto-Oligosaccharides of DP 3 to 7
We have earlier shown that O. polymorpha maltase-isomaltase MAL1 could use maltotriose and
maltotetraose as a substrate, while malto-oligosaccharides (MOS) of higher degree of polymerization
(DP) were not hydrolyzed [16]. We showed that MOS of DP3 (see Table 1), DP4, DP5, DP6 and DP7 served
as substrates for BaAG2 (Figure S4). Assay of reaction course indicated that exo-hydrolysis occurred—a
glucose residue was stripped off from the oligomer. Activity on MOS was only moderate and a
substantial proportion of it stayed unreacted even after extended (22 h) reaction time (see Figure S4). The
MAL62 of S. cerevisiae that was assayed alongside could not hydrolyze MOS longer than maltotetraose
(DP4) (Figure S4).
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2.4.6. The Hydrolysis of Amylose, Amylopectin and Glycogen
Surprisingly, we detected the ability of BaAG2 to hydrolyze polysaccharides that is a rather
exceptional feature among maltases. After we noticed that BaAG2 could hydrolyze soluble starch with
the release of glucose, we performed a more detailed assay testing the hydrolysis of a set of polymeric
α-glucans: amylose and amylopectin from potato, glycogen from oysters and dextrans of Mw 20 and
110 kDa. Commercial amylolytic enzymes amyloglycosidase (glucoamylase) from Aspergillus niger,
and α-amylase from Aspergillus oryzae and S. cerevisiae MAL62 were used as reference enzymes.
Hydrolysis of the polymers was evaluated according to the release of glucose and by TLC analysis
of reaction products. The commercial enzymes hydrolyzed amylose, amylopectin and glycogen
rapidly and with the expected pattern of products (Figure 7). Dextrans were hydrolyzed only by the
amyloglycosidase, and the release of glucose was minimal. BaAG2 and ScMAL62 had no activity on
dextrans. However, BaAG2 exhibited moderate, but clearly detectable and recordable exo-hydrolysis
of amylose, amylopectin and glycogen. The activity was the highest with amylopectin, and the lowest
with amylose (Figure 7). From amylopectin (5 g/L), 0.1 g/L of glucose was released by 24 h, and 0.3 g/L
by 72 h of the reaction. In the case of ScMAL62, no hydrolysis of amylose was detected, and hydrolysis
of glycogen and amylopectin became detectable only by 72 h of the reaction (Figure 7).
 
Figure 7. Hydrolysis of polysaccharides (5 g/L) by BaAG2, ScMAL62 and amyloglycosidase of A. niger
(AG) and α-amylase of A. oryzae (α-AM). Samples withdrawn at indicated time points were analyzed
using TLC. Reaction mixtures were spotted on TLC plates alongside with reference sugars (M): Glc
(30 mM glucose); Mal (10 mM maltose); MalTri (10 mM maltotriose); DP4 (10 mM maltotetraose). The
same marker sugars were used in all assays but are marked only on TLC plate of glycogen degradation.
C—control sample without the enzyme but containing 5 g/L bovine serum albumin (BSA) incubated
at the same conditions for 74/96 h. Glucose release was quantified enzymatically. See Materials and
Methods, paragraphs 4.3 and 4.6 for details. SDs of two to three replicates are shown by error bars.
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2.4.7. The Transglycosylation of Maltose
Many α-glucosidases can transglycosylate and produce short oligosaccharides, especially at
high concentration of the substrate [17–21]. We assayed this possibility by incubating BaAG2 with
250 and 500 mM maltose up to 72 h and analyzed the reaction products by HPLC. The maltase
MAL62 of S. cerevisiae was used as a reference. Figure 8 and Table S3 show that already within
2 h at 250 mM (85.6 g/L) maltose concentration, BaAG2 produced maltotriose (4.2 g/L) and panose,
α-d-Glc-(1→6)-α-d-Glc-(1→4)-d-Glc (1.6 g/L), in addition to a maltose hydrolysis product—glucose.
By 72 h of reaction, the maltotriose content was decreased and panose content increased to 2.6 g/L
(Figure 8, Table S3). The ScMAL62 produced only maltotriose under the same conditions, and its
amount was considerably lower than in the case of BaAG2—only 2.0 g/L produced by 2 h of reaction
(Figure 8, Table S3). Transglycosylation of maltose was enhanced at 500 mM (171.2 g/L) concentration:
up to 13.3 g/L of maltotriose was produced by 2 h and 10.4 g/L of panose by 72 h of reaction. Notably,
a new transglycosylation product, isomaltose, emerged. It was produced by both enzymes, but its
concentration was certainly higher in the case of BaAG2—its concentration in the 72-h reaction sample
was 5.2 g/L (Table S3). By 24 h of reaction with 500 mM maltose, the amount of transglycosylation
products was 12.6% of total sugars in the reaction mixture, while the respective value for the MAL62
protein was about three times less—4.5% (see Table S3).
Figure 8. Transglycosylation of maltose by BaAG2 and ScMAL62. 20 μg/mL of the enzyme was reacted
with 250 mM or 500 mM of maltose. Samples from the reaction mixtures were withdrawn at designated
time points, heated to terminate the reaction and analyzed for sugar composition by HPLC as described
in Materials and Methods, paragraphs 4.5. and 4.6. Total amount of detected saccharides at each time
point was equalled to 100%. Products were identified using glucose, maltose, isomaltose, maltotriose
and panose as references. SDs of two to three HPLC measurements at each time point were up to 20%.
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We tested panose hydrolysis by BaAG2 and conclude that it accumulated in transglycosylation
reaction since it was not hydrolyzed by the enzyme even during extended (22 h) reaction time
(Figure S3). In contrast, maltotriose was hydrolysed by BaAG2 (Figure 5, Table 1), and due to that, its
content decreased at prolonged transglycosylation reaction (Figure 8, Table S3).
3. Discussion
Utilization of α-glucosidic sugars by maltases and isomaltases has earlier been thoroughly
studied in S. cerevisiae because metabolism of these sugars is crucial in brewing and baking [22,48].
However, transport and intracellular hydrolysis of α-glucosidic sugars have also been investigated
in Ogataea polymorpha [25] and Schizosaccharomyces pombe [33,49]. A maltase has been characterized
from C. albicans [41] and four maltase-isomaltases from Scheffersomyces stipitis [12]. Genes potentially
encoding for either maltases, isomaltases or maltase-isomaltases were recently discovered in the
genomes of many non-conventional yeasts [12]. Yeast species with deep phylogeny were expected to
possess ancient-like α-glucosidases [12]. Figure 9 shows the phylogram of selected yeast species and
A. oryzae based on sequence analysis of D1/D2 domains of large subunit ribosomal RNA to illustrate
the evolutionary relationships between the species. B. adeninivorans and Lipomyces starkeyi belong to
basal group of Saccharomycotina [50]. Based on phylogenetic analysis of orthologous proteins [4], this
group diverged from S. cerevisiae lineage 200 to 400 million, and from the CTG clade 200 million years
ago. The basal group is considered very heterogeneous, its most studied member is Yarrowia lipolytica
(not presented in Figure 9) and the most basal lineage to this group and all Saccharomycotina is
Lipomyces starkeyi [50].
Figure 9. Phylogram based on analysis of D1/D2 domains of large subunit ribosomal RNA (rRNA)
gene sequences of ten yeast species and of a filamentous fungus Aspergillus oryzae. The bootstrap values
(1000 replicates) are shown at the nodes. The scale bar shows the number of base substitutions per site.
The Saccharomycotina clades according to [50] are designated by background coloring.
On the phylogram (Figure 9), B. adeninivorans clusters with Lipomyces starkeyi. Genes for eight
intracellular α-glucosidases (five maltases and three isomaltases) were predicted in the genome of
L. starkeyi. In the phylogram of α-glucosidases from non-conventional yeasts, all eight Lipomyces
enzymes clustered with those of B. adeninivorans [12]. However, these putative α-glucosidases of
L. starkeyi have not been cloned for protein expression and characterization. In Kelly et al. an
extracellular α-glucosidase from L. starkeyi was biochemically characterized [51]. Unfortunately, the
sequence data of this protein is not available. The above-mentioned enzyme of L. starkeyi had equally
high activity on maltose and isomaltose, but it also hydrolyzed maltotriose, isomaltotriose, panose,
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amylopectin and starch. Its activity with starch and amylopectin comprised 31 and 42% of that with
maltose and isomaltose, and due to this feature, the authors considered it more similar to fungal rather
than yeast enzymes [51]. Interestingly, this enzyme did not hydrolyze sucrose and had a quite low
activity on pNPG. Typically, yeast α-glucosidases hydrolyze pNPG more rapidly than maltose. or
sucrose [16,24] (Table 1) whereas the opposite is true for maltases of bacteria and archaea [52–54].
Our study showed that BaAG2 is a maltase. BaAG2 efficiently hydrolyzed maltose and maltose-like
sugars, but could not hydrolyze isomaltose, palatinose nor α-MG that are specific substrates for yeast
isomaltases (Figure 5, Table 1). Isomaltose, isomaltose-like sugars as well as acarbose and glucose
competitively inhibited pNPG hydrolysis by BaAG2 and increased thermostability of the enzyme
(Table 2; Figure 6). We also discovered a very strong inhibition of BaAG2 by Tris with the Ki of
70.5 μM (Table 2). Tris also considerably increased thermostability of BaAG2 in a DSF assay (Figure 6).
As thermostability of S. cerevisiae isomaltases was also elevated in the presence of Tris [55], it may
bind to the active site of these enzymes. Literature mining revealed Tris as a competitive inhibitor of
Bacillus brevis maltase with the Ki of 14.5 mM [56]. In a yeast Brettanomyces bruxellensis (former name
Br. lambicus), both extra- and intracellular maltases were inhibited not only by acarbose (Ki values
between 28.5 and 57 μM) but also by Tris (Ki values between 7.45 and 15.7 mM) [57]. Compared to
Br. bruxellensis and Bacillus brevis maltases, BaAG2 was much more sensitive to Tris. The pH optimum of
BaAG2 was in a moderate acidic region as in the case of other yeast maltases [23,24]. The temperature
optimum for BaAG2 was between 40–50 ◦C, with maximum activity (530 U/mg) achieved at 45 ◦C.
Thermostability of the enzyme was not high—after keeping the enzyme at 45 ◦C for 30 min, the
enzyme’s activity dropped to 46% from the initial. Incubation for 30 min at 50 ◦C totally inactivated
the enzyme (Figure 4). According to literature data, thermolability has been reported for some other
yeast α-glucosidases. For example, the four isomaltases of S. cerevisiae had all low thermostability.
Of those, the IMA1 was most stable, and IMA5 the least stable [55].
According to Hasegawa et al., the MalT protein of A. oryzae that has 51% of sequence identity to
BaAG2 (Table S2) exhibited pNPG-hydrolyzing activity, its expression was induced when grown on
maltose, and thereby the MalT was defined by the authors as a maltase [36]. To date no additional data
on MalT protein is available. The intracellular maltase (MAL1) protein of Schizosaccharomyces pombe,
with 43.2% of sequence identity to BaAG2 hydrolyzed pNPG and maltose, but had also activity on
soluble starch, and some activity on sucrose [33].
Intriguingly, BaAG2 had a detectable hydrolytic activity on MOS with DP up to 7, glycogen,
amylose and amylopectin (Figure 7 and Table S4). We assume that the ability to hydrolyze MOS and to
cleave polymeric α-glucans, at least to some extent, may be characteristic to maltases of early-diverged
yeasts. As BaAG2 is an intracellular enzyme, and this yeast possesses a secreted glucoamylase [9],
the maltase BaAG2 has most probably no role in starch degradation. However, yeasts synthesize
glycogen as a reserve polysaccharide [58]. Considering that BaAG2 had a remarkable activity on
glycogen, the enzyme may contribute to glycogen catabolism in B. adeninivorans. We hypothesize that
the ability to degrade malto-oligosaccharides and α-glycosidic polysaccharides may be characteristic
for the maltases of yeasts with deep phylogeny. Isolation and study of α-glucosidases of the most
basal lineages to Saccharomycotina, for example Lipomyces starkeyi, should verify the correctness of
this hypothesis.
Several GHs of yeasts and filamentous fungi exhibit transglycosylating activity. For example,
α-glucosidase of a yeast X. dendrorhous (syn. Pfaffia rhodozyma) produced from maltose a large
proportion of transglycosylation products with α-1,6 linkage, among which panose was the most
abundant [17]. It has been shown that the S. cerevisiae maltase also produced panose from maltose, yet
transglycosylating activity of the Saccharomyces enzyme was more than three times smaller compared to
the X. dendrorhous enzyme. Both enzymes also synthesized isomaltose and maltotriose, but the latter was
rapidly used by the enzymes and was therefore not present among the final products [17]. We showed
that maltotriose was produced from maltose also by BaAG2 (Figure 8, Table S3), but as it serves as a
substrate for the enzyme (Table 1), it was eventually hydrolyzed. α-Glucosidases of filamentous fungi
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have been suggested as feasible catalysts for transglycosylation. Thus, an Aspergillus enzyme with high
transglycosylating activity was reported to produce panose and isomaltose from maltose [18,59,60].
When an A. nidulans α-glucosidase with strong transglycosylating activity was reacted with 5 g/L
maltose during 6 h, approximately 50% of maltose was converted to transglycosylation products, 60%
of which was isomaltose [60]. Notably, in addition to maltotriose and panose, isomaltose was also
detected among the transglycosylation products produced from maltose by BaAG2 (Figure 8, Table S3).
Isomaltose synthesis from maltose was also confirmed for ScMAL62, even though the content of it was
only minimal (Figure 8, Table S3).
4. Materials and Methods
4.1. Yeast and Bacterial Strains, Cultivation of B. adeninivorans
Blastobotrys (Arxula) adeninivorans LS3 (CBS 8244) was kindly provided by Assoc. Prof. V. Passoth
(SLU, Uppsala, Sweden). The yeast strain was grown on solid YPD medium (20 g/L peptone, 20 g/L
glucose, 10 g/L yeast extract, 20 g/L agar) at 30 ◦C 24 h for harvesting the cells for genomic DNA
extraction. E. coli DH5α (Thermo Fisher Scientific, Waltham, MA, USA) was used for DNA cloning and
plasmid production. E. coli BL21 (DE3) [61] was used for heterologous expression of BaAG2. The ability
of B. adeninivorans to grow on sugars was assayed as in [12]. Yeast cells grown overnight on BD Difco
YNB medium (Thermo Fisher Scientific, Waltham, MA, USA) without amino acids containing 2 g/L
glucose were used as inoculum. The YNB medium was supplemented with 2 g/L of a filter-sterilized
sugar (glucose, maltose, maltotriose, isomaltose, maltulose, α-methylglucoside, sucrose, raffinose,
melibiose, turanose, palatinose, melezitose or trehalose). The cells were incubated on Greiner 96-well
flat-bottom transparent polystyrene microplates (Greiner Bio-One, Frickenhausen, Germany) in 200 μl
under agitation for 24 h at 37 ◦C. Optical density of the culture at 600 nm was measured against
inoculated medium without sugar at the beginning and end of the experiment using an Infinite M200
PRO microplate reader (Tecan Group Ltd., Männedorf, Switzerland) equipped with Tecan i-control v.
1.7 software from the same provider. Two independent experiments with two parallel measurements
were conducted.
4.2. Cloning, Heterologous Expression and Protein Purification
Genomic DNA of B. adeninivorans was extracted using PowerMax Soil DNA Isolation
Kit (MoBio Laboratories, Carlsbad, CA, USA) and the standard protocol by manufacturer.
The oligonucleotide primers Ba20130g_PURICter_Fw (5′ TAACTTTAAGAAGGAGATATACAT
ATGGTTCTAGGATTTTTCAAAAAG 3′) and Ba20130g_PURICter_Rev (5′ GCTATTAATGATGATG
ATGATGATGGATTTCATAGATGACTGCCTCCA 3′), designed according to the gene sequence of
rna_ARAD1D20130g, were applied to amplify a 1789 bp fragment that represented the coding sequence
of BaAG2 [12]. In the primers, the nucleotides annealing with the pURI3Cter vector [62] are shown in
bold and those annealing with the BaAG2 gene sequence are shown in italics. The ATG start codon
and the stop codon are underlined in the primer sequences. Recombinant Pfu polymerase (Thermo
Fisher Scientific, Waltham, MA, USA) and 2.6 ng per μL of reaction mixture of genomic DNA were
used in amplification. The PCR product was cloned into a pJET vector from CloneJET PCR Cloning Kit
(Thermo Fisher Scientific, Waltham, MA, USA), yielding pJET-BaAG2. To produce the BaAG2 protein
with a C-terminal His6-tag, an expression plasmid pURI3-AG2Cter was constructed by cloning the
BaAG2 gene into pURI3-Cter vector similarly as in [63]. Insertion of the BaAG2 gene into the vector
was confirmed by DNA sequencing. The cloning procedure was conducted with recombinant Pfu
polymerase (Thermo Fisher Scientific, Waltham, MA, USA). DNA Clean & Concentrator-5 Kit (Zymo
Research, Irvine, CA, USA) was used for purification and concentration of PCR products. Plasmid
DNA was purified with FavorPrep Plasmid Extraction Mini Kit (Favorgen Biotech Corp., Ping-Tung,
Taiwan). The MAL62-containing plasmid pURI-ScMAL62Cter [12] was used to produce the S. cerevisiae
maltase protein that was analyzed as a reference.
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The pURI3-BaAG2Cter and pURI-ScMAL62Cter containing the BaAG2 gene or MAL62 gene,
respectively, were electroporated into E. coli BL21 (DE3) for heterologous expression. A simplified
autoinduction medium as in [64] was used for protein overproduction: the LB-based medium
(20 g/L tryptone, 5 g/L yeast extract, 5 g/L NaCl) was supplemented with 25 mM phosphate buffer
(Na2HPO4/KH2PO4; pH 7.2) and 3 g/L glycerol to which filter-sterilized 0.25 g/L glucose and 1 g/L
lactose were added. Medium for transformant selection contained ampicillin (Amp, 150 mg/L) for
plasmid preservation. Bacterial cells were grown overnight in LB-Amp medium at 37 ◦C and diluted
100 times in autoinduction medium. At first, the cultures were incubated for 2 h at 37 ◦C followed
by 20-h incubation at 22 ◦C. The cells were harvested by centrifugation (2400× g, 10 min) at 4 ◦C and
stored at −20 ◦C until further use. Cells were disrupted by sonication with Ultrasonic Homogenizer
(Cole-Parmer Instrument Company, Vernon Hills, IL, USA) in 100 mM K-phosphate buffer (pH 6.5)
with the cOmplete, EDTA-free Protease Inhibitor Cocktail (Roche Diagnostics, Mannheim, Germany),
and centrifuged 30 min at 2400 × g at 4 ◦C. The resulting supernatants were syringe-filtered (pore
size 0.45 μm) and loaded onto an IMAC HisTrap FF column coupled with an ÄKTAprime plus
chromatography system (GE Healthcare, Uppsala, Sweden). Further purification steps were conducted
as described in [63]. Proteins were quantified by measuring the absorbance at 280 nm. The respective
extinction coefficients of BaAG2 [133,855 1/(M × cm)] and ScMAL62 [148,990 1/(M × cm)] were
computed at ExPASy Proteomics Server (http://expasy.org). Purified proteins were maintained in 100
mM K-phosphate buffer (pH 6.5) at 4 ◦C.
4.3. Determination of Substrate Specificity, Kinetic Parameters and Inhibition
Hydrolysis of pNPG was assayed as in [16,40] according to the release of p-nitrophenol. 100 mM
K-phosphate buffer (pH 6.5) was used and reactions were conducted at 30 ◦C if not stated otherwise.
The purified enzyme was unstable if diluted therefore 5 g/L bovine serum albumin (BSA) was added
to the dilution buffer as a protein stabilizer to retain its full catalytic activity. For preliminary assay of
substrate specificity of BaAG2, the enzyme was reacted with 100 mM concentration of various potential
substrates: maltose, sucrose, maltotriose, isomaltose, melezitose, maltulose, turanose, palatinose or
α-MG. At fixed time points, aliquots were withdrawn, combined with three volumes of 200 mM
Tris buffer (pH 8.3) and subsequently heated at 96◦C for 5 min to stop the reaction. The content of
the released glucose was determined spectrophotometrically as in [16,47]. The activities (μmoles of
glucose released per minute per mg of protein; U/mg) were calculated from initial velocities of the
reaction. For kinetic analysis, initial rates of p-nitrophenol or glucose release from substrates were
measured at four to seven concentrations ranging from 0.1–3.0 mM for pNPG and 2.5–250 mM for di-
and trisaccharides. At least three independent measurements for each substrate and concentration
were made. BaAG2 content in reaction mixtures ranged from 0.02 to 3.5 μg/mL. The initial velocity
data analysis with enzyme kinetics module of the SigmaPlot (Systat Software, San Jose, CA, USA)
yielded kinetic parameters (Km, Vmax) for the enzyme. kcat and kcat/Km were calculated from these data.
The theoretical Mw value of 67,901 Da for the kcat calculation was computed in ExPASy Proteomics
Server (http://expasy.org).
Inhibition of BaAG2 was studied by incubating a suitable amount of enzyme (0.035–0.13 μg/mL)
with 0.2–2.0 mM pNPG in the presence of following potential inhibitors: 5 μM acarbose, 0.1 mM Tris,
5 mM palatinose, 10 mM isomaltose, 10 mM glucose, 100 mM α-methylglucoside, 100 mM trehalose
or 400 mM fructose. The Ki values were calculated using enzyme kinetics module of the SigmaPlot
(Systat Software, San Jose, CA, USA).
Differential scanning fluorimetry (DSF) was used to evaluate the thermostability of BaAG2 in the
presence and absence of ligands. The concentration of BaAG2 was used with 2 μM and for ligands:
100 mM fructose, 50 mM palatinose, 50 mM glucose, 5 mM Tris and 5 mM acarbose. The reaction was
conducted in 50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) (HEPES) buffer (pH 7.0)
with 150 mM NaCl. The experiment was based on [16,47,65] with above-mentioned modifications.
At least two independent experiments were performed with two technical replicates.
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Degradation of glucose polymers, i.e., amylopectin-free amylose from potato, amylopectin from
potato, glycogen from oysters and dextrans of Mw 20 kDa and 110 kDa, was assayed in K-phosphate
buffer (100 mM, pH 6.5) containing 0.2 g/L Na-azide. Polysaccharide concentration in the reaction
mixture was 5 g/L, and 20 μg/mL of the enzyme was used. At desired time points (2 h, 24 h, 74/96 h)
aliquots were withdrawn and heated to stop the reaction. A negative control containing 20 μg/mL BSA
instead of the enzyme was incubated alongside. Concentration of released glucose was measured as
described above and 3 μl of the samples were analysed on TLC. Maltase from S. cerevisiae (ScMAL62),
amyloglycosidase from Aspergillus niger (Sigma-Aldrich, Merck, Darmstadt, Germany) and α-amylase
from Aspergillus oryzae (Sigma-Aldrich, Merck, Darmstadt, Germany) were reacted with tested glucose
polymers for comparison.
To assay the hydrolysis of malto-oligosaccharides (DP 4-7), panose and melezitose by BaAG2
and ScMAL62, 50 mM of the sugar was reacted with 2.6 μg/mL of the enzyme in K-phosphate buffer
(100 mM, pH 6.5) containing 0.1 g/L of Na-azide and samples were withdrawn at fixed time points.
20 mM isomelezitose (transglycosylation product from sucrose of Ogatae polymorpha MAL1) was also
tested as a potential substrate. The reaction samples were analyzed using TLC.
4.4. Determination of pH and Temperature Optima, Evaluation of Thermostability
Initial velocity of 1 mM pNPG hydrolysis by BaAG2 was measured at 30 ◦C in BSA-supplemented
buffers of varied pH (from 3.8 to 8.5) using McIlvaine’s buffer (Na-phosphate/citrate buffer) [66] and
100 mM K-phosphate buffer to cover respective pH-interval, and data were plotted against the pH
to determine the pH optimum. Hydrolysis of 1 mM pNPG was measured at varied temperatures
from 20 to 65 ◦C. Initial velocity data were plotted against the temperature to reveal the temperature
optimum. For thermostability determination, BaAG2 was incubated in 100 mM K-phosphate buffer
(pH 6.5) buffer containing 5 g/L BSA for 30 min at temperatures 10, 20, 30, 37, 45 and 50 ◦C. After
cooling the samples on ice, residual activity of the enzyme was determined according to the hydrolysis
of 1 mM pNPG at 30 ◦C. Every temperature point was assayed in triplicate. The activity measured
after incubation at 10 ◦C was taken as 100%.
4.5. Study of Transglycosylation
20 μg/mL of the enzyme (BaAG2 or ScMAL62) was incubated in 100 mM K-phosphate buffer
(pH 6.5) with 0.2 g/L Na-azide and 250 mM or 500 mM maltose at 30 ◦C up to 72 h. The samples with
BaAG2 also contained 5 g/L BSA. Samples were withdrawn at fixed intervals, heated at 95 ◦C to stop
the reaction and analysed on TLC and by HPLC.
4.6. Chromatography of Substrates and Reaction Products
To visualize hydrolysis and polymerization products, the TLC analysis was conducted as in [16]
on Silica Gel 60 F254 plates with concentrating zone (Merck, Darmstadt, Germany). 0.5 μl of the
stopped reaction mixture were spotted onto the plate and sugars were separated with two runs
in chloroform:acetic acid:water (6:7:1, v:v:v) [67]. For the analysis of products of polysaccharide
degradation, 3 μl of the reaction mixtures were spotted. Sugars were visualized by immersion of the
plates in aniline-diphenylamine reagent and subsequent heating of the dried plates at 100 ◦C [68].
HPLC analysis was performed similarly as in [65]. Glucose and fructose were used to calibrate
the column. Fructose, maltose, sucrose, isomaltose, palatinose, turanose, maltotriose, panose and
melezitose were used as reference sugars.
4.7. Alignment of RNA and Protein Sequences and Construction of the Phylogram
Gene sequences from domains 1 and 2 (D1/D2) of large subunit ribosomal RNA were aligned
to build a neighbor-joining phylogenetic tree [69] of yeasts using MEGA v. 7.0 [70]. The maximum
composite likelihood model [71] with 1000 bootstrap replicates was applied. Protein sequences were
aligned using Clustal Omega [72] to calculate identity values of the proteins.
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4.8. Extraction of Amino Acid Signature from the Alignments and Visualization of Respective Positions on the
three-dimensional (3D) Model of S. cerevisiae Isomaltase IMA1
Protein sequences of S. cerevisiae maltase MAL62 (UniProtKB: P07265), S. cerevisiae isomaltase
IMA1 (UniProtKB: YGR287C), O. polymorpha maltase-isomaltase MAL1 (UniProtKB: Q9P8G8) and
B. adeninivorans AG2 were aligned using Clustal Omega [72] and amino acids corresponding to IMA1
signature positions determining the substrate specificity [12,15] were extracted from the alignment.
The S. cerevisiae IMA1 structure in complex with isomaltose (PDB: 3AXH) [29] was visualized with
PyMol [30] and amino acid signature was designated on the structure.
5. Conclusions
According to the literature data, a non-conventional yeast Blastobotrys (Arxula) adeninivorans
belonging to the basal group of Saccharomycotina diverged in the evolution of yeasts hundreds of
millions of years before Saccharomyces and can be considered as a yeast species with deep phylogeny. The
genome of B. adeninivorans encodes two putative α-glucosidases. In current work, one of them, BaAG2,
was produced in E. coli and characterized in detail. BaAG2 was proven to be a maltase—hydrolysing
α-1,4 and α-1,3 but not α-1,6 linkages in glucose-containing substrates. Interestingly, BaAG2 was
strongly and competitively inhibited not only by acarbose, a diabetes drug and a well-known inhibitor
of α-glucosidases, but also by Tris. Importantly, at high maltose concentrations, BaAG2 exhibited
transglycosylating ability producing potentially prebiotic di- and trisaccharides: isomaltose, panose
and maltotriose. Thus, BaAG2 may have a biotechnological value. In contrast to yeast maltases,
BaAG2 showed exo-hydrolytic activity on starch, amylose, amylopectin and glycogen. S. cerevisiae
maltase MAL62 assayed for comparison had only minimal ability towards these polymers and its
transglycosylating activity was much lower.
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Abbreviations
BaAG2 α-glucosidase 2 of Blastobotrys adeninivorans
BSA bovine serum albumin
DP degree of polymerization








ScMAL62 maltase MAL62 of Saccharomyces cerevisiae
SD standard deviation
TLC thin layer chromatography
Tm melting temperature
Tris tris(hydroxymethyl)aminomethane
YNB Yeast Nitrogen Base
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Abstract: Given its potential role in the synthesis of novel prebiotics and applications in the
pharmaceutical industry, a strong interest has developed in the enzyme levansucrase (LSC, EC 2.4.1.10).
LSC catalyzes both the hydrolysis of sucrose (or sucroselike substrates) and the transfructosylation of
a wide range of acceptors. LSC from the Gram-negative bacterium Erwinia tasmaniensis (EtLSC) is an
interesting biocatalyst due to its high-yield production of fructooligosaccharides (FOSs). In order
to learn more about the process of chain elongation, we obtained the crystal structure of EtLSC
in complex with levanbiose (LBS). LBS is an FOS intermediate formed during the synthesis of
longer-chain FOSs and levan. Analysis of the LBS binding pocket revealed that its structure was
conserved in several related species. The binding pocket discovered in this crystal structure is an
ideal target for future mutagenesis studies in order to understand its biological relevance and to
engineer LSCs into tailored products.
Keywords: glycoside hydrolase; GH68; fructosyltransferase; fructooligosaccharides; FOS biosynthesis;
prebiotic oligosaccharides
1. Introduction
In the last decade, interest has grown towards levan/inulin oligosaccharides. They have a wide
range of applications, from personal care to packaging. These molecules are especially relevant for
their medical applications and prebiotic activity [1–5].
Levansucrases (LSCs, EC: 2.4.1.10) and inulosucrases (INUs, EC: 2.4.1.9) are major
fructosyltransferases employed as biocatalysts in the synthesis of fructans and fructooligosaccharides
(FOSs). Both are members of glycosyl hydrolase family 68 (GH68) [6]. LSC catalyzes the
transfructosylation of the fructose component of sucrose by using a variety of acceptor molecules,
forming β-(2,6)-linked oligofructans. When a water molecule acts as an acceptor, the reaction results in
the hydrolysis of sucrose into glucose and fructose [1].
LSCs are used in the fermentative production of microbial oligosaccharides and polysaccharides
due to their ability to interact with low-cost substitutes of sucrose, e.g., syrups and molasses [7,8].
The existence of a wide spectrum of nonconventional fructosyl acceptors explains the
biotechnological interest in LSCs. These enzymes can interact with nonconventional fructosyl acceptors
and donors [9], such as monosaccharides, disaccharides, and sucrose homologs. For example, LSCs
from Pseudomonas syringae pv. tomato DC3000 and Pseudomonas aurantiaca are able to transfructosylate
deoxy sugars or alditols such as fucose, ribose, sorbitol, and xylitol [10]. Among nonconventional
Int. J. Mol. Sci. 2020, 21, 83; doi:10.3390/ijms21010083 www.mdpi.com/journal/ijms89
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substrates, lactose has been one of the most extensively studied. This is due to its combined role with
sucrose in a reaction catalyzed by LSCs from Bacillus spp. (B. methylotrophicus SK21.002 [11], B. subtilis
NCIMB 11871 [12], and B. licheniformis [13]) to produce lactosucrose, which is a trisaccharide with
prebiotic activity [14].
Aromatic alcohols such as phenol derivatives (e.g., hydroquinone) [15] and isoflavones
(e.g., puerarin) [16] can also be transfructosylated by LSCs from B. subtilis (SacB, BsLSC) and
Gluconacetobacter diazotrophicus (GdLSC), respectively. The improved physical, chemical, and bioactive
properties (solubility, stability, availability, and activity) of these glycosides make them relevant to
pharmaceutical applications.
In the last decade, several studies have been carried out to understand which residues are the
most relevant in the reaction mechanism [2]. Thanks to these studies, engineered glycosyltransferases
can be used to obtain specific compounds such as FOSs (e.g., 6-nystose) instead of high-molecular
weight (HMW) levan [17].
To better describe the relevant residues, the active site of LSC is commonly divided into layers.
Moving from the sucrose binding site outwards, there are three layers: the first, second, and third.
Mutations S173A, S173G, and S422A (first layer) in the LSC of Bacillus megaterium (BmLSC, PDB ID:
3OM7) increase transfructosylate activity by 194%, 53%, and 42%, respectively [18]. In P. syringae pv.
tomato, LSC3 with the E146Q mutation (second layer) exhibits increased production of FOSs compared
to wildtype [19]. SacB of B. subtilis with a Y429N mutation (second layer) has mostly hydrolytic activity
and can produce short-chain FOSs instead of HMW levan [20].
Due to the high-yield production of FOSs, the product spectrum and well-optimized production
of recombinant enzyme in Escherichia coli, LSCs from Erwinia tasmaniensis (EtLSC) [21] and
Erwinia amylovora (EaLSC) [22,23] are interesting candidates for engineered LSCs that produce
tailor-made fructans.
The structure of LSC is known in B. subtilis, B. megaterium, E. amylovora, E. tasmaniensis, and
G. diazotrophicus. LSCs have similar structures, and their active sites possess common structural
features [24], such as the triad of amino acids involved in catalysis (Asp46, Asp203, and Glu287 in
EaLSC) [25]. LSC has been successfully crystallized in complex with sucrose (B. subtilis, Protein Data
Bank (PDB) ID: 1PT2), raffinose (B. subtilis, PDB ID: 3BYN), fructose, and glucose (E. amylovora, PDB ID:
4D47). While the sucrose binding site is conserved, superficial areas and volumes vary across species
due to variability in the surrounding loops [2,25].
In this report, we present the first known crystal structure of an LSC, EtLSC, in complex with
levanbiose (LBS). LBS is an intermediate in the synthesis of oligolevans in the LSC enzyme. The complex
was obtained by soaking EtLSC apo crystals (PDB ID: 6FRW) in a concentrated solution of sucrose
(0.5 M) in order to trap reaction intermediates/products in the crystals. We describe an unexplored
plausible binding site for LBS. We analyzed conserved amino acids in the binding pocket of LBS and
compared their structural arrangement to other LSCs from Gram-positive and -negative bacteria. The
aims of these analyses were to understand the biological relevance of the binding pocket and explore
possible implications for LSC engineering.
2. Results and Discussion
The structure of LSC from E. tasmaniensis in complex with LBS was determined with a maximum
resolution of 1.58 Å (space group P 41212). Data collection and structure-refinement statistics are
summarized in Table 1. Atomic coordinates and experimental-structure factors were deposited in the
PDB with PDB ID: 6RV5.
Overall, the protein structure showed great similarity with apo EtLSC (PDB ID: 6FRW) [21] and
its closest homolog EaLSC in complex with glucose and fructose (PDB ID: 4D47) [25].
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Resolution range (Å) 45.21–1.58 (1.64–1.58)
Space group P 41212
a, b, c (Å) and α, β, γ (◦) 127.886, 127.886, 58.268; 90, 90, 90
Total reflections 552,442 (86,048)
Unique reflections 162,091 (25,949)
Multiplicity 3.4 (3.3)
Completeness (%) 99.47 (99.95)
Mean I/sigma(I) 20.50 (2.91)





Reflections used in refinement 66,162 (6515)
Reflections used for R-free 3263 (343)
R-work 0.1456 (0.2640)
R-free 0.1929 (0.2902)
CC (work) 0.966 (0.827)




RMS (bonds) (Å) 0.017
RMS (angles) (◦) 2.02
Ramachandran favored (%) 96.34
Ramachandran allowed (%) 3.41
Ramachandran outliers (%) 0.24
Rotamer outliers (%) 1.87
Clashscore 5.97




Statistics for highest-resolution shell shown in parentheses.
Both EtLSC and EaLSC act via a distributive (nonprocessive) mechanism. This mechanism is
known to produce low-molecular weight (LMW) levan and a mixture of FOSs [2]. For example, EaLSC
and EtLSC mainly produce short-chain FOSs with 3–6 degrees of polymerization (DP) [21,22], while the
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main product of GdLSC is 1-kestose [24,26]. Furthermore, BmLSC produces FOSs with a DP ranging
from 2 to 20 [27]. Even SacB can catalyze the formation of LMW levan under conditions that favor a
nonprocessive mechanism [28].
The complex process of polymerization is the main factor that determines the wide range of
products synthesized by LSC. Specifically, the DP is increased via a cycle of fructosyl capture, transfer,
and release of fructosylated intermediates. These intermediates belong to one of two main types of
FOS, n fructose units with glucose moiety (GFn) or exclusively n fructose units (Fn). LBS, a fructose
dimer, is an intermediate that seems to be produced in the late phase of the reaction. It was described
as a secondary intermediate in the LSC from B. subtilis (SacB) [28].
Both types of FOS (GFn and Fn) have been found in the product mixture from EtLSC, and the
following species were identified: Levanbiose (F2), levantriose (F3), 6-kestose (GF2), 6-nystose (GF3),
and 6,6,6-kestopentaose (GF4) [21].
A comparison of the structure of EtLSC (this report, PDB ID: 6RV5) and EaLSC (PDB ID: 4D47)
was obtained by applying the same soaking procedure with sucrose but with different soaking times,
revealing that different products bind to different locations on the enzyme. Although there was
similarity between the products of hydrolysis (glucose and fructose) trapped in EaLSC [25] and LBS
trapped in EtLSC (PDB ID: 6RV5), these molecules did not bind in similar pockets. In fact, LBS was
bound to an exposed pocket on the surface of EtLSC (Figure 1A) while the products of hydrolysis were
located inside the active site of EaLSC (Figure 1B). The active site was within the inner part of the
β-propeller, which is also found in other LSCs.
Figure 1. Comparison of ligand location in levansucrases (LSCs) from Erwinia tasmaniensis and Erwinia
amylovora. (A) Cartoon representation of E. tasmaniensis LSC (EtLSC) structure with levanbiose (LBS)
bound (PDB ID: 6RV5). Note: ligand molecule shown as green stick; active-site surface highlighted
in black. (B) Cartoon representation of E. amylovora LSC (EaLSC) structure with fructose and glucose
bound (PDB ID: 4D47). Note: ligands (hydrolysis products) shown as green sticks; active-site surface
highlighted in black.
The complex of LBS with EtLSC was formed during the soaking of protein crystals with sucrose.
It was located in a small pocket defined by residues Ala34, Phe35, Pro36, Val37, Arg73, Ile89,
Trp371, Phe376, Arg377, and Ile378 (Figure 2A). LBS formed three hydrogen bonds with the Arg377
sidechain—LBS O1 interacted with Nη2, while LBS O2 and O3 interacted with Nε. LBS O4 formed
another hydrogen bond with the N atom of the Ile378 backbone. Other residues in the pocket interacted
with a nonpolar part of the molecule through hydrophobic bonds.
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Figure 2. LBS binding pocket. (A) LBS interaction with EtLSC (PDB ID: 6RV5). Note: ligand molecule
shown as green stick. (B) Representation of 2Fobs−Fcalc electron density map of the LBS binding site.
Note: electron-density map contoured at 1.5 σ. (C) Representation of polder map (omit map that
excludes bulk solvent around omitted region) calculated with exclusion of LBS molecule. Note: polder
map contoured at 4 σ.
Two water molecules were present in the pocket. The first water molecule (residue 648 in the
PDB) formed hydrogen bonds with LBS O4 and the mainchain oxygen of Phe376. Backbone O of
Ile378, Arg73 Nη1/Nη2, and LBS O1 formed bonds with a second water molecule (residue 696 in the
PDB). After model building (see material and methods section) the residues and the waters of the
binding pocket clearly fit the 2Fobs−Fcalc electron density map (Figure 2B) and the LBS perfectly fit the
unbiased omit Polder map (Figure 2C)
LBS binding caused two noticeable movements in the sidechains of residues located in its binding
pocket. This was remarkable when compared with the EtLSC apo structure (PDB ID: 6FRW) sharing
the same crystallization conditions. The indole ring of the Trp371 sidechain tilted approximately 50◦,
and the benzyl moiety of Phe376 flipped 77.7◦. Both residues moved toward the LBS moiety in the
pocket (Figure 3). The movement of these two residues suggests that binding is mediated by one of the
two fructose units in LBS.
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Figure 3. Residue movement upon LBS binding. Relevant conformational changes involved residues
W371 and F376. Note: magenta, EtLSC structure with LBS; grey, apo enzyme (PDB ID: 6FRW).
Considering all the LSC studies to date, it can be concluded that LSCs from Gram-negative
bacteria produce short-chain FOSs, while those from Gram-positive bacteria produce longer-chain
oligosaccharides or levan (either LMW or HMW). Some structural features have been proven to be
correlated with the length of the product, and are therefore different in Gram-negative and -positive
bacteria [25]. For example, an arginine-to-histidine mutation at position 360 in SacB has been proposed
as a switch in the production of either long- or short-chain FOSs [29]. Arginine is substituted by
histidine in the LSCs of Gram-negative bacteria, including EaLSC and EtLSC, without losing the ability
to perform the transfructosylation reaction.
It has previously been proposed that the loop formed by residues 366–380 contain residues that are
able to shape the product spectrum of LSCs [25]. We compared the loop formed by residues 368–378 in
EtLSC with other LSC structures available in the PDB (Figure 4A,B). From examining the available
crystal structures, it is clear that the presence of LBS in the analyzed region could only be compatible
with LSCs from Gram-negative bacteria. The loop conformation in structures of E. amylovora [25] and
G. diazotrophicus [24] could allow for the presence of an LBS molecule (Figure 4A). In contrast, loop
conformation is incompatible with LBS binding in the LSCs from Gram-positive bacteria B. subtilis [30]
and B. megaterium [31] due to a ligand clash (Figure 4B). However, loop conformations could be
influenced by crystal packing, and their variability could be limited. This may be explained by the
involvement of loops in crystal contacts, as in the case of BmLSC. As a solution, loops could adopt
slightly different conformations to allow for the required flexibility.
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Figure 4. Comparison of LBS binding pocket in different LSC structures. (A) Proposed binding of LBS
to structures with similar loop conformations. Note: grey and blue, E. tasmaniensis (PDB ID: 6RV5 and
6FRW respectively); magenta, E. amylovora (PDB ID: 4D47); and yellow, Gluconacetobacter diazotrophicus
(PDB ID: 1W18). (B) Superimposition of LBS on structures with different loop conformations. Note:
marine blue, B. subtilis (PDB ID: 1OYG); cyan and pink, B. megaterium (PDB ID: 3OM7 and 3OM2,
respectively).
Nevertheless, conformations of loops surrounding the sucrose binding site [25], the presence
of an LBS binding site, and other structural features may suggest a correlation with the synthesis of
short-chain FOSs in Gram-negative bacteria. The chain length of fructans is determined by enzyme
concentration and consequently by enzyme-product interactions [28]. Therefore, a stable LSC–LBS
intermediate could favor the production of shorter-chain FOSs. The presence of LBS in the superficial
pocket might also favor contacts between adjacent LSC molecules in the solution and increase enzyme
density, thereby enhancing the probability of enzyme-product interactions in the active site. The ability
to hold small oligofructans (e.g., LBS) in close vicinity to the active site of the enzyme may increase the
likelihood that these molecules are used as fructose acceptors that therefore increase the production of
small/medium DP oligosaccharides.
However, LSC structures currently available in the PDB belong to a restricted number of organisms,
and further studies are required to gain a clear understanding of the differences between Gram-positive
and -negative bacteria. Furthermore, the mechanism behind LBS migration towards or away from the
active site, and its effect on the spectrum of generated products is still unclear.
3. Materials and Methods
The production of recombinant LSC from E. tasmaniensis (strain Et1/99) and its crystallization
have been previously described [21]. In brief, the PCR-amplified gene was cloned into a pMCSG49
vector [32] and then expressed in E. coli BL21(DE3) star pLysS cells. Purified EtLSC was concentrated
to 10 mg/mL (20 mM HEPES pH 7.5, 150 mM NaCl) and used for crystallization.
The crystals were grown by hanging drop vapor diffusion from drops consisting of 1 μL EtLSC
solution and 1μL precipitants (28% glycerol, 14% PEG4000, 2.5 mM manganese(II) chloride tetrahydrate,
2.5 mM cobalt(II) chloride hexahydrate, 2.5 mM nickel(II) chloride hexahydrate, and 2.5 mM zinc
acetate dihydrate). The crystals were then soaked in a sucrose-containing solution corresponding to
the crystallization drop to a final concentration of 0.5 M at different soaking times. Following this,
crystals were flash-frozen in liquid N2.
Diffraction data were collected on an XRD1 station of the synchrotron ELETTRA [33], Trieste,
Italy (wavelength 1.000 Å, temperature 100 K, detector Pilatus 2 M), and processed with XDS [34].
Phase information was obtained by molecular replacement using the EtLSC apo structure (PDB ID:
6FRW) [21] as the input model for MOLREP [35]. The obtained starting model was iteratively refined
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with Coot [36], REFMAC5 [37], and PHENIX [38]. The quality of the model was assessed using
MOLPROBITY [39]. The final refinement statistics for the structure are reported in Table 1.
The electron-density map and polder map [40] were calculated using REFMAC and PHENIX,
respectively. Crystallographic figures were created using PyMOL (The PyMOL Molecular Graphics
System, Version 2.20 Schroedinger, LLC).
4. Conclusions
In this study, we presented the crystal structure of EtLSC in complex with LBS. LBS, produced by
EtLSC by soaking the crystals in a solution containing 0.5 M sucrose, binds to an unusual pocket that
has not been previously reported. The pocket is a plausible site of interaction for LBS and fructose-like
intermediates and could therefore be relevant to FOS production in EtLSC. This pocket contains
residues conserved across Erwinia spp. and it may have a similar role in these bacteria.
Further studies (e.g., mutagenesis) are required to understand the possible relevance of the loop
formed by residues 368–378, and the role of Arg377 in the determination of the product spectrum of
EtLSC and EaLSC. This pocket could be a target for engineered LSCs with tuned specificity and/or
increased yield of Fn and/or low-DP FOSs.
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GH68 Glycosyl hydrolase family 68
HMW High-molecular weight
LMW Low-molecular weight
DP Degree of polymerization
References
1. Oner, E.T.; Hernandez, L.; Combie, J. Review of Levan Polysaccharide: From a Century of Past Experiences
to Future Prospects. Biotechnol. Adv. 2016, 34, 827–844. [CrossRef] [PubMed]
2. Ortiz-Soto, M.E.; Porras-Domínguez, J.R.; Seibel, J.; López-Munguía, A. A Close Look at the Structural
Features and Reaction Conditions that Modulate the Synthesis of Low and High Molecular Weight Fructans
by Levansucrases. Carbohydr. Polym. 2019, 219, 130–142. [CrossRef]
3. Combie, J.; Öner, E.T. From Healing Wounds to Resorbable Electronics, Levan can Fill Bioadhesive Roles in
Scores of Markets. Bioinspir. Biomim. 2018, 14. [CrossRef] [PubMed]
4. Xu, W.; Ni, D.; Zhang, W.; Guang, C.; Zhang, T.; Mu, W. Recent Advances in Levansucrase and Inulosucrase:
Evolution, Characteristics, and Application. Crit. Rev. Food Sci. Nutr. 2018, 59, 3630–3647. [CrossRef]
[PubMed]
5. González-Garcinuño, Á.; Tabernero, A.; Domínguez, Á.; Galán, M.A.; Martin del Valle, E.M. Levan and
Levansucrases: Polymer, Enzyme, Micro-Organisms and Biomedical Applications. Biocatal. Biotransfor. 2018,
36, 233–244. [CrossRef]
96
Int. J. Mol. Sci. 2020, 21, 83
6. Cantarel, B.L.; Coutinho, P.M.; Rancurel, C.; Bernard, T.; Lombard, V.; Henrissat, B. The Carbohydrate-Active
EnZymes Database (CAZy): An Expert Resource for Glycogenomics. Nucleic Acids Res. 2009, 37, D233–D238.
[CrossRef]
7. Özcan, E.; Öner, E.T. Microbial Production of Extracellular Polysaccharides from Biomass Sources.
In Polysaccharides; Kishan, G.R., Jean-michel, M., Eds.; Springer International Publishing: Geneva, Switzerland,
2015; pp. 161–184.
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Abstract: Mycobacteria produce two major lipoglycans, lipomannan (LM) and lipoarabinomannan
(LAM), whose broad array of biological activities are tightly related to the fine details of their
structure. However, the heterogeneity of these molecules in terms of internal and terminal covalent
modifications and complex internal branching patterns represent significant obstacles to their
structural characterization. Previously, an endo-α-(1→6)-D-mannanase from Bacillus circulans proved
useful in cleaving the mannan backbone of LM and LAM, allowing the reducing end of these
molecules to be identified as Manp-(1→6) [Manp-(1→2)]-Ino. Although first reported 45 years ago, no
easily accessible form of this enzyme was available to the research community, a fact that may in part
be explained by a lack of knowledge of its complete gene sequence. Here, we report on the successful
cloning of the complete endo-α-(1→6)-D-mannanase gene from Bacillus circulans TN-31, herein
referred to as emn. We further report on the successful production and purification of the glycosyl
hydrolase domain of this enzyme and its use to gain further insight into its substrate specificity using
synthetic mannoside acceptors as well as LM and phosphatidyl-myo-inositol mannoside precursors
purified from mycobacteria.
Keywords: endo-α-(1→6)-d-mannase; mannoside; Mycobacterium; lipomannan; lipoarabinomannan;
phosphatidylinositol mannosides
1. Introduction
Two complex α-(1→6)-linked D-mannose-containing lipoglycans, lipomannan (LM) and
lipoarabinomannan (LAM) populate the cell envelope of mycobacteria [1]. They are essential to the
integrity of the cell envelope [2] and play important roles in the immunopathogenesis of mycobacterial
infections [1,3,4]. LM and LAM are believed to share a mannosylated phosphatidyl-myo-inositol lipid
anchor and a mannan backbone composed of α-(1→6)-linked-D-mannopyranosyl residues occasionally
branched with α-(1→2)-D-mannopyranosyl residues [1]. Despite recent advances in the biosynthetic
pathway of these lipoglycans, the fine details of the structure of their mannan backbone, specifically,
the precise distribution of the α-(1→2)-D-mannopyranosyl residues along the mannan backbone,
is not known with certainty. To help in these analyses, two types of glycosyl hydrolases capable
of hydrolyzing the mannan backbone of LM and LAM have traditionally been used: An exo-type
Int. J. Mol. Sci. 2019, 20, 6244; doi:10.3390/ijms20246244 www.mdpi.com/journal/ijms99
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α-(1→2,3,6)-mannosidase (EC # 3.2.1.24), which cleaves the terminal mannopyranosyl residues from the
non-reducing end [5] and an endo-α-(1→6)-D-mannanase (EC # 3.2.1.101), which cleaves the glycosidic
bond between two internal mannopyranosyl residues [6]. While the first enzyme can be purified from
Jack bean and is commercially available, to the best of our knowledge, no commercial source of the
second enzyme is available. The endomannanase hydrolyzing α-(1→6)-D-mannopyranosyl residues
was discovered in 1974 by Ballou and co-workers [7] who then went on to purify this enzyme from the
soil bacterium, Bacillus circulans [8], and subsequently shared this enzyme with other laboratories [6,9].
Some 24 years later, the gene encoding this enzyme, aman6, was identified by reverse genetics [10] but
found to encode a protein only about half the size of that purified by Ballou et al., even though the
recombinant product of the gene apparently displayed the expected catalytic activity on an (undefined)
α-(1→6)-D-mannan substrate releasing 6α-mannotriose and 6α-mannobiose [10] [Figure S1]. Efforts
by our laboratory to re-clone this gene by PCR based on its published sequence consistently failed,
suggestive of potential rearrangements in the Sau3AI-digested chromosomal DNA libraries used in the
isolation of aman6 [10]. As a part of our continued effort to decipher the biosynthetic pathway of LM
and LAM and establish the fine details of their structure, here, we report on the cloning of the full-size
endo-α-(1→6)-D-mannanase gene (which we named emn) and its use to recombinantly express and
purify the glycosyl hydrolase domain of this enzyme. The cleavage properties of the glycosyl hydrolase
domain of Emn on synthetic mannoside acceptors, purified LM from Mycobacterium smegmatis and
biosynthetic precursors, phosphatidyl-myo-inositol di- and hexa-mannosides, were investigated using
mass spectrometry.
2. Results and Discussion
2.1. Cloning of the Full-Size Endo-α-(1→6)-d-Mannanase Gene from Bacillus circulans TN-31
Using reverse genetics, Maruyama et al. identified aman6 as the gene encoding the
endo-α-(1→6)-D-mannanase from B. circulans TN-31 by screening a Sau3A1-digested genomic DNA
library of this bacterium. The aman6 gene was reported to encode a 589-amino acid-long protein with a
36 amino-acid signal peptide (GenBank accession number AB024331) [10]. Attempts to PCR-amplify
aman6 in our laboratory using primers to the reported nucleotide sequence were unsuccessful. The
nucleotide BLAST analysis of aman6 yielded a gene, gymC10_1685 from Paenibacillus sp. Y412MC10,
with 88% DNA sequence identity to aman6 on the first 1722-bp but a substantially larger coding
sequence totaling 3249-bp instead of 1767 bp for aman6. Using primers specific to the 5′-end of aman6
and to the downstream region of gymC10_1685, a 3522 bp-long PCR product was amplified from B.
circulans TN-31 genomic DNA. The fragment encompasses a 3255 bp-long open reading frame encoding
a 1084 amino acid protein with a 33 amino acid signal peptide (Figure S1). The molecular weight of
the mature protein (131 kDa) matches that of the endo-α-(1→6)-D-mannanase purified by Ballou and
collaborators from the same bacterium [8]. We named the full-size endomannanase gene emn. The
mature Emn protein consists of a glycosyl hydrolase family 76 (GH-76) catalytic domain from amino
acids 36 to 360 followed by three consecutive family six carbohydrate-binding modules from residues
392 to 522, 534 to 657 and 670 to 793, and a domain of unknown function (DUF4959) from residues 811
to 902. The GH-76 CaZy family of glycosyl hydrolases consists of α-(1→6)-mannanases (EC # 3.2.1.101)
and α-glucosidases (EC # 3.2.1.20), whereas family six carbohydrate-binding modules are non-catalytic
domains thought to facilitate the binding of the catalytic GH domain to its substrate(s).
2.2. Expression and Purification of the Glycosyl Hydrolase Domain of Emn
The production of the mature Emn protein from a pET14b expression plasmid in E. coli BL21
pLysS proved to be toxic to the cells and failed to yield any detectable protein product. We were,
however, able to produce, using the same expression system, a 43 kDa N-terminally His6-tagged
recombinant protein encompassing the glycosyl hydrolase domain of Emn (hereafter referred to as
GH-emn) corresponding to residues 36 to 400 of the full-size enzyme (Figure S1) and to purify it to
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near-homogeneity using a combination of nickel affinity chromatography and gel filtration (Figure S2).
The purified GH-emn protein was stored at –80 ◦C in 20 mM Tris pH 7.5 buffer containing 150 mM
NaCl and 20% glycerol for over 24 months without any appreciable loss of activity.
2.3. Digestion of Synthetic Mannoside Substrates
The purified GH domain of Emn was then tested for glycosyl hydrolase activity using two synthetic
unbranched linear substrates consisting of octyl trimannoside (α-d-Manp- (1→6)-α-d-Man-(1→6)-α-d-Man-
(1→octyl)) and octyl pentamannoside (α-d-Manp-(1→6)-α-d-Man-(1→6)-α-d-Man-(1→6)-α-d-Man-
(1→6)-α-d-Man-(1→octyl)). These substrates are structurally similar to those originally used by Ballou
and co-workers [8] to study the substrate specificity of the purified, native, full-size enzyme. Those
used by Ballou were unsubstituted at the reducing end, whereas those we evaluated harbor an octyl
aglycon at their reducing end to facilitate the identification of the hydrolytic products of the reaction
and thus, exactly where the enzyme cleaves. Enzyme assays were carried out as described under
Materials and Methods in liquid chromatography—mass spectrometry (LC/MS) sample vials at 50 ◦C
for 16 h [8]—after which the reaction mixture was directly injected into the LC/MS instrument without
further purification. Figure 1A–B shows the base peak chromatograms of octyl trimannoside and its
GH-emn digestion products. The mass spectrum of the only major peak found for the substrate (peak
(i)) showed a major [M–H] ion at m/z 615.29 as well as an ion at m/z 675.30 [M+HAc–H] and an ion at
m/z 661.29 [M+HCOOH–H], all corresponding to the parent molecule, Manp3-(1→octyl) (Figure 1C).
In contrast, the base peak chromatogram of the enzymatic products revealed the loss of peak (i) with
the concomitant appearance of two new peaks, (ii) and (iii). The mass spectrum of peak (ii) showed a
strong ion at m/z 377.08 [M+Cl–] corresponding to Manp2 (Figure 1D), whereas peak (iii) yielded a
signal at m/z 351.20 [M+HAc–H] corresponding to Manp-(1→octyl) (Figure 1E). These data show that
the enzyme cleaves the trisaccharide at glycosidic bond of the middle Manp residue (labeled as M2 in
Figure 1F) unit rather than the glycosidic bond of the Manp residue at either end of the trimannoside
unit (labeled as M1 and M3 in Figure 1F).
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Figure 1. LC/MS analysis of the GH-emn-digested synthetic octyl trimannoside. (A,B) Base peak
chromatograms showing the elution profiles of the substrate (A) and products of the enzymatic reaction
(B). (C) Mass spectrum of the undigested synthetic octyl trimannoside at m/z 615.28 [M-H] as well as
formate and acetate adducts. (D,E) Mass spectra of the products of the reaction: mannobiose (peak
(ii)) (D) with a free reducing end at m/z 377.08 [M+Cl–] and Manp1-octyl (peak (iii)) (E) at m/z 291.18
[M-H], 337.18 (M+formate) and 351.2 (M+acetate). (F) Cartoon showing the location of the mannosyl
cleavage (thicker arrow) of the octyl trimannoside at residue M2. The red arrow indicates the absence
of cleavage by the enzyme.
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A similar hydrolytic pattern was obtained upon digestion of the octyl pentamannoside by GH-emn
(Figure 2). In general, Manp1-4 as free reducing components were found as [M+Cl–] ions and Manp1, 2, 3,
and 5-(1→octyl) as [M+HAc–H] ions. The extracted ion chromatograms for these ions were integrated
to obtain areas used to calculate the data presented in Figure 2A,B. The amounts of these ions varied
with the enzyme concentration used (Figure 2A,B). Importantly, no Manp4-(1→octyl) was detected with
any amount of enzyme, as predicted from the data of Manp3-(1→octyl) (Figure 1). Complete digestion
occurred at the two highest enzyme concentrations (50 and 100 μg/mL) yielding only Manp2-(1→octyl)
and Manp1-(1→octyl) in a ratio of approximately 2:1 and the free mannosides Manp2 and Manp1 in a
0.9:1 ratio. Traces of Manp3-(1→octyl) (Figure 2A) along with oligomannosides Manp4 and Manp3
(Figure 2B) were only detected when less enzyme was used in the assay, suggesting that these products
are further cleaved to form Manp1-(1→octyl), and free Manp2 and Manp1. Collectively, these results
indicate that GH-emn cleaves the octyl pentamannoside substrate at three different positions, as
summarized in Figure 2C. At all three cleavage positions, the enzyme binds to three mannosyl residues
and cuts between the middle Man and the reducing end Man. Consistently with that binding, the
enzyme cannot further process Manp2-(1→octyl) or Man2, in agreement with previous studies from Dr.
Ballou’s laboratory [8].
Figure 2. Digestion of octyl pentamannoside with increasing concentrations of GH-emn. (A) Percentage
area of products containing an octyl chain. (B) Molar percentage of oligomannosides with a free
reducing end. (C) Cartoon showing the locations of the three possible mannosyl cleavage sites. The
thicker arrow denotes the dominant cleavage site having three mannosyl residues at the non-reducing
end and the dotted arrows indicate other, less favored cleavage sites. The further cleavage of the
released Manp4 and Manp3 is not shown.
2.4. Digestion of Phosphatidyl-Myo-Inositol-Mannosides
The reducing end of LM and LAM consists of phosphatidyl-myo-inositol where the myo-inositol
residue is mannosylated at positions C-2 and C-6. This lipid anchor may be esterified with up
to four acyl chains [1]. Phosphatidyl-myo-inositol mannosides, also known as PIMs, may also
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exist as free glycolipids populating the inner and outer membranes of mycobacteria [11]. Tri-
and tetra-acylated phosphatidyl-myo-inositol dimannosides (Ac1PIM2 and Ac2PIM2) and tri- and
tetra-acylated phosphatidyl-myo-inositol hexamannosides (Ac1PIM6 and Ac2PIM6) are the most
abundant form of PIMs found in the mycobacterial cell envelope [11]. As expected from the results
above, GH-emn showed no activity on deacylated PIM2 (d-PIM2) which lacksα-(1→6)-linked mannosyl
residues (Figure S3).
Since earlier work has established that purified, native, Emn lacks activity on yeast mannan in
which the backbone is substituted with Manp-α-(1→3)- and α-(1→2)-linked residues [7,8], we sought
to determine whether GH-emn could cleave the pentamannoside extending from the six-position
of myo-inositol in deacylated Ac2PIM6 (d-PIM6). In this molecule, the first three mannosyl residues
attached to O-6 of the inositol are linked via α-(1→6) glycosidic linkages and the last two mannosyl
residues are present as the dimannoside α-Manp-(1→2)-α-Manp attached to position 2 of the third
Manp from the inositol residue (Figure 3). PIM6, as received from BEI, is a mixture containing both
PIM2 (shown above to not be a substrate for GH-emn) and PIM6 in equal amounts. Hence, we
needed to focus our analysis on the released free mannosides rather than the inositol-containing
components. GH-emn activity on intact d-PIM6 was analyzed by LC/MS in the negative ion mode.
Upon enzymatic treatment, the amount of intact d-PIM6 (MS and structure shown in Figure 3D)
decreased dramatically (Figure 3A,B). Concomitantly, the chromatogram and mass spectrum of
the enzyme-treated sample were dominated by a peak at m/z 701.19 [M+Cl–] corresponding to the
tetramannoside, D-Manp-(1→2)-α-D-Manp-(1→2)-α-D-Manp-(1→6)-α-D-Manp-(1→6) (Figure 3C,E).
No ions corresponding to the mono-, di-, tri- or penta- mannosides were observed in the enzyme-treated
sample. These results indicate that the GH-emn can tolerate an α-(1→2)-linked dimannoside
substitution at the non-reducing terminus (M4 in Figure 3F) of the α-(1→6 trimannoside component
(M4, M3, and M2) of d-PIM6.
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Figure 3. LC/MS analysis of undigested and GM-emn-digested deacylated PIM6. (A,D) Extracted Ion
Chromatogram (A), structure (D), and mass spectrum (D) of d-PIM6 (m/z 652.18 [M–2H]) before enzyme
treatment. (B) Extracted ion chromatograms (EIC) of d-PIM6 (m/z 652.18 [M–2H]) after digestion
with GH-emn. The EIC of m/z 701.19 [M+Cl–] shown in panel (C) corresponds to the dominant
tetramannoside product of d-PIM6 after digestion with GH-emn. Its mass spectrum is shown in panel
(E). (F) Cartoon showing the location of the mannosyl cleavage site of GH-emn to form Man4. The red
arrows indicate the absence of cleavage by the enzyme.
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2.5. Analysis of Endomannanase-Digested LAM and LM
Next, we tested the endomannanase activity of GM-emn on the acylated forms of LM and LAM
from M. smegmatis. Complete digestion of these substrates after an overnight incubation with GH-emn
was evident from the analysis of the products of the reaction by SDS-PAGE followed by silver staining
(Figure 4). Enzymatic digestion of LM and LAM further resulted in a low molecular weight product
migrating slightly faster than acylated PIM6 (Figure 4, lanes 3, 5 and 6), which we tentatively attribute
to di- or tri-mannosylated forms of phosphatidyl-myo-inositol released from the reducing end of
both lipoglycans.
Figure 4. Silver-stained SDS PAGE showing the GH-emn digestion products of native M. smegmatis
LM and LAM. MWM: Molecular weight marker.
To gain further insight into the nature of the fragments released by GH-emn from deacylated M.
smegmatis LM (d-LM), the products of the reaction were also analyzed by LC/MS. The LC/MS profile of
undigested d-LM was dominated by doubly, triply and quadruply charged, long-chain, high-molecular
weight (range of 2,700 to 6,800 Da) mannans containing 15 to 40 mannosyl residues (Figure 5A). The
most abundant components appeared as triply charged series [M–3H] of ions at m/z 1406.77, 1460.79,
1514.81, 1568.82, 1622.84, 1676.86 and 1730.88 corresponding to LM molecules with 24 to 34 mannosyl
residues. The less abundant quadruply-charged series [M–4H] corresponded to mannans with 27 to
40 mannosyl residues, while the least abundant doubly-charged series contained 24 to 33 mannosyl
residues. Together, these results confirm that the mannan backbone of M. smegmatis LM is composed
of up to 40 mannosyl residues. GH-emn digestion of this heterogeneous population of d-LM resulted
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in two major ions at m/z 657.16 and 819.21, corresponding to the mass of d-PIM2 and d-PIM3 released
from the reducing end (Figure 5B). Additionally, the presence of oligomannans (with free reducing
ends) was deduced from the presence of singly, doubly and triply charged series of ions matching the
mass of Manp2 and higher oligomers with odd numbers of mannosyl residues from Manp3 to Manp27
(Figure 5B). These oligomannans result from the presence of O-2 mannosyl substitutions at various
positions of the mannan backbone of LM, preventing GH-emn from cutting. Their detailed structure
awaits further characterization.
Figure 5. Negative ion mass spectra of deacylated LM from M. smegmatis before and after digestion
with GH-emn. (A) Mass spectrum of undigested d-LM. The spectrum shows the mass distribution
of the mannan backbone of d-LM which contains up to 40 mannosyl residues (differing by the mass
of one hexose). Inset: The isotopic pattern for quadruply-charged d-LM with 40 mannosyl residues
indicates the sensitivity of the mass spectrometer for high-molecular weight compounds. (B) Mass
spectrum of d-LM after digestion by GH-emn. The mass spectra for three different retention times (RT)
are shown. At all retention times, the spectra are dominated by singly-charged PIM2 and PIM3. RT 2.6
and 2.8 min show the presence of ions for Man17 to Man27 [M-3H] and Man9 to Man17 [M-2H]. RT
3.0 min shows low-molecular weight oligomannosides (Man2 to Man7) as singly charged and doubly
charged chlorine adducts.
3. Materials and Methods
3.1. Cloning, Expression and Purification the Glycosyl Hydrolase Domain of Emn
B. circulans TN-31 (ATCC®290101™) was obtained from the American Type Culture Collection
and grown on agar medium at 30 ◦C as recommended by the ATCC. Genomic DNA was
isolated using a standard extraction protocol. The coding sequence of the full-length mature
protein (3150 bp) was amplified using primers Emn1 (5′-CTCGAGTATACCGCATCAGATGGGG-3′)
and Emn2 (5′-CTCGAGTTACTCCAAGCCATCCTGCC-3′). The glycosyl hydrolase domain sequence of
emn (GH-emn; 1092 bp) was PCR-amplified using primers GH-emn1 (5′-CATATGTATACCGCATCAGAT
GGGG-3′) and GH-emn2 (5′-CTCGAGTTAATTGTAGCGTTCCGCTTCGA-3′). Both PCR fragments
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were cloned into the Nde/ and XhoI sites of the pET14b expression plasmid and transformed into
E. coli BL21 DE3 pLysS. For GH-emn production, freshly prepared LB broth containing 100 μg/mL
ampicillin was inoculated with a preculture of pET14b-GH-emn transformant and incubated at 30 ◦C
until optical density measured at 600 nm (OD600) reached 0.2. Gene expression was induced by adding
isopropyl-β-thio-galactopyranoside (1 mM final concentration) to the culture medium. After 4 h of
induction at 30 ◦C, cells were collected by centrifugation and resuspended in lysis buffer consisting
of Tris-HCl pH 7.5 containing 150 mM NaCl, 1 mM MgCl2, 1 μg/mL DNase and protease inhibitor
cocktail (Sigma, St. Louis, MO, USA). Cells were broken using a French press (1500 psi; 3 passages) and
cell debris were removed by ultracentrifugation at 4 ◦C for 30 min at 110,000 × g. The supernatant was
then applied to a His-trap column (GE Healthcare, Pittsburgh, PA, USA) and the protein eluted in a
gradient of 10–500 mM imidazole, prior to gel filtration using a Superdex 200 column (GE Healthcare).
Aliquots of the purified GH-emn protein were stored at –80 ◦C in 20 mM Tris pH 7.5 buffer containing
150 mM NaCl and 20% glycerol until further use. Protein concentrations were determined using the
Pierce BCA protein assay kit as recommended by the manufacturer.
3.2. Assays Using Synthetic Mannosides Substrates
α-d-Manp-(1→6)-α-d-Man-(1→6)-α-d-Man-(1→octyl] (octyl trimannoside-) and α-d-Manp-(1→6)
-α-d-Man-(1→6)-α-d-Man-(1→6)-α-d-Man-(1→6)-α-d-Man-(1→octyl (octyl pentamannoside) were
chemically synthesized as described [12,13]. Endomannanase reaction mixtures contained the synthetic
mannosides (100 μM) and purified GH-emn (0 to 500 μg/mL) in a total volume of 100 μL in 10 mM
ammonium acetate buffer (pH 6). Control reactions contained buffer in place of the purified enzyme.
Enzymatic reactions were carried out in LC/MS vials at 50 ◦C for 16 h at which point the enzyme was
inactivated by heating at 65 ◦C for 30 min [8]. In the experiment where increasing concentrations of
GH-emn were used, the reactions mixture were incubated at 50 ◦C for 2 h instead of 16 h.
3.3. Assays Using Purified Mycobacterial PIMs and Lipoglycans
Purified M. tuberculosis H37Rv phosphatidyl-myo-inositol hexamannosides (PIM6) and M.
smegmatis LAM were received from BEI resources. LM was extracted and purified from M. smegmatis
whole cells as described previously [14]. Purified PIM6 (20 μg) was deacylated using monomethylamine
following an established procedure [15] and further digested with GH-emn (0.25 mg/mL) in 10 mM
ammonium acetate buffer (pH 6) for 24 h at 50 ◦C. Native LM from M. smegmatis (50 μg) was deacylated
with 0.2 N NaOH (200 μL) at 37 ◦C and then neutralized with 10% aqueous glacial acetic acid.
Deacylated LM (d-LM) was separated from sodium salts using an Amicon ultra-0.5 mL centrifugal
filter (3 kDa MWCO) and resuspended in 10 mM ammonium acetate buffer (pH 6) prior to digestion
with GH-emn as described for d-PIM6. D-LM and d-PIM6 before and after enzymatic digestion were
analyzed by LC/MS (see next section).
Native LAM (40 μg) and LM (40 μg) from M. smegmatis digested with GH-emn (50 μg) in 100 mM
citrate phosphate buffer pH 6.6 for 16 h at 50 ◦C were also was analyzed by SDS-PAGE followed by
silver staining alongside 10 μg of undigested starting material.
3.4. Analysis of Substrates and Reaction Products by Liquid Chromatography—Mass Spectrometry
Separation of the GH-emn-digested products was performed using a reverse-phase X-bridge C18
column (50 mm × 2.1 mm; 1.7 μM) on a Waters ACQUITY UPLC system. The mobile phases used were
water (solvent A), acetonitrile (solvent B) and 0.5 M ammonium acetate (solvent C) under the following
gradient conditions: 0–0.3 min (10% B), 0.3–3 min (70% B), 3–4.8 min (98% B), and 4.8–6.8 min (10% B)
at a flow rate of 400 μL/min. A constant 2% solvent C was maintained throughout the LC run.
Mass spectrometry (MS) was performed using a Bruker maXis plus II high-resolution quadrupole
time-of-flight (Q-TOF). The electrospray ionization (ESI) source settings were as follows: end plate offset
voltage 500 V, capillary voltage 3500 V, nebulizer gas pressure 3.0 bar, dry gas flow rate 10 L/min. Two
different tune parameters were used for analyzing native and GH-emn-digested products. For detecting
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low molecular compounds, the tune parameters were: funnel RF 300 Vpp, multipole RF 300 Vpp, ion
energy 3.0 eV, low mass range for ion transmission m/z 100, collision energy 8.0 eV, collision RF 450 Vpp,
pre-pulse storage 5.0 μs, ion cooler RF 800 Vpp and transfer time 80.0 μs. For detecting high molecular
weight, d-LM tune parameters were: funnel RF 400 Vpp, multipole RF 400 Vpp, ion energy 3.0 eV,
low mass range for ion transmission m/z 600, collision energy 8.0 eV, collision RF 2500 Vpp, pre-pulse
storage 5.0 μs, ion cooler RF 800 Vpp and transfer time 140 μs. A data analysis was performed using
Bruker compass data analysis 4.4 SR1.
4. Conclusions
The full-length endo-α-(1→6)-D-mannanase gene from B. circulans TN-31 was successfully cloned
for the first time and its glycosyl hydrolase domain expressed and purified in active and stable form
from E. coli. The analysis of the digestion pattern of synthetic mannosides, PIM and LM provided further
insights into the substrate specificity of the endomannanase domain of the enzyme. The availability of
this enzyme, together with a better understanding of its catalytic activity, should greatly facilitate the
structural analysis of α-(1→6)-D-mannan-containing polysaccharides, including mycobacterial LM
and LAM.
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6244/s1.
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Abstract: Beta-glucosidases (β-glucosidases) have attracted considerable attention in recent years
for use in various biotechnological applications. They are also essential enzymes for lignocellulose
degradation in biofuel production. However, cost-effective biomass conversion requires the use of
highly efficient enzymes. Thus, the search for new enzymes as better alternatives of the currently
available enzyme preparations is highly important. Thermophilic fungi are nowadays considered as
a promising source of enzymes with improved stability. Here, the crystal structure of a family GH3
β-glucosidase from the thermophilic fungus Chaetomium thermophilum (CtBGL) was determined at a
resolution of 2.99 Å. The structure showed the three-domain architecture found in otherβ-glucosidases
with variations in loops and linker regions. The active site catalytic residues in CtBGL were identified
as Asp287 (nucleophile) and Glu517 (acid/base). Structural comparison of CtBGL with Protein
Data Bank (PDB)-deposited structures revealed variations among glycosylated Asn residues. The
enzyme displayed moderate glycosylation compared to other GH3 family β-glucosidases with
similar structure. A new glycosylation site at position Asn504 was identified in CtBGL. Moreover,
comparison with respect to several thermostability parameters suggested that glycosylation and
charged residues involved in electrostatic interactions may contribute to the stability of the enzyme at
elevated temperatures. The reported CtBGL structure provides additional insights into the family
GH3 enzymes and could offer new ideas for further improvements in β-glucosidases for more efficient
use in biotechnological applications regarding cellulose degradation.
Keywords: glycoside hydrolase; cellulose degradation; thermophilic fungus; β-glucosidases;
Chaetomium thermophilum; protein structure; fungal enzymes
1. Introduction
Beta-glucosidases (β-glucosidases) are key cellulolytic enzymes that catalyze the hydrolysis of
cellobiose to glucose. They are terminal enzymes of the cellulase system as they act during the final step
of the cellulose degradation. Although beta-glucosidases do not act directly on cellulose, their activity
is important to circumvent the inhibitory effect of cellobiose on endoglucanases and cellobiohydrolases.
Consequently, inclusion of β-glucosidases in cellulase preparations can synergistically increase the
hydrolytic efficiency of other cellulolytic enzymes [1].
Beta-glucosidases (β-glucoside glucohydrolases, EC 3.2.1.21; BGL) have been found in the
glycoside hydrolase (GH) families GH1, GH3, GH5, GH9, GH30, and GH116 of the CAZy
database [2]. They are anomeric configuration-retaining enzymes that operate through the canonical
double-displacement glycosidase mechanism, except those of the GH9 family.
Despite their extensive use in biotechnological application, structural data on fungalβ-glucosidases
are still scarce. Many fungal BGLs are classified as part of the GH3 family, one of the largest CAZy
Int. J. Mol. Sci. 2019, 20, 5962; doi:10.3390/ijms20235962 www.mdpi.com/journal/ijms111
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families with over 13,600 annotated protein sequences. Two fungal β-glucosidase structures currently
available are produced by the mesophilic fungus Aspergilus aculeatus [3] and the moderate thermophilic
Rasamsonia emersonii [4], respectively. A third structure produced by the mesophilic fungus Trichoderma
reesei of BGL1 has been deposited in the Protein Data Bank (PDB), but no paper has been published yet.
Recently, the structure of the filamentous fungus Neurospora crassa Cel3A (NcCel3A) was reported at
2.25 Å resolution [5], as well as structures of GH3 β-glucosidases from Hypocrea jecorina (a teleomorph
of Trichoderma reesei) [6], Aspergilus niger [7], Aspergillus fumigatus, and Aspergillus oryzae [8].
The first structure of a β-glucosidase, that of barley (Hordeum vulgare) exo-1,3-1,4-glucanase ExoI
(HvExoI) [9] showed a two-domain architecture: An N-terminal (α/β)8 TIM-barrel that hosts the
catalytic nucleophile aspartate and an (α/β)6 sandwich domain where the acid/base glutamate resides.
Subsequent studies, however, revealed variations in the modular architecture of GH3 β-glucosidases
with the first domain to adopt a collapsed/incomplete triosephosphate isomerase (TIM)-barrel domain
and the presence of a third domain with a fibronectin FnIII-like fold. The function of the third domain
is still unknown, although it has been suggested to stabilize the incomplete TIM-barrel domain [4].
Notably, a fourth domain has also been identified in Kluyveromyces marxianus and Pseudoalteromonas sp.
BB1 β-glucosidases [10,11].
Thermophilic fungi have attracted considerable attention in recent years as an alternative reservoir
of thermostable cellulases for cellulose degradation [12,13]. Importantly, thermophilic fungi can
produce thermostable enzymes that can be used at temperatures up to 70 ◦C, whereas enzymes from
mesophilic organisms are typically active up to 50 ◦C. The importance of using thermophilic cellulases
in cellulose degradation stems from the fact that, at higher temperatures, cellulose swells and becomes
more susceptible to breaking. Various thermophilic fungi have been studied in recent years and
their β-glucosidases have been characterized [12]. Understanding the structure–function–stability
relationships in fungal β-glucosidases is therefore important for finding new and better alternatives
for industrial biocatalysts. Hydrolysis rate, inhibitors, and stability are considered critical factors for
the efficient use of β-glucosidases in complex biomass hydrolysis [14]. Moreover, β-glucosidases have
been suggested for use in the synthesis of various glycoconjugates, and a GH3 β-glucosidase from the
thermophilic fungus Myceliophthora thermophila has been found to act as an efficient biocatalyst in alkyl
glycoside synthesis [15].
Here, we report the crystal structure of a β-glucosidase from the thermophilic filamentous fungus
Chaetomium thermophilum (CtBGL) at a resolution of 2.99 Å, and compare it with other β-glucosidases
of the GH3 family. This is the second structure of a β-glucosidase produced by a thermophilic fungus,
and therefore, it is expected to provide further insights into the structure–function relationship of this
family of enzymes in high-temperature settings.
2. Results
2.1. Quality of the Structure
The crystal structure of CtBGL was refined using data up to 2.99 Å resolution. The final Rcryst and
Rfree (5% of the reflections excluded from refinement) were 0.201 and 0.252, respectively (Table 1). The
structure exhibits good stereochemistry despite the limited resolution with root mean square deviation
(rmsd) in bond lengths and bond angles of 0.007 Å and 0.94◦, respectively. The Ramachandran
plot shows 92.8% of the residues in the most favorable regions and 1.0% in disallowed regions.
Residues that fall into the disallowed regions belong to flexible parts of the structure with weak
electron density. Structure quality statistics for CtBGL fall within the distribution found in other
crystal structures of similar resolution as analyzed and displayed by POLYGON [15]. The refined
structure contains 836 residues of the mature protein, starting at residue Trp32. The full-length cDNA
encodes for a 867-residue enzyme and the first 16 residues have been suggested to act as a secretion
signal peptide [16]. Residues 17–31 at the N-terminal were not modeled, owing to lack of adequate
electron density, possibly due to high flexibility. The enzyme crystallized with one molecule in the
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crystallographic asymmetric unit in contrast to other β-glucosidases that crystallize either with two
molecules such as the β-glucosidases from Aspergillus oryzae (AoβG) and A. fumigatus (AfβG) [8],
A. aculeatus (AaβG) [8] and NcCel3A [5], or with four molecules in the asymmetric unit such as
ReCel3A [4]. The solvent content is unusually high (~77%) for a protein crystal, which could explain
the low resolution of the data and the disintegration of the crystals during manipulation prior to
mounting. The NCS dimer found in other β-glucosidases is seen in CtBGL as a crystallographic dimer
that involves the −Y, −X, −Z+ 12 symmetry-related molecule.






Unit cell dimensions a, b, c (Å) 121.9, 121.9, 264.9
No. of molecules/asymmetric units 1
Mosaicity (◦) 0.070
Resolution range (Å) 20.0–2.99 (3.11–2.99) *
Total measurements/unique reflections 222508 (22974)/41051 (4513)









No. of protein atoms 6457
Ligand atoms 12
No. of Sugar Atoms 355
No. of Water Molecules 6
Geometry
rmsd in bond lengths (Å) 0.007
rmsd in bond angles (◦) 0.94
Most favorable regions (%) 92.8









Lowest energy conformations 23/85.2
Highest energy conformations 4/14.8
* Values for the outermost resolution shell are shown in parentheses.
2.2. Overall Structure Comparisons
Structure-based sequence alignment (Figure 1) showed that CtBGL has the highest structural
similarity with NcCel3A (PDB id 5nbs), as indicated by the root mean square deviation (rmsd) of
0.60 Å for 831 aligned residues (sequence identity 72%), followed by Aspergilus fumigatus AfβG (PDB
id 5fji; rmsd 0.81 Å; seq. identity 62%), ReCel3A (PDB id 5ju6; rmsd 0.84 Å; 62.0%) and Aspergillus
aculeatus AaBgl1 (4iig; 0.83 Å; 62.0%). Lower similarities were found with Hypocrea jecorina HjCel3A
(3zyz; 1.21 Å; 47%).
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Figure 1. Structure-based sequence alignment of CtBGL with members of GH3 family. Secondary
structure elements are shown on the top of the alignment, while the red triangles below the alignment
indicate the catalytic conserved residues (Asp287 and Glu517 in CtBGL). Disulfide bonds are depicted
with green numbers. The three domains are indicated. A column is framed if more than 70% of its
residues are similar according to physicochemical properties. Frames in red background with white
letters depict strict identity. The figure was constructed with ESPript [16].
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2.3. Description of the Structure
The structure of CtBGL (Figure 2) consists of three distinct domains, similar to other GH3 family
members: A catalytic triose phosphate isomerase (TIM) barrel-like domain (Leu51–Ser354), an α/β
sandwich domain (His396–Gly596) and a FnIII (fibronectin type III) domain (Thr663–Gln867) with
a prominent insertion region (677–766). A linker region (residues 355–394) connects domain 1 to
domain 2 and a second linker region (600–662) connects domain 2 to domain 3. The 39-residue linker
between domain 1 and domain 2 is comparable to that in NcCel3A and significantly longer than the
linker in other GH3 β-glucosidases such as HjCel3A and HvExoI with only 18 and 16 residues in
length, respectively. In NcCel3A, the linker comprises 42 residues (residues 341–383) with a 25-residue
(residues 351–376) insertion previously described as a hydrophobic linker responsible for the activation
of ReCel3A and AaBgl in organic solvents [5]. This insertion has been coined as loop II and contains
several aromatic residues, of which CtGBL Phe364 (Phe352 in NcCel3A) and CtGBL Trp367 (Trp355 in
NcCel3A) are the most conserved. Moreover, loop II contains residues Phe366, Trp367, and Trp377 that
line up one side of the substrate-binding site, and they are also found in NcCel3A (Phe354, Trp355,
and Trp365, respectively) with variations in other β-glucosidases, such as ReCel3A and AaBgl1. It has
been suggested that this loop is stabilized by interactions with the N-glycans from a neighboring
glycosylated Asn residue (Asn57 in NcCel3A) [5]. In CtBGL, the equivalent residue is Asn72, which is
also glycosylated (see below).
Figure 2. Overall crystal structure of CtBGL in ribbon representation. The domains, linkers, and loops
are shown in different colors and labeled: Catalytic TIM barrel-like domain (blue), α/β sandwich domain
(green), FnIII domain (yellow), loop I (gold), linker 1 (cyan), loop II or insertion region (magenta), loop
III (orange), loop IV (orange–red), linker 2 (gray), loop V (brown). The N-glycans and glucose in the
active site are shown as gray sticks. The figure was created with UCSF Chimera [17].
CtBGL second domain, an (α/β)6 sandwich fold, is structurally well conserved among all the
GH3 enzymes. It consists of residues His396 to Gly596 and includes loops III and IV that encompass
residues Gly433–Val467 and Ala513–Asn536, respectively (Figure 3). Loop III houses the conserved
cysteine residues Cys442 and Cys447, which form a disulfide bridge that stabilizes the folded loop III
architecture. Ser458 and Asp444 are also highly conserved in all compared structures. This domain
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hosts the catalytic acid Glu517 in loop IV, which is found to be conserved in all of the compared
β-glucosidases, CtBGL, NcCel3A, ReCel3A, HjCel3A, AaBgl1, and Thermotoga neapolitana β-glucosidase
3B (TnBgl3B). Moreover, the architecture and location of loops III and IV, which constitute one site of
the active site cavity in between loops I and II, are also found conserved. Ser458, Asp444, and Glu517
are found pointing downwards from the loop regions and towards the active site.
 
Figure 3. Overview of domain 2 in ribbon representation CtBGL superimposed with the compared
structures. Domain 2 is colored orange; loops III and IV in CtBGL, NcCel3A, ReCel3A, and TnBgl3B
are colored in green, blue, cyan, and yellow, respectively, for structural comparisons. Linker 2 loop is
colored in black, and the active site is depicted by the bound BGC in sphere representation.
Domain 2 of the CtBGL structure is followed by a second linker region (Linker 2; residues
Lys597–Ser660). This linker region exhibits an extended structure, which almost resembles a boundary
that separates domain I and domain II from domain III. The extended linker region probably plays a
role in stabilizing loops I and IV.
The FnIII-like domain 3 was first observed in the GH3 family in the TnBgl3B structure [18].
It consists of residues Tyr661–Asn867 that form a beta sandwich composed of a total of nine β-strands
arranged in two layers ofβ-sheets with three and fourβ-strands, respectively. Loop V takes an extended
structure and encompasses domain I. Importantly, loop V is present in NcCel3A, ReCel3A, and AaBgl1,
but it is absent in TnBgl3B and HjCel3A (Figure 4). Several conserved aromatic residues, namely,
Tyr716, Tyr718, Tyr733, and Phe740, are found in loop V. Tyr716 and Tyr733 are found to be conserved
in all structures except HjCel3A and TnBgl3B, where loop V is absent, while Tyr718 is replaced by Trp
in ReCel3A and AaBgl1. Moreover, Phe740 is replaced by a Tyr residue in ReCel3A and a His residue in
AaBgl1. These conserved aromatic residues form π-stack interactions with N-acetyl-β-d-glucosamine
(GlcNAc) residues. Also, conserved in loop V is Asn720, which was found to be N-glycosylated.
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Figure 4. Loop V comparisons in (a) CtBGL, (b) NcCel3A, (c) ReCel3A, (d) AaBgl1, (e) HjCel3A, and (f)
TnBgl3B. Domain 3 is colored in yellow and the loop V is represented by red coloration. Domains 1 and
2 are colored in the same color in each enzyme and differently amongst the enzymes.
2.4. Glycosylation Sites
Potential glycosylation sites were observed in the CtBGL structure in 10 positions, all in Asn
residues (Table 2). The glycosylation sites found in CtBGL when compared with other structures
showed some variations. A unique glycosylation site was observed in CtBGL at Asn504 on the surface
of the molecule, where the corresponding aligned structures had either a different residue or a gap
in the structure-based alignment (Table 3). Asn259 was found highly conserved and glycosylated
in all structures. Moreover, ReCel3A possess 16 glycosylation sites [4], similarly to Aspergillus
β-glucosidases [8]. On the other hand, HjCel3A showed the lowest number of glycosylation sites, with
only two glycosylated sites (Asn208 and Asn310 in chains A and B, respectively). As observed before
in this class of β-glucosidases, all glycosylation sites in CtBGL were also located on one face of the
molecule (Figure 5).
A total of 27 glycan moieties were found in CtBGL. The glycans ranged in length from single
GlcNAc to longer chain. The longest glycosylation chain was composed of eight residues. The
overall degree of glycosylation in CtBGL can be considered as moderate when compared against other
glycosylation chains, such as those found in ReCel3A and AaBGL1, with the longest chain composed
of 10 residues and 45–50 glycosylation residues in total per chain in the crystallographic asymmetric
unit. Interestingly, the glycosylation pattern in CtBGL showed high GlcNAc-type N-glycans, while
ReCel3A and AaBGL1 displayed high mannose-type N-glycans. A total of 15 GlcNAc residues were
identified in CtBGL. Out of the total 10 glycosylation sites in CtBGL, three of them were found to
consist of a single GlcNAc monosaccharide. Single GlcNAc monosaccharides in other enzymes,
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such as AaBGL1, were obtained possibly as a result of a treatment with endoglycosidase H prior to
crystallization. In the case of CtBGL, no endoglycosidase treatment was employed. Similarly, single
GlcNAc molecules were found in AfβG (in Asn543 and Asn715) without any attempt of enzymatic
cleavage. It is possible that, in these cases, the enzymes were subjected to endoglycosidase activity
during the expression stage. The other seven N-glycosylation sites in CtBGL ranged from two to eight
monosaccharides. The N-glycan at CtBGL Asn329 was located in domain I of the enzyme and consisted
of eight monosaccharides (two GlcNAc, five α-d-Man, and one β-d-Man). Extra densities that could
accommodate another two monosaccharide molecules were present in the electron-density map, but
they were not modeled owing to lack of clarity. It was, nevertheless, the largest N-glycan structure in
CtBGL and was involved in forming multiple H-bonds with the enzyme residues at Thr293, Asp730,
Val295, Gly734, and Tyr733 and a pi-sigma interaction with Tyr733 residue. The structural equivalent
Asn residue in AaBgl1 (Asn322) had a long-length glycan with eight Man and two GlcNAc that were
also involved in extensive stabilizing interactions with domain I. N-glycans at positions Asn72 and
Asn720 were located in domains I and III, respectively, with loop V residues in between them. They
both participated in interactions with protein residues. The N-glycan at Asn72 was found to interact
in conventional H-bonding interactions with Ala90, Tyr716, Tyr718, and in pi-sigma interaction with
Tyr715 from domain III. The N-glycan at Asn720 interacted with Arg710 via H-bonding and Tyr704 via
weak van der Waals interactions. A long chain glycan moiety at Asn259 at the outer surface of the
enzyme was found to interact via H-bonding with Ser35, Glu36, and Asp229.
Notably, the protein glycans were also shown to exhibit a potential binding affinity for
polysaccharides such as cellulose [19] and aromatic compounds [20,21]. This suggests a possible
role of N-glycans in promoting cellulose binding and also in protein–glycan interactions. Glycans in
β-glucosidases can stabilize the crystal packing contacts and also participate in hydrogen-bonding
interactions at the dimer interface [8]. There are two glycosylated Asn residues at the dimer interface
of β-glucosidases that provide protein–glycan interactions between the two chains. One of those
Asn residues corresponds to Asn531 in CtBGL. This Asn bears only two monosaccharide molecules,
whereas, for comparison, the equivalent Asn residue in AaGL1 has seven monosaccharides with the
terminal ones able to reach the adjacent subunit. The second Asn residue that participates in dimer
interface contacts is not present in CtBGL. The lack of these contacts could therefore contribute to




Figure 5. Distribution of glycosylation sites in the CtBGL structure. GlcNAc is shown in blue,
β-d-mannose in green, α-d-mannose in orange, and BGC in magenta.
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Table 2. Glycosylation sites and glycan descriptions in CtBGL.











Table 3. Comparison of glycosylation sites %.
CtBGL NcCel3A(5nbs) AaBgl1 (4iif) ReCel3A (5ju6) HjCel3A (3zyz) #
Asn72 (+) Asn57 (+) Asn61 (+) Asn61 (+) Gly30 (−)
Asn259 (+) Asn248 (+) Asn252 (+) Asn249 (+) Asn208 (+)
Asn322 (+) Asn311 (+) Asn315 (+) Asn312 (+) Ala270 (−)
Asn329 (+) Asn318 (+) Asn322 (+) Asn319 (+) Ser277 (−)
Asn504 (+) Asp492 (−) Ala496 (−) Ala492(−) Lys428 (−)
Asn531 (+) Asn519 (+) Asn523 (+) Asn519 (+) Asn455 (−)
Asn572 (+) Asn560 (+) Asn564 (+) Asn560 (+) Gln496 (−)
Asn698 (+) Ser687 (−) Asn690 (+) Asn685 (+)
Asn720 (+) Asn710 (+) Asn712 (+) Asn707 (+)
Asn744(+) Lys734 (−) Gly736 (−) Asn731 (+)
% (+) depicts glycosylation, (−) absence of glycosylation # In subunit A.
2.5. Active Site
The active site is located in a shallow pocket near the interface of the first and second domain.
A molecule of β-d-glucose (BGC) was fitted at the active site based on residual electron density observed
in electron density Fo–Fc difference maps. The source of the β-d-glucose is most likely the growth
medium used as no β-d-glucose was used during crystallizations or soaking. Two catalytic residues
were identified, Asp287 (nucleophile) at the N-terminal TIM-barrel domain and Glu517 (acid/base) at
the sandwich α/β domain II. Both catalytic residues were found conserved in the GH3 family members
(Figure 6). The corresponding catalytic residues were Asp276/Glu505 in NcCel3A, Asp277/Glu505 in
ReCel3A, Asp280/Glu509 in AaBgl1, Asp236/Glu441 in HjCel3A, and Asp242/Glu458 in TnBgl3B. The
collapsed TIM-barrel model of domain I is vital for the proper accession of the active site. It was found
that near the active site, the second barrel β strand (Gly87 to Thr89) was much shorter and antiparallel,
which creates an active site much wider and accessible when compared with GH3 enzyme structures
with complete TIM-barrel fold [6]. An additional electron density present at the active site next to BGC
was not interpretable and may suggest a bound buffer molecule, MPD from the crystallization mother
liquor, or a partially bound glucose molecule.
2.6. CtBGL Thermostability
CtBGL has been found to be thermostable at 50 ◦C and to retain half of its activity after incubation
at 65 ◦C for 55 min [22]. The enzyme also retains 29.7% of its activity after incubation at 70 ◦C for
10 min. In regard to most other β-glucosidases from thermophilic fungi, CtBGL exhibits comparable
thermostability, as previously reported [22]. In contrast, A. fumigatus β-glucosidase has been found
highly thermostable and able to retain most of its activity for at least 19 h at 65 ◦C [23].
Protein thermostability is usually hard to predict and there is no a common mechanism yet
available [24,25]. Several factors of protein thermostability have been proposed that could provide
some clues (Table 4). Solvent-accessible surface (SAS), charged residues, and glycosylation patterns are
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some of the key indicators. The structure of HjCel3A from the mesophilic fungus Hypocrea jecorina
had the lowest SAS (22812 Å2), owing to the smaller number of residues and the lack of loop V.
Similarly, loop V was absent in TnBgl3A and the SAS value was reduced. The SAS values for the other
β-glucosidases, including CtBGL, were quite similar, i.e., around 28100 Å2.
Figure 6. Active site structure comparisons of (a) CtBGL, (b) NcCel3A, (c) ReCel3A, (d) TnBgl3B,
(e) HjCel3A, and (f) AaBGL1. The corresponding conserved nucleophile Asp is colored in dark green
and the acid/base Glu is colored in yellow. Both residues are labeled in red. Carbon atoms are colored
differently in each enzyme. The active site BGC is displayed with its solvent-excluded surface for
visual clarity.
Charged residues in the structures can contribute to structural integrity and, in turn,
to thermostability. The negatively (Asp and Glu) and positively (Arg and Lys) charged residues may
provide a stability profile of the structure [26]. The numbers showed significant variations when the
proteins were compared. In particular, HjCelA showed reduced numbers of positively and negatively
charged residues, despite its high thermostability with an optimum temperature at 90 ◦C and an
unfolding temperature of ~88 ◦C depending on the enzyme concentration [27]. The number was
increased for the β-glucosidases from other thermophilic and mesophilic β-glucosidases. In addition,
AfβG, despite its high thermostability, was also characterized by a similar content of charged residues,
suggesting that the strength of individual ion–pair interactions may play a key role.
Finally, the glycosylation pattern found may also contribute to the thermostability of the enzyme
by promoting interactions with amino acid residues. It has been shown that glycosylation enhances
the solubility, reduces the aggregation, and increases the thermal stability of proteins [28,29]. The exact
mechanism by which the enzyme glycosylation pattern affects the overall function and structure of
proteins is not yet well understood. Analysis of protein structures deposited in the Protein Data Bank
has suggested that N-glycosylation causes no significant local or global structural changes; however,
it decreases the protein dynamics, thus leading to increased stability [26]. Aglycosylated proteins
are, in general, found to be less stable, and therefore aggregate more easily than its glycosylated
counterparts at certain temperatures. Thus, glycosylation has been suggested as a potential factor to
enhance enzyme solubility, stability, and function [30]. Thermostability measurements in HjCel3A
samples with different degree of N-glycosylation revealed the same melting temperature (74.0 ± 0.2 ◦C),
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thus suggesting that the effect of glycosylation may be case-specific and other factors could play a
role. Interestingly, TnBgl3B that lacks glycosylation exhibited thermostability, most likely as a result of
the high numbers of charged residues. Nevertheless, the moderate glycosylation in CtBGL could not
be ruled out as a contributing factor to the limited stability of the enzyme compared to other more
thermostable β-glucosidases characterized by extensive glycosylation. Further studies are, however,
required to better understand the role of glycosylation in β-glucosidases and in protein stability.
Table 4. Comparison of thermostability parameters.








19 h at 65 ◦C
[23]








Asp + Glu (−) 93 95 92 87 113 55
Arg + Lys (+) 66 67 65 59 93 51
Pro: Gly 0.51 0.55 0.51 0.61 0.58 0.52
Val (%) 7.0 7.9 8.0 7.5 9.2 8.8
Amino acid residues 867 844 841 857 721 714
SAS (Å2) 28,502.9 28,092.1 28,074.9 28,481.7 26,430.0 22,551.0
Intra-chain salt Bridges 46 49 42 44 39 34
H-bonding interactions 12 ∞ 22 25 22 23 8
Interface area, Å2 1544.2 ∞ 1324.3 1445.3 1322.5 1253.1 699.3
Helical content (%) 21.2 21.8 21.8 20.5 26.5 23.7
Sugars 27 45 (chain A) 44 % 50 (chain C) NA $ 2
∞ In the crystallographic dimer. % Prior to crystallization, the enzyme was subjected to endoglycosidase H treatment
with ~50% of the N-glycans removed [3]. $ The enzyme was produced in Escherichia coli.
3. Materials and Methods
3.1. Protein Expression, Purification, and Crystallization
Protein expression and purification of the β-glucosidase from Chaetomium thermophilum CT2 was
carried out as previously described [22]. Briefly, the enzyme (Uniprot id A6YRT4) was produced
in Pichia pastoris GS115 cells and purified by ion-exchange chromatography on a DEAE-Sepharose
(Pharmacia, Uppsala, Sweden) to homogeneity as judged by SDS-PAGE. β-Glucosidase activity was
assayed with salicin using the Miller’s method and also detected in native polyacrylamide gel using
4-methylumbeliferyl-β-d-glucopyranoside [22]. The activity of the enzyme was 1.62 ± 0.20 U/mg
(1 U corresponds to the release of 1 μM of glucose per min) from three independent measurements at
optimum conditions of pH and temperature.
3.2. Protein Crystallization
Prior to crystallization, the enzyme solution was concentrated to ~10 mg/mL with Amicon® Ultra
Centrifugal Filters (10,000 MW cut-off) (Millipore, MA, USA) in 10 mM HEPES–NaOH, pH 7.0 buffer.
Crystals were obtained by the hanging-drop vapor diffusion method at 16 ◦C using a well solution of
35–45% v/v MPD (Sigma-Aldrich, St. Louis, MO, USA). The drops were prepared by mixing 2 μL of
protein solution with an equal volume of well solution. The crystals grew as octahedra to a maximum
size of approximately 0.06 × 0.06 × 0.08 mm3 within a period of 1 month.
3.3. Data Collection and Processing
Data were collected on the X13 beamline at EMBL-Hamburg (c/o DESY) from a single crystal under
cryogenic (100 K) temperature using a MARCCD detector. The presence of MPD in the crystallization
was sufficient for cryoprotection, thus no additional cryoprotectant was needed. One hundred and
fifty diffraction images were collected from a single crystal with a rotation range of 0.45◦ per image.
Data processing was carried out with XDS [32]. The crystal was found to belong to the tetragonal
space group P41212/P43212. Assuming one molecule in the asymmetric unit, the Matthews coefficient
VM [33] is 5.4 Å3/Da corresponding to a solvent content of ~77%.
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3.4. Structure Determination and Refinement
Initial phases were obtained with molecular replacement using Phaser [34], as implemented in
Phenix 1.15.2_3472 [35]. The crystal structure of Aspergillus aculeatus β-glucosidase in complex with
castanospermine (PDB id 4iif; sequence identity 61.5%) was used as a search model after pruning side
chains with Sculptor [36] based on sequence alignment considerations. Initially, the search was carried
out assuming two molecules in the asymmetric unit, but no solution was produced. Based, however,
on the statistics for one molecule (TFZ = 30.9), the search was limited to one molecule and a single
solution was obtained in space group P41212. Refinement was carried out using simulated annealing
(1000 K) in Phenix with maximum likelihood as target function. The refinement was alternated with
model visualization and rebuilding using Coot 0.8.9 [37]. Tight restraints were used to avoid overfitting
of the structure to the data, owing to the low resolution. The progress of the refinement was monitored
by the Rfree with 5% of the reflections used for the calculations [38]. High-resolution structures were
used to assist the rebuilding in places with poor electron density and ambiguities in atom positions.
Structure validation was performed with tools implemented in Phenix and Coot. The stereochemistry
and conformation of the sugars were tested with Privateer [39]. Data collection and final refinement
statistics are shown in Table 1. The atomic coordinates and the structure factors have been deposited to
the Protein Data Bank under the accession code 6SZ6.
3.5. Structure Analysis
PDBeFold [40] was employed to identify structural similarities between CtBGL and deposited
PDB structures. Structure-based sequence alignment was performed with UCSF Chimera 1.13.1 [41].
ESPript 3 [16] was used in rendering sequence similarities and secondary structure information from
aligned sequences. Salt bridges were calculated using ESBRI (http://bioinformatica.isa.cnr.it/ESBRI/).
SAS area was calculated using PDBePISA [42]. The values for charged residues were calculated using
the ExPASy server (http://web.expasy.org/protparam/) ProtParam tool [43].
4. Conclusions
The CtBGL structure was determined at 2.99 Å resolution and refined to good stereochemical and
refinement numbers, despite the limited resolution. The structure exhibited a three-domain architecture
with two linker regions as other β-glucosidase structures. Variations in the length of the first linker
regions and the third domain were identified. CtBGL showed the highest structural similarity with
NcCel3A. The catalytic residues at the active site were identified as Asp287 (nucleophile) and Glu517
(acid/base). CtBGL showed a low number of glycans at glycosylation sites compared to other heavily
glycosylated GH3 β-glucosidases. Charged residues and the glycosylation pattern are suggested as
potential contributing factors for the thermostability properties of CtBGL. The analysis presented in
this study could offer new ideas towards further improvements in β-glucosidases for better use in
biotechnological applications.
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Abstract: Uridine-5’-diphosphate (UDP)-glucose is reported as one of the most versatile building
blocks within the metabolism of pro- and eukaryotes. The activated sugar moiety is formed by
the enzyme UDP-glucose pyrophosphorylase (GalU). Two homologous enzymes (designated as
RoGalU1 and RoGalU2) are encoded by most Rhodococcus strains, known for their capability to
degrade numerous compounds, but also to synthesize natural products such as trehalose comprising
biosurfactants. To evaluate their functionality respective genes of a trehalose biosurfactant producing
model organism—Rhodococcus opacus 1CP—were cloned and expressed, proteins produced (yield up
to 47 mg per L broth) and initially biochemically characterized. In the case of RoGalU2, the Vmax
was determined to be 177 U mg−1 (uridine-5’-triphosphate (UTP)) and Km to be 0.51 mM (UTP),
respectively. Like other GalUs this enzyme seems to be rather specific for the substrates UTP and
glucose 1-phosphate, as it accepts only dTTP and galactose 1-phoshate in addition, but both with
solely 2% residual activity. In comparison to other bacterial GalU enzymes the RoGalU2 was found to
be somewhat higher in activity (factor 1.8) even at elevated temperatures. However, RoGalU1 was
not obtained in an active form thus it remains enigmatic if this enzyme participates in metabolism.
Keywords: glycosylation; UDP-glucose pyrophosphorylase; UDP-glucose; nucleotide donors;
Rhodococcus, Actinobacteria, gene redundancy; Leloir glycosyltransferases; activated sugar; UTP
1. Introduction
Uridine-5’-diphosphate (UDP)-glucose is a key metabolite in most organisms and thus used in a
variety of reactions of the sugar and starch metabolism, sugar interconversions, amino and nucleotide
sugar metabolism, biosynthesis of antibiotics and cell envelope components, and as precursor for
different primary and secondary metabolites [1–3]. Being an interesting and valuable compound,
UDP-glucose attracted more and more attention for biotechnological applications. As an example, in
glycosylation reactions, their production and application in fine chemical scale could be shown [1–3].
It was presented that whole cell catalysis by sucrose synthase (SuSy) with UDP as precursor led
to large-scale production of 100 gUDP-glucose/L with a yield of 86% [3]. Another report with 0.1 g/L
of free SuSy could achieve 144 gUDP-glucose/L with a comparable conversion rate of 85% based on
the precursor UDP [1]. The enzymatic production of various sugar-nucleotides can be realized via
several UDP-glucose synthesizing enzymes (Scheme 1). Glycosyltransferases, like sucrose synthase,
are the most common used representatives [1,4–7]. Nucleotidyl transferases, like UDP-glucose
pyrophosphorylase have been known for a long time but were seldom employed as biocatalysts to
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produce UDP-glucose, maybe due to low specific activities. Those enzymes are more often studied for
their metabolic role.
Scheme 1. Reactions in which UDP-glucose is consumed or formed. UDP: Uridine-5’-diphosphate,
UMP: Uridine-5’-monophosphate, UTP: Uridine-5’-triphosphate, NAD+/NADH: Nicotinamide adenine
dinucleotide in the oxidized and reduced form.
UDP-glucose pyrophosphorylases (GalU or UGPase; EC 2.7.7.9) catalyze the reversible reaction of
glucose 1-phosphate and UTP into UDP-glucose and inorganic pyrophosphate (PPi). Enzymes of the
GalU family are ubiquitous and can be found among the tree of life [8]. With respect to bacteria mostly
proteobacterial GalUs have been studied. Like many other nucleotidyl transferases, also GalU requires
divalent cations to promote the reaction (Scheme 2). In most cases magnesium ions are employed,
and so far only magnesium chloride has been investigated [9–16]. The reaction mechanism follows
a sequential bi-bi-mechanism starting with the binding of UTP to the active site, in presence of a
magnesium ion [17], followed by the binding of glucose 1-phosphate. The octahedral coordination
sphere of the magnesium positions the substrates in the right way and enables the nucleophilic attack
of glucose 1-phosphate on UTP [18]. A lysine, an aspartate and several water molecules within the
active site help to stabilize the position of the substrates and cofactor for the proper nucleophilic attack
of the phosphoryl oxygen of glucose 1-phosphate towards the α-phosphor atom of UTP [17]. Finally,
PPi is released from the GalU/Mg2+/UDP-glucose complex [17].
GalU enzymes have been shown to play crucial roles in galactose fermentation [19]. Other metabolic
pathways in which this enzyme family is active are similar like the ones UDP-glucose itself plays
an important role. It produces UDP-glucose as precursor for sucrose, glucan and amylose in the
sugar and starch metabolism. Furthermore, it plays a role in galactose metabolism and glucuronate
interconversion, where galactose 1-phosphate is over all converted into UDP-glucuronate with the
help of a hexose 1-phosphate uridylyl transferase and a UDP-glucose 6-dehydrogenase. In amino
sugar and nucleotide sugar metabolism, GalU is active in interconverting different UDP-sugars via the
intermediate UDP-glucose. Additionally, it can be found in glycolipid metabolism and the synthesis
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of antibiotics. Respectively, many GalU enzymes from several organisms have been investigated
to date, e.g., GalUs of plants [20–24], of mammals [25–27], including human [28], parasites [29],
and many different bacteria [9,10,12,13,30–33], only to name a few groups. Fields of study included
the determination of structures [17,30,34], biochemical characterization [14,31,35,36] and biological
function [15,33,37].
Scheme 2. Proposed reaction mechanism of UDP-glucose pyrophosphorylase, adapted from Kim
et al. [17].
During those studies, it became clear that many organisms also carry a gene encoding for a
GalF, a homologous and putative regulatory protein towards GalU. In E. coli the function of the GalF
protein was determined by Ebrecht and co-workers [19] to putatively regulate or even interact with
GalU while maintaining a low UDP-glucose pyrophosphorylase activity (0.004% of EcGalU). It seems
to be an evolutionary artefact, which was observed for several other Enterobacteria, as exemplarily
different species and strains of Klebsiella, Yersinia, Pectobacterium, Shigella, Escherichia, Pantoea, Salmonella,
Serratia, and some others [19]. Both proteins, GalU and GalF, seem to have evolved independently
from a common ancestor, but only GalU kept the initial enzymatic role. Apparently, GalF underwent
several mutations, which led to a much lower activity compared to GalU. By means of mutagenesis
of identified key residues, the activity of GalF was restored and comparable to GalU and even a
physiological complementation of a GalU-knockout strain was possible [19]. GalUs are known to
have two important conserved motifs: The N-terminal one, which is involved in the binding of the
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uracil ring with the sequence G-X-G-T-R-X-L-P-X-T-K (X stands for any amino acid) [8,38] and a
V-E-K-P-motif with an important lysine for glucose 1-phosphate binding [38–40]. The GalF of E. coli
was shown to have the same V-E-K-P-motif, but instead of G-L-G-T-R, GalF has G-L-G-M-H residues
in the N-terminal motif [19]. By means of mutagenesis it could be shown that the alteration of T-R
into M-H was possibly the reason for the reduced UDP-glucose pyrophosphorylase activity of E. coli
GalF. But, the actual function of GalF among Enterobacteria still remains unclear. If gene redundancy
and physiological flexibility here between E. coli GalU and GalF is of relevance is not yet clarified.
Furthermore, it remains enigmatic why this presence of homologous GalU/GalF-proteins has so far
only been reported for Enterobacteria among the bacteria. However, in the genomes of Rhodococcus
species, gene redundancy plays a crucial role [20,22,27,41–43]. Interestingly, most Rhodococcus species
also carry two galU genes which we will highlight herein for the first time. Thus, R. opacus 1CP encodes
for two isoforms of the GalU enzyme—RoGalU1 and RoGalU2, which have not been characterized
yet. In some cases, it could be shown that enzymatic isoforms derived from rhodococci have the same
or only a slightly different function, so that it was assumed that the coding isogenes have evolved
independently from a common ancestor [44]. However, the functionality of respective proteins has
not been investigated so far. Furthermore, to the best of our knowledge studies on UDP-glucose
pyrophosphorylases in Rhodocccus species have not been carried out. Herein we describe the redundant
GalU enzymes of R. opacus 1CP whereas one was found to be active as recombinant enzyme and might
participate in several metabolic pathways, which is discussed in detail. Phylogenetic analysis of the
amino acid sequences of GalU proteins of several rhodococci, Enterobacteria, and Actinobacteria helps
to further understand the role of RoGalU1 and RoGalU2. This will also give more information on gene
redundancy in Actino- and Enterobacteria in general.
2. Results
2.1. Genome Mining and Phylogenetic Analyses
Via a genome mining approach two genes encoding for two UDP-glucose pyrophosphorylases
(GalUs) were identified in Rhodococcus opacus 1CP. The respective genes and amino acid sequences
used for codon usage optimization were derived from the NCBI protein accession numbers
ANS26426 (RoGalU1, theoretical size: 33.2 kDa, GenBank accession number of the codon usage
optimized nucleotide sequence: MN617759) and ANS26629 (RoGalU2, theoretical size: 33.9 kDa,
GenBank accession number of the codon usage optimized nucleotide sequence: MN617760). They have
a sequence identity of more than 70% on amino acid level to each other when compared over full length.
Having a look at the genomic environment of both genes, various genes were found flanking
RogalU1, which were involved in the sugar- and nucleotide metabolism, e.g., a mannose 6-phosphate
isomerase, a D-glycero-D-manno-heptose 1-phosphate guanosyltransferase or a undecaprenyl-phosphate
galactose phosphotransferase, whereas RogalU2 is flanked by cation channels, heat shock proteins or
putative regulatory proteins.
Analyzing the amino acid sequences of the GalUs originating from R. opacus 1CP, both contain the
same motifs for uracil binding, G-X-G-T-R-F-L-P (start: amino acid 17 in EcGalU sequence; 18 and
21 in RoGalU1 and RoGalU2, respectively). Equally, both display the V-E-K-P motif (start: amino
acid 200 in EcGalU sequence; 199 and 202 in RoGalU1 and RoGalU2, respectively) with the important
lysine (K202 in EcGalU) for binding of glucose 1-phosphate (see Figure 1; the subsequent numbering
of amino acids is according to EcGalU; [19]). Interestingly, only the GalF of E. coli shows an alteration
from T20-R21 to M-H in the first motif, which was shown before to be the reason for the reduced
UDP-glucose pyrophosphorylase activity of E. coli GalF. Large parts of RoGalU1 and RoGalU2 are
identical and seem to be conserved. Several of those conserved amino acids can be found in EcGalU
and/or EcGalF, respectively. Furthermore, all four sequences share the same residues for the hydrogen
bonding of the uracil ring (A16-G17 and Q109), and at least the Rhodococcus GalUs and EcGalU have the
same amino acids for the phosphoryl binding of UDP-glucose (G179, K202 and G-A-G-D, start: amino
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acid: 234). The overall alignment indicates that the structure of all four proteins should be highly
similar, as the secondary elements presented by α-helical and β-sheet areas of EcGalU are present in
RoGalU1 and RoGalU2, as well.
Figure 1. Alignment of RoGalU1 and RoGalU2 with the GalU and GalF amino acid sequences of E. coli
K-12 [19], executed with the MUSCLE algorithm [45,46] in the program MEGA X [47] for multiple
sequence alignment with default settings and imaged with ESPript 3.0 [48]. Conserved amino acids
are color-coded. Red box with white letters: strictly identical amino acids, yellow box with black
bold letters: similar amino acids, which are conserved among at least two sequences, black squiggles
with α or η signs: α-helical structures, black arrows with β sign: β-sheet structures, TT: strict β-turns,
TTT: strict α-turns, grey stars: residues with alternate conformations.
The alignment (Figure 1; part of the complete alignment with all 48 amino acid sequences) that
underlies the phylogenetic tree (Figure 2) shows remarkable sequence similarities and again huge
conserved areas between the GalU sequences of different actinobacterial species and especially strains
of Rhodococcus, Mycobacterium, Corynebacterium, and Gordonia. As they are close relatives, it is not
surprising that those sequences cluster together. It is striking that there are two sequence sections
around the G-X-G-T-R-F-L-P (start: amino acid 17) motif and the V-E-K-P (start: amino acid 200) motif,
which are highly conserved among all chosen sequences. Besides those and the highly conserved
motifs for binding of the substrates and products, there are also three more conserved motifs: One
G-L-G-H sequence (start: amino acid 114) before and two sequences between the V-E-K-P motif and the
C-terminus, namely G-R-Y-L-L (start: amino acid 216) and Q-L-T-D-A-I (start: amino acid 240) within
all analyzed sequences. In addition, those seem to be highly conserved, not only among Actinobacteria,
131
Int. J. Mol. Sci. 2019, 20, 5809
but also Enterobacteria. Furthermore, the sequences contain single conserved amino acids, like G53,
F72, E79, D137, Y178, S210, G261, D265, and G267 (Figure 1).
Figure 2. Phylogenetic tree of RoGalU1 and RoGalU2 with similar characterized or related UDP-glucose
pyrophosphorylase sequences. The evolutionary history was inferred by using the Maximum Likelihood
method and JTT matrix-based model [49]. The tree with the highest log likelihood (−13775.30) is shown.
The percentage of trees in which the associated taxa clustered together is shown next to the branches.
Initial tree(s) for the heuristic search were obtained automatically by applying Neighbor-Join and
BioNJ algorithms to a matrix of pairwise distances estimated using a JTT model, and then selecting the
topology with superior log likelihood value. The tree is drawn to scale, with branch lengths measuring
the number of substitutions per site. This analysis involved 48 amino acid sequences. There was a total
of 375 positions in the final dataset. Evolutionary analyses were conducted in MEGA X [47].
The above described alignment was used and completed by numerous GalU protein sequences
in order to generate a distance tree for a phylogenetic analysis (Figure 2). The first big branch of the
tree contains all actinobacterial proteins, which are very close relatives. Within those, also Rhodococcus
enzymes form one big cluster. Interestingly, the enzymes from the same strains do not cluster together,
but form two different smaller clusters. The Rhodococcus strains containing only one GalU protein
are mapped within the branch of our tested and active RoGalU2. The second big branch of the tree
contains Actinobacteria in the upper part, Firmicutes, and Proteobacteria in the lower part.
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2.2. Recombinant Expression of RogalU1 in E. coli, Purification, and Renaturation
For characterization purposes in more detail RogalU1 was cloned into the expression vector
pET16bP. After transformation of chemically competent E. coli BL21(DE3) pLysS with pET16bP-RogalU1
overexpression and respective protein production and purification were carried out as described
in the material and methods section. The SDS-PAGE in Figure 3a shows the expected molecular
weight of RoGalU1 of 33 kDa, but most of the produced enzyme is present as insoluble protein in
the cells. The formation of those inclusion bodies was determined from the greyish to white color of
the pellet after crude cell extract preparation. Hence, it was tried to renature the misfolded protein
with the Thermo Scientific Pierce Protein Refolding Kit according to the manufacturer’s instruction.
Unfortunately, it was not possible to obtain RoGalU1 in an active and soluble form. Also, protein within
the inclusion bodies only had a marginal residual enzyme activity. This was determined to be <0.001
U mg−1 by means of the standard test which is described in the materials and methods section (4.6).
In this work, we determined throughout enzyme activity with respect to product formation (1 U
corresponds to the formation of 1 μmol UDP-glucose per minute). In order to turn inclusion bodies
into native protein, the expression was altered with respect to various media and cultivation conditions.
All efforts failed and thus this enzyme was not characterized further.
 
(a) (b) 
Figure 3. SDS-PAGE gels of RoGalU1 (a) and RoGalU2 (b). Arrows indicate the expected molecular
weight of 33 kDa for RoGalU1 and 34 kDa for RoGalU2. SP: soluble proteins, IB: inclusion bodies,
PP: purified protein, M: Marker.
2.3. Recombinant Expression in E. coli, Purification and Production of Active RoGalU2
The gene RogalU2 was treated as described in the materials and methods and similarly as the
RogalU1 described above. In this case, it was possible to produce about 47 mg of pure, soluble protein
with an expected molecular weight of 34 kDa (see Figure 3b) from 25 g wet biomass. The maximum
enzyme activity observed was 3.6 U mg−1 in the direction of UDP-glucose formation, using the standard
reaction conditions. In addition, different media for gene expression were tested (LB, TB, or NB),
but no significant difference in terms of protein yield or activity was found. TB medium was the fastest
medium for cell growth and led to most biomass, therefore using TB auto induction medium for later
large-scale production was an obvious choice.
In order to validate the oligomeric state of the enzyme, a size exclusion chromatography under
non-denaturizing conditions was performed in duplicates with two different concentrations of the
protein (0.2 and 2.0 mg mL−1), each. The elution profiles were similar in those cases (not shown).
The respective calibration was also measured twice and revealed the occurrence of this protein mostly
in a hexameric state (188 kDa elution volume vs. subunit size of 34 kDa; Figures 3 and 4). Thus, we can
state that under these conditions the protein was present mostly in a single hydrodynamic state and
therefore protein characterization can be performed.
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(a) (b) 
Figure 4. Size exclusion chromatography of RoGalU2 (a) and the corresponding calibration
measurements (b). The calibration curve was prepared with the following proteins of known molecular
weight (given in brackets): Ribonuclease (13.7 kDa), Carbonic Anhydrase (29 kDa), Conalbumin (75 kDa),
Aldolase (158 kDa) and Ferritin (440 kDa). All elutions were performed in a buffer containing 50 mM
Hepes, pH 7.0 and 1 mM magnesium chloride. See methods Section 4.5. The protein concentration was
either 0.2 or 2.0 mg mL−1 whereas the latter is presented herein.
2.4. Determining Optimum Reaction Conditions for RoGalU2
In order to collect proper kinetic data for the enzyme activity of RoGalU2 in the direction of
UDP-glucose formation, it was necessary to find optimum reaction conditions. In addition, the product
detection method and fitting procedure had to be established. UDP-glucose formation by RoGalU2 was
determined by HPLC as described in materials and methods section. A typical result and a respective





Figure 5. Enzymatic conversion of UTP and glucose 1-phosphate into UDP-glucose and PPi. In (a) the
HPLC chromatograms of a time course from 0 to 7 min are presented and the determined concentration
of UDP-glucose was used to calculate a product formation rate as shown in (b). For this analysis the
standard enzyme assay and determination methods as described in materials and methods section
have been used.
Firstly, the reaction temperature was varied from 4 ◦C to 87 ◦C. There was an activity plateau
determined between 40 ◦C and 45 ◦C, with a maximum observed enzyme activity of 6.7 U mg−1
(Figure 6a). To monitor the stability of RoGalU2 at different temperatures, the enzyme was incubated
for 30 min at temperatures ranging from 0 ◦C to 70 ◦C. The activity assay was then carried out at
45 ◦C. RoGalU2 shows at least 80% of activity when incubated for 30 min between 19 ◦C and 45 ◦C
(see Figure 6b). Because of the higher activity that could be achieved at 42 ◦C versus 45 ◦C, it was
decided to perform all subsequent experiments at 42 ◦C.
134
Int. J. Mol. Sci. 2019, 20, 5809
 
(a) (b) 
Figure 6. Temperature-dependent activity (a) and stability (b) of purified RoGalU2 enzyme was
measured in triplicates. Activity was measured with pre-incubation of the assay mixture (2 mM UTP,
2 mM glucose 1-phosphate, 4 mM MgCl2, 50 mM Hepes buffer, pH 7.0, 30 μg RoGalU2, 1 mL reaction
volume) at indicated temperatures. The enzyme was stored on ice and directly used for measurements.
For stability measurements the enzyme was incubated shaking for 30 min at indicated temperatures
and directly used for activity assay at 45 ◦C. Means and standard deviations are shown. 100% relative
RoGalU2 activity correspond to 6.7 U mg−1 ((a), activity) and 5.0 U mg−1 ((b), stability), respectively.
To verify the dependence of RoGalU2 on magnesium the concentration of magnesium chloride
and magnesium sulfate present in the standard reaction setup at 42 ◦C was varied between 0–10 mM.
For magnesium salt concentrations below 1 mM, the standard buffer of the enzyme had to be exchanged
by a buffer without magnesium chloride freshly prior to respective experiments since RoGalU2 is not
stable in a buffer without magnesium. The activity was also measured after every buffer exchange.
Figure 7 shows the absolute dependence of the activity on the concentration of magnesium ions. There is
no activity and thus UDP-glucose formation measurable without magnesium salt. The highest activity
was determined to be 5.2 U mg−1 with magnesium chloride and 9.5 U mg−1 with magnesium sulfate,
in the presence of only 1 mM of the respective salt. When increasing the magnesium concentration,
the RoGalU2 activity decreases significantly, falling below 60% with 10 mM magnesium salt. Thus, it can
be concluded that magnesium is a crucial cofactor for the enzyme as presented in Scheme 2, respectively.
Figure 7. Relative RoGalU2 enzyme activity depending on the MgCl2 and MgSO4 concentration
between 0 mM and 10 mM. Assay mixture contained 2 mM UTP, 2 mM glucose 1-phosphate, 0–10 mM
MgCl2 or MgSO4, 50 mM Hepes buffer, pH 7.0, 30 μg RoGalU2. Reaction was carried out at 42 ◦C
in 1 mL reaction volume. Means with standard deviations of triplicate measurements are shown.
100% relative RoGalU2 activity correspond to 5.2 U mg−1.
The activity of RoGalU2 with respect to magnesium salts was most similar at a concentration of
4 mM. Thus, further divalent cations were tested as metal chloride salts at 4 mM each like manganese,
nickel, cobalt, calcium, and zinc. In addition, trivalent metal cations like iron and aluminum were
tested. No activity was observed with the trivalent metal chlorides. For all other divalent chlorides,
the relative activity was below 20%. Thus, a magnesium dependency was clearly determined.
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To test whether masking of the magnesium by means of EDTA results in a reduced enzyme
activity, we applied 1 mM EDTA to the reaction solution and could not observe any activity. Therefore,
the standard assay was used but at a lower magnesium chloride concentration, which was set to 1 mM
as well. We also tested the reaction in presence of acetonitrile as solvent and received the same result.
This was of importance since acetonitrile was used to stop the reactions prior to HPLC analysis as well
as to adjust samples towards elution conditions. Thus, it was proven that acetonitrile was a proper
reagent to stop the reaction.
Different buffers like Bis-Tris, MOPS, sodium phosphate and imidazole were also tested to see
whether the enzymatic activity can be further increased. The pH of the reaction solution was also
varied ranging from 6.6–9.3 in total and split into the following ranges of different buffers: 6.6–7.4
(Imidazole), 7.4–8.4 (Hepes), and 7.6–9.3 (Tris-HCl). Figure 8 shows a graph with the comparison of
RoGalU2 activities measured in those reaction solutions.
Figure 8. RoGalU2 enzyme activity depending on the buffer (a) and pH (b) of the reaction solution. (a)
Assay mixtures contained 1.5 mM UTP, 250 mM glucose 1-phosphate, 1 mM MgCl2, 50 mM buffer,
pH 7.4, 1.7 μg RoGalU2. Reaction was carried out at 42 ◦C in 1 mL volume. (b) Assay mixtures
contained 1.5 mM UTP, 250 mM glucose 1-phosphate, 1 mM MgCl2, 50 mM Imidazole, pH 6.6–7.4
(black triangle) or 50 mM Hepes, pH 7.4–8.4 (black circle) or 50 mM Tris-HCl, pH 7.6–9.3 (white circle),
1.7 μg RoGalU2. Reaction was carried out at 42 ◦C in 1 mL volume. Means with standard deviations are
shown out of a minimum set of three independent measurements. 100% relative activities correspond
to 126 U mg−1 (a) and 109 U mg−1 (b).
In none of the used buffers the relative RoGalU2 activity dropped below 60%. But it was possible
to increase the relative activity up to 180% with Imidazole at pH 7.4. The pH profile even shows
an increase up to 250% in activity when Imidazole or Tris-HCl are used at pH values of around 7.5.
Interestingly, there is no significant difference when Hepes buffer is used at pH values between 7.4
and 8.3 or when Tris-HCl is used between pH 8.1 and 9.1. Here we only observed relative RoGalU2
activities around 80%.
The above described results allowed to formulate an improved enzyme assay with the following
conditions: 1.5 mM UTP, 250 mM glucose 1-phosphate, 1 mM magnesium chloride, 50 mM Hepes,
pH 7.4, 42 ◦C in 1 mL reaction volume. Even though the activity of RoGalU2 is higher with Imidazole
pH 6.6–7.4 or Tris-HCl pH 7.6, we decided to continue using Hepes pH 7.4, because the standard
deviation with Hepes buffer was found to be much smaller than with other buffers. This might be due
to the weaker buffering properties of Tris-HCl or Imidazole in the applied range.
2.5. Enzyme Kinetics with RoGalU2
In order to collect proper kinetic data, the above described improved enzyme assay was employed.
Thus, we could now determine the common kinetic constants Km, Vmax, kcat, and kcat/Km by means of
varying the substrate concentrations. Already here we like to state the Km and thus kcat values have to
be considered as apparent values as later indicated in Table 1. This is necessary as a saturation of the
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enzyme by both substrates cannot be secured as the later on presented data show. Pre-experiments
defined 1.5 mM UTP and 250 mM of glucose 1-phosphate as most suitable fixed concentrations for
the variation of the opposite substrate, respectively. As shown in Figure 9 UTP was varied between
10 μM and 5 mM with a fixed concentration of 250 mM glucose 1-phosphate. The data were fitted
to the model of Yano and Koga [50] (Equation (2), see Methods section) for substrate inhibition,
because above 1.5 mM UTP a strong substrate inhibition became obvious. Below this concentration,
the RoGalU2-activity reaches a maximum observed activity of about 122 U mg−1. The calculated Vmax
was determined to be 177 U mg−1 according to the inhibition fit of Yano and Koga [50].
Figure 9. RoGalU2 enzyme activity depending on the UTP concentration between 10 μM and 5 mM
at a fixed glucose 1-phosphate concentration of 250 mM. Fit is calculated by the Model of Yano and
Koga [50], for enzyme kinetics with substrate inhibition. The assay mixture contained 0.01–5 mM UTP,
250 mM glucose 1-phosphate, 1 mM MgCl2, 50 mM Hepes buffer, pH 7.4, 1.7 μg RoGalU2. Reaction was
carried out at 42 ◦C in 1 mL volume. Mean values with standard deviations from triplicates are shown.
Figure 10 shows the graphs for substrate variation of glucose 1-phosphate between 50 μM and
500 mM with 1.5 mM UTP in each reaction. Figure 10a shows a Michaelis–Menten-like kinetic at
concentrations between 50 μM and 10 mM. This is common for many GalU enzymes as discussed later.
But with a closer look at the data, it became clear that the model does not describe the values in a
proper way. In contrast to common Michaelis–Menten kinetics, the RoGalU2 activity still increased,
beyond the concentration of 10 mM glucose 1-phosphate applied. Therefore, the collection of data
for higher glucose 1-phosphate concentrations was necessary and showed a kinetic behavior that
was different from general models that describe enzyme kinetics (Figure 10b), with a maximum
observed activity of about 119 U mg−1. No model allowed to fit the obtained data properly. Further,
we repeated the experiments with other batches of protein and the results were similar. To achieve a
maximum formation rate of UDP-glucose, a high concentration of glucose 1-phosphate was mandatory,
resulting in those data.
The kinetic properties of RoGalU2 are summarized in Table 1. Further, to describe the substrate
scope of RoGalU2, we used UTP, ATP, GTP, CTP, and dTTP as nucleotides and glucose 1-phosphate,
galactose 1-phosphate, ribose 5-phosphate and glucose as sugars in different combinations to each other.
Only with sugar 1-phosphates and UTP or dTTP, product formation was detectable. Nevertheless,
the relative activity of the reaction of dTTP and glucose 1-phosphate could not be evaluated due
to unavailability of a product standard. A low relative RoGalU2 activity of 2% was observable
when galactose 1-phosphate and UTP were tested (100% relative RoGalU2 activity corresponded to
8.1 U mg−1). With other nucleotides or sugars no activity or product formation was observable.
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(a) (b) 
Figure 10. RoGalU2 enzyme activity depending on the glucose 1-phosphate concentration between
50 μM and 500 mM at a fixed UTP concentration of 1.5 mM. Data for glucose 1-phosphate concentrations
between 0 and 10 mM were fit to the kinetic model of Michaelis–Menten (a). The data obtained over
the total glucose 1-phosphate variation are presented in (b), whereas no fit was able to describe the
data. Assay mixture contained 0.05–500 mM glucose 1-phosphate, 1.5 mM UTP, 1 mM MgCl2, 50 mM
Hepes buffer, pH 7.4, 1.7 μg RoGalU2. Reaction was carried out at 42 ◦C in 1 mL volume. Means with
standard deviations are shown from a minimum of triplicates.
Table 1. Kinetic properties of RoGalU2.
Varied Substrate UTP 1 Glucose 1-Phosphate 1
conc. [mM] 0.01–5 0.05–10 0.05–500
apparent Km [mM] 0.51 0.9 150
Vmax [U mg−1] 2 177 6.75 -
Vmax,ob [U mg−1] 3 122 6.68 119
apparent kcat [s−1] 96.2 3.7 65
KI [mM] 2.61 - 225
kcat/Km [μM−1 s−1] 0.19 0.004 0.0004
1 Assay mixture contained substrates at varied concentrations given whereas the other substrate was set constant
at 250 mM glucose 1-phosphate or 1.5 mM UTP, respectively, 1 mM MgCl2, 50 mM Hepes buffer, pH 7.4, 1.7 μg
RoGalU2. Reaction was carried out at 42 ◦C in 1 mL volume. All experiments were performed at least in triplicates.
Fits were according Michaelis–Menten or Yano and Koga [50]. 2 The specific activity was obtained from fitting the
data. 3 The maximal observed activity was taken as a read out from the plot.
3. Discussion
UDP-glucose pyrophosphorylases are important enzymes for the general metabolism of many
organisms as highlighted in the introduction. However, among the bacterial representatives mostly
GalU enzymes from Proteobacteria have been studied. To a lesser extent, GalUs of Actinobacteria were
described, as for example some information are available for the ones originating of Mycobacterium or
Streptomyces species [10,13,51]. Here we wanted to add knowledge and studied the enzyme family
from rhodococci, which is interesting from a phylogenetic as well as mechanistic point of view. In a
model organism, Rhodococcus opacus 1CP, relevant for trehalose biosurfactant production or aromatic
compound degradation [52,53], two isogenes encoding for UDP-glucose pyrophosphorylases were
identified and described for the first time herein.
A phylogenetic tree based on an alignment of 48 protein sequences of partially characterized
UDP-glucose pyrophosphorylases was generated (Figure 2). The tree is separated into two groups;
proteobacterial and actinobacterial representatives. It should be stressed that some protein sequences
have been annotated as GalU and others as GalF enzymes or regulatory proteins, respectively, but in
most cases this has not been experimentally verified.
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The first group contains GalU- or GalF-designated protein sequences of partially characterized
UDP-glucose pyrophosphorylases or related sequences from Actinobacteria, the other contains
GalUs and GalFs from Proteobacteria. The branch of actinobacterial enzymes is separated again
into two subgroups; Corynebacteriales and other orders of Actinobacteria. Within the branch of
corynebacterial enzymes different Rhodococcus species cluster together. Gene products derived from
soil or wastewater populating rhodococci (which encode for two GalU enzymes) cluster into two
subbranches, respectively. Within those, GalUs of the zoonotic pathogen or animal infecting Rhodococcus
species, such as R. coprophilus and R. hoagie (equii), as well as those Rhodococcus strains that only comprise
a single GalU gene form one cluster. Herein, the protein RoGalU2 from our model strain is localized.
An exception is the plant pathogenic R. fascians, which also encodes for only one GalU protein. It seems
more related to a pathogenic Nocardia then to other rhodococci enzymes. From those Rhodococcus species
carrying two GalUs, a second branch is formed in which the protein RoGalU1 clusters. Another branch
within corynebacterial representatives is formed by GalUs of the genera Gordonia, Mycobacterium and
Corynebacterium. And another more distant group of the actinobacterial GalUs contains enzymes
of the genera Streptomyces, Kineococcus and Arthrobacter. Interestingly, Arthrobacter also has strains
carrying two isoforms of GalU proteins, but they form a group far from the Rhodococcus proteins.
A similar behavior is present in the group of proteobacterial GalUs including some annotated but also
experimentally verified GalFs. Here the enzymes are arranged according to their phylogenetic relation
as expected. However, E. coli and Erwinia amylovora each encode two related proteins which form
distinct branches.
As the branch of proteins named GalU2 also contains other actinobacterial GalUs only having
one GalU isoform, it is possible that GalU2 is the older protein with the initial function in the genus
Rhodococcus. Thus, GalU1 might have evolved from GalU2 and gained the function of a UDP-glucose
pyrophosphorylase. But the genetic environment of the respective coding genes does not support
this hypothesis. The genetic environment of RogalU1 is more related to the sugar metabolism with
sugar-phospho transferases and sugar-phospho isomerases, whereas the genetic environment of
RogalU2 comprises many putative and for the sugar or amino metabolism unspecific genes. It consists
of different genes coding for cation and phosphate channels, transmembrane proteins, conductance
and mechanosensitive channels, acting as an osmotic release valve in response to osmotic stress, as well
as ATP converting enzymes and heat shock proteins. Interestingly, the gene cluster of RogalU1 is only
available in R. jostii RHA1, whereas the gene cluster surrounding RogalU2 is present in many other
Actinobacteria, like N. farcinica, M. smegmatis, M. tuberculosis, C. glutamicum, among others. Therefore,
the RogalU2 cluster seems to be the more common one for Actinobacteria.
Interestingly, RoGalU2 has 99% amino acid sequence identity to the GalU regulator GalF of R. opacus
PD630. However, this GalF designation for strain PD630 is based only on a bioinformatic annotation
and no other galU gene is present in the genome of R. opacus PD630. Thus, this protein must also be
an UDP-glucose pyrophosphorylase and not a regulatory element. RoGalU1 only has 83% sequence
identity to this mentioned protein of R. opacus PD630. Thus, it seems likely that the protein more related
to our RoGalU2 is of importance for rhodococci, which will need to be verified by further studies and
representatives. GalF of E. coli only has a slight residual UDP-glucose pyrophosphorylase activity.
E. coli GalF showed a drastically increased activity and substrate specificity for glucose 1-phosphate
when exchanging the methionine in position 15 into a threonine and the histidine in position 16
into an arginine (both within the G-X-G-T-R-F-P-L motif of GalUs), which are the corresponding
residues in E. coli GalU [19]. In the sequences of RoGalU1 and RoGalU2, there is no alteration in
the G-X-G-T-R-F-L-P motif. Thus, a regulatory role among the Rhodococcus proteins is excluded at
this stage.
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The underlying alignment of the distance tree shows that GalU enzymes in general are very
conserved among bacteria, and that the degree of conservation within Actinobacteria is even higher.
The first 100 amino acids are almost fully conserved with only some exceptions. As the two largest
conserved areas of all shown sequences are around the motifs for substrate and product binding, it is
obvious that the reaction mechanism is very likely the same in all bacterial GalU enzymes. It is striking
that there are also four more motifs and several single amino acids which are highly conserved among
bacterial GalU sequences. The tyrosine of the G-R-Y-L-L motif and the leucine in the Q-L-T-D-A motif
are also mentioned by Aragão et al. to form a hydrophobic cap to the base of the sugar ring in the
active site [9]. It could be possible that the other motifs and amino acids are not only important for
the structure formation, like establishing the subunit interaction, but also for the construction of the
active site, the binding of substrate and product or even the binding of magnesium ions as cofactors.
They could help to stabilize the nucleophilic attack of glucose 1-phosphate to UTP or to bring the active
site in the right conformation when the substrates are bound.
Hence, both genes RogalU1 and RogalU2 were successfully cloned into expression systems and
protein production for a subsequent biochemical characterization was studied. It was not possible to
produce active and soluble RoGalU1. In addition, the inclusion bodies obtained had only a low residual
enzyme activity. Neither the optimization of medium or expression conditions nor the renaturation
of wrongly folded protein lead to soluble and active RoGalU1. Inclusion bodies can be avoided or
reduced by different methods. Reduction of the expression temperature to 14–16 ◦C or even lower,
reduction of the expression time or ITPG concentration could possibly increase the amount of soluble
active protein [54]. Also, co-expression of the gene of interest with chaperones, are reported to help
folding the protein in the right way [55]. The production of a fusion protein with mCherry or other
suitable proteins can increase the protein solubility as well [2]. The sole production of inclusion bodies
of a GalU from M. tuberculosis could be overcome by using an expression system which was more
related to the donor organism, so gene expression was achieved in competent M. smegmatis cells and
the mycobacterial specific expression vector pMIP12 for improved gene expression [51].
RoGalU2 was successfully overproduced and purified in reasonable amounts compared to
literature, but with a higher yield of insoluble recombinant RoGalU2, as well [13]. SDS-PAGE revealed
the expected molecular weight of about 34 kDa. Within bacteria this molecular weight corresponds to
that of other GalUs [12,13,56]. The oligomeric state of the protein was determined to be hexameric by
size-exclusion chromatography. But the other known bacterial GalUs were shown to be dimers [10,31]
or tetramers [8,9,12,17,30]. Only Lai et al. reported the GalU of M. tuberculosis strain H37Rv to be
dimeric and hexameric in solution [13]. As the latter one is closely related to our target RoGalU2 this
fits well to our findings (Figure 2). But we did observe a hexameric state under applied conditions,
which can be studied in more detail by altering the buffer or presence of divalent ions through the
size exclusion chromatography. Respectively, the presence of a protein in a single hydrodynamic state
allowed us to study the biochemical properties in more detail.
RoGalU2 with a Vmax of 177 U mg−1 (UTP) and 119 U mg−1 (G1P), respectively, has a high activity
compared to other bacterial GalUs. Many other bacterial GalUs show activities between 0.1 U mg−1
for M. tuberculosis GalU [13] and 90 U mg−1 for Xantomonas campestris [31]. Similar or slightly higher
activities for bacterial GalUs are known as well, like 270 U mg−1 for Streptomyces coelicolor GalU [10]
and 340 U mg−1 for E. coli GalU [19]. Higher activities are only known from eukaryotes [24,57,58].
RoGalU2 also showed a high apparent turnover frequency (app. kcat) with 96 s−1. But this value is
very heterogeneous among bacteria, showing lower, similar and higher turnover frequencies [13,19,30].
An overview on bacterial GalU enzymes is provided in Table 2.
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Table 2. Kinetic properties of UDP-glucose pyrophosphorylases used for the phylogenetic analysis.
Units are given in brackets in the table head, unless otherwise indicated.
Organism and Protein
Vmax [U mg−1] Km [mM] kcat [s−1] c [mM] Ref.
UTP G1P UTP G1P UTP G1P UTP G1P










E. coli K-12 GalU 340 0.17 0.035 187 2 2 [19]
E. coli K-12 GalF 0.015 0.36 0.52 0.008 2 2 [19]
M. tuberculosis H37Rv GalU 2.5–2.7
3





4 55.034 0.001–0.014 0.008–0.054 [13,51]
E. amylovora CFBP 1430 GalU 14.4 32.5 0.027 0.007 7.9 17.2 0.006–0.1 0.003–0.1 [30]
S. coelicolor A3 (2) GalU 270 >10 0.06 149 ≤20 n.s. [10]
B. bifidum PRL2010 GalU 13 0.042 0.098 12 0–2 0–2 [59]
X. capestris pv. campestris str. 8004 GalU 60–90 0.21 0.06 40 n.s. 0-8 [31]
X. axonopodis pv. citris str. 306 GalU 60–90 0.11 n.s. 29 n.s. n.s. [31]
S.thermophilus LY03 GalU 0.2 n.s. n.s. 0.11 1.25 1 [32]
1 for glucose-1-phosphate concentrations up to 10 mM; 2 for glucose-1-phosphate concentrations between 10–500 mM;
3 [51]; 4 [13]; n.s.: not specified; The Km and kcat values in case of RoGalU2 are apparent values, see Table 1.
The maximum activity was observed between 40 ◦C and 45 ◦C and the protein was stable up to
45 ◦C. The enzymatic activity drastically decreased after an incubation for 30 min at higher temperatures.
Other GalUs have temperature optima around only 37 ◦C [60,61]. Only nucleotidyltransfrases of
thermophilic bacteria and Archaea have a higher temperature optimum [62,63] and a half-life of
30 min at 95 ◦C [36]. However, RoGalU2 originates from a mesophilic Actinobacterium, R. opacus
1CP, which grows best at 30 ◦C. Thus, this temperature optimum was not expected for a metabolically
relevant enzyme. Only two other enzymes of this strain showed a higher temperature activity or
stability so far; a flavin-dependent monooxygenase [64] and membrane-linked isomerase [65].
The use of magnesium sulfate with respect to UDP-glucose pyrophosphorylases was not described
in literature before. Here we show the definite dependency on magnesium ions and an activity increase
to 180% when using sulfate as anion instead of chloride. The total electronegativity of sulfate is higher
than of chloride, which could be advantageous for charge neutralization and coordination of the
phosphoryl oxygen. This could then help binding UTP and implementing the nucleophilic attack,
which is the base for the proposed reaction mechanism (Scheme 2) [17,18]. Another possibility is
that the sulfate variant of magnesium salt forms a more stable complex with UTP than the chloride.
As Kleczkowski already reported, those complexes could be the actual substrates for GalUs and that
free UTP inhibits the reaction when present in too high concentrations [66]. This is in agreement
to our kinetic study in which substrate inhibition was determined at higher UTP concentrations
(Figure 9). Furthermore, this is supported by the results obtained by the variation of magnesium
salt concentration. There the activity of RoGalU2 decreased rapidly when the concentration of the
magnesium salt was higher than 1–2 mM. It is likely that the activity increases when both, the cofactor
and UTP, are fed in equimolar concentrations. But an experimental set up will need to verify this
hypothesis. Other groups did not report the occurrence of substrate inhibition. Here, we describe a
substrate inhibition for both, glucose 1-phosphate and UTP. The only report showing a similar behavior
of a GalU enzyme at increasing glucose 1-phosphate concentrations is for the enzyme from potato by
Gupta and colleagues [57]. But it has to be noted that the tested glucose 1-phosphate concentration
range was quite small (0.05–1 mM) and the activity still increased at 1 mM [57].
GalUs show activities with the same divalent metal ions that were tested with RoGalU2 and also
the same degree of inhibition by EDTA [12,36,63,67]. Thus, a clear preference for Mg2+ is demonstrated
for all GalU enzymes.
The literature reported pH range tolerated by GalUs is huge, between pH 5.5 and pH 10.0, but the
optimum is often found around pH 7.5 [13,36,63,67]. RoGalU2 behaves expectedly with a pH optimum
of around 7.5, depending on the buffer. However, it maintains a comparable high activity up to a pH
of about 9 and thus behaves as many GalU enzymes.
RoGalU2 accepts UTP and dTTP as nucleotides, as well as glucose 1-phosphate and galactose
1-phosphate as sugar phosphates. Substrate promiscuity is known for some GalUs, whereas some
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are very specific [39]. Indeed, it has been reported that GalUs from S. coelicolor, Salmonella enterica,
Sphingomonas elodea, and E. coli are able to accept both UTP and dTTP as substrates [10,40,68,69],
whereas for example the GalU from Helicobacter pylori is specific only for UDP [17]. It has been shown
for H. pylori that configuration of the active site prevents a thymine from binding due to steric clashes
with a methionine residue (M105) [17]. Superposition of a RoGalU2 homology model, produced
using SWISS-MODEL [70,71], with the crystal structure from H. pylori in complex with UDP-glucose
(pdbID 3JUK, [17]) shows that RoGalU2 does not have a methionine but a proline residue in the
designated position. This observation is similar to what has been reported for S. elodea and E. coli
GalUs having a proline and an alanine, respectively, at that position and also being active towards
dTTP [39]. Furthermore, RoGalU2 is also able to take galactose 1-phosphate as a substrate, but the
enzyme is less active (only 2% residual activity), as was observed for S. elodea and E. coli GalUs [30].
It has been suggested that this less favorable binding of galactose 1-phosphate is due to the loss of
the H-bond formed between the glucose 1-phosphate and the main-chain nitrogen atom of a glycine
residue (Gly179 E. coli and Gly180 in RoGalU2 homology model) [39].
Having all this in mind and the optimal conditions for RoGalU2 experimentally verified, we
could use this knowledge to obtain a maximum observed activity value for this UDP-glucose
pyrophosphorylases in the direction of UDP-glucose formation (Figure 11). Under optimal conditions
the activity of RoGalU2 was 270 U mg−1, which is an increase in activity of about 37%. Thus this
enzyme is among the most active GalUs of bacteria and might be interesting to be studied for various
biotechnological applications described recently [72].
Figure 11. RoGalU2 activity of the improved activity assay compared to an assay with optimal reaction
conditions. Reaction solution for improved test contained 1.5 mM UTP, 250 mM glucose 1-phosphate,
1 mM MgCl2, 50 mM Hepes, pH 7.4, 1.7 μg RoGalU2. Reaction was carried out at 42 ◦C in 1 mL scale.
Reaction solution for optimal test contained 1.5 mM UTP, 250 mM glucose 1-P, 1 mM MgSO4, 50 mM
Imidazol, pH 7.4, 1.7 μg RoGalU2. Reaction was carried out 43 ◦C in 1 mL scale. Means with standard
deviations are shown (triplicates).
4. Materials and Methods
4.1. Bacterial Strains, Plasmids, and Gene Synthesis
Protein sequences of the UDP-glucose pyrophosphorylases RoGalU1 and RoGalU2 of Rhodococcus
opacus 1CP were taken from the NCBI accessions ANS26426 (RoGalU1) and ANS26629 (RoGalU2),
respectively. The corresponding genes RogalU1 (914 bp) and RogalU2 (932 bp) used in this study
were codon usage optimized to increase the expression level in E. coli and synthesized by Eurofins
Genomics (Ebersberg, Germany) with flanking restriction sites of NdeI and NotI (GenBank accession
numbers of the codon usage optimized nucleotide sequences of RogalU1: MN617759 and RogalU2:
MN617760). Both genes were delivered in separate vectors (pEX-A2). They were cloned into the
expression vector pET16bP (5740 bp) carrying a resistance against ampicillin, a DNA sequence that
allowed the production of the GalU proteins with an N-terminal Histidine10-tag and an additional
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DNA sequence for the gene expression induction with isopropyl β-D-1-thiogalactopyranoside (IPTG)
(see Table 3).
Table 3. Strains, plasmids, and primers used in this study.
Sample Relevant Characteristics Source, Reference
Strains
R. opacus 1 CP
Benzoate+, 4-hydroxybenzoate+, 3-chlorobenzoate+, phenol+, 4-chlorophenol+,
2,4-dichlorophenol+, 2-chlorophenol+, 3-methylphenol+, 4-methylphenol+,
phthalate+, isophthalate+, n-alkanes+ (C10-C16), styrene+
[64,73]
E. coli DH5α fhuA2 Δ(argF-lacZ) U169 phoA glnV44 Φ80 Δ(lacZ)M15 gyrA96 recA1 relA1 endA1thi-1 hsdR17 NEB
1
E. coli BL21(DE3) pLysS fhuA2 [lon] ompT gal (λ DE3) [dcm] ΔhsdS λ DE3 = λ sBamHIo ΔEcoRI-Bint::(lacI::PlacUV5::T7 gene1) i21 Δnin5 NEB
1
Plasmids
pEX-A2 multiple cloning site, Lac-Promoter, pUC origin, Ampr Eurofins 2
pET16bP pET16b with additional multiple cloning site; allows production of recombinantproteins with N-terminal Histidine10-Tag and gene expression induction with IPTG
Wehmeyer 3
pEX-A2-RogalU1 pEX-A2 vector with recombinant UDP-glucose-pyrophosphorylase gene 1 of R.opacus 1 CP (RogalU1) 914 bp, NCBI protein accession: ANS26426 This study
pEX-A2-RogalU2 pEX-A2 vector with recombinant UDP-glucose-pyrophosphorylase gene 2 of R.opacus 1 CP (RogalU2) 932 bp, NCBI protein accession: ANS26629 This study
pET16bP-RogalU1 pET16bP vector with recombinant UDP-glucose-pyrophosphorylase gene 1 of R.opacus 1 CP (RogalU1) This study
pET16bP-RogalU2 pET16bP vector with recombinant UDP-glucose-pyrophosphorylase gene 2 of R.opacus 1 CP (RogalU2) This study
Primer
pET16bP-fw 5’ - CATCACAGCAGCGGCCATATCGAAG - 3’ This study
pET16bP-rev 5’ - CAGCTTCTTTTCGGGCTTTGTTAG - 3’ This study
1 New England Biolabs Inc. or 2 Eurofins Genomics as a commercial source. 3 personal communication by
U. Wehmeyer.
4.2. Protein Production
Transformation of E. coli BL21(DE3) pLysS was carried out as recommended by New England
Biolabs Inc. (Ipswich, Massachusetts, USA).
Protein production was realized in a 1 L scale in a Fernbach flask in standard LB medium
(lysogenic broth: 10 g L−1 trypton, 5 g L−1 yeast extract, 10 g L−1 sodium chloride) with 100 mg L−1
ampicillin as well as 50 mg L−1 chloramphenicol. Expression cultures were inoculated 1:50 with
an overnight pre-culture at 37 ◦C of E. coli BL21(DE3) pLysS-pET16bP-RogalU1 or E. coli BL21(DE3)
pLysS-pET16bP-RogalU2 in the same medium used for the expression culture. The main culture was
incubated for about 2 h at 37 ◦C until an OD600 of 0.2–0.3 could be observed. After cooling down to
20 ◦C, the gene expression and thus protein production started after induction with 0.5 mM isopropyl
β-D-1-thiogalactopyranoside (IPTG) at an OD600 of 0.3–0.4.
The large-scale protein production was performed in an analog manner in a 10 L Eppendorf
bioreactor in TB autoinduction medium [74] with the same concentrations of antibiotics and inoculation
culture as described above.
After 22 h the protein production was stopped in both cases by harvesting the cells at 4 ◦C and
5000× g for 30 min. After washing with 25 mM sodium phosphate buffer, pH 7.1, pelleted cells were
frozen and stored at −80 ◦C in portions of about 25 g of wet biomass.
4.3. Purification of Recombinant Proteins
For purification 25 g of pelleted cells were thawed as fast as possible in a warm water bath and
mixed gently with 25 mL of a buffer containing the following compounds: 25 mM sodium phosphate
buffer, pH 7.1, 100 mM sodium chloride, 1 mM magnesium chloride, 240 U of DNase I and 20 mg
of lysozyme. After incubation at 30 ◦C for 45 to 60 min the cells were sonicated 10 times for 30 s
with an intensity of 70% (Bandelin Sonoplus HD 2070, MS 72) and centrifuged at 12,000× g at 4 ◦C
for 20 min. Another two centrifugation steps with the supernatant followed at 4 ◦C, 50,000× g for
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30 min, each. The clear supernatant was filtered through 0.45 μm and 0.2 μm filter, respectively,
before purification with an Äkta Prime Plus FPLC system with 5 mL HisTrap HP nickel column
(GE Healthcare) with a flow of 5 mL min−1. For equilibration of the affinity chromatography column
a buffer containing 25 mM sodium phosphate buffer, pH 7.1, 300 mM sodium chloride and 25 mM
imidazole was used. Protein loading was performed with equilibration buffer containing 25 mM
imidazole. Unspecific proteins were washed off the column with equilibration buffer containing 40 mM
imidazole. Protein purification was then performed by applying a linear gradient from 40–500 mM
imidazole in this buffer in a course of total 10–20 mL elution, depending on the injection volume.
The protein of interest was eluted at 500 mM imidazole.
Fractions that showed UDP-glucose pyrophosphorylase activity were pooled and precipitated
with 80% saturated ammonium sulfate solution. The precipitated protein was dissolved and stored
in a buffer of 50 mM Hepes, pH 7.0, 100 mM sodium chloride and 1 mM magnesium chloride.
Protein aliquots were stored at –80 ◦C for long term storage or at 4 ◦C for short term storage and had
concentrations of about 2–8 mg mL−1.
Here, it needs to be mentioned that RoGalU2 has a very low extinction coefficient due to the low
amount of aromatic amino acids in the polypeptide chain and thus purifying by following the UV/VIS
trace was somewhat difficult.
4.4. Renaturation of RoGalU1
Isolation of inclusion bodies and renaturation of the wrongly folded RoGalU1 was realized
with the Thermo Scientific Pierce Protein Refolding Kit according to the manufacturer’s instruction,
but without any EDTA in the buffers or solutions. The RoGalU1 concentrations for the renaturation
were 1 mg mL−1 and 10 mg mL−1, respectively.
4.5. Protein Determination
Determination of the protein concentration was done as described before by Bradford [75] with a
bovine serum albumin (BSA) standard. Identification of the proteins was performed by determination
of the molecular weight with sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
and coomassie staining [76]. Furthermore, the oligomeric state of the proteins was determined by
size exclusion chromatography using a 24 mL Superdex 200 10/300 GL column (GE Healthcare),
the manufacturers protocol and a calibration standard mix containing Ferritin, Conalbumin,
Carbonic Anhydrase, Ribonuclease, and Aprotinin. Dextran Blue was used to determine the
void volume of the size exclusion column. The buffer that was used for this method contained
50 mM Hepes, pH 7.0 and 1 mM magnesium chloride and was the same as used for the most
characterization experiments.
4.6. Enzyme Activity Assay
The specific enzyme activity of RoGalU1 and RoGalU2 was measured only in the direction of
UDP-glucose formation in a reaction volume of 1 mL. The following assay composition was used
in this work mostly and thus designated as standard test. The reaction solution for initial activity
measurements contained 2 mM UTP, 2 mM glucose 1-phosphate, 4 mM magnesium chloride, and 50 mM
Hepes, pH 7.0. Pre-incubation of the reaction samples was done for 15 min at 30 ◦C and the reaction
was started by addition of 30 μg of enzyme, unless otherwise indicated. Samples of 100 μL were taken
after defined time points to determine the initial reaction rates. Therefore, the reaction was stopped by
adding 100 μL acetonitrile and vortexing in order to denature proteins. After centrifugation for 2 min
at 20,000× g 100 μL of the clear supernatant were used for HPLC analysis.
In order to characterize GalU enzymes the above described standard assay was altered with
respect to buffer, pH, temperature and various other additives during experimentation and to find
optimal reaction conditions.
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The enzyme activity is expressed as U mg−1. Respectively, 1 U corresponds to the formation of
1 μmol UDP-glucose per minute. This value is then referred to the amount of enzyme in the assay.
4.7. Product Determination by HPLC for Specific Enzyme Activity Evaluation
HPLC measurement was performed with a Thermo Scientific Dionex Ultimate 3000 with UV/VIS
detector and Macherey-Nagel EC 150/4.6 Nucleoshell HILIC column with a particle size of 2.7 μm.
For determination of UDP-glucose formation an isocratic chromatography program was used with
70% acetonitrile and 30% 134 mM ammonium acetate, pH 5.35 at a flow of 1.3 mL min−1 and an
oven temperature of 30 ◦C. Detection of UDP-glucose was done at a wave length of 260 nm with an
injection volume of 5 μL. Calibration was carried out with appropriate concentrations of a UDP-glucose
standard under the same conditions.
For data evaluation and calculation of product formation the area of the UDP-glucose peak was
used and referred to the time point of the enzyme assay to obtain an initial rate. Those rates were
plotted according to the enzyme kinetic models for analysis.











have been used. Equation (1) was used for non-limiting conditions and 2 for the cases of substrate inhibition.
5. Conclusions
The biochemical characterization of UDP-glucose pyrophosphorylases has been reported for
several organisms. Here, we described the first characterization of a UDP-glucose pyrophosphorylase
from a Rhodococcus strain that contained two isogenes coding for GalUs. Based on phylogenetic
analyses and activity data obtained it seems obvious that RoGalU2 represents the metabolically active
enzyme, whereas the role of RoGalU1 remains enigmatic and needs to be investigated. Furthermore,
the activity of RoGalU2 is higher than that of some other reported GalUs, but the use of conventional
kinetic models is limited. Therefore, further biochemical investigation will be necessary. In addition,
this is the first report of the use of magnesium sulfate as metal cofactor. The sulfate salt of magnesium
was able to double the activity of RoGalU2. A maximum activity of RoGalU2 of about 270 U mg−1 was
determined which renders it a candidate for further biocatalytic investigations.
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Abstract: Muramidases/lysozymes are important bio-molecules, which cleave the glycan backbone
in the peptidoglycan polymer found in bacterial cell walls. The glycoside hydrolase (GH) family
22 C-type lysozyme, from the folivorous bird Opisthocomus hoazin (stinkbird), was expressed in
Aspergillus oryzae, and a set of variants was produced. All variants were enzymatically active,
including those designed to probe key differences between the Hoatzin enzyme and Hen Egg White
lysozyme. Four variants showed improved thermostability at pH 4.7, compared to the wild type.
The X-ray structure of the enzyme was determined in the apo form and in complex with chitin
oligomers. Bioinformatic analysis of avian GH22 amino acid sequences showed that they separate out
into three distinct subgroups (chicken-like birds, sea birds and other birds). The Hoatzin is found in
the “other birds” group and we propose that this represents a new cluster of avian upper-gut enzymes.
Keywords: lysozyme; peptidoglycan cleavage; avian gut GH22; crystal structure
1. Introduction
Peptidoglycans are unique to prokaryotic organisms and consist of a glycan backbone of muramic
acid and glucosamine (both N-acetylated), cross-linked with peptide chains. In Gram-positive bacteria
(e.g., Staphylococcus aureus) the glycan backbone is highly cross-linked, while it is only partially
cross-linked in Gram-negative bacteria, such as Escherichia coli. The cross-linking amino acid chain
contains L-alanine, D-glutamic acid, meso-diaminopimelic acid, and D-alanine in E. coli, or L-alanine,
D-glutamine, L-lysine, and D-alanine, with a five-glycine interbridge between tetrapeptides, in the
case of S. aureus [1]. The unique composition of both the carbohydrate polymer and the peptide
cross-linker means that only specialised enzymes can hydrolyse peptidoglycans. Lysins (amidases,
lysozymes/muramidases and peptidases) are such specialised bio-molecules. The term lysozyme, or
muramidase, is broadly used to describe the enzymes that cleave the β-1,4-glycosidic bond between
N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM) (or vice versa) in the carbohydrate
backbone of peptidoglycan, Figure 1.
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Figure 1. The cleavage site of the cell wall glycan by lysozyme/muramidase.
In nature, the β-1,4 bonds of peptidoglycan are cleaved by a structurally diverse set of enzymes.
Lysozymes/muramidases (EC 3.2.1.17) are found in several glycoside hydrolase families in the
Carbohydrate-Active enZYmes Database (CAZy, www.cazy.org [2]), including GH18, 19, 22, 23, 24,
25, 73 and 108, some of which, such as GH25, remain largely uncharacterized biochemically. While
the first three families have very low sequence identities, they do have some common structural
features, consisting of a constant core of two helices and a three-stranded β-sheet that accommodates
the substrates in the inter-domain cleft [3]. Higher organisms typically have enzymes from several
GH families, e.g., Gallus gallus has at least three from GH18, GH22 and GH23. An excellent review of
“Lysozymes in the animal kingdom” [4] summarises a wealth of information on the enzymes, and their
classification into subfamilies—lysozymes C (chicken-type, the archetypal lysozymes), G (goose-type)
and I (invertebrate). Subfamilies C and I are both grouped in CAZy family GH22, while G is in GH23.
CAZy has over 700 entries for GH22, almost all from Eukaryota, but the 3D structure has only
been determined for about 25 species. The most well-known is the C-type lysozyme from G. gallus
(chicken), commonly called Hen Egg White Lysozyme (HEWL), which is almost synonymous with
lysozyme. The deposited structures are dominated by the enzymes from chickens and Homo sapiens.
While the overall amino acid sequences identity is quite low, the structural similarity of the C-type
lysozymes is very high. A partial explanation for this is assumed to be due to the four conserved
disulphide bridges, that ensure a compact and rather rigid 3D arrangement.
The structure of HEWL revealed the GH22 fold [5] to be a α + β motif, made up of five α-helical
regions and five containing β-strands, with two catalytic groups, Glu35 and Asp52. The active site
consists of six subsites (originally termed A, B, C, D, E and F, but now more generally named −4, −3,
−2, −1, +1 and +2) [6], which bind up to six consecutive sugar residues. The glycosidic bond between
the N-acetyl muramic acid (NAM) at subsite −1, and the N-acetyl -glucosamine (NAG) at subsite +1, is
weakened by steric distortion of the sugar ring in subsite −1, and is the target of the hydrolytic cleavage.
In 2001, experimental evidence for the correct working mechanism of HEWL was finally established [7],
with the hydrolysis of the β-(1,4)-glycosidic bond occurring through a double displacement reaction.
This mechanism is believed to apply to all members of this very broad class of enzymes.
HEWL has over 25 years of recorded use in wine and cheese making [8], and, classically
C-type GH22 lysozymes have been known to act as antimicrobials, or at least as microbial growth
inhibitors [9,10]. In addition, some mammalian (typically ruminant) GH22s have been proposed to
have a digestive role in the stomach, where they could degrade bacteria after the front-gut fermentation
process [11]. More recently, lysozymes have been proposed to modulate the bacterial flora and to
digest bacterial cell wall debris, thereby affecting the immune system [12].
If selected lysozymes could be expressed in a heterologous host, suitable for industrial production,
these could be used in applications where peptidoglycans are present and their elimination would
be useful (such as biofilms, washing and nutritional supplements). For a long time, the literature
indicated that lysozymes were difficult to express in such hosts. In particular, the group of David
Archer at the University of Nottingham published more than 10 papers on the heterologous expression
of HEWL and human lysozyme in Aspergilli [13] and, indeed, in Pichia, albeit with limited yields being
obtained. Furthermore, the lack of gastric stability has been a hindrance for commercializing HEWL as
an animal feed additive.
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With the aim of expressing a digestive lysozyme in a suitable fungal host, the literature was
scanned for a GH22 C-type lysozyme with high stability at low pH (gastric conditions). Earlier reports
had indicated the extraordinary stability of the digestive lysozyme from Opisthocomus hoazin at low
pH [14], and the corresponding cDNA sequence (Genbank entry AAA73935.1) had been published [15].
O. hoazin, known as the Hoatzin, or stinkbird, lives in parts of the rainforest in South America.
The Hoatzin is unique in being the only known bird with crop fermentation in the foregut [15,16].
A recent review of avian crop function covers the importance of digestion in bird species [17]. In some
respects, digestion in the Hoatzin gut seems more like that of ruminants than other folivorous birds,
and is derived from the morphological and microbiological environment in the digestion tract [14].
Both ruminants and Hoatzins express high levels of gastric lysozyme and use fermentation in their
foregut. This enables the Hoatzin to take advantage of energy from both the cellular content and
the cell wall polysaccharides of hydrolysed bacteria [18]. Lysozyme is an important element of the
Hoatzin’s digestion system, wherein the digestive tract of the Hoatzin can also be found. Based on the
predicted amino acid sequence, HEWL and O. hoazin lysozyme (henceforth OhLys) have very different
isoelectric points. As a result, quite different properties for their selectivity might be expected.
We here report the successful cloning and expression in Aspergillus oryzae (NCBI:txid90341) of a
synthetic gene, corresponding to OhLys. Mutational studies were applied to modify the activity and/or
stability of OhLys. In addition, we have determined the crystal structure of the apo enzyme and of
complexes with reaction products (chito-oligosaccharides). This is the first structure of an avian GH22
lysozyme/muramidase outside the chicken-like sub-group.
2. Results
2.1. Expression of OhLys and Variants in Aspergillus
HEWL, the best characterized GH22, shows a surprising level of promiscuous chitinolytic
activity [19]. As the Aspergillus fungal cell wall consists mainly of chitin, expression of an enzyme
with chitinase activity may be expected to counter-select high-level expressing transformants. Indeed,
Archer et al. previously concluded that proteolysis occurs in HEWL between Gly49 and Ser50 when it
is expressed in A. niger [20]. In contrast, our results show that OhLys can be expressed at a reasonable
level (about 1 g/L) in A. oryzae, with about 30 variants being produced and shown to be active in the
turbidity assay.
2.2. Crystal Structure of the Apo Enzyme and Its Chitotriose Complex
Crystals of the apo enzyme belong to the orthorhombic space group P212121 with one molecule
in the asymmetric unit, Table 1. As expected, OhLys has a typical GH22 lysozyme fold (Figure 2).
The chain was traced from Glu1 through to Cys126, with a glycerol from the cryoprotectant, four
Cl− ions and 200 water molecules. There are four disulphide bridges (Cys6–Cys126, Cys30–Cys114,
Cys63–Cys79 and Cys75–Cys93) in the structure.
Table 1. Crystallographic statistics.
Data Collection (a)
Data set Apo-Native Mutant Ligand complex
Beamline I02 I04
Wavelength (Å) 0.9795 0.9795
PDB code 6T5S 6T6C
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Table 1. Cont.
Data Collection (a)
Resolution range (Å) 42.02-1.5 (1.53–1.50) 42.21-1.25 (1.27–1.25)
Number of reflections 109904 304278
Unique reflections 21950 38043
Monomers in asymmetric unit 1 1
Completeness (%) 99.8 (97.1) 99.9 (99.1)
<I/σ(I)> 12.3 (1.9) 13.4 (2.8)
CC1/2 (b) 0.998 (0.646) 0.998 (0.535)
Multiplicity 5.0 (3.2) 8.0 (4.5)
Rmeas (c) 0.082 (0.637) 0.111 (1.013)
Refinement statistics
Fraction of free reflections 0.050 0.050
Final Rcryst 0.116 0.108
Final Rfree 0.166 0.134
R.m.s. deviations from ideal geometry (target values are given in parentheses)
Bond distances (Å) 0.015(0.013) 0.018(0.013)
Bond angles (◦) 1.74 (1.64) 2.19 (1.71)
Average main chain B values (Å2) 12.5 9.1
Average side chain B values (Å2) 16.1 13.3
Average B values for Ligand (Å2) - 25.5
Molprobity score 1.85 1.94
Ramachandran favoured (%) (d) 95.16 96.03
Ramachandran outliers (%) (d) 0.0 0.0
Clash score 6.34 7.77
(a) values in parentheses correspond to the highest resolution shell. (b) CC1/2 values for Imean are calculated by
splitting the data randomly in half. (c) Rmeas is defined as Σ
√
(N/N-1)|I - <I>|/Σ I, where I is the intensity of the
reflection. (d) Ramachandran plot analysis was carried out by MOLPROBITY [21].
Figure 2. The 3D structure of O. hoazin lysozyme (OhLys). (A) OhLys shown as ribbons with the
chitotriose from the complex as ball and stick binding in sites -1 to -3. The position of the catalytic Glu35
and Asp51 (cylinders) are taken from the apo structure. Three key residues which were subsequently
mutated to resemble those in Hen Egg White Lysozyme (HEWL) are also shown as cylinders: Arg50,
Tyr61 and Tyr108. (B) Superposition of the OhLys (blue) on HEWL (yellow).
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The GH22 fold is highly conserved over a range of organisms, as can be seen in Table 2, where the
r.m.s. difference in Cα position over between 112 and 125 residues is between 0.79 and 1.4Å, from
rainbow trout to mouse. The 3D structure is highly conserved; the chains are of very similar lengths
in all species, with almost no deletions or insertions. The structures show a remarkably high level
of similarity, greater than might be expected for the sequence identity, with the r.m.s. difference in
Cα positions showing little correlation with the evolutionary tree for the GH22 lysozymes discussed
below. In part, this likely reflects the conserved set of disulphide bridges in these enzymes. The only
variation is in the so-called calcium loop, at the bottom of the structure in Figure 1, with residues in the
range 45–51, which is displaced in a couple of the structures. This loop is occupied by a sodium ion in
several deposited PDB files. The last two GH22 structures in the Table, from bivalves, show somewhat
more extensive differences in several loops, hence the reduced number of equivalent Cα atoms.
Table 2. The structures of GH22 lysozymes in the PDB and their similarity to OhLys.
Species Common Name PDB Resn. Å RMS Å No. Cα
Oncorhynchus mykiss Rainbow trout 1lmq 1.6 0.78 125
Bos taurus Cow 2z2f 1.5 0.86 125
Homo sapiens Human 133l 1.77 0.87 125
Pelodiscus sinensis Chinese soft-shelled turtle 2gv0 1.9 0.92 125
Tachyglossus aculeatus Australian echidna: Spiny anteater 1jug 1.9 0.93 124
Phasianus colchicus Ring necked pheasant 1ghl 2.1 0.94 125
Coturnix japonica Japanese quail 2ihl 1.4 0.95 124
Mus musculus Mouse 4yf2 2.1 0.97 123
Canis lupus familiaris Dog 1qqy 1.85 1.02 122
Gallus gallus Chicken 3lzt 0.94 1.05 125
Anas platyrhynchos Duck/Mallard 5v8g 1.2 0.98 125
Colinus virginianus Virginia quail: Northern bobwhite 1dkj 2 1.09 125
Equus caballus Horse 2eql 2.5 1.14 123
Bombyx mori Domestic silk worm 1GD6 2.5 1.17 112
Meleagris gallopavo Turkey 135l 1.3 1.18 125
Musca domestica House Fly Lys1 2fbd 1.9 1.19 108
Antheraea mylitta Silkworm 1IIZ 2.4 1.27 112
Numida meleagris Helmeted guidea fowl 1hhl 1.9 1.31 125
Musca domestica House Fly Lys2 3cb7 1.9 1.4 111
Meretrix lusoria Bivalve 3ab6 1.78 2.33 80
Tapes japonica Bivalve 2dqa 1.6 2.36 81
The overall charge of OhLys differs somewhat from that of other C-type lysozymes (Table 3). This
increase in negative charge of OhLys is evident in the surface electrostatics of the enzyme (Figure 3).
While the significance of this is not clear, it should be noted that the peptidoglycan substrate is also a
charged molecule, and that peptidoglycan from different bacterial sources have different pI. So, charge
interactions between the enzyme and the substrate at working pH are probably functionally important.
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Table 3. The number of charged residues and pI for four representative lysozymes. Histidines have
been excluded from the positive set.
OhLys Bovine House Fly HEWL
No. Residues 126 129 122 129
Negative Charge: Asp and Glu 20 15 9 9
Positive Charge: Arg and Lys 13 14 10 17
Ratio (negative/positive) 1.5 ≈1 ≈1 0.5
Total Charged 33 29 19 26
Theoretical pI 5.1 6.5 7.7 9.3
Figure 3. Electrostatic surface charge (red: negative and blue: positive) for OhLys, HEWL, Bovine gut
lysozyme and house fly gut lysozyme, calculated at pH 7.0, within CCP4mg. (A) viewed from the
active site side of the enzymes, (B) from the opposite side. The single clear observation is that the rear
(B) of OhLys carries a substantially higher negative charge. The structures were superposed using the
Gesamt option in CCP4mg. The ligand is taken from the OhLys complex.
Co-crystallisation of the inactive variants of the enzyme with chito-oligosaccharides was partially
successful. Screening for ligand complexes was carried out with the supposed inactive mutants, E35A
and D51A. E35A itself crystallised readily in INDEX screen no. 7 (Hampton Research) in Falcon 24
well plates, producing large, well-diffracted crystals, while it was not possible to obtain crystals from
the D51A mutant. Co-crystallisations of E35A were set up with chitobiose, chitotriose, chitotetraose,
chitopentaose and chitohexaose, and were successful with chitobiose, chitotetraose, and chitohexaose.
The resulting electron density clearly confirmed the Glu to Ala mutation.
The electron density for the crystal soaked in chitohexaose is shown in Figure 4, which shows
excellent density for the −2 and −3 subsite sugars, and good density for −1, with poorly ordered
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density for −4, with a significant difference in density around this subsite. Unfortunately, there is no
density in the +1 subsite—a key aim of the experiment had been to observe sugar bound across the
point of catalysis between −1 and +1. It is evident that the mutant retains a sufficient level of residual
activity to hydrolyse; at the high protein concentrations of a prolonged crystallization, the chitohexaose
substrate to a mixture of the two, three and four membered sugars. The density for the chitotetraose
ligand is essentially identical to this, while the chitotriose only shows binding in sites −1 to −3. Sites
+1 and +2 do appear to be accessible in the structure, and binding of non-hydolysable chitohexaose
analogues, for example, with sulphur replacing the glycosidic oxygens, might prove successful if such
ligands should become available.
Figure 4. Electron density maps for the ligand from the crystal co-crystallised with chitohexaose.
The REFMAC maximum likelihood weighted map, contoured at 1 σ, is shown in blue, the difference
map, contoured at 2.5 σ in green (positive), and red (negative), with phases calculated prior to the
incorporation of any ligand atoms in refinement. The catalytic residues are superposed from the
apo structure.
2.3. Position of OhLys in the GH22 Family Tree: the Avian Gut Enzymes
A bioinformatic analysis of GH22 amino acid sequences shows that vertebrates and invertebrates
separate into different subgroups, and in the vertebrates, avian species separate out into three distinct
subgroups (chicken-like birds, sea birds and other birds), represented in a tree (Figure 5). OhLys is
found in the “other birds” group. We propose that this cluster represents avian upper-gut enzymes
and that there is a physiological reason for this differentiation; one observation is that seabirds and
“other birds” feed their chicks, while the chicken-like group does not. In the chicken-like group, high
amounts of lysozyme are found in the egg. There is, at present, no conclusion as to which avian
lysozymes are digestive gut/crop enzymes. While, for a few (Hoatzin, for example) it has it been firmly
established that the lysozyme functions in the crop, it is of note that the avian “upper gut” group
(including the Hoatzin, Zebra finch, dove and others, Figure 5) lies on a separate branch of the tree
from the avian-egg enzymes, and has conserved changes relative to HEWL. A number of the produced
variants addresses the conserved differences between HEWL and the “upper gut” group (for example,
Arg50, discussed below). We propose that the “upper gut” lysozymes are utilized differently in these
species and that this division will allow for further work regarding the digestive system in birds (and
other organisms) by comparing their GH22s. The sequences of the proposed avian gut lysozymes are
aligned in Figure 6A and the Hoazin sequence compared to HEWL in Figure 6B.
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Figure 5. Phylogenetic tree of avian GH22 lysozymes, marked with different colours for different types
of birds (red: chicken-like, violet: seabirds, and green: “other birds”/“upper gut”). Truncated sequences
were omitted from the analysis and sequences that are more than 98% identical are shown as one entry.
Known 3D structures in the PDB are indicated by coloured squares (green: OhLys and red: pdb). A list




Figure 6. (A) Sequences of the proposed avian gut set of GH22 lysozymes: the SWISSPROT/PDB codes
and full species names are listed in Supplementary Table S1. (B) For comparison, the alignment of
OhLys with HEWL. The sequence numbers correspond to OhLys. Conserved residues are highlighted
in red; conservative changes are shown in red text. There is a single deletion at residue 45 in the OhLys
sequence, and a loss of two amino acids at the C-terminus. The Hoatzin sequence is that reported
from the gene sequencing [15], and does not include the two amino acid insertion after residue 1 in the
OhLys variant. Figure produced using ESPrpt [22]. Three key differences are indicated by * (R50/T51,
Y61/W62 and Y108/V109): each of these residues was mutated from its OhLys amino acid to that in
HEWL, as part of the mutational studies. The first two of these are totally conserved in the avian gut
family in (A), the latter is either Y or V.
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2.4. Properties of OhLys and Variants
2.4.1. The Extended Set of OhLys Variants
In these variants, a kexin-like protease B (kexB) site was introduced between the signal and the
mature region, inserting a lysine and arginine (*1aK *1bR) between residues Glu1 and Ile2 of the wild
type sequence. The variants listed in Table S2 were originally designed to probe a number of properties,
as shown, and, while these were not all characterised in detail, the results of some mutations are briefly
described below.
A selected set of variants was produced in larger amounts, purified and tested for pH optimum, and
thermostability, Tm, was measured using Nano differential scanning fluorimetry (Table 4) (all variants
derived from OhLys-KexB). The data show that R50T is destabilized at both pH 4.7 and 8.0, while D90A
and Y108V are stabilized, especially at pH 8.0. In summary, Arg at position 50 makes OhLys more
stable, while the D90A and Y108V changes to HEWL residues make the enzyme more alkaline-stable.
The latter pair would make these two constructs good candidates for applications requiring high
pH stability.
Table 4. Thermostability, as examined by nanoDSF.
Tm (
◦C) at pH 4.7 Tm (◦C) at pH 8.0
OhLys-KexB wt 65.2 55.4
R50T 59.8 53.3






2.4.2. Retention of Activity of OhLys at Low pH
The pH activity profile on peptidoglycan from Micrococcus lysodeikticus was measured for the
wild-type and a set of mutants. It cannot be guaranteed that this corresponds directly to the activity
on the peptidoglycan found in the real in vivo situation. The pH optimum of the WT OhLys is 4.4,
while the KexB insertion increases this to ~5.0. The optimum remains at 5.0 for the other mutants,
only reverting to ~4.4 for the R50T and Y61W variants. These values should be compared with those
reported earlier for a set of digestive and more typical lysozymes [11], which showed that the optima
for three ruminants were in the range 4.5–5.0, while those for the typical chicken and pig lysozymes
had a broad peak between 6 and 8, with the leaf-eating monkey lysozyme around 5.2. This supports
the acquisition of a low pH optimum for OhLys, as a crop digestive enzyme, which has evolved
independently of the ruminant set.
From the pH curves of the variants (Figure 7) it was clear that almost all constructs with the kexB
insertion had a shift in the pH optimum, from pH 4.4 to about pH 5. It seems likely that this is caused
by the additional positive residues, which increase the pI. Five of the seven variants had higher activity
than the WT, while two had lower. The two variants with the Y61W mutation had the highest activity
compared to HEWL. Variant R50T had significantly lower activity and stability than the WT, and it
seems that activity at pH 5 has almost been eliminated. Arg50 is adjacent to the catalytic Asp51 in the
chain (Figure 8) and its sidechain is hydrogen-bonded to the sidechains of Asp65 and Thr68, and to the
backbone O of Gly47. Both Asp65 and Thr68 are in the loop region from Cys63 to Cys79. Removal
of the Arg50 sidechain will remove these hydrogen bond possibilities and could, therefore, lead to a
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slight rearrangement of this part of the structure, leading to a new position of the catalytic Asp51 and
decreased stability of this part of the enzyme.
  
Figure 7. The pH profiles of wild-type OhLys, the OhLys-KexB wt, and a selected set of variants,
all derived from OhLys–KexB.
Figure 8. The position of Arg50 adjacent to the catalytic Asp51 in the sequence, showing the residues
with which its side chain forms H-bonds, shown as dashed lines.
The two variants with the Y61W mutation had the highest activity. Kumagai and co-workers
mutated Trp62 to His in HEWL, and observed an altered substrate-binding mode [23]. In OhLys,
the corresponding residue is Tyr61, which is found frequently among GH22s, with the Trp almost
exclusively occurring in HEWL. Variant R50T had significantly lower activity and stability.
The low pH optimum and pepsin resistance reported earlier for OhLys (Kornegay et al., 1994 and
Ruiz et al., 1994) were confirmed for the enzyme expressed in A. oryzae. A comparison of activity after
incubation under gastric conditions, between HEWL and OhLys, is shown in Figure 9.
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Figure 9. Activity of (A) HEWL and (B) OhLys measured by the turbidity assay after incubation,
as described above under “In vitro stability of OhLys vs. HEWL under gastric conditions”. OhLys
retains a high level of activity after one hour (close to 100%), while that of HEWL has dropped
substantially. These results refer to WT OhLys.
3. Discussion
The major aim of this study, which was successfully achieved, was to establish a possible alternative
lysozyme to HEWL for application in animal feed, where the low gastric stability of HEWL posed
a major problem for survival in the stomach, so the enzyme could act in the intestine (where most
peptidoglycan is present, either dead or alive). The Hoatzin had been previously described as having
a gastric stable GH22 lysozyme, and, in addition, it is a creature in which the genome had been
sequenced (although more common now, this information is still only available for a limited number
of birds). Expression in a micro-organism is essential for an economically viable commercial product,
so successful overexpression in an Aspergillus oryzae host presents an important advance in this, and
enables protein engineering for modifying properties, such as pH-optimum or T-stability. The results
confirmed that the enzyme showed considerably better gastric stability, key for its potential application,
compared to that of HEWL, reported previously in [11]. The pH optimum of wild type OhLys was 4.5.
While the chicken feed application has been superseded by the development of a GH25 muramidase
into a successful commercial product (BalanciusTM from DSM nutritional products, Kaiseraugst,
Switzerland) [24,25], the observations made for OhLys could be useful in other applications.
With regard to the variants, possibly the most important observation is that a range of mutations
could be made and expressed quite easily, while retaining stability and catalytic activity. The quality of
the experimental analysis of the properties of the mutants was limited by the OD assay, which, while
being a well-established lysozyme analytical tool, is not highly reproducible. The introduction of the
KexB mutation, involving the insertion of two residues *1aK *1bR, increased the pH optimum by one
pH unit, and this remained essentially unchanged in the set of mutants based on this variant. The kexB
mutation was not successful in allowing removal of the N-terminal Glu. Finally, some mutations
appeared to have higher specific activity, and four variants had higher thermal stability.
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Bioinformatic analysis of avian GH22 amino acid sequences shows that they separate into three
distinct subgroups (chicken-like birds, sea birds and other birds). OhLys is found in the “other birds”
group, and we propose that this cluster represents avian upper-gut enzymes and that there is a
physiological reason for this differentiation.
The structure presented here is the first to be determined for the avian upper-gut subset of GH22
lysozymes, and is, as expected, very similar overall to other C-type lysozymes. The close similarity
in the 3D structure for this family—more than might be expected for the sequence similarity—is
assumed to be at least in part due to the disulfide bridges. Indeed, it is notable that the enzymes can be
different, with, for example, low sequence ID and different pH-optima, despite having such similar
structural frameworks. The binding of the ligand in subsites −4, −3, −2 and −1 is typical for this family.
Unfortunately, the “inactive” mutant retained sufficient activity to degrade longer oligosaccharide
substrates, and so the complexes did not span the −1 and +1 sites as planned. However, the long active
site cleft is accessible to ligand in the crystals, which may prove beneficial in future.
In summary, we present the first structure and a ligand complex of a digestive lysozyme from a
new sub-group of GH22s from the avian upper gut. OhLys can be expressed in a production-relevant
host and protein engineering can be performed to optimize the performance.
4. Materials and Methods
4.1. Cloning, Expression and Purification of OhLys
4.1.1. Heterologous Expression of OhLys in Aspergillus oryzae
According to the published Genbank entry (AAA73935.1, [15]) genomic DNA was extracted from
a frozen hoatzin tissue sample provided by the Louisiana State University Museum of Vertebrate
Zoology collection (Opisthocomus hoazin (GenBank® accession number L36032) and the sequence
determined. This was used as a starting point to design an artificial coding region (CDR), which
was adapted to Aspergillus oryzae codon usage. The CDR was amplified by PCR, and cloned into
an expression vector using InFusion cloning. Resulting clones were sequenced on both strands and
transformed into an A. oryzae (NCBI:txi 90341) expression host. Transformants were grown for four
days in yeast extract/Peptone/Mannitol 5 g/3 g/25 g per liter supplemented media in a microtiter plate,
and the expression in the resulting supernatants was evaluated by SDS-PAGE. The best transformant
was spore purified twice.
4.1.2. Fermentation and Purification
The transformant was fermented in shaker flasks at 30 ◦C for 72 h. Culture broths were filtered
through filtration cloth, and, subsequently, through a 0.2 μm filtration unit (Nalgene, Thermo Fisher
Scientific, Waltham, MA, USA) to remove the Aspergillus host. Solid NaCl was added to a final
concentration of 200 mM and the pH was adjusted to pH 5.5 with 20% CH3COOH. The adjusted
enzyme solution was applied to a SP-sepharose FF column (GE Healthcare (Brondby, Denmark)), which
was equilibrated in 50 mM CH3COOH/NaOH, 200 mM NaCl, pH 5.5. The column was thoroughly
washed with an equilibration buffer to remove loosely bound protein. The enzyme was eluted using a
linear NaCl gradient (200 mM to 1000 mM) in 50 mM CH3COOH/NaOH, pH 5.5 over five column
volumes. OhLys eluted as a single peak, and the purity was analysed by SDS-PAGE. The resultant
protein solution was concentrated to 26 mg mL−1 and buffer exchanged into 25 mM HEPES pH 7.5,
using a Vivaspin ((Sartorius, Goettingen, Germany) 10-kDa cut-off concentrator. Edman degradation
on the purified protein indicated an N-terminus, corresponding to the expected (EIIPRCELVK-),
and intact molecule mass spectrometry gave a molecular weight of 14260.4 g/mol (theoretical value
14,260.9 g/mol).
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4.2. Expression of OhLys Variants
In the first variant, a kexin-like protease B (kexB) site was introduced between the signal and
the mature region, inserting a lysine and arginine (*1aK *1bR) between residues Glu1 and Ile2 of the
wild-type sequence. The aim had been to remove the N-terminal glutamate, to avoid pyro-glutamate
formation, but unfortunately no cleavage was observed with kexB, and the result was a construct with
an N-terminal sequence of E-1 K0 R1 I2 I3 P4 R5 C6 E7 L8 V9- (the residues are numbered from -1, so
as to retain the normal mature sequence for the bulk of the chain), instead of the hoped for IIPRCELV-.
This is henceforth referred to as OhLys-kexB.
Subsequent variants were made by established methods (see WO 2012/035103 [26]) starting from
the OhLys-kexB variant, rather than the true wild-type. Variants were transformed into an A. oryzae
host and the expression estimated by SDS-page. Where appropriate, the activity was evaluated using
a turbidity assay, with Micrococcus luteus as substrate (see below). The variants fell into two groups,
described in the following sections. The first aimed to prepare enzymatically inactive constructs for
co-crystallisation with ligands, and the second group targeted changing a number of properties, as
listed in Table S1, including three aimed at key differences between OhLys and HEWL: R50T, Y61W
and Y108V.
4.2.1. Inactive Catalytic Site Variants
Based on the OhLys-kexB variant, four variants (E35A, E35Q, D51A and D51N) of the catalytic
residues E35 and D51 were produced and purified with the methods described above. The aim was to
express an inactive enzyme for co-crystallisation with ligand.
4.2.2. The Extended Set of Variants
An extensive set of variants was created, all starting from the OhLys-kexB variant, and are briefly
summarised in Supplementary Table S1. A key observation was that that all these variants were shown
to retain enzyme activity using the turbidity assay below, supporting the robustness of the OhLys fold.
4.2.3. Preparation of Micrococcus Lysodeikticus Substrate
Before use, M. lysodeikticus cells were resuspended in citric acid/phosphate buffer pH 4.4 in a
concentration of 0.5 mg cells/mL and the optical density (OD) was measured at 540 nm. The cell
suspension was adjusted so the cell concentration equaled an OD540 of 1.0, and the adjusted cell
suspension was stored cold before use. Resuspended cells were used within 4 h.
4.2.4. Turbidity Assay of Activity
The OD-drop assay measures lysozyme activity through a reduction in OD (light scattering) caused
by cell lysis (cell wall hydrolysis), as described in many papers on HEWL [11,27]. Here, the activities
of OhlLys and variants were determined by measuring the decrease (drop) in absorbance/optical
density of a solution of resuspended Micrococcus lysodeikticus ATTC No. 4698 (Sigma-Aldrich M3770),
measured in a spectrophotometer at 540 nm (https://www.sigmaaldrich.com/technical-documents/
protocols/biology/enzymatic-assay-of-lysozyme.html and [28]).
4.2.5. Measurement of Lysozyme Activity in the Turbidity Assay
The lysozyme sample was diluted to a concentration in the range 100–200 mg enzyme protein/L in
citric acid/phosphate buffer pH 4.4 and kept on ice until use. In a 96 well microtiterplate (Nunc), 200 μL
of the substrate was added to each well, and the plate incubated at 37 ◦C for 5 min in a VERSAmax
microplate reader (Molecular Devices, Wokingham, United Kingdom). Following incubation, the
absorbance of each well was measured at 540 nm (start value). To start, the activity measurement
20 μL of the diluted lysozyme samples was added to the 200 μL substrate in each well and kinetic
measurement of absorbance at 540 nm was initiated for a minimum of 30 min, up to 24 h, at 37 ◦C.
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The measured absorbance at 540 nm was monitored for each well, and over time, and a drop-in
absorbance was taken as the drop-in lysozyme activity. To compare results from the turbidity assay,
the samples to be compared were tested in the same experimental run, using the same buffer and
substrate batch.
4.3. Biophysical Properties of OhLys and Variants
4.3.1. pH Optimum of OhLys
pH activity curves between pH 3 and 7 were recorded using the turbidity assay described above,
but with the pH of the citrate/phosphate buffer adjusted to the relevant value. All samples were diluted
to an enzyme concentration of 50 μg/mL. The wild type enzyme, without the KR insertion, had a pH
optimum of pH 4.4.
4.3.2. In Vitro Stability of OhLys vs. HEWL under Gastric Conditions
OhLys and HEWL were incubated for 0, 15, 30 and 60 min in artificial gastric juice (HCl pH 2,
1 mg/mL pepsin, 0.1 M NaCl) at 37 ◦C, and their activity determined using the turbidity assay
described above.
4.3.3. Thermostability of Variants Using Nano Differential Scanning Fluorescence
Nano Differential Scanning Fluorescence (NanoDSF) was performed with a Prometheus NT.48
instrument (NanoTemper Technologies GmbH, München, Germany). Purified OhLys variants (in either
250 mM Na-acetate, pH 4.7, or 20 mM tris(hydroxymethyl)aminomethane, pH 8.0) were loaded into
nanoDSF standard grade capillaries (NanoTemper Technologies GmbH; catalogue number PR-C002)
through capillary action. Three capillaries were filled for each sample. The capillaries were then placed
into the instrument (up to 48 single capillaries can be loaded in a single run) and the laser intensity
required for optimum signal generation was determined. The samples were run with the following
experimental setting: temperature slope 2 ◦C/minute, start temperature 20 ◦C and end temperature
95 ◦C. The data were analysed using the software supplied with the instrument (PR.ThermControl
v2.0.4, NanoTemper Technologies GmbH) and the Tm (for the ratio 350 nm/330 nm).
4.4. Apo-Enzyme Crystallisation and Structure Solution
Crystals of apo-OhLys, the wild-type, not the kexB variant, were grown in 96-well MRC
crystallisation PlatesTM (Molecular Dimensions Ltd.), set up by a Mosquito Nanodrop crystallisation
robot (Molecular Dimensions Ltd.). A total of 150 nl of protein was mixed with 150 nl of mother liquor
solution. Crystals grew in 0.1 M MIB system (malonic acid, imidazole, boric acid), with pH 4.0 and 25%
Peg 3350, corresponding to conditions B1–B4 of the PACT premierTM screen (Molecular Dimensions
Ltd.). Crystals were cryoprotected in a mother liquor solution, incorporating 25% glycerol prior to
flash freezing in liquid nitrogen. Diffraction data were collected at the European Synchrotron Radiation
Facility beamline ID23-1, at 100 K to 1.5 Å resolution.
All computations were carried out using programs from the CCP4 suite [29], unless otherwise
stated. Data were processed with MOSFLM [30,31], and scaled and merged with AIMLESS. The apo
structure was solved by molecular replacement, using PHASER [32], with the coordinates of a human
mutant lysozyme (PDB code: 1gft) as a search model. The starting model was improved manually
using COOT [33], alternating with cycles of REFMAC [34]. The structure was validated using
MOLPROBITY [35] prior to deposition.
4.5. Ligand Complexes Crystallization and Structure Solution
Screening for ligand complexes was carried out with the supposedly inactive mutants, E35A
and D51A, both of which contained the kexB dipeptide insertion. E35A itself crystallised readily in
INDEX screen no. 7 (Hampton Research) in Falcon 24 well plates, producing large, well-diffracted
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crystals, while it proved impossible to obtain crystals of the D51A mutant. Co-crystallisations of
E35A were set up with chitobiose, chitotriose, chitotetraose, chitopentaose and chitohexaose, and
were successful with chitobiose, chitotetraose, and chitohexaose. Crystals were harvested and frozen,
and data were collected at the Diamond Light Source beam line IO4 for all three co-crystals. They
were all isomorphous with those of the apo-enzyme, which was therefore used as the starting model.
There was electron density in the active site of all three structures, but the density did not span the
active site, and was restricted to the −1, −2 and −3 subsites, for a maximum of three monosaccharides.
As the three structures were so similar, only that resulting from the chitohexaose sample was fully
refined. It is assumed that the “inactive” E35A mutant had retained a low level of activity, sufficient to
hydrolyse the longer oligosaccharides during complex formation and/or crystal growth.
For both the apo enzyme and the ligand complex, data collection and refinement statistics are
given in Table 1. Structural figures were drawn with CCP4mg [36].
4.6. Patents
The patent application “Lysozymes” (WO 2012/035103) [26] was based on the protein engineering
work described in this paper.
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Abbreviations
CAZy Carbohydrate-Active enZYmes Database
GH glycoside hydrolase
HEWL HEWL: hen egg white lysozyme
NAG N-acetylglucosamine
NAM N-acetylmuramic acid
OhLys Opisthocomus hoazin lysozyme
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Abstract: Deep Eutectic Solvents (DES) were investigated as new reaction media for the synthesis
of alkyl glycosides catalyzed by the thermostable α-amylase from Thermotoga maritima Amy A.
The enzyme was almost completely deactivated when assayed in a series of pure DES, but as
cosolvents, DES containing alcohols, sugars, and amides as hydrogen-bond donors (HBD) performed
best. A choline chloride:urea based DES was further characterized for the alcoholysis reaction
using methanol as a nucleophile. As a cosolvent, this DES increased the hydrolytic and alcoholytic
activity of the enzyme at low methanol concentrations, even when both activities drastically dropped
when methanol concentration was increased. To explain this phenomenon, variable-temperature,
circular dichroism characterization of the protein was conducted, finding that above 60 ◦C, Amy A
underwent large conformational changes not observed in aqueous medium. Thus, 60 ◦C was set as
the temperature limit to carry out alcoholysis reactions. Higher DES contents at this temperature
had a detrimental but differential effect on hydrolysis and alcoholysis reactions, thus increasing the
alcoholyisis/hydrolysis ratio. To the best of our knowledge, this is the first report on the effect of
DES and temperature on an enzyme in which structural studies made it possible to establish the
temperature limit for a thermostable enzyme in DES.
Keywords: Enzymatic glycosylation; alkyl glycosides (AG)s; Deep eutectic solvents (DES); Amy A;
alcoholysis; hydrolysis; methanol; circular dichroism; protein stability; alpha-amylase
1. Introduction
Alkyl glycosides (AGs) are a class of non-ionic surfactants prepared from renewable agricultural
resources, namely starch and fats or their derivatives [1]. AGs contain a carbohydrate head group such
as glucose, galactose, maltose, xylose, α-cyclodextrin, and a hydrocarbon tail, usually a primary alcohol
of different chain length of saturated or unsaturated nature [2,3]. Their high biodegradability and a low
toxicity make them attractive for many applications such as cosmetics, foods, the extraction of organic
dyes, membrane protein research, and pharmaceuticals [4]. The industrial production of alkyl glycosides
has been typically achieved by traditional organic chemical procedures. However, this strategy requires
multiple protection, deprotection and activation steps, the preparation of an anomerically-pure AG
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requiring high temperature and pressure, as well as the use of toxic catalysts, harmful chemicals,
dangerous solvents, and other harsh conditions that adversely impact the environment and human
health [4,5].
Considering that one of the most interesting properties of enzymes is their regio- and stereo-
selectivity, a biocatalytic approach represents an interesting alternative to cope with this limitation.
Moreover, the reactions are conducted under mild temperature and pH conditions which minimize
side reactions [6–13]. In this context, AGs have been successfully prepared enzymatically, by applying
glycosidases, such as β-galactosidases, β-glucosidases [14], or β-xylosidases [15], among others.
Nevertheless, reports dealing with α-amylases are scarce [1,16–18].
The natural reaction of α-amylases (E.C. 3.2.1.1) is the hydrolysis of internal α-1,4-glycosidic
bonds in starch through a double-displacement mechanism in which a covalent intermediate glycosyl
enzyme is deglycosylated by water [19]. Like all retaining glycosidases, α-amylases can also catalyze
transfer reactions which result from the affinity of alternative molecules other than water as glucosyl
acceptors. Sugars are the most efficient group of acceptors studied (transglycosylation reactions),
but glucosyl residue may also be transferred to alcohols (alcoholysis reactions) [20]. As water
is the natural medium in these reactions, the transfer yield is always limited by the competition
with hydrolysis. Deep eutectic solvents (DES) usually consist of a salt (most frequently quaternary
ammonium salts such as choline chloride) and a complexing agent acting as a hydrogen bond donor
(e.g. urea). Replacing the conventional aqueous solvent by alternative solvents such as DES offers
the possibility to favor transglycosylation activity. Therefore, together with enzyme engineering, a
strategy based on solvent engineering is a promising alternative to improve the synthesis yield of
industrially-relevant alkyl-glycosides.
The aim of this work was to study the effect of DES as alternative reaction media for the α-amylase
catalyzed synthesis of alkyl-glycosides. DES share many characteristics of ionic liquids, including
their capacity to dissolve compounds of different polarities, their availability, and their environmental
friendliness. Recent studies indicate that pure DESs or cosolvents represent “green” alternatives for
reaction media in lipase-catalyzed synthesis [21–23]. Few reports exist, however, on enzymes reactions
other than lipases in DES, as they generally have high viscosities and require temperatures higher
than 50 ◦C, either for melting, or simply to reduce the medium viscosity. Amy A, an α-amylase from
T. maritima, is a stable enzyme, active at temperatures above 80 ◦C, and thus considered particularly
suited for application in DES.
2. Results
In the present work, a series of 12 deep eutectic solvents (DES) were prepared. The selection of
DES was based on viscosity and literature data reporting biocatalytic reactions in the corresponding
solvents. Notably, natural deep eutectic solvents (NADES) without water or choline chloride as a
salt are highly viscous, and therefore, are unsuitable for enzymatic reactions. On the other hand,
Cholinium (Ch+), a natural Generally Recognized as Safe (GRAS) compound, commonly used as a
food additive, is the preferred hydrogen bond acceptor (HBA) [24]. Thus, choline chloride was the
most common HBA selected in combination with hydrogen bond donors (HBD) of different structure:
amides, carboxylic acids, alcohols, and polyols (sugars). The composition of all the assayed DES and
their preparation method are reported in Table S1 in Supplementary Information.
2.1. Screening of DES for Application in α-amylase Catalyzed Reactions and Effect of Water Content on
Enzyme Activity and Stability
While lipases can be used in essentially water-free media or systems with low water activity [25,26],
most enzymes require water for activity [27–31]. In this context, a screening in 2 stages was designed
to evaluate the viability of DESs in Amy A catalyzed reactions. In a first stage, DESs were assayed as
pure solvent and cosolvent in order to define the minimal amount of water required for the reaction.
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In the second stage, the DES or water: DES mixtures were assayed as reaction media for transfer
reactions with methanol as the acceptor substrate, using maltotriose as a glucosyl donor.
To identify the required amount of water for enzyme activity, the 12 selected DES were used as
solvents in reactions containing increasing water concentrations of 0, 5, 10, 25, 50, 75, and 100% (v/v),
with maltotriose as a substrate. Substrate conversion was measured as the amount of maltotriose
hydrolyzed to maltose and glucose. Further hydrolysis of maltose to glucose was not considered.
In the absence of water (0%), methanol (5% v/v) was included in the reaction to provide a reactive
nucleophile. In Figure 1, substrate conversion after 4 h of reaction is shown as a function of the water
content. DES-containing acidic groups were not suitable solvents at any water concentration assayed,
and were therefore not included in the figure.
Figure 1. Effect of water content in water:DES cosolvent systems on maltotriose conversion in α-
amylase-catalyzed hydrolysis reactions. No reaction was observed on choline chloride:malonic acid
(1:1) and choline chloride:levulinic acid (1:2).
As shown in Figure 1, significant α- amylase hydrolytic activity takes place in solvents containing
only 10% water or less for several DES, except for choline chloride:malonic acid (1:1) and choline
chloride:levulinic acid (1:2), for which no activity was observed. In order to include enzyme stability
in the assay, samples were taken from the same reactions after 4 h and checked for residual amylase
activity on starch. Figure 2 shows the residual amylase activity after 4 h reaction in DES, based on
the I-/I2 staining assay. Residual amylose produces a blue stain, indicating that the amylase was
deactivated by the corresponding DES at some time during the reaction. Clear wells indicate the
presence of active amylase. The yellow color (column 7) was formed, probably from a side reaction of
the DES with iodine.
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Figure 2. Screening for α-amylase stability in DES:water cosolvent mixtures as detected by the I-/I2
staining assay with amylose, after 4h reactions in the corresponding DES. 1. choline chloride:urea
(1:2); 2. choline chloride:methyl urea (1:2), 3. choline chloride:malonic acid (1:1), 4. choline
chloride:levulinic acid (1:2), 5. choline chloride:ethylene glycol (1:2), 6. choline chloride:D-isosorbide
(1:2); 7. MPh3PBr:glycerol (1:2), 8. choline chloride:glycerol (1:3); 9. choline chloride:benzyl alcohol
(1:2); 10. choline chloride:1,3-propanediol:water (1:1:1); 11. choline chloride:glucose:water (4:1:4);
12. choline chloride:sucrose:water (5:2:5).
In the last row of Figure 2, it may be observed that the enzyme was fully inactive after 4 h of
reaction when 100% DESs were used as solvent. Also, the enzyme inactivated in those reactions
containing acidic DESs (columns 3–4), probably as a result of a severe pH shift, as reported for acidic
DES [32,33]. A similar inactivation profile was observed with DES 9 (choline chloride:benzyl alcohol
(1:2)). In the case of choline chloride:urea (1:2) and choline chloride:1,3-propanediol:water (1:1:1),
the activity was retained with 90% of DES. No information could be obtained on amylase stability
in methyl (triphenyl) phosphoniumbromid (MPh3PBr):glycerol (column 7), probably due to a side
reaction of the iodine-staining solution with the DES (yellow color). Amylase activity was retained in
all reactions containing choline chloride:glucose:water (column 11) and choline chloride:sucrose:water
(column 12). From this analysis, choline chloride:urea (1:2), choline chloride:1,3-propanediol:water
(1:1:1), choline chloride:glucose:water (4:1:4); and choline chloride:sucrose:water (5:2:5) were defined
as the most adequate DESs for amylase reactions. However, this is a preliminary qualitative analysis
based on a staining procedure so further exploration of the enzyme stability is required.
2.2. Screening for Transfer to Alcohols (Alcoholysis) in Selected DES
The initial screening evaluating the hydrolytic activity of the α-amylase in DES/water systems
allowed us to identify DESs in which the α-amylase activity could be retained after several hours.
The six most promising DESs were selected for a second screening with methanol as the acceptor to
screen for alcoholytic activity (see materials and methods). As shown in Figure 1, water was required for
Amy A stability, but as water also competes as a nucleophile, both water and methanol concentrations
were varied in order to identify the conditions for an optimal alcoholysis:hydrolysis ratio.
Methanol was assayed in a 5–30% v/v of total volume concentration range, with the remaining
volume corresponding to the DES:water solvent. In the latter, water concentration ranged between 5 to
40% (v/v), while DES completed the remaining 60–95% (v/v). The same stability assay where blue wells
indicate enzyme deactivation was performed. A general trend may be observed in Figure 3 for all the
assayed DESs, as low water and high methanol concentrations tend to deactivate the enzyme. In effect,
when the assay was carried out in a DES:buffer solvent containing 90% DES (10% buffer), no activity
was observed in all cases except for choline chloride:sucrose:water with low methanol concentrations of
5 or 10% (v/v). All other solvents required a minimum of 20% (v/v) water as a cosolvent. Although one
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would expect Amy A to tolerate low concentrations of water, the presence of water in some DES, like
choline chloride:1, 3-propanediol:water (1:1:1) required an additional 10% more buffer in the DES:water
solvent, as well as the choline chloride:glucose:water (4:1:4) DES that required 60%.
Figure 3. Retained Amy A activity as evaluated after 12 h of reaction in DES:water:MeOH
systems at 75 ◦C. A reaction aliquot was taken to see retaining activity. The assay shown here
was carried out with 1% starch (w/v) as a substrate at 50 ◦C. Six different DESs were screened:
(a) choline chloride:urea (1:2); (b) choline chloride:D-isosorbide (1:2); (c) choline chloride:glycerol (1:3);
(d) choline chloride:1,3-propanediol:water (1:1:1); (e) choline chloride:glucose:water (4:1:4); (f) choline
chloride:sucrose:water (5:2:5). Methanol was tested in a range between 5–30% (v/v) of the total volume as
indicated. The remaining volume was completed by a DES:buffer solution in which DES concentration
was varied as indicated in each panel.
The alcoholysis reactions were analyzed by HPLC using an ELSD detector. However, the
high concentration of the DESs components in some cases interfered with certain product peaks.
Additionally, some DESs contained alcohols such as 1, 3-propanediol, glycerol, sucrose, and
D-isosorbide. These alcohols represent potential nucleophiles in addition to methanol or water
that could compete as acceptors in the transfer reactions. Accordingly, the unidentified peaks probably
correspond to products formed from such alcoholysis reactions. However, reference compounds for
these substances are not available, making identification and quantification difficult. From these results,
we decided to select chloride:urea (1:2) DES as cosolvent. In the first experiment, maltotriose was
used as the glycosyl donor. The results are summarized in Figure 4a–c. Conversion was based on the
remaining maltotriose concentration after reaction.
Figure 4a shows that higher DES concentrations in the reaction result in lower conversion levels,
most likely due to both low activity and stability of the enzyme (for stability see Figures 1 and 3).
Similarly, conversions levels also decrease in the presence of high methanol concentrations. It must be
considered, however, that the conversion of maltotriose can be achieved by hydrolysis, alcoholysis,
or transglycosylation. Therefore, in order to evaluate the specific production of the targeted
methyl-glycosides, the concentrations of products obtained from alcoholysis were quantified by
HPLC. Methyl-glucoside, methyl-maltoside, and interestingly, also methyl-maltotrioside were detected.
The formation of the latter indicated a transfer reaction of oligosaccharides, as observed earlier by our
group using Amy A [16]. In order to reduce the number of poly-glycosylated methanol products, a
glucoamylase (GA) digestion treatment of the reaction products obtained with Amy A was carried
out. It was found that this enzyme was capable not only of transforming the residual dextrins to
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glucose through the hydrolysis of glucose units linked to amylose non-reducing ends, but also of
hydrolyzing the poly-glucosylated methanol forms to the simplest mono-glucosylated form [16,17].
The highest methyl-glycoside concentrations of approximately 39 mM (9.51 g/L) were obtained using
methanol at 10% (v/v) in 60% choline chloride:urea (30% water). This concentration was higher than
previously reported (7.5 g/L) [16]. Figure 4c shows the percentage of transfer to methanol as compared
to hydrolysis. Higher methanol concentrations generally lead to a higher methanolysis vs. hydrolysis
ratio, as expected. However, above 10% methanol (v/v), no further increase could be observed in methyl
glycoside production in all reactions. The overall conversion was low with high DES concentrations
(Figure 4a).
Figure 4. Methanolysis with maltotriose as substrate using Amy A as catalyst in choline chloride:urea
(1:2):water as a solvent with increasing amounts of MeOH. (a) Maltotriose conversion, (b) Alcoholysis
evaluated as methyl-glucoside synthesis after glucoamylase treatment of the glucosylated products
(see text), (c) final yield of methanolysis reaction.
2.3. Exploration of Alcoholysis Activity in Choline Chloride:Urea (1:2):Water DES Using Starch as
Glucosyl Donor
The use of maltotriose as a glycosyl donor showed promising results; however, this is an expensive
substrate for industrial purposes. We therefore decided to use starch, as it is not only an economic
alternative, but it also offers a stabilizing effect on amylases. In previous works, it was shown that with
15% (w/v) starch, conversions higher than 90% were obtained in methanol concentrations up to 20%
(v/v) [16,18].
In a preliminary experiment, the alcoholysis reaction products using different concentrations of
methanol (10, 20 and 30% v/v) and DES (0%–50% v/v) were quantified during the reaction in periods of
6, 12, and 24 h. Overall, the amount of methyl-glucoside (MG) obtained did not change much after 6 h
of reaction (data not shown). DES produced an increment in alcoholysis yield when methanol was
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used at 10%; however, there was no further yield increase with higher concentrations of methanol in
the DES system. In contrast, in a buffer system, higher alcoholysis yields were observed up to 30%
methanol concentrations (data not shown). These and the results with maltotriose as a glycosyl donor
prompted us to investigate whether DES could have a destabilizing effect on the enzyme, especially
because the reaction was carried out at a high temperature (85 ◦C).
2.4. Stability of Amy A in Mixtures of DES-Methanol
The far-UV region of circular dichroism spectra is sensitive to changes in the secondary structure
of proteins, and can be used to monitor the stability of the protein under different conditions. Figure 5
shows the CD spectra of the protein at DES concentrations from 60 to 80%. Light scattering due to
the high DES concentration precluded the comparison of spectra below 210 nm. However, Figure 5
shows the negative signal around 220 nm, characteristic of proteins that present secondary structures.
This negative signal looks similar for all the DES mixtures containing water at 25 ◦C, suggesting
minimal changes in secondary structure. In contrast, Amy A in pure DES showed a near 50% decrease
in the signal at this wavelength, suggesting the loss of the secondary structure, and in good agreement
with the lack of activity observed under this condition.
Figure 5. Far-UV region of the CD spectra of Amy A in pure phosphate buffer and in choline
chloride:urea (2:1) DES/buffer mixtures (20 to 100% (v/v) of DES) at 25 ◦C. Pure DES solid red line; 80%
DES dashed green line; 70% DES blue dashed line; 60% DES blue solid line; buffer, black solid line.
The activity assay, however, was carried out at 85 ◦C; therefore, we decided to carry out temperature
scans of Amy A registering the signal at 220 nm at different concentrations of DES and MeOH. Figure 6
shows the change of signal by increasing and then decreasing the temperature from 25 ◦C to 90 ◦C; the
insets show the CD spectra before and after heating to 90 ◦C and cooling back the protein solutions to
25 ◦C. Interestingly, the proteins in DES/water mixtures showed minimal differences from the proteins
in the buffer, even though the concentrations of DES were as high as 80% (Figure 6a–c). The protein
did not show significant changes in the mean residue ellipticity at 220 nm ([θ] mre) upon heating in
any of the DES-buffer mixtures, showing a final spectrum that was practically unchanged. However,
methanol turned out to be the major destabilizing factor. Even with only 10% methanol, a cooperative
decrease in the signal was observed between 60 and 80 ◦C (Figure 6d–f). After reaching a minimum,
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the signal increased and the refolding process did not follow the same curve as the unfolding, showing
considerable loss of the secondary structure. It is noteworthy that although the sample containing 80%
DES lost about 35% of its [θ]mre at 220 nm, even at 25 ◦C (Figure 6f), after heating and cooling, it had
a signal that was similar to those of the samples containing less DES, suggesting that the secondary
structure was disturbed more by the increase of methanol concentration than by that of DES. When
the methanol concentration increased to 20%, the sample containing 80% DES lost about 50% of the
secondary structure, even at 25 ◦C (Figure 6i), but there was only a limited further loss of signal upon
heating, and the refolding signal stayed steady. In contrast, the samples with 60% DES-20% MeOH
and 70%DES-20% MeOH showed a high secondary structure content at 25 ◦C, and went through an
irreversible unfolding when heated to 90 ◦C (Figure 6g,h). Again, the signal after cooling was similar
for all samples containing 20% MeOH, around −1000 mdeg*cm2/dmol, implying a major dependence
on MeOH concentration.
Figure 6. CD temperature scans of Amy A from 25 ◦C to 90 ◦C in different choline chloride:urea (1:2)
DES and MeOH concentrations. Main chart: Amy A heating signal (red) and cooling signal (blue) at
220 nm. Inset: Far UV-CD spectra before heating (red) and after cooling (blue). (a) 60% DES; (b) 70%
DES; (c) 80% DES; (d) 60% DES, 10% MeOH; (e) 70% DES, 10% MeOH; (f) 80% DES, 10% MeOH; (g)
60% DES, 20% MeOH; (h) 70% DES, 20% MeOH; (i) 80% DES, 20% MeOH.
Since major irreversible changes can occur in most of the conditions at temperatures above 60 ◦C,
we decided to check the reversibility of heating the protein to only 60 ◦C for all conditions. As can
be observed in Figure 7, even when there were subtle changes in [θ]mre at 220 nm upon heating, the
final protein spectrum looked very similar to the initial one. Thus, we established 60 ◦C as the limit
temperature to be able to compare the yield of alcoholysis reaction for all conditions.
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Figure 7. CD temperature scans of Amy A from 25 ◦C to 60 ◦C in different choline chloride:urea (1:2)
DES and MeOH concentrations. Main chart: Amy A heating signal (red) and cooling signal (blue)
at 220 nm. Inset: Far UV-CD spectra before heating (red) and after cooling (blue). (a) 60% DES, 10%
MeOH; (b) 70% DES, 10% MeOH; (c) 80% DES, 10% MeOH; (d) 60% DES, 20% MeOH; (e) 70% DES,
20% MeOH; (f) 80% DES, 20% MeOH.
2.5. Activity of Amy A at 60 ◦C
Amy A is a thermostable enzyme with an optimal temperature at 85 ◦C, an advantage under the
high temperature required for starch solubilization and for DES viscosity reduction. However, the
structural information we obtained established a temperature limit for the alcoholysis reaction which
was well below the optimal temperature. We measured activity at 60 ◦C under the different solvent
conditions, including with an aqueous buffer, which is not reported at this temperature. Table 1 shows
the Vmax and KM values at 60◦C for the hydrolysis reaction.
Table 1. Kinetic constants of amylase Amy A.
Condition KM (mg/mL) Vmax (μmol/mg *min)
No DES 2.8 ± 0.5 196 ± 10
60% DES 5.7± 1.7 27 ± 4
60% DES 10% MeOH 1.7± 0.6 3.6 ± 0.4
Measurements at 60 ◦C, in buffer 50 mM Tris pH7 containing 150 mM NaCl and 2 mM CaCl2. The results are the
average of three replicates and the errors represent one standard deviation.
Hydrolytic activity was reduced almost three-fold by decreasing the temperature to 60 ◦C, relative
to that at Topt (85 ◦C) in aqueous buffer in good agreement with the observations by Liebl, et al. [32].
At 60 ◦C, in the absence of DES, Amy A follows a typical M-M model (Figure S1). However, in
the presence of 60% DES with or without 10% methanol, an inhibitory effect was observed as the
starch concentration increased (Figure S1). The apparent inhibition might be explained by the high
viscosity in the resultant reaction medium as a result of the high concentration of both DES and
starch, making diffusion a limiting factor for the catalytic efficiency as observed in other enzymes
by the addition of trehalose [34–36]. For this reason, initial velocities up to 8 mg/mL were fit to the
Michelis-Menten equation to estimate catalytic parameters (Figure S2). Table 1 shows that hydrolytic
activity decreases by almost an order of magnitude in the presence of DES, and that the addition of
10% MeOH decreases this value by another order of magnitude, while KM increased twice in DES,
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reflecting the lower availability of substrate in the active site. The presence of methanol in DES, on the
other hand, decreased slightly KM, probably as a result of reduced viscosity. Nevertheless, relevant for
our purposes is the ratio of alcoholysis to hydrolysis reaction, which defines the final product yield
and purity.
2.6. Alcoholysis Yield by Amy A at 60 ◦C
Alcoholysis initial rates are difficult to measure, since product quantification requires the hydrolysis
of methyl-oligosaccharides and quantification of the resultant methyl-glucoside by HPLC (Figure S3).
Instead, as a point of comparison, we decided to measure the final yield of both hydrolysis (measured
by reducing sugars) and alcoholysis (measured by the amount of methyl-glucoside) after 18 h reaction,
when presumably both reactions had reached equilibrium. We carried out alcoholysis with T. maritima
α-amylase using 10% of methanol and varying the DES concentration from 10 to 80%. The product
concentration after 18 h of incubation at 60 ◦C is compared to that obtained under the same conditions
in the absence of DES in Figure 8. The systems with higher DES concentration (70 and 80%) have a
very high viscosity when mixed with starch, making the medium and the measurement unmanageable.
We excluded these experiments from the plots.
Figure 8. Methanolysis of starch after 18 h using Amy A as a catalyst, and 10% MeOH in different
concentrations of choline chloride:urea (1:2):water DES as a solvent. (a) shows the yield of alcoholysis
reaction (expressed as mM of methyl-glucoside); (b) the yield of hydrolysis (expressed as equivalent to
dextrose in mM) and (c) the alcoholysis/hydrolysis ratio. The values were calculated as described in
Materials and Methods.
As shown in Figure 8, alcoholysis yield remained practically unchanged up to 20% DES, and still
reasonably high up to 40% DES, while hydrolysis yield showed a constant decrease as DES concentration
increased, so that the alcoholysis:hydrolysis ratio increased with the increase of DES concentration.
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3. Discussion
Water activity is a key parameter affecting glycosidase-catalyzed synthesis. On one hand, a
sufficiently high-water activity (aw = 0.6) is required by glycosidases to retain activity, but on the
other hand, a high-water content promotes hydrolysis, thus decreasing the overall transfer reaction to
alcohols [4]. In each catalytic event an α-amylase-glycan intermediate is formed whose sugar moiety
may be transferred to water or methanol. The selectivity of this transfer depends on the concentration
of nucleophiles and their specificities defined by their corresponding rate constants [27,30]. For most
α-amylases, transglycosylation reactions are unfavorable under normal conditions. To become
significant, they require a high concentration of substrates and low water activities [3,4]. Amy A has
an important transglycosidic activity; however, its α-1,4 hydrolytic activity seems to be also higher,
so a rather limited transference of glycosyl residues to methanol occurs [16,20]. Although DES was
envisioned as a way to reduce water content in the reaction mixture, water is always required in small
amounts to ensure activity and stability. Thus, achieving an anhydrous medium that would eliminate
the hydrolysis reaction that competes with the production of alkyl glycosides is not possible, indicating
that some hydration is needed to form an aqueous shell around the protein that allows it to fold and
the necessary lubrication in the active site to work, as has also been observed by others [33]; this
contrasts with lipases for which DES seem sufficient to mimic the water layer covering active enzymes
in alternative reaction media to water [21,22].
Despite the need for water in the reaction medium, further studies with the choline chloride:urea
DES demonstrated that DES can improve the reaction selectivity to the desired production of alkyl
glucosides. Increasing concentrations of DES reduced both hydrolysis and alcoholysis, but this
reduction was higher for the undesired hydrolysis reaction, reducing its production more than that of
the alcoholysis reaction, resulting in an increase in selectivity.
Circular dichroism (CD) structural studies revealed that the loss of activity might result from
thermal denaturation in reactions media with high DES content. Surprisingly, MeOH disturbed
the structure of Amy A more than DES. This loss of structure was prevented by performing the
reaction at temperatures below the transition temperature observed at the thermal denaturation curves.
This decrease in temperature reduced the enzyme activity; as a result, the reaction time should be
elongated to increase the yield of methyl glycosides.
4. Materials and Methods
4.1. Materials
Glucoamylase from A<.spergillus niger, choline chloride, soluble starch, maltotriose, urea, methyl
urea, malonic acid, levulinic acid, ethylene glycol, D-isosorbide, MPh3PBr, glycerol, benzyl alcohol,
1,3-propanediol, glucose, sucrose, α-methyl-glucoside, and methanol were purchased from Sigma
Chemical Co. (St. Louis, MO, USA).
4.2. Analytical Procedures
Amylase from T. maritima, Amy A, was obtained from the heterologous expression in E. coli as
described previously [16,20]. Cells containing the overexpressed protein were lysed by sonication and
partially purified via heat precipitation. The protein concentration of the applied α-amylase stock was
15 mg mL−1 for initial screening. To determine catalytic parameters, the protein extracts were further
purified through Ni2+ affinity columns as previously described [16]
4.3. Synthesis of Deep Eutectic Solvents (DES)
The DES used in this work were synthesized in two different ways. In the first method, a thermal
approach was used, which consisted in mixing and heating the components of eutectic solvent until a
liquid was formed. A vacuum was applied in order to avoid water entering the system, particularly
in cases where hygroscopic compounds such as choline chloride were used. The second method
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consisted of the dissolution of the components in water followed by freeze-drying [37]. Table S1 in
supplementary information, summarizes the preparation of each DES used in this work.
4.4. Screening of Deep Eutectic Solvents for Application in α-amylase Catalyzed Reactions
Twelve DESs were used from the list presented in Table S1 (see supplementary data) for
analysis in α-amylase-catalyzed reactions: 1. choline chloride:urea (1:2); 2. choline chloride:methyl
urea (1:2), 3. choline chloride:malonic acid (1:1), 4. choline chloride:levulinic acid (1:2), 5.
choline chloride:ethyleneglycol (1:2), 6. choline chloride:D-isosorbide (1:2); 7. MPh3PBr:glycerol
(1:2), 8. choline chloride:glycerol (1:3); 9. choline chloride:benzyl alcohol (1:2); 10. choline
chloride:1,3-propanediol:water (1:1:1); 11. choline chloride:glucose:H2O (4:1:4); 12. choline
chloride:sucrose:H2O (5:2:5). The 12 DES were tested in 96-well PCR plates each at different water
concentrations of 0, 5, 10, 25, 50, 75, and 100% (v/v) to determine the minimum amount of water needed
for enzyme activity, using 50 mM maltotriose as substrate. In order to provide a reactive nucleophile,
methanol (5% v/v) was added to those reactions not containing water (0%). The reaction containing 0%
water contained methanol as a nucleophile instead of water, and lyophilized Amy A was used. The
PCR plate was sealed with a silicone microplate sealing mat to avoid water or methanol evaporation.
After 4 h incubation in a PCR cycler at 75 ◦C, samples of each reaction were quenched (20 μl of sample
+ 180 μl of 0.225 M HCl) and analyzed via HPLC to determine remaining maltotriose.
4.5. Stability of Amy A in the Different Deep Eutectic Solvents
In order to determine the stability of Amy A during the reaction time that took place in the
different DES systems, 20 μl samples from each reaction after 4 h incubation was diluted in 180 μl of a
50 mM Tris-HCl, 2 mM CaCl2 buffer at pH 7.0, containing 1% (w/v) starch and incubated at 50 ◦C for
1 h. To visualize the remaining enzyme activity, 100 μl of this reaction were diluted 1:2 in water and
stained with 20 μl of a 5 mM I-/I2 solution.
4.6. Screening for Alcoholytic Activity in Selected DES
Based on the first screening, only six different DES were further screened for alcoholytic
activity: choline chloride:urea (1:2); choline chloride:D-isosorbide (1:2); choline chloride:glycerol
(1:3); choline chloride:1,3-propanediol:water (1:1:1); choline chloride:glucose:water (4:1:4); choline
chloride:sucrose:water (5:2:5). Methanol was tested in a range between 5–30% v/v of the total volume.
The remaining volume was completed by a DES:buffer solution in which DES concentration ranged
between 60–95% v/v. Thus, the six DES under the 16 different conditions could be evaluated in a 96-well
plate. Then, 50 mM maltotriose was used as substrate, 5 μl of a 15 mg/mL Amy A solution obtained
after purification by heat precipitation were added as described above. The total reaction volume was
150 μl in all reactions. Reactions were carried out at 75 ◦C in a PCR cycler. The same stability test as
described above was carried out for each sample after 4 h of reaction. The reactions were additionally
analyzed by HPLC. The percentage of conversion was estimated from the remaining maltotriose.
4.7. Product Quantification by HPLC
When maltotriose was used as substrate, the reaction products were analyzed by HPLC in an
Ultimate 3000 equipped with a 300 RS Pump, a 3000 RS Autosampler and a RS Column Compartment,
using an ELSD 2000ES Alltech detector. Both maltooligosaccharides and methyl-glucosides could
be separated and detected using a Prevail Carbohydrate column (acetonitrile:water 70:30 as mobile
phase, flow: 1 mL/min, column T: 30 ◦C, ELSD T: 80 ◦C, nitrogen Flow: 1.7 L/min). When starch was
used as substrate, reaction products were analyzed in a Waters-Millipore 510 HPLC system equipped
with an automatic sampler (model 717 Plus) (Waters Corp., MA, USA), a refractive-index detector
(Waters 410) (Waters Corp., MA, USA) and a Hypersil GOLD™ Amino column (Thermo Scientific,
Paisley, UK) using acetonitrile:water (80:20) as the mobile phase at a flow rate of 1.0 mL/min. The peak
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areas were measured and compared against those of a standard curve containing known amounts
of methyl-glucoside.
To calculate the % conversion of the reaction, the following formula was used:
%Conversion =
[Maltotriose]inicial − [Maltotriose] f inal
[Maltotrios]inicial
× 100
4.8. Hydrolysis Activity Assay
The enzyme activity of Amy A from T. maritima was determined by measuring the initial velocities
of reducing sugars released at saturation starch concentration by the 3,5-dinitrosalicylic acid method,
as reported previously [38]. The reaction was carried out in 1 mL of 10 mg/mL soluble starch dissolved
in 50 mM Tris, 150 mM NaCl, 2 mM CaCl2 buffer, pH 7, at 85 ◦C. A unit of enzyme activity was
defined as the amount of enzyme required to release 1 μmol of glucose equivalents per minute.
For the characterization of Amy A at 60 ◦C, the activity measurements were carried out varying the
starch concentration from 1 mg/mL to 20 mg/mL and using as a solvent mixtures containing 50 mM
Tris, 150 mM NaCl, 2 mM CaCl2 buffer, pH 7, and variable v/v concentrations of DES and methanol.
The initial velocities were plotted against starch concentration and the data fit to the Michaelis-Menten
equation to obtain the catalytic parameters.
4.9. Alcoholysis Reactions with Methanol and Starch in Choline Chloride:Urea 1:2 DES as co Solvent
Alcoholysis reactions were performed in 2 mL Eppendorf tubes which were tightly sealed to avoid
methanol and water evaporation. DES concentration was varied from 0 to 80%, using 10% methanol
and 10% starch as a glycosyl donor, and 50 mM Tris, 150 mM NaCl, 2 mM CaCl2 buffer at pH 7 to
complete the 100% volume. The solvent mixture was homogenized and pre-equilibrated at the reaction
assay temperature before adding 20 U of Amy A to start the reaction, which was incubated during 18 h
at the defined temperature according to the experiment.
4.10. Hydrolysis Quantification at the End Point of Reaction
The determination of reducing sugars was evaluated as described above from a 1:50 dilution of the
final reaction. The hydrolysis events were estimated by subtracting the equivalents of the alcoholysis
reaction from the equivalent of the reducing sugars.
4.11. Alcoholysis Reaction Measurement
The measurement of alcoholysis is complicated by the diversity of products possible. To reduce
the complexity, the final reaction products were hydrolyzed for 12 h at 50 ◦C with A. niger glucoamylase
(25 U/mL), which is an exoglycosidase that hydrolyses α-1,4-glycosidic bonds from the non-reducing
end, transforming any alcoholysis product in glucose plus methyl-glucoside for each alcoholysis event.
At the end of incubation period, all the samples were centrifuged at 13,000 rpm for 15 min and filtered
through a 0.22 μm nylon membrane before the analyses by HPLC as described above, using a standard
curve of methyl-glucoside to quantify the amount in each sample.
4.12. Alcoholysis Yield and Alcoholysis/Hydrolysis Ratio
When a hydrolysis reaction takes place, for each molecule of a reducing substrate cleaved, one
additional reducing end is formed, increasing in one its contribution to the solution reducing power; in
contrast, when an alcoholysis reaction occurs, there is no real gain in reducing power. Therefore, a
measure of the increasing equivalent glucose concentration measured by the DNS method, as described
above, reflects the number of hydrolysis events that occurred during the reaction, while the number of
alcoholysis events can be independently determined through the quantification of the increase in alkyl
glucoside concentration in the same period of time. From these data it is possible to determine the
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number of hydrolysis and alcoholysis events in the reaction, as well as an alcoholysis/hydrolysis ratio







4.13. Structural Characterization of Amy A in Choline Chloride:Urea 1:2 DES as co Solvent
Circular dichroism spectra (CD) were recorded on a J-710 spectropolarimeterTM (Jasco, USA)
equipped with a Peltier temperature control using a 1.00 mm path length cell. Three CD scans were
recorded and averaged from 190 to 260 nm for each sample containing 0.3 mg/mL of Amy A in 10 mM
Phosphate, 0.5 mM CaCl2 buffer at pH 7 at 25 ◦C and varying the DES (60%–80% v/v) and methanol (0,
10 and 20 % (v/v)) concentrations.
4.14. Thermal Stability of Amy A in Choline Chloride:Urea 1:2 DES as co Solvent
Thermal stability of Amy A was determined by following the CD signal at 220 nm during
a temperature scan from 25 ◦C to 90◦ at a rate of 1 ◦C/min of all the samples described above.
The reversibility of any change observed was also evaluated by following the CD signal at 220 nm in
the return to 25 ◦C and recording a final spectrum for comparison with the initial one.
5. Conclusions
We demonstrated that Amy A can perform both hydrolysis and alcoholysis in media containing
deep eutectic solvents (DES) using starch or maltotriose as substrates. However, the enzyme activity
and stability in each medium depends on the nature of the DES. The possibility of reducing water
activity using alternative reaction media as the DES cosolvent was successful to a certain degree,
as shown by the increase in the alcoholysis/hydrolysis ratio; however, it was found that using pure
DES had a destabilizing effect. The alcholysis yield measured as methyl-glucoside with the optimal
DES cosolvent was 20% greater than that previously reported in an aqueous buffer with the same
methanol concentration.
Our results highlight the importance of performing variable temperature structural studies to
determine the temperature limit at which an enzyme is operative.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/20/21/
5439/s1.
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Abstract: Strain GA A07 was identified as an intestinal Bacillus bacterium of zebrafish, which has
high efficiency to biotransform the triterpenoid, ganoderic acid A (GAA), into GAA-15-O-β-glucoside.
To date, only two known enzymes (BsUGT398 and BsUGT489) of Bacillus subtilis ATCC 6633
strain can biotransform GAA. It is thus worthwhile to identify the responsible genes of strain
GA A07 by whole genome sequencing. A complete genome of strain GA A07 was successfully
assembled. A phylogenomic analysis revealed the species of the GA A07 strain to be Bacillus
thuringiensis. Forty glycosyltransferase (GT) family genes were identified from the complete genome,
among which three genes (FQZ25_16345, FQZ25_19840, and FQZ25_19010) were closely related
to BsUGT398 and BsUGT489. Two of the three candidate genes, FQZ25_16345 and FQZ25_19010,
were successfully cloned and expressed in a soluble form in Escherichia coli, and the corresponding
proteins, BtGT_16345 and BtGT_19010, were purified for a biotransformation activity assay.
An ultra-performance liquid chromatographic analysis further confirmed that only the purified
BtGT_16345 had the key biotransformation activity of catalyzing GAA into GAA-15-O-β-glucoside.
The suitable conditions for this enzyme activity were pH 7.5, 10 mM of magnesium ions, and 30 ◦C.
In addition, BtGT_16345 showed glycosylation activity toward seven flavonoids (apigenein, quercetein,
naringenein, resveratrol, genistein, daidzein, and 8-hydroxydaidzein) and two triterpenoids (GAA and
antcin K). A kinetic study showed that the catalytic efficiency (kcat/KM) of BtGT_16345 was not
significantly different compared with either BsUGT398 or BsUGT489. In short, this study identified
BtGT_16345 from B. thuringiensis GA A07 is the catalytic enzyme responsible for the 15-O-glycosylation
of GAA and it was also regioselective toward triterpenoid substrates.
Keywords: Nanopore sequencing; ganoderic acid; Bacillus thuringiensis; biotransformation;
glycosyltransferase; whole genome sequencing
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1. Introduction
Glycosyltransferase (GT, EC 2.4.x.y) exists in all living beings and is able to catalyze the
glycosylation of molecules such as proteins, nucleic acids, polysaccharides, and lipids. Most GTs
use a nucleotide-activated sugar donor, such as uridine diphosphate (UDP)-glucose, in the catalytic
reaction. According to a carbohydrate-activating enzyme (CAZy) database, GTs are classified into 107
families [1]. Among them, GTs that use small molecules (such as flavonoids or triterpenoids) as sugar
acceptors are classified into the GT1 family. Many members of the GT1 family with activities toward
flavonoids have been identified [2,3], however, very few GT1 family members with glycosylation
activities toward triterpenoids were reported until recently [4].
Biotransformation of xenobiotics by either a microorganism’s whole cells or purified enzymes may
form more-bioactive metabolites than the precursor molecules [5–9]. Among different biotransformations,
glycosylation was shown to improve water solubility, stability, and bioactivities of flavonoids, such as
anti-oxidant and anti-allergic activities [10–12]. Glycosylation of triterpenoids to form saponins can also
improve some bioactivities of the triterpenoid precursors. For examples, dozens of reports showed that
triterpenoid glycosides, ginseng saponins, from the medicinal plant ginseng, possess more bioactivities
involved in the central nervous system, cardiovascular system, immune system, anticarcinogenic
activities, and diabetes mellitus, than do ginseng triterpenoid aglycones [13]. Therefore, using GT to
biotransform xenobiotics to new glycoside compounds is a worthy field of study.
Ganoderic acid A (GAA) is a triterpenoid isolated from the medicinal fungus, Ganoderma lucidum [14].
In addition to GAA, more than 300 different kinds of triterpenoids have been isolated from Ganoderma
spp. [15], and studies suggested that these triterpenoids may possess many bioactivities [15–17].
Despite numerous kinds of triterpenoids having been identified from G. lucidum, very few natural
Ganoderma triterpenoids exist in the form of glycosides (saponins) [15]. In addition, only five microbial
GTs were found to biotransform triterpenoids into new bioactive derivatives [1–4]. Taken together,
finding GTs that target Ganoderma triterpenoids could potentially expand the diversities of both GT
enzymes and Ganoderma triterpenoids.
Our previous study identified an intestinal bacterium of zebrafish, Bacillus sp. GA A07 strain,
which could biotransform GAA into GAA-15-O-β-glucoside [18]. In order to identify the GTs of the
GA A07 strain responsible for this triterpenoid biotransformation, the complete genome of the strain
was resolved using both Nanopore long-read and BGI short-read sequencing technologies. Candidate
GT genes were then discovered by comparing them to the CAZy database [1] and also subsequently
searching potential sequences against five triterpenoid-glycosylation genes [4,19–24]. These candidate
genes were then subcloned and overexpressed in Escherichia coli; the biotransformation activities of the
purified recombinant GTs were also determined.
2. Results
2.1. Comparison of GAA-15-O-β-Glucoside Production between B. subtilis ATCC 6633 and Bacillus sp. GA A07
Our previous study identified two Bacillus strains with the ability to biotransform GAA to
GAA-15-O-β-glucoside, B. subtilis ATCC 6633 [4] and Bacillus sp. GA A07 [18]. To compare the
biotransformation activity between the two strains, fermentation broths of the two strains fed with GAA
were analyzed by ultra-performance liquid chromatography (UPLC) during cultivation. Results showed
that Bacillus sp. GA A07 possessed 12.5-fold higher GAA biotransformation activity than B. subtilis
ATCC 6633 after a 24 h incubation of GAA (Figure 1). Based on these results, the complete genome of
the GA A07 strain was resolved to identify the GTs responsible for the triterpenoid biotransformation.
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Figure 1. Time course of ganoderic acid A (GAA)-15-O-β-glucoside production (circle symbols) and
cell growth (triangle symbols) by either Bacillus subtilis ATCC 6633 (solid) or Bacillus sp. GA A07 (open).
The two strains were cultivated in Luria-Bertani (LB) media with shaking at 180 rpm and 30 ◦C. GAA
at 1 mg/mL was added to the fermentation broth as the optical density (OD) at 600 nm of the culture
reached 0.6, and cultivation continued for another 32 h. During cultivation, the fermentation broth was
analyzed by ultra-performance liquid chromatography (UPLC). The UPLC operating conditions are
described in the Materials and Methods section.
2.2. Genome Sequencing, Assembly, Annotation, and Reclassification of the GA A07 Strain
Genome sequencing of Bacillus sp. GA A07 was performed in order to determine the enzymes
that contribute to GAA glycosylation. Totally 1,217,502,092 base pairs (bps) were sequenced from
142,886 Nanopore reads. The average read length was 8521 bps. The assembly process (outlined in the
Materials and Methods section) yielded a complete circular genome along with four circular plasmids
(GenBank BioProject accession no. PRJNA557365; Genome accession no. CP042270). The genome
size was 5,272,357 bps with a G+C percentage of 35.33%. Totally, 5094 putative protein-coding genes,
106 transfer RNA (tRNA) genes, and 42 ribosomal RNA (rRNA) genes were annotated for the GA A07
strain, as shown in the circular genome map (Figure 2).
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Figure 2. Circular genome map of the Bacillus thuringiensis GA A07 strain. The six rings from the
outer to inner side represent (1) assembled scaffolds, (2) genes in the forward strand, (3) genes in the
reverse-complement strand, (4) transfer RNA (tRNA) genes, (5) ribosomal RNA (rRNA) genes, and (6)
the GC content distribution per 1000 bps.
The 16S gene tree was only able to group the GA A07 strain with other Bacillus species (including B.
subtilis, B. thuringiensis, B. cereus, and B. anthracis) [18]; however, the actual species to which it belonged
could not be determined using only the 16S rRNA gene. Thus, we employed a two-step method to
identify which species the GA A07 strain belongs to. First, we used three different approaches [25–27],
namely average nucleotide identity (ANI), average amino acid identity (AAI), and a tetra correlation
search (TCS), to find the most closely related species to the GA A07 strain. All methods identified
B. thuringiensis as the closest species (B. thuringiensis serovar canadensis identified by both the ANI
and AAI approaches and B. thuringiensis BMB171 identified by the TCS approach). We then built a
phylogenetic tree (Figure 3) from 250 single-copy marker genes (the full list of marker genes can be
found in Table S1). Figure 3 revealed the GA A07 strain indeed belongs to the group of B. thuringiensis.
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Figure 3. Phylogenetic tree for the Bacillus thuringiensis GA A07 strain. The tree was built from
250 single-copy marker genes. Two Paenibacillus genomes were included as outgroups. The GA A07
strain is marked in bold font. See the Materials and Methods section for details.
2.3. Phylogenetic Analysis of GTs from the GA A07 Strain
Previous studies showed that five microbial GTs were validated to have triterpenoid glycosylation
activity, including BsYjiC (GenBank Protein accession no. NP_389104) from B. subtilis 168 [19–23],
UGT109A1 (GenBank Protein accession no. ASY97769) from B. subtilis CTCG 63501 [24,28], BsGT1
(GenBank Protein accession no. ANP92054) from B. subtilis KCTC 1022 [29], and two GTs, BsUGT398
and BsUGT489, from B. subtilis ATCC 6633 (GenBank Protein accession nos. WP_003225398 and
WP_003220489, respectively) [4]. To classify which genes were responsible for the biotransformation
of GAA, GT genes were first annotated from the GA A07 genome. The 40 identified GT genes were
then used to build a phylogenetic tree using the five validated genes with triterpenoid glycosylation
activities (Figure 4). Among the 40 GTs, one GT1 (FQZ25_19010) and two GT28 (FQZ25_16345,
FQZ25_19840) family genes were most closely related to the five validated genes (marked by stars in
Figure 4), and were considered putative gene candidates.
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Figure 4. Molecular phylogenetic analysis of glycosyltransferase (GT) candidates inferred from the
maximum likelihood (ML) method. The best-fit ML model selection was mtREV24+I [30], and the tree
with the highest log likelihood (−21419.90) is shown. The percentage of trees in which the associated
taxa clustered together is shown next to the branches. Initial trees for the heuristic search were
automatically obtained by applying the Neighbor-joining and BioNJ algorithms to a matrix of pairwise
distances estimated using a Jones–Taylor–Thornton (JTT) model and then selecting the topology with
the superior log likelihood value. The rate variation model allowed for some sites to be evolutionarily
invariable ([+I], 0.00% sites). The tree is drawn to scale, with branch lengths measured in the number of
substitutions per site. This analysis included 45 amino acid sequences. All positions with less than 95%
site coverage were eliminated, i.e., fewer than 5% alignment gaps, missing data, and ambiguous bases
were allowed at any position (partial deletion option). There were 184 positions in the final dataset.
Evolutionary analyses were conducted using MEGA X [31].
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2.4. Cloning, Overexpression, and Purification of GT from the GA A07 Strain in E. coli
To obtain the pure GT for the assay of the GAA biotransformation, the three candidate genes
(FQZ25_16345, FQZ25_19010, and FQZ25_19840) were subcloned into the pETDuet-1™ expression
vector (Figure S1a) and overexpressed with a fusion of His-tag in the amino-terminal in E. coli BL21 (DE3),
and the produced GT proteins, respectively designated BtGT_16345, BtGT_19010, and BtGT_19840,
were purified with Ni2+ chelate affinity chromatography. Among them, BtGT_16345 (Figure S1b)
and BtGT_19010 (Figure S1d) were successfully purified (shown as a single band in the sodium
dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) analysis). In contrast, BtGT_19840
could not be purified due to the insoluble form of the expressed proteins (Figure S1c).
2.5. Activity Assays of Recombinant GT Proteins toward GAA
The purified enzymes were incubated with 0.02 mg/mL of GAA, 10 mM of Mg2+, and 1 mM of
UDP-glucose at pH 8 and 40 ◦C for 30 min. After incubation, the reaction mixtures were assayed
by UPLC. Results showed that BtGT_16345 catalyzed GAA to GAA-15-O-β-glucoside (Figure 5a),
while BtGT_19010 did not catalyze GAA (Figure 5b).
Figure 5. Biotransformation of ganoderic acid A (GAA) by purified BtGT_16345 (a) and BtGT_19010 (b).
Purified enzymes (10 μg/mL) were incubated with 1 mM UDP-glucose and 0.02 mg/mL of GAA in the
presence of 50 mM Tris at pH 8.0 and 10 mM MgCl2. Before (the 0-min curve) or after (the 30-min curve)
30 min of incubation at 40 ◦C, the mixtures, together with the standard GAA or GAA-15-O-β-glucoside,
were analyzed by UPLC. UPLC conditions are described in the Materials and Methods section.
2.6. Catalytic Conditions for BtGT_16345
The activity of purified BtGT_16345 was determined at different pH values and temperatures,
and with different metal ions. Many GTs utilize divalent metal ion cofactors, and Mg2+ was found to
be present in native crystals of some GTs [32]. Results showed that the suitable catalytic conditions for
BtGT_16345 protein were at pH 7.5 and 30 ◦C, with 10 mM of Mg2+ (Figure 6).
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Figure 6. Effects of pH (a), temperature (b), and metal ions (c) on BtGT_16345 activity. The standard
condition was set to 10 μg/mL of the purified enzyme, 1 mg/mL of ganoderic acid A (GAA), 10 mM of
MgCl2, and 10 mM of UDP-glucose in 50 mM of Tris at pH 8.0 and 40 ◦C. To determine suitable reaction
conditions, different pH values, temperatures, and metal ions in the standard condition were replaced
with the tested condition. Relative activities were obtained by dividing the area of the product peak of
the reaction in the UPLC profile by that of the reaction at the standard condition and are presented as
mean values (n = 3) along with error bars representing standard deviations.
2.7. Substrate Specificity of BtGT_16345
To determine the substrate specificity of BtGT_16345, the GAA triterpenoid, two additional
non-GAA triterpenoids, and seven flavonoids were used as substrates for biotransformation assays
(Figure 7a). Conversion of each product was calculated by dividing the peak area of each product by
that of the initial input substrate in the UPLC chromatogram. Thus, the calculation of the conversion
was only based on the UPLC area due to the different extinctions coefficients of the various products.
Our results showed that BtGT_16345 exhibited glycosylation activity toward all tested flavonoids as
well as GAA and antcin K, however no activity was detected toward another triterpenoid, celastrol
(Figure 7b). In contrast, the purified recombinant BtGT_19010 was not functional on any tested
compounds, including GAA.
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Figure 7. Substrate specificity of BtGT_16345. (a) Chemical structures of the test compounds.
(b) Conversion (%) of the test compounds by BtGT_16345. For the substrate specificity assay, 1 mg/mL
of different compounds was mixed with 10 μg/mL of BtGT_16345, 10 mM of UDP-glucose, 10 mM of
MgCl2, and 50 mM of PB at pH 7.0 and incubated at 30 ◦C for 30 min. After incubation, the reaction
mixture was analyzed by UPLC. UPLC conditions are described in the Materials and Methods section.
Conversion of each product was calculated by dividing the peak area of each product by that of the
input substrate before biotransformation in the UPLC chromatogram. For biotransformation with
multiple products, each product is presented by a bar with a different background pattern.
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2.8. Kinetic Study of BtGT_16345 toward GAA
Figure 1 shows that B. thuringiensis GA A07 possessed higher GAA biotransformation activity
than B. subtilis ATCC 6633. Moreover, the GTs of B. subtilis ATCC 6633 responsible for catalyzing the
biotransformation were identified as BsUGT398 and BsUGT489 in a previous study [4]. To compare
the catalytic efficiency of GTs toward GAA from the two strains, a kinetic study was performed on
the three GTs: BsUGT398, BsUGT489, and BtGT_16345. Both recombinant purified BsUGT398 and
BsUGT489 were obtained from a previous study [4]. The kinetic study was performed by using different
concentrations of GAA as the substrate for the individual testing GT enzyme and the reaction velocity
at each concentration of GAA was obtained from the slope of the plot of time versus the amount of the
product (Figure 8). The kinetic parameters were calculated by nonlinear regression analysis applied to
Michaelis–Menten equation (Table 1). Results showed that BsUGT398 exhibited the significant highest
GAA-binding affinity with a KM value of 90.71 ± 14.86 μM, while BsUGT489 exhibited the highest
turnover number with a kcat value of 0.9336 ± 0.0626 s−1. However, the catalytic efficiency (kcat/KM)
of BtGT_16345 did not show significantly different compared with either BsUGT398 or BsUGT489
(Table 1).
 
Figure 8. Kinetic study of BsUGT398 (a); BsUGT489 (b); and BtGT_16345 (c). Different concentrations
of GAA were mixed with 10 μg purified GT protein, 10 mM UDP-glucose, 10 mM MgCl2, and 50 mM
PB (pH 7.0) for BtGT_16345, or 50 mM of Tris (pH 8.0) for BsUGT398 and BsUGT489 in 1 mL reaction
mixture and incubated at 30 ◦C for BtGT_16345, or 40 ◦C for BsUGT398 and BsUGT489 for 20 min.
During the incubation, samples from each reaction were removed and analyzed by UPLC every 2 min.
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The reaction rate for each concentration of GAA was obtained from the slope of the plot of the amount
of product over time. The amount of GAA-15-O-β-glucoside produced from the reaction was calculated
from the peak area of the UPLC analysis normalized to a standard curve. The reaction velocity at each
concentration of GAA was obtained from the slope of the plot of time versus the amount of the product
and presented as mean values (n = 2) along with error bars representing standard deviations. The UPLC
operation procedure was described in the Materials and Methods section. The kinetic parameters were
calculated by nonlinear regression analysis applied to Michaelis-Menten equation as the description in
the Materials and Methods section.
Table 1. Kinetic parameters of GT toward GAA.
GT KM (μM) kcat (s−1) kcat/KM (s−1 mM−1)
BsUGT398 90.71 ± 14.86 0.1401 ± 0.0051 1.5445 ± 0.2592
BsUGT489 793.96 ± 124.09 0.9336 ± 0.0626 1.1759 ± 0.2000
BtGT_16345 263.82 ± 24.78 0.2944 ± 0.0109 1.1159 ± 0.1127
3. Discussion
This study sequenced and assembled the complete genome of the GA A07 strain for strain
classification and GT identification. The circular map in Figure 2 not only contained critical information
about the genome (including the numbers of protein-coding genes, ribosomal RNA genes, and tRNA
genes, and the GC content distribution on the genome) but also revealed several interesting
characteristics. For example, the GC proportions were higher on the rRNA regions, and that the rRNA
genes were grouped in a portion of the genome (especially between positions 1.2 M to 1.5 M) instead of
distributed evenly on the genome. The distribution of the protein-coding genes were also uneven for
both forward and reverse-complement strands, in which genes in forward strand were more abundant
in half of the genome (from positions 1.2 M to 3.75 M) while genes in reverse-complement strand were
in greater number in another half of the genome. We consider these characteristics outside the scope of
this manuscript but may warrant future genome analysis to find their underlying meanings.
The phylogenetic tree built from 16S genes could only identify that the phylogenetic placement of
the GA A07 strain was very closely related to a group of Bacilli, including B. thuringiensis, B. anthracis,
B. cereus, and B. subtilis [18]. Herein, a three-step approach was applied to identify strain GA A07:
(1) downloading all available Bacillus genomes; (2) applying ANIs, AAIs, and a TCS to pinpoint the most
closely related species/strain among Bacillus; and (3) building a phylogenetic tree using 250 single-copy
marker genes. This approach helped us reclassify strain GA A07 as a part of B. thuringiensis (Figure 3).
Figure 4 further shows putative GTs identified from the novel genome sequence and three GT
candidates, one GT1 (BtGT_19010) and two GT28s (BtGT_16345, BtGT_19840), were grouped with the
five triterpenoid-glycosylation GTs (BsYjiC, UGT109A1, BsGT1, BsUGT398, and BsUGT489).
Previous studies identified B. subtilis ATCC 6633 and B. thuringiensis GA A07 were able to
biotransform GAA into GAA-15-O-β-glucoside [4,18]. Herein B. thuringiensis GA A07 exhibited over
10-fold higher biotransformation activity than B. subtilis ATCC 6633 (Figure 1). Through a genome-centric
analysis, we further identified that BtGT_16345, which belongs to the GT28 family, exhibited good
glycosylation activity toward GAA (Figure 5). This is the first report that a GT28 enzyme, not only
GT1, can catalyze GAA triterpenoids. From the results of the kinetics study, the catalytic efficiency
(kcat/KM) of BtGT_16345 for B. thuringiensis GA A07 did not show significantly different compared with
either BsUGT398 or BsUGT489 for B. subtilis ATCC 6633 (Table 1). Therefore, BtGT_16345 identified
in B. thuringiensis GA A07 might not be the major contributor to 10-fold higher biotransformation
activity. BtGT_19840, the activity of which could not be evaluated in this study owing to an inability to
obtain its soluble expression, may contribute to the higher GAA biotransformation of B. thuringiensis.
Other possible reasons include: (1) higher expression of BtGT with GAA biotransformation activity,
(2) a higher uptake rate of GAA into cells; (3) a higher UDP-glucose concentration accumulating in
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cells, and (4) other enzymes and/or coenzymes cooperating in cells, may account for the contribution
of the higher catalytic efficiency of B. thuringiensis GA A07.
Although over 500,000 GTs were identified in the CAZy database, only six microbial GTs were
found to exhibit glycosylation activities toward triterpenoids, including BtGT_16345 (this study),
BsYjiC [19–23], UGT109A1 [24,28], BsGT1 [29], BsUGT398, and BsUGT489 [4]. BtGT_16345, which was
classified into the GT28 family, is the only exception out of the other five GTs that belong to the GT1
family [1]. Previous studies showed that these GT1 enzymes catalyzed the glycosylation of several
flavonoids at multiple positions to form mixture of flavonoid glycosides [19–24,28,29]. In the present
study, BtGT_16345 exhibited similar catalytic activities toward seven flavonoids to form multiple
products (Figure 7). These results revealed that microbial GTs potentially accept a broader range of
different flavonoids as catalytic substrates and exhibit less regioselectivity toward flavonoid substrates
than do plant GTs [2,3].
As to triterpenoid substrates, both BsYjiC [19–23] and UGT109A1 [24,28] catalyzed O-glycosylation
toward triterpenoids at multiple positions (C-3, C-6, C-12, and C-20). As a result, one triterpenoid
substrate can potentially be biotransformed into many types of triterpenoid glycosides. The above
reports revealed that the two GT1s were less regioselective toward triterpenoid substrates. In contrast,
BtGT_16345 specifically catalyzed glycosylation at the C-15 position out of the three hydroxyl
groups capable of the O-glycosylation (C-7, C-15, and C-26) of GAA and no other glycosylated
products were detected during the biotransformation using the analytical techniques herein (Figure 5).
Moreover, only one product was produced by BtGT_16345 from the biotransformation toward antcin
K, another triterpenoid containing four sites capable of O-glycosylation (C-3, C-4, C-7, and C-26)
(Figure 7). BtGT_16345 was regioselective toward triterpenoid substrates, and could be further used
for industrial applications or stepwise biosynthesis for structure-activity studies.
4. Materials and Methods
4.1. Microorganism and Chemicals
The Bacillus sp. GA A07 strain was isolated from intestinal bacteria of zebrafish in our previous
study [18]. Both purified recombinant BsUGT398 and BsUGT489 were obtained in our previous
study [4]. Antcin K was obtained by a procedure in our previous study [33]. GAA and celastrol
were bought from Baoji Herbest Bio-Tech (Xi-An, Shaanxi, China). 8-OHDe was prepared according
to Wu et al.’s [34] method. Other flavonoids were purchased from Sigma (St. Louis, MO, USA)
or Tokyo Chemical Industry (Tokyo, Japan). UDP-glucose was purchased from Cayman Chemical
(Ann Arbor, MI, USA). All materials needed for the polymerase chain reaction (PCR), including primers,
deoxyribonucleotide triphosphate, and Taq DNA polymerase, were purchased from MDBio (Taipei,
Taiwan). The pETDuet-1 plasmid was purchased from Novagen (Madison, WI, USA). Restriction
enzymes and DNA ligase were obtained from New England Biolabs (Ipswich, MA, USA). Other reagents
and solvents used were of high quality, and were purchased from commercially available sources.
4.2. Whole-Genome Sequencing
Bacillus sp. GA A07 cells were harvested from Luria-Bertani (LB) plates pre-cultured in a 25 ◦C
incubator for 3 days. Genomic DNA of cells was extracted with a ZR Soil Microbe DNA Kit™ (D6001,
Zymo Research, Irvine, CA, USA). Genomic DNA (1~3 μg) was end-repaired and ligated with NB12
barcode sequencing adaptors (EXP-NBD104, Native Barcoding Expansion 1-12) via a KAPA Hyper Prep
Kit (Cat#KR0961, Kapa Biosystems, Wilmington, MA, USA), following the manufacturer’s instructions.
The barcoded genomic DNA library was premixed with LB and SQB buffer of the Ligation Sequencing
Kit (SQK-LSK109, Oxford Nanopore Technologies, UK) loaded in a Flow Cell (R9.4.1; FLO-MIN106),
and sequenced by MinION devices for 24 h. For short-read sequencing, the genomic DNA library was
fragmented by Covaris S220 with a 350-bp size peak, a peak incident power of 140 W, a duty factor of
10, 200 cycles per burst, and a treatment time of 100 s. Sheared DNA fragments were then used for
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library construction with the MGIEasy DNA Library Prep Kit v1.1. The library was sequenced with
the BGISEQ-500RS sequencer by Tri-I Biotech (New Taipei, Taiwan).
4.3. Genome Assembly and Annotation
Nanopore reads were first error-corrected using canu v1.8 [35] (parameters:
-correct -nanopore-raw); the error-corrected reads were then assembled using
wtdbg2 v2.4 [36]. The yielded assembly was mapped to BGISEQ-500RS paired-end
sequences (trimmed using SOAPnuke v2.0.7 [37]; parameters: filter -l 10 -q 0.5
-n 0.1 -M 2 –adaMR 0.5 -f AAGTCGGAGGCCAAGCGGTCTTAGGAAGACAA -r
AAGTCGGATCGTAGCCATGTCGTTCTGTGAGCCAAGGAGTTG) using bowtie2v 2.2.3 [38].
The mapping SAM file was first converted to a sorted indexed BAM file using SAMtools v1.9-45 [39]
(samtools sort; samtools index) and then used as input for the assembly error correction tool,
Pilon v1.23 [40].
4.4. Reclassification of GA A07 Strain
In total, 882 Bacillus genomes were downloaded to identify the most closely related species.
FastANI v1.2 [41] was leveraged to identify the most closely related species (i.e., the ones with the
highest average nucleotide identity compared to the GA A07 genome). Average amino acid identity was
also checked by the following steps: (1) Prodigal v2.6.3 [25] was used to in batch-predict protein-coding
genes from the genomes, and genes were converted into amino acid sequences; (2) amino acid identities
between the GA A07 genome and all downloaded Bacillus genomes were compared using BLASTP [26]
(parameters: -max_target_seqs 1 -evalue 1e-10); and (3) the mean value of the best-hit identities was
calculated and was regarded as the average amino acid identity between the two genomes. The Tetra
Correlation Search (TCS) function implemented in the JSpeciesWS webserver [27] was also pursued to
find the most closely related bacterial genome based on tetra-nucleotide composition evidence.
Only genomes with better assembly quality (defined as genomes with at most ten scaffolds) were
used to build the phylogenetic tree. The tree was generated using ezTree [42], which is capable of
identifying single-copy marker genes among input genomes, thereby creating a concatenated alignment
of all marker genes, and using FastTree 2 [43] with the Jones–Taylor–Thornton (JTT) evolutionary
model and 1000 resampling tests to construct a reliable tree. The nwk file of the phylogenetic tree was
then visualized using Molecular Evolutionary Genetics Analysis (MEGA) X software [31].
4.5. Identification and Analysis of GT Genes
The dbCAN2 webserver [44] was employed to identify potential GTs from the B. thuringiensis GA
A07 genome. An unrooted phylogenetic tree of all extracted GT protein sequences was constructed
using MEGA X software [31] with the maximum-likelihood method, 500 bootstrap replications,
the general reversible mitochondrial model [30], and partial deletion.
4.6. Fermentation and Biotransformation of GAA
Bacillus subtilis ATCC 6633 or B. thuringiensis GA A07 was cultivated in a 250-mL baffled Erlenmeyer
flask containing 20 mL of LB medium with 5% of glucose at 180 rpm and 28 ◦C. When the OD600 of the
cell culture reached 0.6, 1 mg/mL of GAA was added to the broth. Cultivation was carried out for
another 32 h, and fermentation broth (0.5 mL) of the culture was taken at predicted time intervals and
used for the UPLC analysis to measure the biotransformation activity.
4.7. UPLC Analysis
The UPLC system (Acquity UPLC H-Class, Waters, Milford, MA, USA) was equipped with an
analytic C18 reversed-phase column (Kinetex® C18, 1.7 μm, 2.1 i.d. × 100 mm, Phenomenex, Torrance,
CA, USA). The operating conditions of UPLC for analysis of GAA, antcin K, and celastrol were
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consistent with those of our previous study [4] except for the 430-nm absorbance detection of celastrol.
Operating conditions for flavonoids were from our previous study [11].
4.8. Expression and Purification of GT from GA A07 Strain
Genomic DNA of the GA A07 strain was isolated using the commercial kit Geno PlusTM (Viogene,
Taipei, Taiwan). Candidate GT genes were amplified from genomic DNA using a PCR with specific
primer sets (Table S2). The amplified GT genes were subcloned into the pETDuet-1™ vector through
suitable restriction enzyme sites (Table S2) to obtain the expression vector, pETDuet-BtGT (Figure S1a).
Expression vectors were transformed into E. coli BL21 (DE3) via electroporation to obtain recombinant
E. coli.
Recombinant BtGT_16345, BtGT_19840, and BtGT_19010 were produced and purified from the
recombinant E. coli, and analyzed by SDS-PAGE (Figure S1b–d). The protein concentration was
determined by a Bradford assay using bovine serum albumin as the standard. The experimental
procedures were the same as those in our previous study [4].
4.9. In Vitro Biotransformation Assay
In vitro biotransformation was performed using purified GT proteins. In a 0.1mL standard reaction
mixture, 1 μg of purified GT protein, 0.02 mg/mL of GAA, 1 mM of UDP-glucose, 10 mM of MgCl2,
and 50 mM of Tris at pH 8.0 were added. The reaction was carried out at 40 ◦C for 30 min, stopped by
adding 0.9 mL of methanol, and analyzed by UPLC.
For optimization experiments, different pH values, temperatures, and metal ions were replaced in
the standard reaction, where 1 mg/mL of GAA was used. For pH testing, PB at pH 6.0 to 7.5, and Tris
buffer at pH 8.0 and pH 9.0 were used. For metal ion testing, 10 mM of MgCl2, CaCl2, or MnCl2 was
used. The relative activity was obtained by dividing the area of the product peak of the reaction in the
UPLC profile by that of the reaction with Tris pH 8.0, at 40 ◦C, and with 10 mM of MgCl2.
For the substrate specificity assay, 25 mg/mL of the substrate soluble in dimethyl sulfoxide
conditions, all tested substances were soluble in the reaction buffer. 1 mg/mL of different test compounds
was mixed with 1 μg of purified GT protein, 10 mM of UDP-glucose, 10 mM of MgCl2, and 50 mM of
PB pH 7.0 in a 0.1mL reaction mixture and incubated at 30 ◦C for 30 min. After incubation, the reaction
mixture was analyzed by UPLC.
For the kinetic experiments, different concentrations of GAA were mixed with 10 μg of purified GT
protein, 10 mM of UDP-glucose, 10 mM of MgCl2, and 50 mM of PB at pH 7.0 for BtGT_16345, or 50 mM
of Tris at pH 8.0 for BsUGT398 and BsUGT489 in a 1-mL reaction mixture and incubated at 30 ◦C for
BtGT_16345, or 40 ◦C for BsUGT398 and BsUGT489 for 20 min. During incubation, samples from each
reaction were taken out and analyzed by UPLC every 2 min. The amount of GAA-15-O-β-glucoside
produced from the reaction was calculated from the peak area of the UPLC analysis normalized to
a standard curve. The reaction velocity at each concentration of GAA was obtained from the slope
of the plot of time versus the amount of the product. The kinetic parameters were calculated by
nonlinear regression analysis applied to Michaelis-Menten equation using SigmaPlot 14.0 software
(Systat Software, San Jose, CA, USA). The kcat values were calculated using the predicted molecular
mass for each recombinant enzyme.
5. Conclusions
A novel GT28 family enzyme, BtGT_16345, from a new genome assembly of the B. thuringiensis GA
A07 strain, was identified that can biotransform GAA into GAA-15-O-β-glucoside. To our knowledge,
BtGT_16345 is the first GT28 family enzyme with triterpenoid glycosylation activity.
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Abstract: Amylases are probably the best studied glycoside hydrolases and have a huge
biotechnological value for industrial processes on starch. Multiple amylases from fungi and microbes
are currently in use. Whereas bacterial amylases are well suited for many industrial processes due to
their high stability, fungal amylases are recognized as safe and are preferred in the food industry,
although they lack the pH tolerance and stability of their bacterial counterparts. Here, we describe
three amylases, two of which have a broad pH spectrum extending to pH 8 and higher stability
well suited for a broad set of industrial applications. These enzymes have the characteristic GH13
α-amylase fold with a central (β/α)8-domain, an insertion domain with the canonical calcium binding
site and a C-terminal β-sandwich domain. The active site was identified based on the binding of the
inhibitor acarbose in form of a transglycosylation product, in the amylases from Thamnidium elegans
and Cordyceps farinosa. The three amylases have shortened loops flanking the nonreducing end of
the substrate binding cleft, creating a more open crevice. Moreover, a potential novel binding site
in the C-terminal domain of the Cordyceps enzyme was identified, which might be part of a starch
interaction site. In addition, Cordyceps farinosa amylase presented a successful example of using the
microseed matrix screening technique to significantly speed-up crystallization.
Keywords: α-amylase; starch degradation; biotechnology; structure
1. Introduction
The use of enzymes in industrial processes is a multi-billion-dollar market. One of the first
enzymes discovered in 1833 was diastase, an enzyme able to hydrolyze starch [1]. Nowadays, amylases,
also able to hydrolyze starch, constitute up to 25% of the market for enzymes and have virtually
replaced chemical methods for degrading starch in the industrial sector (reviewed in [2]). Amylases are
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the most important class of enzymes for degrading starch and can be subdivided into three subclasses:
α-, β-, and gluco-amylases based on their reaction specificity and product profiles. α-amylases degrade
the α- 1,4 linkage between adjacent glucose units and are extensively used for example in bioethanol
production or in washing powder and detergents [3] (and reviewed in [4]). One of the most widely
used α-amylases is that from Bacillus licheniformis, known under the tradename “Termamyl”. Microbial
amylases are generally used in detergent applications and other industrial processes, including
bioethanol production, with new amylases, in particular those from hyperthermophilic organisms,
offering further improvement in the production process (reviewed in [5]).
α-amylases belong to glycoside hydrolase family 13 (GH13) in the CAZy database classification [6].
They have a (β/α)8 barrel domain harboring the active site, a subdomain which includes the canonical
calcium binding site inserted between the third β-strand and the third α-helix and a C-terminal
β-sandwich domain, thought to be important for the interaction with raw starch (reviewed in [7]) [8,9].
Amylases follow a retaining mechanism with an aspartate as nucleophile and one glutamate as general
acid/base [10,11]. Up to ten consecutive sugar subsites forming the active site cleft have been identified
in bacterial amylases [12].
To date, recombinant fungal amylases have been isolated from mesophilic hosts such as Aspergillus
oryzae and are of particular interest to the food industry as they match the temperature and pH range
used in typical applications in the baking process, where they are active in the dough but inactivated
during baking. Due to the widespread use of fungal enzymes for the production of food and food
ingredients (such as citric acid), they are classified as GRAS (generally recognized as safe) organisms
by organizations including the FDA (US Food and Drug Administration) [13].
Up till now, fungal enzymes with a higher pH-tolerance and thermostability have not been reported.
Here, we describe the structure and function of three novel α-amylases from Cordyceps farinosa (CfAM),
Rhizomucor pusillus (RpAM) and Thamnidium elegans (TeAM) with a higher stability and pH-tolerance
with the potential to act as novel biocatalysts for various industrial processes. The sequence of all three
enzymes groups them in the GH13 sub-family 1 along with, for example, the amylase from Aspergillus
oryzae (also known as TAKA amylase). However, unlike other fungal amylases, the enzymes in this
study have been shown to have a broad pH profile with an optimum around pH 5 while retaining
activity at pH 8. Furthermore, their more open crevice leads to the production of longer oligomers
compared to TAKA amylase.
The native RpAM and TeAM have a four-domain fold with a carbohydrate binding domain
(CBM20) at the C-terminus and a short serine-rich linker in between, while native CfAM lacks this
CBM20 domain. In this study, only the core of the amylases including the A, B and C domains was
cloned and expressed. In addition, crystallization of Cordyceps farinosa amylase again demonstrates the
power of the microseed matrix screening technique [14].
2. Results
2.1. Biochemical Characterization
The pH, temperature and product profiles were characterized for all three amylases. Of great
desire are amylases with a broader pH-tolerance compared to TAKA amylase. Our analysis showed
that all three amylases have a pH optimum around 5. Whereas TeAM has no significant activity
above pH 7, RpAM and CfAM retain significant activity at pH 7 extending up to a pH of 9 (Figure 1a).
In particular, CfAM shows the highest pH tolerance, retaining 70% of its activity at pH 8. RpAM
and TeAM both show a pronounced shoulder, suggesting the involvement of more titratable residues
in the substrate recognition and catalysis process. The temperature profiles reveal that RpAM and
CfAM also have a considerably higher thermotolerance compared to TAKA and TeAM (Figure 1b).
In particular, RpAM retains full activity even at 80 ◦C, making it an attractive enzyme for industrial
high temperature starch saccharification processes. Compared to TAKA amylase, all three amylases
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show a tendency to produce higher amounts of oligomers with a degree of polymerization (dp) of
three, with trace amounts of oligomers with a dp of up to seven for TeAM (Figure 1c).
 
Figure 1. Biochemical characterization of RpAM, CfAM. TeAM and TAKA. (a) pH-profile of all three
amylases in comparison with TAKA amylase; (b) temperature profile of all three amylases in comparison
with TAKA amylase; (c) product profile of all three amylases and the abundance of oligomers with a
degree of polymerization (dp) of 1 to 7 after hydrolysis of starch.
2.2. Overall Fold
The structures were solved using molecular replacement starting from the A. oryzae amylase
as template (pdb-ID: 7taa and 3vx0) to a resolution of 1.4 Å for RpAM, 1.2 Å for TeAM and 1.35 Å
for CfAM, respectively. The final model of RpAM includes two monomers in the asymmetric unit
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comprising residues 1 to 438 in both chains, which superpose on each other with an r.m.s.d. of 0.54 Å.
The model of TeAM contains one monomer in the asymmetric unit including residues 1 to 438. For
CfAM, there are two monomers in the asymmetric unit comprising residues 19 to 459 for chain A and
19 to 460 for chain B, which superpose with an r.m.s.d. of 0.3 Å. All three amylases have the classical
domain structure with a central (β/α)8-barrel with the active site located on its C-terminal face, together
with a small subdomain, inserted between the third strand and helix and a C-terminal β-sandwich
(Figure 2a). All three superpose with each other (Figure 2b) and with TAKA-amylase with an r.m.s.d.
between 0.6 to 0.9 Å for up to 423 residues. Two conserved disulphide bridges stabilize flexible loops
in subdomains A and B. There is an additional disulphide bridge in CfAM, located in the C-terminal
domain. All three α-amylases have the conserved canonical calcium binding site located between the
(β/α)8-barrel and the insertion domain B.
Figure 2. Structural overviews. (a) ribbon representation of the structure of CfAM amylase in ribbon
representation. The domains are colored separately with the central barrel in purple. subdomain B
in yellow and the C-terminal β-sandwich in green. The bound ligands acarbose transglycosylation
product (ATgp) and maltose are shown as spheres; (b) structural superposition of CfAM (purple) TeAM
(orange) and RpAM (green).
2.3. Ligand Binding Site
Although all three amylases were co-crystallized with acarbose, a well-known inhibitor for
amylases, a complex with acarbose bound was only obtained for TeAM and CfAM. The reason why
acarbose was not bound to RpAM is not clear. As expected, the acarbose was found in the substrate
binding cleft in each monomer of TeAM and CfAM, with the acarviosine unit sitting in subsites -1 and
+1, (Figure 3a–d). In both enzymes, the binding mode is conserved, and the ligands superpose with
each other (Figure 3e), except for the monomer in subsite -4. The distorted pseudosugar valieneamine
in subsite 1 with its 2H3 half chair conformation mimics the conformation of the putative transition
state along the catalytic itinerary of α-amylases. Additional density in subsites -2 and -3 and -4 was
modelled as a second acarbose unit, covalently attached to the first acarbose. The catalytic nucleophile
D190/D192(CfAM/TeAM) is in a near attack conformation poised to react with the anomeric carbon,
whilst the catalytic acid/base E214/E216(CfAM/TeAM) forms a hydrogen bond with the bridging
nitrogen of the glycosidic bond with the 4-deoxyglucose in subsite +1. In addition, a hydrogen bond
with H194/H196 stabilizes the 4-deoxyglucose in that subsite. The+3 subsite is formed by the sugar tong,
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composed of Y142/144 of subdomain B and F216/218 of the central domain, sandwiching the glucose
between them. The reducing end of acarbose is stabilized by a hydrophobic platform interaction with
Y240/F242 and a hydrogen bond with the main chain nitrogen of G218/G220. Interestingly, additional
density at the non-reducing end was observed and was modelled as an additional acarbose unit in
subsites −2 and −3 and −4. The glucose in subsite −2 is stabilized by multiple hydrogen bonds with
D323/325, R327/329 and W375/377. The glucose in subsite −3 is held in place by only one hydrogen
bond with D323/325. The last visible part of the acarbose molecule is the acarviosine unit in subsite −4,
which is not stabilized by direct interactions with the protein. Furthermore, the acarviosine unit is
in two different positions in the two structures, reflecting the lack of strong stabilizing interactions
between the ligand and the protein beyond subsite −3 (Figure 3e).
Figure 3. Acarbose transglycosylation product binding in CfAM and TeAM. (a,b) stick representation
of the acarbose derived transglycosylation product in the substrate binding crevice of CfAM and TeAM,
respectively. The 2Fo-Fc electron density around the ligands is contoured at 0.3 e/Å3. The interacting
residues are shown as cylinders. (c,d) hydrogen bonding pattern between ATgp and CfAM and TeAM
in the active site. (e) stereo view of the overlay of the binding crevice of CfAM (purple) and TeAM
(orange). The residues and the ligands overlap very closely with the only major difference being the
orientation of the acarviosine subunit in subsite -4.
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2.4. Secondary Glucose Binding Site
In CfAM, a secondary binding site in domain C was identified and modelled as maltose located at
the edge of the β-sandwich (Figure 4). The glucose units are held in place mainly via hydrogen bonds
without the usual stacking interactions with aromatic side chains.
Figure 4. The secondary maltose binding site in the C-terminal domain of CfAM. (a) stereo view showing
the maltose in cylinder representation with the corresponding 2Fo-Fc electron density contoured at
0.4 e/Å3. The interacting residues are shown as blue cylinders; (b) superposition of the C-terminal
domain (green) with the CBM20 domain from A. niger glucoamylase (pdb-ID: 1ac0) in beige. The
bound β-cyclodextrin of CBM20 and the maltose unit are shown as glycoblocks [15].
2.5. N-Glycosylation
There are three N-glycosylation sites, one at N144 in RpAM and two at N180 and 412 in TeAM.
We observed only the core GlcNAc residue in all three enzymes. In the case of TeAM, this is due to the
deglycosylation procedure with EndoH.
2.6. Isoasparate Formation
We observed the formation of an isoaspartate by succinimide formation and deamidation of N120
in chain B of RpAM. The same asparagine in chain A shows high flexibility and the resulting density
suggest partial isoaspartate formation, but a model could not be built with confidence.
3. Discussion
We have analyzed structurally and functionally three novel fungal α-amylases with potential to
be used in the food industry and other industrial processes. All three structures determined show the
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canonical amylase fold and overlap with each other with an r.m.s.d. of 0.54 Å (Figure 1b). Further
analysis of the sequence showed that both RpAM and CfAM have a slightly lower number of charged
residues and a higher number of hydrophobic residues compared to TeAm and TAKA amylase, which
might contribute to the higher thermostability of these two variants. Increased internal hydrophobicity
while keeping external hydrophilicity was found to correlate well with the thermostability of Bacillus
α-amylases [16]. Furthermore, the shortened loops in these enzymes may also contribute to the overall
rigidity of the enzymes and therefore the thermostability as observed for other enzymes as well [17,18].
The substrate crevice in all three amylases, if defined on the basis of protein carbohydrate
interactions, spans from subsite -3 to +3. Having only three defined subsites for the non-reducing end is
common for amylases and is in line with the number of donor subsites described for the TAKA-amylase.
Potentially, there could be more subsites for additional carbohydrate units at the reducing end, which
might connect the active site crevice with the observed second binding site (see below).
The observed complexes are most likely the result of limited transglycosylation, an unusual
side reaction previously reported in crystallo for several amylases—for example, TAKA-amylase [19].
Though this reaction is common in the closely related CGTases (GH13_2) and amylomaltases (GH77),
it was not observed in solution for α-amylases. However, in crystals, transglycosylation products with
10 or more units have been reported as a result of multiple transglycosylation events. Interestingly, the
final complex always has the pseudosaccharide unit, thought to mimic the transition state, in the -1
subsite, rendering the enzyme inactive. Other binding modes are clearly possible as evidenced by the
final product and a pre-Michaelis complex observed for GH77 Thermus aquaticus amylomaltase with
acarbose [20].
All three amylases have as their hallmark a shortened loop between β2/α3 and two shorter loops
in subdomain B located between β3 and α4 of the central (β/α)8-barrel, compared to structures of
other fungal amylases, e.g., TAKA-amylase (Figure 5a). The importance of subdomain B for the
physicochemical properties—for example, pH-stability, as well as substrate and product specificity,
is well known [21–24]. Indeed, the shorter loops open up the substrate crevice on the non-reducing
end (Figure 5b), which might explain the shift in the product profile for all three amylases towards
oligomers with a higher dp compared to TAKA amylase (Figures 1c and 5c).
The C-terminal domain in α-amylases is implicated in starch binding and shows structural
similarity to classic CBM domains, based on an analysis using PDBeFOLD [25]. The additional binding
site in this domain in CfAM strengthen the role of this domain in substrate binding. Additional
carbohydrate binding sites have been observed as well for example in barley α-amylase 1 [26]. While
none of these sites overlap with the binding site seen in CfAM, a structure of a CBM20 in complex with
β-cyclodextrin revealed two binding sites, with the site termed SB1 in close proximity to the binding
site in CfAM (Figure 4b) [27]. This was confirmed to be the primary binding site for the interaction with
raw starch, and it is likely that the observed binding site in CfAM is a genuine carbohydrate binding
site. Furthermore, it is intriguing to speculate about a potential path from the primary substrate crevice
to the secondary glucose binding site, which could be rather easily thought as a simple extension of
the acarbose from the reducing end.
Only limited information about the influence of glycosylation on amylase activity is available.
It was shown that, for α-amylase, Amy1 from the yeast Cryptococcus flavus N-glycosylation enhances
thermostability and resistance to proteolytic degradation [28]. The same effect is observed for
Trichoderma reesei Cel7a [29]. Indeed, N144 is located in an extended loop and N-glycosylation might
help to shield the loop against proteolytic attack. The other two glycosylation sites are located in or at
the beginning of secondary structure elements, with N412 being located in the C- domain.
The observed isoaspartate formation is thought usually to be an age-related side effect of protein
decomposition, but a functional role cannot be ruled out [30]. Indeed, it was shown in GH77
enzymes that such unusual posttranslational rearrangement might play a functional role in glycoside
hydrolases [31,32]. The observed isoaspartate is located in one of the shortened loops in subdomain B
close to the substrate binding cleft, suggesting a functional role in CfAM as well.
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Figure 5. (a) Stereo view of all three amylases compared to TAKA-amylase with the three shortened
loops in the front marked with arrows. The ligand in CfAM is shown as sticks to identify the active site;
(b) surface representation of CfAM with the bound ligand. The substrate is more open on the donor
subsite; (c) surface representation of TAKA-amylase. The elongated loops create a more restricted
active site crevice precluding the binding mode observed in CfAM and TeAM due to steric clashes.
4. Materials and Methods
4.1. Macromolecule Production
The coding sequence of CfAM for the A, B and C domains was amplified from Cordyceps
farinosa gDNA by the polymerase chain reaction (PCR). The PCR fragment was obtained
using primer pairs: 5′-ACACAACTGGGGATCCACCATGAAGCTTACTGCGTCCCTC-3′ and
5′-GATGGTGATGGGATCCTTACTGCGCAACAAAAACAATGGG-3′. The fragment was then ligated
in the expression vector pSUN515 using BamHI and XhoI restriction sites. The ligation protocol
was performed according to the IN-FUSION™ Cloning Kit instructions. A transformation of TOP10
competent E. coli cells (Tiangen, Beijing China) with the plasmid, containing the CfAM gene, was
performed and positive clones confirmed by sequencing. The transformation of Aspergillus oryzae
(strain MT3568) with the expression vector comprising CfAM gene was performed according to patent
application WO95/002043 [33]. After incubation for 4–7 days at 37 ◦C, spores of four transformants
were inoculated into 3 mL of YPM medium. After 3-day cultivation at 30 ◦C, the culture broths were
analyzed by SDS-PAGE to identify the transformant producing the largest amount of recombinant
mature amylase with an estimated size of 48 kDa. Spores from the best expressing transformant were
cultivated in YPM medium in shake flasks for 4 days at a temperature of 30 ◦C. The culture broth was
harvested by filtration using a 0.2 μm filter device, and the filtered fermentation broth was used for
purification and further assays.
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RpAM was cloned and expressed in a similar manner as CfAM while TeAM was expressed in Pichia
pastoris with a similar protocol to that described for the lipase from Gibberella zeae [34]. The entire coding
sequence of TeAM was amplified from cDNA by the polymerase chain reaction and transformation into
ElectroMax DH10B competent cells (Invitrogen, Waltham, MA, USA) by electroporation. Transformed
cells were plated on LB plates containing 100 mM ampicillin. After overnight incubation at 27 ◦C,
a positive clone was selected by colony PCR and confirmed by sequencing. The plasmid DNA of
the positive clone was linearized with PmeI (NEB, Ipswich, MA, USA) and transformed into Pichia
pastoris KM71 (Invitrogen, Waltham, MA, USA) following the manufacturer’s instructions. An amylase
positive clone was inoculated into 3 mL buffered minimal sorbitol complex medium and incubated
at 28 ◦C for 3 days until the OD600 reached 20. Methanol was added to the culture daily to a final
concentration of 0.5% for the following 4 days. On day 4 of induction, the culture supernatant was
separated from the cells by centrifugation and the pH of the supernatant was adjusted to 7.0.
The CfAM culture broth was precipitated with ammonium sulphate (80% saturation), then
dialyzed with 20 mM Na-acetate at pH 5.0. The solution was loaded on to a Q Sepharose Fast Flow
column (GE Healthcare, Brondby, Denmark) equilibrated with 20 mM Na Acetate at pH 5.0. Protein
was eluted with a salt gradient from zero to 1 M NaCl Fractions were analyzed for amylase activity
and pooled accordingly. The flow-through fraction, containing the bulk of amylase activity was
supplemented with ammonium sulphate to a final concentration of 1.2 M and then loaded on to Phenyl
Sepharose 6 Fast Flow column (GE Healthcare, Brondby, Denmark). The activity was eluted by a linear
gradient of decreasing salt concentration. The fractions with activity were analyzed by SDS-PAGE and
then concentrated for further use.
Amylase activity was detected by Azo dyed and azurine cross-linked hydroxyethyl-amylose
(AZCL-HE-amylose) (Megazyme International Ireland Ltd., Bray, Ireland) as substrate. In addition,
10μL enzyme sample and 120 μL 0.1% substrate at pH 7 were mixed in a microtiter plate and incubated
at 50 ◦C for 30 min. Then, 70 μL supernatant was transferred to a new microtiter plate and the
absorption at 595 nm determined. All reactions were done as duplicates.
4.2. Biochemical Characterisation
4.2.1. pH Optimum
To determine the pH Optimum, each enzyme (3 μL of a 0.5 mg/mL solution) was incubated with
40 μL 1% substrate (AZCL-HE-amylose) (Megazyme International Ireland Ltd., Bray, Ireland). The pH
between 2 and 11 was adjusted using 100 μL of B&R buffer (Britton–Robinson buffer: 0.1 M boric acid,
0.1 M acetic acid, and 0.1 M phosphoric acid, adjusted to pH-values 3.0, 4.0, 5.0, 6.0, 7.0, 8.0, 9.0, 10.0
and 11.0 with HCl or NaOH) [35]. The reactions were incubated at 30 ◦C for 30 min and afterwards
60 μL were transferred in a new microtiter plate and the absorption was measured at 595 nm.
4.2.2. Temperature Optimum
To determine the Temperature Optimum, each enzyme was incubated with 100 μL 0.1% substrate
(AZCL-HE-amylose) (Megazyme International Ireland Ltd., Bray, Ireland) in 50 mM Na Acetate pH 4.3.
The substrate solution was preincubated at 20–90 ◦C for 5 min and the reaction was started by addition
of 3 μL of enzyme solution (0.5 mg/mL). The reaction mixture was further incubated at the respective
temperature for 30 min at 950 rpm. The reaction was stopped by rapid cooling on ice. Afterwards,
60 μL of each reaction was transferred in a microtiterplate and the absorption was measured at 595 nm.
Each reaction was performed in triplicate.
4.2.3. Product Profile
For product profile determination, each enzyme (15 μL) was incubated with 120 μL 0.1% substrate
(AZCL-HE-amylose) (Megazyme International Ireland Ltd., Bray, Ireland) at pH 5 and 62 ◦C for 14 h.
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70 μL of each reaction was mixed with equal amounts of Acetonitril. The mixture was centrifuged for 30
min at 16.000× g and the supernatant was analyzed using HPAEC with pulsed amperometric detection.
4.3. Crystallisation
4.3.1. RpAM
The concentrated protein was mixed with acarbose in a molar ration of 4:1 before the initial
screening in 96 well format using commercially available screens. An initial hit (0.2 M NaCl, 0.1 M
Na-acetate pH 4.6, 30% MPD) was further refined in 24-well format using the initial crystals as seeds.
Crystals suitable for data collection were cryoprotected using 25% glycerol and flash frozen in liquid
nitrogen prior data collection.
4.3.2. TeAM
Prior to providing the sample to York, the protein was deglycosylated using Endo-H treatment.
The protein was concentrated using Amicon (Merck, Germany) filter units and stored at −80 ◦C for later
use. For the crystallization, the protein was mixed with 5 mM acarbose prior to setting up the screen.
Initial screens were set up in a 96-well sitting drop format using commercially available screens. Initial
hits were further refined in a 24-well hanging drop format. The best crystals grew in 0.1 M di-hydrogen
phosphate, 1.8 M ammonium sulphate. Crystals were cryoprotected by addition of ethylene glycol to a
final concentration of 15%. The crystals were flash frozen in liquid nitrogen prior to data collection.
4.3.3. CfAM
Prior to crystallization, the protein was concentrated to 22.5 mg/mL by ultrafiltration in an Amicon
centrifugation filter unit (Millipore), aliquoted to 50 μL; aliquots that were not immediately set up for
crystallization were flash frozen in liquid nitrogen and stored at −80◦C to use later in optimizations.
Initial crystallization experiments were carried out in the presence or absence of 4 mM CaCl2 and
40 mM acarbose. An initial hit was obtained for an acarbose complex, in just one condition (H3, Bis-tris
5.5, 25% w/v PEG3350) of JCSG screen (Figure 6a), out of total 192 conditions in two initial screens
set up – JCSG and PACT premier™HT-96 (Molecular Dimensions (Suffolk, UK)). The crystals were
imperfect and were used to make the seeding stock. The seeding stock was prepared and microseed
matrix screening (MMS, recent review in [14]) carried out using an Oryx robot (Douglas Instruments
(Hungerford, UK)) according to the published protocols [36,37]. Briefly, crystals were crushed, and
diluted with ~50 μL of mother liquor. The solution was transferred into a seed bead containing reaction
tube and vortexed for three minutes. The seeding stock was used straightaway, and the remaining
seeds were frozen and kept at™20 ◦C. MMS was carried out in the PACT screen, giving a significant
number of hits (Figure 6b). Crystals from condition A11 were used to make a seeding stock for the
next seeding round. This time it was not a “classical” MMS-seeding into a random screen, but rather
seeding into an optimization screen based on the initial conditions, but with different pH, salts and
PEGs/PEG concentrations. The crystallization drops contained 150 nl protein + 50 nl seeding stock +
100 nl mother liquor from a new random screen. The final, good quality crystal was obtained in 12%
PEG 3350 0.2 M NaNO3, CAPS pH 11.0 (Figure 6c).
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Figure 6. Crystal optimization using microseed matrix screening.
4.4. Data Collection and Processing
The data were collected at Diamond on beam line I02, processed by XDS [38], and scaled with
Aimless [39]. The statistics are shown in Table 1.
Table 1. Data collection and processing statistics.
CfAM TeAM RpAM
Diffraction source Diamond I02 Diamond I02 ESRF ID29
Wavelength (Å) 0.9795 0.9795 1.0004
Temperature (K) 100 100 100
Space group P1 P212121 P1
a, b, c (Å) 56.88, 61.97, 70.40 51.02, 56.63, 166.01 51.22, 62.60, 66.81
α, β, γ (◦) 79.33, 82.88, 67.99 90, 90, 90 77.03, 81.04, 89.62
Resolution range (Å) 33.1–1.35 (1.37–1.35) 48.76–1.20 (1.22-1.20) 43.21–1.4 (1.42–1.40)
Total No. of reflections 342,708 1,149,540 315,876
No. of unique reflections 163,777 150,529 146,177
Completeness (%) 85.3 (38.2) 99.8 (96.7) 92.9 (61.9)
Redundancy 2.1 (2.1) 7.6 (4.6) 2.2 (2.1)
〈I/σ(I)〉 13.7 (10.3) 14.1(1.7) 9.6 (2.3)
Rr.i.m. 0.076 (0.129) 0.021 (0.446) 0.030 (0.225)
CC1/2 0.983 (0.970 0.999 (0.615) 0.998 (0.892)
Overall B factor from
Wilson plot (Å2) 6.8 8.7 8.1
Values for the outer shell are given in parentheses.
4.5. Structure Solution and Refinement
The structure of RpAM was solved by molecular replacement with Molrep [40], using TAKA
amylase as template (PDB-ID:7taa). The structure of TeAM was solved with Molrep using the model of
RpAM. The CfAM structure was solved using Molrep [40] with 3vx0 α-amylase from Aspergillus oryzae
as a model. The final models were built using automated chain tracing with Buccaneer [41], followed
by manual building in Coot [42], iterated with reciprocal space refinement using Refmac [43]. The
statistics are summarized in Table 2.
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Table 2. Structure solution and refinement.
CfAM TeAM RpAM








Completeness (%) 85.3 (39.7) 99.8 (96.7) 92.8 (89.2)
No. of reflections, working set 155,488 143,033 138,848
No. of reflections, test set 8289 7574 7328
Final Rcryst 0.113 (0.09) 0.110 (0.27) 0.136 (0.22)
Final Rfree 0.150 (0.17) 0.134 (0.29) 0.164 (0.26)
Cruickshank DPI 0.051 0.027 0.056
No. of subunits in the asymmetric unit 2 1 2
No. of non-H atoms Chain A/B Chain A Chain A/B
Protein 3557/3609 3570 3662/3592
Ion 1/2 1 1/1
Ligand 99/120 133 14/36
Water 875 568 943
Total 8263 4272 8306
R.m.s. deviations
Bonds (Å) 0.0191 0.0163 0.0147
Angles (◦) 2.06 1.937 1.875
Average B factors (Å2) Chain A/B Chain A Chain A/B
Protein 10/8.7 12.9 12.9/12.3
Ions
Ca2+ 6.7/5.8 9.5 7.39/7.5
Na2+ N/A/10.9
Ligand 19.6/18.0 22.2 19.2/21.4
Water 19.0 28.8 24.21
Ramachandran plot
Most favoured (%) 98.6 97.7 97.2
Allowed (%) 1.4 2.3 2.7
Values for the outer shell are given in parentheses.
5. Conclusions
Taken together, we describe the structural and functional characterization of three novel fungal
α- amylases with enhanced stability, of which two, CfAM and RpAM, have a higher pH optimum
and greater temperature tolerance, well suited for usage in the detergent or saccharification industry.
The structures reveal that these amylases follow the canonical domain structure of α-amylases, and
that three shortened loops between β2/α3 and in subdomain B are likely to be responsible for the
altered enzymatic properties of the amylases compared to TAKA-amylase. For the first time, we have
unambiguously identified up to three different N-glycosylation sites in α-amylases in the structures.
Furthermore, the observed formation of an isoaspartate from an asparagine in one of the shortened
loops might play a functional role. The complexes with acarbose derived transglycosylation products
define seven subsites of the substrate binding crevice and helped to identify the catalytic residues
unambiguously. In addition, a new previously unobserved carbohydrate binding site was revealed in
the C-terminal β-sandwich domain of CfAM, which might be important for the initial interaction with
its polymeric substrate.
6. Patents
The Rhizomucor pusillus amylase and the use of this amylase in various industrial applications
have been claimed in patent application WO2006065579. A close homologue of the Thamnidium elegans
amylase was claimed in patent application WO2006069290 including the use in industrial applications.
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Abstract: β-Glucosidases are key enzymes in the process of cellulose utilization. It is the last enzyme
in the cellulose hydrolysis chain, which converts cellobiose to glucose. Since cellobiose is known to
have a feedback inhibitory effect on a variety of cellulases, β-glucosidase can prevent this inhibition
by hydrolyzing cellobiose to non-inhibitory glucose. While the optimal temperature of the Clostridium
thermocellum cellulosome is 70 ◦C, C. thermocellum β-glucosidase A is almost inactive at such high
temperatures. Thus, in the current study, a random mutagenesis directed evolutionary approach
was conducted to produce a thermostable mutant with Kcat and Km, similar to those of the wild-type
enzyme. The resultant mutant contained two mutations, A17S and K268N, but only the former was
found to affect thermostability, whereby the inflection temperature (Ti) was increased by 6.4 ◦C. A17
is located near the central cavity of the native enzyme. Interestingly, multiple alignments revealed
that position 17 is relatively conserved, whereby alanine is replaced only by serine. Upon the
addition of the thermostable mutant to the C. thermocellum secretome for subsequent hydrolysis of
microcrystalline cellulose at 70 ◦C, a higher soluble glucose yield (243%) was obtained compared to
the activity of the secretome supplemented with the wild-type enzyme.
Keywords: Cellulase; random mutagenesis; cellulose degradation; structural analysis
1. Introduction
Cellulose, the major polymer in the plant cell wall, is the most abundant organic resource on
Earth, and cellulosic is a primary feedstock for the production of ethanol-based biofuels. Cellulose
is a highly crystalline homopolymer composed of individual chains of glucose, which form a planar
structure, reinforced by inter and intra-chain hydrogen bond interactions [1]. Depending on the source,
each chain contains from 100 to more than 10,000 glucose units, with the disaccharide cellobiose
(composed of two glucose units oriented at 180◦ along the chain axis) being its smallest repetitive
unit [2]. In order to utilize cellulose as a resource for biofuel production, the chain must first be
enzymatically hydrolyzed into its primary monomeric glucose units. The glucose is then used as a
carbon source for alcoholic fermentation to produce bioethanol. Alternative fermentation processes
can also be used for the production of various other biochemicals such as butanol, acetone, lactic acid,
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succinic acid and more. Thus, efficient enzymatic hydrolysis of the cellulose is crucial for increasing
the cost-effectiveness of the bioethanol and biochemical production process [3,4].
In the plant cell wall, cellulose is encompassed by the hemicelluloses and lignin, which together
create a chemically complex and recalcitrant structure [5,6]. The plant cell wall structure and the rigid
nature of cellulose itself render the cellulose degradation process extremely difficult. For efficient
degradation, a diverse set of plant cell wall-degrading enzymes is therefore required [7,8]. Cellulose
hydrolysis is mediated by three major types of enzymes: endoglucanases, exoglucanases and
β-glucosidases that work in synergy [9]. Endoglucanases can cleave the cellulosic chains in the
middle, creating reducing and non-reducing ends. Exoglucanases hydrolyze the cellulosic chains
from the newly formed chain ends in a “processive” (sequential) manner, leading to the formation
of the soluble disaccharide cellobiose. Finally, β-glucosidases are capable of cleaving cellobiose
into soluble glucose units. Cellobiose is known to serve as a strong feedback inhibitor (mainly for
exoglucanases) [10], thus highlighting the significance of the β-glucosidases not only in providing
the end product (glucose) but also in preventing feedback inhibition. For example, near-complete
inhibition of the cellulosome of Clostridium thermocellum was observed at a concentration of only 2%
cellobiose [11,12]. The addition of its native β-glucosidase A (BglA) was able to relieve inhibition, and
thus to enhance the rate and degree of solubilization of crystalline cellulose [13,14]. The important role
of BglA was also demonstrated by manipulating C. thermocellum 27405 to overexpress the BglA gene
in vivo. The resultant strain demonstrated increased total cellulolytic activity during growth [15].
Extensive efforts have been made during the last decades for the development and assembly of
efficient cellulolytic enzymatic cocktails. However, cellulose degradation is still not efficient enough to
be cost effective [3,16]. One of the key bottlenecks for achieving cost-effective degradation of plant
cell wall biomass is the requirement for large amounts of cellulases (about 100–200 g of cellulase per
gallon of cellulosic ethanol) [17]. In this context, thermostable enzymes are gaining wide interest
in the industry, since they are better suited for harsh process conditions, such as those used for the
bioethanol production [18]. Thermostability of enzymes can be increased by genetic modification.
Increasing the thermostability of an enzyme, while retaining its activity, is thought to enhance its
overall performance, especially for the extended time periods necessary for degradation of cellulosic
substrates [19,20]. Moreover, thermostable enzymes can be recycled more efficiently, thereby lowering
overall production costs [21,22]. Finally, thermostable processes can reduce contamination [23].
Taken together, engineering thermostable enzymes is important to achieve the relatively low-cost
biodegradation of biomass for the production of cellulosic ethanol [24]. Indeed, a wide range of bacterial
or fungal cellulases was subjected to genetic modification to increase their thermostability [24–28].
C. thermocellum is a thermophilic bacterium, and its cellulosome is considered to be one of the most
efficient natural systems for cellulose conversion [29]. Our group and others have previously reported
the design of highly thermostable mutants derived from C. thermocellum cellulolytic enzymes, such as
the endoglucanase Cel8A [30–32] and the exoglucanase Cel48S [33], which have proved to be stable at
very high temperature ranges (around 80 ◦C). In nature, C. thermocellum utilizes cell-surface-bound
cellulosomes to hydrolyze the cellulose into soluble cellobiose and other cellodextrins, which are then
actively transported into the cells and hydrolyzed to glucose by periplasmic β-glucosidase [10,34].
The maximal cellulose degradation capacity mediated by the C. thermocellum cellulosome could be
achieved at 70 ◦C [35]. However, the results reported here demonstrate inactivation of the recombinant
C. thermocellum BglA (Clo1313_2020) at such high temperatures. Thus, and due to the important role of
β-glucosidases, enhancing the thermostability of C. thermocellum BglA is of great significance and was
the goal of the current study.
Directed evolution, which consists of random mutagenesis and high-throughput screening
approaches, is a powerful technique which does not require prior functional, structural, or mechanistic
knowledge. Only suitable and effective screening strategies for the desired activity are required [36,37].
The chromogenic product released from p-nitrophenyl-β-d-1,4-glucopyranoside (pNPG, an analogue
of the natural substrate of β-glucosidase: cellobiose), enables efficient and rapid screening. Indeed,
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directed evolution methodologies have already been used in the past for enhanced thermostability of
β-glucosidases from other (mostly mesophilic) organisms [36,38,39], which resulted in the creation
of mutants stable at temperature ranges of 50–60 ◦C (the natural wild-type range of C. thermocellum
recombinant enzymes). In the current study, we used the directed evolution strategy based on the
substrate analogue pNPG, in order to create and reveal thermostable mutants of C. thermocellum
BglA. The functionality of this mutant was also validated under near-natural conditions, namely by
examining the contribution of the thermostable BglA to the hydrolyses of microcrystalline cellulose by
C. thermocellum cellulase mixtures.
2. Results
2.1. Construction and Screening of C. Thermocellum BglA Clones Library
In order to generate thermostable mutants of C. thermocellum BglA, in vitro directed evolution
was applied on the full-length open reading frame (ORF) of the Clo1313_2020 gene. High numbers
of mutation events per clone enable broad screening, but, in contrast, too many mutation events per
clone might mask the desired mutation events. Here, a frequency leading to ~20% active clones was
chosen. Mutation frequency is determined by two parameters: the template amount and the number
of polymerase reaction cycles. Hence, by using different template amounts and different thermal
cycle numbers, appropriate mini-libraries were created. The amount of 100 ng DNA template and
23 PCR thermal cycles led to 23% active colonies, which were used to create a library of ~40,000 clones.
Sequencing eight active and non-active clones revealed an average of three and seven mutation events
per active and non-active clones, respectively. In the next step, the library was screened for thermostable
clones. About 8000 clones were screened, revealing 40 thermostable (red) clones.
2.2. Characterization of the Thermostable Mutants
In order to verify and quantify the thermostability of the detected clones, their residual activity
after heat shock was calculated (residual activity was defined as the activity of the heat-shocked lysate
× 100/activity of non-heated lysate). The residual activities of the two most thermostable clones were
149% and 140% higher than the wild type. The most thermostable clone was sequenced, revealing one
silent mutation and two mutation events: A17S and K268N (herein referred to as Mut 1). The second
thermostable clone revealed a single mutation event: S39T (referred here as Mut 2).
For further characterization, the two thermostable mutants and the wild-type BglA enzyme
were recombinantly expressed in E. coli and purified. Purified enzymes were subjected to heat-shock
treatment (66–72 ◦C, 1 h) and residual activities were calculated (Figure 1). Indeed, both mutants
were more thermostable than the wild-type enzyme, with Mut 1 being more thermostable than Mut
2. Mut 1 lost only ~40% of its activity (residual activity ~60%) after heat-shock at 68.4 ◦C. Under the
same conditions, Mut 2 lost ~90% of its activity, and the wild-type BglA totally lost its activity. After
heat-shock at 70 ◦C, both the wild-type and Mut 2 enzymes totally lost their activity, while Mut 1 still
exhibited residual activity of ~9.5%.
The kinetic parameters of the wild type and Mut 1 were measured (Table 1). Mut 1 revealed
relatively similar and only slightly higher catalytic efficiency (Kcat/Km), with no statistical differences
between the Kcat and Km values compared to the wild type enzyme. The effect of each mutation event
(namely A17S and K268N) on the thermostability of Mut 1 was examined. For this purpose, two
recombinant enzymes were constructed and purified, one containing only the A17S mutation, and
the other only K268N. The enzymes were subjected to heat-shock (66–72 ◦C, 1 h), and the residual
activities were calculated (Figure 1). A17S demonstrated similar thermostability to Mut 1, indicating the
major contribution of this substitution to the thermostability. In contrast, K268S did not demonstrate
improvement in its thermostability (compared to that of the wild type), indicating that the improved
thermostability derived only from the A17S mutation event. Using site-direct mutagenesis, A17 was
substituted with other polar amino acids, namely, threonine, glutamine and asparagine. The resultant
221
Int. J. Mol. Sci. 2019, 20, 4701
enzymes (A17T, A17Q and A17N) demonstrated much lower activity and thermostability, compared to


























Figure 1. Thermostability of the various C. thermocellum BglA mutants. Wild-type (WT) C. thermocellum
BglA and the different mutants were incubated at 66–72 ◦C for 1 h, followed by activity assay
(using p-nitrophenyl-β-d-1,4-glucopyranoside [pNPG], an analogue of the natural β-glucosidase
substrate). Residual activity of the different mutants (defined as the activity of the heat-shocked
enzyme × 100/activity of the non-heated enzyme) was calculated. Mut 1 and A17S demonstrated
similar thermostability.
Table 1. Kinetic parameters of pNPG hydrolysis by wild-type C. thermocellum BglA and the thermostable
mutant (Mut 1).
Title Wild Type Mut 1
Vmax [M·s−1] 9.92 × 10−7 ± 6.57 × 10−8 9.1 × 10−7 ± 3.97 × 10−8
Kcat [s−1] 76 ± 5.036 70 ± 3.05
Km [mM] 6.7 ± 1.111 5 ± 0.59
Kcat/Km [s−1·M−1] 11,282 ± 900 14,018 ± 867
Kinetic parameters of C. thermocellum BglA and Mut 1 were measured by pNPG assay, and calculated by nonlinear
fit by GraphPadPrism software.
The inflection temperatures (Ti) of the wild-type, Mut 1 and A17S enzymes were measured using
a NanoTemper Tycho NT.6 instrument. This assay is based on the changes in the intrinsic fluorescence
from the aromatic amino acid residues tryptophan and tyrosine (measured at 350 nm and 330 nm).
During the assay, the temperature of the protein solution is ramped from 35 ◦C to 95 ◦C for a 3 min
period, accompanied by continuous measurement of the fluorescence. Changes in the fluorescence
signal indicate transitions in the folding state of a protein. The midpoint temperature at which a
transition occurs is called the inflection temperature (Ti) [40–42]. The Ti of wild-type BglA, Mut 1
and A17S were 79.3 ± 0.08, 85.7 ± 0.15 and 85.7 ± 0.16 ◦C, respectively, demonstrating an increase of
~6.4 ◦C in the Ti (Figure 2). The effect of cellobiose (the natural substrate of β-glucosidases) added
to the reaction mixture (at 1 mM) on the Ti was also tested. The results were similar (80 ± 0.48 ◦C,
85.9 ± 0.53 ◦C and 85.8 ± 0.1 ◦C for the wild-type, Mut 1 and A17S, respectively), indicating no stability
effect in the presence of cellobiose.
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Figure 2. Inflection temperatures (Ti) of wild-type (WT) C. thermocellum BglA, Mut 1 and A17S.
The inflection temperatures were measured using a NanoTemper Tycho NT.6 instrument as described
in the Methods section.
The amino acid sequence of C. thermocellum BglA was BLASTed against the NCBI nonredundant
protein database. BLAST results for the residues adjacent to the A17S mutation event are represented
schematically by the diagrams of amino acids frequencies in Figure 3. The residues near position
17 were found to be relatively conserved. Interestingly, the only amino acid replacing the alanine in
position 17 in the different homologues was serine.
Figure 3. Amino acid frequencies in the residues surrounding the A17S mutation event. The relevant
amino acid sequence of C. thermocellum BglA was BLASTed against the NCBI nonredundant protein
database. The top 1000 hits were used to create the distribution scheme using WEBLOGO. Position 17
is marked by the red circle.
2.3. Structural Aspects of BglA
The crystal structure of wild-type C. thermocellum BglA was recently determined in our lab
(PDB code 5OGZ, Table S1). BglA adopts the expected (β/α)8 TIM barrel fold, typically observed for
clan-A β-glucosidases, with two active-site glutamates, Glu166 on strand β4 and Glu355 on strand β7,
presumed to act as catalytic acid/base and nucleophile, respectively. Structure alignment of the Bg1A
structure with those of four other family-1 β-glucosidases revealed that the glutamate residues are
positioned very similarly with respect to the aligned structures. In addition, the distance between their
Cδ atoms is 5.33 Å, consistent with the properties of a retaining β-glycosidase. These highly conserved
motifs are responsible for substrate binding and enzymatic hydrolysis of the glycosidic bond within
the active site.
Figure 4A shows the position of A17, which is located in a loop near the central cavity of the
enzyme. The nearby coding region of K268, however, which is located in an outer α-helix, was
relatively non-conserved (data not shown).
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Figure 4. Structural analysis of C. thermocellum BglA. (A) Crystal structure of C. thermocellum BglA.
α-Helices are colored purple. β-sheets are colored blue. Ala17 and Lys268 (the two mutated positions
in Mut 1) are displayed by spheres. (B) Ala17 and its adjacent residues. Carbon atoms are shown in
white, oxygen atoms in red and nitrogen atoms in blue. Analysis was performed using PyMol software.
2.4. Advantage of Thermostable BglA in the Cellulose Hydrolysis Process
The contribution of thermostable BglA (Mut 1) to the cellulose hydrolysis process was examined.
For this purpose, microcrystalline cellulose (Avicel) was hydrolyzed by the C. thermocellum secretome,
supplemented with either Mut 1 or wild-type BglA at 60 and 70 ◦C, and the concentration of the
released soluble glucose was measured (Figure 5). Final glucose concentrations in the Mut 1 samples
were higher than those of the wild-type samples at both temperatures. However, this advantage was
much higher while working at 70 ◦C (57.4 mM in Mut 1 versus 21.7 mM in the wild-type samples), and
lower while working at 60 ◦C (47.1 mM in Mut 1 versus 40.1 mM in the wild-type).
Figure 5. Hydrolysis of microcrystalline cellulose by the C. thermocellum secretome. Solutions containing
the C. thermocellum secretome were applied on Avicel with or without the addition of BglA (wild-type
or mutant), followed by incubation at either 60 or 70 ◦C for 48 h. The concentration of the released
soluble glucose was measured by HPLC. Mut 1 showed higher glucose yields at both temperatures,
with significant advantage at 70 ◦C. The experiment was conducted in triplicate. Bars indicate
standard deviation.
In addition, Mut 1 was integrated in our lab into a thermostable designer cellulosome [43]. To do
so, a plasmid was created containing clone 1 attached to the gene segment coding for the dockerin
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module from Clostridium clariflavum. The expressed recombinant enzyme was successfully integrated
into an artificial thermostable designer scaffoldin, which also contained appropriate dockerin-bearing
thermostable Clostridium thermocellum mutants of both exoglucanase Cel48S and endoglucanase
Cel8A. The resulting thermostable designer cellulosome exhibited a 1.7-fold enhancement in cellulose
degradation (compared to the action of conventional designer cellulosomes that contain the respective
wild-type enzymes). The results were published by Moraïs et al. in 2016 [43].
3. Discussion
Developing thermostable and highly active cellulase preparations is critical for achieving
cost-effective enzymatic deconstruction of cellulosic biomass [24]. In this report, directed evolution
was conducted on the β-glucosidase A gene of the thermophilic bacterium, C. thermocellum, to produce
a potent thermostable mutant (Mut 1), which contained two mutations: Alanine at position 17 was
substituted with serine, and lysine at position 258 was substituted with asparagine. However, only
the A17S mutation was found to be responsible for the observed thermostability. The residues near
position 17 were found to be conserved among the top 1000 homologous sequences of C. thermocellum
β-glucosidase A. The observed conservation can indicate the important role of this position and on
the importance of alanine 17 to the functionality of the enzyme [44,45]. The fact that serine was the
only amino acid replacing alanine in position 17 in the different homologues is fully consistent with
our results, in which the alanine-to-serine mutation produced a functional and thermostable mutant
enzyme. Indeed, substitution of A17 with threonine, glutamine and asparagine resulted in almost
inactive enzymes. According to Daniel et al. (1996), the enhanced stability of proteins can be achieved
by an additional stabilizing force which is equivalent to only a few weak interactions [31,46]. Indeed,
single mutation events were found to increase the thermostability of various cellulases [31,36,47]. In the
case of C. thermocellum BglA, substitution of serine for alanine would likely result in hydrogen bonding
with His 121 (Figure 4B), both of which are located near the active site. The newly created hydrogen
bond would presumably help stabilize the enzyme. Our results also demonstrate that a single point
mutation can increase the thermostability of the already naturally thermostable C. thermocellum BglA,
thereby increasing its Ti by 6.4 ◦C.
Mut 1 showed increased activity over the wild-type enzyme, with a much higher effect at 70 ◦C
versus 60 ◦C (the optimum growth temperature for C. thermocellum). These results, together with the
fact that Mut 1 has similar Kcat and Km, indicate that the mutation affects mainly the thermostability,
rather than the activity of the enzyme. Directed evolution conducted on the mesophilic bacterium
Paenibacillus polymyxa BglA revealed a more thermostable mutant containing the same A17S mutation
event [36]. This mutation event increased the half-life of thermoinactivation by 11-fold, when applied at
50 ◦C. In addition, the authors obtained a lower Km and a higher Kcat, resulting in doubling the catalytic
efficiency. Considering the crystal structure of P. polymyxa BglA, a possible explanation for those
effects was suggested [36]. The alanine at position 17 occurred in the internal cavity, buried among
Gln20, His121, Trp398 and Trp406, near the active site. It was suggested that the alanine-to-serine
substitution increased the residue volume, which in turn was assumed to be important for enzyme
thermostability [48]. In addition, the proximity of the newly substituted polar residue (serine) to the
above-mentioned amino acids, all of which participate in the ligand binding, was suggested to increase
the binding affinity [49]. The crystal structure of C. thermocellum BglA revealed a similar structure
(Figure 4B) to that of P. polymyxa BglA, with the Ala17 buried in the internal cavity among Gln20,
His121, Trp402 and Trp410. Thus, a very similar mechanism may well be valid for C. thermocellum
BglA although no significant effect on Km was measured.
Chromogenic substrates are often used for the screening of enzyme activity, since they enable rapid
visual detection of the desired phenotype. However, improved hydrolysis of the synthetic chromogenic
substrate does not necessarily correlate with that of the natural substrate of the enzyme [38,50,51]. Thus,
a verification step of the enzymatic activity on the natural substrate is required following screening on
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substrate analogues. Thus, the contribution of Mut 1 to cellulose hydrolysis was tested in this study,
thereby revealing its advantage at higher temperatures.
In nature, the assembly of the catalytic units of C. thermocellum into cellulosomes containing
cellulose-binding modules (CBMs) resulted in the formation of higher local cellobiose concentrations
at particular sites. However, C. thermocellum BglA does not possess a CBM module, and is not targeted
towards the increased local cellobiose concentration. Instead, cellulosome-generated cellobiose is
transported directly into the cell [34], and hydrolyzed to glucose by periplasmic β-glucosidases.
In cell-free enzymatic systems, such as that reported here, removal of inhibitory cellobiose can be
performed by adding BglA to the assay. Thus, targeting the recombinant BglA to the increased local
cellobiose concentration might improve hydrolysis efficiency. In a former study conducted by our lab,
we reported the design of a recombinant form of the wild-type C. thermocellum BglA, which possessed
the ability to directly bind to the cellulosome via cohesin-dockerin interaction [52]. Integration of BglA
into the C. thermocellum cellulosome led to higher degradation levels of microcrystalline cellulose and
pretreated switchgrass, compared to cellulosomes supplemented with the soluble wild-type form of
the enzyme. By using the same technique, the thermostable Mut 1 was incorporated into thermostable
designer cellulosomes, which now demonstrated a 1.7-fold enhancement in cellulose degradation,
compared to a non-thermostabilized designer cellulosome preparation [43]. These results further
emphasize the advantage of thermostable mutants for improving lignocellulosic biomass conversion.
Several approaches can be applied to design thermostable cellulases. In the current study, the
directed evolution approach was used for the improvement of C. thermocellum BglA. This strategy
is based on random mutagenesis and sequential screening rather than a rational hypothesis-based
approach. This powerful method does not require preliminary knowledge about the structure of the
enzyme, and can reveal mutations that would not be revealed by knowledge-dependent approaches.
However, in the future, the recently solved crystal structure of C. thermocellum BglA (Table S1) can be
used for rational design, in order to further improve the thermostability and activity of Mut 1. [53].
Overall, the current study demonstrates that natural thermostable cellulases can be further
improved. Exposing the “hidden” potential of plant cell wall-degrading enzymes is thus an important
step towards cost-effective conversion of plant biomass into bioethanol or other biochemicals.
4. Materials and Methods
4.1. Random Mutagenesis and Library Construction
A library of C. thermocellum BglA mutant clones was created as previously described [30,31]
with minor modifications. Different quantities (20, 100 or 400 ng) of the C. thermocellum BglA open
reading frame Clo1313_2020, cloned in a pET28a plasmid, were used as a template for error prone
PCR according to the manufacturer’s instructions, using Gene-Morph II Random Mutagenesis Kit
(Stratagene, La Jolla, CA, USA). Thermal cycling parameters were 95 ◦C for 2 min followed by 18, 23 or
27 cycles of 95 ◦C for 1 min, 55 ◦C for 45 s and 72 ◦C for 2 min, followed by a final step of 72 ◦C for
10 min. T7 promoter primer and T7 terminator primer were used for amplification. The resulting PCR
products were applied on 0.75% agarose gel. Extracted bands were treated with DpnI and diluted
100 times. The solution was then used as a template for sequential PCR reaction using ReadyMix™ Taq
PCR Reaction Mix (Sigma-Aldrich, Rehovot, Israel) with primers: CAGTCCATGGCAAAGATAAC
(NcoI restriction site) and CACGCTCGAGGAAACCGTTGTTTTTGATTAC (XhoI restriction site).
The thermal cycling parameters followed the manufacturer’s instruction, with an annealing temperature
of 55 ◦C and elongation time of 2 min. The amplified products were purified, restricted with NcoI and
XhoI according to the manufacturer’s instructions and ligated to the pET28a-based plasmid treated
with NcoI/XhoI and shrimp alkaline phosphatase (SAP). The ligated plasmids were treated with SacI in
order to remove unrestricted vector. (New England Biolabs, UK enzymes were used in the restriction
and ligation process). Plasmids were then electrotransformed into E. coli XL1 electro-competent cells
and purified using a miniprep kit (QIAprep Spin Miniprep Kit, Qiagen, Redwood City, CA, USA),
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creating minilibraries. The minilibraries were transformed into E. coli BL21 competent cells and
plated on LB plates, containing 1.5% agar, 4 μM isopropyl β-d-1-thiogalactopyranoside (IPTG) and
50 μg/mL kanamycin. The plates were incubated overnight at 37 ◦C. A solution of 25 mM citrate buffer,
pH = 6.1, containing 0.75% agar, was then boiled, cooled to 45 ◦C and supplemented with Magenta
GlcA (5-Bromo-6-chloro-3-indolyl β-d-glucuronide cyclohexylammonium salt, Sigma Aldrich) to a
final concentration of 0.02%, and applied onto the plates, creating an additional layer. The plates were
dried for 1 h at room temperature and then incubated at 60 ◦C for 1.5 h (until red colonies appeared).
The percentage of the red colonies was calculated and the parameters leading to 20–30% active clones
were further used to increase library.
4.2. Screening for Thermostable Clones
Library screening was performed as detailed in the previous section with two additional steps:
Plasmids were transformed into E. coli BL21 competent cells and plated on LB plates containing 1.5%
agar, 4 μM IPTG and 50 μg/mL kanamycin. The plates were incubated overnight at 37 ◦C. They were
then replicated on fresh LB agar plates using silk snippets, heat-shocked at 70 ◦C for 50 min and cooled
at 4 ◦C. A layer of 25 mM citrate buffer, pH 6.1, 0.75% agar and 0.02% Magenta GlcA, was added to the
plates (as detailed above), which were dried for 1 h at room temperature and then incubated at 60 ◦C
for 1.5 h. The replicates were used to purify the plasmids of selected red colonies, and selected clones
were sequenced. A plate containing wild-type C. thermocellum BglA was used as a control.
4.3. Residual Activity of Overexpressing BglA Colonies
Colonies overexpressing thermostable mutants (as indicated by the appearance of red color) were
grown on liquid LB medium (0.5 mL), containing 0.1 mM IPTG and 50 μg/mL kanamycin, overnight
at 37 ◦C in 96-deep-well plates. In order to extract the proteins, each well was supplemented with
20 μL of Popculture (Novagene, Darmstadt, Germany), DNaseI and lysozyme, and the plate was
incubated at 37 ◦C for 20 min. The lysate was diluted 30 times in 50 mM citrate buffer, pH 6.1. Diluted
lysate (100 μL) was incubated at 66 ◦C for 75 min and cooled on ice. Then, 15 μL of heated and
non-heated samples were added to 1 mM p-nitrophenyl-β-d-glucopyranoside (pNPG, Sigma Aldrich,
St. Louis, MO, USA) solution and incubated for 45 min at 60 ◦C. The reaction was terminated by
adding 85 μl of 1 M carbonate buffer, pH 9.5, and optical densities of the samples were measured at a
wavelength of 405 nm. Residual activity was calculated by comparing the activity of the heated versus
non-heated samples.
4.4. Protein Expression and Purification
The resulting C. thermocellum BglA mutants and wild-type enzymes were produced by expression
of relevant plasmids into E. coli BL21 (lDE3) pLysS cells. The proteins were extracted and purified on
an Ni-nitrilotriacetic acid (NTA) column (Qiagen, Hilden, Germany), as reported earlier [30]. Purity of
the recombinant proteins was assessed by SDS-PAGE on 12% acrylamide gels, and fractions, containing
the pure recombinant protein, were pooled and concentrated using AmiconUltra 15 mL 50,000 MWCO
concentrators (Millipore, Bedford, MA, USA). Protein concentration was estimated from the absorbance
at 280 nm, based on the known amino acid composition of the protein, using the Protparam tool
(http://www.expasy.org/tools/protparam.html). Proteins were stored in 50% (v/v) glycerol at −20 ◦C.
4.5. Stability Assay
Solutions of 50 mM citrate buffer, pH 6, containing 7 μg/mL of the recombinant enzymes, were
incubated at 66–72 ◦C for 1 h and then cooled on ice. Heated and non-heated samples were diluted to
a final enzymatic concentration of 1.05 μg/mL in a solution of 50 mM citrate buffer, pH 6.1, containing
1 mM pNPG, incubated for 10 min at 60 ◦C, cooled on ice, and supplemented with equal amounts of 1 M
carbonate buffer, pH 9.5. Optical densities of the samples were measured at a wavelength of 405 nm.
Residual activity was calculated by comparing the activity of the heated versus non-heated enzymes.
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4.6. Kinetic Parameters Measurements
A solution of 50 mM citrate buffer, pH 6.1, containing 0–25 mM pNPG, was supplemented with a
concentration of 13 nM enzyme (wild-type or mutant) and incubated at 60 ◦C for 8 min in a preheated
96-well plate, accompanied by continued measurements at OD405. The concentrations of end product
(p-nitrophenol) were calculated using known concentrations of p-nitrophenol. Kinetic parameters were
calculated by nonlinear fit using the GraphPadPrism software (GraphPad Software, Inc., San Diego,
CA, USA)
4.7. Sequence Analysis
The protein sequence of C. thermocellum BglA (ADU75064.1) was BLASTed against the NCBI
non-redundant protein database. The top 1000 hits with E-value < 0.001 were further aligned.
Frequency of amino acids was visualized using WEBLOGO version 2.8.2.
4.8. Purification of the C. Thermocellum Secretome
C. thermocellum DSM1313 was grown on GS-2 medium (0.5 g/L K2HPO4, 0.5 g/L MgCl2·6H2O,
0.5 g/L KH2PO4, 1.3 g/L (NH4)2SO4, 0.002 g/L resazurin, 10.5 g/L MOPS buffer, 5 g/L yeast extract,
1.25 mg/L iron(II) sulfate and 0.5 mM CaCl2, adjusted with 10 M NaOH to a final pH of 7.2) with 0.5%
microcrystalline cellulose (Avicel, Sigma Aldrich, St. Louis, MO, USA) in batch culture. Nitrogen
flushing was used to achieve anaerobic conditions. After 48 h of incubation at 60 ◦C, growth medium
was centrifuged (10,808× g, 10 min). Soluble proteins were precipitate by 80% ammonium sulfate
and re-suspended in Tris-buffered saline (TBS) buffer, pH 7.4. Protein concentration was measured by
Bradford assay, using Bio-Rad protein assay solution (Bio-Rad) [54].
4.9. Cellulose Hydrolysis Assay
A quantity of 0.6 mg/mL of C. thermocellum secretome solution was applied to a suspension of
250 mg/mL of microcrystalline cellulose in 20 mM citrate buffer, pH 6.1, with or without the addition
of 2 μg/mL BglA (wild-type or mutant) in a reaction volume of 2 mL. Samples were incubated at
60 and 70 ◦C for 48 h, and centrifuged (16,100× g, 5 min). Released soluble sugars were analyzed
by high-pressure liquid chromatography (HPLC, Agilent Infinity 1260 system, Agilent Technologies,
Santa Clara, CA, USA) using an Aminex®HPX-87H Ion Exclusion column (Bio-Rad, Hercules, CA,
USA) with a guard column, mobile phase of 5 mM H2SO4 (flow-through of 0.6 mL/min at 45 ◦C) in an
Agilent 1260 Infinity LC system with RID detector (G1362A). Experiments were performed in triplicate.
4.10. Ti Measurements
Recombinant BglA enzymes in TBSx1 buffer (with and without the addition of 1 mM cellobiose)
were used for Ti measurements, using a NanoTemper Tycho NT.6 instrument Agentek (1987) Ltd.,
Tel Aviv, Israel), according to the manufacturer’s instructions [42].
Supplementary Materials: Supplementary material can be found at http://www.mdpi.com/1422-0067/20/19/4701/
s1.
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Abstract: ArthβDG is a dimeric, cold-adapted β-d-galactosidase that exhibits high hydrolytic
and transglycosylation activity. A series of crystal structures of its wild form, as well as its
ArthβDG_E441Q mutein complexes with ligands were obtained in order to describe the mode of
its action. The ArthβDG_E441Q mutein is an inactive form of the enzyme designed to enable
observation of enzyme interaction with its substrate. The resulting three-dimensional structures
of complexes: ArthβDG_E441Q/LACs and ArthβDG/IPTG (ligand bound in shallow mode) and
structures of complexes ArthβDG_E441Q/LACd, ArthβDG/ONPG (ligands bound in deep mode),
and galactose ArthβDG/GAL and their analysis enabled structural characterization of the hydrolysis
reaction mechanism. Furthermore, comparative analysis with mesophilic analogs revealed the most
striking differences in catalysis mechanisms. The key role in substrate transfer from shallow to deep
binding mode involves rotation of the F581 side chain. It is worth noting that the 10-aa loop restricting
access to the active site in mesophilic GH2 βDGs, in ArthβDG is moved outward. This facilitates
access of substrate to active site. Such a permanent exposure of the entrance to the active site may be
a key factor for improved turnover rate of the cold adapted enzyme and thus a structural feature
related to its cold adaptation.
Keywords: galactosidase; hydrolysis; reaction mechanism; complex structures; cold-adapted; GH2
1. Introduction
Glycosyl hydrolases (GHs) are sugar processing enzymes, divided into families based on their
structures. This is the reason why the lactose processing β-d-galactosidases (βDGs) belong to different
GH families: GH1, GH2, GH35, GH42, and GH59. Their common structural feature is presence of a
TIM-barrel type catalytic domain followed by a variety of β-architecture domains, which nature and
occurrence differ among GH subfamilies [1].
The most studied β-d-galactosidase in the GH2 family is bacterial lacZ βDG from Escherichia coli
(EcolβDG) [2–4]. It is a large homotetramer, where each monomer consists of 1023 amino acids. Its
primary mode of action is to catalyze the hydrolysis of lactose to d-galactose and d-glucose. To achieve
its full catalytic efficiency EcolβDG requires the presence of divalent ions such as Mg2+ or Mn2+, which
can result in 5−100-fold increase of activation depending on the substrate. Within the EcolβDG catalytic
site, two subsites can be distinguished: the first exhibits high specificity for binding the galactose
moiety, whereas the second provides a platform for weak binding of different moieties [5]. If an excess
Int. J. Mol. Sci. 2019, 20, 4301; doi:10.3390/ijms20174301 www.mdpi.com/journal/ijms233
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of galactose occurs, EcolβDG exhibits transglycosylation activity that results in formation of allolactose,
a disaccharide composed of d-galactose and d-glucose moieties linked through a β-(1,6)-glycosidic
bond [6,7].
Lactose processing enzymes are commonly used in the dairy industry for production of lactose-free
products. Keeping dairy products in refrigerated conditions results in crystallization of lactose that
leads to an undesirable grainy texture. That is why lactose removal is used for improving the quality
of final products, such as ice-creams and some types of cheeses [8,9].
Another example of an enzyme from GH2 family, commonly used in dairy industry, is yeast βDG
from Klyvuromyces lactis (KlyvβDG) [10]. Similar to EcolβDG, it consists of 1032 aa and its functional
form is a homotetramer. Not only it catalyzes lactose hydrolysis, but also transglycosylation reaction
that results in formation of galactose derivatives, among other alkyl-galactosides [11], gal-mannitol, [12],
and bionic acids [13].
However, the usage of a cold-adapted enzyme, exhibiting similar catalytic efficiency to ones
already implemented but at lower temperatures (4–18 ◦C), is highly sought after. Especially for the
food industry, removing the need for a heating step not only brings the costs of production down, but
it also prevents potential mesophilic contamination and loss of nutritional value of food products due
to heating, and production of unwanted products by thermal conversion [14,15].
ArthβDG is an interesting candidate for industrial use. Not only can it hydrolyze lactose at a rate
comparable to βDG from Klyvuromyces lactis but it exhibits additional transglycosylation activity [16].
Galactooligosaccharides (GOS) and heterooligosaccharides (HOS) are prebiotics, which are important
for human health. That is why, with constantly increasing evidence of their consumption benefits, they
found their way into infant nutrition and special nutrition, and more recently have become increasingly
present in everyday food products [17–26].
The modification of transglycosylase activity specificity and efficiency may be achieved by
controlling reaction equilibrium or by enzyme engineering. Studies concentrated on introducing
mutations into subsites of GHs showed that the modulation of hydrolysis and transglycosylation
activities can be achieved by means of knowledge-based enzyme engineering. However, the role of
individual amino acids in the active site must be discovered as a basis for successful design of an
enzyme with specific, desired activities [27].
ArthβDG is a five-domain protein of molecular weight 110 kDa. The catalytic domain, in form of
TIM barrel, is surrounded by three IG-like domains and, as typical for the GH2 family, an N-terminal
super β-sandwich domain. Regardless of low sequence identity, this monomer’s architecture is
strikingly similar to KlyvβDG and EcolβDG, which enabled determination of catalytic residues E441
and E517. Cold-adapted ArthβDG possesses a functional dimer (not typical for the GH2 family). The
dimer is stabilized by head-to-tail interactions between Domains 1 and Domains 5 from neighboring
molecules [28]. The same oligomerization state, though shaped differently, was previously described
by us for another cold-adapted β-d-galactosidase from Paracoccus sp. 32d for which we had determined
crystal structure [29]. Thanks to comparative analysis, the structural features that may play a key
part in its cold-adaptation were described. Most interesting was maximization of energy gain from
the surface residue–solvent interactions, that was obtained by reduction of oligomerization state and
formation of hydrophobic patches on the protein’s surface [30].
The comprehensive structural study of cold-adapted ArthβDG reaction mechanism is a first
necessary stage for the knowledge-based enzyme engineering that could lead to creation of an
enzyme that would not only hydrolyze lactose, but also effectively convert it to the beneficial
for human health GOS and HOS at cold conditions. Usage of native protein would limit us
to analysis of substrate binding using substrate analogs which could not by hydrolyzed by the
enzyme, such as isopropyl β-d-1-thiogalactopyranoside (IPTG), or less preferable substrates such as
ortho-nitrophenyl-β-galactoside (ONPG). However, thanks to designing an inactive mutant in which
catalytic E441, acting as acid catalyst, was substituted with the structurally isomorphous glutamate
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residue, we were able to obtain complexes with the natural substrate lactose bound in both deep and
shallow binding modes.
2. Results
2.1. Crystal Structures of ArthβDG and ArthβDG_E441Q Complexes
During soaking of ArthβDG crystals with ONPG and X-gal (5-bromo-4-chloro-3-indolyl-
β-D-galactopyranoside) a coloration of crystals was observed. It was rapid for crystals soaked
with X-gal, as they turned intensely blue within 3 min (Figure 1B).
 
Figure 1. The crystals of ArthβDG: after addition of ONPG (A); after 2 h of soaking in X-gal (B). The
crystals of ArthβDG_E441Q mutein soaked 24 h with mixture of lactose and galactose (C).
Different short soaking times (in a range of 10 s to 10 min, 22 crystals tested) and excess of X-gal
(from 3 to 20 molar access in respect to protein concentration) gave intensely blue coloration of soaked
crystals. This indicates that the enzyme in the crystal was in its active form and performed hydrolysis
of X-gal. The structure solved using diffraction data collected from blue crystals was identical with
the ArthβDG/GAL obtained by soaking with lactose. It means that X-gal, similarly to lactose, was
hydrolyzed by enzyme during soaking of native crystals in ligand solution. Blue color came from
5,5′-dibromo-4,4′-dichloro-indigo—a dimer of the second product (5-bromo-4-chloro-3-hydroxyindol)
of X-gal hydrolysis. The blue dye is either deposited in solvent channels of the crystal or randomly
bound to the surface of protein. If the dimerized product of X-gal hydrolysis would be bound
specifically, it should be detectible in the resulting crystal structure, because it contains two Br atoms,
which give strong picks on the electron density maps.
Soaking of ArthβDG crystals with ONPG resulted in a yellow halo around the soaked crystals
(Figure 1A); however, the rate of ONPG hydrolysis was probably lower than X-gal as the coloration
was visually observed only after more than an hour soaking. For the crystal soaked in ONPG for
15 min, the color was not observed and the complex of ArthβDG with ONPG bound was formed - an
intact ONPG was visible in the active site after determining the crystal structure.
Crystals of ArthβDG soaked with lactose underwent fast deterioration, and a very short soaking
time was required to obtain crystals still suitable for diffraction experiments. The diffraction data
collected after only 1 min of soak with lactose resulted in the crystal structure with galactose. This
is evidence that the active enzyme performed hydrolysis of lactose in crystal, in such fast rate, and
product of reaction–galactose, bound in active site was visible in electron density maps.
The soaking of ArthβDG_E441Q mutein crystals with lactose yielded no complex in solved
crystal structures, as for soaking times up to 6 h no ligand was found in the structure and for longer
soaking times crystals were destroyed. We have succeeded in determining the crystal structure of
ArthβDG_E441Q complex with lactose after soaking crystals of ArthβDG_E441Q with mixtures of
lactose-galactose (Figure 1C) and lactose-fructose for 24 h. After this time, crystals of the mutein
complexes were still without visible signs of deterioration and resulted in very good resolution data.
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The complex structures of lactose bound in shallow and deep mode were obtained while subjecting
those crystals to diffraction experiments.
The crystal structures of ArthβDG complexes with galactose (2.1 Å), IPTG (2.2 Å), ONPG (2.8 Å),
and its mutein ArthβDG_E441Q (1.8 Å) in complexes with lactose (LAC) bound in shallow mode
ArthβDG_E441Q/LACs (1.9 Å) and in deep mode ArthβDG_E441Q/LACd (1.8 Å) were processed in
trigonal space group P3121, the same as ArthβDG native structure. Matthew’s volume calculation [31]
revealed that no changes in crystal packing were detected, and protein monomer was present in each
asymmetric unit. Crystal structures of these complexes were solved in PHENIX by isomorphous
replacement using rigid body procedure and the native structure of ArthβDG (PDB ID: 6ETZ) as a
model. This allowed us to obtain the molecule in the same position and orientation in all the analyzed
structures, which facilitated comparison of not only the structures, but also electron densities. The
details for the diffraction data collection and processing are presented in Table 1. Each structure was
further refined in PHENIX.REFINE, including TLS parameters [32] defined for each domain. The
resulting refinement statistics are given in Table 1.
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2.2. Active Center of ArthβDG and ArthβDG_E441Q Mutein
Catalytic site of ArthβDG, located at the bottom of a relatively wide funnel on the top of catalytic
Domain 3, is complemented with parts of the chain from Domain 1 and Domain 5 at the entrance of
the active cavity (Figure 2). The funnel leading to the active site has a strongly acidic character, which
is beneficial for binding of carbohydrate substrates (Figure 3).
Figure 2. The dimer of ArthβDG_E441Q and the zoom of one of the active site cavities with lactose.
 
Figure 3. The surface potential visualization at the active site of ArthβDG (A), ArthβDG_E441Q (B),
EcolβDG (C), and KlyvβDG (D).
238
Int. J. Mol. Sci. 2019, 20, 4301
The active site cavity has an acidic character throughout, which facilitates the binding of the
saccharide substrate, which is typically lactose. Such a shape of the active site cavity is observed
for other βDGs with transglycosylation activities: EcolβDG and KlyvβDG [4,7,10] as it facilitates the
binding of a larger acceptor of galactosyl group, such as galactose, fructose, or salicin. ArthβDG forms
a widely open entrance to its catalytic site, which makes it more accessible for the substrate but also
promotes product dissociation. Both, easier product dissociation and active sites not being shielded or
restricted from solvent may be considered as structural cold-adaptation as it influences the enzymes’
turnover rate.
2.3. Structural Analysis of Reactions’ Mechanism Catalyzed by ArthβDG
All determined crystal structures showed precisely the changes in the active site of the enzyme
in different stages of catalyzed reaction. Visualizing these structural changes helps to understand
and explain a classical Koshland double-displacement mechanism occurring during hydrolysis of
(1,4)-β-O-glycosidic bond catalyzed by ArthβDG (Figure 4).
Figure 4. The reaction mechanism of Koshland double displacement with the catalytic residues
numbered as for ArthβDG [33].
Determined crystal structures of ArthβDG complexes with specific ligands may be divided into
three groups: complexes with substrates and their analogues (early complexes) ArthβDG_E441Q/LACs,
ArthβDG/IPTG; the second group are intermediates complexes ArthβDG_E441Q/LACd ArthβDG/ONPG;
and the third one is the complex with product ArthβDG/GAL.
The early complexes with substrate show LAC and IPTG binding in shallow mode, intermediate
complexes depicts deep binding of substrate that directly precedes formation of galactosyl-enzyme
covalent bond, and the product complex allows description of the product release process.
At the early stage of the reaction, the substrate is bound in the shallow binding site where the
galactosyl group is stabilized by a number of H-bonds between its hydroxyl groups and residues
N110, E441, E517, M481, H520, and H368 via water molecules and by an interaction with a sodium ion.
Additionally, the glucosyl moiety of lactose is stabilized by H395 and E398 via a water molecule, even
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though there is already an interaction between substrate and catalytic residues (E441 and E517), and
the position of the substrate does not allow access to O-glycosidic bond (Figure 5).
Figure 5. Early complexes of ArthβDG with saccharide substrate and substrate analogue: the molecule
of lactose (A) and IPTG (B) bound at shallow binding site.
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The insertion of substrate into deep binding is associated with movement of F581 phenyl ring,
which rotates around Cα-Cβ bond causing shift of aromatic ring by 2.9 Å in the direction of the active
center, reducing the volume of the shallow binding site (Figure 6). Surprisingly, no movement of
backbone is observed during the transfer of ligand from shallow to deep binding site. During substrate
transfer into the deep binding site, the galactosyl moiety, properly positioned in shallow binding stage,
is moved deeper into the active site by approximately 2.4 Å being at the same time rotated around an
axis perpendicular to the sugar ring by approximately 60◦.
 
Figure 6. Enzyme active site of shallow and deep binding of lactose. Electron density 2Fo-Fc map of
lactose in deep (A) and shallow (B) binding mode (contoured at 1σ). Superposition of enzyme active
site in both structures (C).
In the deep binding site of ArthβDG, the galactosyl ring is stabilized by direct interactions of
its hydroxyl groups with E441 (Q441 in mutein), E517, H368, D207, sodium ion and N440, D584,
H520 (latter observed by deeper bound lactose in complex of ArthβDG_E441Q_LACd). Now in
ArthβDG_E441Q_LACd, the NH2 from the amide group of Q441 interacts directly with oxygen from
the glycosidic bond of lactose, which is 2.6Å away (Figure 7A). In ArthβDG/ONPG, the carboxyl group
of E441 interacts directly with oxygen from the glycosidic bond of ONPG, which is at a distance of
2.8 Å (Figure 7B).
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Figure 7. Late complexes of ArthβDG with substrates: the molecules of lactose (A) and ONPG (B).
The superposition of active sites of ArthβDG with EcolβDG shows the conservation of amino
acids involved in stabilization of the galactosyl moiety. However, these two enzymes differ in the
242
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stabilization of a second moiety of β-d-galactoside (Figure 8). If we consider binding of the natural
substrate, lactose, the second moiety is glucopyranose. In the active site of EcolβDG, the glucopyranose
ring is stabilized by π-stacking interaction with W999. However, in the ArthβDG active site, W999
is substituted by C985. This cysteine residue does not influence stabilization of substrate in shallow
binding mode. However, when lactose is bound in deep mode, the center of the glucopyranose ring is
at a distance of 4.4 Å from C985 making π-sulphur interaction possible. Thus, substitution of W999
with C985 reduces stabilization of the second moiety of β-d-galactoside during shallow binding mode,
but is still creating stabilizing interactions when the substrate is bound in deep mode. Furthermore,
this results in creating more space in the close vicinity of the active site by substituting the bulky indol
group with a smaller cysteine residue side chain.
Figure 8. Superposition of catalytic sites of ArthβDG with lactose bound in deep mode (green) and
EcolβDG (purple).
After the hydrolysis reaction is completed, the F581 side chain moves back into its previous
position, opening the way for galactose molecule evacuation from the active site (Figure 9).
The product, now in half-chair conformation, is still stabilized by a number of interactions: D207,
H368, N440, E441, Y482, E517, H520, and C985 (Figure 7). The ‘open’ position of F581 is also observed
for unliganded structures of ArthβDG (PDB IDs: 6ETZ) and its mutant ArthβDG_E441Q, suggesting
that its movement is dependent upon substrate presence at the shallow binding site.
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Figure 9. Complex structure of ArthβDG with galactose in half-chair conformation bound in the
active center.
3. Discussion
GH2 family β-d-galactosidases are sugar configuration-retaining enzymes that follow a classical
Koshland double-displacement mechanism. These crystal structures of ArthβDG complexes with
ligands enabled characterization of the active site and determined which residues take part in two
modes of substrate binding: deep and shallow.
The large rotation of the galactosyl residue during deep binding would most probably result in
forming π-stacking interaction with W548. Such a form of intermediate stabilization was described
for EcolβDG [7]. It should be noted that a tryptophan residue is the preferred aromatic amino acid
for binding of carbohydrates [34,35] and is frequently present in carbohydrate binding domains of
proteins. In the case of ArthβDG, only one tryptophan, W548, is located in the bottom of the active site.
Additionally, three tryptophan residues are present at the entrance to the catalytic pocket (W402, W470,
and W773), where they may form platforms for initial sugar binding. Another amino acid which is
considered to play an important role in carbohydrate binding is histidine. The active site of ArthβDG
contains several histidine residues: H334, H368, H395, H520, and H553. Among them, H368 and H520
are directly involved in stabilizing the galactosyl moiety. H520 is primarily involved in stabilization of
hydroxyl group O6 of the galactosyl moiety during shallow binding of substrate. When the substrate
is moved deeper into catalytic site, H368 stabilizes the position of hydroxyl group O3. It must be noted
that the catalytic site architecture of ArthβDG is composed such a way that only a sugar moiety with a
proper conformation of hydroxyls O2, O3, and O4 can be effectively bound in the active site. Hence,
residues forming H-bonds with hydroxyl groups in these positions H368, N440, and D207, play a
crucial role in enzyme’s specificity.
It is worth noting that a typical chair conformation of the galactosyl ring in substrate (1C4) is
changing to a half-chair (3H4)hkkkkHhhh conformation in the still bound product of the half-reaction.
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There are many conformations of pyranose ring possible in solution; however, some of them are more
stable than others. In the case of lactose, it usually has a relaxed chair conformation in solution. The
double displacement mechanism, in which lactose is hydrolyzed by retaining galactosidases, such
as ArthβDG, undergoes formation of two oxocarbenium ion-like transition states (Figure 4). Such
transition states must be formed with sp2 hybridization and formation of a positive charge on anomeric
carbon atom of the substrate. Only a few conformations of galactosyl moiety allow sp2 hybridization
on anomeric carbon, one of which is half-chair conformation 3H4, observed for the galactose bound in
active site of ArthβDG [36].
The rotation of F581 (F601 in EcolβDG) was described as one of the factors associated with the
deep binding mode, together with 10 Å movement of a 10-aa loop from Domain 5. However, in the
case of ArthβDG, the movement of F581 and D207 are the only conformational changes accompanying
the reaction mechanism. In fact, the 10-aa loop in ArthβDG is stabilized by a number of strong
interactions with other parts of Domain 5, in a position allowing better access of the substrate to the
active site. It should be noted that it is one of the regions of ArthβDG in which the backbone differed
significantly from homologous structures. These facts lead us to consider this permanent exposure of
the entrance to the active site as a structural adaptation towards activity in cold conditions. Fewer
structural hindrances for substrate entering and product leaving the active site can result in a higher
turnover rate. Analysis of these obtained crystal structures shows that ArthβGD forms a widely open
entrance to its catalytic site, which makes it more accessible for the saccharide substrate and promotes
product dissociation.
Both galactosyl binding sites, shallow and deep ones, form a net of H-bonds that stabilize this part
of the substrate. On the other hand, the glucosyl moiety of lactose, or the non-galactose moieties of
IPTG and ONPG, are hardly stabilized by any interactions during shallow binding. The EcolβDG W999
is substituted at ArthβDG with a cysteine residue which may stabilize the second sugar ring of the
substrate by π-sulphur interactions during deep binding, however such a substitution would render
the enzyme less specific toward binding a sugar moiety at this position. Thus, not only disaccharides,
but also other galactosides are processed by ArthβDG. The enzyme’s lack of preference for the second
moiety in galactoside may be the main reason for its ability to hydrolyze a wide variety of substrates, as
well as for its ability to transfer galactosyl group to a variety of acceptors [16] resulting in an interesting
range of potentially useful heterooligosaccharides.
4. Materials and Method
4.1. Site-Directed Mutagenesis of Gene Encoding ArthβDG
The gene encoding the ArthβDG enzyme, which was previously cloned into the pBAD/Myc-His
A expression vector [16], has been mutated in a site-specific manner using the Q5 Site-Directed
Mutagenesis Kit (NEB, Ipswich, MA, USA) following the manufacturer’s protocol. For this purpose,
a pair of mutagenic primers was designed and synthesized (Genomed, Warszawa, Poland). Primer
ForBglAr32cBm441: 5′GTCCCTGGGCAACCAGGCGGCACCGG3′ and primer RevBglAr32m441:
5′CACATGACCACCGAGGCGTGGTTCTTGTCGCGC3′ allowed us to introduce a point mutation at
1321 nucleotide position in the gene substituting G with C resulting in the substitution of glutamic acid
(E) residue with glutamate (Q) residue in the 441 position of the amino acid chain of ArthβDG. Hence,
the product of mutated gene expression has been called ArthβDG_E441Q. In theory, this amino acid
change should abolish β-d-galactosidase activity of mutein ArthβDG_E441Q.
PCR cycling conditions were as follows: (1) Initial DNA denaturation at 98 ◦C for 30 s; then
(2) 25 cycles of PCR product amplification consisting of 10 s of DNA denaturation at 98 ◦C, 20 s of
mutagenic primers annealing at 70 ◦C, and 3 min 20 s of PCR product extension at 72 ◦C; and (3)
the final PCR product extension at 72 ◦C for 7 min. After PCR, the amplified DNA product was
directly added to unique Kinase-Ligase-DpnI (KLD) enzymes mix. Then the product of KLD reaction
(5 min at room temperature) was directly used to transform NEB 5-alpha chemically competent
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E.coli cells (the lacZ deletion mutant, Δ (lacZ) M15). After that, transformants were spread on
Luria–Bertani agar plates (10 g L−1 of peptone K, 5 g L−1 of yeast extract, 10 g L−1 of NaCl, and
15 g L−1 of agar) supplemented with ampicillin (100 μg mL−1), X-Gal (40 μg mL−1) and l-arabinose
(200 μg mL−1). After plate incubation—firstly at 37 ◦C for 12 h, and then at 22 ◦C for next 12 h—a few
recombinant colonies without β-d-galactosidase activity were chosen for further studies. Plasmids
isolated using the ExtractMe Plasmid DNA Kit (Blirt, Gdansk, Poland) from selected recombinants were
sequenced (Genomed, Warszawa, Poland) and analyzed (blast2go on-line tool). Recombinant plasmid
pBAD-Bgal32cB_E441Q(A) harboring the properly mutated Arthrobacter sp. 32cB β-d-galactosidase
gene under the control of the PBAD promoter was used for effective production of ArthβDG_E441Q
mutein in E. coli host [16].
4.2. Expression and Purification of ArthβDG and ArthβDG_E441Q
Heterologous expressions of recombinant ArthβDG and ArthβDG_E441Q proteins were performed
in the E. coli LMG 194 cells transformed with pBAD-Bgal32cB and pBAD-Bgal32cB_E441Q plasmids,
respectively, as previously described. [25] Both proteins were purified by two ion-exchange
chromatography steps (weak anion exchanger and strong anion exchanger), followed by a size-exclusion
chromatography step.
The fractions containing ArthβDG were identified by SDS-PAGE electrophoresis run on 10%
SDS-polyacrylamide gel and by enzymatic activity assay with ONPG as a substrate [25], whereas the
fractions containing ArthβDG_E441Q were identified by SDS-PAGE only, due to lack of enzymatic
activity. The sample buffer was changed into 0.05 M HEPES pH 7.0 and the samples were concentrated
using 50 kDa cut-offmembrane Vivaspin filters (Sartorius, Goettingen, Germany) up to the protein
concentration of 15 mg/mL.
4.3. ArthβDG Crystallization and Diffraction Data Collection
Crystals of ArthβDG and ArthβDG_E441Q mutein were grown using the same optimization
matrix of 25–45% TacsimateTM and pH ranges between 6.0–8.0. All the drops were set up using a
seed stock prepared from crystals of ArthβDG grown at 35% TacsimateTM pH 7.0 and diluted 10,000
times. Numerous attempts of co-crystallization with ligands were undertaken but no crystal structures
of desired complexes were obtained. Furthermore, addition of natural substrate, lactose, prevented
formation of ArthβDG_E441Q crystals even at very low concentration of added ligand. Crystal
structures of investigated ArthβDG and ArthβDG_E441Q complexes were obtained by soaking of
native and mutant crystals with desired ligand or ligands mixture. Soaking was performed by adding
powder of ligand directly to the crystallization drop. The soaking experiments were performed for
15 min, 30 min, 1 h, 2 h, 6 h, 14 h, and 24 h prior to flash-freezing. The crystals, prior to mounting
and flash-freezing, were protected with 60% TacsimateTM of pH corresponding to crystallization
conditions [37].
High-resolution diffraction data were collected using synchrotron sources on beamlines 14.1 and
14.2 at BESSY, Berlin, Germany and P13 beamline at PETRA, DESY Hamburg, Germany. The diffraction
images were collected with fine slicing 0.1◦ and diffraction data were processed using XDSapp [38].
Crystal structures were solved and refined using the PHENIX program suite [39]. As a model, the
structure of ArthβDG (PDB ID: 6ETZ) was used.
Author Contributions: M.R. performed crystallization; M.R. and A.B. performed synchrotron diffraction data
collection, processing, structure solving, and carried out structural analysis; M.R. purified enzyme, refined the
structures; M.R. and A.B. prepared the manuscript; M.W. performed native ArthβDG enzyme expression in E. coli
and determined the purification protocol; H.C. designed and performed site-direct mutagenesis experiment
resulted in a gene encoding ArthβDG_E441Q mutein; A.W.-W. performed ArthβDG-E441Q mutein expression in
E.coli; A.B. coordinated the project.
Funding: This research was funded by National Science Centre of Poland grant number 2016/21/B/ST5/00555
(A.B.) and 2018/28/T/ST5/00233 scholarship (M.R.).
246
Int. J. Mol. Sci. 2019, 20, 4301
Acknowledgments: We thank HZB for the allocation of synchrotron radiation beamtime at BL 14.1, BL 14.2, and
PETRA synchrotron at P13.
Conflicts of Interest: The authors declare that they have no conflict of interest.
Abbreviations
ArthβDG β-d-galactosidase from Arthrobacter sp. 32cB
EcolβDG β-d-galactosidase from Escherichia coli









1. Talens-Perales, D.; Górska, A.; Huson, D.H.; Polaina, J.; Marín-Navarro, J. Analysis of Domain Architecture
and Phylogenetics of Family 2 Glycoside Hydrolases (GH2). PLoS ONE 2016, 11, e0168035. [CrossRef]
[PubMed]
2. Cohn, M.; Monod, J. Purification and properties of the beta-galactosidase (lactase) of Escherichia coli. Biochim.
Biophys. Acta 1951, 7, 153–174. [CrossRef]
3. Jacobson, R.H.; Zhang, X.J.; DuBose, R.F.; Matthews, B.W. Three-dimensional structure of beta-galactosidase
from E. coli. Nature 1994, 369, 761–766. [CrossRef] [PubMed]
4. Juers, D.H.; Matthews, B.W.; Huber, R.E. LacZ beta-galactosidase: Structure and function of an enzyme of
historical and molecular biological importance. Protein Sci. 2012, 21, 1792–1807. [CrossRef] [PubMed]
5. Brás, N.F.; Fernandes, P.A.; Ramos, M.J. QM/MM Studies on the β-Galactosidase Catalytic Mechanism:
Hydrolysis and Transglycosylation Reactions. J. Chem. Theory Comput. 2010, 6, 421–433. [CrossRef] [PubMed]
6. Juers, D.H.; Rob, B.; Dugdale, M.L.; Rahimzadeh, N.; Giang, C.; Lee, M.; Matthews, B.W.; Huber, R.E. Direct
and indirect roles of His-418 in metal binding and in the activity of beta-galactosidase (E. coli). Protein Sci.
2009, 18, 1281–1292. [CrossRef] [PubMed]
7. Juers, D.H.; Heightman, T.D.; Vasella, A.; McCarter, J.D.; Mackenzie, L.; Withers, S.G.; Matthews, B.W. A
structural view of the action of Escherichia coli (lacZ) beta-galactosidase. Biochemistry 2001, 40, 14781–14794.
[CrossRef] [PubMed]
8. Harju, M. Milk sugars and minerals as ingredients. Int. J. Dairy Technol. 2001, 54, 61–63. [CrossRef]
9. Harju, M.; Kallioinen, H.; Tossavainen, O. Lactose hydrolysis and other conversions in dairy products:
Technological aspects. Int. Dairy J. 2012, 22, 104–109. [CrossRef]
10. Pereira-Rodriguez, A.; Fernandez-Leiro, R.; Gonzalez-Siso, M.I.; Cerdan, M.E.; Becerra, M.; Sanz-Aparicio, J.
Structural basis of specificity in tetrameric Kluyveromyces lactis beta-galactosidase. J. Struct. Biol. 2012, 177,
392–401. [CrossRef]
11. Stevenson, D.E.; Stanley, R.A.; Furneaux, R.H. Optimization of alkyl beta-D-galactopyranoside synthesis from
lactose using commercially available beta-galactosidases. Biotechnol. Bioeng. 1993, 42, 657–666. [CrossRef]
12. Klewicki, R.; Belina, I.; Wojciechowska, A.; Klewicka, E.; Sójka, M. Synthesis of Galactosyl Mannitol Derivative
Using β-Galactosidase from Kluyveromyces lactis. Pol. J. Food Nutr. Sci. 2017, 67, 33–39. [CrossRef]
13. Wojciechowska, A.; Klewicki, R.; Sójka, M.; Klewicka, E. Synthesis of the Galactosyl Derivative of Gluconic
Acid with the Transglycosylation Activity of β-Galactosidase. Food Technol. Biotechnol. 2017, 55, 258–265.
[CrossRef]
14. Cavicchioli, R.; Charlton, T.; Ertan, H.; Omar, S.M.; Siddiqui, K.S.; Williams, T.J. Biotechnological uses of
enzymes from psychrophiles. Microb. Biotechnol. 2011, 4, 449–460. [CrossRef]
15. Cavicchioli, R.; Siddiqui, K.S.; Andrews, D.; Sowers, K.R. Low-temperature extremophiles and their
applications. Curr. Opin. Biotechnol. 2002, 13, 253–261. [CrossRef]
247
Int. J. Mol. Sci. 2019, 20, 4301
16. Pawlak-Szukalska, A.; Wanarska, M.; Popinigis, A.T.; Kur, J. A novel cold-active β-d-galactosidase with
transglycosylation activity from the Antarctic Arthrobacter sp. 32cB–Gene cloning, purification and
characterization. Process Biochem. 2014, 49, 2122–2133. [CrossRef]
17. Boehm, G.; Fanaro, S.; Jelinek, J.; Stahl, B.; Marini, A. Prebiotic concept for infant nutrition. Acta Paediatr.
2003, 92, 64–67. [CrossRef]
18. Lee, L.Y.; Bharani, R.; Biswas, A.; Lee, J.; Tran, L.A.; Pecquet, S.; Steenhout, P. Normal growth
of infants receiving an infant formula containing Lactobacillus reuteri, galacto-oligosaccharides, and
fructo-oligosaccharide: A randomized controlled trial. Matern. Health Neonatol. Perinatol. 2015, 1, 9.
[CrossRef]
19. Li, M.; Monaco, M.H.; Wang, M.; Comstock, S.S.; Kuhlenschmidt, T.B.; Fahey, G.C., Jr.; Miller, M.J.;
Kuhlenschmidt, M.S.; Donovan, S.M. Human milk oligosaccharides shorten rotavirus-induced diarrhea and
modulate piglet mucosal immunity and colonic microbiota. ISME J. 2014, 8, 1609–1620. [CrossRef]
20. Hughes, C.; Davoodi-Semiromi, Y.; Colee, J.C.; Culpepper, T.; Dahl, W.J.; Mai, V.; Christman, M.C.;
Langkamp-Henken, B. Galactooligosaccharide supplementation reduces stress-induced gastrointestinal
dysfunction and days of cold or flu: A randomized, double-blind, controlled trial in healthy university
students. Am. J. Clin. Nutr. 2011, 93, 1305–1311. [CrossRef]
21. Kunz, C.; Rudloff, S. Biological functions of oligosaccharides in human milk. Acta Paediatr. 1993, 82, 903–912.
[CrossRef]
22. Torres, D.P.; Gonçalves, M.; Teixeira, J.A.; Rodrigues, L.R. Galacto-Oligosaccharides: Production, Properties,
Applications, and Significance as Prebiotics. Compr. Rev. Food Sci. Food Saf. 2010, 9, 438–454. [CrossRef]
23. McVeagh, P.; Miller, J.B. Human milk oligosaccharides: Only the breast. Acta Paediatr. 1997, 33, 281–286.
[CrossRef]
24. Musilova, S.; Rada, V.; Vlkova, E.; Bunesova, V. Beneficial effects of human milk oligosaccharides on gut
microbiota. Benef. Microbes. 2014, 5, 273–283. [CrossRef]
25. Mussatto, S.I.; Mancilha, I.M. Non-digestible oligosaccharides: A review. Carbohydr. Polym. 2007, 68, 587–597.
[CrossRef]
26. Oliveira, D.L.; Wilbey, R.A.; Grandison, A.S.; Roseiro, L.B. Milk oligosaccharides: A review. Diary Technol.
2015, 68, 305–321. [CrossRef]
27. Manas, N.H.A.; Illias, R.M.; Mahadi, N.M. Strategy in manipulating transglycosylation activity of glycosyl
hydrolase for oligosaccharide production. Crit. Rev. Biotechnol. 2018, 38, 272–293. [CrossRef]
28. Rutkiewicz-Krotewicz, M.; Pietrzyk-Brzezinska, A.J.; Wanarska, M.; Cieslinski, H.; Bujacz, A. In Situ Random
Microseeding and Streak Seeding Used for Growth of Crystals of Cold-Adapted beta-D-Galactosidases:
Crystal Structure of beta DG from Arthrobacter sp. 32cB. Crystals 2018, 8, 13. [CrossRef]
29. Rutkiewicz-Krotewicz, M.; Pietrzyk-Brzezinska, A.J.; Sekula, B.; Cieśliński, H.; Wierzbicka-Woś, A.; Kur, J.;
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Abstract: In family GH13 of the carbohydrate-active enzyme database, subfamily 18 contains
glycoside phosphorylases that act on α-sugars and glucosides. Because their phosphorolysis reactions
are effectively reversible, these enzymes are of interest for the biocatalytic synthesis of various
glycosidic compounds. Sucrose 6F-phosphate phosphorylases (SPPs) constitute one of the known
substrate specificities. Here, we report the characterization of an SPP from Ilumatobacter coccineus with
a far stricter specificity than the previously described promiscuous SPP from Thermoanaerobacterium
thermosaccharolyticum. Crystal structures of both SPPs were determined to provide insight into their
similarities and differences. The residues responsible for binding the fructose 6-phosphate group
in subsite +1 were found to differ considerably between the two enzymes. Furthermore, several
variants that introduce a higher degree of substrate promiscuity in the strict SPP from I. coccineus were
designed. These results contribute to an expanded structural knowledge of enzymes in subfamily
GH13_18 and facilitate their rational engineering.
Keywords: GH13_18; sucrose phosphorylase; glycoside phosphorylase; Ilumatobacter coccineus;
Thermoanaerobacterium thermosaccharolyticum; crystallography
1. Introduction
Glycoside phosphorylases (GPs) are carbohydrate-active enzymes that catalyze the reversible
cleavage of glycosidic bonds using inorganic phosphate [1–3]. In their physiological context, they
provide a degradative route for carbohydrates and glycosides that is more energy-efficient when
compared to hydrolysis. Their glycosyl phosphate reaction products can enter various pathways,
such as glycolysis, without prior activation by a kinase, saving one molecule of ATP [4]. Because of
the reversibility of the phosphorolytic reaction, GPs are also attractive enzymes for the synthesis of
glycosidic bonds in vitro. One of the most well-studied GPs in that regard is sucrose phosphorylase
(SP; EC 2.4.1.7), which catalyzes the phosphorolysis of sucrose into α-d-glucose 1-phosphate (Glc1P)
and d-fructose. Thanks to the high energy content of sucrose and the enzyme’s remarkable substrate
promiscuity, SP is often applied as a catalyst in cost-effective transglucosylation reactions using the
cheap and renewable substrate sucrose as a glucosyl donor [5–10]. Moreover, SP has been a target in
various engineering studies to further alter its specificity, selectivity, and thermostability [11–15].
Sucrose phosphorylase is found in subfamily 18 of glycoside hydrolase family GH13 (GH13_18)
according to the Carbohydrate-Active Enzyme database (http://www.cazy.org) [16,17]. While searching
this subfamily for more thermostable SPs, we previously came across a peculiar putative SP from the
thermophile Thermoanaerobacterium thermosaccharolyticum. Although the enzyme did show significant
activity on sucrose, as was expected, its kinetic parameters revealed that sucrose is in fact not its native
substrate. Instead, a clear preference for sucrose 6F-phosphate was observed, making it the first sucrose
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6F-phosphate phosphorylase (SPP; EC 2.4.1.329) ever reported [18]. A few key residues responsible for
the difference in specificity were identified through homology modeling and mutagenesis. Furthermore,
the T. thermosaccharolyticum SPP (TtSPP) was shown to accept an even wider range of substrates than
the known SPs, offering opportunities for biotechnological applications and further engineering. For
instance, a mutant of TtSPP was rationally designed to achieve high activity towards bulky phenolics
such as resveratrol, enabling the quantitative production of a resveratrol glucoside [19]. The same
mutant could also be applied for the synthesis of glucosylated 3-hydroxy-β-lactams [20].
The discovery of TtSPP hinted at a broader functional diversity in the family left to uncover and
triggered the search for other novel GH13_18 enzymes in recent years. By characterizing proteins from
unexplored branches of the phylogenetic tree, phosphorylases from Meiothermus silvanus, Spirochaeta
thermophila, and Escherichia coli were found to be dedicated to the substrate 2-O-α-d-glucosylglycerate
(EC 2.4.1.352) [21]. Further, a comparison of distinctive active site sequence motifs in different branches
of the tree led to the discovery of a Marinobacter adhaerens enzyme that acts as a configuration-retaining
2-O-α-d-glucosylglycerol phosphorylase (EC 2.4.1.359) [22]. In this work, we report the expression and
characterization of an SPP from Ilumatobacter coccineus YM16–304 (IcSPP) with active site sequence
motifs that are different from the motifs found in TtSPP or in the phosphorylases with other specificities
in the GH13_18 subfamily. The enzyme shows high activity on sucrose 6F-phosphate, but unlike TtSPP,
it does not catalyze reactions with alternative substrates. Crystal structures of the two SPPs were
determined to allow for a comparison of their active site. Automated docking and mutational analyses
were carried out to obtain variants of IcSPP with a less stringent specificity.
2. Results and Discussion
2.1. Choice of the Target Sequence
As knowledge on the diversity of substrate specificities in subfamily GH13_18 expanded, a
few sequence motifs that are highly conserved among enzymes sharing the same specificity could
be identified. Such signature motifs were first detected in sucrose 6F-phosphate phosphorylases
and glucosylglycerate phosphorylases and were then utilized to predict that the putative sucrose
phosphorylase from M. adhaerens is actually a glucosylglycerol phosphorylase [18,21,22]. Perhaps the
most distinct specificity-determining region is the so-called loop A, found in domain B’ between strand
β7 and helix α7 of the catalytic domain (Figure 1). For example, one position in that loop carries a
glutamine residue in all enzymes except glucosylglycerate phosphorylases, where glutamate is present
instead. Likewise, glucosylglycerol phosphorylases possess a conserved VGA motif that is absent in
all other enzymes.
Another clade of interesting enzymes was encountered by thoroughly searching the subfamily’s
phylogenetic tree for more sequences with an aberrant motif in loop A. These atypical sequences
feature several notable conservations that are not found in any other clades, such as a YYQ motif and
a lysine at a position where others hold glycine, valine, or asparagine. The enzymes in the target
clade primarily originate from the microbial classes Clostridia, Flavobacteriia, and Acidimicrobiia. We set
out to elucidate their properties and selected a candidate from Ilumatobacter coccineus YM16–304 for
expression and characterization. Very recently, Tauzin et al. already reported the characterization of
an enzyme from the gut bacterium Ruminococcus gnavus that shows the same characteristic residues
in loop A [23]. That enzyme, which has 52% sequence identity to the homologue from Ilumatobacter
coccineus presented here, was found to be an SPP with a very strict specificity.
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Figure 1. (a) Phylogenetic tree of protein sequences classified in subfamily GH13_18. A selection
of representatives that have been characterized and reported in the literature are indicated with
their UniProt ID. (b) Simplified phylogenetic tree showing the sequence logo of an acceptor site
loop for the proteins in the branch. Motifs mentioned in the main text are highlighted. Black
triangle, IcSPP-like sucrose 6F-phosphate phosphorylases (target clade in this study); white triangle,
TtSPP-like sucrose 6F-phosphate phosphorylases; star, glucosylglycerol phosphorylases (GGoP);
grey circle, Bifidobacterium-like sucrose phosphorylases; white circle, lactic acid bacteria-like sucrose
phosphorylases; black circle, glucosylglycerate phosphorylases (GGaP).
2.2. Expression and Characterization of IcSPP
IcSPP, provided with a C-terminal His6-tag, was recombinantly expressed in E. coli and purified
to apparent homogeneity by affinity chromatography. Approximately 12 mg of purified protein was
obtained from a 250 mL culture. The protein migrated in sodium dodecyl sulfate-polyacrylamide
gel electrophoresis as a single band with an apparent molecular mass that is in accordance with the
theoretical mass deduced from the amino acid sequence (59.9 kDa; Figure S1).
The activity in synthetic direction was determined for more than 30 different putative acceptor
substrates, using Glc1P as glucosyl donor (Table S1). When fructose 6-phosphate was added, the
measured specific activity (45 ± 3 U/mg) was in the same range as reported wild-type activities of other
GH13_18 phosphorylases. However, no activity was observed on any of the other compounds. These
results indicate that the enzyme is a sucrose 6F-phosphate phosphorylase with strict specificity (Figure 2),
consistent with the earlier characterization of the homologous R. gnavus SPP by Tauzin et al. [23].
Reactions in the physiologically relevant degradative direction confirmed the high activity on sucrose
6F-phosphate (53 ± 4 U/mg) and the lack of activity on other compounds. IcSPP and the R. gnavus SPP
described previously thus behave very differently from the promiscuous T. thermosaccharolyticum SPP
(TtSPP) that resides in a different clade of the subfamily’s phylogenetic tree.
Figure 2. Reaction catalyzed by sucrose 6F-phosphate phosphorylase.
The biochemical properties of IcSPP were investigated. The optimal pH in the synthesis direction
of the reactions was 6.5, and more than 50% of the maximum activity was retained within the pH range
of 5.5 to 8 (Figure S2A). In the phosphorolytic direction, the optimum was reached at pH 6. Optimal
activity was achieved at a temperature of 35 ◦C (Figure S2B), which is in line with the mesophilic nature
of the Ilumatobacter strain that the protein originates from [24]. The enzyme followed Michaelis–Menten
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kinetics at the tested substrate concentrations (Table 1). Notably, the affinity for fructose 6-phosphate
appears to be considerably higher in IcSPP (KM 2.0 ± 0.3 mM) than in TtSPP (KM 15.1 ± 2.3 mM).
Table 1. Apparent kinetic parameters of I. coccineus sucrose 6F-phosphate phosphorylase at 35 ◦C and
50 mM 3-(N-morpholino)propanesulfonic acid (MOPS) pH 7.0 (phosphorolysis) or 50 mM MES pH 6.5
(synthesis).
Reaction Substrate KM (mM) kcat (s−1) kcat/KM (mM−1s−1)
Phosphorolysis sucrose 6F-phosphate 11.3 ± 1.8 126 ± 15 11.2
phosphate 7.8 ± 1.2 110 ± 9 14.1
Synthesis α-d-glucose 1-phosphate 18.8 ± 3.6 45 ± 3 2.4
fructose 6-phosphate 2.0 ± 0.3 40 ± 4 20
2.3. Structural Comparison of IcSPP and TtSPP
The crystal structures of the SPPs from I. coccineus and T. thermosaccharolyticum were determined
to 2.05 Å and 1.83 Å resolution, respectively (Table S2; PDB codes 6S9U and 6S9V). The IcSPP crystals
contained one protein molecule in the asymmetric unit, whereas the TtSPP crystals contained two.
Overall, the monomers showed high structural similarity to the Bifidobacterium adolescentis sucrose
phosphorylase (BaSP; PDB codes 2GDU, 2GDV, 1R7A), the only other GH13_18 enzyme of which a
three-dimensional structure is currently known [13,25,26], despite the limited sequence identity of
TtSPP and IcSPP to BaSP (35.1% and 26.3%, respectively). Four distinct domains can be discerned in
these three enzymes. Domain A (residues 1–93, 198–328, and 389–470 in IcSPP) is the largest and forms
the (β/α)8-barrel that is characteristic to the GH13 family. The domain at the C-terminal end (residues
471–523) is made up of a five-stranded antiparallel β-sheet. However, the backbone conformation of
the two remaining domains B (residues 94–197) and B’ (residues 329–388) appears to be more variable
(Figure 3). Domain B in BaSP and TtSPP contains two antiparallel β-sheets formed by two strands
each, flanked by two short α-helices. In IcSPP, the inner sheet immediately flanking the barrel is
considerably larger and formed by three strands instead of two. IcSPP also has an additional set of two
strands constituting a third, outermost β-sheet. Domain B’ in BaSP is a coil region with two α-helices.
In both SPPs, however, part of the coil region is replaced by a β-sheet made out of antiparallel strands.
Furthermore, those strands are larger in IcSPP than they are in TtSPP.
IcSPP seems to exist as a monomer, whereas TtSPP in the crystal structure forms dimers. BaSP
was also shown to form dimers, but the arrangements of the TtSPP and BaSP dimers are quite different
(Figure S3), and the TtSPP dimer interface is somewhat smaller compared to that of BaSP (780 Å2
versus 960 Å2). Based on size exclusion chromatography and light scattering analysis, both IcSPP and
TtSPP, unlike BaSPP, are present as monomers in solution at pH 7. Thus, the dimers observed in the
TtSPP crystals probably do not represent a functional state of the protein.
A closer look was taken at the sequence and structure of the active site (Figure 4, Figure 5, Figure S4).
It seems that the architecture of subsite −1 is essentially identical in BaSP and the SPPs and most likely
across all GH13_18 enzymes. Subsite −1 is dedicated to the recognition of the glucosyl moiety of the
donor substrate. Residues that form hydrogen bonds to the glucosyl group are highly conserved, both
in sequence and in structure (Asp49, His87, Arg195, His295, Arg399 in TtSPP) (Figure 5a). The same is
evidently true for the catalytic nucleophile and general acid/base at the tips of β-sheets 4 and 5 of the
(β/α)8-barrel, and the aspartate that crucially stabilizes the transition state. These catalytic residues
are, respectively, found at Asp197, Glu238, and Asp296 in TtSPP. In IcSPP, they are found at Asp223,
Glu264, and Asp327. Only the arginine that interacts with OH3 and OH4 is an exception to the strict
conservation in subsite −1 as it is substituted by lysine in IcSPP.
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Figure 3. Differences in domains B (yellow) and B’ (teal) of (a) BaSP, (b) TtSPP, and (c) IcSPP. The
C-terminal domain is shown in red, loop A within domain B’ is shown in black. Schematic secondary
structure topology diagrams for loop B and B’ are shown left and right of the structure, respectively.
Figure 4. Partial multiple sequence alignment of BaSP, TtSPP, and IcSPP. Catalytic residues are indicated
by a purple sphere. Residues suggested to be involved in binding of fructose 6-phosphate, according to
automated docking, are highlighted in blue.
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Figure 5. Active site of sucrose 6F-phosphate phosphorylases (SPPs). (a) Overlay of the −1 subsite of
BaSP (green), TtSPP (blue), and IcSPP (yellow), with the glucosyl moiety of sucrose from the crystal
structure of BaSP (PDB code 2GDU). Residue numbering according to TtSPP. Arg399 is substituted
by Lys in IcSPP (asterisk). (b) Close-up view of the active site in TtSPP with a bound sulfate ion.
(c) Close-up view of the active site in IcSPP with a bound phosphate ion. The catalytic residues are
shown in purple. An overlay of sucrose from the structure of BaSP is shown for reference. Automated
docking of sucrose 6F-phosphate in (d) TtSPP and (e) IcSPP. All figures of TtSPP were made using
molecule B from the asymmetric unit of the crystal structure.
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One tetrahedral sulfate ion is present in subsite +1 of TtSPP. It is held by hydrogen bonds with
Tyr201, Arg134, and His344 (Figure 5b). Mutagenesis previously confirmed that the latter two are
involved in binding the phosphate moiety of sucrose 6F-phosphate [18]; hence, the sulfate group in
the crystal structure is probably situated at that particular binding site. In the structure of IcSPP, a
phosphate ion is found interacting with Arg152, Glu264, Asp327, Tyr377, and Gln378 in the active
site. One of the oxygen atoms of phosphate is in close proximity to the likely position of the anomeric
carbon of the glucosyl donor. This observation suggests that the complexed molecule takes on the
binding mode of the phosphate that attacks the covalent glucosyl-enzyme intermediate during the
enzyme’s double displacement reaction (Figure 5c) [27,28].
Automated docking was performed to predict the binding mode of sucrose 6F-phosphate in
the SPP structures. For both enzymes, a cluster could be obtained where the glucosyl moiety of the
substrate was located in subsite −1, in full agreement with the structure of BaSP in complex with
sucrose. The anomeric carbon atom, as well as the oxygen atom of the glycosidic linkage, were at an
appropriate distance and angle from the catalytic residues. Although the possibility of conformational
rearrangements upon binding must be considered, several residues that participate in hydrogen
bonding with the fructose 6-phosphate moiety could be identified in subsite +1, and these residues are
fully conserved among sequences from the same phylogenetic branch. Arg134, Arg195, Tyr201, His344,
Gln345, and Arg399 fulfill this role in TtSPP (Figure 5d). Furthermore, the position of the substrate’s
phosphate group indeed matches the position of the sulfate molecule that was seen in the crystal
structure. In IcSPP, the predicted binding partners are Arg152, Glu264, Lys364, Gln378, and Lys434
(Figure 5e). Clearly, the set of amino acids responsible for substrate binding in subsite +1 is different
between the two enzymes. For instance, Lys364 of IcSPP is considered to be properly situated to interact
with fructose 6-phosphate, while no obvious function is predicted for the corresponding serine residue
in TtSPP. As another example, IcSPP houses a tyrosine at position 377, just like sucrose phosphorylases
do at the equivalent position. In TtSPP, on the other hand, a histidine residue is present instead.
Mutating this histidine into tyrosine lowers the activity of TtSPP on fructose 6-phosphate almost
fivefold [18]. Finally, it is worth noting that one of the strictly conserved residues in loop A of IcSPP-like
enzymes, Lys373 (Figure 1b), is not among the predicted substrate-binding residues. Its sidechain
is pointed away from the active site in the crystal structure (Figure S5), just like the conserved Asn
residue that is present at the corresponding position in SP. The reason for their conservation remains
unknown for now, although it is conceivable that they play a role in the backbone rearrangements that
loop A undergoes during catalysis [26].
2.4. Mutagenesis
Despite the structural differences, an obvious reason for the strict specificity of IcSPP in contrast to
the promiscuous behavior of TtSPP is not readily apparent from their active site layout alone. Therefore,
the possibility of introducing alternative activities in IcSPP by means of mutagenesis was explored.
We hypothesized that by disrupting the interaction network with the phosphate group from sucrose
6F-phosphate, the acceptor site might recognize compounds lacking that phosphate group and take on
a more relaxed shape in general. The residues participating in hydrogen bonds with the phosphate,
according to the docking analysis, are Arg152, Lys364, and Lys434. Tyr377 was also targeted because
of its close proximity, although its role in substrate binding is more ambiguous. All residues were
substituted by the amino acid that is found at the equivalent position in TtSPP. However, position 152
is occupied by arginine in both SPPs and was therefore mutated into alanine to remove the side chain
while retaining the structural integrity of the backbone [29]. An additional alanine mutant was also
created at position 434 due to the similar properties of the lysine and arginine sidechains found in
IcSPP and TtSPP, respectively.
All mutants were evaluated in the synthesis direction, using α-d-glucose 1-phosphate as the
glucosyl donor (Table 2). Determination of the kinetic parameters for glucosyl acceptor fructose
6-phosphate pointed out that all mutants suffer a pronounced drop in activity and/or affinity. Mutation
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K434R seemed to be the least detrimental in terms of activity, as was expected. However, the most
drastic effect on turnover rate and affinity was observed when the same residue was mutated into
alanine. The affinity of mutant Y377H for fructose 6-phosphate decreased only slightly, supporting the
results of the docking experiment.
Table 2. (Left) Apparent kinetic parameters of I. coccineus sucrose 6F-phosphate phosphorylase mutants
using 50 mM glucose 1-phosphate at 35 ◦C and pH 6.5. (Right) Transglucosylation activity using 50
mM glucose 1-phosphate and 30 mM (fructose 6-phosphate; Fru6P), 50 mM (d-glycerate), or 200 mM
(others) acceptor at 30 ◦C and pH 6.5, expressed with hydrolysis as reference.
Mutant
Kinetics Fru6P vacceptor/vwater
KM (mM) kcat (s−1) Fru6P Fructose Glycerol d-Glycerate
Wild-type 2.0 ± 0.3 40.0 ± 3.8 1360 ± 120 - - -
R152A 3.3 ± 0.7 1.42 ± 0.11 98 ± 5 6.9 ± 0.3 2.4 ± 0.3 2.5 ± 0.2
K364S 6.3 ± 1.1 0.61 ± 0.04 18 ± 2 1.3 ± 0.1 1.3 ± 0.1 1.3 ± 0.1
Y377H 2.8 ± 0.3 0.80 ± 0.08 21 ± 2 - - -
K434R 10.6 ± 1.9 6.84 ± 0.15 680 ± 45 8.1 ± 0.4 - 4.9 ± 0.4
K434A 33.2 ± 2.9 0.10 ± 0.01 3.5 ± 0.5 2.8 ± 0.4 1.4 ± 0.2 -
(-): No significant transglucosylation activity could be detected.
To assess the ability of the mutants to employ alternative substrates, their activity was measured
using fructose, glycerol, and d-glycerate as the glucosyl acceptor (Table 2). Those reactions represent
the other known wild-type activities that have been discovered in subfamily GH13_18 thus far. Only
variant Y377H, mutated at a position that was not predicted to interact with the phosphate group of
fructose 6-phosphate, was unable to perform any of the alternate transglucosylation reactions. All
others could effectively use fructose to synthesize sucrose. Mutants R152A and K364S also exhibited
activity on glycerol and d-glycerate. However, the substitutions at position 434 had a dissimilar effect
in that regard. Mutant K434R could use the negatively charged d-glycerate but not glycerol, whereas
the opposite was true for K434A. Considering the properties of these variants, it can be concluded
that the breadth of acceptor substrates tolerated by IcSPP can be extended rather easily. Although the
measured activities may sound modest, being merely up to a few times higher than the hydrolytic
side-activity that is inherent to the enzyme’s double displacement mechanism, they are not insignificant.
For reference, the ratio of the transglucosylation activity with glycerol over the hydrolytic activity
ranges between 1.2 and 1.7 with Leuconostoc mesenteroides SP [6], yet this transglucosylation process
was eventually optimized for the production of glucosylglycerol on a commercial scale [30,31].
3. Conclusions
The structures of the highly specific sucrose 6F-phosphate phosphorylase from
Ilumatobacter coccineus and its exceptionally promiscuous homologue from Thermoanaerobacterium
thermosaccharolyticum provided insight into their similarities and differences. The architecture of
subsite +1 showed the most prominent disparities, where a different set of residues appears to be
responsible for substrate recognition. Mutational analysis revealed that the specificity of the I. coccineus
phosphorylase can be loosened up by targeting positions around its predicted phosphate group
binding site. More specifically, single point substitutions at positions Arg152, Lys364, or Lys434 were
sufficient to introduce activity on fructose, glycerol, or d-glycerate, the natural acceptor substrates
of related GH13_18 enzymes. This study finally expanded our structural knowledge of GH13_18,
as the three-dimensional structure of only one enzyme from this subfamily has been described so
far [25]. The findings also open up perspectives for further engineering of SPPs and other GH13_18
phosphorylases. Indeed, it has been established that engineering efforts can be more successful when
starting from a collection of different scaffolds [32,33]. TtSPP was already proven to be a favorable
starting point for mutagenesis [19], and the availability of a crystal structure should promote further
exploration of its capabilities. Moreover, considering how the strict behavior of IcSPP can be loosened
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up, the same might be true for the related glucosylglycerol and glucosylglycerate phosphorylases.
These relaxed enzymes may then turn out to be appealing templates for designing catalysts for the
synthesis of various valuable glucosides and sugars as well.
4. Materials and Methods
4.1. Materials
All chemicals were obtained from Sigma-Aldrich, Merck or Carbosynth unless noted otherwise
and were of the highest purity. α-D-Glucose 1-phosphate was produced in house using sucrose
phosphorylase [34]. The acid glucose 1-phosphatase negative strain Escherichia coli CGSC 8974 was
obtained from the Coli Genetic Stock Center. The E. coli BL21(DE3) strain was obtained from New
England Biolabs.
4.2. Sequence Analysis
All 2405 full-length protein sequences in family GH13, subfamily 18, were extracted from the
CAZy database (http://www.cazy.org) [17] and subsequently aligned with ClustalO using default
settings [35]. A script was written in Python to remove duplicate sequences, retaining only 1254 unique
sequences. A maximum-likelihood phylogenetic tree was constructed using PhyML 3.1 with default
parameters [36] and visualized using iTOL v4 [37]. Sequence logos were generated with WebLogo [38].
Multiple sequence alignments were visualized using ESPript 3.0 [39].
4.3. Gene Cloning and Transformation
The T. thermosaccharolyticum sucrose 6F-phosphate phosphorylase (UniProt code D9TT09) was
expressed as described in earlier work [18]. The amino acid sequence for the I. coccineus phosphorylase
(UniProt code M5A566) was codon-optimized for E. coli, synthesized, and subcloned into a pET21a
vector by restriction digestion with NheI and XhoI and ligation by Life Technologies (Merelbeke,
Belgium). The plasmid was transformed in E. coli CGSC 8974 electrocompetent cells. Sequences are
listed in Table S3.
4.4. Protein Expression and Purification
TtSPP was expressed and purified as described in earlier work [18]. To express IcSPP, 2% of an
overnight culture was inoculated in 500 mL LB medium containing 100 μg/mL ampicillin in a 2 L
Erlenmeyer flask and grown at 37 ◦C with continuous shaking at 200 rpm. The culture was incubated
until OD600 reached ~0.6. Then the temperature was lowered to 18 ◦C, and expression was induced by
adding 0.1 mM isopropyl β-D-1-thio-galactopyranoside. Protein expression took place for 18 h. The
culture was spun down, and the pellet was frozen at −20 ◦C for at least 4 h.
Cell pellets of a 250 mL culture were thawed at 4 ◦C and dissolved in 8 mL lysis buffer that
consists of 0.1 mM phenylmethylsulfonyl fluoride, 1 mg/mL lysozyme, 10 mM imidazole, and 50 mM
phosphate buffered saline. After incubation on ice for 30 min, the lysate was sonicated 3 times for 3 min
(Branson Sonifier 250, level 3, 50% duty cycle) and the resulting extract was centrifuged (9000 rpm, 1 h,
4 ◦C). The supernatant was further purified by means of nickel-nitrilotriacetic acid chromatography as
described by the supplier (Thermo Scientific, Waltham, MA, USA), and the buffer was exchanged to
2-morpholinoethanesulfonic acid (MES) buffer (pH 6.5) in a 30 kDa Amicon Ultra centrifugal filter
(Merck Millipore, Darmstadt, Germany). A NanoDrop ND-1000 (Thermo Scientific, Waltham, MA,
USA) was applied to measure the protein concentration in triplicate, using the extinction coefficients
calculated with the ProtParam tool on the ExPASy server (http://web.expasy.org/protparam/). Molecular
weight and purity were verified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (10% gel).
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4.5. Site-Directed Mutagenesis
Site-directed mutations were introduced with a megaprimer-based whole-plasmid PCR method
described elsewhere [40]. The forward primer contained the desired mutation, whereas the reverse
primer (pET21a_Rv_seq1) was kept constant (Table 3). Template DNA was digested by DpnI treatment
(Westburg, Leusden, Netherlands) for at least 3 h at 37 ◦C. After transformation in E. coli BL21(DE3)
electrocompetent cells, the obtained plasmid was subjected to nucleotide sequencing to verify the
presence of the mutation (Macrogen, Amsterdam, Netherlands).
Table 3. Primers used in this study. Mutations are underlined.








The activity of IcSPP and TtSPP was measured in the phosphorolysis direction of the reversible
reaction by measuring the reduction of NAD+ in the presence of phosphoglucomutase and glucose
6-phosphate dehydrogenase (glucose 1-phosphate assay) [41]. In the synthesis direction, the release
of inorganic phosphate from glucose 1-phosphate could be quantified with the phosphomolybdate
assay [42]. To determine the hydrolytic side-activity, an enzymatic coupled assay with glucose oxidase
and peroxidase was carried out (GOD-POD assay) [43]. The true transglucosylation activity could
be calculated by subtracting the hydrolytic activity from the total activity in synthesis direction, as
determined by the phosphomolybdate assay. Samples were inactivated by the acidic conditions of the
assay solution (phosphomolybdate assay) or by heating for 5 min at 95 ◦C (other assays).
4.7. Characterization of IcSPP
To assess which acceptor substrates IcSPP is active on, ~50 μg/mL enzyme was incubated with
50 mM α-d-glucose 1-phosphate (Glc1P) and 100 mM acceptor in 50 mM MES buffer (pH 6.5) for
30 min at 30 ◦C in a total reaction volume of 1 mL. A sample was taken and analyzed with the
phosphomolybdate and GOD-POD assays. To assess the donor substrates, ~50 μg/mL enzyme was
incubated with 50 mM donor and 50 mM phosphate under the same conditions, and a sample was
analyzed with the Glc1P assay. To precisely quantify the specific activity of IcSPP towards its wild-type
substrates, 5 μg/mL enzyme was added. The reactions were carried out at 37 ◦C for 8 min (reaction
volume of 1 mL), and a sample was taken and analyzed every min.
The influence of pH on activity was checked in the synthesis direction in 50 mM acetate (pH 4.5),
MES (pH 5.0–6.5), or 3-(N-morpholino)propanesulfonic acid (pH 7.0–8.0) at 37 ◦C, and the optimal
temperature was determined in 50 mM MES, pH 6.For each reaction, 5 μg/mL enzyme was incubated
with 50 mM Glc1P and 50 mM fructose 6-phosphate (reaction volume of 1 mL). Samples of 50 μL were
taken every 30 s for 4 min and analyzed with the phosphomolybdate and GOD-POD assays.
The apparent kinetic parameters of IcSPP for its natural substrates were determined at the optimal
temperature and pH in 50 mM MES buffer (reaction volume of 1 mL), with samples taken every minute
for 8 min. The enzyme concentration was 4 μg/mL, and the fixed cosubstrate was either 100 mM
sucrose 6F-phosphate or 100 mM phosphate in the degradation direction, or either 100 mM fructose
1-phosphate or 100 mM Glc1P in the synthesis direction. When evaluating the IcSPP mutants, the
enzyme concentration was increased to 30 μg/mL (K434R) or 400 μg/mL (others) due to their lower
activity. Parameters were calculated by non-linear regression of the Michaelis–Menten equation using
SigmaPlot 11. The molecular weight of 55.9 kDa was used to calculate the turnover number kcat.
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The activity of IcSPP mutants on the alternative acceptor substrates was measured at 30 ◦C and
in 50 mM MES buffer (pH 6.5), with 500 μg/mL enzyme, 50 mM Glc1P, and either 30 mM fructose
6-phosphate, 200 mM fructose, 200 mM glycerol, or 50 mM d-glycerate (reaction volume of 1 mL).
Samples were taken every 2 min for 16 min and analyzed with the phosphomolybdate assay.
4.8. Crystallography
Crystallization screening was preceded by an extra protein purification step using a Superdex
200 10/300 GL column (GE Healthcare, Buckinghamshire, UK) preequilibrated with 100 mM Tris
buffer (pH 7.5) for IcSPP or 20 mM Bis-Tris (pH 7.5) and 150 mM NaCl for TtSPP. Both proteins eluted
as monomers with an apparent molecular weight of about 60 kDa, as confirmed by dynamic light
scattering analysis. Purified IcSPP and TtSPP were concentrated to 9 mg/mL in 10 mM Tris (pH 7.5)
and 6 mg/mL in 10 mM Bis-Tris (pH 7.5) with 75 mM NaCl, respectively. Screening for crystallization
conditions was performed at room temperature in 96-well sitting-drop crystallization plates, using
various commercial crystallization screens and the help of a Mosquito (TTP LabTech) pipetting robot.
Drops were prepared by mixing 200 nL protein solution with 200 nL reservoir solution. Crystals for
IcSPP were obtained in the presence of 20 mM fructose 6-phosphate with a reservoir solution containing
20% PEG 3350, 200 mM Na/K phosphate, and 100 mM Bis-Tris propane buffer (pH 7.5), while crystals
for TtSPP grew in the presence of 40 mM fructose 6F-phosphate with a reservoir solution containing
26% PEG 3350, 100 mM (NH3)2SO4, and 100 mM Bis-Tris propane buffer (pH 5.5). Although fructose
6F-phosphate was present in the crystallization trials, no sugar could be detected in the final structures.
Diffraction data for IcSPP and TtSPP were recorded at the synchrotron (ESRF, Grenoble). Prior to X-ray
data collection, the crystals were flash-cooled in liquid nitrogen using 20% PEG400 as a cryo-protectant.
Processing of the X-ray diffraction data was performed with the program XDS [44] and with the
AIMLESS routines of the CCP4 software suite [45]. The IcSPP crystals belong to space group C2221 and
contain a single polypeptide chain in the asymmetric unit (solvent content of 44%), whereas the TtSPP
crystals belong to space group P212121 and contain two polypeptide chains in the asymmetric unit
(solvent content of 42%). Initial phases and electron maps were obtained by molecular replacement
with the program Phaser [46], using the structure of BaSP (PDB code 1R7A) as a search model. The
resulting models were improved by automatic model building using ARP/wARP [47], followed by
several rounds of model building and refinement, using the program Coot [48] and routines from
the Phenix software suite [49]. Validation of the final structures was performed with the Molprobity
server [50].
4.9. Automated Docking and Protein Figures
The binding of sucrose 6F-phosphate in IcSPP and TtSPP was simulated by ligand docking using
the AutoDock VINA module implemented in YASARA [51]. The default settings were applied, except
for the number of runs which was increased to The correct cluster was selected by comparing the
binding mode of the ligand’s glucosyl moiety in subsite −1 to the binding mode observed in BaSP
(PDB code 2GDU).
All structure manipulations, such as superpositions, were carried out in YASARA. Figures were
rendered in PyMOL [52].
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/20/16/
3906/s1.
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Abstract: Pectate lyases play an important role in pectin degradation, and therefore are highly useful
in the food and textile industries. Here, we report on the cloning of an alkaline pectate lyase gene
(pppel9a) from Paenibacillus polymyxa KF-1. The full-length gene (1350 bp) encodes for a 449-residue
protein that belongs to the polysaccharide lyase family 9 (PL9). Recombinant PpPel9a produced
in Escherichia coli was purified to electrophoretic homogeneity in a single step using Ni2+-NTA
affinity chromatography. The enzyme activity of PpPel9a (apparent molecular weight of 45.3 kDa)
was found to be optimal at pH 10.0 and 40 ◦C, with substrate preference for homogalacturonan
type (HG) pectins vis-à-vis rhamnogalacturonan-I (RG-I) type pectins. Using HG-type pectins
as substrate, PpPel9a showed greater activity with de-esterified HGs. In addition, PpPel9a was
active against water-soluble pectins isolated from different plants. Using this lyase, we degraded
citrus pectin, purified fractions using Diethylaminoethyl (DEAE)-sepharose column chromatography,
and characterized the main fraction MCP-0.3. High-performance gel permeation chromatography
(HPGPC) analysis showed that the molecular mass of citrus pectin (~230.2 kDa) was reduced to
~24 kDa upon degradation. Ultra-performance liquid chromatography - tandem mass spectrometer
(UPLC-MS) and monosaccharide composition analyses demonstrated that PpPel9a worked as an
endo-pectate lyase, which acted primarily on the HG domain of citrus pectin. In vitro testing showed
that the degradation product MCP-0.3 significantly promotes the growth of Lactobacillus plantarum
and L. rhamnosus. In this regard, the enzyme has potential in the preparation of pharmacologically
active pectin products.
Keywords: pectate lyase; Paenibacillus polymyxa; pectins; degradation; Lactobacillus
1. Introduction
Found widely in plants, pectins are composed of d-galacturonic acid (GalA), l-rhamnose (l-Rha),
d-galactose (d-Gal), and l-arabinose (l-Ara) [1,2]. They consist of three structural domains: 1)
homogalacturonan (HG) that is mainly composed of α-1,4-linked d-GalA and thought of as “smooth
regions” in pectin, 2) rhamnogalacturonan I (RGI) domains, and 3) rhamnogalacturonan II (RGII)
domains that are both rich in neutral saccharides and thought as the “hairy regions” [3]. The acidic
residues in pectin are usually esterified or acetylated, which makes pectin a diverse family of anionic
structural hetero-polysaccharides. Pectin shows great potential in the food, pharmaceutical and
polymer industries[1,4,5]. Recent research has shown that pectin has many biological activities, such
as anti-tumor and antioxidation activities, as well as immune regulation activity [4,6]. However, the
molecular weight of natural pectin is too large to be absorbed and utilized by the body. Modified pectin
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with lower molecular weight fragments and lower degrees of esterification would be more favorable for
absorption and utilization, and potentially exhibit greater biological activity. Previous studies reported
that low-molecular-weight modified citrus pectin (MCP) had greater activity against colon, breast, and
gastrointestinal cancer, likely due to decreased expression of galectin-3 [4,7,8]. Low-molecular-weight
MCP (i.e., 3 kDa to 30 kDa) exhibited greater anti-cancer activity by inhibiting the migration, aggregation,
and proliferation of cancer cells compared to parent MCP with molecular weights greater than 30
kDa [9]. Low-molecular-weight MCP also promoted the growth of Bifidobacterium longum, suggesting
that it has potential as a prebiotic agent [10].
Pectin degradation can be achieved by temperature, pH, or enzymatic modification [11]. Among
these, enzymatic modification has a significant advantage [12,13]. Pectinolytic enzymes, known as
pectinases, are a group of enzymes that include hydrolases, lyases, and oxidases, which play important
roles in the degradation and modification of pectin [12,14]. Pectate lyase (EC 4.2.2.2), a member of
the pectinase family, catalyzes the hydrolysis of α-1,4-glycosidic bonds to produce oligosaccharides
with 4-deoxy-α-d-mann-4-enuronosyl groups at their non-reducing end [15,16]. Pectate lyase can
function in either an endo- or exo-mode of action. Unmethylated pectins or pectins with a low degree
of methylation are the preferred substrates for pectate lyases [17]. Depending on their amino acid
sequence, pectate lyases (PL) are divided into five families: PL1, 2, 3, 9, and 10 [18].
These enzymes are widely distributed in microorganisms and plants. Previously, pectate
lyases cloned from bacteria and fungi, such as Bacillus, Erwinia, Aspergillus, Clostridium, Paenibacillus,
Streptomyces, and Klebsiella sp., have been reported [16,17,19]. Various industrial applications with
these enzymes have been investigated, including fruit juice/wine clarification, plant fiber processing,
and paper production [19–21]. Pectinases are good tools in pectin degradation and preparation of
bioactive oligosaccharides [22]. However, there are few reports on the use of pectate lyase in pectin
degradation or pectin structure analysis. In the present study, we cloned a pectate lyase gene belonging
to PL9 from Paenibacillus polymyxa KF-1 and determined the substrate specificity of the recombinant
pectate lyase PpPel9a. The degradation product of citrus pectin by PpPel9a was prepared, analyzed,
and its prebiotic activity was evaluated.
2. Results and Discussion
2.1. Gene Cloning and Sequence Analysis of PL9 Pectate Lyase from P. polymyxa KF-1
Previously, four pectate lyases were identified from the fermentation broth of P. polymyxa KF-1
by liquid chromatograph-mass spectrometer/mass spectrometer (LC-MS/MS) analysis. These enzymes
belong to PL families 1, 3, 9, and 10 [23]. In our previous work, a pectate lyase named PpPel10a was
cloned from P. polymyxa KF-1 and was identified to be a member of PL10 family [23]. Here, the protein
with the UniProt accession number E3E7F9 (NCBI protein ID MK809514) was encoded by an open reading
frame (ORF) of 1350 bp. The protein of 449 amino acids was named as PpPel9a, and the N-terminal
34-amino acids was predicted to be the signal peptide sequence by signalP 5.0 server, which suggested the
extracellular location of the protein. The pI value of PpPel9a without the signal peptide was predicted
to be pH 5.07, similar to that reported for PL9 pectate lyase Pel-15H from Bacillus sp. strain KSM-P15
(4.60) [24], but lower than other PL9 enzymes, such as PelX from Erwinia chrysanthemi 3937 (7.7) [25], and
Exo-PL from E. chrysanthemi EC16 (8.6) [26]. Analysis of the amino acid sequence by Uniprot confirmed
that PpPel9a was a member of PL family 9 pectate lyase family, and the Pfam analysis indicated that
PpPel9a had a β-helix superfamily domain. Multiple sequence alignment analysis showed that the
amino acid sequence of PpPel9a has moderate similarity to other PL9 enzymes, such as pectate lyase
Pel9A from E. chrysanthemi (1RU4) [27], rPel9A from Clostridium stercorarium F-9 (AB106865) [17], and
rhamnogalacturonan lyase from Bacteroides thetaiotaomicron VPI-5482 (PDB accession no. 5OLQ) [28].
The sequence identities were 39.34%, 37.57%, and 42.53%, respectively. The low homology between
PpPel9a and the reported PL9 enzymes indicates that PpPel9a may be a novel enzyme. So far, only
several pectate lyases belonging to PL family 9 have been characterized, including Pel-15H from Bacillus
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sp. strain KSM-P15 (AB028878) [24], rhamnogalacturonan lyase BT4170 from B. thetaiotaomicron VPI-5482
(5OLQ) [28], Exo-PL from E. chrysanthemi EC16 (AAA24850) [26], PelL1 from E. chrysanthemi PY35
(AAF05308) [29], and PelX from E. chrysanthemi 3937 (CAB39324) [25]. The substrate specificity and
biochemical properties of PL9 enzymes have yet to be clarified. In addition, the use of PL9 enzymes in
the degradation of pectins had not been explored. Therefore, in the present study, we chose the gene
encoding for the PL family 9 enzyme from P. polymyxa KF-1 for cloning, expression, and characterization.
So far, only two crystal structures have been reported for enzymes in the PL9 family (http://www.
cazy.org/PL9_structure.html), namely rhamnogalacturonan lyase from B. thetaiotaomicron VPI-5482
(PDB accession no. 5OLQ) [28] and Pel9A from E. chrysanthemi (PDB accession no. 1RU4) [27]. Both
lyases have a right-handed parallel β-helix fold with three short parallel β-sheets (PB1, PB2, and PB3)
and ten turns, with two calcium ion binding sites (Ca-1 and Ca-2). The key components of the active
site comprise Ca-1 on coils 5 and 6, and a lysine in coil 7 that functions as a catalytic base to abstract a
proton from C5. The three-dimensional structure prediction by SWISS-MODEL indicates that PpPel9a
may comprise a 10-coil parallel β-helix domain (Figure S1), similar to Pel9A from E. chrysanthemi
(1RU4) [27]. ClustalW alignment of PpPel9a from P. polymyxa with the two characterized PL9 pectate
lyase amino acid sequences highlighted three highly conserved calcium-binding sites: Asp202, Asp226,
and Asp230 (Figure 1). Similar to the reported PL9 enzymes, the catalytic base in PpPel9a was predicted
to be Lys271, which is different from that in PL1 pectate lyases where the catalytic base is an arginine
(Arg198 in PL1 enzyme BsPelA from Bacillus sp. N16-5 [30], Arg240 in EcPelE from E. chrysanthemi [31],
and Arg300 in BsPel from B. subtilis) [32]. In addition, PpPel9a and PpPel10a have different structures.
PpPel9a has a right-handed parallel β-helix fold, whereas PpPel10a is predominantly α-helical with
short β-strands and irregular coils [23].
Figure 1. Alignment of amino acid sequence of PpPel9a with the PL9 family pectate lyases: Pel9A from
E. chrysanthemi (1RU4) and rhamnogalacturonan lyase from B. thetaiotaomicron VPI-5482 (PDB accession
no. 5OLQ). The conserved Asp were labeled by asterisk and the catalytic base was labeled by triangle.
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2.2. Expression of Recombinant PpPel9a
After induction at 25 ◦C for 20 h, pectate lyase activity in the cytoplasm with polygalacturonic
acid (PGA) as substrate, reached its maximum level (117.4 ± 4.82 U/mg). The recombinant enzyme was
purified by Ni-NTA affinity chromatography, and the purified enzyme showed an approximate 4.5-fold
increase in purity, and a recovery of 28.9% relative to the crude enzyme. Purification yielded 212 mg of
enzyme/liter. This relatively high yield makes PpPel9a a good candidate for industrial applications.
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) indicates that purified
recombinant PpPel9a has a Mw of ~45.3 kDa, consistent with the predicted Mw (Figure 2). The Mw of
PpPel9a was similar to that reported for PL9 enzyme PelL1 from E. chrysanthemi PY35 (43 kDa) [29],
but lower than that reported for other PL9 pectate lyases, such as Pel-15H from Bacillus sp. strain
KSM-P15 (69.55 kDa) [24], Exo-PL from E. chrysanthemi EC16 (76 kDa) [26], PelX from E. chrysanthemi
3937 (76.938 kDa) [25], and Pel9A from C. stercorarium F-9 (135.171 kDa) [17].
Figure 2. Molecular weight of PpPel9a determined by SDS-PAGE: (M) protein molecular weight
markers (PageRuler Prestained Protein Ladder, Thermo Scientific) (1) supernatant of cell lysis from E.
coli BL21 (DE3) cells; (2), supernatant of cell lysis from recombinant E. coli BL21 (DE3) cells harboring
pET-28a-pppel9a plasmid; (3) recombinant enzyme PpPel9a purified from Ni-NTA agarose column.
The specific activity of purified PpPel9a with PGA as substrate, was 298.5 ± 3.6 U/mg, higher than
that reported for PL9 enzymes rPel9A from C. stercorarium (58 U/mg) [17] and Pel-15H from Bacillus
sp. strain KSM-P15 (10.6 U/mg) [24], but lower than the PL1 pectate lyases, such as BacPelA from B.
clausii (675.5 U/mg)[19] and Apel from B. subtilis (1010.0 U/mg) [33]. PL9 enzymes show lower activity
against PGA than PL1 enzymes. This is likely due to the Lys catalytic base in PL9 enzymes being
less potent than Arg in PL1 enzymes. In addition, the third calcium is important in increasing the
acidity of the C5 proton that may be absent in PL9 enzymes [27]. However, PpPel9a exhibited higher
pectate lyase activity than that of PpPel10a when using PGA and citrus pectin (CP) as substrates [23].
The specific activities with PGA using PpPel9a and PpPel10a were 298.5 ± 3.6, and 289 ± 4.9 U/mg,
respectively, while the specific activities on CP by PpPel9a and PpPel10a were 107 ± 0.2, and 98.0 ± 3.6
U/mg, respectively.
2.3. Biochemical Characterization of PpPel9a
The effect of pH on PpPel9a was studied using PGA as a substrate. PpPel9a showed high activity
over the pH range of pH 6 to pH 11, with optimum activity at pH 10 (Figure 3a). The reported PL9
pectate lyases showed different pH optima, such as Exo-PL from E. chrysanthemi EC16 (pH 7.5–8.0) [26],
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PelX from E. chrysanthemi 3937 (pH 8.5) [25], Pel-15H from Bacillus sp. strain KSM-P15 (pH 11.5) [24],
and rPel9A from C. stercorarium (pH 7.0) [17]. The pH profile of PpPel9a was much broader than
reported PL9 enzymes. So far, the pH stability of PL9 enzymes had not been reported. In this
study, the pH stability profile of PpPel9a showed that the enzyme was stable over a wide pH range.
After incubation between pH 5 and pH 11 for 24 h at 25 ◦C, residual activity remained greater than
75% (Figure 3b). The excellent alkali stability of PpPel9a makes the enzyme a good biocatalyst for
pectin degradation.
Figure 3. Effect of pH on activity (a) and stability (b) of PpPel9a. The enzyme activity was detected
by using PGA as a substrate (0.2% w/v). The following buffers were used: 50 mM acetate buffer, pH
2.0–6.0; 50 mM phosphate buffer, pH 6.0–8.0; 50 mM glycine sodium buffer, pH 8.0–11.0.
The maximum activity of PpPel9a was observed at 40 ◦C (Figure 4a), which was lower than PL9
pectate lyases Pel-15H from Bacillus sp. strain KSM-P15 (55 ◦C) [24] and rPel9A from C. stercorarium F-9
(65 ◦C) [17]. A thermostability study showed that PpPel9a was stable below 50 ◦C, where more than 50%
activity was maintained upon incubation for 60 min at 40 ◦C or 50 ◦C (Figure 4b). However, the activity
decreased sharply when the incubation temperature reached 60 ◦C. Therefore, the thermostability of
PpPel9a could be improved.
Figure 4. Effect of temperature on activity (a) and stability (b) of PpPel9a. The enzyme activity was
detected by using 0.2% w/v PGA as a substrate.
The effect of metal ions and chemicals on the activity of PpPel9a was also evaluated, as shown
in Table 1. 5 mM Tween-20 enhanced PpPel9a activity by 22.5%. Fe2+, Co2+, Tween-40, Tween-60,
SDS, Tween-80, and Triton X-100 substantially decreased the activity of PpPel9a, and other metal ions
examined did not significantly affect activity. Furthermore, different Tweens showed different effects
on enzymatic activity.
Generally, Ca2+ plays an important role in the hydrolytic action of pectate lyase. This ion acts
by acidifying the C5 proton of the galacturonate binding to the +1 subsite of pectate lyase [27]. The
enzymatic activities of PL9 enzymes are generally inhibited by treatment with EDTA. For instance,
PelX from E. chrysanthemi 3937 and rPel9A from C. stercorarium F-9 are completely inhibited by 1 mM
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or 0.2 mM EDTA, respectively [17,25]. The activity of the PL10 enzyme PpPel10a is independent of
Ca2+, although the enzymatic activity is significantly enhanced by its presence. Similar to PpPel10a,
the activity of PpPel9a is not completely inhibited by EDTA, with over 76.5% of its enzymatic
activity remaining. As shown in Figure 5, PpPel9a activity is enhanced by addition of Ca2+. In the
presence of 5 mM Ca2+, PpPel19a activity is increased by 166.5%. Therefore, 5 mM Ca2+ was used in
following experiments.
Table 1. Effect of various metal ions and chemicals on the activity of PpPel9a.
Metal Ions or Chemicals (5 mM) Relative Activity (%) 1
NaCl 86.7 ± 3.3
KCl 79.0 ± 0.6
CaCl2 266.5 ± 7.0
MgCl2 94.5 ± 4.6
FeSO4 54.5 ± 0.7
EDTA 63.1 ± 0.5
ZnCl2 88.0 ± 1.6
AlCl3 106.1 ± 6.1
CoCl2 51.4 ± 2.4
SDS 37.7 ± 0.2
Tween-20 122.5 ± 0.6
Tween-40 51.4 ± 2.1
Tween-60 40.0 ± 0.6
Tween-80 2.0 ± 0.1
TritonX-100 4.3 ± 0.3
1 The activity was determined with 0.2% w/v PGA as a substrate.
Figure 5. Effect of Ca2+ on the activity of PpPel9a. Values represent the mean ± SD (n = 3).
Michaelis–Menten parameters of PpPel9a on PGA and CP were determined. The Km values
of PpPel9a for PGA and CP were 0.18 and 0.32 g/L; Vmax values were 298.5 and 107 μmol/min/mg,
respectively, resulting in kcat/Km values of 225.4 and 80.8 s−1, respectively.
2.4. Substrate Specificity Analysis of PpPel9a
Previously reported PL9 pectate lyases, such as Pel-15H from Bacillus sp. strain KSM-P15, PelX
from E. chrysanthemi 3937, and rPel9A from C. stercorarium showed the highest catalytic activity for
PGA, followed by pectins with low or medium methylation (<50%) [17,24,25]. Pectins with high
degrees of methylation (≥50% methylation) were poor substrates for PL9 enzymes. However, the
enzymatic activity of PL9 against RG pectins had yet to be reported. Here, the ability of PpPel9a
to degrade various pectins, including RG-I type and HG-type pectins, were determined. As shown
in Table 2, PpPel9a showed higher activity on HG-type pectins compared with RG-I type pectins.
Using HG-type pectins as substrate, PpPel9a was more active on de-esterified HG-type pectins than
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on esterified HG-type pectins. The highest degradation activity was observed on de-esterified HG
type pectin from citrus (CP-DeHG). Relative to the activity of PpPel9a on CP (100%), the activities of
PpPel9a on CP-DeHG and CP-CeHG are 664% and 44%, respectively. Our results demonstrated that
PL9 enzymes prefer low- or un-methylated HG pectins.
Table 2. Degradation of various pectins by PpPel9a.
Type of Pectin Substrate 1 Specific Activity (U/mg)
Pectin
PGP 48.1 ± 4.9
RGP 59.1 ± 0.1
CP 107.0 ± 0.2
RG-I
PGP-RGI 2.1 ± 0.9
RGP-RGI 21.0 ± 0.3
HG
PGP-HG 106.8 ± 0.6
RGP-HG 68.9 ± 0.5
Completely esterified HG CP-CeHG 47.1 ± 0.1
De-esterified HG CP-DeHG 710.7 ± 3.3
1 CP: citrus pectin; PGP: pectin from Panax ginseng; RGP: pectin from red ginseng.
To explore the use of PpPel9a on the degradation of pectins, eight pectins from different plants
were used as the substrates. The molecular weight distribution of the degradation products was
detected by high-performance gel permeation chromatography (HPGPC). With the exception of ACP,
PpPel9a degraded the pectins to varying degrees to produce low-molecular-weight fractions (Figure 6).
Previously, pectate lyases were reported to exhibit catalytic activity via an endo- or exo-acting
mode by β-elimination [27]. An exo-acting enzyme can produce 4,5-unsaturated GalA (uG1), while
endo-acting enzymes tend to produce only unsaturated dimers or higher-degree polymerization
unsaturated products. Two PL9 enzymes, PelX from E. chrysanthemi 3937 and Exo-PL from
E. chrysanthemi EC16, have been reported as exo-acting pectate lyases, whereas Pel9A from
E. chrysanthemi (1RU4) was reported to act as an endo-pectate lyase [25–27]. To assess the catalytic
mechanism of PpPel9a, the oligomers released from CP by PpPel9a were analyzed by ultra-performance
liquid chromatography - tandem mass spectrometer (UPLC-MS). As shown in Figure 7, no uG1 was
observed upon degradation, which demonstrated that PpPel9a functions as an endo-acting enzyme.
Electrospray ionisation mass spectrometry (ESI-MS) confirmed the UPLC results. Negative ESI-MS gave
a strong peak at m/z 350.92 (unsaturated bigalacturonide, uG2), followed by m/z 527.02 (unsaturated
trigalacturonide, uG3). These results indicate that citrus pectin was degraded by PpPel9a to produce a
mixture of 4, 5-unsaturated oligo-galacturonic acid, confirming the trans-elimination endo-reaction
mechanism of PpPel9a. The catalytic mechanism of PpPel9a was different from that of PpPel10a,
which degraded citrus pectin to produce uG1 and 4,5-unsaturated oligomers, including uG2, uG3,
uG4, and uG5.
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Figure 6. High-performance gel permeation chromatography (HPGPC) analysis of degradation of
pectins from different plants by PpPel9a. Dash line represents the substrate and solid line represents
the degradation product.
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Figure 7. Analysis of the oligomers released from PGA by ultra-performance liquid
chromatography-tandem mass spectrometer (UPLC-MS). The oligosaccharides separated by UPLC
was further analyzed by ESI-MS analysis (small box).
2.5. Degradation of Citrus Pectin and Characterization of the Main Degradation Product
Previously, different methods including heat- and pH-modification were used to prepare modified
citrus pectin. Jackson et al. showed that different treatment protocols of pectin can lead to different
pectin activities, indicating that active molecules obtained from citrus pectin by different treatments
are not the same [34]. Therefore, exploring new preparation techniques may be potentially useful for
obtaining new active molecules. Here, citrus pectin was degraded by PpPel9a, and the degradation
products were purified by using a DEAE sepharose fastflow column. As shown in Figure 8, a major
peak was eluted by using 0.3 M NaCl and prolonging the degradation time or addition of more enzyme
did not cause further degradation. This fraction is called MCP-0.3, and its molecular weight was
determined to be ~24 kDa by HPGPC analysis (Figure S2). Monosaccharide composition analysis
(Table 3) showed that after degradation, the content of GalA increased, while the content of Gal, Ara,
and Glc decreased. The modified 2-Thiobarbituric acid (TBA) method indicated that the content of
RGII domain increased in MCP-0.3 compared to that of CP (Figure S3). The Fourier Transform infrared
spectroscopy (FT-IR) analysis showed that the degree of methyl esterification decreased from 65.5%
in CP to 31.3% in MCP-0.3 (Figure S4), which indicated that the HG domain in CP was removed by
PpPel9a degradation. Based on these results, we deduced that PpPel9a mainly cuts the HG domain in
citrus pectin. Degradation experiments were repeated in triplicate, with similar results being obtained.
The excellent reproducibility demonstrated that PpPel9a is suitable for citrus pectin degradation.
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Figure 8. Elution profile of the degradation product of citrus pectin (CP) by DEAE sepharose fastflow
column. The sugar content and uronic acid content were determined at 490 nm and 525 nm, respectively.
Table 3. Monosaccharide composition of CP and its degradation product MCP-0.3.
Monosaccharide (%)
Man GlcA Rha GalA Glc Gal Xyl Ara Fuc
CP 1.20 0.57 3.62 62.18 4.12 13.73 - 1 14.42 0.16
MCP-0.3 1.12 1.66 3.68 86.97 1.02 2.06 - 2.49 1.00
1 Not detected.
2.6. Growth Effect of MCP-0.3 on Lactobacillus Strains
Pectin fragments have been reported to exhibit good gastroprotective effects. For example,
arabinogalactans from soybean significantly inhibit ethanol-induced gastric lesions in rats [35]. Two
pectins ALR-a and ALR-b from rhizomes of Atractylodes lancea DC showed intestinal immune system
modulating activity [36]. Oligosaccharides from pectin (POS) have been suggested as a new class of
prebiotics, with anti-obesity, anti-toxic, anti-infection, anti-bacterial, and antioxidant properties [37].
Therefore, pectin may be a good source of prebiotic molecules.
The growth effect of freeze-dried MCP-0.3 was assayed in vitro with Lactobacillus plantarum strains
CH4, P3-18, S52, C88, K25 and L. rhamnosus CG strains JAAS8 and ITF-1. As shown in Figure 9,
compared with CP, MCP-0.3 at a concentration of 5 mg/mL significantly promotes the growth of L.
plantarum and L. rhamnosus CG strains. The highest promotion effect was observed on L. plantarum S52
strain. Previously, the B. subtilis pectate lyase rePelB was reported to hydrolyze citrus pectin in a 50 L
reactor. The low-molecular-weight citrus pectin (LCP) obtained significantly promoted the growth of
probiotics Bifidobacterium longum [10]. In addition, the pectin oligosaccharide (POS) fractions obtained
by controlled chemical degradation of citrus peel pectin were reported to promote the selective growth
of probiotics L. paracasei LPC-37 and B. bifidum ATCC 29521 [38]. Here, we reported that the degradation
product of citrus pectin by PpPel9a showed better prebiotic effects than citrus pectin, indicating that
MCP-0.3 may be a good prebiotic agent. PpPel9a had the advantage of reproducible production of
a low-molecular-weight fraction from citrus pectin, which was not the case with PpPel10a. Based
on this, PpPel9a may be useful in preparing pectin fractions with prebiotic activity from pectin-rich
agricultural wastes, such as citrus peel and apple pomace.
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Figure 9. Effects of CP and MCP-0.3 on the growth of L. plantarum strains CH4, P3-18, S52, C88, K25,
and L. rhamnosus CG strains JAAS8 and ITF-1.
3. Materials and Methods
3.1. Strains and Reagents
P. polymyxa KF-1 was isolated and identified by our lab and preserved in China Center for Type
Culture Collection (accession number CCTCC AB 2018146). It was used for supplying the PL9 pectate
lyase gene. E. coli DH5α cells and pGM-Simple-T vector (TIANGEN, Beijing, China) were used for
gene cloning. E. coli BL21 (DE3) cells and pET-28a (+) vector (Novagen, Temecula, California, USA)
were selected for protein expression. L. plantarum strains CH4, P3-18, S52, C88, K25, and L. rhamnosus
CG strains JAAS8 and ITF-1 were kindly provided by Dr Shengyu Li of the Institute of Agrofood
Technology, Jilin Academy of Agricultural Sciences, China. Restriction enzymes and DNA polymerase
were from TaKaRa Biotechnology Co., Ltd. (Dalian, China). DEAE-sepharose fastflow gel were
purchased from GE Healthcare (USA).
3.2. Substrates
Polygalacturonic acid (PGA) and citrus pectin (CP) were from Sigma-Aldrich (St. Louis, MO,
USA). Pectins from Panax ginseng (PGP), red ginseng (RGP), Anemarrhena asphodeloides (AAP), Asparagus
cochinchinensis (ACP), Angelica dahurica (ADP), Angelica pubescens (APP), Leonurus Artemisia (LAP),
Polygonatum sibiricum (PSP), Semen cassia (SCP), and Scutellaria baicalensis (SBP) were isolated by hot
water extraction followed by DEAE-cellulose fractionation according to the method previously reported
by our lab [3,39]. The RG-I type pectins PGP-RGI from P. ginseng, and RGP-RGI from red ginseng, the
HG type pectins PGP-HG from P. ginseng, RGP-HG from red ginseng, were prepared according to the
method reported in Sun et al. [40]. The de-esterified HG type pectin CP-DeHG and the completely
esterified HG type pectin CP-CeHG were prepared from citrus pectin according to the method reported
in Sun et al. [40].
3.3. Analytical Methods
The unsaturated oligomers released from CP by PpPel9a were analyzed by UPLC-MS. The
UPLC-MS was performed using a Waters Acquity UPLC system with tandem UV (232 nm) and
ESI-MS detector. The oligosaccharides were first separated by Acquity UPLC BEH Amide column
(1.7 μm, 2.1 mm × 150 mm) eluted at a flow rate of 300 μL/min and a column oven temperature of
35 ◦C. The mobile phase consisted of three mobile phase lines, (A) 20:80 (v/v) ACN/water, (B) 80:20
(v/v) ACN/water, and (C) 200 mM ammonium formate/50 mM formic acid buffer (pH 3.0). The elution
program was as follows: 0–30 min, 95%−75% B; 30–31 min, 75%−60% B; 31–40 min, isocratic with
60% B; 40–41 min, 60%−95% B; 41–50 min, isocratic with 95% B; 5% buffer (C) was constantly added
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throughout the elution. ESI-MS analysis was performed with a Bruker Daltonics Amazon mass
spectrometer equipped with an electrospray source and an ion trap mass analyzer (Bremen, Germany).
The spectrometer was operated in the negative ion mode (capillary voltage, 4 kV; end plate off set: −300
V; temperature, 200 ◦C; nebulizer gas: 2 bar and dry gas, 6 mL/min). Monosaccharide composition was
analyzed by high performance anion exchange chromatography (HPAEC) method using a CarboPac
PA20 column (3 × 150 mm) assembled to a Dionex ICS-5000 Plus ion chromatographic system [41].
Homogeneity and molecular weight of polysaccharides were estimated by HPGPC with a TSK-gel
G-3000PWXL column (7.8 × 300 mm, TOSOH, Japan) coupled to a Shimadzu high performance liquid
chromatography (HPLC) system. The column was pre-calibrated using standard dextrans (1, 5, 12,
25, and 50 kDa) [42]. The degree of esterification was determined by FT-IR. The degree of methyl
esterification = the area of methyl-esterified carboxyl group/the area of total carboxyl group × 100% [43].
Kdo and Dha were colorimetrically determined using the modified TBA method to check the presence
of RG-II domain in polysaccharides [44].
3.4. Analysis of Pectate Lyase Gene
The ORF of the pectate lyase was analyzed by NCBI ORF finder [45]. The conserved domain
was explored by Pfam [46]. The molecular weight (Mw) and isoelectric point (pI) were calculated
by Compute pI/Mw too [47]. The signal peptide was predicted by SignalP 5.0 Server [48]. Multiple
amino acid sequences alignments were performed by Clustal Omega and exhibited by ESPript 3.0
web server [49,50]. The structure of pectate lyase PpPel9a was predicted by SWISS-MODEL with the
pectate lyase from E. chrysanthemi (PDB accession number: 1RU4) as the template [27]. The model was
exhibited by Pymol software [51].
3.5. Cloning of PL9 Pectate Lyase and Its Expression
The mature pectate lyase encoding gene without the signal peptide
sequence was obtained from the genomic DNA of P. polymyxa KF-1 by PCR
using following primers: 5′-CGCATATGGATGTTCCATCTAACAACCTC-3′ and
5′-CGGGATCCTTACCGTGCCCCTATATTTCCGC-3′. The underlines indicate the NdeI and
BamHI restriction sites, respectively. The PCR amplification was performed by PrimeSTAR® HS DNA
polymerase with the following program: Pre-denaturation at 98 ◦C for 10 s; 30 cycles of 98 ◦C for 10 s, 55
◦C for 15 s, and 72 ◦C for 1.5 min; final extension at 72 ◦C for 10 min. The PCR product was ligased with
pGM-Simple-T vector, transformed into E. coli DH5α competent cells, and plated onto Luria–Bertani
(LB) agar plates supplemented with 100 μg/mL ampicillin according to the manufacturer’s instructions.
Recombinant plasmid was sequenced with T7 (5’-ACATCCACTTTGCCTTTCTC-3’) and SP6
(5’-ATTTAGGTGACACTATAG-3’) as sequencing primers. The recombinant plasmid with correct
insert DNA was double digested by NdeI and BamHI, and ligased into pET-28a (+) vector digested
with the same restriction enzymes. The recombinant plasmid was transformed into E. coli BL21 (DE3)
cells and plated onto LB agar plates supplemented with 30 μg/mL kanamycin.
The positive colony was incubated in 500 mL of LB broth at 37 ◦C for 3 h with shaking at 200 rpm.
Then, the isopropyl β-d-thiogalactoside (IPTG) was added to a final concentration of 0.5 mM. After
induced at 25 ◦C for 20 h, the cells were centrifuged at 5000 rpm and 4 ◦C for 10 min. Then, the cells
were sonicated on ice and centrifuged at 12,000× g and 4 ◦C for 10 min to remove cell debris. The cell
lysate was loaded onto a Ni2+–NTA agarose chromatography (column volume 5 mL), which was
pre-equilibrated with equilibration buffer (20 mM Tris–HCl, 100 mM NaCl, 20 mM imidazole, pH 8.0).
Binding proteins were eluted with a linear gradient of imidazole (20–200 mM) in 20 mM Tris–HCl,
100 mM NaCl, pH 8.0. Fractions with enzymatic activity were pooled and dialyzed against 50 mM
Tris–HCl buffer (pH 9.0). The cell lysate and purified enzyme were analyzed by SDS-PAGE using
10% separating gel and 3.9% stacking gel [52]. The protein concentration of the purified enzyme was
determined using BCA Protein Assay Kit (Beyotime, Beijing, China).
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3.6. Pectate Lyase Activity Assay and Substrate Specificity Analysis of PpPel9a
During expression and purification, the enzymatic activity of PpPel9a was measured by
determining the formed unsaturated bonds at 235 nm with an UV-5100H spectrophotometer (METASH,
Shanghai, China) with soluble PGA as the substrate [19]. The reaction mixture of 200 μL consists of
0.2% (w/v) PGA, 5 mM CaCl2, and 2 μg of purified enzyme was incubated in 50 mM Tris-HCl buffer
(pH 9.0). The reaction mixture was incubated at 40 ◦C for 30 min and the unsaturated bonds produced
by enzymatic degradation were determined at 235 nm. One unit of pectate lyase activity was defined as
the enzyme needed to produce 1 μmol of unsaturated bonds per min. The molar extinction coefficient
was 4600 M−1cm−1.
The substrate specificity of recombinant PpPel9a was determined using different types of pectins,
including HG, RG-I, de-esterified HG, and completely-esterified HG, under standard reaction conditions
(pH 10.0, 40 ◦C, 5 mM CaCl2, 0.2% w/v substrate). The unsaturated bonds released from the substrates
were recorded at 235 nm. The molecular weights of the degradation products were analyzed by
HPGPC method.
The kinetic parameters of PpPel9a on PGA and CP were determined by the A235 method. Purified
recombinant PpPel9a was incubated with PGA or CP at different concentrations (0.1–5 mg/mL) at
40 ◦C in 50 mM glycine–NaOH buffer (pH 10.0) for 10 min. Then, the unsaturated bonds formed were
measured at 235 nm. The Km and kcat values were calculated by GraphPad Prism5.0 software using
non-linear regression. All data are expressed as the means of triplicate measurements.
3.7. Effect of pH, Temperature, and Metal Ions on the Activity and Stability of PpPel9a
The optimal pH of PpPel9a was determined at 40 ◦C for 30 min in 50 mM NaAC buffer (pH 2.0–6.0),
50 mM phosphate buffer (pH 6.0–8.0), and 50 mM glycine–NaOH buffer (pH 8.0–11.0). The temperature
optimum of PpPel9a was measured at 20–80 ◦C for 30 min in 50 mM glycine–NaOH (pH 10.0). The pH
stability of PpPel9a was assayed by measuring its residual activity after incubating the purified enzyme
in 50 mM NaAC buffer (pH 2.0–6.0), 50 mM phosphate buffer (pH 6.0–8.0), and 50 mM glycine–NaOH
buffer (pH 8.0–11.0) at 25 ◦C for 24 h. The thermal stability of PpPel9a was determined by measuring
the residual enzyme activity after incubating the purified enzyme at 20–80 ◦C in 50 mM glycine–NaOH
buffer (pH 10.0) for up to 1 h. In enzymatic characterization, soluble PGA was used as the substrate
with the concentration of 0.2% (w/v), 5 mM CaCl2 was added during enzymatic reaction. Formed
unsaturated products were recorded at 235 nm. All data are expressed as the averages of triplicate
measurements (± SD).
The effects of metal ions and chemical reagents on PpPel9a activity were detected by incubating
the purified enzyme in 5 mM of metal ions and reagents at 25 ◦C for 24 h, then the residual activity was
measured under the standard assay condition with 0.2% (w/v) PGA as the substrate. The enzymatic
activity without adding any metal ions or chemical reagents was marked as 100%. The effect of Ca2+ at
different concentrations (0.1–10 mM) on enzyme activity was determined in 50 mM glycine–NaOH
buffers (pH 10.0) with 0.2% PGA (w/v) as the substrate. Formed unsaturated products were recorded at
235 nm. The enzymatic activity without adding CaCl2 was marked as 100%.
3.8. Degradation of CP by PpPel9a and the Preparation of Degradation Product
First, 2.5 g of CP was incubated with 50 mg of purified recombinant PpPel9a in 50 mM Tris-HCl
buffer (pH 8.0). The enzyamtic degradation lasted for 48 h at 40 ◦C. Then, the reaction mixture was
boiled for 10 min and centrifuged at 10,000× g for 10 min to remove the protein. Then, the degradation
product was freeze-dried and purified by DEAE-sepharose fastflow column. The column (bed volume
25 mL) was eluted by 2 column volume of water, followed by 6 column volume of linear gradient of
0–0.5 M NaCl. The eluate was collected at 4 mL/tube and detected for the distribution of total sugar
by the phenol-sulphuric acid method, and uronic acid by the m-hydroxydiphenyl method [53,54].
The main fraction peak eluted by 0.3 M NaCl was combined, dialyzed against distilled water, and
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freeze-dried. The fraction was named MCP-0.3, and its monosaccharide composition, molecular
weight, RG-II content, and degree of esterification were analyzed by HPAEC, HPGPC, modified TBA
method, and FT-IR, respectively.
3.9. Prebiotic Effect of CP and Its Degradation Product MCP-0.3 on Lactobacillus Strains
The prebiotic effects of CP and MCP-0.3 on Lactobacillus strains were studied as described in
Zheng et al. [41]. Briefly, Lactobacillus strains, including L. rhamnosus strains JAAS8 and ITF-1, and
L. plantarum strains CH4, P3-18, S52, C88, and K25, were pre-cultured in De Man Rogosa Sharpe
(MRS) liquid at 37 ◦C for 16 h. Then, the cells were inoculated with an inoculum size of 2% in 100 μL
modified MRS media containing 5 mg/mL CP or MCP-0.3 as the sole carbon source. Then, the cells
were collected by centrifugation after cultured at 37 ◦C for 16 h and washed twice with PBS buffer.
The cell pellet was re-suspended in 200 μL PBS buffer, and the OD 600 nm was detected by the Tecan
Infinite F50 microplate reader. All data are shown as the averages of triplicate measurements (± SD).
4. Conclusions
In the present study, the PL9 pectate lyase PpPel9a was cloned from P. polymyxa KF-1 and was
used to degrade pectins from different plants. Recombinant PpPel9a was used to degrade citrus pectin,
reproducibly yielding the fraction MCP-0.3 that exhibited good prebiotic effects in vitro. This enzyme
may be a valuable candidate for preparation of low-molecular-weight pectin fractions.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/20/12/
3060/s1.
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Abstract: A halo-thermophilic bacterium, Roseithermus sacchariphilus strain RA (previously known as
Rhodothermaceae bacterium RA), was isolated from a hot spring in Langkawi, Malaysia. A complete
genome analysis showed that the bacterium harbors 57 glycoside hydrolases (GHs), including a
multi-domain xylanase (XynRA2). The full-length XynRA2 of 813 amino acids comprises a family 4_9
carbohydrate-binding module (CBM4_9), a family 10 glycoside hydrolase catalytic domain (GH10),
and a C-terminal domain (CTD) for type IX secretion system (T9SS). This study aims to describe the
biochemical properties of XynRA2 and the effects of CBM truncation on this xylanase. XynRA2 and
its CBM-truncated variant (XynRA2ΔCBM) was expressed, purified, and characterized. The purified
XynRA2 and XynRA2ΔCBM had an identical optimum temperature at 70 ◦C, but different optimum
pHs of 8.5 and 6.0 respectively. Furthermore, XynRA2 retained 94% and 71% of activity at 4.0 M and
5.0 M NaCl respectively, whereas XynRA2ΔCBM showed a lower activity (79% and 54%). XynRA2
exhibited a turnover rate (kcat) of 24.8 s−1, but this was reduced by 40% for XynRA2ΔCBM. Both the
xylanases hydrolyzed beechwood xylan predominantly into xylobiose, and oat-spelt xylan into a
mixture of xylo-oligosaccharides (XOs). Collectively, this work suggested CBM4_9 of XynRA2 has a
role in enzyme performance.
Keywords: glycoside hydrolase; xylanase; carbohydrate-binding module; CBM truncation;
halo-tolerant; xylan hydrolysis
1. Introduction
Xylan is one of the most abundant polymers in plant biomass. The polymer consists of a
β-1,3/1,4-linked xylopyranose backbone with side branches such as O-acetyl, α-4-O-glucuronic acid,
α-l-arabinofuranose, p-coumaric acid, or ferulic acid at C-2 or C-3 positions [1]. Due to such
complexity, a complete hydrolysis of xylan requires synergism of various xylanolytic enzymes
including endo-β-1,4-d-xylanase, β-d-xylosidase, α-d-glucuronidase, α-l-arabinofuranosidase, and
acetylesterase [2]. Among these enzymes, endo-β-1,4-xylanase (E.C. 3.2.1.8) plays a crucial role
in hydrolyzing the β-1,4-glycosidic bonds of the xylan to form xylo-oligosaccharides (XOs) and
xylose. According to the Carbohydrate-Active Enzyme (CAZy) database (http://www.cazy.org) [3],
endo-β-1,4-xylanases are currently grouped in glycosyl hydrolase (GH) 5, 8, 10, 11, 30, 43, 51, 98, and
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141 families. The majority of endo-β-1,4-xylanases belong to GH10 and GH11 families, which are
distinctive of their respective origin, molecular properties, and protein structure [4].
Xylanases are produced by a diverse range of organisms, which include fungi, bacteria, yeast,
algae, protozoa, crustaceans, and insects. Fungal and bacterial xylanases are important due to their
superior properties, which could potentially be applied in industrial processes [5]. As summarized
in a review article [6], xylanases are utilized for the delignification of paper pulp, modification of
cereal food, improvement of digestibility of animal feedstock and production of xylo-oligosaccharides
for pharmaceutical industries. Selection of the types of xylanases for these applications is based on
suitability. For instance, thermostable alkaline xylanases are applicable for efficient biobleaching of
pulp and paper [7], while thermostable acidic xylanases are applicable for animal feed processes [8].
Xylanases which are active and stable in low or high pH values are suitable for hemicellulosic biomass
saccharification [5]. Xylanases with an optimum activity at low temperature and alkaline pH are
applicable in detergent formulation additives [9]. Earlier reports suggested that xylanases obtained
from psychrophilic species could improve the quality of bread and fruit juices [10,11]. Xylanases from
halophilic microorganisms often exhibit salt-tolerance, which can be used for wastewater treatment
and marine/saline food preparation [12].
The protein architecture of endo-β-xylanases comprises a glycoside hydrolase catalytic domain
that is sometimes associated with one or more carbohydrate-binding modules (CBMs) [13].
Endo-β-xylanases without a CBM have also been reported [14–17]. CBMs do not contribute directly to
catalytic mechanisms. However, they play a role in carbohydrate recognition and binding. The presence
of CBM binding allows carbohydrate-active enzymes to concentrate on the polysaccharide surface and
improve the overall catalytic efficiency [18]. There are currently 84 families of CBMs. These CBMs
display considerable variations in substrate specificity against crystalline cellulose, non-crystalline
cellulose, chitin, β-1,3/1,4-glucans, starch, glycogen, xylan, mannan, galactan, and inulin [19]. In the
CAZy database, various families of CBMs were appended with GH10 xylanases, predominantly from
GH 1, 2, 3, 4, 6, 9, 13, and 22, as well as from GH 10, 15, 35, and 37.
A rare halo-thermophilic bacterium, initially designated as Rhodothermaceae bacterium RA (NCBI
taxonomy ID: 1779382), was isolated from a hot spring in Langkawi (6◦25′22.31” N, 99◦48′48.97” E),
Malaysia [20]. The bacterium exhibited a low identity of 16S rRNA (89.3%) and ANI value (79.3) to
the closest strain Rhodothermus marinus DSM 4252T. This information indicates that Rhodothermaceae
bacterium RA might represent a new genus in the family Rhodothermaceae [20,21]. In 2019, Park et al.
reported a strain MEBiC09517T isolated from a port in South Korea [22]. MEBiC09517T was proposed as
the first member of the new genus and the authors suggested that the strain be classified as Roseithermus
sacchariphilus gen. nov., sp. nov. Due to high similarity (ANI value of 96.2%) between Rhodothermaceae
bacterium RA and strain MEBiC09517T, we propose that our strain is a subspecies of Roseithermus
sacchariphilus. To differentiate both strains, we renamed our bacterium Roseithermus sacchariphilus RA.
In this study, a xylanase gene (xynRA2) was cloned from this bacterium. The study aims to describe the
biochemical properties of this enzyme and to understand the effects of CBM truncation on the xylanase.
2. Results and Discussion
2.1. Bioinformatic Analysis
Numerous xylanases have been discovered from extreme habitats such as soda lakes, marine
sediments, and hot springs [23–25]. We previously isolated R. sacchariphilus RA from a saline hot
spring (45 ◦C, pH 7.1, 13,000 mg/L for Cl− ion, and 7900 mg/L for Na+) [26]. A complete genome
sequencing elucidated that strain RA harbors 57 GHs affiliated to 30 families [21]. Two non-homologous
xylanases were identified and designated as XynRA1 and XynRA2 respectively. The xylanase XynRA1
(Genbank: ARA95075.1) has 379 amino acids and lacks a CBM, while the xylanase XynRA2 (Genbank:
ARA92359.1) consists of 813 amino acids and a CBM. XynRA2 was chosen for further study, as we
were interested in the function of the CBM attached to this xylanase.
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XynRA2 and the putative xylanase annotated in the genome of R. sacchariphilus strain MEBiC09517T
are homologs with the identity of 98.6%. The protein sequence of XynRA2 has the identity of
50–65% with xylanases from Rubrivirga marina, Verrucomicrobiae bacterium DG1235, Lewinella nigricans,
Catalinimonas alkaloidigena, Fibrisoma sp. HYT19, Rhodohalobacter sp. SW132, Cellvibrio sp. PSBB006,
and Ignavibacteria bacterium GWC2_36_12. The xylanase XynRA2 shares less than 50% identity with
xylanases from Rhodothermaeota bacterium MED-G12, Hymenobacter chitinivorans, and Siccationidurans
arizonensis. The xylanases mentioned earlier including that of R. sacchariphilus MEBiC09517T were
deduced from genome annotation and have not been heterologously expressed and characterized.
A phylogenetic tree utilizing a neighbor-joining algorithm was built to show a relationship of XynRA2
with selected counterparts (Figure 1a). In comparison to the well-characterized xylanases, XynRA2
is 73.1% in identity to that of xylanase Xyn10A produced by R. marinus DSM 4252 and 52.3% to a
xylanase Xyl2091 from Melioribacter roseus P3M-2 [27,28]. The sequence identity is low between XynRA2
to other well-studied enzymes, including xylanases that are from Fusarium graminearum (38%) [29],
Trichoderma reesei QM6α (28%) [30], Bacillus stearothermophilus T-6 (26%) [31], and Thermoanaerobacterium
saccharolyticum B6A-RI (25%) [32].
 
Figure 1. (a) Protein dendrogram of XynRA2 and its close homologs. The signal peptide sequences
of the proteins were not included in the phylogenetic analysis. Asterisks (*) denote xylanases which
have been characterized, otherwise represent genome annotated xylanases. (b) Schematic domains
arrangement of the respective proteins identified by InterPro. Dotted-line box represents the truncated
region in XynRA2ΔCBM.
A mature XynRA2 protein sequence comprises a CBM (Gln36–Asn198), a catalytic domain
(Glu396–Tyr712), and a CTD (Trp735–Val810) (Figure 1b). The homology model of CBM clearly denoted
the β-sandwich structure formed by eleven anti-parallel β-strands, while that of the catalytic domain
is a typical TIM-barrel consisting of eight alternating β-strands and β-helices (Figure 2a,b). Similar to
xylanases from R. marinus (Xyn10A) and M. roseus (Xyl2091), these enzymes possess a GH10 catalytic
domain. From the multiple sequence alignment with six GH10 xylanases with crystal structures,
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the putative catalytic residues for XynRA2 were identified as Glu520 and Glu635. The linker region
connecting the GH10 domain and CBM comprises 198 residues.
It is likely that in the wild-type R. sacchariphilus RA, XynRA2 is exported across the cytoplasmic
membrane by the Sec pathway due to the presence of a signal peptide (Met1 to Ala33). In addition,
XynRA2 has a CTD that enables the protein to be secreted across the outer membrane by T9SS. The T9SS
protein secretion pathway is also known as Por secretion system (PorSS) [33,34] which was discovered
in Porphyromonas gingivalis for secreting a potent protease gingipains [34]. Besides being identified
in R. sacchariphilus RA, we noticed that in another genome sequencing project, some other annotated
cellulases and hemicellulases incorporated a CTD; however, there has been little research describing
the actual function of T9SS to GH enzymes. The two closest homologs of XynRA2, the Xyn10A from
R. marinus and Xyl2091 from M. roseus also possessed a similar CTD [28,35]. The CTD possesses five
short motifs, in which Motif B, Motif D and Motif E are important for the extensive modification by
T9SS [36,37]. By aligning the CTD region of XynRA2 with other xylanases, the well-conserved Gly
residues were identified in Motif B and Motif D, whereas Arg substituted the almost-conserved Lys in
Motif E [37] (Figure 2c). Proteins that possessed the CTD were found to be cell-anchoring or rely on
CTD for secretion, such as Xyn10A from R. marinus DSM 4252 as well as SprB, RemA, and ChiA from
Flavobacterium johnsoniae [35,36]. Collectively, this suggests that XynRA2 could be a cell-anchoring
enzyme. However, further experimental validation is required.
 
Figure 2. Putative structure of (a) CBM4_9 and (b) GH10 catalytic domain of XynRA2. The models
were colored with the rainbow scheme (blue N-terminus, follows by green, yellow, and red C-terminus);
(c) multiple sequence alignment of XynRA2 CTD with the counterpart of Xyn10A from R. marinus,
Xyl2019 from M. roseus, ChiA from F. johnsoniae, as well as CTD proteins from P. gingivalis and
Parabacteroides distasonis. Amino acid stretch for Motif B, D, and E are indicated by red, blue, and yellow
boxes, respectively. Asterisks (*) indicate fully conserved amino acids while colon (:) indicates amino
acid groups of similar properties.
Based on an InterPro analysis, the CBM of XynRA2 was annotated as CBM4_9. The closest
biochemically characterized xylanase (Xyn10A) from R. marinus DSM 4252 has two dissimilar CBM4_9s
arranged in tandem (Figure 1b), which were denoted as “CBM4-1” and “CBM4-2” in the original
article [38]. Another close homolog, a characterized xylanase (Xyl2091) from M. roseus, also possessed a
CBM4_9 [28]. Interestingly, the amino acid stretch of the CBM4_9 from R. sacchariphilus RA is only 70%
and 51% identical to R. marinus and M. roseus counterparts respectively, suggesting that the affinity
of the three enzymes against hemicellulose might be different. Different families of CBMs such as
CBM6_36 for XynG1-1 [39], CBM13 for XynAS27 [40], and dual CBM9-CBM22 for XynSL3 [24] were
often reported in GH10 xylanases. According to the CAZy, other CBMs associated with xylanases
286
Int. J. Mol. Sci. 2019, 20, 2284
are from families 1, 2, 3, 10, 15, 35, and 37. The CBM4 family from xylanases usually binds to xylan
β-glucan, and/or amorphous cellulose [41,42]. We anticipated the substrate specificity of CBM4_9
in XynRA2 to be similar. Several reports have shown that the removal of the CBMs affected the
biochemical properties of their partnering xylanases [39,40,43]. Therefore, we constructed a mutant
enzyme (designated as XynRA2ΔCBM) by deleting the CBM4_9 but retaining the linker connecting the
CBM to the catalytic domain to evaluate the effect of its truncation on the xylanase.
2.2. Expression of Recombinant XynRA2 and XynRA2ΔCBM
The gene fragments encoding for mature XynRA2 (2349 bp) and XynRA2ΔCBM (1857 bp) were
cloned in pET28a(+), expressed in E. coli BL21 (DE3) and purified using Ni-NTA columns. The purified
enzymes migrated as two distinct bands around 90 kDa and 70 kDa on SDS-PAGE, which were
consistent with the theoretical molecular weight of XynRA2 (89.5 kDa) and XynRA2ΔCBM (68.5 kDa)
respectively (Figure 3a).
 
Figure 3. Molecular properties of purified XynRA2 and XynRA2ΔCBM. (a) SDS-PAGE analysis
of purified XynRA2 and XynRA2ΔCBM. M, BenchMark™ Protein Ladder; A, purified XynRA2; B,
purified XynRA2ΔCBM; (b) effect of pH in the range of 2–11; (c) effect of temperature from 20–90 ◦C;
(d) thermostability at 70 ◦C across 120 min; (e) effect of NaCl from 0–5.0 M concentration.
2.3. Biochemical Characterization of XynRA2 and XynRA2ΔCBM
2.3.1. Effect of pH and Temperature
Using beechwood xylan as the substrate, the purified XynRA2 had maximum activity at pH 8.5
and retained a relatively high activity between pH 7–9. Truncation of the CBM broadened the pH
profile (pH 5–9) with the optimum pH shifted to 6.0 (Figure 3b). Similarly, CBM4_9 truncation changed
the optimum pH from 7.5 to 7.0 for a xylanase PX3 from Paenibacillus terrae HPL-003 [44]. The working
pH for the mutant PX3 also narrowed to pH 5–10, while the native PX3 had an active pH ranging from
3–12. The optimum pHs of xylanase Xyn10A from R. marinus and Xyl2091 from M. roseus were 7.5 and
6.5 respectively [28,45], while that of truncated counterparts was not reported.
The optimum temperature for the activity of native XynRA2 and XynRA2ΔCBM was 70 ◦C.
Overall, the temperature profiles for both enzymes were identical (Figure 3c). To evaluate the
thermostability, XynRA2 and XynRA2ΔCBM were incubated at 70 ◦C without substrate for a specific
interval prior to measuring residual activity. The half-life of both XynRA2 and XynRA2ΔCBM at 70 ◦C
was approximately 45 min; however, XynRA2ΔCBM was more sensitive to prolonged temperature
treatment (Figure 3d). The optimum temperatures of Xyn10A and Xyl2091 were 80 ◦C and 65 ◦C
respectively and their half-lives were about 90 min (80 ◦C) and 160 min (60 ◦C), respectively. Truncation
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of the CBM in Xyn10A from R. marinus also resulted in a decrease in thermostability, indicating that
the CBM with this xylanase also contributed to enzyme stability [46]. Truncation of the CBM from
xylanases from Streptomyce rochei L10904 (Srxyn10) [43], Paenibacillus campinasensis G1-1 (XynG1-1) [39],
and Streptomyces sp. S27 (XynAS27) [40] showed that removal of the CBM did not affect the optimum
temperature of xylanases. However, the truncated versions of XynG1-1 and XynAS27 displayed a
significant decrease in thermostability [39,40]. In contrast, the CBM-truncated variant of Srxyn10 from
S. rochei L10904 exhibited a substantial increase in thermostability at 60–70 ◦C despite sharing similar
optimum temperature with its native counterpart [43].
2.3.2. NaCl Tolerance
The R. sacchariphilus RA was capable of growing in media containing a high concentration of
NaCl [20]. Since XynRA2 is probably expressed as an extracellular cell-bound enzyme, we decided to
investigate the effect of NaCl on xylanase activity. Multiple xylanases are known to exhibited moderate
halo-tolerance, but only limited reports have demonstrated extreme halo-tolerance ability as displayed
by XynRA2 (Table 1). The relative activity of XynRA2 and XynRA2ΔCBM was slightly enhanced
when the catalytic reactions were supplemented with 1.0 M NaCl. Notably, XynRA2 retained 94%
of initial activity at 4.0 M, and 71% at 5.0 M NaCl. Although the mutant XynRA2ΔCBM was more
salt-sensitive, the enzyme retained the relative activity of 79% at 4.0 M and 54% at 5.0 M (Figure 3e).
The reason for the lower halo-tolerance is unknown. In addition, there is a lack of literature elucidating
the relationship between CBM and halo-xylanase activity.
A homology model of XynRA2 catalytic domain demonstrated a high distribution of acidic amino
acids on the protein surface resulting in an overall negative electrostatic potential (Figure 4), which
might explain the excellent protein stability in high NaCl concentration. Theoretically, halo-tolerant
enzymes contain more acidic residues (Asp and Glu) than non-polar residues (Val, Ile, Leu, Met,
and Phe). Halo-tolerant enzymes are also enriched with small residues (Ala, Val, Ser, and Thr) but
lack Lys residue [47]. It has been proposed that excess acidic residues could facilitate the weakening
of hydrophobicity or strengthening of hydrophilic forces on the enzyme surface, which increases
water-binding capacity and prevent proteins aggregation at high salt concentration [48,49].
Table 1. The reported halo-tolerant xylanases and their activity in high concentration of NaCl.
Enzymatic reactions carried out at 0 M of NaCl was treated as 100%.
Xylanases
Activity in NaCl (%)
Strains Reference
3.0 M 4.0 M 5.0 M
XynRA2 95 94 71 R. sacchariphilus RA strain RA This study
M11 60 50 47 Streptomyces viridochromogenes [12]
Xyn512 60 47 32 Flammeovirga pacifica WPAGA1 [23]
XynSL3 60 40 ND Alkalibacterium sp. SL3 [24]
XynA 78 53 ND Glaciecola mesophila KMM 241 [50]
XynA 180 140 100 Zunongwangia profunda [49]
XynSL4 59 41 ND Planococcus sp. SL4 [51]
XynRBM26 96 93 87 Massilia sp. RBM26 [52]
XynAHJ3 40 26 ND Lechevalieria sp. HJ3 [53]
Xylanase 90 87 84 Gracillibacillus sp. TSCPVG [54]
ND: not determined.
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Figure 4. Predicted electrostatic potentials on the surface of XynRA2 catalytic domain from (a) top
and (b) bottom views. The ligand (xylobiose) is bound at the catalytic binding pocket of XynRA2 as
indicated in (a). Red and blue indicate negative and positive electrostatic potentials respectively.
2.3.3. Enzyme Kinetics
The specific activities and the turnover rate (kcat) of the purified XynRA2 and XynRA2ΔCBM
were determined by reacting the enzymes with soluble beechwood xylan. The specific activities
of XynRA2 and XynRA2ΔCBM were 300 U/mg and 160 U/mg respectively. The kcat of the native
and mutant enzymes were 24.8 s−1 and 15.7 s−1, respectively. We found that the truncation of CBM
significantly affected the performance of the enzymes. This finding was in consistent with XynG1-1
from P. campinasensis that CBM truncation reduced the kcat by 20% [39]. Removal of CBM alone did
not affect the kcat of XynAS27 from Streptomyces sp. S27. However, truncating CBM together with the
linker reduced kcat value by 25% [40]. On the other hand, the xylanase variant of Srxyn10 with a CBM
truncation had a three-fold higher specific activity on beechwood xylan than its native counterpart [43].
2.3.4. Substrate and Product Specificities
The purified XynRA2 and XynRA2ΔCBM were incubated with various substrates before analyzing
them using HPLC. Generally, XynRA2 and XynRA2ΔCBM showed similar substrate specificities. Both
enzymes were active on beechwood xylan, oat-spelt xylan, and xylo-oligosaccharides (XOs) such as
X6, X5, X4 but not on X3 and X2. Except for xylose-based carbohydrates, the enzymes were unable
to hydrolyze glucose-, maltose-, and arabinose-derived polymers such as carboxymethylcellulose
(CMC), Avicel™, starch, pullulan, d-cellobiose, and arabinan. The results indicated that the enzymes
did not possess either a cellulase or arabinase activity, suggesting that XynRA2 is a specific GH10
xylanase. This is in agreement with a recent statistical study that showed most of the characterized
GH10 xylanases were mono-specific (96.8%, n = 350) towards xylanosic substrates [4].
We compared the product formation pattern of XynRA2 and XynRA2ΔCBM by reacting the
purified enzymes with beechwood xylan and oat-spelt xylan (Figure 5). Upon reacting XynRA2 with
beechwood xylan, the products constituted a mixture of XOs ranging X6, X5, X4, X3, and X2 at the
beginning of the reaction (15 min). After a prolonged hydrolysis (24 h), xylobiose (X2) was accumulated
as the primary product together with detectable X3 and X1 (Figure 5a), and the product formation
pattern for XynRA2ΔCBM against beechwood xylan was shown in Figure 5b. For reactions of 15 min
and 24 h, the product profile for XynRA2ΔCBM was similar to that of XynRA2. Yet, the ratio of X3
and X2 was slightly different in the 1 h and 3 h reactions. Previous reports on xylanase rXTMA from
Thermotoga maritima and xylanase A from Caldibacillus cellulovorans also showed a variation in the
profiles of XOs produced by native and CBM-depletion xylanases [55,56].
Although the same reaction conditions were used with oat-spelt xylan, we obtained lower sugar
yields, probably due to the physical structure of oat-spelt xylan which consisted of both insoluble
and soluble fractions. Furthermore, the product profiles were also different for beechwood xylan and
oat-spelt xylan. After prolonged reaction, X4, X3, and X2 were accumulated as the major products
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(Figure 5c). Interestingly, oat-spelt xylan was a poor substrate for XynRA2ΔCBM (Figure 5d), as reported
for other xylanases [39,40,57,58]. A lower activity against oat-spelt xylan might be due to the inefficient
binding onto the substrate, as a result of CBM truncation in XynRA2ΔCBM. It has also been recurrently
reported that the truncation of CBMs affects catalytic efficiency of GHs towards other insoluble
substrates but not the soluble counterparts [18,19].
Figure 5. Product analysis of xylan degradation. (a,b) products formed from hydrolysis of beechwood
xylan by XynRA2 and XynRA2ΔCBM, respectively; (c,d) products formed from hydrolysis of
oat-spelt xylan by XynRA2 and XynRA2ΔCBM, respectively. The product peaks shown in this
figure were normalized.
3. Materials and Methods
3.1. Sequence Analysis
The gene sequence of putative xylanase (GenBank: ARA92359.1) was extracted from the complete
genome of R. sacchariphilus RA (GenBank: CP020382.1) [20,21]. The mature xylanase gene was
designated as xynRA2. The protein sequence similarity was assessed using NCBI BLASTp program
(https://blast.ncbi.nlm.nih.gov/Blast.cgi). Multiple sequence alignments were performed using Clustal
Omega (https://www.ebi.ac.uk/Tools/msa/clustalo/). A phylogenetic tree of XynRA2 with its closest
homologs was constructed with the neighbor-joining algorithm using MEGA v7.0 software [59]
with a bootstrap value of 1000. The signal peptide sequence was predicted using SignalP v4.1
(http://www.cbs.dtu.dk/services/SignalP/). Conservative domains were identified using InterPro.
The homology model of XynRA2 was performed using SWISS-MODEL (https://swissmodel.expasy.org/)
with an evolved CBM of Xyn10A from R. marinus (PDB: 3JXS) [60] and GH10 xylanase (XynB) from
Xanthomonas axonopodis pv citri (PDB: 4PN2) complexed with xylotriose as a template [61]. The predicted
model and its surface electrostatic potential were assessed using APBS plugin in PyMOL (v2.2.3,
Schrödinger Inc., New York, NY, USA).
3.2. Cloning of Xylanases
Genomic DNA of R. sacchariphilus RA was extracted using DNeasy Blood & Tissue Kit (Qiagen,
Hilden, Germany). The gene sequence of xynRA2 was amplified from the genomic DNA using a
forward primer GH10F (5′-AGCCATATGCGTGCGCAGAGCAACACCA-3′) and a reverse primer
GH10R (5′-CGATGGGTACTGGTCCGCCTCGAGCACC-3′). The underlined sequences represent
NdeI and XhoI restriction sites respectively. N-terminal signal peptide was not included in the
recombinant enzymes. The truncated gene xynRA2ΔCBM was amplified using primer GH10F-LC
(5′-AGCCATATGCCCCTGGCGGGAGC-3′) and GH10R.
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Both the gene fragments were amplified using Q5® High-Fidelity PCR kit (NEB, Ipswich, MA,
USA). The PCR products were digested with NdeI and XhoI followed by ligation into pET28a(+)
(Novagen, Madison, WI, USA) at the corresponding sites. The recombinant plasmids (pET28a_xynRA2
and pET28a_xynRA2ΔCBM) were separately transformed into E. coli BL21 (DE3) competent cells using
the heat shock method. The transformants were grown in Luria-Bertani (LB) medium containing
50 μg/mL kanamycin at 37 ◦C for 18 h. Transformants harboring the recombinant plasmid were
identified by restriction digestion and DNA sequencing.
3.3. Expression and Purification of Xylanases
The transformed cells were grown in LB medium containing 50 μg/mL kanamycin at 37 ◦C to an
A600 nm of 0.6. Protein expression was induced by addition of isopropyl-β-d-thiogalactopyranoside
(IPTG) at a final concentration of 0.4 mM at 25 ◦C for 18 h. The cells were harvested by centrifugation
(6000× g, 4 ◦C, 10 min) and lysed using B-PER™ Direct Bacterial Protein Extraction Kit (Thermo
Scientific, Waltham, MA, USA) The crude enzyme was collected (12,000× g, 4 ◦C, 10 min) and dialyzed
against 20 mM sodium phosphate buffer (pH 7.4) at 4 ◦C overnight in a SnakeSkin™ Dialysis Tubing
10k MWCO (Thermo Scientific, Waltham, MA, USA). To purify the His-tagged proteins, the crude
enzyme was loaded onto a Ni-NTA Superflow column (Qiagen, Hilden, Germany) equilibrated with
20 mM sodium phosphate buffer (pH 7.4) and 50 mM imidazole. The enzymes were eluted with a
linear gradient of 50–500 mM imidazole in 20 mM phosphate buffer (pH 7.4) containing 500 mM NaCl.
Upon elution, fractions containing the XynRA2 and XynRA2ΔCBM were respectively pooled and
dialyzed against 20 mM sodium phosphate buffer (pH 7.4) at 4 ◦C overnight to remove the remaining
salts. The purity and apparent molecular mass of XynRA2 and XynRA2ΔCBM were validated by
SDS-PAGE. The activity of the purified enzymes was assayed as described below.
3.4. Xylanase Assay
The xylanase activity of XynRA2 and XynRA2ΔCBM was calculated by measuring the reducing
sugars released from substrates using 3,5-dinitrosalicylic acid (DNS) method. The reaction mixtures
contained 50 μL of appropriately diluted enzymes and 500 μL of 1% (w/v) beechwood xylan (Megazyme,
Bray, County Wicklow, Ireland) in 0.1 M Tris-HCl buffer (pH 8.5). The enzymatic reaction was carried
out at 70 ◦C for 15 min, stopped with 500 μL DNS reagent and boiled for 5 min. The absorbance at
540 nm was measured when the reaction mixture is cooled to room temperature. The amount of sugar
released was estimated using a standard curve of d-xylose (Sigma-Aldrich, St. Louis, MO, USA). One
unit (U) of xylanase activity was defined as 1 μmol of reducing sugars released from substrate per
minute per mL of enzyme under the assay condition. The enzyme activity was calculated by this
standard procedure unless otherwise noted. All reactions were performed in at least triplicate.
3.5. Biochemical Characterization of XynRA2 and XynRA2ΔCBM
The optimum pH of XynRA2 was determined in a range of 2–11 at 50 ◦C. The buffers used were
0.1 M of glycine HCl (pH 2–3), sodium acetate (pH 4–6), Tris-HCl (pH 7–9), and glycine-NaOH (pH
10–11) containing 1% (w/v) purified beechwood xylan (Megazyme, Bray, County Wicklow, Ireland).
The optimum temperature of the enzyme was determined over a range of temperature from 20 to
90 ◦C in Tris-HCl buffer (pH 8.5). The optimum pH of XynRA2ΔCBM was determined at 70 ◦C and the
optimum temperature was determined in acetate buffer (pH 6.0). Thermostability of XynRA2 and
XynRA2ΔCBM were determined by measuring the residual activity of the enzyme after pre-incubation
in 0.1 M Tris-HCl buffer (pH 8.5) and 0.1 M acetate buffer (pH 6.0), respectively, at 70 ◦C without
substrate for 2 h. The initial activity of enzymes without pre-incubation was set as 100%.
The effect of NaCl on the activity of XynRA2 and XynRA2ΔCBM was determined at 70 ◦C in
0.1 M Tris-HCl buffer (pH 8.5) and 0.1 M sodium acetate buffer (pH 6.0), respectively, in the presence of
up to 5.0 M NaCl.
291
Int. J. Mol. Sci. 2019, 20, 2284
To determine the specific activities of purified XynRA2 and XynRA2ΔCBM, the enzyme activities
were determined using a xylanase assay as described above, and the protein concentration was
determined by Pierce™ BCA Protein Assay kit (Thermo Scientific, Waltham, MA, USA) using BSA
as a standard. To determine the turnover rate (kcat) of XynRA2 and XynRA2ΔCBM, the respective
enzymatic reaction was carried out at 70 ◦C in 0.1 M Tris-HCl buffer (pH 8.5) and 0.1 M sodium
acetate buffer (pH 6.0) containing 0.1–1.5% (w/v) of purified beechwood xylan. The kcat of the enzymes
were determined based on non-linear regression using PRISM 7 software (GraphPad Software Inc.,
San Diego, CA, USA).
3.6. Analysis of Substrate Specificity and Hydrolysis Products
The substrate specificity of XynRA2 and XynRA2ΔCBM was determined in 0.1 M Tris-HCl (pH 8.5)
and 0.1 M acetate buffer (pH 6.0) containing 1% (w/v) of beechwood xylan, arabinan (Megazyme, Bray,
County Wicklow, Ireland), oat-spelt xylan, CMC, Avicel™, D-cellobiose (Sigma, St. Louis, MO, USA),
pullulan (TCI chemicals, Tokyo, Japan), starch (QReC, Auckland, New Zealand) or 5 mM of X2–X6
xylo-oligosaccharides (Bz Oligo Biotech, Qingdao, China). The reaction mixture contained 50 μL of
purified enzymes and 500 μL of the substrate solutions. The substrate hydrolysis was detected as
described below.
To analyze the hydrolysis products of XynRA2 and XynRA2ΔCBM, the reaction mixtures with
3 U of purified enzymes and 1% (w/v) beechwood xylan and oat-spelt xylan were incubated at
70 ◦C in Tris-HCl buffer (pH 8.5) for 24 h. The hydrolysis products were eluted using Rezex™
RSO-oligosaccharides Ag+ (4%) column (Phenomenex, Torrance, CA, USA) at a flow rate of 1.0 mL/min
at 80 ◦C for 80 min and detected using 1260 Infinity ELSD (Agilent Technologies, Santa Clara, CA,
USA). Xylo- oligosaccharides (X2–X6) and xylose were used as its product standards.
4. Conclusions
Roseithermus is a newly proposed genus in family Rhodothermaceae affiliated to order Rhodothermales.
Currently, the whole taxonomic order is comprised of only 14 type strains. So far, xylanase from
Rhodothermus marinus is the only enzyme that was well characterized. This study described for the first
time the biochemical properties of a xylanase from Roseithermus. The native XynRA2 was active at
alkaline pH and elevated temperature (pH 8.5 and 70 ◦C) while retaining excellent activity even at
5.0 M NaCl. Such properties make XynRA2 a potential candidate for applications involving an alkaline
environment, elevated temperature, and high salinity. In a separate part of the study, the CBM4_9
domain was removed. The data elucidated that CBM truncation affected enzyme specific activity,
turnover rate, pH optimum, and NaCl tolerance, with an additional marginal effect on thermostability.
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Abstract: Xylan, a prominent component of cellulosic biomass, has a high potential for degradation
into reducing sugars, and subsequent conversion into bioethanol. This process requires a range of
xylanolytic enzymes. Among them, β-xylosidases are crucial, because they hydrolyze more glycosidic
bonds than any of the other xylanolytic enzymes. They also enhance the efficiency of the process by
degrading xylooligosaccharides, which are potent inhibitors of other hemicellulose-/xylan-converting
enzymes. On the other hand, the β-xylosidase itself is also inhibited by monosaccharides that may
be generated in high concentrations during the saccharification process. Structurally, β-xylosidases
are diverse enzymes with different substrate specificities and enzyme mechanisms. Here, we review
the structural diversity and catalytic mechanisms of β-xylosidases, and discuss their inhibition
by monosaccharides.
Keywords: biomass; hemicellulose; bioethanol; xylanolytic enzyme; hemicellulase; glycoside hydrolase
1. Introduction
Xylan is a prominent component of cellulosic biomass, a heterogeneous complex of carbohydrate
polymers (cellulose and hemicellulose) and lignin, a complex polymer of phenylpropane units [1–3].
Hemicellulose, including xylan, makes up approximately one-third of the carbohydrate content of
common agricultural and forestry waste [1–3]. It is among the most inexpensive non-food biomass that
is sustainably available in nature in large quantities, and that can be converted into biofuel or other
value-added products, such as low-calorie sweeteners, prebiotics, surfactants and various specialty
chemicals [1,4–6]. Structurally, xylan is a complex heteropolysaccharide with a glycosidic β-(1,4)-linked
d-xylose backbone that is frequently substituted with side chains of arabinose, glucuronic acid and
other groups. In turn, these side chains may be further esterified with acetic, ferulic, and p-coumaric
acids (Figure 1). The type and frequency of the side chains and their substituents vary with the source
of xylans [2,7–11].
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Figure 1. Example of the structure of a plant xylan with the cleavage sites of various xylanolytic
enzymes indicated. A β-d-xylopyranose unit with numbered carbon atoms is shown in the middle.
Glycosidic bonds and xylanolytic enzymes that hydrolyze them are depicted in the same color [7,9].
As a complex heteropolysaccharide, full degradation of xylan into its monosaccharide constituents
requires the concerted action of various hydrolytic xylan-degrading enzymes with different specificities
(Figure 1). These enzymes include α-l-arabinofuranosidase (EC 3.2.1.55), α-d-glucuronidase (EC
3.2.1.139), acetylxylan esterase (EC 3.1.1.72), and p-coumaric acid and ferulic acid esterases (EC 3.1.1.73),
which release the side chain substituents from the xylan backbone, and endo-β-1,4-xylanase (EC
3.2.1.8), which works synergistically with β-xylosidase (EC 3.2.1.37) to break down the xylan backbone.
Endo-β-1,4-xylanase hydrolyses the internal β-(1,4) linkages of the xylan backbone producing short
xylooligosaccharides, while β-xylosidase removes xylose units from the non-reducing termini of
these xylooligosaccharides [2,7,8,10]. In nature, xylanolytic enzymes are mainly found in numerous
saprophytic microorganisms, such as fungi, actinomycetes and other bacteria, as well as in the rumen
biota of higher animals. The microorganisms secrete the enzymes, for example, as a strategy for
expanding their versatility to use primary carbon sources [7,11–14].
Xylan-degrading enzymes have found application as environmentally friendly agents in a wide
range of industrial processes, such as bleaching of paper pulp, deinking of recycled paper, enhancing the
digestibility and nutritional properties of animal feed, degumming of plant fiber sources, manufacturing
of beer and wine, clarification of fruit juices and maceration of fruits and vegetables, preparation of
high-fiber baked goods, and the extraction of coffee [2,7,15,16]. Furthermore, the enzymes are applied
during the saccharification of pretreated agricultural and forestry cellulosic biomass into fermentable
sugars [2,15], e.g., for producing biofuel.
In xylan saccharification, β-xylosidase is a crucial enzyme since, of all the xylanolytic enzymes,
it cleaves the greatest number of glycosidic bonds. [17–19]. In addition, because xylooligosaccharides
are potent inhibitors of endo-β-1,4-xylanases and cellulases, the activity of β-xylosidase can
improve the efficiency of the saccharification process by degrading the xylooligosaccharides and
thus alleviating inhibition of those enzymes [7,11,20–23]. However, most of the characterized
β-xylosidases are, to some extent, also inhibited themselves by xylose, arabinose, glucose, and/or other
monosaccharides [2,11,24–27]. This is an important problem, since in industrial cellulosic biomass
saccharification, the monosaccharides may accumulate to high enough concentrations to significantly
reduce the activity of β-xylosidase, even in simultaneous saccharification and fermentation processes,
where monosaccharides are directly consumed by the fermenting organisms [26,27]. This adverse
property may severely reduce the efficiency of β-xylosidases in the saccharification process.
In this review, the structural diversity, catalytic mechanisms and inhibition by monosaccharides
of β-xylosidases are discussed.
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2. Structural Diversity of β-xylosidases
β-Xylosidases are a group of structurally diverse enzymes with varying specificities, in line
with the diversity of the organisms that produce them and the heterogeneity of their substrates [28].
However, as commonly observed in other glycoside hydrolases (GHs), they hydrolyze the glycosidic
bond via one of two routes, either with overall retention or with overall inversion of the anomeric
carbon configuration [29].
GHs are classified in the Carbohydrate-Active Enzymes database (CAZy; http://www.cazy.org/),
which groups the enzymes into families based on their amino acid sequence similarities [30,31].
As there is a direct relationship between amino acid sequence similarity and similarity of folding, the
classification also represents the structural features and commonality of the catalytic mechanism of the
enzymes. Thus, enzymes in a particular family display highly similar three-dimensional structures
and catalytic mechanisms [29,32]. At present, 161 GH families (GH1 to GH161) are represented on the
CAZy server. Nevertheless, despite divergent amino acid sequences, several different GH families
show significantly similar protein folding and active site architecture. Such GH families are considered
to have a common ancestor and, therefore, have been grouped together into a clan [33]. To date, 18 GH
clans (GH-A to GH-R) have been assigned in the database.
A search using the enzyme classification number for β-xylosidase (EC 3.2.1.37) in the CAZy
database [31] revealed that enzymes with this number are presently found in 11 different GH families
(Table 1). Nevertheless, a further literature examination suggests that 3 families, i.e., GH1, GH54 and
GH116, may not contain enzymes with β-xylosidase activity on natural substrates. The enzymes from
Reticulitermes flavipes (RfBGluc-1; GenPept accession No. ADK12988) [34] and R. santonensis De Feytaud
(GenPept ADT62000) [35] in GH1, and Trichoderma koningii G-39 (TkAbf; GenPept AAA81024) [36] in
GH54 were classified asβ-xylosidases because they hydrolyze artificial nitrophenyl-β-d-xylopyranoside
derivatives. However, to our knowledge there is no evidence that these enzymes are able to release
xylose from natural substrates. Similarly, a bifunctional aryl β-glucosidase/β-xylosidase from the
hyperthermophilic archaeon Saccharolobus solfataricus P2 (formerly Sulfolobus solfataricus; SSO1353;
GenPept AAK41589) in GH116 is called so based on its activity on aryl β-glucosides and β-xylosides,
but the enzyme likely does not hydrolyze xylooligosaccharides [37]. All in all, this suggests that
enzymes with β-xylosidase activity on natural substrates currently occur in only 8 GH families in the
CAZy database, i.e., in GH families 3, 5, 30, 39, 43, 51, 52 and 120.
Table 1. Distribution of the current β-xylosidases in the CAZy database, their catalytic domain fold,














‡ 1 2 A (β/α)8 TIM-barrel Retention Glu Glu
3 103 n.a. # (β/α)8 TIM-barrel Retention Asp Glu
5 1 A (β/α)8 TIM-barrel Retention Glu Glu
30 4 A (β/α)8 TIM-barrel Retention Glu Glu
39 24 A (β/α)8 TIM-barrel Retention Glu Glu
43 96 F 5-bladed β-propeller Inversion Asp § Glu
51 2 A (β/α)8 TIM-barrel Retention Glu Glu
52 11 O (α/α)6-barrel Retention Glu Asp
‡ 54 2 n.a. # β-sandwich % Retention Glu % Asp %
‡ 116 1 O (α/α)6-barrel Retention Glu Asp
120 2 n.a. # right-handed parallel β-helix Retention Asp Glu
†: Catalysis by GHs commonly proceeds with either retention or inversion of the substrate’s anomeric carbon
configuration. See main text for further information. ‡: It is unknown whether the enzymes from GH1, GH54,
and GH116 have β-xylosidase activity on natural substrates. #: Not part of a clan. §: General base; General acid.
%: Not assigned in the CAZy database. Data are from the crystal structure of the α-l-arabinofuranosidase from
Aspergillus kawachii IFO4308 [38].
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2.1. Glycoside Hydrolase Clan A (GH-A)
GH families 1, 5, 30, 39 and 51 are part of clan GH-A, the largest clan in the CAZy database with
currently 23 GH families. Enzymes in this clan all have a (β/α)8 catalytic domain, also known as
triose-phosphate isomerase (TIM) barrel domain [39].
Of clan GH-A, structural data for β-xylosidases are currently only available for GH39, i.e.,
β-xylosidases from Thermoanaerobacterium saccharolyticum B6A-RI (TsXynB; Protein Data Bank code
1px8; Figure 2e) [40], Geobacillus stearothermophilus T-6 (GsXynB1; PDB 2BS9) [41] and Caulobacter
crescentus NA1000 (CcXynB2; PDB 4EKJ) [42]. These enzymes fold into a three-domain structure,
consisting of an N-terminal (β/α)8-barrel catalytic domain, sequentially followed by a β-sandwich
and an α-helical accessory domain. Their structures are very similar. Superposition of the structures
of isolated proteins gave an overall root mean squared deviation (RMSD) of 1.6 Å for 462 amino
acid residues. However, while CcXynB2 exists as a monomer in solution [42], TsXynB and GsXynB1
are present as tetramers [40,41]. The absence of a short amino acid sequence at the C-terminus of
CcXynB2, compared to the other two enzymes, has been suggested to prevent the formation of a stable
tetramer [42]. Additionally, it has been proposed that subtle structural differences in the accessory
domains of these β-xylosidases slightly alter their overall structure and the accessibility of their catalytic
region [42].
In the absence of structural data for β-xylosidases from families GH1, GH5, GH30, and GH51 we
generated homology models to compare the 3D structures of β-xylosidases from the different families
of the GH-A clan. Models were built of the β-glucosidase/β-xylosidase RfBGluc-1 (GH1; Figure 2a) [34],
a β-xylosidase from Phanerochaete chrysosporium BKM-F-1767 (PcXyl5; GenPept AHL69750; GH5;
Figure 2c) [43], a β-glucosidase/β-xylosidase from Phytophthora infestans (PiBGX1; GenPept AAK19754;
GH30; Figure 2d) [44], and an α-l-arabinofuranosidase/β-xylosidase from Arabidopsis thaliana (AtAraf;
GenPept AAF19575; GH51; Figure 2h) [45], using 3D structures of their nearest homologs as templates.
All resulting models display a (β/α)8-barrel catalytic domain that is highly similar to the catalytic
domain of GH39 β-xylosidases (e.g., Figure 2e) and that shows that the catalytic residues of GH39
are present at the equivalent positions in the GH1, GH5, GH30, and GH51 β-xylosidase families.
A multiple structural alignment of the catalytic domains of these models and GH39 β-xylosidases
gave an overall RMSD of 3.4 Å for 168 amino acid residues, with PcXyl being the most divergent
from the other structures. In contrast, the structures of their accessory domains varied with the family.
The accessory domains of GH39 β-xylosidases are absent in RfBGluc-1 and PcXyl5, but they are
retained at a comparable position in PiBGX1 and AtAraf albeit with some modifications. The major
differences are observed for the third domain, in which the GH39 α-helical domain is replaced by a
β-sheet and a loop structure in PiBGX1 and AtAraf, respectively.
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Figure 2. Three-dimensional (3D) structures of β-xylosidases from various GH families. Helix, strand,
and loop structures are colored in magenta, blue, and green, respectively. GH family numbers and
fold type of their catalytic domains are shown. The structures represented are (a) RfBGluc-1 from
Reticulitermes flavipes (GenPept ADK12988); (b) GlyA1 from metagenomic cow rumen fluid (PDB
5K6L); (c) PcXyl5 from Phanerochaete chrysosporium BKM-F-1767 (GenPept AHL69750) (d) PiBGX1 from
Phytophthora infestans (GenPept AAK19754); (e) TsXynB from Thermoanaerobacterium saccharolyticum
B6A-RI (PDB 1PX8); (f) RS223-BX from an uncultured organism (PDB 4MLG); (g) GsXynB3 from
Geobacillus stearothermophilus T-6 (PDB 2EXH); (h) AtAraf from Arabidopsis thaliana (GenPept AAF19575);
(i) GT2_24_00240 from Geobacillus thermoglucosidasius TM242 (PDB 4C1O); (j) TkAbf from Trichoderma
koningii G-39 (GenPept AAA81024); (k) SSO1353 from Saccharolobus solfataricus P2 (GenPept AAK41589);
and (l) TsXylC from Thermoanaerobacterium saccharolyticum JW/SL-YS485 (PDB 3VST). The structures of
(a), (c), (d), (h), (j), and (k) were modeled using PDB entries 3VIK, 1EQP, 2XWE, 2C8N, 1WD3, and 5BVU,
respectively, which belong to the same GH family but do not have β-xylosidase activity. Structure
modeling was performed using the Swiss-Model server [46]. Figure 2, Figure 3, and Figure 6 were
produced using the program PyMol (The PyMOL Molecular Graphics System, v. 0.99, Schrödinger,
LLC, http://www.pymol.org).
2.2. Glycoside Hydrolase Family 3 (GH3)
While GH families 1, 30, 39 and 51 are part of clan GH-A, other β-xylosidases belong to
other families that are not part of this clan. GH3 is one of the largest and most diverse GH
families in the CAZy database [28,47]. It contains more than 23400 entries with various enzyme
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activities, including β-xylosidase, β-glucosidase, β-glucosylceramidase, β-N-acetylhexosaminidase,
andα-l-arabinofuranosidase activities. A number of GH3 enzymes are reported to be bi/multifunctional,
particularly toward synthetic substrates.
Enzymes in family GH3 vary considerably in the lengths of their peptide chains [48,49] and,
consequently, in the number of tertiary structure domains [48,50]. The basic structure of GH3 members
is a single (β/α)8 TIM-barrel domain [48,50], similar to the domain that is observed in clan GH-A.
In most members, the domain is followed by an (α/β)-sandwich domain that varies in size [48], e.g.,
(α/β)6 in Kluyveromyces marxianus NBRC1777 β-glucosidase [51], (α/β)5 in Thermotoga neapolitana
β-glucosidase [49], or even only an αβα motif in Bacillus subtilis 168 β-N-acetylglucosaminidases [52].
Sometimes the order of the domains in the primary structure is reversed [48]. Although these two
domains are generally sufficient to organize the active site of GH3 enzymes, frequently GH3 members
are extended with a fibronectin type III (FnIII) domain of unknown function at the C-terminus of the
(α/β)-sandwich domain [48,49]. Moreover, in some GH3 members, the (α/β)-sandwich domain is
interrupted by a PA14 domain. This domain appeared to be important for the substrate specificity of
the Kluyveromyces marxianus NBRC1777 β-glucosidase [51].
A total of 103 enzymes with β-xylosidase annotation are currently found in GH3, making
it the largest β-xylosidase-containing GH family. A protein domain search using the program
InterProScan 5 [53] revealed that the majority of the GH3 β-xylosidases are composed of three
domains (TIM-barrel, (α/β)-sandwich and FnIII). However, a bifunctional β-xylosidase/β-glucosidase
from Erwinia chrysanthemi D1 (EcBgxA; GenPept AAA80156) [54] has two domains (TIM-barrel and
(α/β)-sandwich) and a β-xylosidase from an environmental sample (G06-24; GenPept ACY24766) [55]
has four domains (TIM-barrel, (α/β)-sandwich, FnIII, and PA14). A phylogenetic analysis clustered
these two enzymes divergently from the other GH3 β-xylosidases [56].
3D Structures of GH3 β-xylosidases are available for a β-xylosidase from the fungus Trichoderma
reesei RutC-30 (TrBxl1; PDB 5A7M; GenPept CAA93248) [57] and a β-glucosidase/β-xylosidase from
metagenomic cow rumen fluid (GlyA1; PDB 5K6L; Figure 2b) [58]. Both structures have a (β/α)8
TIM-barrel, a (α/β)6-sandwich, and a FnIII domain, but at different positions in the primary structure.
As observed for the majority of GH3 structures [48], TrBxl1 has its TIM-barrel domain at the N-terminus,
followed sequentially by the (α/β)-sandwich and FnIII domains. This order is reversed in GlyA1,
where the (α/β)-sandwich domain is at the N-terminus, followed by the FnIII and TIM-barrel domains.
In addition, GlyA1 has an additional domain with unknown structure at its C-terminus [58]. Despite
this, the 3D structures of TrBxl1 and GlyA1 are conserved, with the TIM-barrel and (α/β)-sandwich
domains, as well as the catalytic residues superimposing reasonably well when the domains are
structurally aligned.
2.3. Glycoside Hydrolase Family 43 (GH43)
GH43 is the second largest β-xylosidase-containing GH family with currently 96 members
annotated as β-xylosidase. In addition to β-xylosidases, this family also contains enzymes with
(putative) α-l-arabinofuranosidase, arabinanase, xylanase, galactan 1,3-β-galactosidase, α-1,2-l-
arabinofuranosidase, exo-α-1,5-l-arabinofuranosidase, exo-α-1,5-l-arabinanase, or β-1,3-xylosidase
activities. As observed for the GH3 members, several enzymes in this family are bi/multifunctional.
Together with GH62, GH43 is grouped into clan GH-F in the CAZy database with a structural
characteristic of a 5-bladed β-propeller catalytic domain [59]. Some of its members contain only this
single catalytic domain, and, based on their domain architecture, were classified as type I [60]. In other
members, the catalytic domain is extended with a family 6 carbohydrate-binding module (type II), or a
unique β-sandwich domain that is designated as X19 [61] (type III), or contain an even more complex
domain composition and organization (type IV). The extensions are commonly fused at the C-terminus
of the catalytic domain [60,62], although in a β-xylosidase from G. thermoleovorans IT-08 (GbtXyl43B),
for example, the extension is at the N-terminus [63]. Thus, GH43 contains enzymes that vary both in
the lengths of their primary structure and in their number of structure domains.
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For detailed characterization, enzymes in GH43 have been divided into 37 subfamilies, GH41_1
to GH43_37 [61]. In this classification, β-xylosidases are currently found in 16 different subfamilies,
with the majority belonging to subfamilies GH43_1 and GH43_11. Two GH43_1 β-xylosidase crystal
structures are currently present in the PDB database, i.e., from an uncultured organism (RS223-BX;
PDB 4MLG; Figure 2f) [64] and from a compost metagenome (CoXyl43; PDB 5GLK) [65]. The most
structurally characterized β-xylosidases are from GH43_11, with crystal structures available of seven
differentβ-xylosidases, i.e., theβ-xylosidases from B. subtilis (PDB 1YIF) (Patskovsky et al., unpublished
work), Clostridium acetobutylicum ATCC 824 (CaXyl43_11; PDB 1YI7) (Teplyakov et al., unpublished
work), B. halodurans (PDB 1YRZ) (Fedorov et al., unpublished work), G. stearothermophilus T-6 (PDB
2EXH; Figure 2g) [66], Selenomonas ruminantium GA192 (PDB 3C2U) [67], B. pumilus IPO (PDB 5ZQJ) [68],
and Bacillus sp. HJ14 (PDB 6IFE) [69]. Additionally, GH43 β-xylosidase 3D structures are also found
in subfamilies GH43_12 and GH43_26, i.e., the β-xylosidases from G. thermoleovorans IT-08 (PDB
5Z5D) [70] and C. acetobutylicum ATCC 824 (CaXyl43_26; PDB 3K1U) (Osipiuk et al., unpublished
work), respectively.
While β-xylosidases from GH43_1 and GH43_26 have only a single 5-bladed β-propeller catalytic
domain [64,65] and belong to type I GH43 [60], those from GH43_11 and GH43_12 possess an
additional X19 domain at the C-terminus [66–68,70] and belong to type III GH43 [60]. Although
the architecture of the 5-bladed β-propeller is highly conserved among the GH43 β-xylosidases [64],
structural superposition of the type I and type III catalytic domains gave a high RMSD. This is because
the catalytic domains of the type I enzymes have several significantly longer loops than those of type III.
The single catalytic domain of the type I GH43 β-xylosidases is sufficient for activity, but the enzymes
are strongly activated by divalent metal ions, particularly calcium. Indeed, those metal-containing
enzymes contain a metal-binding site close to the enzymes’ active site [64,65]. In contrast, the type III
GH43 β-xylosidases have no such metal-binding site [66–68,70]. The X19 domain, which is only found
in a subset of GH43 subfamilies [61], appeared to be crucial for catalytic activity of the type III GH43
β-xylosidases, since removing this domain abolished the activity of the GH43_11 β-xylosidases from
Thermobifida fusca YX [71] and Enterobacter sp. [72]. In fact, a loop from the X19 domain contributes a Phe
residue to the active site of the type III β-xylosidases [66–68,70], which is spatially conserved among all
GH43 β-xylosidase structures. Only in CaXyl43_26 this Phe is missing. Unfortunately, no biochemical
evidence is available on the enzyme’s substrate preferences and catalytic activity, but given that all
other enzymes in GH43_26 are α-l-arabinofuranosidases [61], some doubt that CaXyl43_26 is a genuine
β-xylosidase seems justified. These observations suggest that although GH43 β-xylosidases adopt
different overall folds, the enzymes have a common active site organization and use a conserved Phe
to interact with the substrate in subsite −1 (see below; Figure 4b).
2.4. Glycoside Hydrolase Family 52 (GH52)
Currently, GH52 contains 112 entries, of which 11 enzymes are annotated as β-xylosidases.
These β-xylosidases have comparable amino acid sequence lengths of about 700 amino acid residues,
with the exception of a β-xylosidase from G. stearothermophilus 236 (GsXylA, GenPept AAA50863),
which is composed of only 618 amino acid residues. The GH52 β-xylosidases are very similar to each
other with amino acid sequence identities of around 41%–90%. In this family, crystal structures are
available for β-xylosidases from Parageobacillus thermoglucosidasius TM242 (GT2_24_00240; PDB 4C1O;
Figure 2i) [73] and G. stearothermophilus T-6 (Xyn52B2; PDB 4RHH) (Dann et al., unpublished work).
With a sequence identity of 86%, the two proteins fold into almost the same structures; they display
two distinct domains, an N-terminal β-sandwich domain and a C-terminal (α/α)6-barrel domain.
The catalytic residues of the GH52 enzymes, which are Glu-357 and Asp-517 in GT2_24_00240 [73],
are located in the (α/α)6-barrel domain. Protein homology modeling based on the structure of
GT2_24_00240 suggested that the domains are conserved among the GH52 β-xylosidases, except for
the C-terminal domain of GsXylA. Compared to other GH52 β-xylosidases, this latter domain lacks
five α-helices of the C-terminal domain, such that it displays an open half-barrel structure.
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2.5. Glycoside Hydrolase Family 54 (GH54)
Most of the characterized enzymes in GH54 are annotated as α-l-arabinofuranosidases. However,
two sequences in this family are annotated as β-xylosidase. TkAbf from T. koningii G-39 was
characterized as a bifunctional α-l-arabinofuranosidase/β-xylosidase due to its activity on synthetic
nitrophenyl derivatives of α-l-arabinofuranoside and β-d-xylopyranoside with comparable kcat/Km
values [36]. A three-dimensional structure of a GH54 enzyme is currently only available for an
α-l-arabinofuranosidase from A. kawachii IFO4308 (AkAbfB; PDB 1WD3) [38]. The primary structures
of TkAbf (500 residues) and AkAbfB (499 residues) are very similar with an amino acid sequence identity
of 73%. Therefore, the three-dimensional structure of TkAbf was predicted by homology modeling
using the crystal structure of AkAbfB as a template. The predicted model (Figure 2j) consists of two
domains that correspond to the N-terminal catalytic domain and the C-terminal arabinose-binding
domain of the AkAbfB structure [38]. The catalytic domain folds into a β-sandwich similar to that of
clan GH-B enzymes, while the arabinose-binding domain has a β-trefoil structure that belongs to the
family 42 carbohydrate-binding module [28,38].
2.6. Glycoside Hydrolase Family 116 (GH116)
In GH116, SSO1353 is the only enzyme that exhibits β-xylosidase activity. As mentioned
above, this enzyme does not hydrolyze xylooligosaccharides, but it is active on artificial substrates
such as p-nitrophenyl- and methylumbelliferyl-linked β-d-xylopyranosides [37]. Currently, a three-
dimensional structure of a GH116 member is only available for the β-glucosidase from the thermophilic
bacterium T. xylanolyticum LX-11 (TxGH116; PDB 5BVU). This protein folds into an N-terminal
β-sandwich domain and a C-terminal (α/α)6 solenoid catalytic domain [74]. The primary structure
similarity of SSO1353 and TxGH116 is rather low with an amino acid sequence identity of only ~20%.
However, homology modeling of SSO1353 based on the structure of TxGH116 using the Swiss-Model
server [46] produced a relatively good quality model with a Global Model Quality Estimation
(GMQE) value of 0.63 (on a scale of 0–1). As expected, the model displays a two-domain fold, i.e.,
an N-terminal β-sandwich domain and a C-terminal (α/α)6-barrel domain (Figure 2k), very much
like the domain organization of the GH52 proteins (see above). Importantly, the modeling placed the
catalytic nucleophile and acid/base residues of SSO1353 (Glu-335 and Asp-462, respectively) [37] at
about the same positions as those of the GH52 β-xylosidase GT2_24_00240 (Glu-357 and Asp-517,
respectively) [73]. In view of this structural similarity and the conservation of the catalytic residues,
GH families 52 and 116 were recently grouped into clan GH-O [74].
2.7. Glycoside Hydrolase Family 120 (GH120)
Of the 176 sequences that are currently available in the CAZy database for the GH120 family,
two enzymes were characterized and identified as β-xylosidases, i.e., enzymes from Thermoanaerobacterium
saccharolyticum JW/SL-YS485 (TsXylC; GenPept ABM68042) [75] and Bifidobacterium adolescentis
LMG10502 (BaXylB; GenPept BAF39080) [56]. While TsXylC was shown to be active on xylobiose
and xylotriose [75], BaXylB prefers xylotriose or longer xylooligosaccharides as its substrate [56].
The three-dimensional structure of TsXylC has been reported to fold into a core domain of a right-handed
parallel β-helix, a common fold observed in several GHs, polysaccharide lyases, and carbohydrate
esterases. This core domain is intervened by an Ig-like β-sandwich domain (PDB 3VST, Figure 2l).
Both domains are important to organize the active site of the enzyme [25]. BaXylB shares 47% amino
acid sequence identity with TsXylC. A homology model of BaXylB based on the structure of TsXylC
suggested that the active site residues and their positions are conserved in the enzymes, except for
Trp-362 in BaXylB, which is a histidine (His-352) in TsXylC.
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Figure 3. β-Xylosidase active site. Molecular surface drawing of active sites of β-xylosidases colored
according to their electrostatic potential (negative, red; neutral, white; positive, blue). Complexed
ligands are depicted in ball and stick representation with carbon atoms in green. The active sites
are of (a) GlyA1 from metagenomic cow rumen fluid in complex with xylose (PDB 5K6N; GH3);
(b) GsXynB1 from Geobacillus stearothermophilus T-6 in complex with 2,5-dinitrophenyl-β-d-xyloside
(PDB 2BFG; GH39); (c) CoXyl43 from a compost metagenome in complex with xylose and xylobiose
(PDB 5GLN; GH43_1); (d) GsXynB3 from G. stearothermophilus T-6 in complex with xylobiose (PDB
2EXJ; GH43_11); (e) GT2_24_00240 from Parageobacillus thermoglucosidasius TM242 in complex with
xylobiose (PDB 4C1P; GH52); and (f) TsXylC from Thermoanaerobacterium saccharolyticum JW/SL-YS485
in complex with xylobiose (PDB 3VSU; GH120). The electrostatic potential was calculated using the
APBS (Adaptive Poisson–Boltzmann Solver) implemented in the program PyMol [76]. (g) Generalized
schematic diagram of a β-xylosidase active site with a ligand bound at subsites –1 and +1. Catalytic
residues (see below) are represented by carboxylate groups and their catalytic roles are indicated.
The exact positions of the catalytic residues vary with enzymes (see Figure 6).
3. Active Site of β-Xylosidases
Despite the diversity of their three-dimensional folds, all structurally characterized β-xylosidases
display a typical pocket-shaped active site (Figure 3) that is very suitable for exo-acting enzymes [29].
The pocket is negatively charged due to the presence of several acidic residues, but contains also
hydrophobic patches of aromatic residues (Figure 3a–f). It has only a single route for substrates to
enter and products to exit. The active site pocket can be virtually divided into two subsites with
each of them able to accommodate a monosaccharide residue (Figure 3g). One subsite is buried,
and, in several enzyme-xylobiose complexes (e.g., PDBs 2EXJ, 4C1P and 3VSU), interacts with the –1
non-reducing-end xylose (subsite –1), while the other is more open and binds the +1 xylose (subsite +1).
Substrates with more than two xylose residues must have the additional residues beyond +1 exposed
in the bulk solvent [25,67]. The active site architecture seems to be both necessary and sufficient for
β-xylosidase activity of the enzymes.
Furthermore, comparison of active site structures of several β-xylosidase-ligand complexes
suggests that there are similar interactions between the enzymes and their ligands (Figure 4). The ligand
in subsite –1 is strongly bound to the enzyme by a large number of hydrogen bonds and a few
hydrophobic stacking interactions. In contrast, the ligand substrate in subsite +1 interacts less strongly
with the enzyme with less hydrogen bonds but more hydrophobic stacking interactions.
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Figure 4. Interactions between active site residues of β-xylosidases and their ligands. The ligands
2,5-DNPX (2,5-dinitrophenyl-β-d-xyloside) and BXP (β-d-xylobiopyranose) are represented with purple
bonds and their binding subsites -1 and +1 are indicated. Catalytic residues are labeled in magenta.
Hydrogen bonds are shown as dashed lines and their distances are indicated in Å, while hydrophobic
interactions are rendered with arcs. The active sites are of (a) GsXynB1 (PDB 2bfg); (b) GsXynB3 (PDB
2exj); (c) GT2_24_00240 (PDB 4c1p); and (d) TsXylC (PDB 3vsu), which represent β-xylosidases from
GH families 39, 43, 52, and 120, respectively (see caption of Figure 3 for further details of the enzymes).
Interaction analysis and figure preparation were performed using LigPlot+ [77].
4. Catalytic Mechanism of β-Xylosidases
With respect to their catalytic mechanism most GHs can generally be classified into retaining and
inverting enzymes [29,78]. The retaining GHs hydrolyze their substrates with overall retention of the
stereochemistry of the anomeric carbon atom of the hydrolyzed glycosidic bond, while the inverting
GHs yield a product with an inverted stereochemistry of the anomeric carbon atom [29,78]. In both
mechanisms, the enzymes rely on two catalytic carboxylate groups that function as a nucleophile and a
general acid/base in the retaining enzymes, or as a general base and a general acid in the inverting
enzymes, respectively (Figure 5).
The retaining enzymes use a two-step double-displacement mechanism, in which enzyme
glycosylation is followed by deglycosylation. In the glycosylation step, the nucleophile attacks
the anomeric carbon to form a glycosyl–enzyme intermediate with the inverted configuration at
the anomeric carbon. Concomitantly, the (protonated) acid/base residue transfers its proton to the
glycosidic oxygen atom, to cleave the scissile glycosidic bond. Departure of the aglycone creates space
allowing a catalytic water molecule to come closer to the anomeric center. In the deglycosylation
step, the incoming catalytic water molecule, which is activated by the now negatively charged
acid/base, attacks the anomeric carbon to release the glycone product from the intermediate. The attack
re-inverts the inverted configuration of the anomeric carbon and hence the released glycone has
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the same stereochemistry as it had in the substrate. In contrast, the inverting enzymes follow a
single-displacement mechanism to hydrolyze the glycosidic bond. A catalytic water molecule, which is
deprotonated by the general base, does a nucleophilic attack on the anomeric carbon in concert with
the general acid protonating the glycosidic oxygen. This cleaves the scissile glycosidic bond and frees
the glycone with the inverted stereochemistry of its anomeric carbon.
Figure 5. The two common types of catalysis by glycoside hydrolases as adapted from Davies and
Henrissat [29]. (a) The retaining mechanism. The nucleophile and the general acid/base are represented
as B- and AH, respectively. (b) The inverting mechanism. The general base and the general acid
are represented as B- and AH, respectively. The typical distances of the catalytic residues in both
mechanisms are indicated in Å. In most GHs, A and B are either Asp or Glu. See main text for
further details.
Except for the enzymes from family GH43, all β-xylosidases in the CAZy database are predicted
to have a retaining mechanism (Table 1). Among these retaining β-xylosidases, structural data with
bound ligand are available for enzymes from GH3 [58], GH39 [40–42], GH52 [73], and GH120 [25].
A structural alignment of these β-xylosidases on the basis of their bound ligand revealed that the
carboxylate group of their catalytic nucleophiles, which are Glu in GH39 and GH52, and Asp in GH3
and GH120, are spatially conserved relative to the bound ligand (Figure 6a). They are within good
distance (~3.1 Å) and right position for reaction with the anomeric carbon of the scissile glycosidic
bond. On the other hand, the carboxylate group of their catalytic acid/base, which is Glu in GH3,
GH39, and GH120, and Asp in GH52, are spatially less conserved, although they are at productive
hydrogen-bonding positions (~3.2 Å on average) to the corresponding glycosidic oxygen atom.
β-Xylosidases from GH43 are inverting enzymes [79]. They use Asp and Glu as the general base
and general acid, respectively [70,80,81]. Similar to the catalytic acid/base of the retaining β-xylosidases,
their catalytic acid is within hydrogen-bonding distance (~2.7 Å) to the glycosidic oxygen atom of the
scissile bond (Figure 6b). However, compared to the catalytic nucleophile of the retaining β-xylosidases,
their catalytic base is located further away from the anomeric carbon atom of the scissile glycosidic
bond with a distance of ~5.2 Å [65,66,70]. This distance provides sufficient space for accommodating a
catalytic water molecule that can be activated by the catalytic base to attack the anomeric carbon [66].
It has been observed generally for GHs that the distance between the carboxylate groups of the catalytic
base and acid of retaining enzymes is shorter (~5 Å) than the distance between the carboxylates of the
catalytic nucleophile and acid/base of inverting enzymes (~8–10 Å) [29,82]. This is also the case for
the GH43 β-xylosidases. Indeed, in the inverting GH43 β-xylosidase from G. stearothermophilus T-6,
for example, a distance of ~7.9 Å between the carboxylate groups of its catalytic residues has been
observed [66].
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Figure 6. Positions of the catalytic residues relative to the xylosyl moiety bound in subsite -1 of the
active sites of (a) retaining and (b) inverting β-xylosidases. The structures are of GlyA1 (PDB 5K6N;
GH3; carbon atoms in pink), GsXynB1 (PDB 2BFG; GH39; green), GT2_24_00240 (PDB 4C1P; GH52;
cyan), and TsXylC (PDB 3VSU; GH120; blue), which are retaining β-xylosidases, and GsXynB3 (PDB
2EXJ; GH43; white), which is an inverting β-xylosidase (see caption of Figure 3 for further details of the
enzymes). Important distances (in Å) are shown next to dashed lines.
5. Inhibition of β-Xylosidases by Monosaccharides
5.1. Inhibition by d-xylose
Many β-xylosidases are inhibited to varying degrees by their main product d-xylose (Table 2).
For example, the β-xylosidase from the fungus Trichoderma harzianum C is very sensitive to d-xylose
inhibition; its activity is completely inhibited by the presence of only 2 mM d-xylose [83]. In contrast,
the GH39 β-xylosidase from the extreme thermophilic bacterium Dictyoglomus thermophilum DSM 3960
is very resistant to d-xylose, with only 40% inhibition in the presence of 3 M of the sugar [84].







Bacillus halodurans C-125 GH39 200 0 [85]
Bacillus subtilis M015 GH43_11 20 45 [86]
Corynebacterium alkanolyticum ATCC 21511 GH3 200 70 [87]
Dictyoglomus thermophilum DSM 3960 GH39 3000 40 [84]
Geobacillus sp. WSUCF1 GH39 300 50 [88]
Geobacillus thermodenitrificans NG80-2 GH39 400 50 [89]
Geobacillus thermodenitrificans NG80-2 GH43 300 50 [89]
Geobacillus thermodenitrificans NG80-2 GH52 600 50 [89]
Lactobacillus brevis ATCC 14869 GH43_11 100 20 [90]
Lactobacillus brevis ATCC 14869 GH43_12 100 66 [90]
Massilia sp. RBM26 GH43_11 500 50 [91]
Paenibacillus woosongensis KCTC 3953 GH43_35 100 25 [92]
Selenomonas ruminantium GA192 GH43_11 40 57 [93]
Sphingobacterium sp. HP455 GH43_1 247 50 [94]
Thermoanaerobacterium saccharolyticum JW/SL-YS485 GH120 200 30 [75]
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Thermotoga petrophila DSM 13995 GH3 150 50 [95]
Thermotoga thermarum DSM 5069 GH3 1000 50 [96]
Fungi:
Aspergillus nidulans CECT2544 n.a. # 25 44 [97]
Aspergillus niger 11 n.a. # 10 50 [98]
Aspergillus niger ADH-11 GH3 12 50 [99]
Aureobasidium pullulans CBS 58475 n.a. # 6,6 42 [100]
Candida utilis IFO 0639 n.a. # 300 0 [101]
Humicola grisea var. thermoidea GH43_1 603 50 [102]
Humicola insolens Y1 GH43_1 79 50 [103]
Humicola insolens Y1 GH43_11 292 50 [103]
Paecilomyces thermophila J18 n.a. # 139 50 [104]
Phanerochaete chrysosporium BKM-F-1767 GH43_14 50 70 [43]
Pseudozyma hubeiensis NCIM 3574 n.a. # 75 50 [105]
Rhizophlyctis rosea Fischer NBRC 105426 GH43_1 100 49 [106]
Scytalidium thermophilum 77.7.8 n.a. # 200 0 [107]
Trichoderma harzianum C n.a. # 2 100 [83]
Trichoderma reesei QM 9414 GH3 53 80 [108]
Metagenomes:
Synthetic metagenome GH43_1 20 44 [109]
Uncultured rumen metagenome GH3 5 27 [110]
Yak rumen metagenome (RuBg3A §) GH3 5 18 [111]
Yak rumen metagenome (RuBg3B §) GH3 5 3 [111]
#: GH family is not assigned in the CAZy database; §: Protein symbol.
Most characterized β-xylosidases have significant affinity for d-xylose, with reported inhibition
constants (Ki) of less than 10 mM (Table 3). To our knowledge, the β-xylosidase from Talaromyces
emersonii has the highest affinity for d-xylose with a Ki value as low as 1.3 mM [112], suggesting that
the enzyme is very sensitive to inhibition by this monosaccharide. Other β-xylosidases are much less
prone to d-xylose inhibition, such as those from B. pumilus 12 [113], G. thermoleovorans IT-08 [114],
and uncultured bacterium [115] with Ki’s of 26.2, 76, and 145 mM, respectively. So far, the β-xylosidase
from the bacterium Cellulomonas uda [116] is the β-xylosidase with the highest reported Ki value
for d-xylose, i.e., 650 mM, with the caveat that this Ki was determined using crude enzyme. Thus,
in general, and as summarized in Table 3, β-xylosidases have relatively high affinity (low Ki) for
d-xylose and, therefore, they are susceptible to product inhibition by this sugar.






Alkaliphilus metalliredigens QYMF GH43_11 16.2 [18]
Anoxybacillus sp. 3M GH52 21.3 [117]
Bacillus halodurans C-125 GH43_11 62.3 [118]
Bacillus pumilus 12 n.a. # 26.2 [113]
Bacillus pumilus IPO GH43_11 70 [18]
Bacillus subtilis subsp. subtilis str. 168 GH43_11 15.6 [18]
Bacteroides ovatus V975 GH43_1 6.6 [119]
Caldocellum saccharolyticum Tp8T6.3.3.1 n.a. # 40.0 [120]
Cellulomonas uda n.a. # 650.0 [116]
Enterobacter sp. GH43_11 79.9 [72]
Geobacillus thermoleovorans IT-08 GH43_12 76.0 [114]
Lactobacillus brevis ATCC 367 GH43_11 30.1 [18]
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Selenomonas ruminantium GA192 GH43_11 6.24 [121]
Streptomyces sp. CH7 GH3 40.0 [122]
Thermoanaerobacterium saccharolyticum B6A-RI GH39 20 [123]
Thermobifida fusca TM51 GH43_11 67.0 [124]
Thermobifida halotolerans YIM 90462T GH43_11 43.8 [125]
Thermomonospora n.a. # 35-100 [126]
Thermomonospora fusca BD21 n.a. # 19 [127]
Fungi:
Arxula adeninivorans SBUG 724 n.a. # 5.8 [128]
Aspergillus awamori X-100 GH3 7.7 [129]
Aspergillus carbonarius KLU-93 n.a. # 1.9 [130]
Aspergillus fumigatus n.a. # 4.5 [131]
Aspergillus japonicus GH3 2.9 [132]
Aspergillus niger 15 n.a. # 2.9 [133]
Aspergillus niger 90196 GH3 8.3 [134]
Aspergillus niger ATCC 10864 GH3 3.3 [135]
Aspergillus niger NW147 (xlnD I §) GH3 9.8 [136]
Aspergillus niger NW147 (xlnD II §) GH3 13.2 [136]
Aspergillus niger van Tieghem (DSM 22593) GH3 7.5 [137]
Aspergillus oryzae KBN616 GH3 2.7 [138]
Aspergillus terreus IJIRA 6.2 n.a. # 10.5 [139]
Aspergillus versicolor (xylose-induced) n.a. # 5.3 [140]
Aspergillus versicolor (xylan-induced) n.a. # 2.0 [140]
Aureobasidium pullulans CBS 135684 n.a. # 18.0 [141]
Colletotrichum graminicola GH3 3.3 [142]
Fusarium proliferatum NRRL 26517 n.a. # 5.0 [143]
Fusarium verticillioides NRRL 26518 n.a. # 6.0 [144]
Humicola insolens Y1 GH3 29.0 [145]
Neocallimastix frontalis RK 21 n.a. # 4.0 [146]
Neurospora crassa ST A (74 A) GH3 1.7 [147]
Penicillium janczewskii CRM 1348 n.a. # 6 [148]
Penicillium oxalicum 114-2 GH43 28.1 [149]
Penicillium sclerotiorum n.a. # 28.7 [150]
Talaromyces amestolkiae GH3 1.7 [151]
Talaromyces emersonii GH3 1.3 [112]
Thermomyces lanuginosus CAU44 GH43_1 63.0 [152]
Trichoderma koningii G-39 n.a. # 5.0 [153]
Trichoderma reesei (βXTR §) GH3 2.4 [112]
Trichoderma reesei GH3 1.4 [132]
Trichoderma reesei QM 9414 n.a. # 11.0 [154]
Trichoderma reesei RUT C30 n.a. # 2.3 [155]
Trichoderma reesei RUT C30 n.a. # 2.4 [24]
Plant:
Saccharum officinarum L. n.a. # 8.0 [156]
Metagenomes:
Compost starter GH43 145.0 [115]
Mixed microorganism (RS223-BX §) GH43_1 3.4 [19]
Uncultured rumen bacterium GH30_2 10.6 [157]
Uncultured rumen bacterium GH43_1 76.0 [157]
#: GH family is not assigned in the CAZy database; §: Protein symbol.
From Tables 2 and 3 it appears that no direct relationship exists between the inhibition of
β-xylosidases by d-xylose and their organismal origin or GH family. Many β-xylosidases from different
bacteria and fungi suffer from such product inhibition. Likewise, product inhibition is observed for
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β-xylosidases belonging to different GH families. This is reasonable because all β-xylosidases bind the
same substrate (d-xylose oligomers), necessitating affinity for xylosyl residues and some commonality
in their active site structure (see above).
Interestingly, the activity of several β-xylosidases is stimulated by d-xylose, particularly at low
concentration. The β-xylosidase from Thermotoga thermarum DSM 5069 was stimulated by d-xylose
concentrations of up to 500 mM; its maximum activity was observed in the presence of 200 mM d-xylose,
which was ~20% higher than in the absence of the sugar [96]. A similar stimulatory effect has been
reported for the bifunctional β-xylosidase/α-l-arabinofuranosidase from Phanerochaete chrysosporium
BKM-F-1767 [43] and the β-xylosidase from Dictyoglomus thermophilum DSM 3960 [84,158]. However,
the mechanism of such stimulation is currently not known.
5.2. Inhibition by l-arabinose
l-arabinose is one of the monosaccharides produced during enzymatic saccharification of
cellulosic biomass [7,8,28]. It is liberated by the action of α-l-arabinofuranosidases, and, during
the saccharification process, its concentration may sufficiently increase to inhibit the activity of
hemicellulolytic enzymes [115]. Indeed, l-arabinose has been identified as an inhibitor of various
β-xylosidases (Table 4). For instance, 50 mM l-arabinose reduces the activity of the aryl β-xylosidase
from Caldocellum saccharolyticum Tp8T6.3.3.1 by 15% [120], the β-xylosidase from B. pumilus 12 by
21% [113], and the bifunctionalβ-xylosidase/α-l-arabinofuranosidase from P. chrysosporium BKM-F-1767
by ~70% [43]. This is not surprising, since the stereochemistry of l-arabinose near the glycosidic bond
is similar to that of d-xylose [61], explaining its binding in the active site of a β-xylosidase.







Bacillus pumilus 12 n.a. # 50 21 [113]
Caldocellum saccharolyticum Tp8T6.3.3.1 n.a. # 50 15 [120]
Corynebacterium alkanolyticum ATCC 21511 GH3 200 40 [87]
Lactobacillus brevis ATCC 14869 GH43_11 100 39 [90]
Lactobacillus brevis ATCC 14869 GH43_12 100 38 [90]
Paenibacillus woosongensis KCTC 3953 GH43_35 100 40 [92]
Selenomonas ruminantium GA192 GH43_11 80 61 [93]
Fungi:
Aspergillus niger 11 n.a. # 25 10 [98]
Aspergillus niger van Tieghem (DSM 22593) GH3 200 30 [137]
Colletotrichum graminicola GH3 50 15 [142]
Penicillium oxalicum 114-2 GH43 20 11 [149]
Phanerochaete chrysosporium BKM-F-1767 GH43_14 50 70 [43]
#: GH family is not assigned in the CAZy database.
In general, l-arabinose is a weaker inhibitor of β-xylosidase activity than d-xylose. For example,
the β-xylosidase from the fungus Trichoderma reesei RUT C30 is strongly inhibited by d-xylose with
a Ki of 2.4 mM, but it is not inhibited by l-arabinose, even at a concentration of 500 mM [24].
Several other β-xylosidases can also withstand high concentrations of l-arabinose [95,122,141]. Finally,
the β-xylosidase from Enterobacter sp. is competitively inhibited by l-arabinose, but with a quite high
Ki value of 102 mM [72], indicating that the enzyme has only low affinity for l-arabinose.
Intriguingly, at low concentration (~5 mM) l-arabinose stimulates rather than inhibits the
β-xylosidase activity of the bifunctional β-xylosidase/α-l-arabinofuranosidase from P. chrysosporium
BKM-F-1767, as also noticed for d-glucose [43]. Activation by l-arabinose has also been observed for a
furan aldehyde-tolerant β-xylosidase/α-l-arabinofuranosidase procured from a metagenomic sample,
which showed 65% higher β-xylosidase activity compared with the control without l-arabinose [109].
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Although there are many data describing the effects of l-arabinose on inhibition/activation of
β-xylosidase activity, the molecular basis of the effects on activity still needs further investigation.
5.3. Inhibition by Other Monosaccharides
Apart from d-xylose and l-arabinose, d-glucose is another monosaccharide that has been frequently
reported to affect β-xylosidase activity. d-glucose inhibits the β-xylosidase activity of the β-xylosidases
from S. ruminantium GA192 (Ki 44 mM) [27], B. pumilus 12 (9% inhibition at 50 mM) [113], T. harzianum (3%
inhibition at 5 mM) [83], and the bifunctional β-glucosidase/β-xylosidases RuBG3A and RuBG3B from
the metagenome of yak rumen microorganisms (97.5% and 45.6% inhibition, respectively, at 5 mM) [111].
On the other hand, the sugar did not inhibit β-xylosidases from Thermomonospora fusca [159], A. niger
90196 [134], A. oryzae [138], and N. crassa ST A [147] at concentrations of up to 90, 20, 20, and 10 mM,
respectively. The Mg2+-activated β-xylosidase RS223-BX could even withstand much higher d-glucose
concentrations displaying a Ki value of 1270 mM on the substrate p-nitrophenyl-α-l-arabinofuranoside
(pNPA) [19]. Apparently, inhibition by d-glucose varies considerably among β-xylosidases.
Finally, besides d-xylose, l-arabinose, and d-glucose, also other monosaccharides have been
reported to inhibit β-xylosidases, including d-arabinose [26,113], d-erythrose [26], d-fructose [111,138],
d-galactose [26,113,120], d-ribose, and l-xylose [26,113]. Again, the molecular details of the interactions
of these sugars with the enzymes are not known.
5.4. Inhibition Kinetics
The inhibition of β-xylosidases by monosaccharides follows competitive, non-competitive,
or un-competitive inhibition kinetics. For most β-xylosidases, d-xylose acts as a competitive
inhibitor when using p-nitrophenyl-β-d-xyloside (pNPX) as substrate [113,114,120,134]. However,
the β-xylosidase from N. crassa ST A showed non-competitive inhibition by this sugar [147].
Furthermore, d-xylose inhibition of the β-xylosidase from S. ruminantium GA192, which also displays
α-l-arabinofuranosidase activity, followed non-competitive kinetics for its β-xylosidase activity on
pNPX as substrate, but competitive kinetics for its α-l-arabinofuranosidase activity on pNPA as
substrate [26]. This differs slightly from A. carbonarius KLU-93 β-xylosidase, for which d-xylose
was a competitive inhibitor for the conversion of both substrates [130]. Similarly, l-arabinose acts
as a competitive inhibitor for the hydrolysis of pNPA by the RS223-BX β-xylosidase [19], but it is a
non-competitive inhibitor of S. ruminantium GA192 β-xylosidase hydrolyzing pNPX or pNPA [26].
With respect to these substrates, d-arabinose, d-glucose, and d-ribose are competitive inhibitors of S.
ruminantium GA192 β-xylosidase, whereas d-erythrose and l-xylose are non-competitive [26]. As also
observed for S. ruminantium GA192 β-xylosidase, d-glucose inhibition of RS223-BX was competitive
when using pNPA as substrate [19]. Uniquely, un-competitive inhibition was displayed by d-fructose
for the activity of A. oryzae β-xylosidase on pNPX [138]. Thus, commonly, competitive inhibition
by d-xylose is observed. Other monosaccharides can display both competitive and non-competitive
inhibition, and in one case, d-fructose, un-competitive inhibition takes place. The exact mechanism
and the structural details of non-competitive and un-competitive inhibition remain unknown.
5.5. Structural Details of Inhibitor Binding in the Active Site of β-Xylosidases
As discussed above, the active site pockets of β-xylosidases contain two substrate-binding subsites,
subsites –1 and +1, on either side of the scissile bond. In the active site of S. ruminantium GA192
β-xylosidase, the monosaccharides d-arabinose, l-arabinose, d-erythrose, and d-ribose can bind in both
subsites –1 and +1, but d-xylose and l-xylose bind only in subsite –1 [26]. Similarly, d-glucose binds in
one subsite only. Its binding position was speculated to be in subsite –1, with partial occupancy of
subsite +1, because glucose is too large to fit in subsite –1 only. Alternatively, it could bind in such a
way that it excludes binding of a second sugar [26].
In contrast, G. thermoleovorans IT-08 β-xylosidase shows rather dissimilar binding properties
for l-arabinose and d-xylose compared to S. ruminantium GA192 β-xylosidase. Crystal structures
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of G. thermoleovorans IT-08 β-xylosidase revealed that l-arabinose binds exclusively in subsite –1,
while d-xylose prefers subsite +1 [70]. Thus, depending on the enzyme, the –1 and +1 subsites differ in
preference for different monosaccharides, which could also contribute to the differences in inhibition
kinetics observed for the different enzymes.
5.6. Engineering to Reduce β-Xylosidase Inhibition by Monosaccharides
During saccharification of cellulosic biomass, monosaccharides such as d-xylose, l-arabinose,
and d-glucose, may reach concentrations that are high enough to inhibit β-xylosidase activity [26,27].
Therefore, β-xylosidases that are not affected by high monosaccharide concentrations are highly
desirable for the efficiency of the saccharification process. To develop such β-xylosidase variants,
the W145G mutation was introduced into S. ruminantium GA192 β-xylosidase, resulting in a variant
with a 3-fold lower affinity for d-xylose and a 2-fold lower affinity for d-glucose [121]. Subjecting
this variant to saturation mutagenesis of residue 145 yielded variants with even lower affinity for
monosaccharides and higher catalytic activity than wild-type enzyme [27]. Mutation of Trp-145 alters
the affinity of subsite +1 for d-xylose, but not that of subsite -1, where catalysis occurs, suggesting a
strategy for reducing inhibition by monosaccharides by mutating residues of subsite +1 [27]. In the
structure of G. thermoleovorans IT-08 β-xylosidase, d-xylose binds in subsite +1 interacting, among
others, with Asp-198, which is not present in most other β-xylosidases [70]. Therefore, this residue
may be a good target for mutation to obtain G. thermoleovorans IT-08 β-xylosidase variants with lower
affinity for d-xylose.
6. Concluding Remarks
β-Xylosidases are highly diverse in their amino acid sequence. Currently, enzymes with
β-xylosidase activity can be found in 11 different glycoside hydrolase families in the CAZy database, i.e.,
in GH families 1, 3, 5, 30, 39, 43, 51, 52, 54, 116, and 120. They fold into several distinct three-dimensional
structures. While the enzymes from GH families 1, 3, 5, 30, 39, and 51 all show a (β/α)8 TIM-barrel
structure, those from families 43, 52 and 116, 54, and 120 have as their main structural feature a 5-bladed
β-propeller, a (α/α)6-barrel, a β-sandwich, and a right-handed parallel β-helix, respectively. Likewise,
the catalytic mechanism of β-xylosidases is also varied. Although generally β-xylosidases hydrolyze
their substrates with retention of the substrate’s anomeric carbon configuration, the enzymes from GH43
invert the anomeric configuration. However, despite their diversity in overall folds, all structurally
characterized β-xylosidases have a typical pocket-shaped active site with two carbohydrate-binding
subsites, which bind a xylobiosyl moiety of the xylooligosaccharide substrates. Unfortunately,
the active sites of many β-xylosidases also possess a relatively high affinity for monosaccharides,
such as xylose, arabinose, and erythrose, that competitively inhibit the enzymes’ activity. Moreover,
some β-xylosidases are also non-competitively or un-competitively inhibited by monosaccharides.
Such product inhibition limits the application of β-xylosidases in xylan saccharification, since high
monosaccharide concentrations may easily be generated during the process. Therefore, β-xylosidases
with low monosaccharide affinity are highly desirable for various applications. A random mutagenesis
approach has already shown success in reducing the affinity of aβ-xylosidase for d-xylose. Furthermore,
with 3D structures available for a variety of β-xylosidases, rational site-directed mutagenesis may also
be a good approach to render the enzymes less prone to product inhibition.
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Abstract: Enzymes are nature’s catalyst of choice for the highly selective and efficient coupling of
carbohydrates. Enzymatic sugar coupling is a competitive technology for industrial glycosylation
reactions, since chemical synthetic routes require extensive use of laborious protection group
manipulations and often lack regio- and stereoselectivity. The application of Leloir glycosyltransferases
has received considerable attention in recent years and offers excellent control over the reactivity and
selectivity of glycosylation reactions with unprotected carbohydrates, paving the way for previously
inaccessible synthetic routes. The development of nucleotide recycling cascades has allowed for
the efficient production and reuse of nucleotide sugar donors in robust one-pot multi-enzyme
glycosylation cascades. In this way, large glycans and glycoconjugates with complex stereochemistry
can be constructed. With recent advances, LeLoir glycosyltransferases are close to being applied
industrially in multi-enzyme, programmable cascade glycosylations.
Keywords: glycosyltransferase; applied biocatalysis; enzyme cascades; chemoenzymatic synthesis;
sugar chemistry; carbohydrate; Leloir; nucleotide
1. Introduction
Enzymes were already used for the conversion of glycosides even before all stereochemical details
of the known carbohydrates were assigned [1,2]. In 1837, a crude formulation of almonds containing
Int. J. Mol. Sci. 2019, 20, 5263; doi:10.3390/ijms20215263 www.mdpi.com/journal/ijms323
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hydroxynitrile lyases catalyzed the enzymatic hydrolysis of the glycoside amygdalin [3]. Moving
almost two centuries forward, the largest volumetric biocatalytic industrial process is the application of
glucose isomerase for the production of high fructose syrup for food and drink applications, producing
fructose from glucose at 107 tons per year [4]. The secret of the success of enzymes in the production or
treatment of carbohydrates and glycosides is their exquisite stereo- and regioselectivity. The excellent
selectivity of enzymes is required due to the diversity of structural features of carbohydrates [5],
comprising d- and l-epimers, ring size, anomeric configuration, linkages, branching, and oxidation
state(s). Since drug targets often exhibit specificity for all of these structural features, the production
process should not contain any side-products to prevent undesired side-effects [6].
The challenge in the synthesis of carbohydrates is their wide variety of functionalities and
stereochemistry (Figure 1). (Poly)hydroxyaldehydes containing a terminal aldehyde are referred to as
aldoses and (poly)hydroxyketones are defined as ketoses. In aqueous solutions, monosaccharides form
equilibrium mixtures of linear open-chain and ring-closed 5- or 6-membered furanoses or pyranoses,
respectively. For aldoses, the asymmetric ring forms at C-1. For ketoses, it closes at C-2 as an axial (α)
or equatorial (β) hemiacetal or hemiketal, respectively (commonly defined as the anomeric center).
A glycosidic linkage is a covalent O-, S-, N-, or C-bond connecting a monosaccharide to another
residue resulting in a glycoside, while glucoside is specific for a glucose moiety. The equatorial or
axial position of the glycosidic bond is referred to as α- (axial) or β-linkage (equatorial). The number
of carbohydrates linked via glycosidic bonds can be subdivided into oligosaccharides with two to
ten linked carbohydrates, while polysaccharides (glycans) contain more than ten glycosidic bonds.
A glycan either contains multiple different monosaccharides or more than ten glycosidic bonds.
A glycoconjugate contains at least one or more monosaccharides or oligosaccharides covalently
attached to a non-carbohydrate moiety (aglycon). If an oligosaccharide contains an aldose or ketose
that is in equilibrium with its open-chain form, the aldehyde or ketone can be oxidized with chemical
reagents (e.g., with the Benedict reagent). This is referred to as the reducing end in oligosaccharides.
If there is no possibility for the sugar to form the open chain-form, then this is called a non-reducing
end. Non-reducing sugars are found in glycoconjugates (i.e. nucleotides) and oligosaccharides
(i.e., raffinose).
Figure 1. The nomenclature of glycosides and oligosaccharides.
Glycosyltransferases (GTs) catalyze the transfer of a carbohydrate acceptor from an activated sugar
nucleotide donor with high selectivity and yield, enabling the stereo- and regioselective extension
and branching of large glycans and glycoconjugates (Scheme 1). Upon formation of the glycosidic
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bond, the stereochemistry can either be retained or inverted by GTs with high selectivity for the α- or
β-anomer. Leloir glycosyltransferases utilize carbohydrates linked to a nucleotide diphosphate (NDP)
with an α-linked glycosidic bond, where non-Leloir glycosyl transferase utilize a phosphorylated sugar
donor. For both types of glycosyltransferase, the main driving force for the reaction to go to completion
is the exergonic release of either Pi or NDP from their respective sugar donors. The choice of nucleotide
acceptor determines the (stereo) chemical outcome of the type of O-, NH-, S-, C-glycosidic bonds.
Scheme 1. The overall scheme of an enzymatic glycosylation reaction for the biocatalytic synthesis of
glycosides by retaining or inverting glycosyltransferases (GT) using NDP or Pi activated sugar donors
for Leloir and non-Leloir GTs, respectively.
The enzymatic treatment of glycosides is mainly applied in the food industry using non-LeLoir
GTs, enhancing flavors and functionality in complex food formulations, such as debittering [7–9],
sweetening [10,11], or clarification [12–16]. The high costs of nucleotides, enzymes, and (enzymatic)
regeneration systems for the treatment or production of low-value carbohydrate-containing products
limited the application of nucleotide-dependent LeLoir GTs within the industry in the past. However,
recent advancements in glycobiology have sparked interest in the (chemo) enzymatic production
of high-value glycosides and glycoconjugates with high yield and selectivity for pharmaceutical
applications [17–22]. As more LeLoir GTs are being reported with high protein expression, wide
substrate scope, and high selectivity, industrial enzymatic glycosylation for the production of glycosides
and glycoconjugates in vitro is becoming economically feasible. For instance, the expression of a
large part of the human glycosyltransferases is a new hallmark for the production of human glycans
or glycoconjugates [23], simplifying their chemoenzymatic synthesis. Besides these developments,
the reaction methodologies are currently being further optimized. Multi-step enzymatic coupling
with glycosyltransferases using non-natural sugar acceptors and nucleotide sugar donors have been
performed with automated synthesizers and are under development, as was recently reviewed [24].
The enzymatic synthesis of glycosides has received increasing attention in organic synthesis.
However, the application of Leloir glycosyltransferases in a multi-enzymatic sugar coupling process
is challenging from a process design point of view. The high costs, low stability, and difficult or
limited availability of nucleotide sugar donors, in addition to the challenging protein production of
Leloir glycosyltransferases hamper the development of enzymatic glycosylation. As a compromise,
separate nucleotide sugar regeneration cascades and optimization of the protein production of
industrial biocatalysts has been pursued [25]. Although there is a large body of scientific literature
reporting on the biochemical properties and the reactions that glycosyl transferring enzymes catalyze,
the performance of these biocatalytic processes has only sparingly been described. Due to their inherent
complexity, kinetic and thermodynamic parameters have often not been analyzed in detail for the
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production of larger oligosaccharides using Leloir glycosyltransferases. In this review, the possibilities
and limitations for industrial applications of Leloir glycosyltransferases are highlighted from the
intersection of biochemical, chemical, thermodynamic, and reaction engineering perspectives, giving
an overview of the requirements of industrial processes involving glycosyltransferases.
2. Glycosyltransferases in Nature
Glycosyltransferases catalyze the formation of a glycosidic bond between an unactivated acceptor
monosaccharide or aglycon and an activated sugar donor [26] to a di-, oligo-, polysaccharide [27],
lipo(poly)saccharide [28] or peptidoglycan [29]. More than 484,620 glycosyltransferases in over 106
families have been identified according to the carbohydrate active enzymes (CAZy) database under the
Enzyme Commission number E.C.2.4.x.y. (CAZy database, last updated 01/15/18 [30]), representing an
enormous number of metabolic pathways [31]. Glycosyltransferases can be sub-classified based on
four different criteria: (i) the class of substrates [32]; (ii) the protein structure [26]; (iii) the preference
in stereochemistry [27,33]; (iv) the dependency on metals for catalytic activity [26]. Non-Leloir
glycosyltransferases use phosphorylated donors (i.e., lipid polyprenol [34,35], sugar 1-phosphates [32])
and can be described as phosphorylases. The second class are transglycosidases accepting non-activated
di- or polysaccharides as carbohydrate donors. The largest class of glycosyltransferases are the
nucleotide-dependent Leloir glycosyltransferases [26,32,36], named in honor of Luis Federico Leloir,
who received a Nobel prize for the discovery of nucleotide sugar donors in 1970 (Figure 2).
Figure 2. Common sugar nucleotides found in all kingdoms of life. Abbreviations: UDP-Glc,
UDP-glucose; UDP-GalNAc, UDP-N-acetyl-2-deoxy-d-galactosamine; UDP-GalA, UDP-d-galacturonic
acid; UDP-GlcA, UDP-d-glucuronic acid; UDP-GlcNAc, UDP-N-acetyl-2-deoxy-d-glucosamine;
UDP-FucNAc, UDP-N-acetyl-l-fucosamine; UDP-Gal, UDP-d-galactose; CMP-Kdo, CMP-3-deoxy-d-
manno-octulosonate; CMP-Sia, CMP-N-acetylneuraminic acid; GDP-Fuc, GDP-l-fucose; GDP-Man,
GDP-d-mannose; ADP-HEP, ADP-l-glycero-d-manno-heptose.
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The protein sequence and crystallographic data demonstrate that glycosyltransferases are mainly
comprised of five different protein folds (Figure 3) [26,27,37]. Glycosyltransferases having a GT-A or
GT-B fold consist of two β/α/β-Rossmann-like domains, abutting each other in case of the GT-A fold or
facing each other for GT-B folds [26,27,38]. Both folds contain separate donor and acceptor binding
sites [26]. Gloster et al. reported that glycosyltransferases with a GT-A fold belong to the divalent metal
ion dependent class of these enzymes, whereas GT-B folds are often metal ion independent [26,27].
Interestingly, glycosyltransferases having a GT-C fold are non-Leloir glycosyltransferases, utilizing
membrane integrated or membrane linked proteins with lipid phosphate sugar donors, also known
as non-Leloir donors [27,32,37]. The Leloir glycosyltransferases containing a GT-D fold catalyze the
transfer of glucose to hexasaccharide O-linked to serine-rich repeats of bacterial adhesins [39]. The most
recent addition, is the N-acetyl-d-mannose transferase utilizing non-Leloir undecaprenyl-linked
glycosyl diphosphates with a unique GT-E fold [40].
Figure 3. Protein folds of Leloir glycosyltransferases (GT-A, GT-B, GT-D) and non-Leloir
glycosyltransferases (GT-C, GT-E).
For Leloir glycosyltransferases, the binding of the sugar donor nucleotide and acceptor follows
a sequential ordered bi-bi catalytic mechanism via non-covalent interactions of the sugar donor
nucleotide. The binding of the sugar or aglycone acceptor results in an enzyme-substrate ternary
complex [41]. Hydrolysis of the sugar nucleotide donor is prevented by the tight binding in an
unproductive state, where the high affinity of the enzyme for the sugar nucleotide donor is an indicator
for product inhibition (Ki) by the released nucleotide [42]. For Leloir glycosyltransferases, a lower
affinity or promiscuity towards the nucleotide donor results often in less product inhibition [43]. Upon
binding of the sugar nucleotide donor, the enzyme undergoes a conformational change stabilizing the
transition state, resulting in the formation of a glycosidic bond and the release of the nucleotide donor.
Different reaction mechanisms of glycosyltransferases have been described and reviewed [26,27,44–47].
The inverting occurs via a SN2 mechanism, while a retaining transfer can proceed via a concerted
or ion-pair intermediate mechanism through a double displacement via a SN2 mechanism. Also,
a transient covalent intermediate via a SNi-type mechanism has been described for LeLoir GTs (Figure 4).
Inverting glycosyltransferases use general base catalysis (i.e., aspartate or glutamate) [31,48,49] to form
an oxocarbenium ion-like transition state. They show a catalytic rate enhancement by utilizing divalent
metals (i.e. Mn (II) or Mg (II)), which are often coordinated by the amino acid motif Asp-X-Asp.
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Figure 4. Reaction mechanism of glycosyltransferases upon inversion (a) or retention (b,c) of the
anomeric glycosidic bond. The divalent metal (M2+) is not necessarily a requirement for catalytic
activity for GTs.
2.1. Distinguishing Glycosyl Transferases from Glycoside Hydrolases
Two main groups of enzymes can catalyze the regio-, stereo-, and enantioselective coupling
of carbohydrates. Glycoside hydrolases and glycosyltransferases are often combined in biocatalytic
retro-synthetic strategies for linear elongation and branching of oligosaccharides. Glycoside hydrolases
are enzymes that condense a sugar donor with an aglycone acceptor. The broad substrate scope
of glycoside hydrolases has resulted in numerous synthetic applications such as synthesis [50–53]
or hydrolysis [54–57] of glycosidic bonds, and desymmetrization [58]. As a drawback, their broad
substrate scope also leads to the formation of side-products. Glycosylations with glycoside hydrolases
are under kinetic (transglycosylation) or thermodynamic control (direct glycosylation) using activated
and non-activated sugars respectively (Figure 5). With transglycosylation, relatively high yields can
be obtained in comparison with direct glycosylation due to a thermodynamically unfavorable reaction
equilibrium (Keq) in water. As a rule of thumb, transglycosylation should be faster than glycoside
hydrolysis, as otherwise the activated sugars would hydrolyze before the glycosylation reaction is
completed. Also, the rate of hydrolysis of the product should be slower than the activated glycosyl
donor or the product yield decreases. As this is often not the case, an excess of the activated sugar donor
is required under kinetic control. Similar to the coupling of protected glycosyl donors, the donors
for transglycosylation, such as fluoro [59–62], -azido [63], p-nitrophenyl- [64] or p-nitropyridyl- [65],
vinyl- [66], and allyl-glycosides [67] require their separate synthesis. The direct glycosylation is
challenging due to the poor Keq under aqueous reaction conditions, limiting the degree of conversion.
The product yields with direct glycosylation can be improved by adding one substrate in excess,
lowering the water activity [68], and in situ product removal [69].
Leloir glycosyltransferases couple NDP sugar donors with a wide range of sugar acceptors
resulting in the formation of a glycosidic bond. The exclusion of hydrolysis activity of the nucleotide
sugar donor separates glycoside hydrolases from glycosyltransferases. Nevertheless, hydrolysis of
the nucleotide sugar donor in the absence of a sugar acceptor has been reported and is referred to as
“error hydrolysis” [70–73]. Hence, the competition between water or a sugar acceptor as nucleophile
is important for the efficiency of glycosylation. Only a handful of studies investigated the nature
of the hydrolysis activity of Leloir glycosyltransferases with sugar nucleotide donors. For instance,
the bacterial sialyltransferase from Pasteurella dagmatis hydrolyzed the rather hydrolysis-prone
CMP-Neu5Ac in the absence of another substrate [74]. Directed evolution has been shown to
be an effective tool to diminish the degree of hydrolysis of NDP sialyl donor [75,76]. In comparison
to hemiketals, hemiacetals are more stable sugar donor nucleotides (i.e., GDP-l-fucose). Here,
the Leloir glycosyltransferases catalyze hydrolysis to a lesser degree [77]. Interestingly, the affinity
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of water to the active site for the hydrolysis of sugar nucleotide donors has not been determined for
Leloir glycosyltransferases.
 
Figure 5. Exemplary enzymatic glycosylation of an activated sugar donor (green) and acceptor (R-group)
to afford a maximum transient kinetic (blue) product yield catalyzed by a glycoside hydrolase, followed
by reverse hydrolysis towards the thermodynamic product concentration. Direct esterification leads
to the thermodynamic product yield Keq without the requirement for an activated sugar (red) in (a).
LeLoir GTs only catalyze the direct esterification of a nucleotide sugar donor (purple) to thermodynamic
product (red) in (b).
2.2. Recombinant Expression of Glycosyl Transferases
Although protein structures and the reaction mechanism of Leloir glycosyltransferases are widely
investigated, production of the enzyme is often challenging. Heterologous bacterial hosts such as
E. coli often lead to poor expression or formation of inclusion bodies (IBs) in certain cases with
retention of catalytic activity [78,79]. Besides the difficulties in recombinant protein production
and isolation, the half-life of this class of enzymes is often less than a couple of hours [80–82].
Thermostable glycosyltransferases from thermophilic archaea show higher overall stability [43]. Leloir
glycosyltransferases are often aggregation-prone in vitro [83,84]. As a solution to their aggregation,
a large number of solubility tags have been successfully applied to increase the solubility of Leloir
glycosyltransferases [23,79,85,86]. The recent advance of using the fluorescent proteins mCherry [79]
or GFP [23] as tags allowed for both an increase in solubility as well as rapid protein quantification.
For example, the fusion of GFP allowed for a modular expression approach of all human glycoenzymes
in HEK293 cells enabling multi-milligram isolation from the culture media in 65% of all cases [23].
The optimization of protein expression, the number of enzymes discovered, and the
characterization of a wide range of Leloir GTs has led to fundamental insights into their protein
structures, reaction mechanism, and substrate spectrum. The result of this extensive biochemical
knowledge is leading to the adoption of Leloir glycosyltransferases within the field of carbohydrate
chemistry. Next, we will discuss how these biochemical insights have been developing alongside their
application in chemoenzymatic glycosylations of glycoconjugates and oligosaccharides.
3. Application of Glycosyl Transferases in Organic Synthesis
The production of glycosides and glycans requires the use of highly selective catalysts to prevent the
formation of side-products. The development of automated chemical methods such as the solid-phase
production of oligosaccharides using the Seeberger method [87], the Demchenko synthesizer using
HPLC-based platforms for automation [88], and the Yoshida procedure employing an electrochemical
oxidation step [89], improved glycochemistry significantly. The basic principle of elongating a sugar
on a solid particle by performing a coupling-wash-deprotection-wash cycle under computer control
allows for the rapid production of a wide variety of carbohydrates [90–97]. The mechanism of action is
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the assembly of an oligosaccharide using protection group manipulation of either an activated glycosyl
acceptor or donor [98–105]. The purification of the intermediates produced in sequential reactions
remains the largest hurdle for chemical synthesis of an oligosaccharide or glycan. In particular, the
low orthogonality of activated glycosyl donors and acceptors limits multiple glycosylation reactions
in one-pot reactions. Also, the inherently low chemical reactivity of certain glycosidic bond forming
reactions, such as α-sialylation [106–108] and β-mannosylation [109], restrict different types of linkages.
Enzymes which catalyze one-pot glycosylation reactions with unprotected sugars can produce different
types of glycosidic linkages and have expanded the synthetic toolbox of glycochemistry considerably.
Leloir glycosyltransferases (GTs) transfer a nucleotide sugar donor to an aglycon acceptor, forming
O-, N- [110–124] or the rare C- [125–136] and S-glycosidic bonds [137–140] under thermodynamic control.
In comparison to chemical methods, the enzymatic coupling of carbohydrates occurs without the use
of protecting groups in a highly selective manner, allowing for orthogonal one-pot multi-enzymatic
(OPME) reactions. With a few robust GTs, complete libraries of glycans can be constructed [141–143],
which is particularly interesting since most of the human GTs are accessible in heterologous expression
systems [23]. The advantages of employing GTs are their mild reaction conditions, short reaction times,
pH tolerance, high specific activity, and high yields allowing for the (poly)glycosylation of a wide array
of glycans.
3.1. Catalytic Reversibility of Glycosyltransferases
One of the notable discoveries on glycosyltransferases was the recognition that glycosyltransferases
do not catalyze unidirectional reactions [144]. Alternatively, synthetic sugar donors and/or (chemo)
enzymatic regeneration systems either alter the overall Keq or regenerate the nucleotide in situ [145–149].
Such regeneration systems are not always a requirement; the glycosylation with nucleotide sugar
donors allows for repeated glycosylation on a single aglycon (i.e., flavonol-O-diglycoside [150]) or
elongation of a (poly)saccharide, such as glycogen with a molecular weight of up to 107 kDa [151].
The high glycosylation efficiency with Leloir GTs arises from a favorable thermodynamic equilibrium
Keq in these examples, determined by the sugar nucleotide donor and carbohydrate or aglycone
acceptor, pH, and ionic strength. As mentioned earlier, in a few examples the hydrolysis of the
NDP-sugar donor has been reported for Leloir GTs [70–77]. In these particular cases, it is important to
emphasize that the glycosylation with Leloir GTs is under kinetic control, and the sugar acceptor and
water are competing nucleophiles throughout the entire course of reaction [70–77].
A large impact on the field of glycobiology is the improved group estimation method [152,153]
for the determination of the change in Gibbs free energy of formation of glycosylation reactions with
increased accuracy, named eQuilibrator 2.0 [154,155]. In comparison to empiric thermodynamic data (i.e.,
Thermodynamics of Enzyme-Catalyzed reactions Database [156]), prediction tools allow for a much higher
coverage of Gibbs free energies of formation for different compounds. As a drawback, such prediction
methods can lead to contradictory observations due to either experimental uncertainties [157] or incorrect
analysis of given data [158]. Using Equilibrator 2.0, the synthesis of naturally occurring glycosides
with nucleotide diphosphates (NDPs) were shown to be thermodynamically favorable, as is known
for the glycosylation of phenolic [159–170], amino [171,172], or alcoholic [173] aglycones (Figure 6),
and has been reviewed recently [44]. Interestingly, the importance of the pH has been reported for
the glycosylation of acids [167,174,175] resulting in a low Keq < 1 at a neutral pH. The Keq depends
on the pKa of the aglycone- or saccharide acceptor, as well as the terminal phosphate of the sugar
nucleotide donor.
330
Int. J. Mol. Sci. 2019, 20, 5263
Figure 6. Glycosylation of aglycones producing phenolic glycosides, amino glycosides, alcohol
glycosides, ester glycosides, and disaccharides with their estimated Keq. The Keq was calculated from the
Gibbs free energy ΔGr′◦ using the eQuilibrator web interface (http://equilibrator.weizmann.ac.il) [155]
assuming the following conditions: ionic strength 0.1 M, pH 7.0, aglycon (1 mM), UDP (1 mM),
UDP-d-glucose (1 mM), glycosylated product (1 mM), and 298 K.
3.2. Sugar Donors and Acceptors and Their Glycosylation Efficiency
The thermodynamic constraints of enzymatic glycosylations of sugar acceptors with nucleotide
donors for the synthesis of di-, oligo-, or polysaccharides has been explored to a lesser extent.
Sucrose synthase has been employed for the regeneration of nucleotide sugars [25,42,80,176,177].
The equilibrium constant (Keq) of the reaction of sucrose with UDP to afford the sugar donor
UDP-glucose was determined [178]. The pH influences the Keq for the synthesis of UDP-glucose
with Acidithiobacillus caldus sucrose synthase (AcSuSy) due to the (de)protonation of the phosphate
group of the NDP: going from a pH of 5.0 to 7.0 lowered the Keq of 1.14 to less than 0.1 [178].
Enzymatic regeneration of NDP-glucose can also be achieved using trehalose as substrate [179]. For the
regeneration of nucleotide sugars, sucrose has been described as a more attractive d-glucopyranosyl
donor than α, α-d-trehalose due to the lower free energy of the glycosidic bond, resulting in a more
favorable thermodynamic equilibrium [44,180].
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While the type of carbohydrate donor and acceptor determines the glycosylation product,
the respective choice of nucleotide used for activation of the donor glycoside is important from
a thermodynamic point of view. Similar enzyme activities and affinities were observed for the
coupling of UDP-, GDP-, and ADP-glucose with α-d-glucose by trehalose transferase (TreT) from
Pyrococcous horikoshii. However, different Keq were observed for the enzymatic production of
d-trehalose. [43] In line with these observations, a trehalose transferase from Thermoproteus uzoniensis
fused to a mCherry solubility tag also reported different Keq for ADP- and UDP-glucose for the
production of d-trehalose [79]. Hence, the overall extent of conversion for the synthesis of disaccharides
was determined by the thermodynamics of the nucleotide. Although a thorough examination of the
Gibbs free energy of formation of NMP, NDP, or NTP salt or metals pairs in aqueous solution is beyond
the scope of this review, it should be noted that the pKa of nucleotides differ affecting the Gibbs free
energy of formation. Indeed, the ADP/ADP-glucose couple shows the largest Gibbs free energy change
for a transfer of α-glucopyranosyl moiety to a nucleotide, followed by UDP, CDP, and dTDP according
to Equilibrator 2.0 [155]. Nature might evolve enzymes to catalyze either the synthesis of nucleotide
sugar donors or reactions based on the Keq of nucleotides, as TreT of Thermococcus litoralis solely accepts
ADP for the transfer of an α-glucopyranosyl moiety from trehalose to produce ADP-glucose [181].
Oppositely, TreT from Thermoproteus tenax utilizes UDP-glucose for the synthesis of trehalose since
UDP favors synthesis [182]. Further work regarding this is required to elucidate the nature of the effect
of nucleotides on the Keq in a more comprehensive manner.
Under thermodynamic control, Leloir glycosyltransferases produce oligosaccharides if the overall
glycosylation reaction is exergonic (Figure 7). A one-pot procedure using five enzymes allowed for the
production of raffinose and stachyose from sucrose [183], using unpurified cell-free extract formulations
and supplementation of UDP with a total-turnover number (TTN) of 337. Thermodynamic constraints
were observed in the endergonic nucleotide sugar donor production, while coupling of the galactinol,
raffinose, and stachyose were exergonic, thereby driving the overall reaction toward oligosaccharide
synthesis. The estimation of the Gibbs free energy of individual components gives insights into
energetic constraints of one-pot multi-enzyme Leloir glycosyltransferase catalyzed glycosylation
reactions. An understanding of these limitations is essential for the optimization of industrial process
conditions and reactor design (i.e., product removal) of a biocatalytic process.
Figure 7. Enzymatic cascade for the production of stachyose from sucrose with glycosyltransferases.
(a). The standard Gibbs free energy changes of the individual reactions (ΔG◦s, red) and the total
reaction (ΔG◦, grey) shown in (b) [183]. The ΔrG′◦ represents the change of Gibbs free energy
and was calculated using the eQuilibrator web interface (http://equilibrator.weizmann.ac.il) [155]
using the following conditions: ionic strength 0.1 M, pH 7.0, 1 mM of component, 298 K.
Abbreviations: UDP-d-glc, UDP-d-glucose; UDP-d-gal, UDP-d-galactose, SuSy, Sucrose synthase; GalE,
UDP-d-glucose-4-epimerase; GS, galactinol synthase; RS, raffinose synthase; STS, stachyose synthase.
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3.3. NTP Regeneration for NDP-Sugar Donor Production
Recycling of the nucleotide sugar donor is considered essential for the application of Leloir
glycosyltransferases in large scale applications by preventing product inhibition from the released
nucleotide and reducing costs of expensive nucleotides. The use of purified enzymes in comparison to
whole-cell systems is often preferred, due to undesired side-reactions of endogenous enzymes of the
recombinant hosts during glycosylation of complex oligosaccharides. Most of the glycosyltransferases
and enzymes involved in the regeneration of nucleotides operate under neutral conditions and often
require the presence of divalent metals, such as Mg2+ or Mn2+. As Leloir glycosyltransferases use the
elimination of the nucleotide as a driving force for the glycosylation reaction, the high energy gain
poses a problem during the regeneration of NDP-sugar donors. For the production of NTP, the driving
force then has to be derived from even more energy-rich donors.
Four of the most widely applied enzymatic methods for the regeneration of the nucleotide
triphosphates (NTPs) are (see Figure 8): (1) pyruvate kinase using phospho(enol)pyruvate (PEP),
(2) acetate kinase using acetyl phosphate, (3) creatine kinase using creatine phosphate, and (4)
polyphosphate kinase using polyphosphate. The reaction equilibrium for PEP is highly favorable
and the phosphate donor is stable in solution [184]. However, commercial phosphoenolpyruvate is
expensive. Creatine phosphate is an alternative donor which is more affordable, but has considerably
lower energetic advantages than PEP. A cheap energy-rich phosphate donor is acetyl phosphate,
which can be synthesized directly from acetic anhydride and phosphate in excellent yields [185,186].
The disadvantage of using acetyl phosphate is the rapid spontaneous hydrolysis in water, requiring
either continuous supplementation or an excess of acetyl phosphate. The inexpensive (poly)phosphate
is a linear polymer that contains from ten to hundreds of energy-rich phosphate linkages [187].
(Poly)phosphate can drive the glycosylation reaction towards completion by the exergonic cleavage of
the phosphoanhydride bond (ΔG◦ = −30 − −32 kJ·mol−1 [158]) upon phosphorylation of nucleosides
with polyphosphate kinase (PPK). Mono- or diphosphorylation with PPK have been reported for
ATP [184,188–193], UTP [189,194,195], CTP [196,197], tTMP [198], often showing broad promiscuity
towards different nucleotides [187].
 
Figure 8. The use of different energy-rich phosphate donors to regenerate NTP using either pyruvate-
(a), creatine- (b), or acetate kinase (c). The ΔrG′◦ represents the standard change of Gibbs free energy
and was calculated using the eQuilibrator web interface (http://equilibrator.weizmann.ac.il) [155]
using the following conditions: ionic strength 0.1 M, pH 7.0, 1 mM of component, 298 K.
Abbreviations: NDP, nucleotide diphosphate; NTP, nucleotide triphosphate; ADP, adenosine
diphosphate; UDP, uridine diphosphate; CDP, cytidine diphosphate; dTDP; deoxythymidine
diphosphate; PEP, phosphoenolpyruvate.
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Different (re)generation schemes for the in-situ production of nucleotide sugars for the transfer
of a galactosylpyranoside moiety with either stoichiometric amounts of NTP [199], PEP [200],
poly(phosphate) [189], or acetyl phosphate [201] are shown in Figure 9. The main driving force
for the glycosylation reaction is the exergonic hydrolysis of pyrophosphate to phosphate by
pyrophosphatases or alkaline phosphatases. Although it has been suggested that the sacrificial
hydrolysis of NTPs with alkaline phosphatases is beneficial due to the removal of the nucleotide mono-,
di-, or triphosphate inhibitors [44,202], experimental evidence separating thermodynamics (additional
hydrolysis of pyrophosphate) from kinetics (product inhibition) is often not investigated in detail.
It is evident that under thermodynamic control nucleotide regeneration and enzymatic glycosylation
can only occur with highly exergonic sacrificial substrates (i.e., hydrolysis of pyrophosphate), as was
proposed by Hirschbein et al. who compared the energy of hydrolysis of the sacrificial donors as a
rationale for glycosylation efficiency [203]. Besides, for the common nucleotide glycosylation donors
UDP-Glc, UDP-GlcNAc [204], UDP-GlcA [205], UDP-Gal [204], UDP-GalA, UDP-Xyl, GDP-Man,
GDP-Fuc [204], CMP-Neu5Ac [200,204] the (re)generation systems for the production have been
employed for rare or synthetic nucleotide sugar donors, such as CMP-MAnNGc [200], CMP-Man [200],
CMP-ManNac5OMe [200], CMP-Kdo [200], ADP-Hep [206], and dTDP-Rha [207].
Figure 9. Several sacrificial phosphate donors for sugar nucleotide (re)generation systems of
galactosyltransferases using a stoichiometric amount of NTPs (a) [199], PEP (b) [200], PolyPn
(c) [189], and acyl Pi (d) [201]. Abbreviations: PPi, pyrophosphate; Pi, orthophosphate; UMP, uridine
monophosphate; UDP, uridine diphosphate; UTP, uridine triphosphate; UDP-Gal, UDP-d-galactose; ADP,
adenosine diphosphate; ATP, adenosine triphosphate; Gal, d-galactose; Gal1P, d-galactose-1-phosphate;
PEP, (phospho)enol pyruvate; PolyPn, (poly)phosphate; acyl Pi, acetyl phosphate.
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Often, one-pot multienzyme (OPME) cascade reactions do not go to completion without the
thermodynamic driving force from in-situ regeneration systems of nucleotide sugar donors. For instance,
the gram-scale OPME cascade of the glycoconjugate N-acetyl-d-lactosamine resulted in 85% isolated
yields and TTN of 80 for UTP (Figure 10a) [208]. The PEP/UDP-regeneration system produces UTP at
the expense of PEP while the hydrolysis of pyrophosphate provides the thermodynamic driving force to
complete the glycosylation cycle (Figure 10b). Upon replacement of the PEP/UDP-regeneration system
with (poly)phosphate/UDP for the enzymatic production of N-acetyl-d-lactosamine, no additional
pyrophosphatases are required [195]. Here, the required driving force is generated by the hydrolysis of
the energy rich phosphoanhydride bond in (poly) phosphate instead of pyrophosphate hydrolysis.
 
Figure 10. Enzymatic glycosylation for the production of N-acetyl-d-lactosamine from
glucose-6-phosphate and N-acetyl-d-glucosamine (a) [208]. The ΔrG′◦ represents the standard change in
Gibbs free energy (b) was calculated using the eQuilibrator web interface (http://equilibrator.weizmann.
ac.il) [155] using the following conditions: ionic strength 0.1 M, pH 7.0, 1 mM of component,
298 K. Abbreviations: Glc-6-P, d-glucose-6-phosphate; Glc-1-P, d-glucose-1-phosphate; P2O74−,
pyrophosphate; HPO42−, orthophosphate; UDP, uridine diphosphate; PGM, Phosphoglucomutase;
UDPG-P, UDP-glucose pyrophosphorylase; GalE, UDP-galactose epimerase; GalT, galactosyltransferase;
PK, pyruvate kinase.
Besides enzymatic regeneration, the enzymatic NTP synthesis can be performed directly
from nucleosides in the presence of an excess of a phosphate donor reducing the overall costs
of reagents (i.e., less than US$10 per gram UTP). A mutant of uridine kinase from Thermus thermophilus
phosphorylates a broad range of nucleosides [209]. The addition of an excess of acetyl phosphate
allows for the phosphorylation of nucleosides to NMPs with lysates from recombinant E. coli containing
the overexpressed and promiscuous uridine kinase [207]. Advantageously, cell-free extracts from
E. coli contain naturally occurring kinases that catalyze sequential phosphorylations to NTP in high
yields. Recently, a recombinant E. coli strain containing an enzymatic cascade of eight enzymatic
steps showed promising production titers of 1.4 g UTP per liter within 2.5 h starting from uracil [210].
Such regeneration systems have been extended to non-natural nucleosides [207,211,212].
3.4. Chemoenzymatic NTP Regeneration Cascades
The chemoenzymatic synthesis of NDP-sugar donors has been investigated with activated
glucose donors under kinetic control. Although the realization that glycosyltransferases catalyze the
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reverse reaction dates back to 1957 [213], the first application for the glycosylation of nucleotides
with an activated glycosyl fluoride was reported much later in 1999 [214]. The use of β-glucosyl
fluoride for the production of UDP-α-glucose using a flavonoid O- and C-β-glycosyltransferases
has been successful for the production of 3′-β-C-glucosylated phloretin under kinetic control [215].
Disadvantageously, fast hydrolysis of β-glucosyl fluoride in water limits its practical application.
The pioneering work using nitrophenol glycosides demonstrated the broad adaptability of activated
sugar acceptors for the glycosylation of nucleotide donors by altering the thermodynamics of the
reaction [216]. The engineered inverting macrolide-inactivating glycosyltransferase (OleD) from
Streptomyces antibioticus accepts a wide range of conveniently synthesized aromaticβ-d-glucopyranoside
donors for the production of UDP-α-d-glucose in the presence of UDP [145]. The directionality of
the reaction is dependent on the nitrophenol β-d-glucopyranoside donor, ranging from exergonic
favoring UDP-sugar formation to endergonic favoring the production of the aromatic sugar donor [145].
Alternatively, by coupling the 2-chloro-4-nitrophenol glycosides to catalytic amounts of nucleotide
diphosphate, the glycosylation of a wide variety of substrates has been demonstrated [217–219].
However, the undesired hydrolysis of 2-chloro-4-nitrophenol glycosides by Leloir glycosyltransferases
was observed as well [149]. Hence, separating glycosyltransferase from glycoside hydrolase activity is
not always evident in Leloir glycosyltransferases.
3.5. One-Pot Multi Enzyme Cascades
The use of a wide variety of NDP sugar donor regeneration systems coupled to exergonic
sacrificial Pi donors inspired the extension of OPME systems towards oligosaccharides and glycans.
Key to the success of Leloir glycosyltransferases is the selection of glycosyltransferases with high
selectivities towards their substrates, and avoiding the formation of side-products. The human
cancer antigen Globo H is a neutral hexasaccharide glycosphingolipid, which has been synthesized
chemically by a linear sequence of 11 synthesis steps with predesigned building blocks resulting in
a 2.6% overall yield [171]. The optimization of chemical glycosylation using the OptiMer program
with custom-synthesized carbohydrate building blocks constructed Globo H in three consecutive steps,
with an isolated yield of 41% [220]. The OptiMer program was improved to 83% isolated yield by a
one-pot approach using a complex carbohydrate building block containing a Galα1-4Gal bond from a
multi-step synthetic route [221], as is shown in Figure 11. A one-pot biocatalytic coupling of readily
available nucleotide sugar donors UDP-galactose, UDP-N-acetyl-d-glucosamine, and GDP-fucose
with three glycosyltransferases resulted in 54% isolated yield without any nucleotide sugar donor
regeneration cycles [222]. Additional regeneration of the nucleotide sugar donor improved the overall
yield to 94% at large-scale (i.e. 4.5 g allyl Globo-H) [129]. The efficiency of enzymatic glycosylation, the
availability of the nucleotide sugar donors, the simplicity of the one-pot reaction, and the mild reaction
conditions demonstrate the effectiveness of Leloir glycosyltransferases as catalysts for the production
of complex saccharides.
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Figure 11. Reaction scheme of both the multistep chemical glycosylation utilizing previously synthesized
carbohydrate building blocks [221] and enzymatic glycosylation utilizing nucleotide sugar donors for
linear saccharide elongation capped with a terminal vinyl group [129]. The top half of the figure was
adapted from [221], copyright 2006, National Academy of Sciences.
Sequential OPME synthesis allows for the coupling of glycosidic linkages which are synthetically
challenging, such as sialylation. The production of disialoganglioside cancer antigens GD1b and its
derivatives by two sequential α-sialylation reactions has been performed using an engineered Leloir
glycosyltransferase [200] with limited nucleotide donor hydrolysis activity (Figure 12) [223]. Lactose was
converted to the trisaccharide GM3 using α2-3 sialyltransferase 1 (M144D) from Pasteuralla multocida,
followed by a second α3,8-sialylation in 85% yield to GD3 fusing α2-3/8-sialyltransferase from
Campylobacter jejuni. Subsequently, the quantitative enzymatic β1-4-GalNAc coupling to GD2
with β1-4-GalNAc transferase from Campylobacter jejuni followed by β1-3-Gal transfer with
β1-3-galactosyltransferase resulted in GD1b with an overall isolated yield of 73% [223].
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Figure 12. The enzymatic synthesis of GD1b glycan using OPME α2,3-sialylation, α3,8-sialylation,
β1,4-N-acyl-galactosylation, and β1,3-galactosylation with a sacrificial (re)generation system for
N-acetylneuraminic acid (Neu5Ac), N-acetylgalactosamine (GalNAc), and d-galactose (Gal).
4. Reactor Engineering for (Non)-LeLoir Glycosyltransferases
One of the advancements in integrated biocatalytic processes using glycosyltransferases is the
development of automated enzymatic synthesis, using either immobilized substrates or enzymes.
Immobilized substrates allow for the spatiotemporal control of the produced glycoconjugate or
oligosaccharide in a reactor. Two prominent approaches using immobilized substrates exist:
(i) enzymatic solution-phase synthesis with tagged products allowing for rapid purification and (ii)
enzymatic solid-phase synthesis on the surface of an insoluble carrier with soluble substrates and products.
Solution-phase synthesis with a substrate bound to water-soluble [224] or thermo-responsive
polymers [225], fluorous- [217,226–236], ion exchange [237], or lipid-like tags [238] has attracted
much interest since it can bypass compatibility issues between enzymes and solid carriers. The main
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disadvantage of solution-phase assembly of oligosaccharides catalyzed by glycosyltransferases is
the low catalytic efficiency and affinity for the substrates due to different steric and stereoelectronic
properties induced by the substrate-bound tag. Automated enzymatic synthesis of oligosaccharides
with Leloir glycosyltransferases has emerged as a promising approach with the thermoresponsive
polymer poly(N-isopropylacrylamide) (PNIPAM) as a soluble or insoluble support of the sugars,
allowing for the synthesis of the antigen of blood groups A, B, and O, as well as the production of
the ganglioside GM1 in microchannel reactors (Figure 13) [239]. The Wong group reported a variety
of water-soluble polymers of PNIPAM attached to carbohydrates with different linkers to minimize
deleterious effects of the presence of the support on the activity of enzymes [24]. As a disadvantage,
the covalent attachment of oligosaccharides to PNIPAM requires cleavage of the oligosaccharide with
hydrogen peroxide (1M, pH 10), conditions which are incompatible with oxidative labile carbohydrates
(i.e., thiosugars).
Figure 13. Examples of oligosaccharides synthesized with automated enzymatic synthesis where GM1
is a well-known ganglioside, and the antigens of blood types A, B, and O.
Alternatively, substrate bound solid-phase synthesis strategies also received attention [240,241].
The sugar is immobilized on the solid carrier, while the enzyme and sugar nucleotide donor are dissolved
in the mobile phase [242–245]. Requirements for the full automatization of immobilized substrates are
dependent on the development of (i) efficient enzymes; (ii) availability of glycosylation donors; (iii) the
use of carrier and support material and (iv) linkers, spacers, and tags [24]. Continuous biocatalytic
processes using immobilized enzymes are from an engineering perspective highly attractive due to the
ease of reuse of the Leloir glycosyltransferase [189,246–255]. The immobilization of Leloir GTs enables
a simplification of the reactor’s structure and allows for precise control of the enzymatic glycosylation
process [255–257]. The immobilization of glycosyltransferases has been achieved by attachment
onto solid supports [78,128,258–260], entrapment inside a porous carrier [252,261], or cross-linking in
larger aggregates (CLEA) [262], as is shown in Figure 14. Furthermore, after immobilization the
reusability, thermal, pH, and operational stability of the enzymes was often increased [128,262,263].
In particular cases, enzyme immobilization even created a more favorable micro-environment for
enzyme activity [264] and selectivity [265,266].
On the other hand, the reaction conditions in a continuous biocatalytic process with immobilized
enzymes can be harsh from an engineering point of view, due to vigorous mixing, high pressures,
and flow rates. High enzyme stability of Leloir glycosyltransferases is required to tolerate shear
stress [267,268]. Also, due to the lack of an universal enzyme immobilization technique many factors
must be considered [256,268,269], including mode of interactions (i.e., enzyme-substrate/product,
enzyme-carrier, substrate/product-carrier), compatibility of the carrier to reaction conditions (solvent,
temperature, pH, etc.), and the type of reactor or process (i.e., batch reactor, packed-bed reactor, basket
reactor, microfluidic reactor).
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Figure 14. Different modes of immobilization of Leloir glycosyltransferases with entrapment,
cross-linking, or carrier-bound attachment.
Reactor Design for Glycosyltransferases
For industrial applications, besides the appropriate immobilization of the enzymes, the chemical
character of the carrier’s surface is of high importance as are the particle size and pore structure
which need to match the type of reactor: i.e. tank vs. tube/column and the mode of operation:
periodic/batch vs. continuous flow. Conventional stirred tank reactors (STR) [259,266,270,271] are
still frequently applied, but basket and in particular rotating bed reactors [272] are increasingly used
in batch operations. In continuous flow applications, packed-bed (micro)reactors [273] have been
most popular, but structural (micro)reactors [274,275], lab-on-a-chip [276], and capillary microreactors
are on the rise [277]. The STRs are predominantly used in biotechnology owing to cost efficiency
and versatility. However, vigorous mixing results in frequent collisions of fine biocatalyst particles
resulting in tensile and shearing forces which enhance abrasion or disintegration of the enzyme or its
carrier [272]. Moreover, the mixing on a medium and large scale can be insufficient to prevent “hot
spot” formation, resulting in enzyme denaturation. But even more importantly, as mass transfer of
reactants to fine particles of the biocatalysts or freely suspended enzymes is low, the mass transfer
does not keep up the pace of intrinsic activity of the highly active enzymes expressed by turnover
frequency values of about or over 104 s−1. In effect, it is the mass transfer that strongly impacts,
or even fully controls the apparent rate of the enzyme catalyzed reactions carried out in STRs, and that
has unfortunately often been overlooked [277,278]. The recovery of the freely suspended biocatalyst
particles can be challenging, requiring filtration or centrifugation [279]. The biocatalyst recovery
can be simplified using a basket-rotating bed reactor (RBR), which enables simultaneous mixing
and effective percolation of liquid through the bed of the catalyst packed in a cylindrical basket,
thus avoiding the catalysts destruction, enhancing mass transport, and facilitating separation of the
catalyst [280–282]. However, the size of the applied catalyst particles/enzyme carriers needs to be
larger than 0.1–0.2 mm [280,281]. The scale-up of RBRs is challenging due to the large size of the rotor
as well as the power required for rotating, although a 750-L scale has been successfully demonstrated
(Chiralvision. Low-volume continuous flow reactors with flow through channels typically in the range
of diameters 0.1–0.5 mm (capillary microreactors) are better scalable [277,283–285]. The problems
related to scaling up are resolved by numbering up the (micro) reactors in a parallel process, designated
as ‘scaling out’. In particular, if thermal effects are not too strong, as is often the case, for the same
type of packing the scalability is not a problem. Average linear velocity of flowing reactants and a
mean residence time need to be identical on different scales to obtain the same conversion. In addition,
owing to narrow channels the time needed for substrate transfer from the center of the liquid channel
to the wall-attached catalysts is significantly reduced and the transfer of heat and mass increased, with
a positive effect on the apparent reaction rate. Also, the ratio of the active surface of the reactor to its
volume may be increased by a factor of 50 or even much more, (e.g., from about 103 m−1 in industrial
340
Int. J. Mol. Sci. 2019, 20, 5263
reactor to ~5 × 104 m−1 for 0.1 mm capillaries) which results in an increase of volumetric productivity
(space-time-yield) and hence more profit and lower investment costs [277,278,285]. Moreover, the low
reaction volume favors the reduction of potential hazards, particularly important in the case of highly
exothermic reactions or when hazardous substances are involved [278,284]. A simplified approach may
be used to evaluate process boundaries for the capillary microreactors with enzymes attached to the
wall surface [277]. But more in-depth analyses of design and modelling issues for various continuous
flow microreactors have also been reported [285].
Different examples of reactors that have been used with glycosyltransferases are shown in
Figure 15. Stirred tank reactors are flexible in design and operation conditions, but often require
high operation costs and vary in the product quality per batch [128,259,266,270,271]. Microchannel
reactors feature flow-through channels of micrometric sizes that contain the enzyme immobilized on
their wall surface [277]. Packed-bed (micro) reactors contain fine particles with immobilized enzymes
in a flow-through channel, allowing for a higher volumetric activity than microchannel reactors.
The heterogenous biocatalyst should not be able to compact to avoid high pressure drops, while
mass transport between liquid reactants and catalyst surface is enhanced owing to a more chaotic
flow which facilitates mixing. The large pressure drop, even at low flow rates may, however, be a
problem if fine catalyst particles are applied. Structured microreactors contain a reactor core made of
a porous monolithic structure with open, usually curved pores/channels connected with each other
offering excellent mixing and mechanical stability. Moreover, the pressure drop can be significantly
reduced and flow rate increased, compared to the packed-bed reactors, and this boosts productivity.
The enzymes are immobilized either on the external surface of the monolith or in its pores [273].
Figure 15. Different reactor types for the immobilization of Leloir glycosyltransferases.
A packed-bed reactor is a commonly used system for continuous production with a heterogeneous
biocatalyst, especially because one can immobilize simultaneously different enzymes. Schöffer et al.
used glutaraldehyde-activated chitosan spheres [259] and amino- or thiol- functionalized silica
particles [260] as a support for cyclodextrin glucosyltransferase immobilization. The silica-based
biocatalyst was successfully applied in a packed-bed reactor for continuous cyclodextrin production
and maintained 100% of its initial activity after 200 h, whereas activity of the chitosan-based catalyst
decreased to 78% of its initial value already after 50 h. This was ascribed to the super packing of
spheres, resulting in the reduction of bed height by 45%, and thus in a decrease in the residence/reaction
time. However, after washing and re-packing, the spheres recovered 100% of their initial activity.
An interesting effect was observed by Cho, et al. [271], who compared the performance of batch
and continuous packed-bed reactors using Eupergit C250L as an enzyme support. The batch reaction
was performed for trehalose production from maltose using trehalose synthase for more than 20 h.
They found that the product composition was almost the same after 10 h and a maximum trehalose
production yield of 25% was established. Trehalose production was improved using a packed-bed
bioreactor, wherein the yield reached 42% with a retention time of 100 min. The authors claimed that
continuous feeding of fresh substrate into the packed-bed reactor might have eliminated and removed
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inhibitory compounds from the solution such as by-products formed and accumulated during the
batch reaction and thus increased the production yield. A combination of continuous-flow stirred tank
reactor (CSTR) with a packed-bed reactor (PBR) was also studied [270]. A highly concentrated starch
solution was first partially converted to β-cyclodextrins in a CSTR, which resulted in a decrease of
starch viscosity. After that, the reaction mixture was pumped through the PBR. The integrated reactor
offered much higher concentration of the final product than each of the reactors separately.
Integration of two or more reactors attracts increasing attention, especially if two or more enzymes
are applied. For continuous flow nucleoside synthesis Cattaneo, et al. [273] combined a PBR, filled
with purine nucleoside phosphorylase immobilized on silica particles, with uridine phosphorylase
immobilized on a silica monolith. In the first approach, co-immobilization of both enzymes on a
slightly longer silica-filled PBR was tested, and a high immobilization yield was obtained. However,
a very high backpressure of the system (>10 MPa) was registered even at a low flow rate value of
0.1 mL/min, thus hampering the full characterization of the reactor system and resulting in a dramatic
drop in conversion. Nonetheless, the application of a monolithic reactor, which exhibited only 6 MPa
of pressure drop at a flow rate of 0.5 mL/min, combined with a shorter PBR, showed good activity and
stability [273]. The additional advantage of this set-up would be the availability of a single bioreactor
that could be used independently, either for “one-enzyme” synthesis or in a different sequence.
Recently Nidetzky, et al. [277], presented an elegant exemplary glycosylation process with sucrose
phosphorylase immobilized on the internal surface of a microchannel (Figure 16). Its mathematical
model clearly demonstrated that microreactors with the lower hydrolytic channel diameter (dh) exhibit
enhanced performance in terms of conversion and space-time-yield (STY). As the enzyme was attached
on the microchannel’s wall only the external mass transfer had to be considered [285], and the enzymatic
transformations appeared to experience a shift from diffusion to reaction control with miniaturization
of dh (second Damköhler number—DaII < 1). Thus, the microreactors, in consequence of their small dh,
emerge as an effective means of gaining full control of the reaction [277]. However, the practical limits
to the decrease in dh, due to high pressure drop, and increased tendency of microchannel clogging have
to be kept in mind [274,277]. Therefore, to boost both STY and microreactor performance, a combination
of dh decrease and enzyme activity increase appears to be the rational solution [277].
Figure 16. Glass microchannel reactor with immobilized enzyme sucrose phosphorylase attached to
the siliceous wall [277]. Attachment occurs via the highly positively charged Zbasic2 binding module,
which binds to the negatively charged silica surface.
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To summarize, the application of miniaturized synthetic systems and flow microreactors with
immobilized enzymes in particular, attracts attention for the synthesis of more complex carbohydrates.
The reported studies clearly demonstrate important advantages of microreactor-based synthetic
processes: good stability and high activity that allow for very effective/highly productive syntheses
of targeted carbohydrates. While the application of capillary or packed-bed microreactors has been
best characterized, structured microreactors are emerging as a class of miniaturized devices that offer
additional advantages.
5. Summary and Outlook
The discovery, characterization, and engineering of Leloir glycosyltransferases has expanded
the synthetic toolbox to couple, elongate, or branch glycoconjugates, oligosaccharides, and glycans
with high regio- and stereoselectivity. Efficient regeneration systems and large-scale production of
nucleotide sugar donors under either kinetic or thermodynamic control increased the efficiency of
enzymatic glycosylation, reducing overall process costs and the use of stoichiometric amounts of
nucleotide phosphates. In this review, the importance of the thermodynamics of glycosylation reactions
has been given attention, separating kinetics from thermodynamics for the coupling of a wide variety
of NDP sugar donors with acceptors, including sacrificial phosphate donors for NDP (re)generation.
The wide range of different Leloir glycosyltransferases has allowed for the implementation of
enzymes in glycochemistry, and consequently, industrially applicable glycosylation methodologies are
now in progress. The protein production improved significantly by using (fluorescent) solubility tags,
allowing for the production of the biocatalyst in high(er) titers. Despite of the production of enzymes
becoming a routine, no industrial application of Leloir glycosyltransferases for the glycosylation of large
oligosaccharides has yet been scaled to large volumes, in contrast to non-Leloir glycosyltransferase
(i.e., cyclodextrin glycosyltransferases). Until now, one of the main limitations has been the cost-efficient
production of NDP sugar donors, which has been an important topic of interest in the last decade.
Indeed, due to the advance of many chemical and biocatalytic NDP-sugar production processes, their
commercial cost price has been rapidly declining over the last few years.
As the demand for high-value antigens is increasing, the number of biocatalytic glycosylation
processes applied for the synthesis of these complex oligosaccharides can be anticipated to rise. One
trend is the embracement of automated enzymatic synthesizers for the computer-controlled synthesis
of large oligosaccharides using Leloir GTs. In comparison to non-enzymatic coupling strategies, which
mostly rely on protection group chemistry, Leloir GTs have now been shown to couple a wide spectrum
of unprotected sugar acceptors with excellent regio- and enantioselectivity. Due to the availability of
the nucleotide sugar donors and well-established NDP (re)generation systems, Leloir GTs matured as
a competitive glycosylation strategy for the enzymatic synthesis of oligosaccharides.
Future developments for industrial enzymatic glycosylation are expected to mostly be focused on
optimizing the overall glycosylation process conditions. The main drivers for selecting the most optimal
process can be attributed to economic (i.e., revenue of products), development (i.e., time), and process
(i.e., performance) parameters. Multiple aspects influence these important aspects, such as the selection
of the most optimal reactor design, separating batch versus continuous process operation, the choice
of either immobilized substrates to immobilized enzymes, or the use of NDP-regeneration system
or stoichiometric use of NDPs. Different enzymatic solution-phase and solid-phase glycosylation
strategies have been developed for the automated enzymatic synthesis of carbohydrates. The enzymatic
synthesis of an immobilized substrate allows for the purification to become more straight-forward, but
requires the stoichiometric use of enzymes. On the other hand, immobilized Leloir GTs in continuous
operations have been described sparingly in cascade glycosylation reactions. Immobilized enzymes,
ensuring process flexibility and the purification of the produced oligosaccharide are engineering design
challenges which have yet to be met.
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Abstract: Glycoconjugates are the most diverse biomolecules of life. Mostly located at the cell surface,
they translate into cell-specific “barcodes” and offer a vast repertoire of functions, including support
of cellular physiology, lifestyle, and pathogenicity. Functions can be fine-tuned by non-carbohydrate
modifications on the constituting monosaccharides. Among these modifications is pyruvylation,
which is present either in enol or ketal form. The most commonly best-understood example of
pyruvylation is enol-pyruvylation of N-acetylglucosamine, which occurs at an early stage in the
biosynthesis of the bacterial cell wall component peptidoglycan. Ketal-pyruvylation, in contrast, is
present in diverse classes of glycoconjugates, from bacteria to algae to yeast—but not in humans.
Mild purification strategies preventing the loss of the acid-labile ketal-pyruvyl group have led
to a collection of elucidated pyruvylated glycan structures. However, knowledge of involved
pyruvyltransferases creating a ring structure on various monosaccharides is scarce, mainly due to the
lack of knowledge of fingerprint motifs of these enzymes and the unavailability of genome sequences
of the organisms undergoing pyruvylation. This review compiles the current information on the
widespread but under-investigated ketal-pyruvylation of monosaccharides, starting with different
classes of pyruvylated glycoconjugates and associated functions, leading to pyruvyltransferases, their
specificity and sequence space, and insight into pyruvate analytics.
Keywords: pyruvylation; pyruvyltransferase; exopolysaccharides; capsular polysaccharides; cell
wall glycopolymers; N-glycans; lipopolysaccharides; biosynthesis; sequence space; pyruvate analytics
1. Introduction
Pyruvylation is a widespread non-carbohydrate modification of monosaccharides found in
various classes of glycoconjugates. In most cases, the modification is present as a pyruvate (Pyr)
ketal (cyclic acetal/ketal) bridging two hydroxyl groups of a monosaccharide residue and forming
a ring structure [1], where pyruvate is most frequently placed across the 2,3-, 4,6-, or 3,4-positions
(Figure 1I–III). The best-known example of pyruvylation, however, occurs as enol pyruvate (Figure 1IV),
which is elaborated during the biosynthesis of the bacterial cell wall component peptidoglycan [2].
In both modes of pyruvylation, a dedicated pyruvyltransferase catalyses the transfer of the pyruvate
moiety to the monosaccharide target.
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Figure 1. Overview on the most common modes of monosaccharide pyruvylation. Shown is pyruvate
ketal at bridging positions 2,3 (I), 4,6 (II), and 3,4 (III), and enol pyruvate (IV). Arabic numbers indicate
ring positions.
Pyruvate-ketal-modified (henceforth abbreviated as “pyruvylated”) glycoconjugates are found in
various phylogenetic orders of life, including bacteria, yeast, and algae, but not in humans. Pyruvylated
glycoconjugates are typically present in the cell envelope to which they impart a net negative charge;
this is necessary for vital biological functions, such as regulation of the cell influx/efflux processes
and cell–cell interactions including cell aggregation and pathogenic adhesion. Notably, besides
pyruvylation, nature offers various alternate strategies to create anionic cell surfaces, including a
wide range of acidic saccharides (e.g., muramic acid, hexuronic acids, sialic acids) and saccharide
modifications (e.g., succinate, lactate, phosphate) [3]. These compounds further lead to an increased
capability of cells to electrostatically bind cations at the surface, which, in turn, may foster the packing
density of the saccharide portion of glycoconjugates [4].
The repertoire of monosaccharide targets of pyruvylation is quite diverse. The most abundant
pyruvylated monosaccharide with 59 hits in the Carbohydrate Structure Database (CSDB, http:
//csdb.glycoscience.ru/) [5,6] is galactose (Gal). Examples of pyruvylated galactose include, among
others, the capsular polysaccharide of Bacteroides fragilis [7] and Streptococcus pneumoniae [8], N-glycans
of the fission yeast Schizosaccharomyces pombe [9], as well as carragenans [10], and galactans from
algae [11–13]. Recently, pyruvylated N-acetylmannosamine (ManNAc) has emerged as an important
epitope on bacterial “non-classical” secondary cell wall glycopolymers, serving as a cell wall ligand
for cell surface (S-) layer proteins, such as those of the pathogen Bacillus anthracis and the honeybee
saprophyte Paenibacillus alvei [14,15]. There are also examples of pyruvylated monosaccharides on
capsular polysaccharides serving as an immunostimulatory effector [7,16], or contributor to virulence
as in the case of the secondary cell wall polymer of Bacillus cereus [17] or the exopolysaccharide xanthan
of Xanthomonas spp., where pyruvylation is essential for successful colonization and pathogenesis in
planta [18]. Pyruvyl groups on terminal glucose (Glc) and N-acetylgalactosamine (GalNAc) residues
in the lipooligosaccharide of Pseudomonas stutzeri OX1, in contrast, are assumed to have biosynthetic
implications [4]. All these examples are, among others, discussed in detail below.
Several studies dealing with pyruvylated glycans and their structural elucidation are available
in the literature. However, knowledge of the enzymatic machinery governing pyruvylation is
scarce. This is mainly due to missing sequencing data of the organisms, which produce pyruvylated
glycoconjugates of known structure. Thus, despite their predictably widespread occurrence,
pyruvyltransferases are an under-investigated class of enzymes.
This review summarizes the current state of knowledge about pyruvylated glycoconjugates in
nature—focusing on bacterial sources—with an emphasis on the pyruvyltransferases involved in
their biosynthesis.
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2. Enol-Pyruvylation in Peptidoglycan Biosynthesis
The UDP-N-acetylglucosamine-3-O-enol-pyruvyltransferase MurA (EC 2.5.1.7) targets
UDP-N-acetylglucosamine (UDP-GlcNAc) as an acceptor substrate for enol-pyruvyl transfer
from a phosphoenolpyruvate (PEP) substrate, thereby releasing free phosphate and yielding
the UDP-activated form of the essential bacterial cell wall compound N-acetylmuramic acid
(enolpyruvyl-UDP-N-acetylglucosamine; MurNAc). This first committed step of peptidoglycan
biosynthesis is inhibited by the epoxide antibiotic fosfomycin [19]. As a PEP analogue, fosfomycin
binds covalently to the key cysteine residue at position 115/116 (position depending on the source of
enzyme) in the active site of MurA, preventing the formation of UDP-MurNAc [19–21]. The co-crystal
structure of a Cys (cysteine)-to-Ser (serine) mutant of Enterobacter cloacae, MurA, together with its
substrates, revealed that the Cys residue is essential for product release and not directly involved in the
chemical reaction of enol-pyruvyl transfer. The comparison of the product state with the intermediate
state and an unliganded state of MurA indicated that the dissociation of the products is an ordered event,
with inorganic phosphate leaving first, followed by conformational changes that lead to the opening of
the two-domain structure of MurA and the final release of UDP-MurNAc [20]. A recent study on MurA
of the opportunistic pathogen Acinetobacter baumannii revealed that the enzyme exists as a monomer
in solution and has a pH optimum of 7.5 at 37 ◦C. The Km for UDP-GlcNAc is 1.062 ± 0.09 mM and
1.806 ± 0.23 mM for PEP [21]. The relative enzymatic activity is inhibited approximately threefold in
the presence of 50 mM fosfomycin. Superimposition of a model for the A. baumannii enzyme with
MurA of Escherichia coli (E. coli) confirmed the structural similarity in the fosfomycin binding site.
Because of the worldwide spread of antimicrobial resistance and the paucity of novel drugs in the
development pipeline, there has been a renewed interest in fosfomycin as an alternative option for the
treatment of infections caused by multidrug-resistant Gram-negative bacteria [22]. However, it has
to be considered that natural MurA mutants exist that render the respective organisms fosfomycin
resistant. This includes Mycobacteria and Chlamydia species, where Cys-to-Asp mutants occur [20].
Interestingly, NikO, another enol-pyruvyltransferase that is structurally closely related to the
common MurA enzymes and, consequently, inhibited by fosfomycin, plays an essential role in the
biosynthesis of nikkomycins. Nikkomycins are peptide-nucleoside antibiotics, which strongly inhibit
chitin synthesis and, therefore, are effective against fungi and insects. NikO was shown to transfer the
enol-pyruvyl moiety from PEP to the 3′-hydroxyl group of UMP and to be inactivated by fosfomycin
because of alkylation of Cys130. However, the degree of inactivation is not as pronounced as in the
case of common MurA enzymes [23].
3. Ketal-Pyruvylated Glycoconjugates
In this section, an overview of the different classes of pyruvylated glycoconjugates is given,
including glycan composition and structure, as well as functional and biosynthetic aspects, when known.
There is a recent interest in understanding the biosynthetic pathways of pyruvylated
glycoconjugates from bacterial sources, as these pathways might unravel novel targets for therapeutic
intervention. However, the current biosynthesis models for the different classes of glycoconjugates
are in most cases only fragmentarily available and, frequently, they consider in silico predictions of
involved components without experimental evidence.
3.1. Exopolysaccharides
Many organisms produce extracellular polysaccharides (exopolysaccharide, EPS) that are actively
secreted during growth, including bacteria, yeasts, and microalgae [24]. EPSs are a diverse class
of carbohydrate polymers that are composed of either linear or branched repeating units that are
connected with varying stereochemistry. Monosaccharide constituents include pentoses (ribose and
arabinose—especially in Mycobacterium spp.), hexoses (mannose (Man), glucose, fructose, galactose),
deoxysugars (rhamnose (Rha), fucose (Fuc), uronic acids (glucuronic and galacturonic acids), and amino
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sugars (glucosamine, galactosamine, in several cases modified by N-acetylation) [24]. Depending on
the monosaccharide composition, homo- or hetero-polymers are differentiated.
EPSs have a “jelly-like” appearance and are part of the glycocalyx—with which the “cellular sugar
coat” is referred to [24]; as a common feature, they create a protective matrix around cells. The shielding
effect against macromolecules that is conferred by EPS makes some bacteria 1000 times more resistant
to antibiotics than their EPS-free counterparts [25].
Given the high application potential of microbial EPSs in medical fields, biomaterials, food
applications, and in the replacement of petro-based chemicals [26], these glycoconjugates are currently
of high interest.
3.1.1. Xanthan
Xanthan is the main EPS produced by Xanthomonas campestris and other phytopathogenic
Xanthomonas spp. that cause various economically important diseases in mono- and di-cotyledonous
crops. Xanthan enhances the attachment to plant surfaces through its effect on biofilm formation,
promotes pathogenesis by Ca2+ chelation and, thereby, suppression of the plant defence responses in
which Ca2+ acts as a signal [27]. In practical applications, xanthan is frequently used as a viscosifying
agent [28,29].
The pentasaccharide-repeating unit of xanthan consists of two β-(1→4) linked d-Glc residues
as backbone and a trisaccharide side chain, α-(1→3)-linked to every other glucose. The side
chain is composed of α-d-Man, β-d-glucuronic acid (GlcA), and β-d-Man, which are β-(1→2)- and
β-(1→4)-linked to another, respectively [30]. In its natural state, the α-d-Man residue is acetylated
and the β-d-Man is either acetylated or pyruvylated. It was found that the 4,6-ketal-pyruvate (4,6Pyr)
specifically and, to a lesser extent, the acetyl groups that decorate the mannose residues are involved
in Ca2+ chelation [27] and affect bacterial adhesion and biofilm architecture and, hence, contribute to
the bacterium’s virulence [18]. Furthermore, the rheological properties of xanthan are influenced by its
pyruvylation and acetylation pattern [28,31].
Xanthan biosynthesis is encoded in a so-called gum-cluster. Of the 13 encoded genes, gumDMHK
are involved in the synthesis of the pentasaccharide repeat, and gumBCEJ in polymerization and xanthan
export across the outer membrane in a flippase/polymerase (Wzx/Wzy)-dependent pathway. Regarding
the modifications of xanthan, the predicted pyruvyltransferase GumL is hypothesised to catalyse
pyruvylation of β-d-Man residues, while GumF and GumG are involved in β-d-Man acetylation [28,32].
It remains to be determined at which stage of xanthan biosynthesis the modifications are elaborated;
it might be either at the cytoplasmic membrane or in the periplasmic space [32]. To this end, it was
shown that GumK, a glucuronic acid transferase, is active on the lipid-linked trisaccharide precursor
α-Man-(1→3)-β-Glc-(1→4)-β-Glc-P-P-polyisoprenyl, and shows reduced activity on the acetylated
precursor substrate 6-O-acetyl-α-Man-(1→3)-β-Glc-(1→4)-β-Glc-PP-polyisoprenyl [33]. This suggests
that mannose acetylation occurs after the completion of the trisaccharide side chain [32,33]; this might
also hold true for pyruvylation. The xanthan biosynthetic enzymes seem to be highly conserved among
different organisms, except for the mannose-transferase GumI and the pyruvyltransferase GumL,
for which no homologues are found in other organisms [34].
Interestingly, Bacillus sp. strain GL1, which utilizes xanthan for its growth, produces an extra-
cellular xanthan lyase, which catalyses the cleavage of the glycosidic bond between 4,6Pyr-β-d-Man and
β-d-GlcA residues in xanthan side chains and, thus, contributes to depolymerisation of xanthan [35,36].
3.1.2. Succinoglycan
Succinoglycan is a pyruvylated EPS that is produced by Agrobacterium [37,38], Alcaligenes,
Pseudomonas [39], and Rhizobium strains [40], and is of great importance in plant symbiosis.
It is a heteropolymer that is multiply decorated with pyruvate, succinate, and acetate substituents.
While the extent of acetylation and succinylation depends on the strain and the cultivation conditions,
pyruvate is always found in a stoichiometric manner at the terminal β-Glc residue [32]. The repeat
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unit structure of succinoglycan is composed of β-Glc and β-Gal in a molar ratio of 7:1. Nineteen
genes are involved in the polymer’s biosynthesis, which are referred to as exo genes and encoded in
a 16 kb gene cluster. The biosynthesis starts with the production of the nucleotide-activated sugars
UDP-Glc and UDP-Gal, where ExoC (phosphoglucomutase), ExoB (UDP-glucose-4-epimerase), and
ExoN (UDP-pyrophosphorylase) are involved [32,41,42] (Figure 2). The initial step in the biosynthesis is
executed by ExoY, a priming galactosyltransferase transferring a single, reducing-end Gal residue onto
an undecaprenylphosphate (undp-P) carrier. ExoA, exoL, exoM, exoO, exoU, and exoW encode subsequent
glycosyltransferases, which complete the octa-saccharide repeat in a step-wise manner, with each
enzyme transferring a single monosaccharide, each, except for ExoW which transfers the subterminal
and terminal glucoses. Prior to the export of the octasaccharide via a Wzx-dependent pathway,
pyruvylation (at the terminal, non- reducing-end glucose), acetylation, and succinylation reactions
catalysed by ExoV, ExoZ, and ExoH, handed over to ExoQ, which is responsible for polymerization of
the fully modified repeats [43]. Studies on ExoV, the pyruvyltransferase of Shinorhizobium (previously
Rhizobium) meliloti, suggest that pyruvylation is important for polymerization of repeating units and
efficient succinoglycan export [44].
 
Figure 2. Scheme of succinoglycan biosynthesis in Shinorhizobium meliloti [43]. The pyruvylation step
occurs in the cytoplasm at the stage of the undp-PP-linked RU prior to export and polymerization in the
periplasmic space. Pyruvylation (ExoV) is indicated by a star. The order of pyruvylation, acetylation
(ExoZ), and succinylation (Exo) is unknown. RU: repeating unit. Monosaccharide symbols are shown
according to the Symbol Nomenclature for Glycans (SNFG) [45].
For Rhizobium leguminosarum, it was shown that missing pyruvylation on the terminal glucose
residue of the succinoglycan impairs the formation of the nitrogen-fixing symbiosis with Pisum
sativum, supportive of a signalling role of pyruvylation in this process [46]. PssK was identified as the
pyruvyltransferase involved in succinoglycan modification of R. leguminosarum [46].
3.1.3. Salecan
The salt-tolerant soil bacterium Agrobacterium sp. ZX09 is the producer of salecan, a
soluble, succinylated, and pyruvylated EPS with a β-(1→3) glucan structure that is of interest
because of its multiple bioactivities and unusual rheological properties. Its basic repeating unit
structure was initially elucidated as→3)-β-d-Glcp-(1→3)-[β-d-Glcp-(1→3)-β-d-Glcp-(1→3)]-α-d-Glcp-
(1→3)-α-d-Glcp-(1→ [47]. On the basis of amino acid homology with the respective exo genes, it can
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be concluded that succinyl- and pyruvyl-groups are conferred to salecan upon catalysis of SleA
(succinyl-transferase) and SleV (pyruvyltransferase), respectively, both of which are located in a 19.6-kb
gene cluster [48]. The exact positions of the salecan modifications remain to be determined.
3.1.4. Colonic Acid
Colonic acid (CA) or M-antigen is another class of pyruvylated EPS mostly found in
Enterobacteriaceae, including the majority of Escherichia coli strains. CA forms a loosely associated
saccharide mesh that coats the bacteria, often within biofilms. CA is composed of hexasaccharide
repeat units consisting of glucose, two fucoses, two galactoses, and glucuronic acid [49]. Additionally,
acetylation is found on fucose or/and galactose, while pyruvylation is found on the terminal galactose
only, with both modifications occurring non-stoichiometrically [32,50]. The overall structure of CA is
4,6Pyr-α-Galp-(1→4)-β-GlcpA-(1→3)-OAc-α-Galp-(1→3)-α-Fucp-(1→4)-OAc-OAc-α-Fucp-(1→3)-β-
Glc-(1→7)-α-Hepp-(1→6)-α-Glcp-(1→2)-α-Glcp-(1→3)-[α-Galp-(1→6]-α-Glcp-(1→3)-[α-HeppP-(1→7)]
-α-HeppP-(1→3)-[PEtN]α-Hepp-(1→5)-αKdop-(1→, where Kdo is 3-deoxy-d-manno-oct-2-ulosonic acid.
The genetic determinants for CA biosynthesis reside in a 19-gene wca (cps) cluster and are
tightly regulated by a complex signal transduction cascade [51]. The gene cluster encodes six
glycosyl-transferases, named WcaJ, WcaI, WcaE, WcaC, WcaL, and WcaA. Furthermore, a putative
pyruvyl-transferase (WcaK) is encoded next to two predicted acetyltransferases (WcaF and WcaB),
although there are up to three acetylation positions described in CA [50]. Interestingly, WcaF seems
to contribute to biofilm formation of the bacterium, since knocking out of this enzyme led to biofilm
disruption under in vitro conditions [52].
3.1.5. Unclassified Pyruvylated EPS
Up to now, there are several unclassified types of pyruvylated EPSs. The repeating unit structure
of the acidic EPS produced by a mucoid strain of Burkholderia cepacia isolated from a cystic fibrosis
patient was established as→3)-β-d-Galp-(1→3)-4,6Pyr-α-Galp-(1→ [53].
The freshwater biofilm isolate Pseudomonas strain 1.15 produces considerable amounts of an acidic
EPS that is composed of repeating units with the structure→4)-[4,6Pyr-α-d-Galp-(1→4)-β-d-GlcAp-
(1→3)-α-d-Galp-(O→3]-α-l-Fucp-(1→4)-α-l-Fucp-(1→3)-β-d-Glcp-(1→. Furthermore, of the four
different O-acetyl groups present in non-stoichiometric amounts, two were established to be on O-2 of
the 3-linked galactose and on O-2 of the 4-linked fucose [54].
Enterobacter amnigenus, a bacterium isolated from sugar beets, produces an EPS that is rich in
l-Fuc and has a terminal, pyruvylated α-d-Man residue [55].
The cystic fibrosis lung pathogen Inquilinus limosus produces two EPSs with unique structures—an
α-(1→2)-linked mannan and a β-(1→3)-linked glucan—both fully substituted with 4,6-linked pyruvate
ketals [56,57]. Cystic fibrosis is an autosomal recessive disorder and its mortality is due to chronic
microbial colonisation of the major airways that leads to exacerbation of pulmonary infection [58].
While Pseudomonas aeruginosa is one of the most threatening microbes colonizing cystic fibrosis lungs,
the EPS of I. limosus is suspected to play a role in the pathogenesis of the disease.
The bacterium Azorhizobium caulinodans produces a linear homopolysaccharide-type EPS composed
ofα-(1→3)-linked 4,6Pyr-d-Gal residues. The bacterium undergoes a symbiotic interaction with Sesbania
rostrata as a legume host plant, which results in the development of root nodules, accompanied by a
massive production of H2O2. In situ H2O2 localization demonstrated that increased EPS production
during early stages of invasion prevents the incorporation of H2O2 inside the bacteria, suggesting a
role for EPS in protecting the microsymbiont against H2O2 [59].
A special K-antigen-like EPS is found in the marine bacterium Cobetia marina DSMZ 4741, with its
repeating unit composed of ribose and pyruvylated Kdo [60].
Within the EPS structure of the lactic acid bacterium Pediococcus pentosaceus LP28, a pyruvate
modification was described to occur on one of the four constituting monosaccharides (Glc, Gal, Man,
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and GlcNAc) [61]. The EPS biosynthetic gene cluster consists of 12 ORFs containing a priming enzyme,
five glycosyltransferases, and a putative polysaccharide: pyruvyltransferase [61].
EPSs produced by an Erwinia spp. in association with the bacterium Coniothyrium zuluense are
linked to a fungal canker disease of Eucalyptus [62]. One of these EPSs is that of Erwinia stewartii;
another is that of Erwinia futululu, whose structures are identical except for the replacement of one
terminal Glc residue by 4,6Pyr-Galp in the latter, yielding→3)-β-d-Galp-(1→3)[4,6Pyr-α-d-Galp-(1→4)-
β-d-GlcpA-(1→4)][β-d-Glcp-(1→6)]-α-d-Galp-(1→6)-β-d-Glcp-(1→ [63].
Agrobacterium radiobacter (ATCC 53271) produces an anionic EPS that gives aqueous dispersions,
exhibiting high viscosity at low concentrations. The A. radiobacter EPS is composed of a complex
heptadekasaccharide repeating unit, which exposes a subterminal 4,6Pyr-α-d-Glc residue on each of
the two identical tetraglycosyl branches [64].
Methylobacterium sp. is a slime-forming bacterium isolated from a Finnish paper
machine, which is a high EPS producer. Its EPS repeating unit has the structure
→3)-4,6Pyr-α-d-Galp-(1→3)-4,6Pyr-α-d-Galp-(1→3)-α-d-Galp-(1→ [65].
The marine bacterium Alteromonas macleodii subsp. fijiensis isolated from deep-sea hydrothermal
vents displays a pyruvylated mannose in its EPS hexasaccharide repeating unit structure
→4)-β-d-Glcp-(1→4)[4,6Pyr-β-d-Manlp-(1→4)-β-d-GlcpA-(1→3)-α-d-GlcpA-(1→3)]α-d-GalpA-(1→4)-
α-d-Galp-(1→ [66]. Aside from its use in the food industry, this marine polymer has been suggested to
be used for the treatment of cardiovascular diseases and bone healing [67].
3.2. Capsular Polysaccharides
Capsular polysaccharides (CPSs) are also part of the glycocalyx but, in contrast to EPSs, are
covalently connected to the bacterial cell surface via membrane phospholipids [24]. Because of their
prominent cellular localization, CPSs are the first interaction zone of bacteria with the host immune
system, and thus are important virulence factors of many bacteria. Very often, encapsulated bacteria
are pathogenic, whereas capsule-deficient isolates are not [68]. Hence, CPSs are frequently used for the
production of polysaccharide conjugate vaccines [69].
Bacterial capsules are formed primarily from long-chain polysaccharides with repeat-unit
structures. A given bacterial species can produce a range of CPSs with different structures, and
these aid in distinguishing isolates by serotyping [68]. The widespread occurrence and the high
structural differences of CPSs are reflected by 84 capsular serotypes (K-antigens) found alone in E.
coli strains. Essentially, there are four groups of capsules [70]. Group I- and IV-CPS, which are often
found in organisms leading to gastrointestinal diseases, use the Wzx/Wzy-dependent export pathway
and their biosynthesis proceeds on a polyprenol linker. Capsules from groups II and III use the
ABC-transporter export pathway and are frequently present in mucosal pathogens such as Neisseria
meningitidis. Interestingly, a CPS attached via a novel β-linked poly-3-deoxy-d-manno-oct-2-ulosonic
acid linker to the phospholipid lyso-phosphatidylglycerol is present, which in earlier studies was
described as a diacylglycerol because of hydrolysis experiments [68].
3.2.1. Streptococcus pneumoniae CPS
Streptococcus pneumoniae (pneumococcus) is a leading cause of bacterial-induced pneumonia,
meningitis, and bacteraemia globally [71]. Prevnar 13, the most broadly protective pneumococcal
conjugate vaccine, is composed of 13 protein-polysaccharide conjugates consisting of pneumococcal
CPS serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F—each individually linked to the
genetically inactivated diphtheria toxoid CRM197. Currently, approaches on the basis of biocon-jugation
and glycosylation engineering are being pursued as manufacturing alternatives to enable the production
of vaccines with higher protection rates, especially in children [69,72,73].
S. pneumonia CPS serotype 4 (ST4) is a prevalent serotype in vaccine formulations,
containing 2,3-pyruvate ketal on the Gal residue of its repeating units—with the structure
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→3)-β-d-ManpNAc-β-(1→3)-α-l-FucpNAc-(1→3)-GalpNAc-α-(1→4)-2,3Pyr-α-d-Gal-(1→—which has
been shown to be the key component of its specific immunogenic motif [74].
Thus, the pyruvate modification is essential for designing minimal synthetic carbohydrate vaccines
for ST4, as vaccine formulations without pyruvylation would not recognize the natural CPS [8]. It is,
therefore, highly recommended to include the pyruvate ketal epitope in glycoconjugate vaccines [16].
3.2.2. Acinetobacter baumannii CPS
A clinically relevant producer of CPS is the opportunistic pathogen Acinetobacter baumannii,
which triggers infections in immunocompromised patients causing severe nosocomial, bloodstream,
pneumonia, urinary tract infections, and septicaemia [75]. Its clinical importance is related to its low
susceptibility towards most of the antibiotics commonly used [76].
There are seven different capsule loci—KL1, KL2, KL4 KL6, KL7, KL8, KL9—in A. baumannii
genomes. Five of these were found in clonal group 2, whereas two were found in clonal group 1, indicating
that isolates with developing antibiotic resistance have a lot of variations of these loci [77]. The K4
CPS of isolate D78, which is a multiple antibiotic resistant strain, contains the KL4 cluster. The KL4
CPS backbone repeating structure is composed of a trisaccharide of α-N-acetyl-d-quinovosamine
(d-QuipNAc), α-N-acetyl-d-galactosamine uronic acid (α-d-GalpNAcA), and α-d-GalpNAc, which
contains a branching 4,6-pyruvylated GalNAc residue. The trisaccharide structure was elucidated
as→4)[4,6Pyr-α-d-GalpNAc-(1→6)]-α-d-GalpNAc-(1→4)-α-d-GalpNAcA-(1→3)-α-d-QuipNAc-(1→.
The pyruvate ketal is predicted to be transferred by the putative pyruvyltransferase PtrA, however,
without biochemical evidence [78].
3.2.3. Klebsiella CPSs
Pyrogenic liver abscess-causing Klebsiella pneumoniae produces a CPS,
which is composed of trisaccharide repeating units with the structure
→4)-β-d-Glc-(1→4)-2,3(S)Pyr-β-d-GlcA-(1→4)-β-l-Fuc-(1→, in which each glucuronic acid
residue is pyruvylated and additional acetylation of the fucose residue occurs at the C2-OH or
C3-OH [79]. The CPS induces secretion of tumour necrosis factor and interleukin-6 by macrophages
through the Toll-like receptor 4 dependent pathway, which is abandoned when pyruvylation is missing
in the trisaccharide. This finding indicates that pyruvylation on glycoconjugates may be relevant for
immune system stimulation [80]. Previously, the recognition of pyruvylated CPS from K. pneumoniae
by IgM antibodies has been described [81].
The structures of several other pyruvylated Klebsiella CPS structures have been elucidated, however,
without any functional information.
The structure of the CPS from Klebsiella serotype K14 was the first report on the rare case of
a Klebsiella polysaccharide to contain a Galf residue. The repeating hexasaccharide structure was
shown to terminate with a glucose residue carrying a 4,6Pyr modification—→4)-β-d-GlcpA-(1→3)-
β-d-Galf -(1→3)-β-d-Glcp-(1→4)[4,6Pyr-β-d-Glcp-(1→2)][α-l-Rha(1→3)]β-d-Manp-(1→ [82].
Also in the doubly pyruvylated CPS of Klebsiella K12, Galf residues are found; its repeating unit
has the structure 5,6Pyr-β-d-Galf -(1→4)-β-d-GlcpA-(1→3)-β-d-Galf -(1→6)-β-d-Glcp-(1→3)-α-l-Rha-
(1→3)-α-d-Galp-(1→2)[5,6Pyr-β-d-Galf -(1→4)-β-d-GlcpA-(1→3)]-β-d-Galf -(1→6)-β-d-Glcp-(1→3)-α-l
-Rha-(1→3)-α-d-Galp [83].
The structure of the CPS from Klebsiella serotype K70 is composed of linear hexasaccharide
repeating units that contain a Pyr group attached to a (1→2)-linked α-l-Rha residue in every second
repeating unit. The full structure of the Klebsiella K70 CPS is→4)-β-d-GlcpA-(1→4)-α-l-Rhap-(1→2)-α-l-
Rhap-(1→2)-α-d-Glcp-(1→3)-β-d-Galp-(1→2)-3,4Pyr-α-l-Rhap(1→ [84].
The Klebsiella serotype K64 CPS consists of hexasaccharide repeating units, composed
of a →4)-α-d-GlcpA-(1→3)-α-d-Manp-(1→3)-β-d-Galp-(1→4)-α-d-Manp-(1→ backbone with a
4,6Pyr-β-d-Galp and a l-Rha residue attached to the (1→4)-linked α-d-Manp residue at O-2 and
O-3, respectively; the repeating unit further contains one O-acetyl substituent [85].
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The structure of the CPS from Klebsiella type K46 consists of a hexasaccharide repeating unit,
which is unique in having a 4,6Pyr residue on a lateral, but non-terminal sugar residue—[β-d-Glcp-
(1→3)-4,6Pyr-β-d-Manp-(1→4)]→3)-α-d-GlcpA-(1→3)-α-d-Manp-(1→3)-α-d-Galp-(1→ [86].
The Klebsiella K33 CPS revealed to be a tetrasaccharide alditol with the structure
β-d-Glcp-(1→4)[3,4Pyr-β-d-Galp-(1→6)]-β-d-Manp-(1→2)-Ery-ol, where Ery-ol is erythritol [87].
Interestingly, there are two human monoclonal macroglobulins, IgMWEA and IgMMAY [88], which
show specificity for Klebsiella polysaccharides containing 3,4-(K30, K33) and 4,6-(K21, K11) pyruvylated
d-Gal in a pH-dependent manner and with differences in co-precipitation in dependence of the number
of the CPS repeating units (i.e., CPS length) [81]. Of note, agar, which has an internal 4,6Pyr-Gal residue
in its repeating unit, cross-reacts with IgMWEA [81].
Klebsiella rhinoscleromatis is a heavily capsulated bacterium that possesses a
K3-type capsule. The repeating unit of K3 is a pentasaccharide with the structure
→2)-4,6-S-Pyr-α-d-Man-(1→4)-α-d-GalA-(1→3)-α-d-Man-(1→2)-α-d-Man-(1→3)-β-d-Gal-(1→ [89].
The Klebsiella K3 capsule has been shown to be one of the few Klebsiella K types that are able to bind to
the eukaryotic mannose receptor [90].
3.2.4. Bacteroides fragilis CPS A
Bacteroides fragilis is an opportunistic anaerobe, most frequently isolated from
intra-abdominal abscesses [7,91–93]. Its most prominent CPS—CPS A—is composed of
tetrasaccharide repeating units with the structure→4)-α-d-2-N-acetylamido-4-amino-galactopyranose
(AAdGalp)-(1→3)-4,6PyrGalp-(1→3)-[β-d-Galf -(1→3)]α-d-GalpNAc-(1→) [94]. CPS A has been shown
to have a tremendous effect on the immune system of a mammalian host and to be internalized by
antigen-presenting cells [7]. Upon genetic deletion of CPS A, the abscess-inducing capability of the
bacterium was drastically reduced [93]. CPS A from B. fragilis caught recent interest as a carbohydrate
antigen to be used in vaccine formulations instead of conventional cationic proteins such as bovine
serum albumin (BSA) and keyhole limpet hemocyanin (KHL) [92].
CPS A biosynthesis is encoded by a single ~10.7-kb gene locus on the B. fragilis genome [93], and
predictably employs a Wzx/Wzy-dependent pathway, on the basis of genomic evidence (Figure 3).
The gene locus encodes four transferases (WcfN, WcfP, WcfQ, and WcfS), where WcfS is responsible
for the transfer of the AAdGalp residue from its nucleotide activator to an undp-P-lipid carrier as the
first step in the synthesis of the CPS A repeating unit, and WcfR is responsible for the prior transfer of
the amino group on the AdGalp residue to yield AAdGalp, which is crucial for virulence. A recent
in vitro study of the individual enzymatic steps involved in the repeating unit biosynthesis of CPS A
yielded first insight into the sugar pyruvylation reaction, with phosphoenolpyruvate (PEP) serving as
a donor substrate. There is evidence that pyruvylation occurs on the undp-PP-linked disaccharide
repeat unit precursor prior to tetrasaccharide repeat completion, export, and polymerization by a
Wzx/Wzy-dependent system [7]. The pyruvyltransferase WcfO from the CPS A biosynthesis of
B. fragilis [7] is one of the few biochemically characterized enzyme ketal-pyruvyltransferases (for
details, see Section 5.1.2).
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Figure 3. Scheme of capsular polysaccharide (CPS) A biosynthesis in Bacteroides fragilis.
The pyruvylation step occurs in the cytoplasm at the stage of the lipid-PP-linked RU precursor.
Pyruvylation (WcfO) is indicated by a star. Notably, in contrast to succinoglycan biosynthesis (Figure 2),
pyruvylation of the internal Galp of the RU needs to proceed prior to completion of the lipid-PP-linked
tetrasaccharide repeat. RU: repeating unit. Monosaccharide symbols are shown according to the
Symbol Nomenclature for Glycans (SNFG) [45].
3.2.5. Rhodococcus equi CPS
The bacterial horse pathogen Rhodococcus equi elaborates a serotype-specific CPS that
functions as a potential virulence factor [94]. This CPS is a high-molecular-weight
acidic polymer composed of d-Glc, d-Man, pyruvate, and 5-amino-3,5-dideoxynonulosonic
acid (rhodaminic acid, Rho) in the molar ratio of 2:1:1:1. Structural analysis revealed
that the CPS consists of linear pyruvylated tetra-saccharide repeats with the structure
→3)-β-d-Manp-(1→4)-β-d-Glcp-(1→4)-α-d-Glcp-(1→4)-7,9Pyr-α-RhoAmAc-(2→ [95].
3.3. “Non-Classical” Secondary Cell Wall Glycopolymers with Pyruvylated β-d-ManNAc
Anionic secondary cell wall glycopolymers (SCWPs)—among which the wall teichoic acids
(WTA) and the lipoteichoic acids (LTA) are best known—serve as a rich source for both validated
and unexploited pathways that are essential for bacterial virulence and survival [96–98]. Pyruvylated
SCPWs are a less-investigated class of peptidoglycan-attached SCWPs that arouse interest because
they can be hijacked for a predictably widespread mechanism of protein cell surface display in
Gram-positive bacteria [99]. These SCWPs are 5–20 kDa in size, composed of species–specific
repeats, but lack repetitive alditol phosphates and phosphodiester bonds typical of WTAs and
LTAs [100–102]—hence the terminology “non-classical” SCWPs. Importantly, they contain a 4,6-ketal
pyruvylated β-d-ManNAc residue (4,6Pyr-β-d-ManNAc), imparting a negative charge and serving
as a specific cell wall ligand for S-layer homology (SLH) domains usually present in triplicate at
the termini of cell surface proteins [99,103,104]. Among such proteins are S-layer proteins, which
self-assemble into 2D crystalline arrays on the bacterial cell surface [105,106]; they are important
for many biological functions such as maintenance of cell integrity, enzyme display, protection to
phagocytosis, and interactions with the host and its immune system [107]. Because of their unique 2D
crystallization ability, S-layer proteins are of great interest for drug delivery, biomaterial engineering,
and vaccine development [108].
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Fifty-four thousand specific hits within the conserved protein domain family SLH (pfam00395),
showing up most prevalent in the Firmicutes, Cyanobacteria, and Actinobacteria phyla of bacteria,
emphasize the prevalence of this protein domain. Several bacteria synthesizing a suite of SLH proteins
contain pyruvate in their cell wall and have a pyruvyltransferase CsaB ortholog [99,109], which
indicates a functional coupling of SLH domains and SCWP pyruvylation.
The best-known pyruvylated SCWPs are those from B. anthracis and B. cereus strains [14,110,
111], and from P. alvei [15]. The most evident difference between these SCWPs is the presence
of 4,6Pyr-β-d-ManNAc exclusively at the terminal repeat in the former SCWPs, while in that of
P. alvei, the β-d-ManNAc of each repeat is pyruvylated. This might explain the essentiality of the
pyruvyltransferase CsaB in the latter organism [109]. It is conceivable to assume that mono- versus
poly-pyruvylation of β-d-ManNAc has implications with regard to the biosynthetic pathway of the
respective SCWP, especially the mode of activity of the cognate pyruvyltransferase (compare with
Section 5.1.1.).
The genetic determinants and assembly reactions of pyruvylated SCWPs are only beginning to be
discovered. Pyruvylated SCWPs are peptidoglycan-linked polymers, as are WTAs [97,98], however,
they lack experimental evidence of a comparable biosynthetic route.
3.3.1. Bacillus anthracis SCWP
The B. anthracis SCWP is composed of→4)-β-ManNAc-(1→4)-β-GlcNAc-(1→6)-α-GlcNAc-(1→
trisaccharide repeats [102] with strain-dependent galactosylation occurring at the GlcNAc residues, and
are bound to peptidoglycan via a murein linkage unit [14,112]. Notably this SCWP contains a modified
terminal repeat with the structure 4,6-Pyr-β-ManNAc-(1→4)-[3OAc-β-GlcNAc-(1→6)]β-GalN-(1→4)
that is pyruvylated and O-acetylated [14].
A scenario for the biosynthesis of the B. anthracis SCWP has been proposed [113] on the basis of
the bioinformatic prediction of four contributing genomic gene clusters and their genetic manipulation,
accompanied with analyses of mutant cells. The S-layer gene cluster [99,112–114] encodes, among
others, components for pyruvylation (B. anthracis CsaB) and O-acetylation of the terminal SCWP
trisaccharide, and a Wzy-like protein. The other gene clusters play predicted roles in the formation
of lipid-linked precursors of the murein linkage unit and the trisaccharide repeat [112,114–116].
The SCWP biosynthesis model proposes the separate assembly of different undp-PP-linked building
blocks in the cytoplasm—the murein linkage unit, trisaccharide repeat, and terminal modified
trisaccharide [113]—followed by the individual translocation across the cytoplasmic membrane via Wzx,
followed by SCWP polymerization at the outer face of the membrane involving Wzy [113]. This model
does not explain how the different building block precursors converge and how pyruvylation of
β-d-ManNAc is elaborated. A recent study identified PatB1 as O-acetyl-transferase in the terminal repeat
biosynthesis of B. cereus SCWP, proposing an extracellular O-acetylation mechanism [117]. Previously,
it was surmised that the modifications at the terminal trisaccharide emerge post-polymerization and
ligation to peptidoglycan [14].
B. anthracis CsaB is not essential for survival, but it is important for the pathogenesis of infection;
ΔcsaB mutants lacking SCWP pyruvylation fail to retain SLH-domain containing proteins in the cell
wall, leading to an atypical cell morphology [99,118]. Of note, in addition to SCWP [14], the B. anthracis
cell wall contains a polyglycerol phosphate LTA [119] and a poly-γ-d-glutamic acid capsule [101], which
could support the cell wall integrity in a strain devoid of pyruvylation providing the anionic character.
3.3.2. Paenibacillus alvei SCWP
The SCWP of P. alvei consists of →3)-β-d-ManNAc-(1→4)-β-d-GlcNAc-(1→ repeats, where
β-d-ManpNAc of each disaccharide is modified with 4,6-linked pyruvate ketal [15,120]. Notably, an
identical SCWP composition was found in the S-layer carrying Lysinibacillus sphaericus CCM 2177,
where on average, every second β-d-ManNAc residue contains a 4,6Pyr-modification [121].
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P. alvei possesses a polycistronic SCWP biosynthesis gene cluster comprised of csaB, tagA, tagO,
two SLH-protein encoding genes—slhA and spaA—and two ORFs of unknown function [109,122].
For SCWP assembly in P. alvei, distinct enzymatic steps have been investigated [109]. The bacterium
utilizes the subsequent TagO [123] and TagA [124,125] catalysed reactions—typically involved in WTA
biosynthesis to produce the undp-PP-bound murein linkage unit [97,126,127] for the biosynthesis of
the lipid-linked disaccharide substrate needed to generate the repeat unit backbone of its SCWP [15].
Pyruvylation with PEP as donor substrate was experimentally determined in vitro at the stage of the
lipid-linked disaccharide repeat precursor [109] (see Section 5.1.1.).
In P. alvei, no viable deletion mutant could be obtained of either tagO, tagA, or csaB [109]—each of
which is located on the P. alvei genome as a single copy—indicating essentiality of the pyruvylated
SCWP for the bacterium. This might be explained by the presence of pyruvylated SCWP as exclusive
anionic SCWP in P. alvei and may be supportive of the necessity of at least one anionic polymer in the
Gram-positive cell wall [128,129].
3.3.3. Cell Wall Polysaccharide of Paenibacillus polymyxa
Paenibacillus (previously Bacillus) polymyxa AHU 1385 was among the first bacteria for which
a pyruvylated ManNAc residue was described [130]. The pyruvylated epitope is contained
in a →3)-4,6Pyr-ManNAc-(1→4)-GlcNAc-(1→-repeating unit of an SCWP that is presumably
peptidoglycan-linked. However, its clear that assignment to a specific SCWP class has not yet
been reported, nor have any functional implications such as protein binding. Notably, P. polymyxa does
not possess an S-layer.
3.4. SCWPs with Other Pyruvylated Sugar Epitopes
Some SCWPs containing pyruvylated epitopes other than β-d-ManNAc have been reported from
the phylum Actinobacteria. There, sugar pyruvylation mainly serves as a chemotaxonomic marker of
distinct strains, without further knowledge of putative associated functions.
3.4.1. SCWPs from the Genus Promicromonospora
Two strains of the genus Promicromonospora are recently uncovered examples of bacteria, which
possess non-phosphorylated anionic glycopolymers (“non-classical” SCWPs) with pyruvic acid acetals
of R-configuration in their cell wall [131]. Members of this genus produce a mycelium that fragments
into rod-shaped or coccoid elements and are characterised according to different genus-specific
chemotaxonomic markers, including the peptidoglycan of the A4α type [132].
The type strain Promicromonospora citrea 665T contains two “non-classical” SCWPs, namely
a 2-keto-3-deoxy-d-glycero-d-galacto-nononic acid (Kdn)-teichulosonic acid containing polymer
with the repeating unit structure →6)-α-d-Glcp(1→6)-α-d-Glcp3SO3−-(1→4)-α-7,9Pyr-Kdn-(2→,
where the Kdn residue is 7,9-pyruvylated, and a galactan with the repeating unit structure
→3)-α-4,6Pyr-d-Galp-2OAc-(1→, including 4,6-pyruvylation of Gal.
The cell wall of Promicromonospora sp. VKM Ac-1028 contains a teichuronic acid-like structure
with the repeating unit →6)-α-d-Glcp-(1→4)-β-2,3Pyr-d-GlcpA-(1→, where glucuronic acid is
2,3-pyruvylated [131].
3.4.2. Teichoic Acids from the Genus Nocardiopsis
The first description of a pyruvate ketal modification on a classical teichoic acid (TA) was reported
in Nocardiopsis strains, a widespread group among the Actinobacteria [133]. The genus Nocardiopsis is of
pharmaceutical and biotechnological interest because of its ability to produce a variety of secondary
metabolites—accounting for its wide range of biological activities—and, thus, holds promises as a
source of novel bioactive compounds [134].
The major TA of Nocardiopsis metallicus VKM Ac-2522T is a 1,5-poly(ribitol phosphate) TA, with
each ribitol unit carrying a pyruvate ketal group at positions 2 and 4. The major TA of N. halotolerans
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is a poly(glycerol phosphate-N-acetyl-β-galactosaminylglycerol phosphate) structure in which the
GalNAc residue carries a 4,6-ketal pyruvate modification.
3.4.3. Teichoic Acids of Brevibacterium iodinum
Brevibacterium iodinum VKM Ac-2106 produces two distinct WTAs, namely a mannitol-WTA and
a glycerol-TA, present in minor amounts. Mannitol-WTA is a 1,6-poly(mannitol phosphate) bearing
β-d-Glcp residues at the C-2 of mannitol (Man-ol) and, optionally, 4,5-S-Pyr residues. Glycerol-WTA is
a 1,3-poly(glycerol phosphate) substituted at the C-2 of glycerol by α-d-GalpNAc residues bearing
4,6-R-Pyr [135].
3.5. Lipopolysaccharides and Lipooligosaccharides
Lipopolysaccharides (LPSs) of Gram-negative bacteria are a unique family of glycolipids based on a
highly conserved lipid moiety known as lipid A. These molecules are produced by most Gram-negative
bacteria, in which they play important roles in the integrity of the outer-membrane permeability
barrier and participate extensively in the host–pathogen interplay [136,137]. Complete LPSs have a
three-domain molecule architecture; the two-domain variants without an O-antigenic polysaccharide
(O-PS) are termed lipooligosaccharides (LOSs) [138]. Lipid A is the hydrophobic anchor of LPSs;
it is a unique phosphoglycolipid containing glucosamine (GlcN) residues, which are present as
β-(1→6)-linked dimers. The disaccharide contains phosphoryl groups and (R)-3-hydroxy fatty acids
in ester and amide linkages. Variations in the fine structure can arise from the type of hexosamine
present, the degree of phosphorylation, the presence of phosphate substituents, and, importantly,
in the nature, chain length, number, and position of the acyl groups. Lipid A is glycosylated with
a core oligosaccharide (core OS)—typically containing Kdo, a signature molecule of LPS [139], and
heptose residues, which may provide an attachment site for a long-chain O-PS of varying repeating
unit composition. The O-PS provides a major cellular antigen (O-antigen) used for serological typing
of clinical isolates of a given species. Notably, the O-antigen is expressed by most of the clinically
relevant strains and is an important phage receptor; LOS, in contrast has been found to be expressed
by a group of Gram-negatives that colonize genital and respiratory mucosal surfaces [140].
3.5.1. Pseudomonas stutzeri
Analysis of the LPS of Pseudomonas stutzeri OX1 revealed a novel type of highly negatively
charged LOS, containing two 4,6-linked pyruvate ketals linked to N-acetylglucosamine and glucose,
independently [4]. The overall LOS structure has been determined to be 4,6(S)Pyr-β-Glc-(1→3)[4,6(S)Pyr-
β-GlcNAc](1→4)GalNAc(1→3)-Hep7Cm2P4P-(1→3)-Hep2P4P-(1→5)[Kdo-(2→4)]Kdo-(2→6)-β-
GlcN4P-(1→6)-GlcN1P, where P represents a phosphate group and Cm is carbamoyl. P. stutzeri OX1
was isolated from the activated sludge of a wastewater treatment plant, where unusual metabolic
capabilities for the degradation of aromatic hydrocarbons were found. Pyruvate residues might be
used to block elongation of the LPS chain to yield an LOS. This would lead to a less hydrophilic cellular
surface, indicating an adaptive response of P. stutzeri OX1 to a hydrocarbon-containing environment [4].
3.5.2. Providencia alcalifaciens
Bacteria of the genus Providencia are opportunistic human pathogens that cause intestinal and
urinary tract infections. The O-antigen-based serological classification scheme of Providencia alcalifaciens,
Providencia rustigianii, and Providencia stuartii includes 63 O-serogroups [141], most of which are acidic.
Complex core structures have been elucidated in several Providencia O-serogroups [142,143].
P. alcalifaciens O19 differs in its O-PS from other Providencia strains. The O-PS
repeat contains a 4,6-pyruvylated GlcNAc residue and has the complete structure
→2)-β-Fuc3NAc4Ac-(1→3)-4,6(S)Pyr-α-GlcNAc-(1→4)-α-Gal-(1→4)-β-Gal-(1→3)-β-GlcNAc-(1→.
In the NMR spectra of the oligosaccharide, signals of the methyl group of pyruvic acid have been
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observed and the presence of pyruvic acid in two thirds of the O-units in the polysaccharide has been
proven [141].
3.5.3. Shigella dysenteriae
Shigella dysenteriae is an aetiological agent of various intestinal disorders, including shigellosis.
The strains of this bacterium are serologically heterogeneous because of the diversity of the structures
of their O-antigens [144].
The structure of the S. dysenteriae type 10 O-antigen has been revised by Perepelov et al.
in order to account for the acid-labile pyruvate modification that has been lost in a previous
investigation due to acidic treatment of the sample. The full O-PS structure has been elucidated to be
→2)-4,6(S)Pyr-β-d-Manp-(1→3)-α-d-ManpNAc-(1→3)-β-l-Rhap-(1→4)-α-d-GlcpNAc-(1→ [145].
3.5.4. Raoultella terrigena
The enterobacterium Raoultella terrigena is another bacterium that carries a pyruvic
acid modification on its O-PS β-Man residue, located at the O-4 and O-6 positions [146].
The structure of the repeating unit of the O-PS has been determined by means of chemical
and spectroscopic methods and found to be a linear tetrasaccharide with the structure
→2)-4,6(S)-Pyr-β-d-Manp-(1→3)-α-d-ManpNAc-(1→3)-β-l-Rhap-(1→4)-α-d-GlcpNAc-(1→ [146],
which is identical to that of S. dysenteriae type 10 [145].
3.5.5. Proteus mirabilis
The O-PS repeating unit of Proteus mirabilis O16 has been established to be
→3)-β-d-GlcpNAc-(1→3)-4,6-R-Pyr-α-d-GalpNAc1→4)-α-d-GalpA-(1→3)-α-l-Rhap2Ac-(1→ [147].
This structure is significantly different from the O-PS structures of other Proteus spp. from the
serogroup O19, such as Proteus vulgaris, Proteus hauseri, and Proteus penneri strains, and thus was a key
for the reclassification of various Proteus strains.
3.5.6. Cobetia pacifica
The O-PS form the LPS of Cobetia pacifica KMM 3878—an aquatic isolate form
Japan—is composed of sulphated and pyruvylated trisaccharide repeats with the structure
→4)-β-d-Gal-2,3-SO3H-(1→6)-β-d-Gal-3,4-S-Pyr-(1→6)-β-d-Gal-(1→ [148].
3.6. Mycobacterial Glycolipids with Pyruvate
Mycobacteria contain a variety of glycolipids, including, among others, acylated
glucose, acylated trehalose, sulfatides, mannophosphoinositides, and glycopeptidolipids [149].
A crude glycolipid fraction from Mycobacterium smegmatis ATCC 356 obtained by
ethanolic extraction and silica gel chromatography revealed the presence of hitherto
unknown anionic glycolipids [150]. The corresponding glycan moiety has the structure
4,6Pyr-3-O-Me-β-d-Glcp-(1→3)-4,6Pyr-β-d-Glcp-(1→4)-β-d-Glcp-(1→6)-β-d-Glcp-(1→1)-α-d-Glc.
Members of the Mycobacterium avium–Mycobacterium intracellulare (MAI) complex are typeable on
the basis of their specific antigenic glycolipid. For instance, the dominant epitope of the MAI serovar
8-specific glycopeptidolipid is a terminal 4,6Pyr-O-Me-α-d-Glcp unit, whereas that of the MAI serovar
21 has the same terminal pyruvylated glucose devoid of the 3-methoxy group [151]. Healthy individuals
of some populations are carriers of antibodies that are specific to these pyruvylated epitopes on the
glycopeptidolipids. It is currently unclear, if the antibody reflects previous experience with one or both
of these serovars or whether some other common cross-reacting pyruvylated environmental antigen is
involved [151]. However, this finding might have protective implications against mycobacterioses and
other infectious diseases.
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3.7. Pyruvylated Glycoconjugates in Eukaryotes
3.7.1. Eukaryotic Glycolipids
Information on pyruvylated glycoconjugates in eukaryotes is scarce in comparison to their
description in bacteria. It is currently not clear whether this reflects the natural distribution of
pyruvylation or if pyruvylation on eukaryotic glycoconjugates has escaped detection. Notably,
pyruvylation has so far not been detected in humans.
An “exotic” example of a pyruvylated eukaryotic glycoconjugate is the
phosphonoglyco-sphingolipid containing pyruvylated galactose in the nerve fibres of the sea hare
Aplysia kurodai. The glycan structure of this phosphonoglycosphingolipid is 3,4Pyr-β-Gal-(1→3)-α-
GalNAc-(1→3)-α-Fuc-(1→)-2-aminoethylphosphonyl-Fuc-(1→6)-β-Gal-(1→4)-Glc-(l→ [152].
3.7.2. N-Linked Glycans in Yeast
Yeast species are known for the production of high- or oligo-mannosidic N-glycans that are
displayed on various cell surface proteins [153]. In several yeast species (e.g., Saccharomyces cerevisiae,
Candida albicans, Pichia holstii, and Pichia pastoris), phosphate groups or, to a lesser extent, sialic acids
present on these extracellular glycans provide the necessary negative cell surface charge [153–155].
S. pombe is a notable example of a yeast whose net negative surface charge is neither conferred
by phosphate nor by sialic acid. Instead, the N-linked galactomannans of S. pombe have pyruvylated
β-Gal-(1→3)-(PvGal) caps on a portion of the α-Gal-(1→2)-residues in their outer N-glycan chains [156].
S. pombe lacks the ER Man9-α-mannosidase function as known from, for example, Saccharomyces
cerevisiae. Therefore, it adds further mannose and galactose residues to the common N-glycan core
structures, yielding galactomannans [157–159]. At least five different genes are required to synthesize
the PvGal epitope. It is assumed that 4,6Pyr-β-Gal-(1→3) synthesis is carried out by a coordinated
enzymatic system in which the β-Gal-(1→3) residues are first added to the S. pombe galactomannans
and subsequently pyruvylated by the pyruvyltransferase Pvg1p [3] (see Section 5.1.3.). However,
the complete mechanism for PvGal biosynthesis is currently unknown [3].
4,6Pyr-β-Gal is predicted to be the only contributor to the net negative cell surface charge of yeast,
as disruption of the pvg1+ gene resulted in charge abolishment [160].
3.7.3. Pyruvylated Galactans of Algae
Pyruvylated galactan sulphates are often found in red algal polysaccharides, which generally
contain 3-substituted 4,6Pyr-d-Galp residues. Among these galactans is that of Palisada flagellifera,
which represents a highly complex structure with at least 18 different types of derivatives that are
found mostly pyruvylated, 2-sulfated, and 6-methylated [161]. Another galactan is that of Solieria
chordalis, the structure of which remains unknown but was shown to have high immunostimulating
potential [162]. Other examples include the carragenans from Australian red algae of the family
Solieriaceae [10] and galactans of the red seaweed Cryptonemia crenulata [13].
Examples of green algae include the highly pyruvylated and sulfated galactans from tropical
green seaweeds of the order Bryopsidalesor, which have anticoagulant activity [11], such as
that of Codium divaricatum with the structure Galp-(4SO4)-(1→3)-Galp-(1→3)-Galp-(1→3)-Galp and
3,4Pyr-Galp-(6SO4)-(1→3)-Galp [12].
3.7.4. Pyruvylated Proteoglycan
The marine sponge Microcionia prolifera produces a pyruvylated adhesion proteoglycan with
the structure 4,6Pyr-β-Gal-(l→4)-β-GlcNAc-(l→3)-Fuc-(1→ that is involved in species-specific cell
re-aggregation [163].
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4. Methods for Research of Pyruvylated Glycoconjugates
4.1. Isolation of Pyruvylated Bacterial Glycoconjugates
Several protocols for the isolation of glycoconjugates are in use; however, there is no specific
general protocol for pyruvylated glycoconjugates. The procedures are strongly dependent on the
source of the glycoconjugate—with a special emphasis on the cell wall architecture (i.e., Gram-positive
versus Gram–negative bacteria)—and the class of glycoconjugate. Further, for each studied organism,
the extraction protocol needs to be optimised. Because of the chemical nature of the acid-labile pyruvate
entity, as the only commonality, for the isolation of pyruvylated glycoconjugates, acidic conditions
should be avoided to prevent the loss of pyruvate [9,100,145].
For the extraction of EPS, for instance, the types of interactions by which the EPS matrix is
created need to be taken into account, including variable extents of electrostatic interactions, van der
Waal forces, hydrogen bonds, and hydrophobic interactions [164]. In most cases, physical forces are
used to extract EPSs, such as centrifugation and filtration [28], stirring, pumping or shaking, heat
treatment, or sonication [164]. Chemical steps include alkaline treatment with NaOH, addition of
EDTA for removal of cations, addition of NaCl, use of ion exchange resins (e.g., Dowex), or enzymatic
treatment [63,165]. If proteases are used for break-down of co-isolated proteins, an O-deacetylation
step needs to be introduced to avoid the loss of putative acetyl groups on the EPS [55]. All mentioned
chemical additives increase the solubility of the EPS in the aqueous phase; to solubilise EPS with
hydrophobic portions, such as that from Klebsiella pneumoniae, detergents are necessary [166]. For the
precipitation of EPS from the aqueous phase, ethanol is routinely used [65]. To enhance the EPS yield,
often a combination of physical and chemical methods is applied [164].
For the extraction of CPS from Gram-negative bacteria, again, NaCl and EDTA are
recommended [167]. Other protocols for the release of CPS are based on heat treatment of cells
followed by precipitation of the CPS with acetone [80,90].
The isolation of SCWPs—classical and “non-classical” forms—is divided in two main steps:
the purification of the peptidoglycan sacculus, which includes treatment of cells with heat, SDS,
nuclease, and a protease such as trypsin, and extraction of SCWP by either ethanol precipitation
for WTAs, or hydrofluoric acid treatment followed by ethanol precipitation for “non-classical”
SCWPs [115,168,169]. The isolation of “non-classical” pyruvylated SCWP of B. anthracis was recently
described in detail [169].
The extraction of LPS and other cell surface polysaccharides has been described previously [170,
171]. Prior to extraction of LPS, pelleted Gram-negative bacteria are usually depleted from CPS by
aqueous washing [171]; most commonly, LPS is extracted [146,172,173] or, in the case of LOS, with
phenol/chloroform/petrol ether (PCP) [174,175]. The crude extracts are subsequently de-O/N-acylated
under mild acidic or basic conditions, with a preference for the latter. Further purification of the
samples can be achieved by size exclusion and/or ion exchange chromatography [176].
4.2. Pyruvate Analytics
4.2.1. Lectin Approach
Serum amyloid P component (SAP)—a normal plasma glycoprotein—has a Ca2+-dependent
binding specificity for 4,6Pyr-OMe-β-d-Galp (MOPDG) [177], and thus behaves like a lectin and may
be a useful probe for this epitope as present in the cell walls of bacteria and other organisms [178]. SAP
has been found to bind in vitro to K. rhinoscleromatis [89], the cell wall of which is known to contain
this particular pyruvylated epitope. Binding was shown to be less pronounced to X. campestris, which
contains a 4,6Pyr-Manp epitope [18], and no SAP bound to E. coli, which contains pyruvate 4,6-linked
to glucose or to S. pneumoniae type 4, which contains pyruvate 2,3-linked to Galp [74]. Binding of
SAP to those organisms, which it did recognise, was completely inhibited or reversed by millimolar
concentrations of free MOPDG.
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4.2.2. Biochemical Pyruvate Assays
A specifically developed colorimetric/fluorometric assay for ketal-pyruvate detection via enzymatic
oxidation has been incorporated in a recently introduced high throughput screening platform for the
structural analysis of novel EPS structures [179], which underlines the importance of pyruvylated
epitopes. The platform is based on ultra-high performance liquid chromatography coupled with
ultra-violet and electrospray ionization ion trap detection following EPS isolation.
A similar procedure for detection of free pyruvate is used in clinics. Pyruvate serves as an
important metabolite in the citric acid cycle for the screening of liver diseases and genetic disorders in
humans, as these are reflected by high pyruvate levels [180]. The procedure is based on the oxidation
of pyruvate by pyruvate oxidase in the presence of acetyl phosphate, which leads to the production of
CO2 and H2O2. The latter is detected via a fluorometric probe followed by a horseradish peroxidase
reaction, which leads to the formation of resorufin. Colour development can be detected at 570 nm,
and fluorescence at 530–540 nm for excitation and 585–595 nm for emission (Cayman pyruvate assay
kit: https://www.caymanchem.com/pdfs/700470.pdf).
Other methods for pyruvate detection stem from food analytics, as pyruvate is involved in
the degree of pungency of onions. Different methods are on the basis of the determination of total
2,4-dinitrophenylhydrazine-reacting carbonyls in a sample by photometric detection. Furthermore,
oxidation of reduced diphosphopyridine nucleotide (DPNH) by pyruvate can be measured in a coupled
reaction with lactic dehydrogenase. Decrease of the absorbance at 340 nm correlates with the oxidation
of DPNH and, therefore, the concentration of pyruvate [181,182].
Assaying pyruvylation reactions of monosaccharides using HPLC-based approaches is dependent
on the intended mode of detection. Frequently, specifically introduced saccharide modifications are
used for detection purposes. One prominent example is the chemical attachment of para-nitrophenol
(pNP) to the saccharides of interest for monitoring at 265 nm. To determine, for instance, the activity
of the yeast pyruvyltransferase Pvg1p, the pyruvylated product species was separated from the
unpyruvylated educt species using a COSMOSIL 5C18-P revered phase (RP) C18 column with 0.3%
ammonium acetate, pH 7.4, containing 13% acetonitrile as a solvent. The pyruvylated product eluted
from the column earlier than the educt, as monitored by recording the absorbance at 265 nm [160].
Another option is the use of a RP-C18 column in combination with a 1-propanol gradient in 88% 100
mM ammonium bicarbonate, accompanied by the detection of the nitrophenyl-modified sugar at an
absorbance of 405 nm [7].
A more sophisticated fluorescent polyisoprenoid chemical probe—2-amideaniline-undP-PP-
AAdGal-Gal, which equals an acceptor substrate mimic from the B. fragilis CPS A tetrasaccharide
biosynthesis pathway—was established by Sharma et al. to monitor pyruvylation of the fluorescent
lipid-linked substrate by the pyruvyltransferase WcfO directly by HPLC on a C18 column. An isocratic
gradient of 35% 1-propanol with 65% 100 mM ammonium bicarbonate was used, and detection was
done by fluorescence at excitation at 340 nm, and emission at 390 nm [7].
4.2.3. NMR Analysis of Pyruvylation
Nuclear magnetic resonance (NMR) is a versatile tool for the non-invasive structure elucidation
of bacterial polysaccharides, including substitutions such as pyruvic acid [183], which can be
frequently found as 4,6-O, 3,4-O, or 2,3-O acetals. Systematic investigations of defined pyruvylated
monosaccharides revealed stereospecific repeating patterns from which the absolute configuration of
pyruvic acid acetals can be inferred [184]. It was shown that the 13C signal of an equatorial 4,6-pyruvate
methyl group (Figure 4I,II) resonates at ~26 ppm, while the axial methyl group can be found at
~17 ppm. For 3,4 acetals, the 13C shifts have been studied in detail, and the difference between axial
and equatorial methyl groups was found to be much smaller in comparison to 4,6. The 1H difference,
however, is in this case more noticeable [185]. The ring form of the acetal being either 5- (for 3,4-O) or
6- (for 4,6-O) membered is reflected by 13C shifts [186]. It has also been shown that for most 4,6 acetals,
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the configuration of the methyl group is equatorial, which results in an S configuration for the d-gluco-
and d-manno-pyranosyls and an R configuration for the d-galacto-pyranosyls [187].
Figure 4. I and II, equatorial-oriented methyl groups of 4,6 galacto- and manno-pyranosyls. III,
identification of the attachment site of pyruvylation via hetero multiple bond correlation (HMBC).
IV, through-space correlation of the pyruvate methyl group to a ring proton—in this case H3. Pink
arrows indicate though-bond interactions of neighbouring protons (HMBC), while blue arrows indicate
through-space interactions of neighbouring protons (NOE).
In 1H NMR, the presence of pyruvic acid (4,6-, 3,4-, 2,3-) is usually indicated by a single prominent
signal of the methyl group between 1.3–1.7 ppm, with a threefold higher relative intensity (peak
area) in relation to another indicative signal such as the anomeric proton. For repeating units of
polymers, the peak area of the methyl signal relative to another indicative signal reveals the degree of
pyruvate substitution.
In 13C NMR, the presence of pyruvate substitution is usually indicated by the presence of signals
for the pyruvic methyl group around 17–30 ppm (Figure 4, C3). The quaternary acetal carbon (Figure 4,
C2) resonates in the anomeric region around 100 ppm (for 4,6-O) or 110 ppm (for 3,4-O and 2,3-O).
Additionally, the quaternary signal of the carboxylic acid (Figure 4, C1) can be found between 170 and
180 ppm, with the 4,6-pyruvates present more towards 170 ppm and the 2,3 and 3,4 acetals found
closer to 180 ppm [131].
The connectivity between the pyruvate and a saccharide is routinely determined by the
employment of long-range 1H-13C correlation detection methods such as hetero multiple bond
correlation (HMBC) experiments, which usually give correlation information over three and more
bonds from the corresponding ring protons to the quaternary carbon of the acetal (Figure 4III).
Therefore, 4,6-, 3,4-, or 2,3-pyruvic acetal identification is straightforward. The absolute configuration
of the pyruvic acid acetal can be confirmed by through-space correlation experiments such as 1D or
2D NOESY (nuclear Overhauser and exchange spectroscopy), ROESY (rotating frame Overhauser
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enhancement spectroscopy), or GOESY (gradient nuclear Overhauser and exchange spectroscopy)
(Figure 4, IV) [74,146,188,189].
4.2.4. MS analysis of Pyruvylation
Mass spectrometry in combination with NMR is a very powerful tool to determine the presence
and position of pyruvylation in oligo- or polysaccharides. Common approaches are based on the
break-up of polysaccharides by acid hydrolysis, methanolysis, and then either silylation [59,66] or
acetylation [148], followed by gas chromatography (GC) or electrospray ionization-mass spectrometry
(ESI-MS) analysis of the resulting monosaccharides [190]. Usually, characteristic patterns in the mass
spectrum at the monosaccharide level are observed in the presence of pyruvates, such as a characteristic
fragment ion at m/z 363 (M-COOMe) consistent with a molecular mass of 422, which would be
indicative of a methyl O-(1-carboxyethylidene)hexopyranoside methyl ester di-O-trimethylsilyl-ether.
Comparison of the methylation analysis on native and depyruvylated polysaccharides allows for the
pinning down the initial position of the acetalic linkages. Methanolysis and reductive cleavage have
been described for the analysis of pyruvate-containing polysaccharides [191]. General procedures for
the MS analysis of oligosaccharides have been reviewed in detail elsewhere [192,193].
5. Ketal-Pyruvyltransferases
5.1. Substrate Specificity of Ketal-Pyruvyltransferases
The pyruvyltransferase CsaB from the SCWP biosynthesis pathways of P. alvei [109], the
pyruvyltransferase WcfO from CPS A biosynthesis of B. fragilis [7], and the pyruvyltransferase
Pvg1p from the N-glycan biosynthesis of S. pombe [161] are among the few studied enzyme orthologues.
5.1.1. CsaB from P. alvei
P. alvei CsaB catalyses the pyruvate modification on a β-d-ManNAc residue present in every
SCWP repeat; the resulting 4,6-β-d-ManNAc is the essential epitope for the binding of the bacterium’s
SLH domain-containing S-layer protein SpaA, as revealed from the co-crystal structure of synthetic
pyruvylated ligand with truncated SpaASLH [104,194]. Supporting data comes from isothermal titration
calorimetry, revealing binding between these modules only when the pyruvate entity was present [104].
Notably, a comparable mode of binding is elaborated between the S-layer protein Sap of B. anthracis
and its pyruvylated SCWP [195]. However, poly-pyruvylation, as in the P. alvei SCWP, is not found in
the B. anthracis SCWP, where only the β-d-ManNAc of the terminal repeat is modified [14].
For B. anthracis, a model for a Wzx/Wzy-dependent biosynthesis has been proposed, including
cytoplasmic pyruvylation of the terminal repeating unit; however, the model is without any evidence
of the nature of the acceptor substrate and biochemical proof of CsaB activity [113].
Concerning the pyruvyltransferase CsaB from P. alvei, in an in vitro enzyme assay, the necessity
of a lipid-portion of the acceptor could be unambiguously demonstrated; neither free ManNAc nor
a nucleoside-diphosphate-linked substrate was accepted as a substrate [109]. Using P. alvei TagA
in combination with a synthetic 11-phenoxy-undecyl-PP-α-GlcNAc acceptor and UDP-ManNAc as
substrate, it was demonstrated that TagA is an inverting UDP-α-d-ManNAc:GlcNAc-lipid carrier
transferase of P. alvei. The produced 11-phenoxyundecyl-PP-α-d-GlcNAc-(1→4)-β-d-ManNAc
compound was an acceptor substrate for 4,6-ketalpyruvyl transfer catalysed by recombinant P. alvei
CsaB using PEP as a donor substrate [109], yielding a lipid-PP-linked pyruvylated disaccharide
precursor (Figure 5).
Subsequent steps of SCWP biosynthesis in P. alvei remain elusive, as there is currently neither in
silico nor experimental data available favouring a Wzx/Wzy- or ABC transporter-dependent pathway.
377
Int. J. Mol. Sci. 2019, 20, 4929
Figure 5. In vitro one-pot reaction involving the Paenibacillus alvei enzymes MnaA, TagA, and CsaB in
combination with a synthetic lipid-PP-GlcNAc primer, demonstrating the preference of P. alvei CsaB
for a lipid-PP-linked disaccharide substrate [109]. Pyruvylation (CsaB) is indicated by a star. RU:
repeating unit. Monosaccharide symbols are shown according to the Symbol Nomenclature for Glycans
(SNFG) [45].
5.1.2. WcfO from B. fragilis
The necessity of a lipid-PP-bound substrate for pyruvyltransferase activity is supported by
studies on the pyruvyltransferase WcfO from the B. fragilis CPS A biosynthesis; CPS A is composed of
tetrasaccharide repeats containing an internal 4,6Pyr-Gal residue. On the basis of the stepwise enzymatic
processing of an undp-PP-AAdGalp precursor in vitro, pyruvylation by WcfO was predicted to occur in
the cytoplasm at the stage of the lipid-linked CPS A repeat unit precursor undp-PP-AAdGalp-Gal before
completion of the tetrasaccharide repeat and completion of the CPS A in the periplasm [7,93] (Figure 3).
Importantly, WcfO was inactive on UDP-galactose or pNP-galactose, supporting the requirement of a
lipid-P carrier for pyruvyltransferase activity of WcfO [7].
Enzymatic transfer of pyruvate onto lipid-bound sugar intermediates has also been previously
described in CPS biosynthesis of Rhizobium trifolii [196,197] and in xanthan biosynthesis of Xanthomonas
campestris [31].
5.1.3. Pvg1p from S. pombe
In contrast, the third functionally characterized 4,6-ketal-pyruvyltransferase, Pvg1p from S.
pombe, was proven in vitro with both pNP-β-Gal and pNP-β-lactose serving as suitable acceptor
substrates [160]. According to studies of the pyruvylation mechanism, Pvg1p resides in the membrane
of the Golgi apparatus where it adds the pyruvate moiety to the Gal caps of its N-glycans. For this
purpose, PEP is transported by two transporters, Pet1p and Pet2p, into the lumen of the Golgi apparatus
where it serves as a donor substrate for the pyruvylation reaction [160].
A recent study has determined the crystal structure of the Pvg1p enzyme [160]. Pvg1p consists of 12
α-helices and 12 β-sheets, with 2 α/β/α domains at the N- and C-terminal half regions. Charged surface
representation analysis revealed a positively charged cleft situated between the N- and C-terminal
halves of Pvg1p, which suggests a possible mode of binding that may accommodate the negatively
charged PEP donor substrate. Since neither PEP- nor pNP-β-Gal-co-crystal structures with the enzyme
could be obtained, the empty substrate-binding cleft was used as a scaffold for computational substrate
modelling using PEP [198]. In the proposed computational model, residues R217, R337, L338, and H339
form direct hydrogen bond contacts with PEP. Residues L338, H339, and D240 also appear to function
in maintaining the shape of the PEP-binding pocket via a set of specific interactions. The crystallization
study indicated that the pyruvylation process mimics sialyation; interestingly, Pvg1p shows resistance
to sialidase digestion. Thus, a better characterization of the effects of pyruvylation might facilitate
the development of pharmaceutical glycoproteins [198]. From the same research group, an enzyme
was characterised as a 4,6Pyr-β-d-Gal-releasing enzyme (PyrGal-ase) with specificity for the (1→3)
yeast linkage; mammalian (1→4)-linked PyrGal could not be hydrolysed. The physiological role of the
PyrGal-ase in the Bacillus strain from where it was isolated is currently unknown [199].
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Except for the three characterized pyruvyltransferases, no data on neither the activity nor
the substrate specificity of pyruvyltransferases is available in the literature. This is surprising,
considering that pyruvylation on glycoconjugates is widely distributed in nature. Future research
on ketal-pyruvyltransferases should be directed towards mechanistic investigations of the enzyme’s
mode of catalysis, as well as inhibitor screening, similar to that of the enol-pyruvyltransferase MurA,
which is a prominent target of antibiotics.
5.2. Challenges in Research of Ketal-Pyruvyltransferases
Currently, no definite classification of pyruvyltransferases is possible, although orthologous
enzymes are predicted in various organisms. The Carbohydrate-Active enZYme (CAZy) database
(http://www.cazy.org/) reveals, for instance, putative polysaccharide pyruvyltransferases from
Clostridium stercorarium subsp. stercorarium DSM 8532 and Clostridium thermosuccinogenes DSM
5807 belonging to the glycosyltransferase 4 (GT4) family, with a classification as retaining GT type B
fold-like glycosyltransferases.
The reasons for the limited number of characterised pyruvyltransferases are due to the challenges
faced with the set-up of in vitro enzyme assays. While commercially available PEP has been proven
to be a suitable donor substrate for the transfer of the pyruvyl moiety in distinct cases [7,109,195],
the availability of suitable acceptor substrates is a limiting factor. Free saccharides have not been
recognised as acceptor substrates by the pyruvyltransferases investigated so far [7,109]. According
to our current knowledge, these enzymes instead require more elaborate intermediates from the
pyruvylated glycoconjugate’s biosynthesis pathway. Depending on the glycoconjugate structure and
its mode of biosynthesis—which might be an en bloc (involving an ABC transporter) or sequential
synthesis (involving a Wzx flippase and a Wzy polymerase) according to the terminology introduced for
LPS biosynthesis routes [97,98,138,200], yielding pyruvylation as either a pre- or post-polymerization
modification—di-, tri-, or even oligosaccharide repeating units might be required. Furthermore,
most glycoconjugates are biosynthesized on a membrane-embedded lipid carrier, such as undp-P or
diacylglycerol. Such lipid-linked glycan precursors usually cannot be purified from the natural source
in sufficient quantity and purity because of the high turnover rates and efficient recycling pathways of
these lipid carriers, which are shared between several cellular glycoconjugate biosynthesis pathways,
including that of peptidoglycan [201].
Thus, complex saccharide acceptor substrates are required, which are not commercially available.
These compounds need to be produced along sophisticated and laborious chemical synthesis schemes,
which also need to account for a lipophilic portion, either in the form of the native lipid carrier or a
simplified mimic thereof.
For identifying a suitable acceptor substrate for an in vitro pyruvyltransferase assay, a delicate
balance between the best possible acceptor mimic and solubility needs to be found in order to enable
subsequent analytical procedures. To overcome all these challenges, the development of novel chemical,
enzymatic, or chemo-enzymatic synthesis strategies for acceptor substrate production is a current
major focus in pyruvyltransferase research.
5.3. Sequence Space of Ketal-Pyruvyltransferases
This review aimed at exploring the currently known sequence variation (extant sequence space) of
pyruvyltransferases and their taxonomic distribution on the basis of the three functionally characterized
sequences—P. alvei CsaB (K4ZGN3), S. pombe Pvg1p (Q9UT27), and B. fragilis WcfO (Q5LFK7).
5.3.1. Methods
The best 50 sequence hits of BLAST searches with K4ZGN3_CsaB, Q9UT27_Pvg1p, and
Q5LFK7_WcfO were aligned with MAFFT using the algorithm FFT-NS-2. The three alignments
were then used as queries for hmmsearch [202] on the UniProtKB database, setting significant E-values
for sequences <9.0 × 10−30 and for hits <9.9 × 10−30. Results were restricted to hits showing a
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pyruvyltransferase domain (PS_pyruv_trans domain; Pfam: PF04230). The resulting three sequence
selections were filtered for incomplete sequences and annotated according to their taxonomy using
the online tool SeqScrub [203]. The sequences were further submitted to the Enzyme Function
Initiative-Enzyme Similarity Tool (EFI-EST) [204] with an initial BLAST E-value of 1 × 10−5 to calculate
sequence similarity networks (SSNs). Sequences were restricted to a length between 250 and 600 amino
acids, and the calculated networks were displayed at an alignment score cut-off of 1 × 10−50.
5.3.2. Results
Three independent database searches based on the biochemically characterized
pyruvyltransferases CsaB, Pvg1p, and WcfO resulted in three sequence selections of 2053, 1019,
and 233 sequences, respectively. When comparing these selections, it was found that they did not
share any protein sequences, implicating that the sequence space covered by these searches does not
overlap. It is, therefore, conceivable to assume that more pyruvyltransferase sequences and organisms
harbouring a pyruvyltransferase gene exist, which are not covered in this study. Additionally, the
comparison shows that there are at least three different types of pyruvyltransferases that do not
share a close sequence relationship. Judging from the number of sequences in the selections and
the extent of their taxonomic distribution, pyruvyltransferases from the SSN of CsaB (CsaB-like),
and pyruvyltransferases from the SSN of Pvg1P (Pvg1P-like) seem to be the most common types
of pyruvyltransferases, while WcfO-like pyruvyltransferases might be more of a specialized type
of pyruvyltransferase.
Looking at the taxonomic distribution of these types of pyruvyltransferases in the SSNs (Figure 6),
it can be seen that CsaB-like pyruvyltransferases occurred mainly in the phyla of Firmicutes and
Cyanobacteria; Pvg1p-like pyruvyltransferases occurred mainly in the phyla of Proteobacteria and
Firmicutes; and WcfO-like pyruvyltransferases occurred almost exclusively in the phyla of Bacteroidetes,
Proteobacteria, and Firmicutes. In most cases, these different phyla separated nicely into different clades.
For the SSN of Pvg1p-like pyruvyltransferases, however, there were two clusters where Proteobacteria
were heavily mixed with Firmicutes and Bacteroidetes, and in the SSN of WcfO-like pyruvyltransferases,
Proteobacteria were found to be heavily mixed with Bacteroidetes. Such mixed sequence populations
might occur because of the high rates of lateral gene transfer among Proteobacteria [173]. Looking across
all three SSNs, there was typically only one major cluster for each phylum. The only exception was
pyruvyltransferase sequences from Firmicutes, which showed multiple big clusters in all three SSNs,
indicating that Firmicutes might carry multiple types of pyruvyltransferases.
 
Figure 6. Sequence similarity networks illustrating the extant sequence space around Paenibacillus alvei
CsaB (K4ZGN3), Schizosaccharomyces pombe Pvg1p (Q9UT27), and Bacteroides fragilis WcfO (Q5LFK7).
The three characterized sequences—CsaB, Pvg1p, and WcfO—are highlighted by yellow circles.
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Analysing the functionally characterized pyruvyltransferase CsaB in the context of its surrounding
sequence space showed the enzyme to be a typical representative of the biggest cluster (Firmicutes) in the
CsaB-like SSN. The same goes for WcfO, which was also found within the biggest cluster (Bacteroidetes
and Proteobacteria) of the WcfO-like SSN. Pvg1p, on the other hand, was found at the border of a
minor Ascomycota clade in the Pvg1p-like network and, therefore, cannot be considered a typical
representative of this network. It is interesting to note, however, that Pvg1p is a pyruvyltransferase
from the fungal phylum of Ascomycota, but the sequence search based on Pvg1p resulted mainly in
bacterial sequences from Proteobacteria and Firmicutes, rather than other fungal sequences.
In addition to CsaB, Pvg1p, and WcfO, this review further discussed 48 putative
pyruvyltransferases, and about half of their corresponding amino acid sequences were present
within the calculated SSNs. Possible reasons for this incomplete recovery of sequences in the SSNs
were the lack of genome sequencing data, missing or faulty taxonomic annotation of sequences, and
the fragmentary coverage of the pyruvyltransferase sequence space in the performed SSN analysis.
Note that this study refrained from removing sequences showing 100% sequence identities (possible
duplicates), meaning that the utilized datasets included all currently known pyruvyl-transferase entries
found under the given search parameters on UniProtKB. It is inevitable that this leads to a possible
bias in sequence counts towards organisms that are more heavily sequenced than others, but at the
same time, it guarantees the representation of the full taxonomic distribution of pyruvyltransferases.
From these datasets, the phyla Firmicutes, Proteobacteria, Cyanobacteria, and Bacteroidetes were found to
be the phyla where pyruvyltransferases are most common.
From this study, it is evident that the pyruvyltransferase sequences available in public
databases are extremely diverse, and without the availability of further biochemically characterized
pyruvyltransferases, predictions of pyruvyltransferases based on amino acid sequences have to be
interpreted with care.
6. Discussion
Pyruvyltransferases are a widespread but little investigated class of carbohydrate-active enzymes,
which transfer a pyruvate moiety from a PEP donor to various monosaccharide targets (Table 1).
This leads to a wealth of glycoconjugates carrying this modification. Pyruvylation can be found in almost
all classes of glycoconjugates—including EPS, CPS, CA, LPS, LOS, SCWP, and N-glycans—occurring
in bacteria, algae, and yeast, but not in humans. Importantly, pyruvylation imparts an anionic
character to the glycoconjugates, which is pivotal to many biological functions. Described functions
include the influence on the viscosity of the EPS, bacterial symbiosis with plants [18,28,46],
immunostimulatory effects (mostly of CPSs [7,93]), employment of sialylation-like properties
in human-type oligosaccharides [198], and cell wall anchoring relying on the Pyr-β-d-ManNAc
epitope [14,99,104,195], to name a few. However, learning more about the biological significance
of pyruvylated glycoconjugates and delineating a possible association between the position of
pyruvylation and functionality are remaining challenges for future research.
Regrettably, for most of the described pyruvylated glycoconjugates, the genetic determinants of
the modification are unknown because of missing genome sequencing data of the respective organisms.
Given the widespread occurrence and the importance of sugar pyruvylation in nature, there is a
high interest in the research community to identify pyruvyltransferases and gain insight into the
mechanism of pyruvylation, especially with regard to the high potential to reveal novel functions and
drug target points.
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Up until now, three orthologous pyruvyltransferases have been biochemically investigated [7,111,161].
However, they do not show any close sequence relationship (compare with Figure 6). This finding
might point towards a convergent evolution of pyruvyltransferases or a very high evolutionary rate that
underlines the high sequence variability present in this enzyme class. The SSNs established within the
frame of this review indicate that the described sequence space around the three hitherto characterized
sequences was not sufficient to cover the whole extent of sequence variation of pyruvyltransferases. Based
on the currently available sequence information, pyruvyltransferases mainly occur in bacterial phyla of
Firmicutes, Proteobacteria, Cyanobacteria, and Bacteroidetes, and to a lesser extent in eukaryotic species.
Given the relentless spread of antibiotic-resistant organisms, new chemotherapeutic strategies to
overcome infections could be based on intervening in the mechanisms of pyruvylation, an enzymatic
modification detected in almost all classes of cell envelope glycoconjugates.
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